-- phpMyAdmin SQL Dump
-- version 3.5.7
-- http://www.phpmyadmin.net
--
-- Host: localhost
-- Generation Time: Aug 19, 2019 at 04:19 PM
-- Server version: 5.1.73
-- PHP Version: 5.3.9

SET SQL_MODE="NO_AUTO_VALUE_ON_ZERO";
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;

--
-- Database: `reverse_dock`
--

-- --------------------------------------------------------

--
-- Table structure for table `targets`
--

CREATE TABLE IF NOT EXISTS `targets` (
  `protID` char(12) NOT NULL,
  `pdbID` char(4) NOT NULL,
  `hasLig` tinyint(1) DEFAULT NULL,
  `resolu` float DEFAULT NULL,
  `chain` varchar(64) DEFAULT NULL,
  `resiNum` int(11) DEFAULT NULL,
  `classification` varchar(64) DEFAULT NULL,
  `class` varchar(64) DEFAULT NULL,
  `prot_name` varchar(128) DEFAULT NULL,
  `gene_name` varchar(16) DEFAULT NULL,
  `catalytics` varchar(800) DEFAULT NULL,
  `mol_func` varchar(1280) DEFAULT NULL,
  `bio_process` varchar(6500) DEFAULT NULL,
  `pfam` varchar(16) DEFAULT NULL,
  `sequence` varchar(5000) DEFAULT NULL
) ENGINE=MyISAM DEFAULT CHARSET=latin1;

--
-- Dumping data for table `targets`
--

INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('Q00653', '1A3Q', 0, 2.1, 'A/B', 291, 'TRANSCRIPTION / DNA', 'TRANSCRIPTION', 'Nuclear factor NF-kappa-B p100 subunit', 'NFKB2', '', 'chromatin binding<br />\nRNA polymerase II core promoter proximal region sequence-specific DNA binding<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscription coactivator activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\n', 'aging<br />\nextracellular matrix organization<br />\nfollicular dendritic cell differentiation<br />\ngerminal center formation<br />\nI-kappaB kinase/NF-kappaB signaling<br />\ninflammatory response<br />\ninnate immune response<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nNIK/NF-kappaB signaling<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of type I interferon production<br />\nregulation of transcription, DNA-templated<br />\nresponse to cytokine<br />\nresponse to lipopolysaccharide<br />\nrhythmic process<br />\nspleen development<br />\n', 'PF12796.', 'MESCYNPGLDGIIEYDDFKLNSSIVEPKEPAPETADGPYLVIVEQPKQRGFRFRYGCEGPSHGGLPGASSEKGRKTYPTVKICNYEGPAKIEVDLVTHSDPPRAHAHSLVGKQCSELGICAVSVGPKDMTAQFNNLGVLHVTKKNMMGTMIQKLQRQRLRSRPQGLTEAEQRELEQEAKELKKVMDLSIVRLRFSAFLRASDGSFSLPLKPVISQPIHDSKSPGASNLKISRMDKTAGSVRGGDEVYLLCDKVQKDDIEVRFYEDDENGWQAFGDFSPTDVHKQYAIVFRTPPYHKMKIERPVTVFLQLKRKRGGDVSDSKQFTYYPLVEDKEEVQRKRRKALPTFSQPFGGGSHMGGGSGGAAGGYGGAGGGGSLGFFPSSLAYSPYQSGAGPMGCYPGGGGGAQMAATVPSRDSGEEAAEPSAPSRTPQCEPQAPEMLQRAREYNARLFGLAQRSARALLDYGVTADARALLAGQRHLLTAQDENGDTPLHLAIIHGQTSVIEQIVYVIHHAQDLGVVNLTNHLHQTPLHLAVITGQTSVVSFLLRVGADPALLDRHGDSAMHLALRAGAGAPELLRALLQSGAPAVPQLLHMPDFEGLYPVHLAVRARSPECLDLLVDSGAEVEATERQGGRTALHLATEMEELGLVTHLVTKLRANVNARTFAGNTPLHLAAGLGYPTLTRLLLKAGADIHAENEEPLCPLPSPPTSDSDSDSEGPEKDTRSSFRGHTPLDLTCSTKVKTLLLNAAQNTMEPPLTPPSPAGPGLSLGDTALQNLEQLLDGPEAQGSWAELAERLGLRSLVDTYRQTTSPSGSLLRSYELAGGDLAGLLEALSDMGLEEGVRLLRGPETRDKLPSTAEVKEDSAYGSQSVEQEAEKLGPPPEPPGGLCHGHPQPQVH'),
('P11586', '1A4I', 1, 1.5, 'A/B', 301, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'C-1-tetrahydrofolate synthase, cytoplasmic', 'MTHFD1', '5,10-methylenetetrahydrofolate + NADP+ = 5,10-methenyltetrahydrofolate + NADPH.<br />\n5,10-methenyltetrahydrofolate + H2O = 10-formyltetrahydrofolate.<br />\nATP + formate + tetrahydrofolate = ADP + phosphate + 10-formyltetrahydrofolate.<br />\n', 'ATP binding<br />\nformate-tetrahydrofolate ligase activity<br />\nmethenyltetrahydrofolate cyclohydrolase activity<br />\nmethylenetetrahydrofolate dehydrogenase (NAD+) activity<br />\nmethylenetetrahydrofolate dehydrogenase (NADP+) activity<br />\nmethylenetetrahydrofolate dehydrogenase [NAD(P)+] activity<br />\n', '10-formyltetrahydrofolate biosynthetic process<br />\nembryonic neurocranium morphogenesis<br />\nembryonic viscerocranium morphogenesis<br />\nfolic acid metabolic process<br />\nheart development<br />\nhistidine biosynthetic process<br />\nmethionine biosynthetic process<br />\nmethionine metabolic process<br />\nneural tube closure<br />\nneutrophil homeostasis<br />\none-carbon metabolic process<br />\npurine nucleobase biosynthetic process<br />\npurine nucleotide biosynthetic process<br />\nserine family amino acid biosynthetic process<br />\nserine family amino acid metabolic process<br />\nsomite development<br />\ntetrahydrofolate interconversion<br />\ntranssulfuration<br />\n', 'PF01268.', 'MAPAEILNGKEISAQIRARLKNQVTQLKEQVPGFTPRLAILQVGNRDDSNLYINVKLKAAEEIGIKATHIKLPRTTTESEVMKYITSLNEDSTVHGFLVQLPLDSENSINTEEVINAIAPEKDVDGLTSINAGRLARGDLNDCFIPCTPKGCLELIKETGVPIAGRHAVVVGRSKIVGAPMHDLLLWNNATVTTCHSKTAHLDEEVNKGDILVVATGQPEMVKGEWIKPGAIVIDCGINYVPDDKKPNGRKVVGDVAYDEAKERASFITPVPGGVGPMTVAMLMQSTVESAKRFLEKFKPGKWMIQYNNLNLKTPVPSDIDISRSCKPKPIGKLAREIGLLSEEVELYGETKAKVLLSALERLKHRPDGKYVVVTGITPTPLGEGKSTTTIGLVQALGAHLYQNVFACVRQPSQGPTFGIKGGAAGGGYSQVIPMEEFNLHLTGDIHAITAANNLVAAAIDARIFHELTQTDKALFNRLVPSVNGVRRFSDIQIRRLKRLGIEKTDPTTLTDEEINRFARLDIDPETITWQRVLDTNDRFLRKITIGQAPTEKGHTRTAQFDISVASEIMAVLALTTSLEDMRERLGKMVVASSKKGEPVSAEDLGVSGALTVLMKDAIKPNLMQTLEGTPVFVHAGPFANIAHGNSSIIADRIALKLVGPEGFVVTEAGFGADIGMEKFFNIKCRYSGLCPHVVVLVATVRALKMHGGGPTVTAGLPLPKAYIQENLELVEKGFSNLKKQIENARMFGIPVVVAVNAFKTDTESELDLISRLSREHGAFDAVKCTHWAEGGKGALALAQAVQRAAQAPSSFQLLYDLKLPVEDKIRIIAQKIYGADDIELLPEAQHKAEVYTKQGFGNLPICMAKTHLSLSHNPEQKGVPTGFILPIRDIRASVGAGFLYPLVGTMSTMPGLPTRPCFYDIDLDPETEQVNGLF'),
('Q44532', '1A8P', 1, 2, 'A', 258, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Ferredoxin--NADP reductase', 'fpr', '2 reduced ferredoxin + NADP+ + H+ = 2 oxidized ferredoxin + NADPH<br />\n', 'ferredoxin-NADP+ reductase activity<br />\n', '', 'PF00970.', 'MSNLNVERVLSVHHWNDTLFSFKTTRNPSLRFENGQFVMIGLEVDGRPLMRAYSIASPNYEEHLEFFSIKVQNGPLTSRLQHLKEGDELMVSRKPTGTLVTSDLLPGKHLYMLSTGTGLAPFMSLIQDPEVYERFEKVVLIHGVRQVNELAYQQFITEHLPQSEYFGEAVKEKLIYYPTVTRESFHNQGRLTDLMRSGKLFEDIGLPPINPQDDRAMICGSPSMLDESCEVLDGFGLKISPRMGEPGDYLIERAFVEK'),
('O31168', '1A8U', 1, 1.6, 'A/B', 277, 'HALOPEROXIDASE', 'OXIDOREDUCTASE', 'Non-heme chloroperoxidase', 'cpo', 'RH + Cl- + H2O2 = RCl + 2 H2O.<br />\n', 'chloride peroxidase activity<br />\n', '', 'PF00561.', 'MPFITVGQENSTSIDLYYEDHGAGQPVVLIHGFPLSGHSWERQSAALLDAGYRVITYDRRGFGQSSQPTTGYDYDTFAADLNTVLETLDLQDAVLVGFSMGTGEVARYVSSYGTARIAKVAFLASLEPFLLKTDDNPDGAAPKEFFDGIVAAVKADRYAFYTGFFNDFYNLDENLGTRISEEAVRNSWNTAASGGFFAAAAAPTTWYTDFRADIPRIDVPALILHGTGDRTLPIENTARVFHKALPSAEYVEVEGAPHGLLWTHAEEVNTALLAFLAK'),
('P0AC13', '1AJ0', 1, 2, 'A', 282, 'SYNTHASE', 'OTHERS', 'Dihydropteroate synthase', 'folP', '6-hydroxymethyl-7,8-dihydropterin diphosphate + 4-aminobenzoate = diphosphate + dihydropteroate<br />\n', 'dihydropteroate synthase activity<br />\nmetal ion binding<br />\n', 'folic acid biosynthetic process<br />\nresponse to drug<br />\ntetrahydrofolate biosynthetic process<br />\n', 'PF00809.', 'MKLFAQGTSLDLSHPHVMGILNVTPDSFSDGGTHNSLIDAVKHANLMINAGATIIDVGGESTRPGAAEVSVEEELQRVIPVVEAIAQRFEVWISVDTSKPEVIRESAKVGAHIINDIRSLSEPGALEAAAETGLPVCLMHMQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEQAGIAKEKLLLDPGFGFGKNLSHNYSLLARLAEFHHFNLPLLVGMSRKSMIGQLLNVGPSERLSGSLACAVIAAMQGAHIIRVHDVKETVEAMRVVEATLSAKENKRYE'),
('P03706', '1AM7', 0, 2.3, 'A/B/C', 158, 'GLYCOSIDASE', 'OTHERS', 'Endolysin', 'R', 'Endolytic cleavage of the (1->4)-beta-glycosidic linkage between N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc) residues in peptidoglycan with concomitant formation of a 1,6-anhydrobond in the MurNAc residue<br />\n', 'lyase activity<br />\nlysozyme activity<br />\nlytic transglycosylase activity<br />\n', 'cell wall macromolecule catabolic process<br />\ncytolysis<br />\ncytolysis by virus of host cell<br />\ndefense response to bacterium<br />\npeptidoglycan catabolic process<br />\n', 'PF00959.', 'MVEINNQRKAFLDMLAWSEGTDNGRQKTRNHGYDVIVGGELFTDYSDHPRKLVTLNPKLKSTGAGRYQLLSRWWDAYRKQLGLKDFSPKSQDAVALQQIKERGALPMIDRGDIRQAIDRCSNIWASLPGAGYGQFEHKADSLIAKFKEAGGTVREIDV'),
('P28593', '1AOG', 1, 2.3, 'A/B', 485, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Trypanothione reductase', 'TPR', 'Trypanothione + NADP+ = trypanothione disulfide + NADPH.<br />\n', 'electron carrier activity<br />\nflavin adenine dinucleotide binding<br />\ntrypanothione-disulfide reductase activity<br />\n', 'cell redox homeostasis<br />\n', 'PF07992.', 'MMSKIFDLVVIGAGSGGLEAAWNAATLYKKRVAVIDVQMVHGPPFFSALGGTCVNVGCVPKKLMVTGAQYMEHLRESAGFGWEFDRTTLRAEWKKLIAVKDEAVLNINKSYEEMFRDTEGLEFFLGWGSLESKNVVNVRESADPASAVKERLETENILLASGSWPHMPNIPGIEHCISSNEAFYLPEPPRRVLTVGGGFISVEFAGIFNAYKPKDGQVTLCYRGEMILRGFDHTLREELTKQLTANGIQILTKENPAKVELNADGSKSVTFESGKKMDFDLVMMAIGRSPRTKDLQLQNAGVMIKNGGVQVDEYSRTNVSNIYAIGDVTNRVMLTPVAINEAAALVDTVFGTNPRKTDHTRVASAVFSIPPIGTCGLIEEVASKRYEVVAVYLSSFTPLMHNISGSKYKTFVAKIITNHSDGTVLGVHLLGDNAPEIIQGVGICLKLNAKISDFYNTIGVHPTSAEELCSMRTPSYYYVKGEKMEKPSEASL'),
('P23367', '1B63', 1, 1.9, 'A', 331, 'DNA MISMATCH REPAIR', 'OTHERS', 'DNA mismatch repair protein MutL', 'mutL', '', 'ATPase activity<br />\nATP binding<br />\nDNA binding<br />\nidentical protein binding<br />\nmismatched DNA binding<br />\nsingle-stranded DNA binding<br />\n', 'mismatch repair<br />\nregulation of DNA recombination<br />\n', 'PF01119.', 'MPIQVLPPQLANQIAAGEVVERPASVVKELVENSLDAGATRIDIDIERGGAKLIRIRDNGCGIKKDELALALARHATSKIASLDDLEAIISLGFRGEALASISSVSRLTLTSRTAEQQEAWQAYAEGRDMNVTVKPAAHPVGTTLEVLDLFYNTPARRKFLRTEKTEFNHIDEIIRRIALARFDVTINLSHNGKIVRQYRAVPEGGQKERRLGAICGTAFLEQALAIEWQHGDLTLRGWVADPNHTTPALAEIQYCYVNGRMMRDRLINHAIRQACEDKLGADQQPAFVLYLEIDPHQVDVNVHPAKHEVRFHQSRLVHDFIYQGVLSVLQQQLETPLPLDDEPQPAPRSIPENRVAAGRNHFAEPAAREPVAPRYTPAPASGSRPAAPWPNAQPGYQKQQGEVYRQLLQTPAPMQKLKAPEPQEPALAANSQSFGRVLTIVHSDCALLERDGNISLLSLPVAERWLRQAQLTPGEAPVCAQPLLIPLRLKVSAEEKSALEKAQSALAELGIDFQSDAQHVTIRAVPLPLRQQNLQILIPELIGYLAKQSVFEPGNIAQWIARNLMSEHAQWSMAQAITLLADVERLCPQLVKTPPGGLLQSVDLHPAIKALKDE'),
('P34896', '1BJ4', 1, 2.65, 'A', 470, 'TRANSFERASE', 'TRANSFERASE', 'Serine hydroxymethyltransferase, cytosolic', 'SHMT1', '5,10-methylenetetrahydrofolate + glycine + H2O = tetrahydrofolate + L-serine<br />\n', 'glycine hydroxymethyltransferase activity<br />\nidentical protein binding<br />\nL-allo-threonine aldolase activity<br />\nmRNA 5''-UTR binding<br />\nprotein homodimerization activity<br />\npyridoxal phosphate binding<br />\nserine binding<br />\ntranslation repressor activity, nucleic acid binding<br />\n', 'carnitine biosynthetic process<br />\ncellular response to leukemia inhibitory factor<br />\ncellular response to tetrahydrofolate<br />\ndTMP biosynthetic process<br />\nfolic acid metabolic process<br />\nglycine biosynthetic process from serine<br />\nglycine metabolic process<br />\nL-serine catabolic process<br />\nL-serine metabolic process<br />\nnegative regulation of translation<br />\nprotein homotetramerization<br />\nprotein tetramerization<br />\npurine nucleobase biosynthetic process<br />\ntetrahydrofolate interconversion<br />\ntetrahydrofolate metabolic process<br />\n', '', 'MTMPVNGAHKDADLWSSHDKMLAQPLKDSDVEVYNIIKKESNRQRVGLELIASENFASRAVLEALGSCLNNKYSEGYPGQRYYGGTEFIDELETLCQKRALQAYKLDPQCWGVNVQPYSGSPANFAVYTALVEPHGRIMGLDLPDGGHLTHGFMTDKKKISATSIFFESMPYKVNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHISGLVAAGVVPSPFEHCHVVTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLINSAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQVVANCRALSEALTELGYKIVTGGSDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGLLEKDFQKVAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGDKYQAAVQALREEVESFASLFPLPGLPDF'),
('P62942', '1BKF', 1, 1.6, 'A', 107, 'ISOMERASE', 'ISOMERASE', 'Peptidyl-prolyl cis-trans isomerase FKBP1A', 'FKBP1A', 'Peptidylproline (omega=180) = peptidylproline (omega=0)<br />\n', 'activin binding<br />\nenzyme binding<br />\nFK506 binding<br />\nHsp70 protein binding<br />\nion channel binding<br />\nmacrolide binding<br />\npeptidyl-prolyl cis-trans isomerase activity<br />\nprotein homodimerization activity<br />\nsignal transducer activity<br />\nSMAD binding<br />\ntransforming growth factor beta receptor binding<br />\ntype I transforming growth factor beta receptor binding<br />\n', '''de novo'' protein folding<br />\namyloid fibril formation<br />\ncalcium ion transmembrane transport<br />\nchaperone-mediated protein folding<br />\ncytokine-mediated signaling pathway<br />\nheart morphogenesis<br />\nheart trabecula formation<br />\nmuscle contraction<br />\nnegative regulation of phosphoprotein phosphatase activity<br />\nnegative regulation of protein phosphorylation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of protein binding<br />\npositive regulation of protein ubiquitination<br />\nprotein folding<br />\nprotein maturation by protein folding<br />\nprotein peptidyl-prolyl isomerization<br />\nprotein refolding<br />\nregulation of activin receptor signaling pathway<br />\nregulation of amyloid precursor protein catabolic process<br />\nregulation of immune response<br />\nregulation of protein localization<br />\nregulation of ryanodine-sensitive calcium-release channel activity<br />\nrelease of sequestered calcium ion into cytosol<br />\nresponse to caffeine<br />\nresponse to iron ion<br />\nSMAD protein complex assembly<br />\nsupramolecular fiber organization<br />\nT cell activation<br />\nT cell proliferation<br />\ntransforming growth factor beta receptor signaling pathway<br />\nventricular cardiac muscle tissue morphogenesis<br />\n', 'PF00254.', 'MGVQVETISPGDGRTFPKRGQTCVVHYTGMLEDGKKFDSSRDRNKPFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYGATGHPGIIPPHATLVFDVELLKLE'),
('Q06319', '1BUC', 1, 2.5, 'A/B', 383, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Acyl-CoA dehydrogenase, short-chain specific', 'N/A', NULL, 'acyl-CoA dehydrogenase activity<br />\r\nbutyryl-CoA dehydrogenase activity<br />\r\nflavin adenine dinucleotide binding', 'fatty acid metabolic process', 'PF00441.', 'MDFNLTDIQQDFLKLAHDFGEKKLAPTVTERDHKGIYDKELIDELLSLGI\rTGAYFEEKYGGSGDDGGDVLSYILAVEELAKYDAGVAITLSATVSLCANP\rIWQFGTEAQKEKFLVPLVEGTKLGAFGLTEPNAGTDASGQQTIATKNDDG\rTYTLNGSKIFITNGGAADIYIVFAMTDKSKGNHGITAFILEDGTPGFTYG\rKKEDKMGIHTSQTMELVFQDVKVPAENMLGEEGKGFKIAMMTLDGGRIGV\rAAQALGIAEAALADAVEYSKQRVQFGKPLCKFQSISFKLADMKMQIEAAR\rNLVYKAACKKQEGKPFTVDAAIAKRVASDVAMRVTTEAVQIFGGYGYSEE\rYPVARHMRDAKITQIYEGTNEVQLMVTGGALLR'),
('P55263', '1BX4', 1, 1.5, 'A', 341, 'TRANSFERASE', 'TRANSFERASE', 'Adenosine kinase', 'ADK', 'ATP + adenosine = ADP + AMP.<br />\n', 'adenosine kinase activity<br />\nATP binding<br />\nmetal ion binding<br />\nRNA binding<br />\n', 'adenosine salvage<br />\nAMP salvage<br />\ndATP biosynthetic process<br />\npurine-containing compound salvage<br />\nribonucleoside monophosphate biosynthetic process<br />\n', 'PF00294.', 'MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH'),
('O67135', '1C3R', 1, 2, 'A/B', 375, 'LYASE', 'LYASE', 'UDP-N-acetylglucosamine 1-carboxyvinyltransferase', 'murA', 'Phosphoenolpyruvate + UDP-N-acetyl-alpha-D-glucosamine = phosphate + UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine.', 'UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity', 'cell cycle<br />\r\ncell division<br />\r\ncell wall organization<br />\r\npeptidoglycan biosynthetic process<br />\r\nregulation of cell shape<br />\r\nUDP-N-acetylgalactosamine biosynthetic process<br />', 'PF00275.', 'MKNTTLYTYRDYFVIRGGKPLTGKVKISGAKNAALPIMFATILTEEPCTI\r\nTNVPDLLDVRNTLLLLRELGAELEFLNNTVFINPSINSFITNQEIIRRMR\r\nASVLSLGPLLGRFGRAVVGLPGGCSIGARPIDQHLKFFKEAGADVEVREG\r\nYVYVNLKEKRRVHFKFDLVTVTGTENALLYLASVPEESILENIALEPEVM\r\nDLIEVLKKMGAHVKVEGRSAYVKGSENLKGFTHSVIPDRIEAGTFMVGAV\r\nLTDGEILLENARINHLRAVVEKLKLIGGEVVEENGNLRVFRKESLRACDI\r\nETQVYPGFPTDMQAQFMALLSVAKGKSRIKENIFEHRFHHAQELNRLGAN\r\nITVRGNTAYVEGVERLYGSEVYSTDLRASASLVLAGLVAQGETVVRDVYH\r\nLDRGYEKLEEKLKKLGADIERVSELI\r\nTNVPDLLDVRNTLLLLRELGAELEFLNNTVFINPSINSFITNQEIIRRMR\r\nASVLSLGPLLGRFGRAVVGLPGGCSIGARPIDQHLKFFKEAGADVEVREG\r\nYVYVNLKEKRRVHFKFDLVTVTGTENALLYLASVPEESILENIALEPEVM\r\nDLIEVLKKMGAHVKVEGRSAYVKGSENLKGFTHSVIPDRIEAGTFMVGAV\r\nLTDGEILLENARINHLRAVVEKLKLIGGEVVEENGNLRVFRKESLRACDI\r\nETQVYPGFPTDMQAQFMALLSVAKGKSRIKENIFEHRFHHAQELNRLGAN\r\nITVRGNTAYVEGVERLYGSEVYSTDLRASASLVLAGLVAQGETVVRDVYH\r\nLDRGYEKLEEKLKKLGADIERVSEL'),
('Q13126', '1CB0', 1, 1.7, 'A', 283, 'TRANSFERASE', 'TRANSFERASE', 'S-methyl-5''-thioadenosine phosphorylase', 'MTAP', 'S-methyl-5''-thioadenosine + phosphate = adenine + S-methyl-5-thio-alpha-D-ribose 1-phosphate<br />\n', 'phosphorylase activity<br />\nS-methyl-5-thioadenosine phosphorylase activity<br />\n', 'interleukin-12-mediated signaling pathway<br />\nL-methionine salvage from methylthioadenosine<br />\nnucleobase-containing compound metabolic process<br />\npurine ribonucleoside salvage<br />\n', 'PF01048.', 'MASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH'),
('P47712', '1CJY', 1, 2.5, 'A/B', 749, 'HYDROLASE', 'HYDROLASE', 'Cytosolic phospholipase A2', 'PLA2G4A', 'Phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate.<br />\n2-lysophosphatidylcholine + H2O = glycerophosphocholine + a carboxylate.<br />\n', 'calcium-dependent phospholipase A2 activity<br />\ncalcium-dependent phospholipid binding<br />\ncalcium ion binding<br />\nlysophospholipase activity<br />\nphosphatidylcholine 1-acylhydrolase activity<br />\nphospholipase A2 activity<br />\nphospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)<br />\nphospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)<br />\n', 'arachidonic acid metabolic process<br />\narachidonic acid secretion<br />\ncardiolipin acyl-chain remodeling<br />\ncellular response to antibiotic<br />\nicosanoid biosynthetic process<br />\nicosanoid metabolic process<br />\nphosphatidic acid biosynthetic process<br />\nphosphatidylcholine acyl-chain remodeling<br />\nphosphatidylethanolamine acyl-chain remodeling<br />\nphosphatidylglycerol acyl-chain remodeling<br />\nphosphatidylinositol acyl-chain remodeling<br />\nphosphatidylserine acyl-chain remodeling<br />\nphospholipid catabolic process<br />\nphospholipid metabolic process<br />\nplatelet activating factor biosynthetic process<br />\nregulation of cell proliferation<br />\n', 'PF00168.', 'MSFIDPYQHIIVEHQYSHKFTVVVLRATKVTKGAFGDMLDTPDPYVELFISTTPDSRKRTRHFNNDINPVWNETFEFILDPNQENVLEITLMDANYVMDETLGTATFTVSSMKVGEKKEVPFIFNQVTEMVLEMSLEVCSCPDLRFSMALCDQEKTFRQQRKEHIRESMKKLLGPKNSEGLHSARDVPVVAILGSGGGFRAMVGFSGVMKALYESGILDCATYVAGLSGSTWYMSTLYSHPDFPEKGPEEINEELMKNVSHNPLLLLTPQKVKRYVESLWKKKSSGQPVTFTDIFGMLIGETLIHNRMNTTLSSLKEKVNTAQCPLPLFTCLHVKPDVSELMFADWVEFSPYEIGMAKYGTFMAPDLFGSKFFMGTVVKKYEENPLHFLMGVWGSAFSILFNRVLGVSGSQSRGSTMEEELENITTKHIVSNDSSDSDDESHEPKGTENEDAGSDYQSDNQASWIHRMIMALVSDSALFNTREGRAGKVHNFMLGLNLNTSYPLSPLSDFATQDSFDDDELDAAVADPDEFERIYEPLDVKSKKIHVVDSGLTFNLPYPLILRPQRGVDLIISFDFSARPSDSSPPFKELLLAEKWAKMNKLPFPKIDPYVFDREGLKECYVFKPKNPDMEKDCPTIIHFVLANINFRKYRAPGVPRETEEEKEIADFDIFDDPESPFSTFNFQYPNQAFKRLHDLMHFNTLNNIDVIKEAMVESIEYRRQNPSRCSVSLSNVEARRFFNKEFLSKPKA'),
('P22637', '1COY', 1, 1.8, 'A', 507, 'OXIDOREDUCTASE(OXYGEN RECEPTOR)', 'OXIDOREDUCTASE', 'Cholesterol oxidase', 'choB', 'Cholesterol + O2 = cholest-5-en-3-one + H2O2.<br />\nA 3-oxo-Delta5-steroid = a 3-oxo-Delta4-steroid.<br />\n', 'cholesterol oxidase activity<br />\nflavin adenine dinucleotide binding<br />\nsteroid delta-isomerase activity<br />\n', 'cholesterol metabolic process<br />\n', 'PF05199.', 'MTDSRANRADATRGVASVSRRRFLAGAGLTAGAIALSSMSTSASAAPSRTLADGDRVPALVIGSGYGGAVAALRLTQAGIPTQIVEMGRSWDTPGSDGKIFCGMLNPDKRSMWLADKTDQPVSNFMGFGINKSIDRYVGVLDSERFSGIKVYQGRGVGGGSLVNGGMAVTPKRNYFEEILPSVDSNEMYNKYFPRANTGLGVNNIDQAWFESTEWYKFARTGRKTAQRSGFTTAFVPNVYDFEYMKKEAAGQVTKSGLGGEVIYGNNAGKKSLDKTYLAQAAATGKLTITTLHRVTKVAPATGSGYSVTMEQIDEQGNVVATKVVTADRVFFAAGSVGTSKLLVSMKAQGHLPNLSSQVGEGWGNNGNIMVGRANHMWDATGSKQATIPTMGIDNWADPTAPIFAEIAPLPAGLETYVSLYLAITKNPERARFQFNSGTGKVDLTWAQSQNQKGIDMAKKVFDKINQKEGTIYRTDLFGVYFKTWGDDFTYHPLGGVLLNKATDNFGRLPEYPGLYVVDGSLVPGNVGVNPFVTITRLAERNMDKIISSDIQ'),
('P39662', '1CQX', 1, 1.75, 'A/B', 403, 'LIPID BINDING PROTEIN', 'OTHERS', 'Flavohemoprotein', 'hmp', '2 nitric oxide + 2 O2 + NAD(P)H = 2 nitrate + NAD(P)+ + H+<br />\n', 'FAD binding<br />\nheme binding<br />\nmetal ion binding<br />\nnitric oxide dioxygenase activity<br />\noxygen binding<br />\noxygen transporter activity<br />\n', 'response to nitrosative stress<br />\nresponse to toxic substance<br />\n', 'PF00970.', 'MLTQKTKDIVKATAPVLAEHGYDIIKCFYQRMFEAHPELKNVFNMAHQEQGQQQQALARAVYAYAENIEDPNSLMAVLKNIANKHASLGVKPEQYPIVGEHLLAAIKEVLGNAATDDIISAWAQAYGNLADVLMGMESELYERSAEQPGGWKGWRTFVIREKRPESDVITSFILEPADGGPVVNFEPGQYTSVAIDVPALGLQQIRQYSLSDMPNGRSYRISVKREGGGPQPPGYVSNLLHDHVNVGDQVKLAAPYGSFHIDVDAKTPIVLISGGVGLTPMVSMLKVALQAPPRQVVFVHGARNSAVHAMRDRLREAAKTYENLDLFVFYDQPLPEDVQGRDYDYPGLVDVKQIEKSILLPDADYYICGPIPFMRMQHDALKNLGIHEARIHYEVFGPDLFAE'),
('P04278', '1D2S', 1, 1.55, 'A', 176, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Sex hormone-binding globulin', 'SHBG', '', 'androgen binding<br />\nsteroid binding<br />\n', '', 'PF00054.', 'MESRGPLATSRLLLLLLLLLLRHTRQGWALRPVLPTQSAHDPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAEISASAPTSLRSCDVESNPGIFLPPGTQAEFNLRDIPQPHAEPWAFSLDLGLKQAAGSGHLLALGTPENPSWLSLHLQDQKVVLSSGSGPGLDLPLVLGLPLQLKLSMSRVVLSQGSKMKALALPPLGLAPLLNLWAKPQGRLFLGALPGEDSSTSFCLNGLWAQGQRLDVDQALNRSHEIWTHSCPQSPGNGTDASH'),
('P15559', '1D4A', 1, 1.7, 'A/B/C/D', 273, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'NAD(P)H dehydrogenase [quinone] 1', 'NQO1', 'NAD(P)H + a quinone = NAD(P)+ + a hydroquinone.<br />\n', 'cytochrome-b5 reductase activity, acting on NAD(P)H<br />\nidentical protein binding<br />\nNAD(P)H dehydrogenase (quinone) activity<br />\nRNA binding<br />\nsuperoxide dismutase activity<br />\n', 'aging<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of catalytic activity<br />\nnitric oxide biosynthetic process<br />\npositive regulation of neuron apoptotic process<br />\nregulation of cellular amino acid metabolic process<br />\nresponse to estradiol<br />\nresponse to ethanol<br />\nresponse to nutrient<br />\nresponse to toxic substance<br />\nsynaptic transmission, cholinergic<br />\nxenobiotic metabolic process<br />\n', 'PF02525.', 'MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGDMNVILWPIQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIWDETPLYFAPSSLFDLNFQAGFLMKKEVQDEEKNKKFGLSVGHHLGKSIPTDNQIKARK'),
('P83223', '1D4D', 1, 2.5, 'A', 572, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Fumarate reductase flavoprotein subunit', 'SO_0970', 'Succinate + a quinone = fumarate + a quinol.<br />\n', 'fumarate reductase (menaquinone)<br />\nmetal ion binding<br />\nsuccinate dehydrogenase activity<br />\n', 'anaerobic respiration<br />\ntricarboxylic acid cycle<br />\n', 'PF14537.', 'MFTRKIQKTALAMLISGAMAGTAYAAPEVLADFHGEMGGCDSCHVSDKGGVTNDNLTHENGQCVSCHGDLKELAAAAPKDKVSPHKSHLIGEIACTSCHKGHEKSVAYCDACHSFGFDMPFGGKWERKFVPVDADKAAQDKAIAAGVKETTDVVIIGSGGAGLAAAVSARDAGAKVILLEKEPIPGGNTKLAAGGMNAAETKPQAKLGIEDKKQIMIDDTMKGGRNINDPELVKVLANNSSDSIDWLTSMGADMTDVGRMGGASVNRSHRPTGGAGVGAHVAQVLWDNAVKRGTDIRLNSRVVRILEDASGKVTGVLVKGEYTGYYVIKADAVVIAAGGFAKNNERVSKYDPKLKGFKATNHPGATGDGLDVALQAGAATRDLEYIQAHPTYSPAGGVMITEAVRGNGAIVVNREGNRFMNEITTRDKASAAILQQKGESAYLVFDDSIRKSLKAIEGYVHLNIVKEGKTIEELAKQIDVPAAELAKTVTAYNGFVKSGKDAQFERPDLPRELVVAPFYALEIAPAVHHTMGGLVIDTKAEVKSEKTGKPITGLYAAGEVTGGVHGANRLGGNAISDIVTYGRIAGASAAKFAKDN'),
('P38038', '1DDG', 1, 2.01, 'A/B', 374, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Sulfite reductase [NADPH] flavoprotein alpha-component', 'cysJ', 'H2S + 3 NADP+ + 3 H2O = sulfite + 3 NADPH<br />\n', 'flavin adenine dinucleotide binding<br />\nFMN binding<br />\nNADP+ binding<br />\nriboflavin reductase (NADPH) activity<br />\nsulfite reductase (NADPH) activity<br />\n', 'cysteine biosynthetic process<br />\nhydrogen sulfide biosynthetic process<br />\nsulfate assimilation<br />\n', 'PF00667.', 'MTTQVPPSALLPLNPEQLARLQAATTDLTPTQLAWVSGYFWGVLNQQPAALAATPAPAAEMPGITIISASQTGNARRVAEALRDDLLAAKLNVKLVNAGDYKFKQIASEKLLIVVTSTQGEGEPPEEAVALHKFLFSKKAPKLENTAFAVFSLGDSSYEFFCQSGKDFDSKLAELGGERLLDRVDADVEYQAAASEWRARVVDALKSRAPVAAPSQSVATGAVNEIHTSPYSKDAPLVASLSVNQKITGRNSEKDVRHIEIDLGDSGMRYQPGDALGVWYQNDPALVKELVELLWLKGDEPVTVEGKTLPLNEALQWHFELTVNTANIVENYATLTRSETLLPLVGDKAKLQHYAATTPIVDMVRFSPAQLDAEALINLLRPLTPRLYSIASSQAEVENEVHVTVGVVRYDVEGRARAGGASSFLADRVEEEGEVRVFIEHNDNFRLPANPETPVIMIGPGTGIAPFRAFMQQRAADEAPGKNWLFFGNPHFTEDFLYQVEWQRYVKDGVLTRIDLAWSRDQKEKVYVQDKLREQGAELWRWINDGAHIYVCGDANRMAKDVEQALLEVIAEFGGMDTEAADEFLSELRVERRYQRDVY'),
('P04040', '1DGF', 1, 1.5, 'A/B/C/D', 497, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Catalase', 'CAT', '2 H2O2 = O2 + 2 H2O<br />\n', 'aminoacylase activity<br />\nantioxidant activity<br />\ncatalase activity<br />\nenzyme binding<br />\nheme binding<br />\nmetal ion binding<br />\nNADP binding<br />\noxidoreductase activity, acting on peroxide as acceptor<br />\nprotein homodimerization activity<br />\nreceptor binding<br />\n', 'aerobic respiration<br />\naging<br />\ncellular response to growth factor stimulus<br />\ncellular response to oxidative stress<br />\ncholesterol metabolic process<br />\nhemoglobin metabolic process<br />\nhydrogen peroxide catabolic process<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of NF-kappaB transcription factor activity<br />\nneutrophil degranulation<br />\nosteoblast differentiation<br />\npositive regulation of cell division<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\nprotein homotetramerization<br />\nprotein tetramerization<br />\nresponse to activity<br />\nresponse to cadmium ion<br />\nresponse to drug<br />\nresponse to estradiol<br />\nresponse to ethanol<br />\nresponse to fatty acid<br />\nresponse to hydrogen peroxide<br />\nresponse to hyperoxia<br />\nresponse to hypoxia<br />\nresponse to inactivity<br />\nresponse to insulin<br />\nresponse to L-ascorbic acid<br />\nresponse to lead ion<br />\nresponse to light intensity<br />\nresponse to ozone<br />\nresponse to phenylpropanoid<br />\nresponse to reactive oxygen species<br />\nresponse to vitamin A<br />\nresponse to vitamin E<br />\ntriglyceride metabolic process<br />\nureteric bud development<br />\nUV protection<br />\n', 'PF00199.', 'MADSRDPASDQMQHWKEQRAAQKADVLTTGAGNPVGDKLNVITVGPRGPLLVQDVVFTDEMAHFDRERIPERVVHAKGAGAFGYFEVTHDITKYSKAKVFEHIGKKTPIAVRFSTVAGESGSADTVRDPRGFAVKFYTEDGNWDLVGNNTPIFFIRDPILFPSFIHSQKRNPQTHLKDPDMVWDFWSLRPESLHQVSFLFSDRGIPDGHRHMNGYGSHTFKLVNANGEAVYCKFHYKTDQGIKNLSVEDAARLSQEDPDYGIRDLFNAIATGKYPSWTFYIQVMTFNQAETFPFNPFDLTKVWPHKDYPLIPVGKLVLNRNPVNYFAEVEQIAFDPSNMPPGIEASPDKMLQGRLFAYPDTHRHRLGPNYLHIPVNCPYRARVANYQRDGPMCMQDNQGGAPNYYPNSFGAPEQQPSALEHSIQYSGEVRRFNTANDDNVTQVRAFYVNVLNEEQRKRLCENIAGHLKDAQIFIQKKAVKNFTEVHPDYGSHIQALLDKYNAEKPKNAIHTFVQSGSHLAAREKANL'),
('P32890', '1DJR', 1, 1.3, 'D/E/F/G/H', 103, 'TOXIN', 'OTHERS', 'Heat-labile enterotoxin B chain', 'eltB', '', '', 'killing of cells of other organism<br />\npathogenesis<br />\n', 'PF01376.', 'MNKVKCYVLFTALLSSLYAHGAPQTITELCSEYRNTQIYTINDKILSYTESMAGKREMVIITFKSGETFQVEVPGSQHIDSQKKAIERMKDTLRITYLTETKIDKLCVWNNKTPNSIAAISMKN'),
('P00914', '1DNP', 1, 2.3, 'A/B', 471, 'LYASE (CARBON-CARBON)', 'LYASE', 'Deoxyribodipyrimidine photo-lyase', 'phrB', 'Cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in DNA).<br />\n', 'deoxyribodipyrimidine photo-lyase activity<br />\nDNA binding<br />\nnucleotide binding<br />\n', 'DNA repair<br />\nprotein-chromophore linkage<br />\n', 'PF00875.', 'MTTHLVWFRQDLRLHDNLALAAACRNSSARVLALYIATPRQWATHNMSPRQAELINAQLNGLQIALAEKGIPLLFREVDDFVASVEIVKQVCAENSVTHLFYNYQYEVNERARDVEVERALRNVVCEGFDDSVILPPGAVMTGNHEMYKVFTPFKNAWLKRLREGMPECVAAPKVRSSGSIEPSPSITLNYPRQSFDTAHFPVEEKAAIAQLRQFCQNGAGEYEQQRDFPAVEGTSRLSASLATGGLSPRQCLHRLLAEQPQALDGGAGSVWLNELIWREFYRHLITYHPSLCKHRPFIAWTDRVQWQSNPAHLQAWQEGKTGYPIVDAAMRQLNSTGWMHNRLRMITASFLVKDLLIDWREGERYFMSQLIDGDLAANNGGWQWAASTGTDAAPYFRIFNPTTQGEKFDHEGEFIRQWLPELRDVPGKVVHEPWKWAQKAGVTLDYPQPIVEHKEARVQTLAAYEAARKGK'),
('P13500', '1DOK', 0, 1.85, 'A/B', 76, 'CHEMOATTRACTANT', 'OTHERS', 'C-C motif chemokine 2', 'CCL2', '', 'CCR2 chemokine receptor binding<br />\nchemokine activity<br />\nheparin binding<br />\nprotein kinase activity<br />\nreceptor binding<br />\n', 'aging<br />\nangiogenesis<br />\nanimal organ morphogenesis<br />\nanimal organ regeneration<br />\nastrocyte cell migration<br />\ncell adhesion<br />\ncell surface receptor signaling pathway<br />\ncellular calcium ion homeostasis<br />\ncellular homeostasis<br />\ncellular response to ATP<br />\ncellular response to dexamethasone stimulus<br />\ncellular response to drug<br />\ncellular response to estradiol stimulus<br />\ncellular response to fatty acid<br />\ncellular response to fibroblast growth factor stimulus<br />\ncellular response to glucose stimulus<br />\ncellular response to high density lipoprotein particle stimulus<br />\ncellular response to insulin stimulus<br />\ncellular response to interferon-gamma<br />\ncellular response to interleukin-1<br />\ncellular response to interleukin-6<br />\ncellular response to lipopolysaccharide<br />\ncellular response to macrophage colony-stimulating factor stimulus<br />\ncellular response to organic cyclic compound<br />\ncellular response to platelet-derived growth factor stimulus<br />\ncellular response to retinoic acid<br />\ncellular response to tumor necrosis factor<br />\nchemokine-mediated signaling pathway<br />\nchemotaxis<br />\nchronic inflammatory response<br />\ncytokine-mediated signaling pathway<br />\ncytoskeleton organization<br />\nG-protein coupled receptor signaling pathway<br />\nG-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger<br />\nhelper T cell extravasation<br />\nhumoral immune response<br />\ninflammatory response<br />\nJAK-STAT cascade<br />\nleukocyte migration involved in inflammatory response<br />\nlipopolysaccharide-mediated signaling pathway<br />\nlymphocyte chemotaxis<br />\nmacrophage chemotaxis<br />\nMAPK cascade<br />\nmaternal process involved in female pregnancy<br />\nmaternal process involved in parturition<br />\nmonocyte chemotaxis<br />\nnegative regulation of angiogenesis<br />\nnegative regulation of glial cell apoptotic process<br />\nnegative regulation of natural killer cell chemotaxis<br />\nnegative regulation of neuron apoptotic process<br />\nneutrophil chemotaxis<br />\nPERK-mediated unfolded protein response<br />\npositive regulation of apoptotic cell clearance<br />\npositive regulation of calcium ion import<br />\npositive regulation of cellular extravasation<br />\npositive regulation of collagen biosynthetic process<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of GTPase activity<br />\npositive regulation of immune complex clearance by monocytes and macrophages<br />\npositive regulation of leukocyte mediated cytotoxicity<br />\npositive regulation of macrophage chemotaxis<br />\npositive regulation of monocyte chemotaxis<br />\npositive regulation of nitric-oxide synthase biosynthetic process<br />\npositive regulation of protein targeting to membrane<br />\npositive regulation of synaptic transmission<br />\npositive regulation of T cell activation<br />\npositive regulation of tumor necrosis factor production<br />\npositive regulation of wound healing<br />\nprotein kinase B signaling<br />\nprotein phosphorylation<br />\nregulation of cell shape<br />\nregulation of vascular endothelial growth factor production<br />\nresponse to activity<br />\nresponse to amino acid<br />\nresponse to antibiotic<br />\nresponse to bacterium<br />\nresponse to cyclosporin A<br />\nresponse to ethanol<br />\nresponse to gamma radiation<br />\nresponse to heat<br />\nresponse to hypoxia<br />\nresponse to mechanical stimulus<br />\nresponse to progesterone<br />\nresponse to vitamin B3<br />\nresponse to wounding<br />\nsignal transduction<br />\ntransforming growth factor beta receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nviral genome replication<br />\n', 'PF00048.', 'MKVSAALLCLLLIAATFIPQGLAQPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT'),
('P02679', '1DUG', 1, 1.8, 'A/B', 234, 'transferase', 'TRANSFERASE', 'Fibrinogen gamma chain', 'FGG', '', 'cell adhesion molecule binding<br />\nmetal ion binding<br />\nprotein binding, bridging<br />\nprotein homodimerization activity<br />\nreceptor binding<br />\nstructural molecule activity<br />\n', 'blood coagulation<br />\nblood coagulation, fibrin clot formation<br />\ncell-matrix adhesion<br />\ncellular protein complex assembly<br />\ncellular protein metabolic process<br />\ncellular response to interleukin-1<br />\ncellular response to interleukin-6<br />\nextracellular matrix organization<br />\nfibrinolysis<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors<br />\nnegative regulation of platelet aggregation<br />\nplasminogen activation<br />\nplatelet aggregation<br />\nplatelet degranulation<br />\nplatelet maturation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of exocytosis<br />\npositive regulation of heterotypic cell-cell adhesion<br />\npositive regulation of peptide hormone secretion<br />\npositive regulation of protein secretion<br />\npositive regulation of substrate adhesion-dependent cell spreading<br />\npositive regulation of vasoconstriction<br />\npost-translational protein modification<br />\nprotein polymerization<br />\nprotein secretion<br />\nresponse to calcium ion<br />\ntoll-like receptor signaling pathway<br />\n', 'PF08702.', 'MSWSLHPRNLILYFYALLFLSSTCVAYVATRDNCCILDERFGSYCPTTCGIADFLSTYQTKVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIMKYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTIGEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL'),
('P37321', '1E25', 0, 1.9, 'A', 282, 'HYDROLASE', 'HYDROLASE', 'Extended-spectrum beta-lactamase PER-1', 'per1', 'A beta-lactam + H2O = a substituted beta-amino acid<br />\n', 'beta-lactamase activity<br />\n', 'beta-lactam antibiotic catabolic process<br />\nresponse to antibiotic<br />\n', '', 'MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELKKLSALSPN'),
('P03176', '1E2K', 1, 1.7, 'A/B', 331, 'TRANSFERASE', 'TRANSFERASE', 'Thymidine kinase', 'TK', 'ATP + thymidine = ADP + thymidine 5''-phosphate<br />\n', 'ATP binding<br />\nthymidine kinase activity<br />\n', 'DNA biosynthetic process<br />\nTMP biosynthetic process<br />\n', 'PF00693.', 'MASYPCHQHASAFDQAARSRGHNNRRTALRPRRQQEATEVRPEQKMPTLLRVYIDGPHGMGKTTTTQLLVALGSRDDIVYVPEPMTYWRVLGASETIANIYTTQHRLDQGEISAGDAAVVMTSAQITMGMPYAVTDAVLAPHIGGEAGSSHAPPPALTLIFDRHPIAALLCYPAARYLMGSMTPQAVLAFVALIPPTLPGTNIVLGALPEDRHIDRLAKRQRPGERLDLAMLAAIRRVYGLLANTVRYLQCGGSWREDWGQLSGTAVPPQGAEPQSNAGPRPHIGDTLFTLFRAPELLAPNGDLYNVFAWALDVLAKRLRSMHVFILDYDQSPAGCRDALLQLTSGMVQTHVTTPGSIPTICDLARTFAREMGEAN'),
('P22073', '1E4I', 1, 2, 'A', 447, 'HYDROLASE', 'HYDROLASE', 'Beta-glucosidase A', 'bglA', 'Hydrolysis of terminal, non-reducing beta-D-glucosyl residues with release of beta-D-glucose.<br />\n', 'beta-glucosidase activity<br />\nscopolin beta-glucosidase activity<br />\n', 'cellulose catabolic process<br />\n', 'PF00232.', 'MTIFQFPQDFMWGTATAAYQIEGAYQEDGRGLSIWDTFAHTPGKVFNGDNGNVACDSYHRYEEDIRLMKELGIRTYRFSVSWPRIFPNGDGEVNQEGLDYYHRVVDLLNDNGIEPFCTLYHWDLPQALQDAGGWGNRRTIQAFVQFAETMFREFHGKIQHWLTFNEPWCIAFLSNMLGVHAPGLTNLQTAIDVGHHLLVAHGLSVRRFRELGTSGQIGIAPNVSWAVPYSTSEEDKAACARTISLHSDWFLQPIYQGSYPQFLVDWFAEQGATVPIQDGDMDIIGEPIDMIGINYYSMSVNRFNPEAGFLQSEEINMGLPVTDIGWPVESRGLYEVLHYLQKYGNIDIYITENGACINDEVVNGKVQDDRRISYMQQHLVQVHRTIHDGLHVKGYMAWSLLDNFEWAEGYNMRFGMIHVDFRTQVRTPKESYYWYRNVVSNNWLETRR'),
('P0AES2', '1EC8', 1, 1.9, 'A/B/C/D', 446, 'LYASE', 'LYASE', 'Glucarate dehydratase', 'gudD', 'D-glucarate = 5-dehydro-4-deoxy-D-glucarate + H2O.<br />\n', 'glucarate dehydratase activity<br />\nmagnesium ion binding<br />\n', 'D-glucarate catabolic process<br />\n', 'PF13378.', 'MSSQFTTPVVTEMQVIPVAGHDSMLMNLSGAHAPFFTRNIVIIKDNSGHTGVGEIPGGEKIRKTLEDAIPLVVGKTLGEYKNVLTLVRNTFADRDAGGRGLQTFDLRTTIHVVTGIEAAMLDLLGQHLGVNVASLLGDGQQRSEVEMLGYLFFVGNRKATPLPYQSQPDDSCDWYRLRHEEAMTPDAVVRLAEAAYEKYGFNDFKLKGGVLAGEEEAESIVALAQRFPQARITLDPNGAWSLNEAIKIGKYLKGSLAYAEDPCGAEQGFSGREVMAEFRRATGLPTATNMIATDWRQMGHTLSLQSVDIPLADPHFWTMQGSVRVAQMCHEFGLTWGSHSNNHFDISLAMFTHVAAAAPGKITAIDTHWIWQEGNQRLTKEPFEIKGGLVQVPEKPGLGVEIDMDQVMKAHELYQKHGLGARDDAMGMQYLIPGWTFDNKRPCMVR'),
('P01625', '1EFQ', 1, 1.6, 'A', 114, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Immunoglobulin kappa variable 4-1', 'IGKV4-1', '', 'antigen binding<br />\nserine-type endopeptidase activity<br />\n', 'complement activation<br />\ncomplement activation, classical pathway<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nimmune response<br />\nimmunoglobulin production<br />\nleukocyte migration<br />\nreceptor-mediated endocytosis<br />\nregulation of complement activation<br />\nregulation of immune response<br />\n', 'PF07686.', 'MVLQTQVFISLLLWISGAYGDIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTP'),
('P06149', '1F0X', 1, 1.9, 'A/B', 571, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Quinone-dependent D-lactate dehydrogenase', 'dld', '(R)-lactate + a quinone = pyruvate + a quinol<br />\n', '(R)-2-hydroxyglutarate dehydrogenase activity<br />\nD-lactate dehydrogenase (cytochrome) activity<br />\nelectron carrier activity<br />\nFAD binding<br />\nflavin adenine dinucleotide binding<br />\nNAD binding<br />\noxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor<br />\nquinone binding<br />\n', 'aerobic respiration<br />\nanaerobic respiration<br />\nlactate oxidation<br />\nrespiratory electron transport chain<br />\ntransmembrane transport<br />\n', 'PF01565.', 'MSSMTTTDNKAFLNELARLVGSSHLLTDPAKTARYRKGFRSGQGDALAVVFPGSLLELWRVLKACVTADKIILMQAANTGLTEGSTPNGNDYDRDVVIISTLRLDKLHVLGKGEQVLAYPGTTLYSLEKALKPLGREPHSVIGSSCIGASVIGGICNNSGGSLVQRGPAYTEMSLFARINEDGKLTLVNHLGIDLGETPEQILSKLDDDRIKDDDVRHDGRHAHDYDYVHRVRDIEADTPARYNADPDRLFESSGCAGKLAVFAVRLDTFEAEKNQQVFYIGTNQPEVLTEIRRHILANFENLPVAGEYMHRDIYDIAEKYGKDTFLMIDKLGTDKMPFFFNLKGRTDAMLEKVKFFRPHFTDRAMQKFGHLFPSHLPPRMKNWRDKYEHHLLLKMAGDGVGEAKSWLVDYFKQAEGDFFVCTPEEGSKAFLHRFAAAGAAIRYQAVHSDEVEDILALDIALRRNDTEWYEHLPPEIDSQLVHKLYYGHFMCYVFHQDYIVKKGVDVHALKEQMLELLQQRGAQYPAEHNVGHLYKAPETLQKFYRENDPTNSMNPGIGKTSKRKNWQEVE'),
('P17117', '1F5V', 1, 1.7, 'A/B', 240, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Oxygen-insensitive NADPH nitroreductase', 'nfsA', 'An oxidized nitroaromatic compound + NADPH = a reduced nitroaromatic compound + NADP+<br />\n', 'chromate reductase activity<br />\nFMN binding<br />\noxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor<br />\n', '', 'PF00881.', 'MTPTIELICGHRSIRHFTDEPISEAQREAIINSARATSSSSFLQCSSIIRITDKALREELVTLTGGQKHVAQAAEFWVFCADFNRHLQICPDAQLGLAEQLLLGVVDTAMMAQNALIAAESLGLGGVYIGGLRNNIEAVTKLLKLPQHVLPLFGLCLGWPADNPDLKPRLPASILVHENSYQPLDKGALAQYDEQLAEYYLTRGSNNRRDTWSDHIRRTIIKESRPFILDYLHKQGWATR'),
('P13631', '1FCY', 1, 1.3, 'A', 235, 'GENE REGULATION', 'OTHERS', 'Retinoic acid receptor gamma', 'RARG', '', 'DNA binding<br />\nretinoic acid receptor activity<br />\nretinoid X receptor binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'anterior/posterior pattern specification<br />\ncanonical Wnt signaling pathway<br />\ncellular response to leukemia inhibitory factor<br />\ncellular response to retinoic acid<br />\nembryonic camera-type eye development<br />\nembryonic eye morphogenesis<br />\nembryonic hindlimb morphogenesis<br />\nface development<br />\nglandular epithelial cell development<br />\ngrowth plate cartilage chondrocyte growth<br />\nHarderian gland development<br />\nmulticellular organism growth<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of chondrocyte differentiation<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nneural tube closure<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell proliferation<br />\npositive regulation of programmed cell death<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprostate gland epithelium morphogenesis<br />\nregulation of cell size<br />\nregulation of myelination<br />\nregulation of myeloid cell differentiation<br />\nresponse to retinoic acid<br />\nretinal pigment epithelium development<br />\nretinoic acid receptor signaling pathway<br />\ntrachea cartilage development<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'MATNKERLFAAGALGPGSGYPGAGFPFAFPGALRGSPPFEMLSPSFRGLGQPDLPKEMASLSVETQSTSSEEMVPSSPSPPPPPRVYKPCFVCNDKSSGYHYGVSSCEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKEAVRNDRNKKKKEVKEEGSPDSYELSPQLEELITKVSKAHQETFPSLCQLGKYTTNSSADHRVQLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLICGDRMDLEEPEKVDKLQEPLLEALRLYARRRRPSQPYMFPRMLMKITDLRGISTKGAERAITLKMEIPGPMPPLIREMLENPEMFEDDSSQPGPHPNASSEDEVPGGQGKGGLKSPA'),
('P28861', '1FDR', 1, 1.7, 'A', 248, 'FLAVOPROTEIN', 'OTHERS', 'Flavodoxin/ferredoxin--NADP reductase', 'fpr', '2 reduced ferredoxin + NADP+ + H+ = 2 oxidized ferredoxin + NADPH<br />\nReduced flavodoxin + NADP+ = oxidized flavodoxin + NADPH<br />\n', 'FAD binding<br />\nferredoxin-NADP+ reductase activity<br />\noxidoreductase activity<br />\n', 'fructose catabolic process<br />\niron-sulfur cluster assembly<br />\nresponse to drug<br />\nresponse to superoxide<br />\n', 'PF00970.', 'MADWVTGKVTKVQNWTDALFSLTVHAPVLPFTAGQFTKLGLEIDGERVQRAYSYVNSPDNPDLEFYLVTVPDGKLSPRLAALKPGDEVQVVSEAAGFFVLDEVPHCETLWMLATGTAIGPYLSILQLGKDLDRFKNLVLVHAARYAADLSYLPLMQELEKRYEGKLRIQTVVSRETAAGSLTGRIPALIESGELESTIGLPMNKETSHVMLCGNPQMVRDTQQLLKETRQMTKHLRRRPGHMTAEHYW'),
('P41972', '1FFY', 1, 2.2, 'A', 917, 'LIGASE / RNA', 'LIGASE', 'Isoleucine--tRNA ligase', 'ileS', 'ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L-isoleucyl-tRNA(Ile).<br />\n', 'aminoacyl-tRNA editing activity<br />\nATP binding<br />\nisoleucine-tRNA ligase activity<br />\nmetal ion binding<br />\ntRNA binding<br />\n', 'isoleucyl-tRNA aminoacylation<br />\n', 'PF08264.', 'MDYKETLLMPKTDFPMRGGLPNKEPQIQEKWDAEDQYHKALEKNKGNETFILHDGPPYANGNLHMGHALNKILKDFIVRYKTMQGFYAPYVPGWDTHGLPIEQALTKKGVDRKKMSTAEFREKCKEFALEQIELQKKDFRRLGVRGDFNDPYITLKPEYEAAQIRIFGEMADKGLIYKGKKPVYWSPSSESSLAEAEIEYHDKRSASIYVAFNVKDDKGVVDADAKFIIWTTTPWTIPSNVAITVHPELKYGQYNVNGEKYIIAEALSDAVAEALDWDKASIKLEKEYTGKELEYVVAQHPFLDRESLVINGDHVTTDAGTGCVHTAPGHGEDDYIVGQKYELPVISPIDDKGVFTEEGGQFEGMFYDKANKAVTDLLTEKGALLKLDFITHSYPHDWRTKKPVIFRATPQWFASISKVRQDILDAIENTNFKVNWGKTRIYNMVRDRGEWVISRQRVWGVPLPVFYAENGEIIMTKETVNHVADLFAEHGSNIWFEREAKDLLPEGFTHPGSPNGTFTKETDIMDVWFDSGSSHRGVLETRPELSFPADMYLEGSDQYRGWFNSSITTSVATRGVSPYKFLLSHGFVMDGEGKKMSKSLGNVIVPDQVVKQKGADIARLWVSSTDYLADVRISDEILKQTSDVYRKIRNTLRFMLGNINDFNPDTDSIPESELLEVDRYLLNRLREFTASTINNYENFDYLNIYQEVQNFINVELSNFYLDYGKDILYIEQRDSHIRRSMQTVLYQILVDMTKLLAPILVHTAEEVWSHTPHVKEESVHLADMPKVVEVDQALLDKWRTFMNLRDDVNRALETARNEKVIGKSLEAKVTIASNDKFNASEFLTSFDALHQLFIVSQVKVVDKLDDQATAYEHGDIVIEHADGEKCERCWNYSEDLGAVDELTHLCPRCQQVVKSLV'),
('P35340', '1FL2', 1, 1.9, 'A', 310, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Alkyl hydroperoxide reductase subunit F', 'ahpF', '', 'alkyl hydroperoxide reductase activity<br />\nelectron carrier activity<br />\nFAD binding<br />\nflavin adenine dinucleotide binding<br />\nNAD binding<br />\nNADPH binding<br />\nprotein disulfide oxidoreductase activity<br />\n', 'cell redox homeostasis<br />\nresponse to reactive oxygen species<br />\n', 'PF07992.', 'MLDTNMKTQLKAYLEKLTKPVELIATLDDSAKSAEIKELLAEIAELSDKVTFKEDNSLPVRKPSFLITNPGSNQGPRFAGSPLGHEFTSLVLALLWTGGHPSKEAQSLLEQIRHIDGDFEFETYYSLSCHNCPDVVQALNLMSVLNPRIKHTAIDGGTFQNEITDRNVMGVPAVFVNGKEFGQGRMTLTEIVAKIDTGAEKRAAEELNKRDAYDVLIVGSGPAGAAAAIYSARKGIRTGLMGERFGGQILDTVDIENYISVPKTEGQKLAGALKVHVDEYDVDVIDSQSASKLIPAAVEGGLHQIETASGAVLKARSIIVATGAKWRNMNVPGEDQYRTKGVTYCPHCDGPLFKGKRVAVIGGGNSGVEAAIDLAGIVEHVTLLEFAPEMKADQVLQDKLRSLKNVDIILNAQTTEVKGDGSKVVGLEYRDRVSGDIHNIELAGIFVQIGLLPNTNWLEGAVERNRMGEIIIDAKCETNVKGVFAAGDCTTVPYKQIIIATGEGAKASLSAFDYLIRTKTA'),
('O43708', '1FW1', 1, 1.9, 'A', 216, 'ISOMERASE / TRANSFERASE', 'TRANSFERASE', 'Maleylacetoacetate isomerase', 'GSTZ1', '4-maleylacetoacetate = 4-fumarylacetoacetate<br />\nRX + glutathione = HX + R-S-glutathione<br />\n', 'glutathione peroxidase activity<br />\nglutathione transferase activity<br />\nidentical protein binding<br />\nmaleylacetoacetate isomerase activity<br />\nprotein homodimerization activity<br />\n', 'glutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nL-phenylalanine catabolic process<br />\ntyrosine catabolic process<br />\n', 'PF14497.', 'MQAGKPILYSYFRSSCSWRVRIALALKGIDYKTVPINLIKDRGQQFSKDFQALNPMKQVPTLKIDGITIHQSLAIIEYLEEMRPTPRLLPQDPKKRASVRMISDLIAGGIQPLQNLSVLKQVGEEMQLTWAQNAITCGFNALEQILQSTAGIYCVGDEVTMADLCLVPQVANAERFKVDLTPYPTISSINKRLLVLEAFQVSHPCRQPDTPTELRA'),
('P18314', '1FWE', 1, 2, 'C', 567, 'HYDROLASE', 'HYDROLASE', 'Urease subunit alpha', 'ureC', 'Urea + H2O = CO2 + 2 NH3<br />\n', 'nickel cation binding<br />\nurease activity<br />\n', 'urea catabolic process<br />\n', 'PF01979.', 'MSNISRQAYADMFGPTVGDKVRLADTELWIEVEDDLTTYGEEVKFGGGKVIRDGMGQGQMLAADCVDLVLTNALIVDHWGIVKADIGVKDGRIFAIGKAGNPDIQPNVTIPIGAATEVIAAEGKIVTAGGIDTHIHWICPQQAEEALVSGVTTMVGGGTGPAAGTHATTCTPGPWYISRMLQAADSLPVNIGLLGKGNVSQPDALREQVAAGVIGLKIHEDWGATPAAIDCALTVADEMDIQVALHSDTLNESGFVEDTLAAIGGRTIHTFHTEGAGGGHAPDIITACAHPNILPSSTNPTLPYTLNTIDEHLDMLMVCHHLDPDIAEDVAFAESRIRRETIAAEDVLHDLGAFSLTSSDSQAMGRVGEVILRTWQVAHRMKVQRGALAEETGDNDNFRVKRYIAKYTINPALTHGIAHEVGSIEVGKLADLVVWSPAFFGVKPATVIKGGMIAIAPMGDINASIPTPQPVHYRPMFGALGSARHHCRLTFLSQAAAANGVAERLNLRSAIAVVKGCRTVQKADMVHNSLQPNITVDAQTYEVRVDGELITSEPADVLPMAQRYFLF');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P01579', '1FYH', 0, 2.04, 'A/D', 129, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Interferon gamma', 'IFNG', '', 'cytokine activity<br />\ninterferon-gamma receptor binding<br />\n', 'adaptive immune response<br />\nantigen processing and presentation<br />\napoptotic process<br />\nCD8-positive, alpha-beta T cell differentiation involved in immune response<br />\ncell cycle arrest<br />\ncell surface receptor signaling pathway<br />\ncellular response to interleukin-18<br />\ncellular response to lipopolysaccharide<br />\ndefense response to bacterium<br />\ndefense response to protozoan<br />\ndefense response to virus<br />\nendoplasmic reticulum unfolded protein response<br />\nextrinsic apoptotic signaling pathway<br />\nhumoral immune response<br />\ninterferon-gamma-mediated signaling pathway<br />\ninterleukin-12-mediated signaling pathway<br />\nmovement of cell or subcellular component<br />\nnegative regulation of epithelial cell differentiation<br />\nnegative regulation of fibroblast proliferation<br />\nnegative regulation of gene expression<br />\nnegative regulation of glomerular mesangial cell proliferation<br />\nnegative regulation of growth of symbiont in host<br />\nnegative regulation of interleukin-17 production<br />\nnegative regulation of myelination<br />\nnegative regulation of smooth muscle cell proliferation<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nneutrophil apoptotic process<br />\nneutrophil chemotaxis<br />\npositive regulation of autophagy<br />\npositive regulation of calcidiol 1-monooxygenase activity<br />\npositive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response<br />\npositive regulation of cell proliferation<br />\npositive regulation of chemokine biosynthetic process<br />\npositive regulation of core promoter binding<br />\npositive regulation of epithelial cell migration<br />\npositive regulation of exosomal secretion<br />\npositive regulation of fructose 1,6-bisphosphate 1-phosphatase activity<br />\npositive regulation of fructose 1,6-bisphosphate metabolic process<br />\npositive regulation of gene expression<br />\npositive regulation of interleukin-12 biosynthetic process<br />\npositive regulation of interleukin-12 production<br />\npositive regulation of interleukin-1 beta secretion<br />\npositive regulation of interleukin-23 production<br />\npositive regulation of interleukin-6 biosynthetic process<br />\npositive regulation of isotype switching to IgG isotypes<br />\npositive regulation of killing of cells of other organism<br />\npositive regulation of membrane protein ectodomain proteolysis<br />\npositive regulation of MHC class II biosynthetic process<br />\npositive regulation of neuron differentiation<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of osteoclast differentiation<br />\npositive regulation of peptidyl-serine phosphorylation of STAT protein<br />\npositive regulation of protein complex assembly<br />\npositive regulation of protein deacetylation<br />\npositive regulation of protein import into nucleus, translocation<br />\npositive regulation of protein localization to plasma membrane<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of protein serine/threonine kinase activity<br />\npositive regulation of smooth muscle cell apoptotic process<br />\npositive regulation of synaptic transmission, cholinergic<br />\npositive regulation of T cell proliferation<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of tumor necrosis factor (ligand) superfamily member 11 production<br />\npositive regulation of tumor necrosis factor production<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\npositive regulation of vitamin D biosynthetic process<br />\nprotein import into nucleus, translocation<br />\nregulation of defense response to virus by host<br />\nregulation of glial cell proliferation<br />\nregulation of hepatocyte proliferation<br />\nregulation of insulin secretion<br />\nregulation of interferon-gamma-mediated signaling pathway<br />\nregulation of neuronal action potential<br />\nregulation of protein ADP-ribosylation<br />\nregulation of regulatory T cell differentiation<br />\nregulation of the force of heart contraction<br />\nresponse to drug<br />\nresponse to virus<br />\nsensory perception of mechanical stimulus<br />\nT cell receptor signaling pathway<br />\n', 'PF00714.', 'MKYTSYILAFQLCIVLGSLGCYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSPAAKTGKRKRSQMLFRGRRASQ'),
('P02675', '1FZB', 1, 2.9, 'B/E', 328, 'BLOOD COAGULATION', 'OTHERS', 'Fibrinogen beta chain', 'FGB', '', 'chaperone binding<br />\nprotein binding, bridging<br />\nreceptor binding<br />\nstructural molecule activity<br />\n', 'adaptive immune response<br />\nblood coagulation<br />\nblood coagulation, fibrin clot formation<br />\ncell-matrix adhesion<br />\ncellular protein complex assembly<br />\ncellular response to interleukin-1<br />\ncellular response to leptin stimulus<br />\nextracellular matrix organization<br />\nfibrinolysis<br />\ninduction of bacterial agglutination<br />\ninnate immune response<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors<br />\nplasminogen activation<br />\nplatelet aggregation<br />\nplatelet degranulation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of exocytosis<br />\npositive regulation of heterotypic cell-cell adhesion<br />\npositive regulation of peptide hormone secretion<br />\npositive regulation of protein secretion<br />\npositive regulation of substrate adhesion-dependent cell spreading<br />\npositive regulation of vasoconstriction<br />\nprotein polymerization<br />\nresponse to calcium ion<br />\ntoll-like receptor signaling pathway<br />\n', 'PF08702.', 'MKRMVSWSFHKLKTMKHLLLLLLCVFLVKSQGVNDNEEGFFSARGHRPLDKKREEAPSLRPAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQERPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQLYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ'),
('P02671', '1FZD', 1, 2.1, 'A/B/C/D/E/F/G/H', 201, 'BLOOD COAGULATION', 'OTHERS', 'Fibrinogen alpha chain', 'FGA', '', 'metal ion binding<br />\nprotein binding, bridging<br />\nreceptor binding<br />\nstructural molecule activity<br />\n', 'adaptive immune response<br />\nblood coagulation<br />\nblood coagulation, common pathway<br />\nblood coagulation, fibrin clot formation<br />\ncell-matrix adhesion<br />\ncellular protein complex assembly<br />\ncellular protein metabolic process<br />\nextracellular matrix organization<br />\nfibrinolysis<br />\ninduction of bacterial agglutination<br />\ninnate immune response<br />\nnegative regulation of blood coagulation, common pathway<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors<br />\nplasminogen activation<br />\nplatelet aggregation<br />\nplatelet degranulation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of exocytosis<br />\npositive regulation of heterotypic cell-cell adhesion<br />\npositive regulation of peptide hormone secretion<br />\npositive regulation of protein secretion<br />\npositive regulation of substrate adhesion-dependent cell spreading<br />\npositive regulation of vasoconstriction<br />\npost-translational protein modification<br />\nprotein complex assembly<br />\nprotein polymerization<br />\nresponse to calcium ion<br />\ntoll-like receptor signaling pathway<br />\n', 'PF08702.', 'MFSMRIVCLVLSVVGTAWTADSGEGDFLAEGGGVRGPRVVERHQSACKDSDWPFCSDEDWNYKCPSGCRMKGLIDEVNQDFTNRINKLKNSLFEYQKNNKDSHSLTTNIMEILRGDFSSANNRDNTYNRVSEDLRSRIEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIAKDLLPSRDRQHLPLIKMKPVPDLVPGNFKSQLQKVPPEWKALTDMPQMRMELERPGGNEITRGGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNRNPGSSGTGGTATWKPGSSGPGSTGSWNSGSSGTGSTGNQNPGSPRPGSTGTWNPGSSERGSAGHWTSESSVSGSTGQWHSESGSFRPDSPGSGNARPNNPDWGTFEEVSGNVSPGTRREYHTEKLVTSKGDKELRTGKEKVTSGSTTTTRRSCSKTVTKTVIGPDGHKEVTKEVVTSEDGSDCPEAMDLGTLSGIGTLDGFRHRHPDEAAFFDTASTGKTFPGFFSPMLGEFVSETESRGSESGIFTNTKESSSHHPGIAEFPSRGKSSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHEGTHSTKRGHAKSRPVRDCDDVLQTHPSGTQSGIFNIKLPGSSKIFSVYCDQETSLGGWLLIQQRMDGSLNFNRTWQDYKRGFGSLNDEGEGEFWLGNDYLHLLTQRGSVLRVELEDWAGNEAYAEYHFRVGSEAEGYALQVSSYEGTAGDALIEGSVEEGAEYTSHNNMQFSTFDRDADQWEENCAEVYGGGWWYNNCQAANLNGIYYPGGSYDPRNNSPYEIENGVVWVSFRGADYSLRAVRMKIRPLVTQ'),
('P16581', '1G1T', 1, 1.5, 'A', 157, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'E-selectin', 'SELE', '', 'oligosaccharide binding<br />\nphospholipase binding<br />\nsialic acid binding<br />\ntransmembrane signaling receptor activity<br />\n', 'actin filament-based process<br />\nactivation of phospholipase C activity<br />\ncalcium-mediated signaling<br />\nheterophilic cell-cell adhesion via plasma membrane cell adhesion molecules<br />\ninflammatory response<br />\nleukocyte cell-cell adhesion<br />\nleukocyte migration<br />\nleukocyte migration involved in inflammatory response<br />\nleukocyte tethering or rolling<br />\npositive regulation of receptor internalization<br />\nregulation of inflammatory response<br />\nresponse to interleukin-1<br />\nresponse to lipopolysaccharide<br />\nresponse to tumor necrosis factor<br />\n', 'PF00008.', 'MIASQFLSALTLVLLIKESGAWSYNTSTEAMTYDEASAYCQQRYTHLVAIQNKEEIEYLNSILSYSPSYYWIGIRKVNNVWVWVGTQKPLTEEAKNWAPGEPNNRQKDEDCVEIYIKREKDVGMWNDERCSKKKLALCYTAACTNTSCSGHGECVETINNYTCKCDPGFSGLKCEQIVNCTALESPEHGSLVCSHPLGNFSYNSSCSISCDRGYLPSSMETMQCMSSGEWSAPIPACNVVECDAVTNPANGFVECFQNPGSFPWNTTCTFDCEEGFELMGAQSLQCTSSGNWDNEKPTCKAVTCRAVRQPQNGSVRCSHSPAGEFTFKSSCNFTCEEGFMLQGPAQVECTTQGQWTQQIPVCEAFQCTALSNPERGYMNCLPSASGSFRYGSSCEFSCEQGFVLKGSKRLQCGPTGEWDNEKPTCEAVRCDAVHQPPKGLVRCAHSPIGEFTYKSSCAFSCEEGFELHGSTQLECTSQGQWTEEVPSCQVVKCSSLAVPGKINMSCSGEPVFGTVCKFACPEGWTLNGSAARTCGATGHWSGLLPTCEAPTESNIPLVAGLSAAGLSLLTLAPFLLWLRKCLRKAKKFVPASSCQSLESDGSYQKPSYIL'),
('P49888', '1G3M', 1, 1.7, 'A/B', 294, 'TRANSFERASE', 'TRANSFERASE', 'Estrogen sulfotransferase', 'SULT1E1', '3''-phosphoadenylyl sulfate + estrone = adenosine 3'',5''-bisphosphate + estrone 3-sulfate<br />\n', 'aryl sulfotransferase activity<br />\nestrone sulfotransferase activity<br />\nflavonol 3-sulfotransferase activity<br />\nsteroid binding<br />\nsteroid sulfotransferase activity<br />\nsulfotransferase activity<br />\n', '3''-phosphoadenosine 5''-phosphosulfate metabolic process<br />\nestrogen catabolic process<br />\nestrogen metabolic process<br />\nethanol catabolic process<br />\npositive regulation of fat cell differentiation<br />\nsteroid metabolic process<br />\nsulfation<br />\n', 'PF00685.', 'MNSELDYYEKFEEVHGILMYKDFVKYWDNVEAFQARPDDLVIATYPKSGTTWVSEIVYMIYKEGDVEKCKEDVIFNRIPFLECRKENLMNGVKQLDEMNSPRIVKTHLPPELLPASFWEKDCKIIYLCRNAKDVAVSFYYFFLMVAGHPNPGSFPEFVEKFMQGQVPYGSWYKHVKSWWEKGKSPRVLFLFYEDLKEDIRKEVIKLIHFLERKPSEELVDRIIHHTSFQEMKNNPSTNYTTLPDEIMNQKLSPFMRKGITGDWKNHFTVALNEKFDKHYEQQMKESTLKFRTEI'),
('O14717', '1G55', 1, 1.8, 'A', 390, 'TRANSFERASE', 'TRANSFERASE', 'tRNA (cytosine(38)-C(5))-methyltransferase', 'TRDMT1', 'S-adenosyl-L-methionine + cytosine(38) in tRNA = S-adenosyl-L-homocysteine + 5-methylcytosine(38) in tRNA<br />\n', 'RNA binding<br />\ntRNA (cytosine-5-)-methyltransferase activity<br />\ntRNA methyltransferase activity<br />\n', 'response to amphetamine<br />\ntRNA methylation<br />\ntRNA modification<br />\n', '', 'MEPLRVLELYSGVGGMHHALRESCIPAQVVAAIDVNTVANEVYKYNFPHTQLLAKTIEGITLEEFDRLSFDMILMSPPCQPFTRIGRQGDMTDSRTNSFLHILDILPRLQKLPKYILLENVKGFEVSSTRDLLIQTIENCGFQYQEFLLSPTSLGIPNSRLRYFLIAKLQSEPLPFQAPGQVLMEFPKIESVHPQKYAMDVENKIQEKNVEPNISFDGSIQCSGKDAILFKLETAEEIHRKNQQDSDLSVKMLKDFLEDDTDVNQYLLPPKSLLRYALLLDIVQPTCRRSVCFTKGYGSYIEGTGSVLQTAEDVQVENIYKSLTNLSQEEQITKLLILKLRYFTPKEIANLLGFPPEFGFPEKITVKQRYRLLGNSLNVHVVAKLIKILYE'),
('P06715', '1GES', 1, 1.74, 'A/B', 450, 'OXIDOREDUCTASE(FLAVOENZYME)', 'OXIDOREDUCTASE', 'Glutathione reductase', 'gor', '2 glutathione + NADP+ = glutathione disulfide + NADPH.<br />\n', 'electron carrier activity<br />\nFAD binding<br />\nglutathione-disulfide reductase activity<br />\nNADP binding<br />\n', 'cell redox homeostasis<br />\nglutathione metabolic process<br />\n', 'PF07992.', 'MTKHYDYIAIGGGSGGIASINRAAMYGQKCALIEAKELGGTCVNVGCVPKKVMWHAAQIREAIHMYGPDYGFDTTINKFNWETLIASRTAYIDRIHTSYENVLGKNNVDVIKGFARFVDAKTLEVNGETITADHILIATGGRPSHPDIPGVEYGIDSDGFFALPALPERVAVVGAGYIAVELAGVINGLGAKTHLFVRKHAPLRSFDPMISETLVEVMNAEGPQLHTNAIPKAVVKNTDGSLTLELEDGRSETVDCLIWAIGREPANDNINLEAAGVKTNEKGYIVVDKYQNTNIEGIYAVGDNTGAVELTPVAVAAGRRLSERLFNNKPDEHLDYSNIPTVVFSHPPIGTVGLTEPQAREQYGDDQVKVYKSSFTAMYTAVTTHRQPCRMKLVCVGSEEKIVGIHGIGFGMDEMLQGFAVALKMGATKKDFDNTVAIHPTAAEEFVTMR'),
('P00807', '1GHP', 1, 1.76, 'A', 257, 'HYDROLASE', 'HYDROLASE', 'Beta-lactamase', 'blaZ', 'A beta-lactam + H2O = a substituted beta-amino acid<br />\n', 'beta-lactamase activity<br />\n', 'beta-lactam antibiotic catabolic process<br />\nresponse to antibiotic<br />\n', '', 'MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF'),
('P24232', '1GVH', 1, 2.19, 'A', 396, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Flavohemoprotein', 'hmp', '2 nitric oxide + 2 O2 + NAD(P)H = 2 nitrate + NAD(P)+ + H+<br />\n', 'FAD binding<br />\nfatty acid binding<br />\nheme binding<br />\nhydroperoxide reductase activity<br />\nmetal ion binding<br />\nnitric oxide dioxygenase activity<br />\noxygen binding<br />\noxygen transporter activity<br />\n', 'cellular response to nitrosative stress<br />\nnitric oxide catabolic process<br />\nresponse to nitrosative stress<br />\nresponse to toxic substance<br />\n', 'PF00970.', 'MLDAQTIATVKATIPLLVETGPKLTAHFYDRMFTHNPELKEIFNMSNQRNGDQREALFNAIAAYASNIENLPALLPAVEKIAQKHTSFQIKPEQYNIVGEHLLATLDEMFSPGQEVLDAWGKAYGVLANVFINREAEIYNENASKAGGWEGTRDFRIVAKTPRSALITSFELEPVDGGAVAEYRPGQYLGVWLKPEGFPHQEIRQYSLTRKPDGKGYRIAVKREEGGQVSNWLHNHANVGDVVKLVAPAGDFFMAVADDTPVTLISAGVGQTPMLAMLDTLAKAGHTAQVNWFHAAENGDVHAFADEVKELGQSLPRFTAHTWYRQPSEADRAKGQFDSEGLMDLSKLEGAFSDPTMQFYLCGPVGFMQFTAKQLVDLGVKQENIHYECFGPHKVL'),
('P31992', '1GYX', 1, 1.35, 'A/B', 76, 'ISOMERASE', 'ISOMERASE', 'Tautomerase PptA', 'pptA', '', 'intramolecular oxidoreductase activity, interconverting keto- and enol-groups<br />\n', 'cellular aromatic compound metabolic process<br />\n', 'PF01361.', 'MPHIDIKCFPRELDEQQKAALAADITDVIIRHLNSKDSSISIALQQIQPESWQAIWDAEIAPQMEALIKKPGYSMNA'),
('P08174', '1H03', 0, 1.7, 'P/Q', 125, 'IMMUNE SYSTEM PROTEIN', 'IMMUNE_SYS_PROT', 'Complement decay-accelerating factor', 'CD55', '', 'lipid binding<br />\nvirus receptor activity<br />\n', 'CD4-positive, alpha-beta T cell cytokine production<br />\ncomplement activation, classical pathway<br />\nER to Golgi vesicle-mediated transport<br />\ninnate immune response<br />\nnegative regulation of complement activation<br />\nneutrophil degranulation<br />\npositive regulation of CD4-positive, alpha-beta T cell activation<br />\npositive regulation of CD4-positive, alpha-beta T cell proliferation<br />\npositive regulation of cytosolic calcium ion concentration<br />\nregulation of complement activation<br />\nregulation of lipopolysaccharide-mediated signaling pathway<br />\nrespiratory burst<br />\n', 'PF00084.', 'MTVARPSVPAALPLLGELPRLLLLVLLCLPAVWGDCGLPPDVPNAQPALEGRTSFPEDTVITYKCEESFVKIPGEKDSVICLKGSQWSDIEEFCNRSCEVPTRLNSASLKQPYITQNYFPVGTVVEYECRPGYRREPSLSPKLTCLQNLKWSTAVEFCKKKSCPNPGEIRNGQIDVPGGILFGATISFSCNTGYKLFGSTSSFCLISGSSVQWSDPLPECREIYCPAPPQIDNGIIQGERDHYGYRQSVTYACNKGFTMIGEHSIYCTVNNDEGEWSGPPPECRGKSLTSKVPPTVQKPTTVNVPTTEVSPTSQKTTTKTTTPNAQATRSTPVSRTTKHFHETTPNKGSGTTSGTTRLLSGHTCFTLTGLLGTLVTMGLLT'),
('P12724', '1H1H', 1, 2, 'A', 133, 'HYDROLASE', 'HYDROLASE', 'Eosinophil cationic protein', 'RNASE3', '', 'endonuclease activity<br />\nlipopolysaccharide binding<br />\nnucleic acid binding<br />\nribonuclease activity<br />\n', 'antibacterial humoral response<br />\nantimicrobial humoral immune response mediated by antimicrobial peptide<br />\nantimicrobial humoral response<br />\ndefense response to Gram-negative bacterium<br />\ndefense response to Gram-positive bacterium<br />\ninduction of bacterial agglutination<br />\ninnate immune response<br />\ninnate immune response in mucosa<br />\nneutrophil degranulation<br />\nRNA catabolic process<br />\n', 'PF00074.', 'MVPKLFTSQICLLLLLGLMGVEGSLHARPPQFTRAQWFAIQHISLNPPRCTIAMRAINNYRWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNISNCTYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI'),
('P30043', '1HDO', 1, 1.15, 'A', 204, 'BILIVERDIN-IX BETA REDUCTASE', 'OXIDOREDUCTASE', 'Flavin reductase (NADPH)', 'BLVRB', 'Reduced riboflavin + NADP+ = riboflavin + NADPH<br />\nBilirubin + NAD(P)+ = biliverdin + NAD(P)H<br />\n', 'biliverdin reductase activity<br />\nriboflavin reductase (NADPH) activity<br />\n', 'heme catabolic process<br />\n', 'PF13460.', 'MAVKKIAIFGATGQTGLTTLAQAVQAGYEVTVLVRDSSRLPSEGPRPAHVVVGDVLQAADVDKTVAGQDAVIVLLGTRNDLSPTTVMSEGARNIVAAMKAHGVDKVVACTSAFLLWDPTKVPPRLQAVTDDHIRMHKVLRESGLKYVAVMPPHIGDQPLTGAYTVTLDGRGPSRVISKHDLGHFMLRCLTTDEYDGHSTYPSHQYQ'),
('P03956', '1HFC', 1, 1.5, 'A', 169, 'METALLOPROTEASE', 'OTHERS', 'Interstitial collagenase', 'MMP1', 'Cleavage of the triple helix of collagen at about three-quarters of the length of the molecule from the N-terminus, at 775-Gly-|-Ile-776 in the alpha-1(I) chain<br />\n', 'endopeptidase activity<br />\nmetalloendopeptidase activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'cellular protein metabolic process<br />\ncollagen catabolic process<br />\nextracellular matrix disassembly<br />\nleukocyte migration<br />\npositive regulation of protein oligomerization<br />\nproteolysis<br />\nviral process<br />\n', 'PF00045.', 'MHSFPPLLLLLFWGVVSHSFPATLETQEQDVDLVQKYLEKYYNLKNDGRQVEKRRNSGPVVEKLKQMQEFFGLKVTGKPDAETLKVMKQPRCGVPDVAQFVLTEGNPRWEQTHLTYRIENYTPDLPRADVDHAIEKAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHELGHSLGLSHSTDIGALMYPSYTFSGDVQLAQDDIDGIQAIYGRSQNPVQPIGPQTPKACDSKLTFDAITTIRGEVMFFKDRFYMRTNPFYPEVELNFISVFWPQLPNGLEAAYEFADRDEVRFFKGNKYWAVQGQNVLHGYPKDIYSSFGFPRTVKHIDAALSEENTGKTYFFVANKYWRYDEYKRSMDPGYPKMIAHDFPGIGHKVDAVFMKDGFFYFFHGTRQYKFDPKTKRILTLQKANSWFNCRKN'),
('Q52546', '1HKQ', 1, 2.75, 'A/B', 132, 'DNA BINDING PROTEIN', 'OTHERS', 'Replication protein', 'repA', NULL, 'DNA-directed DNA polymerase activity<br />\r\nidentical protein binding<br />', 'DNA replication initiation', 'PF01051.', 'MMVENKVTQSNKLIESSHTLTLNEKRLVLCAASLIDSRKPLPKDGYLTIR\r\nADTFAEVFGIDVKHAYAALDDAATKLFNRDIRRYVKGKVVERMRWVFHVK\r\nYREGQGCVELGFSPTIIPHLTMLHKEFTSYQLKQIGSLSSFYAVRLYELM\r\nSQFIKLKQRECTLAQLREMFDLGDKYQDVKDMRKRVLYPALEEVNKNTDL\r\nTVAVEPRRQGRRIIGFSFTIAKNDQLALSLE'),
('P0A6R0', '1HNJ', 1, 1.46, 'A', 317, 'TRANSFERASE', 'TRANSFERASE', '3-oxoacyl-[acyl-carrier-protein] synthase 3', 'fabH', 'Acetyl-CoA + malonyl-[acyl-carrier-protein] = acetoacetyl-[acyl-carrier-protein] + CoA + CO2<br />\n', '3-oxoacyl-[acyl-carrier-protein] synthase activity<br />\nbeta-ketoacyl-acyl-carrier-protein synthase III activity<br />\n', 'fatty acid biosynthetic process<br />\nfatty acid metabolic process<br />\n', 'PF08545.', 'MYTKIIGTGSYLPEQVRTNADLEKMVDTSDEWIVTRTGIRERHIAAPNETVSTMGFEAATRAIEMAGIEKDQIGLIVVATTSATHAFPSAACQIQSMLGIKGCPAFDVAAACAGFTYALSVADQYVKSGAVKYALVVGSDVLARTCDPTDRGTIIIFGDGAGAAVLAASEEPGIISTHLHADGSYGELLTLPNADRVNPENSIHLTMAGNEVFKVAVTELAHIVDETLAANNLDRSQLDWLVPHQANLRIISATAKKLGMSMDNVVVTLDRHGNTSAASVPCALDEAVRDGRIKPGQLVLLEAFGGGFTWGSALVRF'),
('P04818', '1HVY', 1, 1.9, 'A/B/C/D', 288, 'TRANSFERASE', 'TRANSFERASE', 'Thymidylate synthase', 'TYMS', '5,10-methylenetetrahydrofolate + dUMP = dihydrofolate + dTMP.<br />\n', 'cofactor binding<br />\ndrug binding<br />\nfolic acid binding<br />\nnucleotide binding<br />\nprotein homodimerization activity<br />\nsequence-specific mRNA binding<br />\nthymidylate synthase activity<br />\ntranslation repressor activity, nucleic acid binding<br />\n', 'aging<br />\ncartilage development<br />\ncell growth<br />\ncell proliferation<br />\ncircadian rhythm<br />\ndevelopmental growth<br />\nDNA biosynthetic process<br />\ndTMP biosynthetic process<br />\ndTTP biosynthetic process<br />\ndUMP metabolic process<br />\nimmortalization of host cell by virus<br />\nintestinal epithelial cell maturation<br />\nliver regeneration<br />\nnegative regulation of translation<br />\nnucleobase-containing small molecule interconversion<br />\nregulation of transcription involved in G1/S transition of mitotic cell cycle<br />\nresponse to cytokine<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to folic acid<br />\nresponse to glucocorticoid<br />\nresponse to organophosphorus<br />\nresponse to progesterone<br />\nresponse to toxic substance<br />\nresponse to vitamin A<br />\ntetrahydrofolate interconversion<br />\nuracil metabolic process<br />\n', 'PF00303.', 'MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV'),
('P08254', '1HY7', 1, 1.5, 'A/B', 173, 'HYDROLASE', 'HYDROLASE', 'Stromelysin-1', 'MMP3', 'Preferential cleavage where P1'', P2'' and P3'' are hydrophobic residues.<br />\n', 'endopeptidase activity<br />\nmetalloendopeptidase activity<br />\nmetallopeptidase activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'cellular response to nitric oxide<br />\ncollagen catabolic process<br />\nextracellular matrix disassembly<br />\nnegative regulation of hydrogen peroxide metabolic process<br />\npositive regulation of oxidative stress-induced cell death<br />\npositive regulation of protein oligomerization<br />\nproteolysis<br />\n', 'PF00045.', 'MKSLPILLLLCVAVCSAYPLDGAARGEDTSMNLVQKYLENYYDLKKDVKQFVRRKDSGPVVKKIREMQKFLGLEVTGKLDSDTLEVMRKPRCGVPDVGHFRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPETPLVPTEPVPPEPGTPANCDPALSFDAVSTLRGEILIFKDRHFWRKSLRKLEPELHLISSFWPSLPSGVDAAYEVTSKDLVFIFKGNQFWAIRGNEVRAGYPRGIHTLGFPPTVRKIDAAISDKEKNKTYFFVEDKYWRFDEKRNSMEPGFPKQIAEDFPGIDSKIDAVFEEFGFFYFFTGSSQLEFDPNAKKVTHTLKSNSWLNC'),
('P19480', '1HYU', 1, 2, 'A', 521, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Alkyl hydroperoxide reductase subunit F', 'ahpF', '', 'alkyl hydroperoxide reductase activity<br />\nelectron carrier activity<br />\nflavin adenine dinucleotide binding<br />\nNAD binding<br />\nprotein disulfide oxidoreductase activity<br />\n', 'cell redox homeostasis<br />\nresponse to reactive oxygen species<br />\n', 'PF07992.', 'MLDTNMKTQLRAYLEKLTKPVELIATLDDSAKSAEIKELLAEIAELSDKVTFKEDNTLPVRKPSFLITNPGSQQGPRFAGSPLGHEFTSLVLALLWTGGHPSKEAQSLLEQIRDIDGDFEFETYYSLSCHNCPDVVQALNLMAVLNPRIKHTAIDGGTFQNEITERNVMGVPAVFVNGKEFGQGRMTLTEIVAKVDTGAEKRAAEALNKRDAYDVLIVGSGPAGAAAAVYSARKGIRTGLMGERFGGQVLDTVDIENYISVPKTEGQKLAGALKAHVSDYDVDVIDSQSASKLVPAATEGGLHQIETASGAVLKARSIIIATGAKWRNMNVPGEDQYRTKGVTYCPHCDGPLFKGKRVAVIGGGNSGVEAAIDLAGIVEHVTLLEFAPEMKADQVLQDKVRSLKNVDIILNAQTTEVKGDGSKVVGLEYRDRVSGDIHSVALAGIFVQIGLLPNTHWLEGALERNRMGEIIIDAKCETSVKGVFAAGDCTTVPYKQIIIATGEGAKASLSAFDYLIRTKIA'),
('P06993', '1HZ4', 1, 1.45, 'A', 370, 'TRANSCRIPTION ACTIVATOR', 'TRANSCRIPTION', 'HTH-type transcriptional regulator MalT', 'malT', '', 'ATP binding<br />\nDNA binding<br />\nidentical protein binding<br />\ntrisaccharide binding<br />\n', 'carbohydrate metabolic process<br />\nregulation of transcription, DNA-templated<br />\ntranscription, DNA-templated<br />\n', 'PF00196.', 'MLIPSKLSRPVRLDHTVVRERLLAKLSGANNFRLALITSPAGYGKTTLISQWAAGKNDIGWYSLDEGDNQQERFASYLIAAVQQATNGHCAICETMAQKRQYASLTSLFAQLFIELAEWHSPLYLVIDDYHLITNPVIHESMRFFIRHQPENLTLVVLSRNLPQLGIANLRVRDQLLEIGSQQLAFTHQEAKQFFDCRLSSPIEAAESSRICDDVSGWATALQLIALSARQNTHSAHKSARRLAGINASHLSDYLVDEVLDNVDLATRHFLLKSAILRSMNDALITRVTGEENGQMRLEEIERQGLFLQRMDDTGEWFCYHPLFGNFLRQRCQWELAAELPEIHRAAAESWMAQGFPSEAIHHALAAGDALMLRDILLNHAWSLFNHSELSLLEESLKALPWDSLLENPQLVLLQAWLMQSQHRYGEVNTLLARAEHEIKDIREDTMHAEFNALRAQVAINDGNPDEAERLAKLALEELPPGWFYSRIVATSVLGEVLHCKGELTRSLALMQQTEQMARQHDVWHYALWSLIQQSEILFAQGFLQTAWETQEKAFQLINEQHLEQLPMHEFLVRIRAQLLWAWARLDEAEASARSGIEVLSSYQPQQQLQCLAMLIQCSLARGDLDNARSQLNRLENLLGNGKYHSDWISNANKVRVIYWQMTGDKAAAANWLRHTAKPEFANNHFLQGQWRNIARAQILLGEFEPAEIVLEELNENARSLRLMSDLNRNLLLLNQLYWQAGRKSDAQRVLLDALKLANRTGFISHFVIEGEAMAQQLRQLIQLNTLPELEQHRAQRILREINQHHRHKFAHFDENFVERLLNHPEVPELIRTSPLTQREWQVLGLIYSGYSNEQIAGELEVAATTIKTHIRNLYQKLGVAHRQDAVQHAQQLLKMMGYGV'),
('P14061', '1I5R', 1, 1.6, 'A', 327, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Estradiol 17-beta-dehydrogenase 1', 'HSD17B1', '17-beta-estradiol + NAD(P)+ = estrone + NAD(P)H.<br />\n', 'catalytic activity<br />\nestradiol 17-beta-dehydrogenase activity<br />\nestradiol binding<br />\nNADP+ binding<br />\nsteroid binding<br />\n', 'estrogen biosynthetic process<br />\nestrogen metabolic process<br />\nsteroid biosynthetic process<br />\n', 'PF00106.', 'MARTVVLITGCSSGIGLHLAVRLASDPSQSFKVYATLRDLKTQGRLWEAARALACPPGSLETLQLDVRDSKSVAAARERVTEGRVDVLVCNAGLGLLGPLEALGEDAVASVLDVNVVGTVRMLQAFLPDMKRRGSGRVLVTGSVGGLMGLPFNDVYCASKFALEGLCESLAVLLLPFGVHLSLIECGPVHTAFMEKVLGSPEEVLDRTDIHTFHRFYQYLAHSKQVFREAAQNPEEVAEVFLTALRAPKPTLRYFTTERFLPLLRMRLDDPSGSNYVTAMHREVFGDVPAKAEAGAEAGGGAGPGAEDEAGRGAVGDPELGDPPAAPQ'),
('P0ACQ4', '1I69', 1, 2.7, 'A/B', 219, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Hydrogen peroxide-inducible genes activator', 'oxyR', '', 'bacterial-type RNA polymerase core promoter proximal region sequence-specific DNA binding<br />\ntranscription factor activity, bacterial-type RNA polymerase core promoter proximal region sequence-specific binding<br />\n', 'cellular response to DNA damage stimulus<br />\nregulation of DNA-templated transcription, initiation<br />\nresponse to nitrosative stress<br />\nresponse to oxidative stress<br />\ntranscription, DNA-templated<br />\n', 'PF00126.', 'MNIRDLEYLVALAEHRHFRRAADSCHVSQPTLSGQIRKLEDELGVMLLERTSRKVLFTQAGMLLVDQARTVLREVKVLKEMASQQGETMSGPLHIGLIPTVGPYLLPHIIPMLHQTFPKLEMYLHEAQTHQLLAQLDSGKLDCVILALVKESEAFIEVPLFDEPMLLAIYEDHPWANRECVPMADLAGEKLLMLEDGHCLRDQAMGFCFEAGADEDTHFRATSLETLRNMVAAGSGITLLPALAVPPERKRDGVVYLPCIKPEPRRTIGLVYRPGSPLRSRYEQLAEAIRARMDGHFDKVLKQAV'),
('P00953', '1I6K', 1, 1.72, 'A', 328, 'LIGASE', 'LIGASE', 'Tryptophan--tRNA ligase', 'trpS', 'ATP + L-tryptophan + tRNA(Trp) = AMP + diphosphate + L-tryptophyl-tRNA(Trp).<br />\n', 'ATP binding<br />\ntryptophan-tRNA ligase activity<br />\n', 'tryptophanyl-tRNA aminoacylation<br />\n', 'PF00579.', 'MKTIFSGIQPSGVITIGNYIGALRQFVELQHEYNCYFCIVDQHAITVWQDPHELRQNIRRLAAKYLAVGIDPTQATLFIQSEVPAHAQAAWMLQCIVYIGELERMTQFKEKSAGKEAVSAGLLTYPPLMAADILLYNTDIVPVGEDQKQHIELTRDLAERFNKRYGELFTIPEARIPKVGARIMSLVDPTKKMSKSDPNPKAYITLLDDAKTIEKKIKSAVTDSEGTIRYDKEAKPGISNLLNIYSTLSGQSIEELERQYEGKGYGVFKADLAQVVIETLRPIQERYHHWMESEELDRVLDEGAEKANRVASEMVRKMEQAMGLGRRR'),
('P37747', '1I8T', 1, 2.4, 'A/B', 367, 'ISOMERASE', 'ISOMERASE', 'UDP-galactopyranose mutase', 'glf', 'UDP-alpha-D-galactopyranose = UDP-alpha-D-galactofuranose<br />\n', 'flavin adenine dinucleotide binding<br />\nUDP-galactopyranose mutase activity<br />\n', 'lipopolysaccharide biosynthetic process<br />\n', 'PF03275.', 'MYDYIIVGSGLFGAVCANELKKLNKKVLVIEKRNHIGGNAYTEDCEGIQIHKYGAHIFHTNDKYIWDYVNDLVEFNRFTNSPLAIYKDKLFNLPFNMNTFHQMWGVKDPQEAQNIINAQKKKYGDKVPENLEEQAISLVGEDLYQALIKGYTEKQWGRSAKELPAFIIKRIPVRFTFDNNYFSDRYQGIPVGGYTKLIEKMLEGVDVKLGIDFLKDKDSLASKAHRIIYTGPIDQYFDYRFGALEYRSLKFETERHEFPNFQGNAVINFTDANVPYTRIIEHKHFDYVETKHTVVTKEYPLEWKVGDEPYYPVNDNKNMELFKKYRELASREDKVIFGGRLAEYKYYDMHQVISAALYQVKNIMSTD'),
('P05362', '1IAM', 0, 2.1, 'A', 185, 'Viral protein receptor', 'OTHERS', 'Intercellular adhesion molecule 1', 'ICAM1', '', 'integrin binding<br />\nreceptor activity<br />\ntransmembrane signaling receptor activity<br />\nvirus receptor activity<br />\n', 'acute inflammatory response to antigenic stimulus<br />\nadhesion of symbiont to host<br />\ncell adhesion<br />\ncell adhesion mediated by integrin<br />\ncell aging<br />\ncellular response to alkaloid<br />\ncellular response to dexamethasone stimulus<br />\ncellular response to glucose stimulus<br />\ncellular response to hypoxia<br />\ncellular response to interleukin-1<br />\ncellular response to interleukin-6<br />\ncellular response to leukemia inhibitory factor<br />\ncellular response to lipopolysaccharide<br />\ncellular response to nutrient levels<br />\ncellular response to tumor necrosis factor<br />\nestablishment of endothelial barrier<br />\nestablishment of endothelial intestinal barrier<br />\nestablishment of Sertoli cell barrier<br />\nextracellular matrix organization<br />\nheterophilic cell-cell adhesion via plasma membrane cell adhesion molecules<br />\ninterferon-gamma-mediated signaling pathway<br />\nleukocyte cell-cell adhesion<br />\nleukocyte migration<br />\nmembrane to membrane docking<br />\nnegative regulation of calcium ion transport<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors<br />\novarian follicle development<br />\npositive regulation of actin filament polymerization<br />\npositive regulation of cellular extravasation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of GTPase activity<br />\npositive regulation of leukocyte adhesion to vascular endothelial cell<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of vasoconstriction<br />\nreceptor-mediated virion attachment to host cell<br />\nregulation of cell shape<br />\nregulation of immune response<br />\nregulation of leukocyte mediated cytotoxicity<br />\nregulation of ruffle assembly<br />\nresponse to amino acid<br />\nresponse to amphetamine<br />\nresponse to copper ion<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to gonadotropin<br />\nresponse to insulin<br />\nresponse to ionizing radiation<br />\nresponse to sulfur dioxide<br />\nsensory perception of sound<br />\nT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell<br />\nT cell antigen processing and presentation<br />\n', 'PF03921.', 'MAPSSPRPALPALLVLLGALFPGPGNAQTSVSPSKVILPRGGSVLVTCSTSCDQPKLLGIETPLPKKELLLPGNNRKVYELSNVQEDSQPMCYSNCPDGQSTAKTFLTVYWTPERVELAPLPSWQPVGKNLTLRCQVEGGAPRANLTVVLLRGEKELKREPAVGEPAEVTTTVLVRRDHHGANFSCRTELDLRPQGLELFENTSAPYQLQTFVLPATPPQLVSPRVLEVDTQGTVVCSLDGLFPVSEAQVHLALGDQRLNPTVTYGNDSFSAKASVSVTAEDEGTQRLTCAVILGNQSQETLQTVTIYSFPAPNVILTKPEVSEGTEVTVKCEAHPRAKVTLNGVPAQPLGPRAQLLLKATPEDNGRSFSCSATLEVAGQLIHKNQTRELRVLYGPRLDERDCPGNWTWPENSQQTPMCQAWGNPLPELKCLKDGTFPLPIGESVTVTRDLEGTYLCRARSTQGEVTRKVTVNVLSPRYEIVIITVVAAAVIMGTAGLSTYLYNRQRKIKKYRLQQAQKGTPMKPNTQATPP'),
('P25963', '1IKN', 0, 2.3, 'D', 236, 'TRANSCRIPTION FACTOR', 'TRANSCRIPTION', 'NF-kappa-B inhibitor alpha', 'NFKBIA', '', 'enzyme binding<br />\nheat shock protein binding<br />\nidentical protein binding<br />\nNF-kappaB binding<br />\nnuclear localization sequence binding<br />\nprotein complex binding<br />\ntranscription factor binding<br />\nubiquitin protein ligase binding<br />\n', 'apoptotic process<br />\ncellular response to cold<br />\ncellular response to organic cyclic compound<br />\ncytoplasmic sequestering of NF-kappaB<br />\ncytoplasmic sequestering of transcription factor<br />\nFc-epsilon receptor signaling pathway<br />\nI-kappaB kinase/NF-kappaB signaling<br />\nlipopolysaccharide-mediated signaling pathway<br />\nliver regeneration<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of DNA binding<br />\nnegative regulation of lipid storage<br />\nnegative regulation of macrophage derived foam cell differentiation<br />\nnegative regulation of myeloid cell differentiation<br />\nnegative regulation of NF-kappaB transcription factor activity<br />\nnegative regulation of Notch signaling pathway<br />\nnucleotide-binding oligomerization domain containing 1 signaling pathway<br />\nnucleotide-binding oligomerization domain containing 2 signaling pathway<br />\npositive regulation of cellular protein metabolic process<br />\npositive regulation of cholesterol efflux<br />\npositive regulation of inflammatory response<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein deubiquitination<br />\nprotein import into nucleus, translocation<br />\nregulation of cell proliferation<br />\nregulation of NF-kappaB import into nucleus<br />\nresponse to exogenous dsRNA<br />\nresponse to muramyl dipeptide<br />\nresponse to muscle stretch<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nT cell receptor signaling pathway<br />\ntoll-like receptor 4 signaling pathway<br />\ntumor necrosis factor-mediated signaling pathway<br />\nviral process<br />\n', 'PF00023.', 'MFQAAERPQEWAMEGPRDGLKKERLLDDRHDSGLDSMKDEEYEQMVKELQEIRLEPQEVPRGSEPWKQQLTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTESEFTEFTEDELPYDDCVFGGQRLTL'),
('P29218', '1IMB', 1, 2.2, 'A/B', 277, 'HYDROLASE', 'HYDROLASE', 'Inositol monophosphatase 1', 'IMPA1', 'Myo-inositol phosphate + H2O = myo-inositol + phosphate<br />\nAlpha-D-galactose 1-phosphate + H2O = D-galactose + phosphate<br />\n', 'identical protein binding<br />\ninositol monophosphate 1-phosphatase activity<br />\ninositol monophosphate 3-phosphatase activity<br />\ninositol monophosphate 4-phosphatase activity<br />\ninositol monophosphate phosphatase activity<br />\nlithium ion binding<br />\nmagnesium ion binding<br />\nmanganese ion binding<br />\nprotein homodimerization activity<br />\n', 'inositol biosynthetic process<br />\ninositol metabolic process<br />\ninositol phosphate dephosphorylation<br />\ninositol phosphate metabolic process<br />\nphosphate-containing compound metabolic process<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol phosphorylation<br />\nsignal transduction<br />\n', 'PF00459.', 'MADPWQECMDYAVTLARQAGEVVCEAIKNEMNVMLKSSPVDLVTATDQKVEKMLISSIKEKYPSHSFIGEESVAAGEKSILTDNPTWIIDPIDGTTNFVHRFPFVAVSIGFAVNKKIEFGVVYSCVEGKMYTARKGKGAFCNGQKLQVSQQEDITKSLLVTELGSSRTPETVRMVLSNMEKLFCIPVHGIRSVGTAAVNMCLVATGGADAYYEMGIHCWDVAGAGIIVTEAGGVLMDVTGGPFDLMSRRVIAANNRILAERIAKEIQVIPLQRDDED'),
('P69905', '1IRD', 1, 1.25, 'A', 141, 'OXYGEN STORAGE / TRANSPORT', 'OTHERS', 'Hemoglobin subunit alpha', 'HBA1', '', 'heme binding<br />\niron ion binding<br />\noxygen binding<br />\noxygen transporter activity<br />\n', 'bicarbonate transport<br />\ncellular oxidant detoxification<br />\nhydrogen peroxide catabolic process<br />\noxygen transport<br />\npositive regulation of cell death<br />\nprotein heterooligomerization<br />\nreceptor-mediated endocytosis<br />\nresponse to hydrogen peroxide<br />\n', 'PF00042.', 'MVLSPADKTNVKAAWGKVGAHAGEYGAEALERMFLSFPTTKTYFPHFDLSHGSAQVKGHGKKVADALTNAVAHVDDMPNALSALSDLHAHKLRVDPVNFKLLSHCLLVTLAAHLPAEFTPAVHASLDKFLASVSTVLTSKYR'),
('Q10588', '1ISI', 1, 2.1, 'A/B', 265, 'HYDROLASE', 'HYDROLASE', 'ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2', 'BST1', 'NAD+ + H2O = ADP-D-ribose + nicotinamide.<br />\n', 'ADP-ribosyl cyclase activity<br />\ncyclic ADP-ribose hydrolase<br />\nNAD(P)+ nucleosidase activity<br />\nNAD+ nucleosidase activity<br />\nNAD+ nucleotidase, cyclic ADP-ribose generating<br />\nphosphorus-oxygen lyase activity<br />\ntransferase activity<br />\n', 'C-terminal protein lipidation<br />\nhumoral immune response<br />\nNAD metabolic process<br />\nneutrophil degranulation<br />\npositive regulation of B cell proliferation<br />\npositive regulation of cell proliferation<br />\nregulation of actin cytoskeleton organization<br />\nregulation of calcium-mediated signaling<br />\nregulation of cell-matrix adhesion<br />\nregulation of cellular extravasation<br />\nregulation of inflammatory response<br />\nregulation of integrin-mediated signaling pathway<br />\nregulation of neutrophil chemotaxis<br />\nregulation of peptidyl-tyrosine phosphorylation<br />\nregulation of superoxide metabolic process<br />\nsignal transduction<br />\n', 'PF02267.', 'MAAQGCAASRLLQLLLQLLLLLLLLAAGGARARWRGEGTSAHLRDIFLGRCAEYRALLSPEQRNKNCTAIWEAFKVALDKDPCSVLPSDYDLFINLSRHSIPRDKSLFWENSHLLVNSFADNTRRFMPLSDVLYGRVADFLSWCRQKNDSGLDYQSCPTSEDCENNPVDSFWKRASIQYSKDSSGVIHVMLNGSEPTGAYPIKGFFADYEIPNLQKEKITRIEIWVMHEIGGPNVESCGEGSMKVLEKRLKDMGFQYSCINDYRPVKLLQCVDHSTHPDCALKSAAAATQRKAPSLYTEQRAGLIIPLFLVLASRTQL'),
('P16444', '1ITU', 1, 2, 'A/B', 369, 'HYDROLASE', 'HYDROLASE', 'Dipeptidase 1', 'DPEP1', 'Hydrolysis of dipeptides<br />\n', 'cysteine-type endopeptidase inhibitor activity involved in apoptotic process<br />\ndipeptidase activity<br />\ndipeptidyl-peptidase activity<br />\nGPI anchor binding<br />\nmetallodipeptidase activity<br />\nmetalloexopeptidase activity<br />\nmodified amino acid binding<br />\nzinc ion binding<br />\n', 'antibiotic metabolic process<br />\ncellular lactam catabolic process<br />\ncellular response to calcium ion<br />\ncellular response to drug<br />\ncellular response to nitric oxide<br />\nglutathione metabolic process<br />\nhomocysteine metabolic process<br />\nleukotriene metabolic process<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell migration<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nxenobiotic metabolic process<br />\n', 'PF01244.', 'MWSGWWLWPLVAVCTADFFRDEAERIMRDSPVIDGHNDLPWQLLDMFNNRLQDERANLTTLAGTHTNIPKLRAGFVGGQFWSVYTPCDTQNKDAVRRTLEQMDVVHRMCRMYPETFLYVTSSAGIRQAFREGKVASLIGVEGGHSIDSSLGVLRALYQLGMRYLTLTHSCNTPWADNWLVDTGDSEPQSQGLSPFGQRVVKELNRLGVLIDLAHVSVATMKATLQLSRAPVIFSHSSAYSVCASRRNVPDDVLRLVKQTDSLVMVNFYNNYISCTNKANLSQVADHLDHIKEVAGARAVGFGGDFDGVPRVPEGLEDVSKYPDLIAELLRRNWTEAEVKGALADNLLRVFEAVEQASNLTQAPEEEPIPLDQLGGSCRTHYGYSSGASSLHRHWGLLLASLAPLVLCLSLL'),
('P26440', '1IVH', 1, 2.6, 'A/B/C/D', 394, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Isovaleryl-CoA dehydrogenase, mitochondrial', 'IVD', 'Isovaleryl-CoA + electron-transfer flavoprotein = 3-methylcrotonyl-CoA + reduced electron-transfer flavoprotein.<br />\n', 'flavin adenine dinucleotide binding<br />\nisovaleryl-CoA dehydrogenase activity<br />\n', 'branched-chain amino acid catabolic process<br />\nfatty acid beta-oxidation using acyl-CoA dehydrogenase<br />\nleucine catabolic process<br />\n', 'PF00441.', 'MATATRLLGWRVASWRLRPPLAGFVSQRAHSLLPVDDAINGLSEEQRQLRQTMAKFLQEHLAPKAQEIDRSNEFKNLREFWKQLGNLGVLGITAPVQYGGSGLGYLEHVLVMEEISRASGAVGLSYGAHSNLCINQLVRNGNEAQKEKYLPKLISGEYIGALAMSEPNAGSDVVSMKLKAEKKGNHYILNGNKFWITNGPDADVLIVYAKTDLAAVPASRGITAFIVEKGMPGFSTSKKLDKLGMRGSNTCELIFEDCKIPAANILGHENKGVYVLMSGLDLERLVLAGGPLGLMQAVLDHTIPYLHVREAFGQKIGHFQLMQGKMADMYTRLMACRQYVYNVAKACDEGHCTAKDCAGVILYSAECATQVALDGIQCFGGNGYINDFPMGRFLRDAKLYEIGAGTSEVRRLVIGRAFNADFH'),
('P13922', '1J3K', 1, 2.1, 'A/B', 280, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Bifunctional dihydrofolate reductase-thymidylate synthase', 'N/A', '5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH.<br />\r\n5,10-methylenetetrahydrofolate + dUMP = dihydrofolate + dTMP.<br />', 'dihydrofolate reductase activity<br />\r\nthymidylate synthase activity<br />', 'dTMP biosynthetic process<br />\r\nglycine biosynthetic process<br />\r\none-carbon metabolic process<br />\r\ntetrahydrofolate biosynthetic process<br />', 'PF00186.', 'MMEQVCDVFDIYAICACCKVESKNEGKKNEVFNNYTFRGLGNKGVLPWKC\r\nNSLDMKYFRAVTTYVNESKYEKLKYKRCKYLNKETVDNVNDMPNSKKLQN\r\nVVVMGRTNWESIPKKFKPLSNRINVILSRTLKKEDFDEDVYIINKVEDLI\r\nVLLGKLNYYKCFIIGGSVVYQEFLEKKLIKKIYFTRINSTYECDVFFPEI\r\nNENEYQIISVSDVYTSNNTTLDFIIYKKTNNKMLNEQNCIKGEEKNNDMP\r\nLKNDDKDTCHMKKLTEFYKNVDKYKINYENDDDDEEEDDFVYFNFNKEKE\r\nEKNKNSIHPNDFQIYNSLKYKYHPEYQYLNIIYDIMMNGNKQSDRTGVGV\r\nLSKFGYIMKFDLSQYFPLLTTKKLFLRGIIEELLWFIRGETNGNTLLNKN\r\nVRIWEANGTREFLDNRKLFHREVNDLGPIYGFQWRHFGAEYTNMYDNYEN\r\nKGVDQLKNIINLIKNDPTSRRILLCAWNVKDLDQMALPPCHILCQFYVFD\r\nGKLSCIMYQRSCDLGLGVPFNIASYSIFTHMIAQVCNLQPAQFIHVLGNA\r\nHVYNNHIDSLKIQLNRIPYPFPTLKLNPDIKNIEDFTISDFTIQNYVHHE\r\nKISMDMAA'),
('P25815', '1J55', 0, 2, 'A', 95, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Protein S100-P', 'S100P', '', 'cadherin binding<br />\ncalcium-dependent protein binding<br />\ncalcium ion binding<br />\nmagnesium ion binding<br />\nRAGE receptor binding<br />\ntransition metal ion binding<br />\n', 'endothelial cell migration<br />\nneutrophil degranulation<br />\nresponse to organic substance<br />\n', 'PF01023.', 'MTELETAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFIVFVAAITSACHKYFEKAGLK'),
('Q9WZD5', '1J6O', 0, 1.8, 'A', 256, 'HYDROLASE', 'HYDROLASE', 'Uncharacterized protein', 'TM_0667', NULL, 'deoxyribonuclease activity', 'DNA catabolic process', 'PF01026.', 'MVDTHAHLHFHQFDDDRNAVISSFEENNIEFVVNVGVNLEDSKKSLDLSK\r\nTSDRIFCSVGVHPHDAKEVPEDFIEHLEKFAKDEKVVAIGETGLDFFRNI\r\nSPAEVQKRVFVEQIELAGKLNLPLVVHIRDAYSEAYEILRTESLPEKRGV\r\nIHAFSSDYEWAKKFIDLGFLLGIGGPVTYPKNEALREVVKRVGLEYIVLE\r\nTDCPFLPPQPFRGKRNEPKYLKYVVETISQVLGVPEAKVDEATTENARRI\r\nFLEVKE'),
('P00439', '1J8U', 1, 1.5, 'A', 325, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Phenylalanine-4-hydroxylase', 'PAH', 'L-phenylalanine + tetrahydrobiopterin + O2 = L-tyrosine + 4a-hydroxytetrahydrobiopterin.<br />\n', 'iron ion binding<br />\nphenylalanine 4-monooxygenase activity<br />\n', 'catecholamine biosynthetic process<br />\ncellular amino acid biosynthetic process<br />\nL-phenylalanine catabolic process<br />\nneurotransmitter biosynthetic process<br />\n', 'PF01842.', 'MSTAVLENPGLGRKLSDFGQETSYIEDNCNQNGAISLIFSLKEEVGALAKVLRLFEENDVNLTHIESRPSRLKKDEYEFFTHLDKRSLPALTNIIKILRHDIGATVHELSRDKKKDTVPWFPRTIQELDRFANQILSYGAELDADHPGFKDPVYRARRKQFADIAYNYRHGQPIPRVEYMEEEKKTWGTVFKTLKSLYKTHACYEYNHIFPLLEKYCGFHEDNIPQLEDVSQFLQTCTGFRLRPVAGLLSSRDFLGGLAFRVFHCTQYIRHGSKPMYTPEPDICHELLGHVPLFSDRSFAQFSQEIGLASLGAPDEYIEKLATIYWFTVEFGLCKQGDSIKAYGAGLLSSFGELQYCLSEKPKLLPLELEKTAIQNYTVTEFQPLYYVAESFNDAKEKVRNFAATIPRPFSVRYDPYTQRIEVLDNTQQLKILADSINSEIGILCSALQKIK'),
('P20839', '1JCN', 0, 2.5, 'A/B', 514, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Inosine-5''-monophosphate dehydrogenase 1', 'IMPDH1', 'Inosine 5''-phosphate + NAD+ + H2O = xanthosine 5''-phosphate + NADH<br />\n', 'DNA binding<br />\nIMP dehydrogenase activity<br />\nmetal ion binding<br />\nnucleic acid binding<br />\nRNA binding<br />\n', 'GMP biosynthetic process<br />\nGTP biosynthetic process<br />\nlymphocyte proliferation<br />\nneutrophil degranulation<br />\npurine ribonucleoside monophosphate biosynthetic process<br />\n', 'PF00571.', 'MADYLISGGTGYVPEDGLTAQQLFASADGLTYNDFLILPGFIDFIADEVDLTSALTRKITLKTPLISSPMDTVTEADMAIAMALMGGIGFIHHNCTPEFQANEVRKVKKFEQGFITDPVVLSPSHTVGDVLEAKMRHGFSGIPITETGTMGSKLVGIVTSRDIDFLAEKDHTTLLSEVMTPRIELVVAPAGVTLKEANEILQRSKKGKLPIVNDCDELVAIIARTDLKKNRDYPLASKDSQKQLLCGAAVGTREDDKYRLDLLTQAGVDVIVLDSSQGNSVYQIAMVHYIKQKYPHLQVIGGNVVTAAQAKNLIDAGVDGLRVGMGCGSICITQEVMACGRPQGTAVYKVAEYARRFGVPIIADGGIQTVGHVVKALALGASTVMMGSLLAATTEAPGEYFFSDGVRLKKYRGMGSLDAMEKSSSSQKRYFSEGDKVKIAQGVSGSIQDKGSIQKFVPYLIAGIQHGCQDIGARSLSVLRSMMYSGELKFEKRTMSAQIEGGVHGLHSYEKRLY'),
('P17707', '1JL0', 1, 1.5, 'A/B', 334, 'LYASE', 'LYASE', 'S-adenosylmethionine decarboxylase proenzyme', 'AMD1', 'S-adenosyl-L-methionine = S-adenosyl 3-(methylthio)propylamine + CO2<br />\n', 'adenosylmethionine decarboxylase activity<br />\nputrescine binding<br />\n', 'polyamine metabolic process<br />\nS-adenosylmethioninamine biosynthetic process<br />\nS-adenosylmethionine metabolic process<br />\nspermidine biosynthetic process<br />\nspermine biosynthetic process<br />\n', 'PF01536.', 'MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSESSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMFNPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS'),
('P05412', '1JNM', 0, 2.2, 'A/B', 62, 'TRANSCRIPTION / DNA', 'TRANSCRIPTION', 'Transcription factor AP-1', 'JUN', '', 'cAMP response element binding<br />\nchromatin binding<br />\nDNA binding<br />\nenzyme binding<br />\nGTPase activator activity<br />\nHMG box domain binding<br />\nidentical protein binding<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nRNA binding<br />\nRNA polymerase II activating transcription factor binding<br />\nRNA polymerase II core promoter proximal region sequence-specific DNA binding<br />\nRNA polymerase II distal enhancer sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, sequence-specific DNA binding<br />\nR-SMAD binding<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscriptional activator activity, RNA polymerase II transcription factor binding<br />\ntranscription coactivator activity<br />\ntranscription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscription factor activity, RNA polymerase II distal enhancer sequence-specific binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\ntranscription regulatory region DNA binding<br />\nubiquitin protein ligase binding<br />\n', 'aging<br />\nangiogenesis<br />\naxon regeneration<br />\ncellular response to cadmium ion<br />\ncellular response to calcium ion<br />\ncellular response to hormone stimulus<br />\ncellular response to potassium ion starvation<br />\ncellular response to reactive oxygen species<br />\ncircadian rhythm<br />\neyelid development in camera-type eye<br />\nFc-epsilon receptor signaling pathway<br />\nleading edge cell differentiation<br />\nlearning<br />\nliver development<br />\nmembrane depolarization<br />\nmicroglial cell activation<br />\nmonocyte differentiation<br />\nnegative regulation by host of viral transcription<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of DNA binding<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of protein autophosphorylation<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress<br />\noutflow tract morphogenesis<br />\npositive regulation by host of viral transcription<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell differentiation<br />\npositive regulation of DNA replication<br />\npositive regulation of DNA-templated transcription, initiation<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of epithelial cell migration<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of monocyte differentiation<br />\npositive regulation of neuron apoptotic process<br />\npositive regulation of pri-miRNA transcription from RNA polymerase II promoter<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nRas protein signal transduction<br />\nregulation of cell cycle<br />\nregulation of cell proliferation<br />\nregulation of sequence-specific DNA binding transcription factor activity<br />\nrelease of cytochrome c from mitochondria<br />\nresponse to cAMP<br />\nresponse to cytokine<br />\nresponse to drug<br />\nresponse to hydrogen peroxide<br />\nresponse to lipopolysaccharide<br />\nresponse to mechanical stimulus<br />\nresponse to muscle stretch<br />\nresponse to radiation<br />\nSMAD protein import into nucleus<br />\nSMAD protein signal transduction<br />\ntransforming growth factor beta receptor signaling pathway<br />\n', 'PF00170.', 'MTAKMETTFYDDALNASFLPSESGPYGYSNPKILKQSMTLNLADPVGSLKPHLRAKNSDLLTSPDVGLLKLASPELERLIIQSSNGHITTTPTPTQFLCPKNVTDEQEGFAEGFVRALAELHSQNTLPSVTSAAQPVNGAGMVAPAVASVAGGSGSGGFSASLHSEPPVYANLSNFNPGALSSGGGAPSYGAAGLAFPAQPQQQQQPPHHLPQQMPVQHPRLQALKEEPQTVPEMPGETPPLSPIDMESQERIKAERKRMRNRIAASKCRKRKLERIARLEEKVKTLKAQNSELASTANMLREQVAQLKQKVMNHVNSGCQLMLTQQLQTF'),
('P0A0N4', '1JT6', 1, 2.54, 'A/B/D/E', 188, 'TRANSCRIPTION', 'TRANSCRIPTION', 'HTH-type transcriptional regulator QacR', 'qacR', '', 'DNA binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\n', 'negative regulation of transcription, DNA-templated<br />\ntranscription, DNA-templated<br />\n', 'PF08360.', 'MNLKDKILGVAKELFIKNGYNATTTGEIVKLSESSKGNLYYHFKTKENLFLEILNIEESKWQEQWKKEQIKCKTNREKFYLYNELSLTTEYYYPLQNAIIEFYTEYYKTNSINEKMNKLENKYIDAYHVIFKEGNLNGEWCINDVNAVSKIAANAVNGIVTFTHEQNINERIKLMNKFSQIFLNGLSK');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P00722', '1JZ8', 1, 1.5, 'A/B/C/D', 1015, 'HYDROLASE', 'HYDROLASE', 'Beta-galactosidase', 'lacZ', 'Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides.<br />\n', 'alkali metal ion binding<br />\nbeta-galactosidase activity<br />\ncarbohydrate binding<br />\nidentical protein binding<br />\nmagnesium ion binding<br />\n', 'lactose catabolic process<br />\n', 'PF02929.', 'MTMITDSLAVVLQRRDWENPGVTQLNRLAAHPPFASWRNSEEARTDRPSQQLRSLNGEWRFAWFPAPEAVPESWLECDLPEADTVVVPSNWQMHGYDAPIYTNVTYPITVNPPFVPTENPTGCYSLTFNVDESWLQEGQTRIIFDGVNSAFHLWCNGRWVGYGQDSRLPSEFDLSAFLRAGENRLAVMVLRWSDGSYLEDQDMWRMSGIFRDVSLLHKPTTQISDFHVATRFNDDFSRAVLEAEVQMCGELRDYLRVTVSLWQGETQVASGTAPFGGEIIDERGGYADRVTLRLNVENPKLWSAEIPNLYRAVVELHTADGTLIEAEACDVGFREVRIENGLLLLNGKPLLIRGVNRHEHHPLHGQVMDEQTMVQDILLMKQNNFNAVRCSHYPNHPLWYTLCDRYGLYVVDEANIETHGMVPMNRLTDDPRWLPAMSERVTRMVQRDRNHPSVIIWSLGNESGHGANHDALYRWIKSVDPSRPVQYEGGGADTTATDIICPMYARVDEDQPFPAVPKWSIKKWLSLPGETRPLILCEYAHAMGNSLGGFAKYWQAFRQYPRLQGGFVWDWVDQSLIKYDENGNPWSAYGGDFGDTPNDRQFCMNGLVFADRTPHPALTEAKHQQQFFQFRLSGQTIEVTSEYLFRHSDNELLHWMVALDGKPLASGEVPLDVAPQGKQLIELPELPQPESAGQLWLTVRVVQPNATAWSEAGHISAWQQWRLAENLSVTLPAASHAIPHLTTSEMDFCIELGNKRWQFNRQSGFLSQMWIGDKKQLLTPLRDQFTRAPLDNDIGVSEATRIDPNAWVERWKAAGHYQAEAALLQCTADTLADAVLITTAHAWQHQGKTLFISRKTYRIDGSGQMAITVDVEVASDTPHPARIGLNCQLAQVAERVNWLGLGPQENYPDRLTAACFDRWDLPLSDMYTPYVFPSENGLRCGTRELNYGPHQWRGDFQFNISRYSQQQLMETSHRHLLHAEEGTWLNIDGFHMGIGGDDSWSPSVSAEFQLSAGRYHYQLVWCQK'),
('P20586', '1K0I', 1, 1.8, 'A', 394, 'HYDROLASE', 'HYDROLASE', 'p-hydroxybenzoate hydroxylase', 'pobA', '4-hydroxybenzoate + NADPH + O2 = protocatechuate + NADP+ + H2O<br />\n', '4-hydroxybenzoate 3-monooxygenase activity<br />\nFAD binding<br />\nflavin adenine dinucleotide binding<br />\n', 'benzoate catabolic process via hydroxylation<br />\n', 'PF01494.', 'MKTQVAIIGAGPSGLLLGQLLHKAGIDNVILERQTPDYVLGRIRAGVLEQGMVDLLREAGVDRRMARDGLVHEGVEIAFAGQRRRIDLKRLSGGKTVTVYGQTEVTRDLMEAREACGATTVYQAAEVRLHDLQGERPYVTFERDGERLRLDCDYIAGCDGFHGISRQSIPAERLKVFERVYPFGWLGLLADTPPVSHELIYANHPRGFALCSQRSATRSRYYVQVPLSEKVEDWSDERFWTELKARLPSEVAEKLVTGPSLEKSIAPLRSFVVEPMQHGRLFLAGDAAHIVPPTGAKGLNLAASDVSTLYRLLLKAYREGRGELLERYSAICLRRIWKAERFSWWMTSVLHRFPDTDAFSQRIQQTELEYYLGSEAGLATIAENYVGLPYEEIE'),
('P11274', '1K1F', 0, 2.2, 'A/B/C/D/E/F/G/H', 72, 'TRANSFERASE', 'TRANSFERASE', 'Breakpoint cluster region protein', 'BCR', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nenzyme binding<br />\nGTPase activator activity<br />\nkinase activity<br />\nprotein serine/threonine kinase activity<br />\nprotein tyrosine kinase activity<br />\nRho guanyl-nucleotide exchange factor activity<br />\n', 'actin cytoskeleton organization<br />\nbrain development<br />\ncellular response to lipopolysaccharide<br />\ndefinitive hemopoiesis<br />\nhomeostasis of number of cells<br />\ninner ear morphogenesis<br />\nintracellular protein transmembrane transport<br />\nintracellular signal transduction<br />\nnegative regulation of blood vessel remodeling<br />\nnegative regulation of cellular extravasation<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of neutrophil degranulation<br />\nnegative regulation of reactive oxygen species metabolic process<br />\nnegative regulation of respiratory burst<br />\nneuromuscular process controlling balance<br />\nplatelet-derived growth factor receptor signaling pathway<br />\npositive regulation of GTPase activity<br />\npositive regulation of phagocytosis<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of cell cycle<br />\nregulation of nitrogen compound metabolic process<br />\nregulation of Rho protein signal transduction<br />\nregulation of small GTPase mediated signal transduction<br />\nregulation of vascular permeability<br />\nrenal system process<br />\nsignal transduction<br />\n', 'PF09036.', 'MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERCKASIRRLEQEVNQERFRMIYLQTLLAKEKKSYDRQRWGFRRAAQAPDGASEPRASASRPQPAPADGADPPPAEEPEARPDGEGSPGKARPGTARRPGAAASGERDDRGPPASVAALRSNFERIRKGHGQPGADAEKPFYVNVEFHHERGLVKVNDKEVSDRISSLGSQAMQMERKKSQHGAGSSVGDASRPPYRGRSSESSCGVDGDYEDAELNPRFLKDNLIDANGGSRPPWPPLEYQPYQSIYVGGMMEGEGKGPLLRSQSTSEQEKRLTWPRRSYSPRSFEDCGGGYTPDCSSNENLTSSEEDFSSGQSSRVSPSPTTYRMFRDKSRSPSQNSQQSFDSSSPPTPQCHKRHRHCPVVVSEATIVGVRKTGQIWPNDGEGAFHGDADGSFGTPPGYGCAADRAEEQRRHQDGLPYIDDSPSSSPHLSSKGRGSRDALVSGALESTKASELDLEKGLEMRKWVLSGILASEETYLSHLEALLLPMKPLKAAATTSQPVLTSQQIETIFFKVPELYEIHKEFYDGLFPRVQQWSHQQRVGDLFQKLASQLGVYRAFVDNYGVAMEMAEKCCQANAQFAEISENLRARSNKDAKDPTTKNSLETLLYKPVDRVTRSTLVLHDLLKHTPASHPDHPLLQDALRISQNFLSSINEEITPRRQSMTVKKGEHRQLLKDSFMVELVEGARKLRHVFLFTDLLLCTKLKKQSGGKTQQYDCKWYIPLTDLSFQMVDELEAVPNIPLVPDEELDALKIKISQIKNDIQREKRANKGSKATERLKKKLSEQESLLLLMSPSMAFRVHSRNGKSYTFLISSDYERAEWRENIREQQKKCFRSFSLTSVELQMLTNSCVKLQTVHSIPLTINKEDDESPGLYGFLNVIVHSATGFKQSSNLYCTLEVDSFGYFVNKAKTRVYRDTAEPNWNEEFEIELEGSQTLRILCYEKCYNKTKIPKEDGESTDRLMGKGQVQLDPQALQDRDWQRTVIAMNGIEVKLSVKFNSREFSLKRMPSRKQTGVFGVKIAVVTKRERSKVPYIVRQCVEEIERRGMEEVGIYRVSGVATDIQALKAAFDVNNKDVSVMMSEMDVNAIAGTLKLYFRELPEPLFTDEFYPNFAEGIALSDPVAKESCMLNLLLSLPEANLLTFLFLLDHLKRVAEKEAVNKMSLHNLATVFGPTLLRPSEKESKLPANPSQPITMTDSWSLEVMSQVQVLLYFLQLEAIPAPDSKRQSILFSTEV'),
('P08263', '1K3Y', 1, 1.3, 'A/B', 221, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase A1', 'GSTA1', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'glutathione peroxidase activity<br />\nglutathione transferase activity<br />\n', 'epithelial cell differentiation<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nlinoleic acid metabolic process<br />\nmetabolic process<br />\n', 'PF00043.', 'MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAKLALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF'),
('P11387', '1K4T', 1, 2.1, 'A', 592, 'ISOMERASE / DNA', 'ISOMERASE', 'DNA topoisomerase 1', 'TOP1', 'ATP-independent breakage of single-stranded DNA, followed by passage and rejoining<br />\n', 'ATP binding<br />\nchromatin binding<br />\ncore promoter sequence-specific DNA binding<br />\nDNA binding<br />\nDNA topoisomerase type I activity<br />\ndouble-stranded DNA binding<br />\nprotein domain specific binding<br />\nprotein serine/threonine kinase activity<br />\nRNA binding<br />\nsingle-stranded DNA binding<br />\nsupercoiled DNA binding<br />\n', 'chromatin remodeling<br />\nchromosome segregation<br />\ncircadian regulation of gene expression<br />\ncircadian rhythm<br />\nDNA replication<br />\nDNA topological change<br />\nembryonic cleavage<br />\npeptidyl-serine phosphorylation<br />\nphosphorylation<br />\nprogrammed cell death<br />\nprotein sumoylation<br />\nresponse to drug<br />\nviral process<br />\n', 'PF14370.', 'MSGDHLHNDSQIEADFRLNDSHKHKDKHKDREHRHKEHKKEKDREKSKHSNSEHKDSEKKHKEKEKTKHKDGSSEKHKDKHKDRDKEKRKEEKVRASGDAKIKKEKENGFSSPPQIKDEPEDDGYFVPPKEDIKPLKRPRDEDDADYKPKKIKTEDTKKEKKRKLEEEEDGKLKKPKNKDKDKKVPEPDNKKKKPKKEEEQKWKWWEEERYPEGIKWKFLEHKGPVFAPPYEPLPENVKFYYDGKVMKLSPKAEEVATFFAKMLDHEYTTKEIFRKNFFKDWRKEMTNEEKNIITNLSKCDFTQMSQYFKAQTEARKQMSKEEKLKIKEENEKLLKEYGFCIMDNHKERIANFKIEPPGLFRGRGNHPKMGMLKRRIMPEDIIINCSKDAKVPSPPPGHKWKEVRHDNKVTWLVSWTENIQGSIKYIMLNPSSRIKGEKDWQKYETARRLKKCVDKIRNQYREDWKSKEMKVRQRAVALYFIDKLALRAGNEKEEGETADTVGCCSLRVEHINLHPELDGQEYVVEFDFLGKDSIRYYNKVPVEKRVFKNLQLFMENKQPEDDLFDRLNTGILNKHLQDLMEGLTAKVFRTYNASITLQQQLKELTAPDENIPAKILSYNRANRAVAILCNHQRAPPKTFEKSMMNLQTKIDAKKEQLADARRDLKSAKADAKVMKDAKTKKVVESKKKAVQRLEEQLMKLEVQATDREENKQIALGTSKLNYLDPRITVAWCKKWGVPIEKIYNKTQREKFAWAIDMADEDYEF'),
('P04424', '1K62', 0, 2.65, 'A/B', 464, 'LYASE', 'LYASE', 'Argininosuccinate lyase', 'ASL', '2-(N(omega)-L-arginino)succinate = fumarate + L-arginine.<br />\n', 'argininosuccinate lyase activity<br />\nidentical protein binding<br />\n', 'ammonia assimilation cycle<br />\narginine biosynthetic process via ornithine<br />\nlocomotory behavior<br />\npost-embryonic development<br />\nurea cycle<br />\n', 'PF14698.', 'MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEMDQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTDLRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVALTRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVAEFLFWASLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKAGRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENMGQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLFSGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA'),
('P0A6E4', '1K97', 1, 2, 'A', 446, 'LIGASE', 'LIGASE', 'Argininosuccinate synthase', 'argG', 'ATP + L-citrulline + L-aspartate = AMP + diphosphate + N(omega)-(L-arginino)succinate.<br />\n', 'argininosuccinate synthase activity<br />\nATP binding<br />\nidentical protein binding<br />\nprotein homodimerization activity<br />\n', 'arginine biosynthetic process<br />\nargininosuccinate metabolic process<br />\nurea cycle<br />\n', 'PF00764.', 'MTTILKHLPVGQRIGIAFSGGLDTSAALLWMRQKGAVPYAYTANLGQPDEEDYDAIPRRAMEYGAENARLIDCRKQLVAEGIAAIQCGAFHNTTGGLTYFNTTPLGRAVTGTMLVAAMKEDGVNIWGDGSTYKGNDIERFYRYGLLTNAELQIYKPWLDTDFIDELGGRHEMSEFMIACGFDYKMSVEKAYSTDSNMLGATHEAKDLEYLNSSVKIVNPIMGVKFWDESVKIPAEEVTVRFEQGHPVALNGKTFSDDVEMMLEANRIGGRHGLGMSDQIENRIIEAKSRGIYEAPGMALLHIAYERLLTGIHNEDTIEQYHAHGRQLGRLLYQGRWFDSQALMLRDSLQRWVASQITGEVTLELRRGNDYSILNTVSENLTYKPERLTMEKGDSVFSPDDRIGQLTMRNLDITDTREKLFGYAKTGLLSSSAASGVPQVENLENKGQ'),
('P00363', '1KF6', 1, 2.7, 'A/M', 602, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Fumarate reductase flavoprotein subunit', 'frdA', 'Succinate + a quinone = fumarate + a quinol<br />\n', 'electron carrier activity<br />\nFAD binding<br />\nfumarate reductase (menaquinone)<br />\nsuccinate dehydrogenase activity<br />\n', 'anaerobic respiration<br />\nbacterial-type flagellum assembly<br />\nbacterial-type flagellum-dependent cell motility<br />\ncellular response to DNA damage stimulus<br />\nelectron transport chain<br />\nfermentation<br />\n', 'PF00890.', 'MQTFQADLAIVGAGGAGLRAAIAAAQANPNAKIALISKVYPMRSHTVAAEGGSAAVAQDHDSFEYHFHDTVAGGDWLCEQDVVDYFVHHCPTEMTQLELWGCPWSRRPDGSVNVRRFGGMKIERTWFAADKTGFHMLHTLFQTSLQFPQIQRFDEHFVLDILVDDGHVRGLVAMNMMEGTLVQIRANAVVMATGGAGRVYRYNTNGGIVTGDGMGMALSHGVPLRDMEFVQYHPTGLPGSGILMTEGCRGEGGILVNKNGYRYLQDYGMGPETPLGEPKNKYMELGPRDKVSQAFWHEWRKGNTISTPRGDVVYLDLRHLGEKKLHERLPFICELAKAYVGVDPVKEPIPVRPTAHYTMGGIETDQNCETRIKGLFAVGECSSVGLHGANRLGSNSLAELVVFGRLAGEQATERAATAGNGNEAAIEAQAAGVEQRLKDLVNQDGGENWAKIRDEMGLAMEEGCGIYRTPELMQKTIDKLAELQERFKRVRITDTSSVFNTDLLYTIELGHGLNVAECMAHSAMARKESRGAHQRLDEGCTERDDVNFLKHTLAFRDADGTTRLEYSDVKITTLPPAKRVYGGEADAADKAEAANKKEKANG'),
('P00747', '1KI0', 1, 1.75, 'A', 253, 'HYDROLASE', 'HYDROLASE', 'Plasminogen', 'PLG', 'Preferential cleavage: Lys-|-Xaa > Arg-|-Xaa; higher selectivity than trypsin<br />\n', 'apolipoprotein binding<br />\nchaperone binding<br />\nendopeptidase activity<br />\nenzyme binding<br />\nkinase binding<br />\nproteasome core complex binding<br />\nprotein antigen binding<br />\nprotein domain specific binding<br />\nreceptor binding<br />\nserine-type endopeptidase activity<br />\nserine-type peptidase activity<br />\n', 'blood coagulation<br />\ncellular protein metabolic process<br />\nextracellular matrix disassembly<br />\nfibrinolysis<br />\ninteraction with symbiont<br />\ninteraction with symbiont via secreted substance involved in symbiotic interaction<br />\nlabyrinthine layer blood vessel development<br />\nmodification by host of symbiont morphology or physiology via secreted substance<br />\nmononuclear cell migration<br />\nmuscle cell cellular homeostasis<br />\nmyoblast differentiation<br />\nnegative regulation of cell-cell adhesion mediated by cadherin<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of cell-substrate adhesion<br />\nnegative regulation of fibrinolysis<br />\nplatelet degranulation<br />\npositive regulation of blood vessel endothelial cell migration<br />\npositive regulation of fibrinolysis<br />\nproteolysis<br />\nproteolysis involved in cellular protein catabolic process<br />\ntissue regeneration<br />\ntissue remodeling<br />\ntrophoblast giant cell differentiation<br />\n', 'PF00051.', 'MEHKEVVLLLLLFLKSGQGEPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILECEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRELRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTEQLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEEDCMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN'),
('P00374', '1KMV', 1, 1.05, 'A', 186, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydrofolate reductase', 'DHFR', '5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH<br />\n', 'dihydrofolate reductase activity<br />\ndrug binding<br />\nfolate reductase activity<br />\nfolic acid binding<br />\nmethotrexate binding<br />\nmRNA binding<br />\nNADPH binding<br />\nsequence-specific mRNA binding<br />\ntranslation repressor activity, nucleic acid binding<br />\n', 'axon regeneration<br />\ndihydrofolate metabolic process<br />\nfolic acid metabolic process<br />\nglycine biosynthetic process<br />\nnegative regulation of translation<br />\nnucleotide biosynthetic process<br />\none-carbon metabolic process<br />\noxidation-reduction process<br />\npositive regulation of nitric-oxide synthase activity<br />\nregulation of removal of superoxide radicals<br />\nregulation of transcription involved in G1/S transition of mitotic cell cycle<br />\nresponse to methotrexate<br />\ntetrahydrobiopterin biosynthetic process<br />\ntetrahydrofolate biosynthetic process<br />\ntetrahydrofolate metabolic process<br />\n', 'PF00186.', 'MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND'),
('P10902', '1KNR', 1, 2.5, 'A', 540, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'L-aspartate oxidase', 'nadB', 'L-aspartate + O2 = iminosuccinate + H2O2.<br />\n', 'flavin adenine dinucleotide binding<br />\nL-aspartate:fumarate oxidoreductase activity<br />\nL-aspartate oxidase activity<br />\n', '''de novo'' NAD biosynthetic process from aspartate<br />\n', 'PF00890.', 'MNTLPEHSCDVLIIGSGAAGLSLALRLADQHQVIVLSKGPVTEGSTFYAQGGIAAVFDETDSIDSHVEDTLIAGAGICDRHAVEFVASNARSCVQWLIDQGVLFDTHIQPNGEESYHLTREGGHSHRRILHAADATGREVETTLVSKALNHPNIRVLERSNAVDLIVSDKIGLPGTRRVVGAWVWNRNKETVETCHAKAVVLATGGASKVYQYTTNPDISSGDGIAMAWRAGCRVANLEFNQFHPTALYHPQARNFLLTEALRGEGAYLKRPDGTRFMPDFDERGELAPRDIVARAIDHEMKRLGADCMFLDISHKPADFIRQHFPMIYEKLLGLGIDLTQEPVPIVPAAHYTCGGVMVDDHGRTDVEGLYAIGEVSYTGLHGANRMASNSLLECLVYGWSAAEDITRRMPYAHDISTLPPWDESRVENPDERVVIQHNWHELRLFMWDYVGIVRTTKRLERALRRITMLQQEIDEYYAHFRVSNNLLELRNLVQVAELIVRCAMMRKESRGLHFTLDYPELLTHSGPSILSPGNHYINR'),
('Q01234', '1KQB', 1, 1.8, 'A/B/C/D', 217, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Oxygen-insensitive NAD(P)H nitroreductase', 'nfsB', '', 'oxidoreductase activity<br />\n', '', 'PF00881.', 'MDIISVALKRHSTKAFDASKKLTAEEAEKIKTLLQYSPSSTNSQPWHFIVASTEEGKARVAKSAAGTYVFNERKMLDASHVVVFCAKTAMDDAWLERVVDQEEADGRFNTPEAKAANHKGRTYFADMHRVDLKDDDQWMAKQVYLNVGNFLLGVGAMGLDAVPIEGFDAAILDEEFGLKEKGFTSLVVVPVGHHSVEDFNATLPKSRLPLSTIVTEC'),
('P08164', '1KQP', 1, 1.03, 'A/B', 271, 'LIGASE', 'LIGASE', 'NH(3)-dependent NAD(+) synthetase', 'nadE', 'ATP + deamido-NAD+ + NH3 = AMP + diphosphate + NAD+<br />\n', 'ATP binding<br />\nmetal ion binding<br />\nNAD+ synthase (glutamine-hydrolyzing) activity<br />\nNAD+ synthase activity<br />\n', 'NAD biosynthetic process<br />\nsporulation resulting in formation of a cellular spore<br />\n', 'PF02540.', 'MSMQEKIMRELHVKPSIDPKQEIEDRVNFLKQYVKKTGAKGFVLGISGGQDSTLAGRLAQLAVESIREEGGDAQFIAVRLPHGTQQDEDDAQLALKFIKPDKSWKFDIKSTVSAFSDQYQQETGDQLTDFNKGNVKARTRMIAQYAIGGQEGLLVLGTDHAAEAVTGFFTKYGDGGADLLPLTGLTKRQGRTLLKELGAPERLYLKEPTADLLDEKPQQSDETELGISYDEIDDYLEGKEVSAKVSEALEKRYSMTEHKRQVPASMFDDWWK'),
('P07771', '1KRH', 1, 1.5, 'A/B', 338, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Benzoate 1,2-dioxygenase electron transfer component', 'benC', 'Reduced ferredoxin + NAD+ = oxidized ferredoxin + NADH.<br />\n', '2 iron, 2 sulfur cluster binding<br />\nelectron carrier activity<br />\nferredoxin-NAD+ reductase activity<br />\nmetal ion binding<br />\n', 'toluene catabolic process<br />\n', 'PF00970.', 'MSLYLNRIPAMSNHQVALQFEDGVTRFIRIAQGETLSDAAYRQQINIPMDCREGACGTCRAFCESGNYDMPEDNYIEDALTPEEAQQGYVLACQCRPTSDAVFQIQASSEVCKTKIHHFEGTLARVENLSDSTITFDIQLDDGQPDIHFLAGQYVNVTLPGTTETRSYSFSSQPGNRLTGFVVRNVPQGKMSEYLSVQAKAGDKMSFTGPFGSFYLRDVKRPVLMLAGGTGIAPFLSMLQVLEQKGSEHPVRLVFGVTQDCDLVALEQLDALQQKLPWFEYRTVVAHAESQHERKGYVTGHIEYDWLNGGEVDVYLCGPVPMVEAVRSWLDTQGIQPANFLFEKFSAN'),
('P00367', '1L1F', 0, 2.7, 'A/B/C/D/E/F', 505, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutamate dehydrogenase 1, mitochondrial', 'GLUD1', 'L-glutamate + H2O + NAD(P)+ = 2-oxoglutarate + NH3 + NAD(P)H<br />\n', 'ADP binding<br />\nATP binding<br />\nglutamate dehydrogenase (NAD+) activity<br />\nglutamate dehydrogenase [NAD(P)+] activity<br />\nGTP binding<br />\nidentical protein binding<br />\nleucine binding<br />\nNAD+ binding<br />\n', 'cellular amino acid biosynthetic process<br />\nglutamate biosynthetic process<br />\nglutamate catabolic process<br />\nglutamine metabolic process<br />\nmitochondrion organization<br />\npositive regulation of insulin secretion<br />\nsubstantia nigra development<br />\ntricarboxylic acid metabolic process<br />\n', 'PF00208.', 'MYRYLGEALLLSRAGPAALGSASADSAALLGWARGQPAAAPQPGLALAARRHYSEAVADREDDPNFFKMVEGFFDRGASIVEDKLVEDLRTRESEEQKRNRVRGILRIIKPCNHVLSLSFPIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFGGAKAGVKINPKNYTDNELEKITRRFTMELAKKGFIGPGIDVPAPDMSTGEREMSWIADTYASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFGDKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILGFPKAKPYEGSILEADCDILIPAASEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLERNIMVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLMSVQESLERKFGKHGGTIPIVPTAEFQDRISGASEKDIVHSGLAYTMERSARQIMRTAMKYNLGLDLRTAAYVNAIEKVFKVYNEAGVTFT'),
('P02788', '1LCF', 1, 2, 'A', 691, 'IRON TRANSPORT', 'METAL_BINDING', 'Lactotransferrin', 'LTF', '', 'cysteine-type endopeptidase inhibitor activity<br />\nDNA binding<br />\nheparin binding<br />\niron ion binding<br />\nlipopolysaccharide binding<br />\nprotein serine/threonine kinase activator activity<br />\nserine-type endopeptidase activity<br />\n', 'antibacterial humoral response<br />\nantifungal humoral response<br />\nantimicrobial humoral immune response mediated by antimicrobial peptide<br />\nantimicrobial humoral response<br />\nbone morphogenesis<br />\ncellular protein metabolic process<br />\ndefense response to Gram-negative bacterium<br />\ndefense response to Gram-positive bacterium<br />\nhumoral immune response<br />\ninnate immune response<br />\ninnate immune response in mucosa<br />\nion transport<br />\niron assimilation by chelation and transport<br />\nkilling of cells of other organism<br />\nmembrane disruption in other organism<br />\nnegative regulation by host of viral process<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of ATPase activity<br />\nnegative regulation of cysteine-type endopeptidase activity<br />\nnegative regulation of lipopolysaccharide-mediated signaling pathway<br />\nnegative regulation of membrane potential<br />\nnegative regulation of osteoclast development<br />\nnegative regulation of single-species biofilm formation in or on host organism<br />\nnegative regulation of tumor necrosis factor (ligand) superfamily member 11 production<br />\nnegative regulation of viral genome replication<br />\nnegative regulation of viral process<br />\nneutrophil degranulation<br />\nossification<br />\npositive regulation of bone mineralization involved in bone maturation<br />\npositive regulation of chondrocyte proliferation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of osteoblast differentiation<br />\npositive regulation of osteoblast proliferation<br />\npositive regulation of protein serine/threonine kinase activity<br />\npositive regulation of toll-like receptor 4 signaling pathway<br />\nregulation of cytokine production<br />\nregulation of tumor necrosis factor production<br />\nretina homeostasis<br />\ntranscription, DNA-templated<br />\n', 'PF00405.', 'MKLVFLVLLFLGALGLCLAGRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQAIAENRADAVTLDGGFIYEAGLAPYKLRPVAAEVYGTERQPRTHYYAVAVVKKGGSFQLNELQGLKSCHTGLRRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARFFSASCVPGADKGQFPNLCRLCAGTGENKCAFSSQEPYFSYSGAFKCLRDGAGDVAFIRESTVFEDLSDEAERDEYELLCPDNTRKPVDKFKDCHLARVPSHAVVARSVNGKEDAIWNLLRQAQEKFGKDKSPKFQLFGSPSGQKDLLFKDSAIGFSRVPPRIDSGLYLGSGYFTAIQNLRKSEEEVAARRARVVWCAVGEQELRKCNQWSGLSEGSVTCSSASTTEDCIALVLKGEADAMSLDGGYVYTAGKCGLVPVLAENYKSQQSSDPDPNCVDRPVEGYLAVAVVRRSDTSLTWNSVKGKKSCHTAVDRTAGWNIPMGLLFNQTGSCKFDEYFSQSCAPGSDPRSNLCALCIGDEQGENKCVPNSNERYYGYTGAFRCLAENAGDVAFVKDVTVLQNTDGNNNEAWAKDLKLADFALLCLDGKRKPVTEARSCHLAMAPNHAVVSRMDKVERLKQVLLHQQAKFGRNGSDCPDKFCLFQSETKNLLFNDNTECLARLHGKTTYEKYLGPQYVAGITNLKKCSTSPLLEACEFLRK'),
('P23526', '1LI4', 1, 2.01, 'A', 432, 'HYDROLASE', 'HYDROLASE', 'Adenosylhomocysteinase', 'AHCY', 'S-adenosyl-L-homocysteine + H2O = L-homocysteine + adenosine.<br />\n', 'adenosylhomocysteinase activity<br />\nadenyl nucleotide binding<br />\nidentical protein binding<br />\nNAD binding<br />\n', 'chronic inflammatory response to antigenic stimulus<br />\ncircadian sleep/wake cycle<br />\nhomocysteine biosynthetic process<br />\nmethylation<br />\none-carbon metabolic process<br />\nresponse to hypoxia<br />\nresponse to nutrient<br />\nS-adenosylhomocysteine catabolic process<br />\nS-adenosylmethionine cycle<br />\nsulfur amino acid metabolic process<br />\n', 'PF05221.', 'MSDKLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARIAGCLHMTVETAVLIETLVTLGAEVQWSSCNIFSTQDHAAAAIAKAGIPVYAWKGETDEEYLWCIEQTLYFKDGPLNMILDDGGDLTNLIHTKYPQLLPGIRGISEETTTGVHNLYKMMANGILKVPAINVNDSVTKSKFDNLYGCRESLIDGIKRATDVMIAGKVAVVAGYGDVGKGCAQALRGFGARVIITEIDPINALQAAMEGYEVTTMDEACQEGNIFVTTTGCIDIILGRHFEQMKDDAIVCNIGHFDVEIDVKWLNENAVEKVNIKPQVDRYRLKNGRRIILLAEGRLVNLGCAMGHPSFVMSNSFTNQVMAQIELWTHPDKYPVGVHFLPKKLDEAVAEAHLGKLNVKLTKLTEKQAQYLGMSCDGPFKPDHYRY'),
('P16233', '1LPB', 1, 2.46, 'B', 449, 'HYDROLASE(CARBOXYLIC ESTERASE)', 'HYDROLASE', 'Pancreatic triacylglycerol lipase', 'PNLIP', 'Triacylglycerol + H2O = diacylglycerol + a carboxylate<br />\n', 'lipase activity<br />\nmetal ion binding<br />\ntriglyceride lipase activity<br />\n', 'intestinal cholesterol absorption<br />\nlipid catabolic process<br />\nlipid digestion<br />\nlipid metabolic process<br />\npositive regulation of triglyceride lipase activity<br />\nretinoid metabolic process<br />\n', 'PF00151.', 'MLPLWTLSLLLGAVAGKEVCYERLGCFSDDSPWSGITERPLHILPWSPKDVNTRFLLYTNENPNNFQEVAADSSSISGSNFKTNRKTRFIIHGFIDKGEENWLANVCKNLFKVESVNCICVDWKGGSRTGYTQASQNIRIVGAEVAYFVEFLQSAFGYSPSNVHVIGHSLGAHAAGEAGRRTNGTIGRITGLDPAEPCFQGTPELVRLDPSDAKFVDVIHTDGAPIVPNLGFGMSQVVGHLDFFPNGGVEMPGCKKNILSQIVDIDGIWEGTRDFAACNHLRSYKYYTDSIVNPDGFAGFPCASYNVFTANKCFPCPSGGCPQMGHYADRYPGKTNDVGQKFYLDTGDASNFARWRYKVSVTLSGKKVTGHILVSLFGNKGNSKQYEIFKGTLKPDSTHSNEFDSDVDVGDLQMVKFIWYNNVINPTLPRVGASKIIVETNVGKQFNFCSPETVREEVLLTLTPC'),
('P14218', '1LPF', 1, 2.8, 'A/B', 477, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydrolipoyl dehydrogenase', 'lpd', 'Protein N6-(dihydrolipoyl)lysine + NAD+ = protein N6-(lipoyl)lysine + NADH.<br />\n', 'dihydrolipoyl dehydrogenase activity<br />\nelectron carrier activity<br />\nflavin adenine dinucleotide binding<br />\n', 'cell redox homeostasis<br />\nglycolytic process<br />\n', 'PF07992.', 'MSQKFDVVVIGAGPGGYVAAIRAAQLGLKTACIEKYIGKEGKVALGGTCLNVGCIPSKALLDSSYKYHEAKEAFKVHGIEAKGVTIDVPAMVARKANIVKNLTGGIATLFKANGVTSFEGHGKLLANKQVEVTGLDGKTQVLEAENVIIASGSRPVEIPPAPLSDDIIVDSTGALEFQAVPKKLGVIGAGVIGLELGSVWARLGAEVTVLEALDKFLPAADEQIAKEALKVLTKQGLNIRLGARVTASEVKKKQVTVTFTDANGEQKETFDKLIVAVGRRPVTTDLLAADSGVTLDERGFIYVDDHCKTSVPGVFAIGDVVRGAMLAHKASEEGVMVAERIAGHKAQMNYDLIPSVIYTHPEIAWVGKTEQTLKAEGVEVNVGTFPFAASGRAMAANDTTGLVKVIADAKTDRVLGVHVIGPSAAELVQQGAIGMEFGTSAEDLGMMVFSHPTLSEALHEAALAVNGHAIHIANRKKR'),
('P04070', '1LQV', 1, 1.6, 'C/D', 33, 'BLOOD CLOTTING', 'OTHERS', 'Vitamin K-dependent protein C', 'PROC', 'Degradation of blood coagulation factors Va and VIIIa.<br />\n', 'calcium ion binding<br />\nserine-type endopeptidase activity<br />\n', 'blood coagulation<br />\ncellular protein metabolic process<br />\nER to Golgi vesicle-mediated transport<br />\nleukocyte migration<br />\nliver development<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of blood coagulation<br />\nnegative regulation of coagulation<br />\nnegative regulation of inflammatory response<br />\npeptidyl-glutamic acid carboxylation<br />\npositive regulation of establishment of endothelial barrier<br />\npost-translational protein modification<br />\nproteolysis<br />\nregulation of circulating fibrinogen levels<br />\nsignal peptide processing<br />\n', 'PF00008.', 'MWQLTSLLLFVATWGISGTPAPLDSVFSSSERAHQVLRIRKRANSFLEELRHSSLERECIEEICDFEEAKEIFQNVDDTLAFWSKHVDGDQCLVLPLEHPCASLCCGHGTCIDGIGSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCTHYCLEEVGWRRCSCAPGYKLGDDLLQCHPAVKFPCGRPWKRMEKKRSHLKRDTEDQEDQVDPRLIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRDKEAPQKSWAP'),
('P09063', '1LVL', 1, 2.45, 'A', 458, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydrolipoyl dehydrogenase', 'lpdV', 'Protein N6-(dihydrolipoyl)lysine + NAD+ = protein N6-(lipoyl)lysine + NADH.<br />\n', 'dihydrolipoyl dehydrogenase activity<br />\nelectron carrier activity<br />\nflavin adenine dinucleotide binding<br />\n', 'cell redox homeostasis<br />\nglycolytic process<br />\n', 'PF07992.', 'MQQTIQTTLLIIGGGPGGYVAAIRAGQLGIPTVLVEGQALGGTCLNIGCIPSKALIHVAEQFHQASRFTEPSPLGISVASPRLDIGQSVAWKDGIVDRLTTGVAALLKKHGVKVVHGWAKVLDGKQVEVDGQRIQCEHLLLATGSSSVELPMLPLGGPVISSTEALAPKALPQHLVVVGGGYIGLELGIAYRKLGAQVSVVEARERILPTYDSELTAPVAESLKKLGIALHLGHSVEGYENGCLLANDGKGGQLRLEADRVLVAVGRRPRTKGFNLECLDLKMNGAAIAIDERCQTSMHNVWAIGDVAGEPMLAHRAMAQGEMVAEIIAGKARRFEPAAIAAVCFTDPEVVVVGKTPEQASQQGLDCIVAQFPFAANGRAMSLESKSGFVRVVARRDNHLILGWQAVGVAVSELSTAFAQSLEMGACLEDVAGTIHAHPTLGEAVQEAALRALGHALHI'),
('Q54873', '1LXK', 1, 1.53, 'A', 721, 'LYASE', 'LYASE', 'Hyaluronate lyase', 'SP_0314', 'Cleaves hyaluronate chains at a beta-D-GlcNAc-(1->4)-beta-D-GlcA bond, ultimately breaking the polysaccharide down to 3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D-glucosamine.<br />\n', 'carbohydrate binding<br />\nhyaluronate lyase activity<br />\n', 'carbohydrate metabolic process<br />\n', 'PF02278.', 'MQTKTKKLIVSLSSLVLSGFLLNHYMTIGAEETTTNTIQQSQKEVQYQQRDTKNLVENGDFGQTEDGSSPWTGSKAQGWSAWVDQKNSADASTRVIEAKDGAITISSHEKLRAALHRMVPIEAKKKYKLRFKIKTDNKIGIAKVRIIEESGKDKRLWNSATTSGTKDWQTIEADYSPTLDVDKIKLELFYETGTGTVSFKDIELVEVADQLSEDSQTDKQLEEKIDLPIGKKHVFSLADYTYKVENPDVASVKNGILEPLKEGTTNVIVSKDGKEVKKIPLKILASVKDAYTDRLDDWNGIIAGNQYYDSKNEQMAKLNQELEGKVADSLSSISSQADRTYLWEKFSNYKTSANLTATYRKLEEMAKQVTNPSSRYYQDETVVRTVRDSMEWMHKHVYNSEKSIVGNWWDYEIGTPRAINNTLSLMKEYFSDEEIKKYTDVIEKFVPDPEHFRKTTDNPFKALGGNLVDMGRVKVIAGLLRKDDQEISSTIRSIEQVFKLVDQGEGFYQDGSYIDHTNVAYTGAYGNVLIDGLSQLLPVIQKTKNPIDKDKMQTMYHWIDKSFAPLLVNGELMDMSRGRSISRANSEGHVAAVEVLRGIHRIADMSEGETKQCLQSLVKTIVQSDSYYDVFKNLKTYKDISLMQSLLSDAGVASVPRPSYLSAFNKMDKTAMYNAEKGFGFGLSLFSSRTLNYEHMNKENKRGWYTSDGMFYLYNGDLSHYSDGYWPTVNPYKMPGTTETDAKRADSDTGKVLPSAFVGTSKLDDANATATMDFTNWNQTLTAHKSWFMLKDKIAFLGSNIQNTSTDTAATTIDQRKLESGNPYKVYVNDKEASLTEQEKDYPETQSVFLESFDSKKNIGYFFFKKSSISMSKALQKGAWKDINEGQSDKEVENEFLTISQAHKQNRDSYGYMLIPNVDRATFNQMIKELESSLIENNETLQSVYDAKQGVWGIVKYDDSVSTISNQFQVLKRGVYTIRKEGDEYKIAYYNPETQESAPDQEVFKKLEQAAQPQVQNSKEKEKSEEEKNHSDQKNLPQTGEGQSILASLGFLLLGAFYLFRRGKNN'),
('O67757', '1M1H', 0, 1.95, 'A', 248, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Transcription termination/antitermination protein NusG', 'nusG', '', '', 'DNA-templated transcription, termination<br />\nregulation of DNA-templated transcription, elongation<br />\nregulation of transcription, DNA-templated<br />\ntranscription antitermination<br />\n', 'PF00467.', 'MSEQQVQELEKKWYALQVEPGKENEAKENLLKVLELEGLKDLVDEVIVPAEEKVVIRAQGKEKYRLSLKGNARDISVLGKKGVTTFRIENGEVKVVESVEGDTCVNAPPISKPGQKITCKENKTEAKIVLDNKIFPGYILIKAHMNDKLLMAIEKTPHVFRPVMVGGKPVPLKEEEVQNILNQIKRGVKPSKVEFEKGDQVRVIEGPFMNFTGTVEEVHPEKRKLTVMISIFGRMTPVELDFDQVEKI'),
('P06241', '1M27', 1, 2.5, 'C', 61, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Tyrosine-protein kinase Fyn', 'FYN', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nCD4 receptor binding<br />\nCD8 receptor binding<br />\ndisordered domain specific binding<br />\nenzyme binding<br />\nephrin receptor binding<br />\ngrowth factor receptor binding<br />\nidentical protein binding<br />\nion channel binding<br />\nmetal ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\npeptide hormone receptor binding<br />\nphosphatidylinositol 3-kinase binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nsignal transducer activity<br />\nT cell receptor binding<br />\ntubulin binding<br />\ntype 5 metabotropic glutamate receptor binding<br />\n', 'activated T cell proliferation<br />\nadaptive immune response<br />\naxon guidance<br />\nblood coagulation<br />\ncalcium ion transport<br />\ncell differentiation<br />\ncell migration<br />\ncellular response to peptide hormone stimulus<br />\ncellular response to platelet-derived growth factor stimulus<br />\ncellular response to transforming growth factor beta stimulus<br />\ncentral nervous system development<br />\ndendrite morphogenesis<br />\ndetection of mechanical stimulus involved in sensory perception of pain<br />\nephrin receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nfeeding behavior<br />\nforebrain development<br />\ninnate immune response<br />\ninterleukin-7-mediated signaling pathway<br />\nintracellular signal transduction<br />\nlearning<br />\nleukocyte migration<br />\nMAPK cascade<br />\nnegative regulation of dendritic spine maintenance<br />\nnegative regulation of extrinsic apoptotic signaling pathway in absence of ligand<br />\nnegative regulation of gene expression<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of protein catabolic process<br />\nnegative regulation of protein ubiquitination<br />\nneuron migration<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\nplatelet activation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of neuron death<br />\npositive regulation of neuron projection development<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of protein localization to nucleus<br />\npositive regulation of protein targeting to membrane<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nprotein phosphorylation<br />\nregulation of apoptotic process<br />\nregulation of calcium ion import across plasma membrane<br />\nregulation of cell proliferation<br />\nregulation of cell shape<br />\nregulation of defense response to virus by virus<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nresponse to amyloid-beta<br />\nresponse to drug<br />\nresponse to ethanol<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nT cell activation<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\n', 'PF07714.', 'MGCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRGGTGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL'),
('P62593', '1M40', 1, 0.85, 'A', 263, 'HYDROLASE', 'HYDROLASE', 'Beta-lactamase TEM', 'bla', 'A beta-lactam + H2O = a substituted beta-amino acid<br />\n', 'beta-lactamase activity<br />\n', 'beta-lactam antibiotic catabolic process<br />\nresponse to antibiotic<br />\n', '', 'MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW'),
('Q52369', '1M70', 0, 1.25, 'A/B/C/D', 190, 'ELECTRON TRANSPORT', 'OTHERS', 'Cytochrome c4', 'cc4', '', 'electron carrier activity<br />\nheme binding<br />\niron ion binding<br />\n', 'oxidation-reduction process<br />\n', 'PF00034.', 'MNKVLVSLLLTLGITGMAHAAGDAEAGQGKVAVCGACHGVDGNSPAPNFPKLAGQGERYLLKQLQDIKAGSTPGAPEGVGRKVLEMTGMLDPLSDQDLEDIAAYFSSQKGSVGYADPALAKQGEKLFRGGKLDQGMPACTGCHAPNGVGNDLAGFPKLGGQHAAYTAKQLTDFREGNRTNDGDTMIMRGVAAKLSNKDIEALSSYIQGLH'),
('Q56839', '1MO9', 1, 1.65, 'A/B', 523, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '2-oxopropyl-CoM reductase, carboxylating', 'xecC', '2-mercaptoethanesulfonate + acetoacetate + NADP+ = 2-(2-oxopropylthio)ethanesulfonate + CO2 + NADPH.<br />\n', '2-oxopropyl-CoM reductase (carboxylating) activity<br />\nflavin adenine dinucleotide binding<br />\n', 'cell redox homeostasis<br />\npropylene catabolic process<br />\n', 'PF07992.', 'MKVWNARNDHLTINQWATRIDEILEAPDGGEVIYNVDENDPREYDAIFIGGGAAGRFGSAYLRAMGGRQLIVDRWPFLGGSCPHNACVPHHLFSDCAAELMLARTFSGQYWFPDMTEKVVGIKEVVDLFRAGRNGPHGIMNFQSKEQLNLEYILNCPAKVIDNHTVEAAGKVFKAKNLILAVGAGPGTLDVPGVNAKGVFDHATLVEELDYEPGSTVVVVGGSKTAVEYGCFFNATGRRTVMLVRTEPLKLIKDNETRAYVLDRMKEQGMEIISGSNVTRIEEDANGRVQAVVAMTPNGEMRIETDFVFLGLGEQPRSAELAKILGLDLGPKGEVLVNEYLQTSVPNVYAVGDLIGGPMEMFKARKSGCYAARNVMGEKISYTPKNYPDFLHTHYEVSFLGMGEEEARAAGHEIVTIKMPPDTENGLNVALPASDRTMLYAFGKGTAHMSGFQKIVIDAKTRKVLGAHHVGYGAKDAFQYLNVLIKQGLTVDELGDMDELFLNPTHFIQLSRLRAGSKNLVSL'),
('Q04828', '1MRQ', 1, 1.59, 'A', 322, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aldo-keto reductase family 1 member C1', 'AKR1C1', '17-alpha,20-alpha-dihydroxypregn-4-en-3-one + NAD(P)+ = 17-alpha-hydroxyprogesterone + NAD(P)H<br />\nTrans-1,2-dihydrobenzene-1,2-diol + NADP+ = catechol + NADPH<br />\nIndan-1-ol + NAD(P)+ = indanone + NAD(P)H<br />\n', '17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity<br />\nalditol:NADP+ 1-oxidoreductase activity<br />\naldo-keto reductase (NADP) activity<br />\nandrosterone dehydrogenase (B-specific) activity<br />\nbile acid binding<br />\ncarboxylic acid binding<br />\nindanol dehydrogenase activity<br />\nketosteroid monooxygenase activity<br />\noxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor<br />\nphenanthrene 9,10-monooxygenase activity<br />\ntrans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity<br />\n', 'bile acid and bile salt transport<br />\nbile acid metabolic process<br />\ncellular response to jasmonic acid stimulus<br />\ncholesterol homeostasis<br />\ndaunorubicin metabolic process<br />\ndigestion<br />\ndoxorubicin metabolic process<br />\nepithelial cell differentiation<br />\nintestinal cholesterol absorption<br />\noxidation-reduction process<br />\nprogesterone metabolic process<br />\nprotein homooligomerization<br />\nresponse to organophosphorus<br />\nretinal metabolic process<br />\nretinoid metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF00248.', 'MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEATKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWCNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAVEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY'),
('O43447', '1MZW', 0, 2, 'A', 177, 'ISOMERASE', 'ISOMERASE', 'Peptidyl-prolyl cis-trans isomerase H', 'PPIH', 'Peptidylproline (omega=180) = peptidylproline (omega=0).<br />\n', 'cyclosporin A binding<br />\npeptidyl-prolyl cis-trans isomerase activity<br />\nribonucleoprotein complex binding<br />\n', 'mRNA splicing, via spliceosome<br />\npositive regulation of viral genome replication<br />\nprotein complex assembly<br />\nprotein folding<br />\n', 'PF00160.', 'MAVANSSPVNPVVFFDVSIGGQEVGRMKIELFADVVPKTAENFRQFCTGEFRKDGVPIGYKGSTFHRVIKDFMIQGGDFVNGDGTGVASIYRGPFADENFKLRHSAPGLLSMANSGPSTNGCQFFITCSKCDWLDGKHVVFGKIIDGLLVMRKIENVPTGPNNKPKLPVVISQCGEM'),
('P10828', '1N46', 1, 2.2, 'A/B', 258, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Thyroid hormone receptor beta', 'THRB', '', 'chromatin DNA binding<br />\nDNA binding<br />\nenzyme binding<br />\nsequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\nthyroid hormone binding<br />\nthyroid hormone receptor activity<br />\ntranscription corepressor activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'animal organ morphogenesis<br />\nfemale courtship behavior<br />\nnegative regulation of female receptivity<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of heart contraction<br />\nsensory perception of sound<br />\ntranscription, DNA-templated<br />\ntranscription initiation from RNA polymerase II promoter<br />\nType I pneumocyte differentiation<br />\n', 'PF00104.', 'MTPNSMTENGLTAWDKPKHCPDREHDWKLVGMSEACLHRKSHSERRSTLKNEQSSPHLIQTTWTSSIFHLDHDDVNDQSVSSAQTFQTEEKKCKGYIPSYLDKDELCVVCGDKATGYHYRCITCEGCKGFFRRTIQKNLHPSYSCKYEGKCVIDKVTRNQCQECRFKKCIYVGMATDLVLDDSKRLAKRKLIEENREKRRREELQKSIGHKPEPTDEEWELIKTVTEAHVATNAQGSHWKQKRKFLPEDIGQAPIVNAPEGGKVDLEAFSHFTKIITPAITRVVDFAKKLPMFCELPCEDQIILLKGCCMEIMSLRAAVRYDPESETLTLNGEMAVTRGQLKNGGLGVVSDAIFDLGMSLSSFNLDDTEVALLQAVLLMSSDRPGLACVERIEKYQDSFLLAFEHYINYRKHHVTHFWPKLLMKVTDLRMIGACHASRFLHMKVECPTELFPPLFLEVFED'),
('Q969G6', '1NB0', 1, 1.7, 'A', 147, 'TRANSFERASE', 'TRANSFERASE', 'Riboflavin kinase', 'RFK', 'ATP + riboflavin = ADP + FMN.<br />\n', 'ATP binding<br />\nmetal ion binding<br />\nriboflavin kinase activity<br />\n', 'apoptotic process<br />\nFMN biosynthetic process<br />\npositive regulation of NAD(P)H oxidase activity<br />\nreactive oxygen species metabolic process<br />\nriboflavin biosynthetic process<br />\nriboflavin metabolic process<br />\n', 'PF01687.', 'MRHLPYFCRGQVVRGFGRGSKQLGIPTANFPEQVVDNLPADISTGIYYGWASVGSGDVHKMVVSIGWNPYYKNTKKSMETHIMHTFKEDFYGEILNVAIVGYLRPEKNFDSLESLISAIQGDIEEAKKRLELPEHLKIKEDNFFQVSKSKIMNGH'),
('P12268', '1NF7', 1, 2.65, 'A/B', 514, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Inosine-5''-monophosphate dehydrogenase 2', 'IMPDH2', 'Inosine 5''-phosphate + NAD+ + H2O = xanthosine 5''-phosphate + NADH<br />\n', 'DNA binding<br />\nIMP dehydrogenase activity<br />\nmetal ion binding<br />\nnucleotide binding<br />\nRNA binding<br />\n', 'cellular response to interleukin-4<br />\nGMP biosynthetic process<br />\nGTP biosynthetic process<br />\nlymphocyte proliferation<br />\nneutrophil degranulation<br />\nprotein homotetramerization<br />\npurine ribonucleoside monophosphate biosynthetic process<br />\nretina development in camera-type eye<br />\n', 'PF00571.', 'MADYLISGGTSYVPDDGLTAQQLFNCGDGLTYNDFLILPGYIDFTADQVDLTSALTKKITLKTPLVSSPMDTVTEAGMAIAMALTGGIGFIHHNCTPEFQANEVRKVKKYEQGFITDPVVLSPKDRVRDVFEAKARHGFCGIPITDTGRMGSRLVGIISSRDIDFLKEEEHDCFLEEIMTKREDLVVAPAGITLKEANEILQRSKKGKLPIVNEDDELVAIIARTDLKKNRDYPLASKDAKKQLLCGAAIGTHEDDKYRLDLLAQAGVDVVVLDSSQGNSIFQINMIKYIKDKYPNLQVIGGNVVTAAQAKNLIDAGVDALRVGMGSGSICITQEVLACGRPQATAVYKVSEYARRFGVPVIADGGIQNVGHIAKALALGASTVMMGSLLAATTEAPGEYFFSDGIRLKKYRGMGSLDAMDKHLSSQNRYFSEADKIKVAQGVSGAVQDKGSIHKFVPYLIAGIQHSCQDIGAKSLTQVRAMMYSGELKFEKRTSSAQVEGGVHSLHSYEKRLF'),
('P37062', '1NHP', 1, 2, 'A', 447, 'OXIDOREDUCTASE (H2O2(A))', 'OXIDOREDUCTASE', 'NADH peroxidase', 'npr', 'NADH + H2O2 = NAD+ + 2 H2O.<br />\n', 'flavin adenine dinucleotide binding<br />\nNADH peroxidase activity<br />\n', 'cell redox homeostasis<br />\n', 'PF07992.', 'MKVIVLGSSHGGYEAVEELLNLHPDAEIQWYEKGDFISFLSCGMQLYLEGKVKDVNSVRYMTGEKMESRGVNVFSNTEITAIQPKEHQVTVKDLVSGEERVENYDKLIISPGAVPFELDIPGKDLDNIYLMRGRQWAIKLKQKTVDPEVNNVVVIGSGYIGIEAAEAFAKAGKKVTVIDILDRPLGVYLDKEFTDVLTEEMEANNITIATGETVERYEGDGRVQKIVTDKNAYDADLVVVAVGVRPNTAWLKGTLELHPNGLIKTDEYMRTSEPDVFAVGDATLIKYNPADTEVNIALATNARKQGRFAVKNLEEPVKPFPGVQGSSGLAVFDYKFASTGINEVMAQKLGKETKAVTVVEDYLMDFNPDKQKAWFKLVYDPETTQILGAQLMSKADLTANINAISLAIQAKMTIEDLAYADFFFQPAFDKPWNIINTAALEAVKQER'),
('P77967', '1NP7', 1, 1.9, 'A/B', 489, 'LYASE', 'LYASE', 'Cryptochrome DASH', 'cry', '', 'DNA binding<br />\nDNA photolyase activity<br />\n', 'DNA repair<br />\nprotein-chromophore linkage<br />\nregulation of transcription, DNA-templated<br />\ntranscription, DNA-templated<br />\n', 'PF00875.', 'MKHVPPTVLVWFRNDLRLHDHEPLHRALKSGLAITAVYCYDPRQFAQTHQGFAKTGPWRSNFLQQSVQNLAESLQKVGNKLLVTTGLPEQVIPQIAKQINAKTIYYHREVTQEELDVERNLVKQLTILGIEAKGYWGSTLCHPEDLPFSIQDLPDLFTKFRKDIEKKKISIRPCFFAPSQLLPSPNIKLELTAPPPEFFPQINFDHRSVLAFQGGETAGLARLQDYFWHGDRLKDYKETRNGMVGADYSSKFSPWLALGCLSPRFIYQEVKRYEQERVSNDSTHWLIFELLWRDFFRFVAQKYGNKLFNRGGLLNKNFPWQEDQVRFELWRSGQTGYPLVDANMRELNLTGFMSNRGRQNVASFLCKNLGIDWRWGAEWFESCLIDYDVCSNWGNWNYTAGIGNDARDFRYFNIPKQSQQYDPQGTYLRHWLPELKNLPGDKIHQPWLLSATEQKQWGVQLGVDYPRPCVNFHQSVEARRKIEQMGVIA'),
('P01133', '1NQL', 0, 2.8, 'B', 53, 'HORMONE / GROWTH FACTOR RECEPTOR', 'HORMONE', 'Pro-epidermal growth factor', 'EGF', '', 'calcium ion binding<br />\nepidermal growth factor receptor binding<br />\ngrowth factor activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\ntransmembrane receptor protein tyrosine kinase activator activity<br />\nWnt-activated receptor activity<br />\nWnt-protein binding<br />\n', 'activation of MAPK activity<br />\nactivation of MAPKK activity<br />\nangiogenesis<br />\nbranching morphogenesis of an epithelial tube<br />\ncanonical Wnt signaling pathway<br />\nDNA replication<br />\nembryonic retina morphogenesis in camera-type eye<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nERK1 and ERK2 cascade<br />\ninterleukin-7-mediated signaling pathway<br />\nmammary gland alveolus development<br />\nMAPK cascade<br />\nmembrane organization<br />\nnegative regulation of cholesterol efflux<br />\nnegative regulation of epidermal growth factor receptor signaling pathway<br />\nnegative regulation of ERBB signaling pathway<br />\nnegative regulation of secretion<br />\nphosphatidylinositol-mediated signaling<br />\nplatelet degranulation<br />\npositive regulation of catenin import into nucleus<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of cerebellar granule cell precursor proliferation<br />\npositive regulation of DNA binding<br />\npositive regulation of epidermal growth factor-activated receptor activity<br />\npositive regulation of gene expression<br />\npositive regulation of hyaluronan biosynthetic process<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of mitotic nuclear division<br />\npositive regulation of peptidyl-threonine phosphorylation<br />\npositive regulation of phosphorylation<br />\npositive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process<br />\npositive regulation of receptor internalization<br />\npositive regulation of transcription, DNA-templated<br />\nregulation of calcium ion import<br />\nregulation of cell motility<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of protein localization to cell surface<br />\nsignal transduction<br />\nSTAT protein import into nucleus<br />\nWnt signaling pathway involved in dorsal/ventral axis specification<br />\n', 'PF00008.', 'MLLTLIILLPVVSKFSFVSLSAPQHWSCPEGTLAGNGNSTCVGPAPFLIFSHGNSIFRIDTEGTNYEQLVVDAGVSVIMDFHYNEKRIYWVDLERQLLQRVFLNGSRQERVCNIEKNVSGMAINWINEEVIWSNQQEGIITVTDMKGNNSHILLSALKYPANVAVDPVERFIFWSSEVAGSLYRADLDGVGVKALLETSEKITAVSLDVLDKRLFWIQYNREGSNSLICSCDYDGGSVHISKHPTQHNLFAMSLFGDRIFYSTWKMKTIWIANKHTGKDMVRINLHSSFVPLGELKVVHPLAQPKAEDDTWEPEQKLCKLRKGNCSSTVCGQDLQSHLCMCAEGYALSRDRKYCEDVNECAFWNHGCTLGCKNTPGSYYCTCPVGFVLLPDGKRCHQLVSCPRNVSECSHDCVLTSEGPLCFCPEGSVLERDGKTCSGCSSPDNGGCSQLCVPLSPVSWECDCFPGYDLQLDEKSCAASGPQPFLLFANSQDIRHMHFDGTDYGTLLSQQMGMVYALDHDPVENKIYFAHTALKWIERANMDGSQRERLIEEGVDVPEGLAVDWIGRRFYWTDRGKSLIGRSDLNGKRSKIITKENISQPRGIAVHPMAKRLFWTDTGINPRIESSSLQGLGRLVIASSDLIWPSGITIDFLTDKLYWCDAKQSVIEMANLDGSKRRRLTQNDVGHPFAVAVFEDYVWFSDWAMPSVMRVNKRTGKDRVRLQGSMLKPSSLVVVHPLAKPGADPCLYQNGGCEHICKKRLGTAWCSCREGFMKASDGKTCLALDGHQLLAGGEVDLKNQVTPLDILSKTRVSEDNITESQHMLVAEIMVSDQDDCAPVGCSMYARCISEGEDATCQCLKGFAGDGKLCSDIDECEMGVPVCPPASSKCINTEGGYVCRCSEGYQGDGIHCLDIDECQLGEHSCGENASCTNTEGGYTCMCAGRLSEPGLICPDSTPPPHLREDDHHYSVRNSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELRHAGHGQQQKVIVVAVCVVVLVMLLLLSLWGAHYYRTQKLLSKNPKNPYEESSRDVRSRRPADTEDGMSSCPQPWFVVIKEHQDLKNGGQPVAGEDGQAADGSMQPTSWRQEPQLCGMGTEQGCWIPVSSDKGSCPQVMERSFHMPSYGTQTLEGGVEKPHSLLSANPLWQQRALDPPHQMELTQ'),
('O75469', '1NRL', 1, 2, 'A/B', 305, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Nuclear receptor subfamily 1 group I member 2', 'NR1I2', '', 'drug binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding<br />\ntranscription coactivator activity<br />\nzinc ion binding<br />\n', 'drug export<br />\nexogenous drug catabolic process<br />\nnegative regulation of transcription, DNA-templated<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nsignal transduction<br />\nsteroid metabolic process<br />\ntranscription initiation from RNA polymerase II promoter<br />\nxenobiotic metabolic process<br />\nxenobiotic transport<br />\n', 'PF00104.', 'MEVRPKESWNHADFVHCEDTESVPGKPSVNADEEVGGPQICRVCGDKATGYHFNVMTCEGCKGFFRRAMKRNARLRCPFRKGACEITRKTRRQCQACRLRKCLESGMKKEMIMSDEAVEERRALIKRKKSERTGTQPLGVQGLTEEQRMMIRELMDAQMKTFDTTFSHFKNFRLPGVLSSGCELPESLQAPSREEAAKWSQVRKDLCSLKVSLQLRGEDGSVWNYKPPADSGGKEIFSLLPHMADMSTYMFKGIISFAKVISYFRDLPIEDQISLLKGAAFELCQLRFNTVFNAETGTWECGRLSYCLEDTAGGFQQLLLEPMLKFHYMLKKLQLHEEEYVLMQAISLFSPDRPGVLQHRVVDQLQEQFAITLKSYIECNRPQPAHRFLFLKIMAMLTELRSINAQHTQRLLRIQDIHPFATPLMQELFGITGS'),
('P27907', '1NSC', 1, 1.7, 'A/B', 390, 'HYDROLASE(O-GLYCOSYL)', 'HYDROLASE', 'Neuraminidase', 'NA', 'Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates<br />\n', 'exo-alpha-(2->3)-sialidase activity<br />\nexo-alpha-(2->6)-sialidase activity<br />\nexo-alpha-(2->8)-sialidase activity<br />\nmetal ion binding<br />\n', 'carbohydrate metabolic process<br />\nviral budding from plasma membrane<br />\n', 'PF00064.', 'MLPSTIQTLTLFLTSGGVLLSLYVSASLSYLLYSDILLKFSSKITAPTMTLDCANASNVQAVNRSATKEMTFLLPEPEWTYPRLSCQGSTFQKALLISPHRFGEARGNSAPLIIREPFIACGPKECKHFALTHYAAQPGGYYNGTREDRNKLRHLISVKLGKIPTVENSIFHMAAWSGSACHDGREWTYIGVDGPDSNALIKIKYGEAYTDTYHSYANNILRTQESACNCIGGDCYLMITDGSASGISKCRFLKIREGRIIKEIFPTGRVEHTEECTCGFASNKTIECACRDNSYTAKRPFVKLNVETDTAEIRLMCTETYLDTPRPDDGSITGPCESNGDKGRGGIKGGFVHQRMASKIGRWYSRTMSKTERMGMELYVRYDGDPWTDSDALAHSGVMVSMKEPGWYSFGFEIKDKKCDVPCIGIEMVHDGGKKTWHSAATAIYCLMGSGQLLWDTVTGVDMAL'),
('P05091', '1O04', 1, 1.42, 'A/B/C/D/E/F/G/H', 500, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aldehyde dehydrogenase, mitochondrial', 'ALDH2', 'An aldehyde + NAD+ + H2O = a carboxylate + NADH.<br />\n', 'aldehyde dehydrogenase (NAD) activity<br />\naldehyde dehydrogenase [NAD(P)+] activity<br />\nelectron carrier activity<br />\nNAD binding<br />\n', 'alcohol metabolic process<br />\ncarbohydrate metabolic process<br />\nethanol catabolic process<br />\nethanol oxidation<br />\n', 'PF00171.', 'MLRAAARFGPRLGRRLLSAAATQAVPAPNQQPEVFCNQIFINNEWHDAVSRKTFPTVNPSTGEVICQVAEGDKEDVDKAVKAARAAFQLGSPWRRMDASHRGRLLNRLADLIERDRTYLAALETLDNGKPYVISYLVDLDMVLKCLRYYAGWADKYHGKTIPIDGDFFSYTRHEPVGVCGQIIPWNFPLLMQAWKLGPALATGNVVVMKVAEQTPLTALYVANLIKEAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGRVIQVAAGSSNLKRVTLELGGKSPNIIMSDADMDWAVEQAHFALFFNQGQCCCAGSRTFVQEDIYDEFVERSVARAKSRVVGNPFDSKTEQGPQVDETQFKKILGYINTGKQEGAKLLCGGGIAADRGYFIQPTVFGDVQDGMTIAKEEIFGPVMQILKFKTIEEVVGRANNSTYGLAAAVFTKDLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYKMSGSGRELGEYGLQAYTEVKTVTVKVPQKNS');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P12931', '1O4A', 1, 1.5, 'A', 108, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Proto-oncogene tyrosine-protein kinase Src', 'SRC', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncadherin binding<br />\nconnexin binding<br />\nenzyme binding<br />\nephrin receptor binding<br />\nestrogen receptor binding<br />\ngrowth factor receptor binding<br />\nheme binding<br />\nhormone receptor binding<br />\ninsulin receptor binding<br />\nintegrin binding<br />\nion channel binding<br />\nkinase activity<br />\nkinase binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nphosphoprotein binding<br />\nprotein C-terminus binding<br />\nprotein kinase activity<br />\nprotein kinase C binding<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\nscaffold protein binding<br />\nSH2 domain binding<br />\nSH3/SH2 adaptor activity<br />\nubiquitin protein ligase binding<br />\n', 'activation of protein kinase B activity<br />\nadherens junction organization<br />\nangiotensin-activated signaling pathway involved in heart process<br />\naxon guidance<br />\nbone resorption<br />\nbranching involved in mammary gland duct morphogenesis<br />\ncell-cell adhesion<br />\ncell cycle<br />\ncell proliferation<br />\ncellular response to fatty acid<br />\ncellular response to fluid shear stress<br />\ncellular response to hypoxia<br />\ncellular response to insulin stimulus<br />\ncellular response to lipopolysaccharide<br />\ncellular response to peptide hormone stimulus<br />\ncellular response to platelet-derived growth factor stimulus<br />\ncellular response to progesterone stimulus<br />\ncellular response to reactive oxygen species<br />\ncentral nervous system development<br />\nentry of bacterium into host cell<br />\nephrin receptor signaling pathway<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nforebrain development<br />\ninnate immune response<br />\nintegrin-mediated signaling pathway<br />\nintracellular estrogen receptor signaling pathway<br />\nintracellular signal transduction<br />\nleukocyte migration<br />\nmacroautophagy<br />\nnegative regulation of anoikis<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway<br />\nnegative regulation of focal adhesion assembly<br />\nnegative regulation of intrinsic apoptotic signaling pathway<br />\nnegative regulation of mitochondrial depolarization<br />\nnegative regulation of protein homooligomerization<br />\nnegative regulation of telomerase activity<br />\nnegative regulation of telomere maintenance via telomerase<br />\nnegative regulation of transcription, DNA-templated<br />\nneurotrophin TRK receptor signaling pathway<br />\noogenesis<br />\nosteoclast development<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nplatelet activation<br />\nplatelet-derived growth factor receptor signaling pathway<br />\npositive regulation of apoptotic process<br />\npositive regulation of canonical Wnt signaling pathway<br />\npositive regulation of cyclin-dependent protein serine/threonine kinase activity<br />\npositive regulation of cytokine secretion<br />\npositive regulation of DNA biosynthetic process<br />\npositive regulation of epithelial cell migration<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of glucose metabolic process<br />\npositive regulation of insulin receptor signaling pathway<br />\npositive regulation of integrin activation<br />\npositive regulation of lamellipodium morphogenesis<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of platelet-derived growth factor receptor signaling pathway<br />\npositive regulation of podosome assembly<br />\npositive regulation of protein autophosphorylation<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of protein localization to nucleus<br />\npositive regulation of protein processing<br />\npositive regulation of protein serine/threonine kinase activity<br />\npositive regulation of small GTPase mediated signal transduction<br />\npositive regulation of smooth muscle cell migration<br />\npositive regulation of transcription, DNA-templated<br />\nprogesterone receptor signaling pathway<br />\nprotein autophosphorylation<br />\nprotein destabilization<br />\nregulation of bone resorption<br />\nregulation of caveolin-mediated endocytosis<br />\nregulation of cell-cell adhesion<br />\nregulation of cell cycle<br />\nregulation of cell projection assembly<br />\nregulation of cell proliferation<br />\nregulation of early endosome to late endosome transport<br />\nregulation of epithelial cell migration<br />\nregulation of intracellular estrogen receptor signaling pathway<br />\nregulation of podosome assembly<br />\nregulation of protein binding<br />\nregulation of vascular permeability<br />\nresponse to acidic pH<br />\nresponse to drug<br />\nresponse to electrical stimulus<br />\nresponse to hydrogen peroxide<br />\nresponse to interleukin-1<br />\nresponse to mechanical stimulus<br />\nresponse to mineralocorticoid<br />\nresponse to nutrient levels<br />\nresponse to virus<br />\nsignal complex assembly<br />\nsignal transduction<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nstress fiber assembly<br />\nsubstrate adhesion-dependent cell spreading<br />\nT cell costimulation<br />\ntranscytosis<br />\ntransforming growth factor beta receptor signaling pathway<br />\nuterus development<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nviral process<br />\n', 'PF07714.', 'MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL'),
('P49841', '1O6L', 1, 1.6, 'C', 10, 'TRANSFERASE', 'TRANSFERASE', 'Glycogen synthase kinase-3 beta', 'GSK3B', 'ATP + [tau protein] = ADP + [tau protein] phosphate.<br />\nATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nbeta-catenin binding<br />\nkinase activity<br />\nNF-kappaB binding<br />\np53 binding<br />\nprotease binding<br />\nprotein kinase A catalytic subunit binding<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\nprotein serine/threonine kinase activity<br />\nRNA polymerase II transcription factor binding<br />\ntau-protein kinase activity<br />\nubiquitin protein ligase binding<br />\n', 'beta-catenin destruction complex assembly<br />\nbeta-catenin destruction complex disassembly<br />\ncanonical Wnt signaling pathway<br />\ncellular response to amyloid-beta<br />\ncellular response to interleukin-3<br />\nchemical synaptic transmission, postsynaptic<br />\ncircadian rhythm<br />\ndopamine receptor signaling pathway<br />\nepithelial to mesenchymal transition<br />\nER overload response<br />\nextrinsic apoptotic signaling pathway in absence of ligand<br />\nglycogen metabolic process<br />\nhippocampus development<br />\nintracellular signal transduction<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of canonical Wnt signaling pathway<br />\nnegative regulation of dopaminergic neuron differentiation<br />\nnegative regulation of glycogen (starch) synthase activity<br />\nnegative regulation of glycogen biosynthetic process<br />\nnegative regulation of neuron death<br />\nnegative regulation of NFAT protein import into nucleus<br />\nnegative regulation of protein binding<br />\nnegative regulation of protein complex assembly<br />\nnegative regulation of protein localization to nucleus<br />\nnegative regulation of type B pancreatic cell development<br />\nneuron projection development<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\npositive regulation of cell-matrix adhesion<br />\npositive regulation of GTPase activity<br />\npositive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway<br />\npositive regulation of mitochondrion organization<br />\npositive regulation of neuron death<br />\npositive regulation of proteasomal ubiquitin-dependent protein catabolic process<br />\npositive regulation of protein binding<br />\npositive regulation of protein catabolic process<br />\npositive regulation of protein complex assembly<br />\npositive regulation of protein export from nucleus<br />\nproteasome-mediated ubiquitin-dependent protein catabolic process<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of cellular response to heat<br />\nregulation of microtubule-based process<br />\nsuperior temporal gyrus development<br />\nWnt signaling pathway<br />\n', 'PF00069.', 'MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST'),
('Q8UCK6', '1O9R', 0, 1.45, 'A/B/C/D/E/F', 162, 'IRON-BINDING PROTEIN', 'METAL_BINDING', 'DNA protection during starvation protein', 'dps', '2 Fe2+ + H2O2 + 2 H+ = 2 Fe3+ + 2 H2O.<br />\n', 'ferric iron binding<br />\noxidoreductase activity, oxidizing metal ions<br />\n', 'cellular iron ion homeostasis<br />\nresponse to stress<br />\n', 'PF00210.', 'MKTHKTKNDLPSNAKSTVIGILNESLASVIDLALVTKQAHWNLKGPQFIAVHELLDTFRTQLDNHGDTIAERVVQLGGTALGSLQAVSSTTKLKAYPTDIYKIHDHLDALIERYGEVANMIRKAIDDSDEAGDPTTADIFTAASRDLDKSLWFLEAHVQEKS'),
('P07445', '1OH0', 1, 1.1, 'A/B', 131, 'ISOMERASE', 'ISOMERASE', 'Steroid Delta-isomerase', 'ksi', 'A 3-oxo-Delta5-steroid = a 3-oxo-Delta4-steroid.<br />\n', 'steroid delta-isomerase activity<br />\n', 'steroid metabolic process<br />\n', 'PF12680.', 'MNLPTAQEVQGLMARYIELVDVGDIEAIVQMYADDATVEDPFGQPPIHGREQIAAFYRQGLGGGKVRACLTGPVRASHNGCGAMPFRVEMVWNGQPCALDVIDVMRFDEHGRIQTMQAYWSEVNLSVREPQ'),
('Q51225', '1OJT', 1, 2.75, 'A', 482, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydrolipoyl dehydrogenase', 'm-6', 'Protein N6-(dihydrolipoyl)lysine + NAD+ = protein N6-(lipoyl)lysine + NADH.', 'dihydrolipoyl dehydrogenase activity<br />\r\nelectron carrier activity<br />\r\nflavin adenine dinucleotide binding<br />', 'cell redox homeostasis', 'PF00364.', 'MALVELKVPDIGGHENVDIIAVEVNVGDTIAVDDTLITLETDKATMDVPA\r\nEVAGVVKEVKVKVGDKISEGGLIVVVEAEGTAAAPKAEAAAAPAQEAPKA\r\nAAPAPQAAQFGGSADAEYDVVVLGGGPGGYSAAFAAADEGLKVAIVERYK\r\nTLGGVCLNVGCIPSKALLHNAAVIDEVRHLAANGIKYPEPELDIDMLRAY\r\nKDGVVSRLTGGLAGMAKSRKVDVIQGDGQFLDPHHLEVSLTAGDAYEQAA\r\nPTGEKKIVAFKNCIIAAGSRVTKLPFIPEDPRIIDSSGALALKEVPGKLL\r\nIIGGGIIGLEMGTVYSTLGSRLDVVEMMDGLMQGADRDLVKVWQKQNEYR\r\nFDNIMVNTKTVAVEPKEDGVYVTFEGANAPKEPQRYDAVLVAAGRAPNGK\r\nLISAEKAGVAVTDRGFIEVDKQMRTNVPHIYAIGDIVGQPMLAHKAVHEG\r\nHVAAENCAGHKAYFDARVIPGVAYTSPEVAWVGETELSAKASGRKITKAN\r\nFPWAASGRAIANGCDKPFTKLIFDAETGRIIGGGIVGPNGGDMIGEVCLA\r\nIEMGCDAADIGKTIHPHPTLGESIGMAAEVALGTCTDLPPQKKK'),
('Q94655', '1ONF', 1, 2.6, 'A', 500, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutathione reductase', 'GR2', '2 glutathione + NADP+ = glutathione disulfide + NADPH.<br />\n', 'electron carrier activity<br />\nflavin adenine dinucleotide binding<br />\nglutathione-disulfide reductase activity<br />\n', 'cell redox homeostasis<br />\n', 'PF07992.', 'MVYDLIVIGGGSGGMAAARRAARHNAKVALVEKSRLGGTCVNVGCVPKKIMFNAASVHDILENSRHYGFDTKFSFNLPLLVERRDKYIQRLNNIYRQNLSKDKVDLYEGTASFLSENRILIKGTKDNNNKDNGPLNEEILEGRNILIAVGNKPVFPPVKGIENTISSDEFFNIKESKKIGIVGSGYIAVELINVIKRLGIDSYIFARGNRILRKFDESVINVLENDMKKNNINIVTFADVVEIKKVSDKNLSIHLSDGRIYEHFDHVIYCVGRSPDTENLKLEKLNVETNNNYIVVDENQRTSVNNIYAVGDCCMVKKSKEIEDLNLLKLYNEERYLNKKENVTEDIFYNVQLTPVAINAGRLLADRLFLKKTRKTNYKLIPTVIFSHPPIGTIGLSEEAAIQIYGKENVKIYESKFTNLFFSVYDIEPELKEKTYLKLVCVGKDELIKGLHIIGLNADEIVQGFAVALKMNATKKDFDETIPIHPTAAEEFLTLQPWMK'),
('P52758', '1ONI', 1, 1.9, 'A/B/C/D/E/F/G/H/I', 136, 'TRANSLATION', 'OTHERS', '2-iminobutanoate/2-iminopropanoate deaminase', 'RIDA', '2-iminobutanoate + H2O = 2-oxobutanoate + NH3<br />\n2-iminopropanoate + H2O = pyruvate + NH3<br />\n', 'deaminase activity<br />\nendoribonuclease activity, producing 3''-phosphomonoesters<br />\nlong-chain fatty acid binding<br />\nplatinum binding<br />\nprotein homodimerization activity<br />\nRNA binding<br />\ntransition metal ion binding<br />\nxenon atom binding<br />\n', 'brain development<br />\nG1 to G0 transition<br />\nkidney development<br />\nlung development<br />\nnegative regulation of epithelial cell proliferation<br />\nnegative regulation of translation<br />\norganonitrogen compound catabolic process<br />\nresponse to lipid<br />\nresponse to salt<br />\n', 'PF01042.', 'MSSLIRRVISTAKAPGAIGPYSQAVLVDRTIYISGQIGMDPSSGQLVSGGVAEEAKQALKNMGEILKAAGCDFTNVVKTTVLLADINDFNTVNEIYKQYFKSNFPARAAYQVAALPKGSRIEIEAVAIQGPLTTASL'),
('Q8GGK7', '1OS6', 1, 1.45, 'A', 71, 'ELECTRON TRANSPORT', 'OTHERS', 'Cytochrome C', 'ppcA', NULL, 'electron carrier activity<br />\r\nheme binding<br />\r\nmetal ion binding<br />', 'sulfur utilization', 'PF02085.', 'MKKVIASLALSVFCAGLAFAADDIVLKAKNGDVKFPHKAHQKAVPDCKKC\r\nHEKGPGKIEGFGKEMAHGKGCKGCHEEMKKGPTKCGECHKK'),
('P00480', '1OTH', 1, 1.85, 'A', 321, 'TRANSFERASE', 'TRANSFERASE', 'Ornithine carbamoyltransferase, mitochondrial', 'OTC', 'Carbamoyl phosphate + L-ornithine = phosphate + L-citrulline.<br />\n', 'amino acid binding<br />\nornithine carbamoyltransferase activity<br />\nphosphate ion binding<br />\nphospholipid binding<br />\n', 'ammonia homeostasis<br />\nanion homeostasis<br />\narginine biosynthetic process via ornithine<br />\ncitrulline biosynthetic process<br />\nliver development<br />\nmidgut development<br />\nornithine catabolic process<br />\nprotein homotrimerization<br />\nresponse to biotin<br />\nresponse to drug<br />\nresponse to insulin<br />\nresponse to zinc ion<br />\nurea cycle<br />\n', 'PF00185.', 'MLFNLRILLNNAAFRNGHNFMVRNFRCGQPLQNKVQLKGRDLLTLKNFTGEEIKYMLWLSADLKFRIKQKGEYLPLLQGKSLGMIFEKRSTRTRLSTETGFALLGGHPCFLTTQDIHLGVNESLTDTARVLSSMADAVLARVYKQSDLDTLAKEASIPIINGLSDLYHPIQILADYLTLQEHYSSLKGLTLSWIGDGNNILHSIMMSAAKFGMHLQAATPKGYEPDASVTKLAEQYAKENGTKLLLTNDPLEAAHGGNVLITDTWISMGQEEEKKKRLQAFQGYQVTMKTAKVAASDWTFLHCLPRKPEEVDDEVFYSPRSLVFPEAENRKWTIMAVMVSLLTDYSPQLQKPKF'),
('P05327', '1OWL', 1, 1.8, 'A', 484, 'LYASE', 'LYASE', 'Deoxyribodipyrimidine photo-lyase', 'phr', 'Cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in DNA).<br />\n', 'deoxyribodipyrimidine photo-lyase activity<br />\nDNA binding<br />\nnucleotide binding<br />\n', 'DNA repair<br />\nprotein-chromophore linkage<br />\n', 'PF00875.', 'MAAPILFWHRRDLRLSDNIGLAAARAQSAQLIGLFCLDPQILQSADMAPARVAYLQGCLQELQQRYQQAGSRLLLLQGDPQHLIPQLAQQLQAEAVYWNQDIEPYGRDRDGQVAAALKTAGIRAVQLWDQLLHSPDQILSGSGNPYSVYGPFWKNWQAQPKPTPVATPTELVDLSPEQLTAIAPLLLSELPTLKQLGFDWDGGFPVEPGETAAIARLQEFCDRAIADYDPQRNFPAEAGTSGLSPALKFGAIGIRQAWRAASAAHALSRSDEARNSIRVWQQELAWREFYQHALYHFPSLADGPYRSLWQQFPWENREALFTAWTQAQTGYPIVDAAMRQLTETGWMHNRCWMIVASFLTKDLIIDWRRGEQFFMQHLVDGDLAANNGGWQWSASSGMDPKPLRIFNPASQAKKFDATATYIKRWLPELRHVHPKDLISGEITPIGRRGYPAPIVNHNLRQKQFKALYNQLKAAIAEPEAEPDS'),
('P06276', '1P0I', 1, 2, 'A', 529, 'HYDROLASE', 'HYDROLASE', 'Cholinesterase', 'BCHE', 'An acylcholine + H2O = choline + a carboxylate<br />\n', 'acetylcholinesterase activity<br />\namyloid-beta binding<br />\ncatalytic activity<br />\ncholine binding<br />\ncholinesterase activity<br />\nenzyme binding<br />\nhydrolase activity, acting on ester bonds<br />\nidentical protein binding<br />\n', 'choline metabolic process<br />\ncocaine metabolic process<br />\nlearning<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of synaptic transmission<br />\nneuroblast differentiation<br />\nresponse to alkaloid<br />\nresponse to drug<br />\nresponse to folic acid<br />\nresponse to glucocorticoid<br />\n', 'PF08674.', 'MHSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMNLTVFGGTVTAFLGIPYAQPPLGRLRFKKPQSLTKWSDIWNATKYANSCCQNIDQSFPGFHGSEMWNPNTDLSEDCLYLNVWIPAPKPKNATVLIWIYGGGFQTGTSSLHVYDGKFLARVERVIVVSMNYRVGALGFLALPGNPEAPGNMGLFDQQLALQWVQKNIAAFGGNPKSVTLFGESAGAASVSLHLLSPGSHSLFTRAILQSGSFNAPWAVTSLYEARNRTLNLAKLTGCSRENETEIIKCLRNKDPQEILLNEAFVVPYGTPLSVNFGPTVDGDFLTDMPDILLELGQFKKTQILVGVNKDEGTAFLVYGAPGFSKDNNSIITRKEFQEGLKIFFPGVSEFGKESILFHYTDWVDDQRPENYREALGDVVGDYNFICPALEFTKKFSEWGNNAFFYYFEHRSSKLPWPEWMGVMHGYEIEFVFGLPLERRDNYTKAEEILSRSIVKRWANFAKYGNPNETQNNSTSWPVFKSTEQKYLTLNTESTRIMTKLRAQQCRFWTSFFPKVLEMTGNIDEAEWEWKAGFHRWNNYMMDWKNQFNDYTSKKESCVGL'),
('Q9RC23', '1P3Y', 1, 2.54, '1', 194, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Mersacidin decarboxylase', 'mrsD', '', 'lyase activity<br />\noxidoreductase activity<br />\n', 'antibiotic biosynthetic process<br />\n', 'PF02441.', 'MSISILKDKKLLIGICGSISSVGISSYLLYFKSFFKEIRVVMTKTAEDLIPAHTVSYFCDHVYSEHGENGKRHSHVEIGRWADIYCIIPATANILGQTANGVAMNLVATTVLAHPHNTIFFPNMNDLMWNKTVVSRNIEQLRKDGHIVIEPVEIMAFEIATGTRKPNRGLITPDKALLAIEKGFKERTKHPSLT'),
('P20132', '1P5J', 1, 2.5, 'A', 328, 'LYASE', 'LYASE', 'L-serine dehydratase/L-threonine deaminase', 'SDS', 'L-serine = pyruvate + NH3<br />\nL-threonine = 2-oxobutanoate + NH3<br />\n', 'L-serine ammonia-lyase activity<br />\nL-threonine ammonia-lyase activity<br />\nprotein homodimerization activity<br />\npyridoxal phosphate binding<br />\n', 'gluconeogenesis<br />\nL-serine catabolic process<br />\npyruvate biosynthetic process<br />\n', 'PF00291.', 'MMSGEPLHVKTPIRDSMALSKMAGTSVYLKMDSAQPSGSFKIRGIGHFCKRWAKQGCAHFVCSSAGNAGMAAAYAARQLGVPATIVVPSTTPALTIERLKNEGATVKVVGELLDEAFELAKALAKNNPGWVYIPPFDDPLIWEGHASIVKELKETLWEKPGAIALSVGGGGLLCGVVQGLQEVGWGDVPVIAMETFGAHSFHAATTAGKLVSLPKITSVAKALGVKTVGAQALKLFQEHPIFSEVISDQEAVAAIEKFVDDEKILVEPACGAALAAVYSHVIQKLQLEGNLRTPLPSLVVIVCGGSNISLAQLRALKEQLGMTNRLPK'),
('P27707', '1P5Z', 1, 1.6, 'B', 260, 'TRANSFERASE', 'TRANSFERASE', 'Deoxycytidine kinase', 'DCK', 'NTP + deoxycytidine = NDP + dCMP<br />\n', 'ATP binding<br />\ndeoxycytidine kinase activity<br />\ndrug binding<br />\nnucleoside kinase activity<br />\nprotein homodimerization activity<br />\n', 'purine-containing compound salvage<br />\npyrimidine nucleoside salvage<br />\npyrimidine nucleotide metabolic process<br />\n', 'PF01712.', 'MATPPKRSCPSFSASSEGTRIKKISIEGNIAAGKSTFVNILKQLCEDWEVVPEPVARWCNVQSTQDEFEELTMSQKNGGNVLQMMYEKPERWSFTFQTYACLSRIRAQLASLNGKLKDAEKPVLFFERSVYSDRYIFASNLYESECMNETEWTIYQDWHDWMNNQFGQSLELDGIIYLQATPETCLHRIYLRGRNEEQGIPLEYLEKLHYKHESWLLHRTLKTNFDYLQEVPILTLDVNEDFKDKYESLVEKVKEFLSTL'),
('P37330', '1P7T', 1, 1.95, 'A/B', 721, 'LYASE', 'LYASE', 'Malate synthase G', 'glcB', 'Acetyl-CoA + H2O + glyoxylate = (S)-malate + CoA<br />\n', 'magnesium ion binding<br />\nmalate synthase activity<br />\n', 'glyoxylate catabolic process<br />\nglyoxylate cycle<br />\ntricarboxylic acid cycle<br />\n', 'PF01274.', 'MSQTITQSRLRIDANFKRFVDEEVLPGTGLDAAAFWRNFDEIVHDLAPENRQLLAERDRIQAALDEWHRSNPGPVKDKAAYKSFLRELGYLVPQPERVTVETTGIDSEITSQAGPQLVVPAMNARYALNAANARWGSLYDALYGSDIIPQEGAMVSGYDPQRGEQVIAWVRRFLDESLPLENGSYQDVVAFKVVDKQLRIQLKNGKETTLRTPAQFVGYRGDAAAPTCILLKNNGLHIELQIDANGRIGKDDPAHINDVIVEAAISTILDCEDSVAAVDAEDKILLYRNLLGLMQGTLQEKMEKNGRQIVRKLNDDRHYTAADGSEISLHGRSLLFIRNVGHLMTIPVIWDSEGNEIPEGILDGVMTGAIALYDLKVQKNSRTGSVYIVKPKMHGPQEVAFANKLFTRIETMLGMAPNTLKMGIMDEERRTSLNLRSCIAQARNRVAFINTGFLDRTGDEMHSVMEAGPMLRKNQMKSTPWIKAYERNNVLSGLFCGLRGKAQIGKGMWAMPDLMADMYSQKGDQLRAGANTAWVPSPTAATLHALHYHQTNVQSVQANIAQTEFNAEFEPLLDDLLTIPVAENANWSAQEIQQELDNNVQGILGYVVRWVEQGIGCSKVPDIHNVALMEDRATLRISSQHIANWLRHGILTKEQVQASLENMAKVVDQQNAGDPAYRPMAGNFANSCAFKAASDLIFLGVKQPNGYTEPLLHAWRLREKESH'),
('P00438', '1PBE', 1, 1.9, 'A', 394, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'p-hydroxybenzoate hydroxylase', 'pobA', '4-hydroxybenzoate + NADPH + O2 = protocatechuate + NADP+ + H2O<br />\n', '4-hydroxybenzoate 3-monooxygenase activity<br />\nFAD binding<br />\nflavin adenine dinucleotide binding<br />\n', 'benzoate catabolic process via hydroxylation<br />\n', 'PF01494.', 'MKTQVAIIGAGPSGLLLGQLLHKAGIDNVILERQTPDYVLGRIRAGVLEQGMVDLLREAGVDRRMARDGLVHEGVEIAFAGQRRRIDLKRLSGGKTVTVYGQTEVTRDLMEAREACGATTVYQAAEVRLHDLQGERPYVTFERDGERLRLDCDYIAGCDGFHGISRQSIPAERLKVFERVYPFGWLGLLADTPPVSHELIYANHPRGFALCSQRSATRSRYYVQVPLTEKVEDWSDERFWTELKARLPAEVAEKLVTGPSLEKSIAPLRSFVVEPMQHGRLFLAGDAAHIVPPTGAKGLNLAASDVSTLYRLLLKAYREGRGELLERYSAICLRRIWKAERFSWWMTSVLHRFPDTDAFSQRIQQTELEYYLGSEAGLATIAENYVGLPYEEIE'),
('Q9AGP8', '1PJ5', 1, 1.61, 'A', 830, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dimethylglycine oxidase', 'dmg', 'N,N-dimethylglycine + H2O + O2 = sarcosine + formaldehyde + H2O2<br />\nN,N-dimethylglycine + tetrahydrofolate = sarcosine + 5,10-methylenetetrahydrofolate<br />\n', 'dimethylglycine oxidase activity<br />\nnucleotide binding<br />\n', '', 'PF01266.', 'MASTPRIVIIGAGIVGTNLADELVTRGWNNITVLDQGPLNMPGGSTSHAPGLVFQTNPSKTMASFAKYTVEKLLSLTEDGVSCFNQVGGLEVATTETRLADLKRKLGYAAAWGIEGRLLSPAECQELYPLLDGENILGGLHVPSDGLASAARAVQLLIKRTESAGVTYRGSTTVTGIEQSGGRVTGVQTADGVIPADIVVSCAGFWGAKIGAMIGMAVPLLPLAHQYVKTTPVPAQQGRNDQPNGARLPILRHQDQDLYYREHGDRYGIGSYAHRPMPVDVDTLGAYAPETVSEHHMPSRLDFTLEDFLPAWEATKQLLPALADSEIEDGFNGIFSFTPDGGPLLGESKELDGFYVAEAVWVTHSAGVAKAMAELLTTGRSETDLGECDITRFEDVQLTPEYVSETSQQNFVEIYDVLHPLQPRLSPRNLRVSPFHARHKELGAFFLEAGGWERPYWFEANAALLKEMPAEWLPPARDAWSGMFSSPIAAAEAWKTRTAVAMYDMTPLKRLEVSGPGALKLLQELTTADLAKKPGAVTYTLLLDHAGGVRSDITVARLSEDTFQLGANGNIDTAYFERAARHQTQSGSATDWVQVRDTTGGTCCIGLWGPLARDLVSKVSDDDFTNDGLKYFRAKNVVIGGIPVTAMRLSYVGELGWELYTSADNGQRLWDALWQAGQPFGVIAAGRAAFSSLRLEKGYRSWGTDMTTEHDPFEAGLGFAVKMAKESFIGKGALEGRTEEASARRLRCLTIDDGRSIVLGKEPVFYKEQAVGYVTSAAYGYTVAKPIAYSYLPGTVSVGDSVDIEYFGRRITATVTEDPLYDPKMTRLRG'),
('P0AFU8', '1PKV', 1, 2.6, 'A/B', 97, 'TRANSFERASE', 'TRANSFERASE', 'Riboflavin synthase', 'ribC', '2 6,7-dimethyl-8-(1-D-ribityl)lumazine = riboflavin + 4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine<br />\n', 'riboflavin synthase activity<br />\n', 'riboflavin biosynthetic process<br />\n', 'PF00677.', 'MFTGIVQGTAKLVSIDEKPNFRTHVVELPDHMLDGLETGASVAHNGCCLTVTEINGNHVSFDLMKETLRITNLGDLKVGDWVNVERAAKFSDEIGGHLMSGHIMTTAEVAKILTSENNRQIWFKVQDSQLMKYILYKGFIGIDGISLTVGEVTPTRFCVHLIPETLERTTLGKKKLGARVNIEIDPQTQAVVDTVERVLAARENAMNQPGTEA'),
('P31939', '1PKX', 1, 1.9, 'A/B/C/D', 592, 'TRANSFERASE', 'TRANSFERASE', 'Bifunctional purine biosynthesis protein PURH', 'ATIC', '10-formyltetrahydrofolate + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide = tetrahydrofolate + 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.<br />\nIMP + H2O = 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide.<br />\n', 'cadherin binding<br />\nIMP cyclohydrolase activity<br />\nphosphoribosylaminoimidazolecarboxamide formyltransferase activity<br />\nprotein homodimerization activity<br />\n', '''de novo'' IMP biosynthetic process<br />\nanimal organ regeneration<br />\nbrainstem development<br />\ncerebellum development<br />\ncerebral cortex development<br />\ndihydrofolate metabolic process<br />\nnucleobase-containing compound metabolic process<br />\nnucleoside metabolic process<br />\npurine ribonucleoside monophosphate biosynthetic process<br />\nresponse to inorganic substance<br />\ntetrahydrofolate biosynthetic process<br />\n', 'PF01808.', 'MAPGQLALFSVSDKTGLVEFARNLTALGLNLVASGGTAKALRDAGLAVRDVSELTGFPEMLGGRVKTLHPAVHAGILARNIPEDNADMARLDFNLIRVVACNLYPFVKTVASPGVTVEEAVEQIDIGGVTLLRAAAKNHARVTVVCEPEDYVVVSTEMQSSESKDTSLETRRQLALKAFTHTAQYDEAISDYFRKQYSKGVSQMPLRYGMNPHQTPAQLYTLQPKLPITVLNGAPGFINLCDALNAWQLVKELKEALGIPAAASFKHVSPAGAAVGIPLSEDEAKVCMVYDLYKTLTPISAAYARARGADRMSSFGDFVALSDVCDVPTAKIISREVSDGIIAPGYEEEALTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQVIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEKLTEVSISSDAFFPFRDNVDRAKRSGVAYIAAPSGSAADKVVIEACDELGIILAHTNLRLFHH'),
('P30041', '1PRX', 0, 2, 'A/B', 224, 'ANTIOXIDANT', 'OTHERS', 'Peroxiredoxin-6', 'PRDX6', '2 R''-SH + ROOH = R''-S-S-R'' + H2O + ROH<br />\nPhosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate<br />\n', 'cadherin binding<br />\ncalcium-independent phospholipase A2 activity<br />\nglutathione peroxidase activity<br />\nperoxiredoxin activity<br />\nphospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)<br />\nphospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)<br />\nprotein homodimerization activity<br />\nubiquitin protein ligase binding<br />\n', 'cell redox homeostasis<br />\ncellular oxidant detoxification<br />\ncellular response to oxidative stress<br />\nglycerophospholipid catabolic process<br />\nhydrogen peroxide catabolic process<br />\nneutrophil degranulation<br />\npositive regulation of mRNA splicing, via spliceosome<br />\nresponse to oxidative stress<br />\n', 'PF10417.', 'MPGGLLLGDVAPNFEANTTVGRIRFHDFLGDSWGILFSHPRDFTPVCTTELGRAAKLAPEFAKRNVKLIALSIDSVEDHLAWSKDINAYNCEEPTEKLPFPIIDDRNRELAILLGMLDPAEKDEKGMPVTARVVFVFGPDKKLKLSILYPATTGRNFDEILRVVISLQLTAEKRVATPVDWKDGDSVMVLPTIPEEEAKKLFPKGVFTKELPSGKKYLRYTPQP'),
('P42593', '1PS9', 1, 2.2, 'A', 671, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '2,4-dienoyl-CoA reductase', 'fadH', 'Trans-2,3-didehydroacyl-CoA + NADP+ = trans,trans-2,3,4,5-tetradehydroacyl-CoA + NADPH<br />\n(2E)-decenoyl-CoA + NADP+ = (2E,4E)-decadienoyl-CoA + NADPH<br />\n(2E)-decenoyl-CoA + NADP+ = (2E,4Z)-decadienoyl-CoA + NADPH<br />\n', '2,4-dienoyl-CoA reductase (NADPH) activity<br />\n4 iron, 4 sulfur cluster binding<br />\nFAD binding<br />\nFMN binding<br />\nmetal ion binding<br />\n', 'fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway<br />\n', 'PF00724.', 'MSYPSLFAPLDLGFTTLKNRVLMGSMHTGLEEYPDGAERLAAFYAERARHGVALIVSGGIAPDLTGVGMEGGAMLNDASQIPHHRTITEAVHQEGGKIALQILHTGRYSYQPHLVAPSALQAPINRFVPHELSHEEILQLIDNFARCAQLAREAGYDGVEVMGSEGYLINEFLTLRTNQRSDQWGGDYRNRMRFAVEVVRAVRERVGNDFIIIYRLSMLDLVEDGGTFAETVELAQAIEAAGATIINTGIGWHEARIPTIATPVPRGAFSWVTRKLKGHVSLPLVTTNRINDPQVADDILSRGDADMVSMARPFLADAELLSKAQSGRADEINTCIGCNQACLDQIFVGKVTSCLVNPRACHETKMPILPAVQKKNLAVVGAGPAGLAFAINAAARGHQVTLFDAHSEIGGQFNIAKQIPGKEEFYETLRYYRRMIEVTGVTLKLNHTVTADQLQAFDETILASGIVPRTPPIDGIDHPKVLSYLDVLRDKAPVGNKVAIIGCGGIGFDTAMYLSQPGESTSQNIAGFCNEWGIDSSLQQAGGLSPQGMQIPRSPRQIVMLQRKASKPGQGLGKTTGWIHRTTLLSRGVKMIPGVSYQKIDDDGLHVVINGETQVLAVDNVVICAGQEPNRALAQPLIDSGKTVHLIGGCDVAMELDARRAIAQGTRLALEI'),
('P13716', '1PV8', 1, 2.2, 'A/B', 330, 'LYASE', 'LYASE', 'Delta-aminolevulinic acid dehydratase', 'ALAD', '2 5-aminolevulinate = porphobilinogen + 2 H2O<br />\n', 'catalytic activity<br />\nidentical protein binding<br />\nporphobilinogen synthase activity<br />\nproteasome core complex binding<br />\nzinc ion binding<br />\n', 'cellular response to interleukin-4<br />\ncellular response to lead ion<br />\nheme biosynthetic process<br />\nnegative regulation of proteasomal protein catabolic process<br />\nneutrophil degranulation<br />\nprotein homooligomerization<br />\nprotoporphyrinogen IX biosynthetic process<br />\nresponse to activity<br />\nresponse to aluminum ion<br />\nresponse to amino acid<br />\nresponse to arsenic-containing substance<br />\nresponse to cadmium ion<br />\nresponse to cobalt ion<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to fatty acid<br />\nresponse to glucocorticoid<br />\nresponse to herbicide<br />\nresponse to hypoxia<br />\nresponse to ionizing radiation<br />\nresponse to iron ion<br />\nresponse to lipopolysaccharide<br />\nresponse to mercury ion<br />\nresponse to methylmercury<br />\nresponse to oxidative stress<br />\nresponse to platinum ion<br />\nresponse to selenium ion<br />\nresponse to vitamin B1<br />\nresponse to vitamin E<br />\nresponse to zinc ion<br />\n', 'PF00490.', 'MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRKTFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDMMDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGARGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQAGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE'),
('P54577', '1Q11', 1, 1.6, 'A', 364, 'LIGASE', 'LIGASE', 'Tyrosine--tRNA ligase, cytoplasmic', 'YARS', 'ATP + L-tyrosine + tRNA(Tyr) = AMP + diphosphate + L-tyrosyl-tRNA(Tyr).<br />\n', 'ATP binding<br />\ninterleukin-8 receptor binding<br />\nRNA binding<br />\nsignal transducer activity<br />\ntRNA binding<br />\ntyrosine-tRNA ligase activity<br />\n', 'apoptotic process<br />\ntRNA aminoacylation for protein translation<br />\ntyrosyl-tRNA aminoacylation<br />\n', 'PF00579.', 'MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVIPSRLDIRVGKIITVEKHPDADSLYVEKIDVGEAEPRTVVSGLVQFVPKEELQDRLVVVLCNLKPQKMRGVESQGMLLCASIEGINRQVEPLDPPAGSAPGEHVFVKGYEKGQPDEELKPKKKVFEKLQADFKISEECIAQWKQTNFMTKLGSISCKSLKGGNIS'),
('P16640', '1Q1R', 1, 1.91, 'A/B', 422, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Putidaredoxin reductase', 'camA', 'Reduced putidaredoxin + NAD+ = oxidized putidaredoxin + NADH<br />\n', 'flavin adenine dinucleotide binding<br />\noxidoreductase activity<br />\n', '(+)-camphor catabolic process<br />\n', 'PF07992.', 'MNANDNVVIVGTGLAGVEVAFGLRASGWEGNIRLVGDATVIPHHLPPLSKAYLAGKATAESLYLRTPDAYAAQNIQLLGGTQVTAINRDRQQVILSDGRALDYDRLVLATGGRPRPLPVASGAVGKANNFRYLRTLEDAECIRRQLIADNRLVVIGGGYIGLEVAATAIKANMHVTLLDTAARVLERVTAPPVSAFYEHLHREAGVDIRTGTQVCGFEMSTDQQKVTAVLCEDGTRLPADLVIAGIGLIPNCELASAAGLQVDNGIVINEHMQTSDPLIMAVGDCARFHSQLYDRWVRIESVPNALEQARKIAAILCGKVPRDEAAPWFWSDQYEIGLKMVGLSEGYDRIIVRGSLAQPDFSVFYLQGDRVLAVDTVNRPVEFNQSKQIITDRLPVEPNLLGDESVPLKEIIAAAKAELSSA'),
('P09238', '1Q3A', 1, 2.1, 'A/B/C', 165, 'HYDROLASE', 'HYDROLASE', 'Stromelysin-2', 'MMP10', 'Similar to stromelysin 1, but action on collagen types III, IV and V is weak<br />\n', 'metalloendopeptidase activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'collagen catabolic process<br />\nextracellular matrix disassembly<br />\nproteolysis<br />\nregulation of cell migration<br />\n', 'PF00045.', 'MMHLAFLVLLCLPVCSAYPLSGAAKEEDSNKDLAQQYLEKYYNLEKDVKQFRRKDSNLIVKKIQGMQKFLGLEVTGKLDTDTLEVMRKPRCGVPDVGHFSSFPGMPKWRKTHLTYRIVNYTPDLPRDAVDSAIEKALKVWEEVTPLTFSRLYEGEADIMISFAVKEHGDFYSFDGPGHSLAHAYPPGPGLYGDIHFDDDEKWTEDASGTNLFLVAAHELGHSLGLFHSANTEALMYPLYNSFTELAQFRLSQDDVNGIQSLYGPPPASTEEPLVPTKSVPSGSEMPAKCDPALSFDAISTLRGEYLFFKDRYFWRRSHWNPEPEFHLISAFWPSLPSYLDAAYEVNSRDTVFIFKGNEFWAIRGNEVQAGYPRGIHTLGFPPTIRKIDAAVSDKEKKKTYFFAADKYWRFDENSQSMEQGFPRLIADDFPGVEPKVDAVLQAFGFFYFFSGSSQFEFDPNARMVTHILKSNSWLHC'),
('Q03154', '1Q7L', 0, 1.4, 'A/C', 198, 'HYDROLASE', 'HYDROLASE', 'Aminoacylase-1', 'ACY1', 'An N-acyl-aliphatic-L-amino acid + H2O = an aliphatic L-amino acid + a carboxylate<br />\nAn N-acetyl-L-cysteine-S-conjugate + H2O = an L-cysteine-S-conjugate + acetate<br />\n', 'aminoacylase activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\nmetallopeptidase activity<br />\n', 'cellular amino acid metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF07687.', 'MTSKGPEEEHPSVTLFRQYLRIRTVQPKPDYGAAVAFFEETARQLGLGCQKVEVAPGYVVTVLTWPGTNPTLSSILLNSHTDVVPVFKEHWSHDPFEAFKDSEGYIYARGAQDMKCVSIQYLEAVRRLKVEGHRFPRTIHMTFVPDEEVGGHQGMELFVQRPEFHALRAGFALDEGIANPTDAFTVFYSERSPWWVRVTSTGRPGHASRFMEDTAAEKLHKVVNSILAFREKEWQRLQSNPHLKEGSVTSVNLTKLEGGVAYNVIPATMSASFDFRVAPDVDFKAFEEQLQSWCQAAGEGVTLEFAQKWMHPQVTPTDDSNPWWAAFSRVCKDMNLTLEPEIMPAATDNRYIRAVGVPALGFSPMNRTPVLLHDHDERLHEAVFLRGVDIYTRLLPALASVPALPSDS'),
('P33673', '1QGI', 1, 1.6, 'A', 259, 'HYDROLASE', 'HYDROLASE', 'Chitosanase', 'csn', 'Endohydrolysis of beta-(1->4)-linkages between D-glucosamine residues in a partly acetylated chitosan.<br />\n', 'chitosanase activity<br />\n', 'carbohydrate metabolic process<br />\n', 'PF01374.', 'MHMSNARPSKSRTKFLLAFLCFTLMASLFGATALFGPSKAAAASPDDNFSPETLQFLRNNTGLDGEQWNNIMKLINKPEQDDLNWIKYYGYCEDIEDERGYTIGLFGATTGGSRDTHPDGPDLFKAYDAAKGASNPSADGALKRLGINGKMKGSILEIKDSEKVFCGKIKKLQNDAAWRKAMWETFYNVYIRYSVEQARQRGFTSAVTIGSFVDTALNQGATGGSDTLQGLLARSGSSSNEKTFMKNFHAKRTLVVDTNKYNKPPNGKNRVKQWDTLVDMGKMNLKNVDSEIAQVTDWEMK'),
('Q16775', '1QH5', 1, 1.45, 'A/B', 260, 'HYDROLASE', 'HYDROLASE', 'Hydroxyacylglutathione hydrolase, mitochondrial', 'HAGH', 'S-(2-hydroxyacyl)glutathione + H2O = glutathione + a 2-hydroxy carboxylate.<br />\n', 'hydroxyacylglutathione hydrolase activity<br />\nmetal ion binding<br />\n', 'glutathione biosynthetic process<br />\nmethylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione<br />\npyruvate metabolic process<br />\n', 'PF16123.', 'MVVGRGLLGRRSLAALGAACARRGLGPALLGVFCHTDLRKNLTVDEGTMKVEVLPALTDNYMYLVIDDETKEAAIVDPVQPQKVVDAARKHGVKLTTVLTTHHHWDHAGGNEKLVKLESGLKVYGGDDRIGALTHKITHLSTLQVGSLNVKCLATPCHTSGHICYFVSKPGGSEPPAVFTGDTLFVAGCGKFYEGTADEMCKALLEVLGRLPPDTRVYCGHEYTINNLKFARHVEPGNAAIREKLAWAKEKYSIGEPTVPSTLAEEFTYNPFMRVREKTVQQHAGETDPVTTMRAVRREKDQFKMPRD'),
('P12532', '1QK1', 0, 2.7, 'A/B/C/D/E/F/G/H', 379, 'TRANSFERASE (CREATINE KINASE)', 'TRANSFERASE', 'Creatine kinase U-type, mitochondrial', 'CKMT1A', 'ATP + creatine = ADP + phosphocreatine<br />\n', 'ATP binding<br />\ncreatine kinase activity<br />\n', 'creatine metabolic process<br />\n', 'PF00217.', 'MAGPFSRLLSARPGLRLLALAGAGSLAAGFLLRPEPVRAASERRRLYPPSAEYPDLRKHNNCMASHLTPAVYARLCDKTTPTGWTLDQCIQTGVDNPGHPFIKTVGMVAGDEETYEVFADLFDPVIQERHNGYDPRTMKHTTDLDASKIRSGYFDERYVLSSRVRTGRSIRGLSLPPACTRAERREVERVVVDALSGLKGDLAGRYYRLSEMTEAEQQQLIDDHFLFDKPVSPLLTAAGMARDWPDARGIWHNNEKSFLIWVNEEDHTRVISMEKGGNMKRVFERFCRGLKEVERLIQERGWEFMWNERLGYILTCPSNLGTGLRAGVHIKLPLLSKDSRFPKILENLRLQKRGTGGVDTAATGGVFDISNLDRLGKSEVELVQLVIDGVNYLIDCERRLERGQDIRIPTPVIHTKH'),
('P04083', '1QLS', 0, 2.3, 'D', 12, 'METAL-BINDING PROTEIN / INHIBITOR', 'METAL_BINDING', 'Annexin A1', 'ANXA1', '', 'annealing helicase activity<br />\ncadherin binding involved in cell-cell adhesion<br />\ncalcium-dependent phospholipid binding<br />\ncalcium-dependent protein binding<br />\ncalcium ion binding<br />\ndouble-stranded DNA-dependent ATPase activity<br />\nhelicase activity<br />\nphospholipase A2 inhibitor activity<br />\nphospholipid binding<br />\nprotein binding, bridging<br />\nprotein homodimerization activity<br />\nreceptor binding<br />\nsingle-stranded DNA binding<br />\nsingle-stranded RNA binding<br />\nstructural molecule activity<br />\n', 'actin cytoskeleton reorganization<br />\nadaptive immune response<br />\nalpha-beta T cell differentiation<br />\narachidonic acid secretion<br />\ncell surface receptor signaling pathway<br />\ncellular response to glucocorticoid stimulus<br />\ncellular response to hydrogen peroxide<br />\nDNA duplex unwinding<br />\nDNA rewinding<br />\nendocrine pancreas development<br />\nestrous cycle<br />\ngliogenesis<br />\nG-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger<br />\ngranulocyte chemotaxis<br />\nhepatocyte differentiation<br />\ninflammatory response<br />\ninnate immune response<br />\ninsulin secretion<br />\nkeratinocyte differentiation<br />\nmonocyte chemotaxis<br />\nmyoblast migration involved in skeletal muscle regeneration<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of exocytosis<br />\nnegative regulation of interleukin-8 secretion<br />\nnegative regulation of phospholipase A2 activity<br />\nnegative regulation of T-helper 2 cell differentiation<br />\nneutrophil clearance<br />\nneutrophil homeostasis<br />\npeptide cross-linking<br />\nphagocytosis<br />\npositive regulation of G1/S transition of mitotic cell cycle<br />\npositive regulation of interleukin-2 production<br />\npositive regulation of neutrophil apoptotic process<br />\npositive regulation of prostaglandin biosynthetic process<br />\npositive regulation of T cell proliferation<br />\npositive regulation of T-helper 1 cell differentiation<br />\npositive regulation of vesicle fusion<br />\npositive regulation of wound healing<br />\nprolactin secretion<br />\nprostate gland development<br />\nregulation of cell shape<br />\nregulation of hormone secretion<br />\nregulation of inflammatory response<br />\nregulation of interleukin-1 production<br />\nregulation of leukocyte migration<br />\nresponse to drug<br />\nresponse to estradiol<br />\nresponse to interleukin-1<br />\nresponse to peptide hormone<br />\nresponse to X-ray<br />\nsignal transduction<br />\n', 'PF00191.', 'MAMVSEFLKQAWFIENEEQEYVQTVKSSKGGPGSAVSPYPTFNPSSDVAALHKAIMVKGVDEATIIDILTKRNNAQRQQIKAAYLQETGKPLDETLKKALTGHLEEVVLALLKTPAQFDADELRAAMKGLGTDEDTLIEILASRTNKEIRDINRVYREELKRDLAKDITSDTSGDFRNALLSLAKGDRSEDFGVNEDLADSDARALYEAGERRKGTDVNVFNTILTTRSYPQLRRVFQKYTKYSKHDMNKVLDLELKGDIEKCLTAIVKCATSKPAFFAEKLHQAMKGVGTRHKALIRIMVSRSEIDMNDIKAFYQKMYGISLCQAILDETKGDYEKILVALCGGN'),
('P16455', '1QNT', 0, 1.9, 'A', 176, 'DNA REPAIR', 'OTHERS', 'Methylated-DNA--protein-cysteine methyltransferase', 'MGMT', 'DNA (containing 6-O-methylguanine) + protein L-cysteine = DNA (without 6-O-methylguanine) + protein S-methyl-L-cysteine<br />\nDNA (containing 4-O-methylthymine) + protein L-cysteine = DNA (without 4-O-methylthymine) + protein S-methyl-L-cysteine<br />\n', 'calcium ion binding<br />\nDNA binding<br />\nDNA-methyltransferase activity<br />\nmethylated-DNA-[protein]-cysteine S-methyltransferase activity<br />\nmethyltransferase activity<br />\n', 'cellular response to ionizing radiation<br />\ncellular response to organic cyclic compound<br />\ncellular response to oxidative stress<br />\nDNA dealkylation involved in DNA repair<br />\nDNA ligation<br />\nmammary gland epithelial cell differentiation<br />\nnegative regulation of apoptotic process<br />\npositive regulation of double-strand break repair<br />\nregulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to folic acid<br />\nresponse to toxic substance<br />\n', 'PF01035.', 'MDKDCEMKRTTLDSPLGKLELSGCEQGLHEIKLLGKGTSAADAVEVPAPAAVLGGPEPLMQCTAWLNAYFHQPEAIEEFPVPALHHPVFQQESFTRQVLWKLLKVVKFGEVISYQQLAALAGNPKAARAVGGAMRGNPVPILIPCHRVVCSSGAVGNYSGGLAVKEWLLAHEGHRLGKPGLGGSSGLAGAWLKGAGATSGSPPAGRN'),
('Q9Z4P0', '1QO8', 1, 2.15, 'A/D', 566, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Fumarate reductase flavoprotein subunit', 'ifcA', 'Succinate + a quinone = fumarate + a quinol.<br />\n', 'fumarate reductase (menaquinone)<br />\nmetal ion binding<br />\nsuccinate dehydrogenase activity<br />\n', '', 'PF14537.', 'MKLKYLVSAMALVVLSSGTAMAKTPDMGSFHADMGSCQSCHAKPIKVTDSETHENAQCKSCHGEYAELANDKLQFDPHNSHLGDINCTSCHKGHEEPKFYCNECHSFDIKPMPFSDAKKKKSWDDGWDQDKIQKAIAAGPSETTQVLVVGAGSAGFNASLAAKKAGANVILVDKAPFSGGNSMISAGGMNAVGTKQQTAHGVEDKVEWFIEDAMKGGRQQNDIKLVTILAEQSADGVQWLESLGANLDDLKRSGGARVDRTHRPHGGKSSGPEIIDTLRKAAKEQGIDTRLNSRVVKLVVNDDHSVVGAVVHGKHTGYYMIGAKSVVLATGGYGMNKEMIAYYRPTMKDMTSSNNITATGDGVLMAKEIGASMTDIDWVQAHPTVGKDSRILISETVRGVGAVMVNKDGNRFISELTTRDKASDAILKQPGQFAWIIFDNQLYKKAKMVRGYDHLEMLYKGDTVEQLAKSTGMKVADLAKTVSDYNGYVASGKDTAFGRADMPLNMTQSPYYAVKVAPGIHHTMGGVAINTTASVLDLQSKPIDGLFAAGEVTGGVHGYNRLGGNAIADTVVFGRIAGDNAAKHALDK'),
('P06239', '1QPC', 1, 1.6, 'A', 279, 'TRANSFERASE', 'TRANSFERASE', 'Tyrosine-protein kinase Lck', 'LCK', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATPase binding<br />\nATP binding<br />\nCD4 receptor binding<br />\nCD8 receptor binding<br />\nidentical protein binding<br />\nkinase activity<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nphosphatidylinositol 3-kinase binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein C-terminus binding<br />\nprotein kinase binding<br />\nprotein phosphatase binding<br />\nprotein serine/threonine phosphatase activity<br />\nprotein tyrosine kinase activity<br />\nSH2 domain binding<br />\nT cell receptor binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nB cell receptor signaling pathway<br />\ncell migration<br />\ncellular zinc ion homeostasis<br />\nhemopoiesis<br />\ninnate immune response<br />\ninterleukin-7-mediated signaling pathway<br />\nleukocyte migration<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\nplatelet activation<br />\npositive regulation of intrinsic apoptotic signaling pathway<br />\npositive regulation of T cell activation<br />\npositive regulation of T cell receptor signaling pathway<br />\nprotein phosphorylation<br />\nregulation of cell proliferation<br />\nregulation of defense response to virus by virus<br />\nregulation of lymphocyte activation<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nrelease of sequestered calcium ion into cytosol<br />\nresponse to drug<br />\nT cell costimulation<br />\nT cell differentiation<br />\nT cell receptor signaling pathway<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF07714.', 'MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP'),
('P0AEK4', '1QSG', 1, 1.75, 'A/B/C/D/E/F/G/H', 262, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Enoyl-[acyl-carrier-protein] reductase [NADH] FabI', 'fabI', 'An acyl-[acyl-carrier protein] + NAD+ = a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH<br />\n', 'enoyl-[acyl-carrier-protein] reductase (NADH) activity<br />\nidentical protein binding<br />\n', 'biotin biosynthetic process<br />\nfatty acid elongation<br />\nlipid biosynthetic process<br />\nprotein homotetramerization<br />\nresponse to antibiotic<br />\n', '', 'MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK'),
('P08473', '1R1H', 1, 1.95, 'A', 696, 'HYDROLASE', 'HYDROLASE', 'Neprilysin', 'MME', 'Preferential cleavage of polypeptides between hydrophobic residues, particularly with Phe or Tyr at P1''<br />\n', 'endopeptidase activity<br />\nexopeptidase activity<br />\nmetalloendopeptidase activity<br />\nmetallopeptidase activity<br />\npeptide binding<br />\nzinc ion binding<br />\n', 'amyloid-beta clearance<br />\namyloid-beta metabolic process<br />\nangiotensin maturation<br />\ncellular response to cytokine stimulus<br />\ncellular response to UV-A<br />\ncellular response to UV-B<br />\ncreatinine metabolic process<br />\nkidney development<br />\nneutrophil degranulation<br />\npeptide metabolic process<br />\nproteolysis<br />\nreplicative senescence<br />\nsensory perception of pain<br />\n', 'PF01431.', 'MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW'),
('Q9KIE5', '1R2J', 1, 2.1, 'A', 366, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'FkbI', 'fkbI', NULL, 'flavin adenine dinucleotide binding<br />\r\noxidoreductase activity, acting on the CH-CH group of donors<br />', NULL, 'PF00441.', 'MPERDALLTDLVGDRAAEWDTSGELPRDLLVRLGADGLLCAEVAAEHGGL\r\nGLGSRENGEFTAHVGSLCSSLRSVMTSQGMAAWTVQRLGDAGQRATFLKE\r\nLTSGKLAAVGFSERQAGSDLSAMRTRVRLDGDTAVVDGHKVWTTAAAYAD\r\nHLVVFGLQEDGSGAVVVVPADTPGVRVERVPKPSGCRAAGHADLHLDQVR\r\nVPAGAVLAGSGASLPMLVAASLAYGRKSVAWGCVGILRACRTAAVAHART\r\nREQFGRPLGDHQLVAGHIADLWTAEQIAARVCEYASDHWDEGSPEMVPAT\r\nILAKHVAAERAAAGAATAAQVLASAGAREGHVVERAYRDAKLMEIIEGSS\r\nEMCRVMLAQHALALPA'),
('Q9BYF1', '1R42', 0, 2.2, 'A', 615, 'HYDROLASE', 'HYDROLASE', 'Angiotensin-converting enzyme 2', 'ACE2', 'Angiotensin II + H2O = angiotensin-1-7 + L-phenylalanine.<br />\n', 'carboxypeptidase activity<br />\nendopeptidase activity<br />\nmetallocarboxypeptidase activity<br />\nvirus receptor activity<br />\nzinc ion binding<br />\n', 'angiotensin catabolic process in blood<br />\nangiotensin maturation<br />\nangiotensin-mediated drinking behavior<br />\npositive regulation of cardiac muscle contraction<br />\npositive regulation of gap junction assembly<br />\npositive regulation of reactive oxygen species metabolic process<br />\nreceptor biosynthetic process<br />\nreceptor-mediated virion attachment to host cell<br />\nregulation of blood vessel diameter<br />\nregulation of cardiac conduction<br />\nregulation of cell proliferation<br />\nregulation of cytokine production<br />\nregulation of inflammatory response<br />\nregulation of systemic arterial blood pressure by renin-angiotensin<br />\nregulation of vasoconstriction<br />\ntryptophan transport<br />\nviral entry into host cell<br />\n', 'PF16959.', 'MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVMGVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF'),
('P23381', '1R6U', 1, 2, 'A/B', 424, 'LIGASE', 'LIGASE', 'Tryptophan--tRNA ligase, cytoplasmic', 'WARS', 'ATP + L-tryptophan + tRNA(Trp) = AMP + diphosphate + L-tryptophyl-tRNA(Trp).<br />\n', 'ATP binding<br />\nkinase inhibitor activity<br />\nprotein domain specific binding<br />\nprotein homodimerization activity<br />\nprotein kinase binding<br />\ntryptophan-tRNA ligase activity<br />\n', 'angiogenesis<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of protein kinase activity<br />\nnegative regulation of protein phosphorylation<br />\npositive regulation of gene expression<br />\npositive regulation of protein complex assembly<br />\nregulation of angiogenesis<br />\nregulation of protein ADP-ribosylation<br />\ntranslation<br />\ntRNA aminoacylation for protein translation<br />\ntryptophanyl-tRNA aminoacylation<br />\n', 'PF00579.', 'MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQ'),
('Q14749', '1R74', 0, 2.55, 'A/B', 294, 'TRANSFERASE', 'TRANSFERASE', 'Glycine N-methyltransferase', 'GNMT', 'S-adenosyl-L-methionine + glycine = S-adenosyl-L-homocysteine + sarcosine.<br />\n', 'folic acid binding<br />\nglycine binding<br />\nglycine N-methyltransferase activity<br />\n', 'cellular nitrogen compound metabolic process<br />\ncellular protein modification process<br />\nglycogen metabolic process<br />\nmethionine metabolic process<br />\none-carbon metabolic process<br />\nprotein homotetramerization<br />\nregulation of gluconeogenesis<br />\nS-adenosylmethionine metabolic process<br />\n', '', 'MVDSVYRTRSLGVAAEGLPDQYADGEAARVWQLYIGDTRSRTAEYKAWLLGLLRQHGCQRVLDVACGTGVDSIMLVEEGFSVTSVDASDKMLKYALKERWNRRHEPAFDKWVIEEANWMTLDKDVPQSAEGGFDAVICLGNSFAHLPDCKGDQSEHRLALKNIASMVRAGGLLVIDHRNYDHILSTGCAPPGKNIYYKSDLTKDVTTSVLIVNNKAHMVTLDYTVQVPGAGQDGSPGLSKFRLSYYPHCLASFTELLQAAFGGKCQHSVLGDFKPYKPGQTYIPCYFIHVLKRTD');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('Q9X592', '1R76', 0, 2.65, 'A', 408, 'LYASE', 'LYASE', 'Pectate lyase', 'pelA', '', 'lyase activity', NULL, 'PF09492.', 'MKRIALLIPLFASNLLIPATVASAAVIGMNEAASALTPSRVSSLPDTQRA\r\nAWQEYLARSEAQLSRDKASLAAELAPGQPLPPPPAEGKGADTMPLDKPAA\r\nWYTSKAARHVADVIVSFQTPAGGWGKNQPRDGALRLPGQHYTGENVAKVK\r\nSGSNDLDAARDRDWHYVGTIDNDATVTEIRFLAQVVSQLAPEEAAPYRDA\r\nALKGIEYLLASQFPNGGWPQVWPLEGGYHDAITYNDDALVHVAELLSDIA\r\nAGRDGFGFVPPAIRTRALEATNAAIHCIVETQVVQDGKRLGWGQQHDALT\r\nLRPTSARNFEPAALSSTESARILLFLMEIEAPSDAVKQAIRGGVAWLNTS\r\nVIRDRAWVKSDQGYQLVTEQGAKPLWSRFYSLDGNKPVFGDRDKTIHDDV\r\nMGISQERRTGYAWYTTSPQKALSAFTKWEKRS'),
('P05193', '1RGY', 1, 1.52, 'A', 360, 'HYDROLASE', 'HYDROLASE', 'Beta-lactamase', 'ampC', 'A beta-lactam + H2O = a substituted beta-amino acid<br />\n', 'beta-lactamase activity<br />\n', 'antibiotic catabolic process<br />\nresponse to antibiotic<br />\n', 'PF00144.', 'MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDRIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ'),
('P68638', '1RID', 1, 2.1, 'A/B', 244, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Complement control protein C3', 'VACWR025', '', 'complement binding<br />\n', 'suppression by virus of host complement activation<br />\n', 'PF00084.', 'MKVESVTFLTLLGIGCVLSCCTIPSRPINMKFKNSVETDANANYNIGDTIEYLCLPGYRKQKMGPIYAKCTGTGWTLFNQCIKRRCPSPRDIDNGQLDIGGVDFGSSITYSCNSGYHLIGESKSYCELGSTGSMVWNPEAPICESVKCQSPPSISNGRHNGYEDFYTDGSVVTYSCNSGYSLIGNSGVLCSGGEWSDPPTCQIVKCPHPTISNGYLSSGFKRSYSYNDNVDFKCKYGYKLSGSSSSTCSPGNTWKPELPKCVR'),
('P36888', '1RJB', 0, 2.1, 'A', 344, 'TRANSFERASE', 'TRANSFERASE', 'Receptor-type tyrosine-protein kinase FLT3', 'FLT3', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncytokine receptor activity<br />\nglucocorticoid receptor binding<br />\nprotein complex binding<br />\nprotein homodimerization activity<br />\nprotein self-association<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\nvascular endothelial growth factor-activated receptor activity<br />\n', 'animal organ regeneration<br />\nB cell differentiation<br />\ncellular response to cytokine stimulus<br />\ncellular response to glucocorticoid stimulus<br />\ncommon myeloid progenitor cell proliferation<br />\ncytokine-mediated signaling pathway<br />\ndendritic cell differentiation<br />\nhemopoiesis<br />\nleukocyte homeostasis<br />\nlymphocyte proliferation<br />\nmyeloid progenitor cell differentiation<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of cell proliferation<br />\npositive regulation of MAPK cascade<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\npro-B cell differentiation<br />\nprotein autophosphorylation<br />\nregulation of apoptotic process<br />\nresponse to organonitrogen compound<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00047.', 'MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSSVGKSSSYPMVSESPEDLGCALRPQSSGTVYEAAAVEVDVSASITLQVLVDAPGNISCLWVFKHSSLNCQPHFDLQNRGVVSMVILKMTETQAGEYLLFIQSEATNYTILFTVSIRNTLLYTLRRPYFRKMENQDALVCISESVPEPIVEWVLCDSQGESCKEESPAVVKKEEKVLHELFGTDIRCCARNELGRECTRLFTIDLNQTPQTTLPQLFLKVGEPLWIRCKAVHVNHGFGLTWELENKALEEGNYFEMSTYSTNRTMIRILFAFVSSVARNDTGYYTCSSSKHPSQSALVTIVEKGFINATNSSEDYEIDQYEEFCFSVRFKAYPQIRCTWTFSRKSFPCEQKGLDNGYSISKFCNHKHQPGEYIFHAENDDAQFTKMFTLNIRRKPQVLAEASASQASCFSDGYPLPSWTWKKCSDKSPNCTEEITEGVWNRKANRKVFGQWVSSSTLNMSEAIKGFLVKCCAYNSLGTSCETILLNSPGPFPFIQDNISFYATIGVCLLFIVVLTLLICHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNVDGRVSECPHTYQNRRPFSREMDLGLLSPQAQVEDS'),
('P51512', '1RM8', 1, 1.8, 'A', 169, 'HYDROLASE', 'HYDROLASE', 'Matrix metalloproteinase-16', 'MMP16', '', 'enzyme activator activity<br />\nmetalloaminopeptidase activity<br />\nmetalloendopeptidase activity<br />\nzinc ion binding<br />\n', 'chondrocyte proliferation<br />\ncollagen catabolic process<br />\ncraniofacial suture morphogenesis<br />\nembryonic cranial skeleton morphogenesis<br />\nendochondral ossification<br />\nextracellular matrix disassembly<br />\nprotein metabolic process<br />\nprotein processing<br />\nproteolysis<br />\n', 'PF11857.', 'MILLTFSTGRRLDFVHHSGVFFLQTLLWILCATVCGTEQYFNVEVWLQKYGYLPPTDPRMSVLRSAETMQSALAAMQQFYGINMTGKVDRNTIDWMKKPRCGVPDQTRGSSKFHIRRKRYALTGQKWQHKHITYSIKNVTPKVGDPETRKAIRRAFDVWQNVTPLTFEEVPYSELENGKRDVDITIIFASGFHGDSSPFDGEGGFLAHAYFPGPGIGGDTHFDSDEPWTLGNPNHDGNDLFLVAVHELGHALGLEHSNDPTAIMAPFYQYMETDNFKLPNDDLQGIQKIYGPPDKIPPPTRPLPTVPPHRSIPPADPRKNDRPKPPRPPTGRPSYPGAKPNICDGNFNTLAILRREMFVFKDQWFWRVRNNRVMDGYPMQITYFWRGLPPSIDAVYENSDGNFVFFKGNKYWVFKDTTLQPGYPHDLITLGSGIPPHGIDSAIWWEDVGKTYFFKGDRYWRYSEEMKTMDPGYPKPITVWKGIPESPQGAFVHKENGFTYFYKGKEYWKFNNQILKVEPGYPRSILKDFMGCDGPTDRVKEGHSPPDDVDIVIKLDNTASTVKAIAIVIPCILALCLLVLVYTVFQFKRKGTPRHILYCKRSMQEWV'),
('P00750', '1RTF', 1, 2.3, 'B', 252, 'SERINE PROTEASE', 'OTHERS', 'Tissue-type plasminogen activator', 'PLAT', 'Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.<br />\n', 'phosphoprotein binding<br />\nreceptor binding<br />\nserine-type endopeptidase activity<br />\n', 'blood coagulation<br />\ncellular protein modification process<br />\nfibrinolysis<br />\nnegative regulation of proteolysis<br />\nplasminogen activation<br />\nplatelet-derived growth factor receptor signaling pathway<br />\nproteolysis<br />\nresponse to hypoxia<br />\nsmooth muscle cell migration<br />\n', 'PF00008.', 'MDAMKRGLCCVLLLCGAVFVSPSQEIHARFRRGARSYQVICRDEKTQMIYQQHQSWLRPVLRSNRVEYCWCNSGRAQCHSVPVKSCSEPRCFNGGTCQQALYFSDFVCQCPEGFAGKCCEIDTRATCYEDQGISYRGTWSTAESGAECTNWNSSALAQKPYSGRRPDAIRLGLGNHNYCRNPDRDSKPWCYVFKAGKYSSEFCSTPACSEGNSDCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDAKPWCHVLKNRRLTWEYCDVPSCSTCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMRP'),
('Q9UKU7', '1RX0', 1, 1.77, 'A/B/C/D', 392, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Isobutyryl-CoA dehydrogenase, mitochondrial', 'ACAD8', 'Isobutyryl-CoA + ETF = methylacrylyl-CoA + reduced ETF.<br />\n', 'acyl-CoA dehydrogenase activity<br />\nflavin adenine dinucleotide binding<br />\n', 'branched-chain amino acid catabolic process<br />\nlipid metabolic process<br />\nregulation of transcription, DNA-templated<br />\ntranscription, DNA-templated<br />\nvaline catabolic process<br />\n', 'PF00441.', 'MLWSGCRRFGARLGCLPGGLRVLVQTGHRSLTSCIDPSMGLNEEQKEFQKVAFDFAAREMAPNMAEWDQKELFPVDVMRKAAQLGFGGVYIQTDVGGSGLSRLDTSVIFEALATGCTSTTAYISIHNMCAWMIDSFGNEEQRHKFCPPLCTMEKFASYCLTEPGSGSDAASLLTSAKKQGDHYILNGSKAFISGAGESDIYVVMCRTGGPGPKGISCIVVEKGTPGLSFGKKEKKVGWNSQPTRAVIFEDCAVPVANRIGSEGQGFLIAVRGLNGGRINIASCSLGAAHASVILTRDHLNVRKQFGEPLASNQYLQFTLADMATRLVAARLMVRNAAVALQEERKDAVALCSMAKLFATDECFAICNQALQMHGGYGYLKDYAVQQYVRDSRVHQILEGSNEVMRILISRSLLQE'),
('O31616', '1RYI', 1, 1.8, 'A/B/C/D', 367, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glycine oxidase', 'thiO', 'Glycine + H2O + O2 = glyoxylate + NH3 + H2O2<br />\nN-ethylglycine + H2O + O2 = glyoxylate + ethylamine + H2O2<br />\nSarcosine + H2O + O2 = glyoxylate + methylamine + H2O2<br />\nD-alanine + H2O + O2 = pyruvate + NH3 + H2O2<br />\nGlyphosate + H2O + O2 = glyoxylate + aminomethylphosphonate + H2O2<br />\n', 'FAD binding<br />\nglycine oxidase activity<br />\noxidoreductase activity<br />\n', 'cellular amino acid metabolic process<br />\nresponse to herbicide<br />\nthiamine biosynthetic process<br />\nthiamine diphosphate biosynthetic process<br />\n', 'PF01266.', 'MKRHYEAVVIGGGIIGSAIAYYLAKENKNTALFESGTMGGRTTSAAAGMLGAHAECEERDAFFDFAMHSQRLYKGLGEELYALSGVDIRQHNGGMFKLAFSEEDVLQLRQMDDLDSVSWYSKEEVLEKEPYASGDIFGASFIQDDVHVEPYFVCKAYVKAAKMLGAEIFEHTPVLHVERDGEALFIKTPSGDVWANHVVVASGVWSGMFFKQLGLNNAFLPVKGECLSVWNDDIPLTKTLYHDHCYIVPRKSGRLVVGATMKPGDWSETPDLGGLESVMKKAKTMLPAIQNMKVDRFWAGLRPGTKDGKPYIGRHPEDSRILFAAGHFRNGILLAPATGALISDLIMNKEVNQDWLHAFRIDRKEAVQI'),
('P02787', '1RYO', 1, 1.2, 'A', 327, 'METAL TRANSPORT', 'METAL_BINDING', 'Serotransferrin', 'TF', '', 'ferric iron binding<br />\nferric iron transmembrane transporter activity<br />\nferrous iron binding<br />\ntransferrin receptor binding<br />\n', 'cellular iron ion homeostasis<br />\ncellular protein metabolic process<br />\ncellular response to iron ion<br />\nferrous iron import across plasma membrane<br />\niron ion homeostasis<br />\nmembrane organization<br />\nplatelet degranulation<br />\npositive regulation of receptor-mediated endocytosis<br />\npost-translational protein modification<br />\nregulation of protein stability<br />\nretina homeostasis<br />\ntransferrin transport<br />\n', 'PF00405.', 'MRLAVGALLVCAVLGLCLAVPDKTVRWCAVSEHEATKCQSFRDHMKSVIPSDGPSVACVKKASYLDCIRAIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVKKDSGFQMNQLRGKKSCHTGLGRSAGWNIPIGLLYCDLPEPRKPLEKAVANFFSGSCAPCADGTDFPQLCQLCPGCGCSTLNQYFGYSGAFKCLKDGAGDVAFVKHSTIFENLANKADRDQYELLCLDNTRKPVDEYKDCHLAQVPSHTVVARSMGGKEDLIWELLNQAQEHFGKDKSKEFQLFSSPHGKDLLFKDSAHGFLKVPPRMDAKMYLGYEYVTAIRNLREGTCPEAPTDECKPVKWCALSHHERLKCDEWSVNSVGKIECVSAETTEDCIAKIMNGEADAMSLDGGFVYIAGKCGLVPVLAENYNKSDNCEDTPEAGYFAIAVVKKSASDLTWDNLKGKKSCHTAVGRTAGWNIPMGLLYNKINHCRFDEFFSEGCAPGSKKDSSLCKLCMGSGLNLCEPNNKEGYYGYTGAFRCLVEKGDVAFVKHQTVPQNTGGKNPDPWAKNLNEKDYELLCLDGTRKPVEEYANCHLARAPNHAVVTRKDKEACVHKILRQQQHLFGSNVTDCSGNFCLFRSETKDLLFRDDTVCLAKLHDRNTYEKYLGEEYVKAVGNLRKCSTSSLLEACTFRRP'),
('Q9LAG2', '1RZ1', 1, 2.1, 'A/B/C/D/E/F/G/H', 161, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Phenol 2-hydroxylase component B', 'pheA2', NULL, 'FMN binding', NULL, 'PF01613.', 'MDDRLFRNAMGKFATGVTVITTELNGAVHGMTANAFMSVSLNPKLVLVSI\r\nGEKAKMLEKIQQSKKYAVNILSQDQKVLSMNFAGQLEKPVDVQFEELGGL\r\nPVIKDALAQISCQVVNEVQAGDHTLFIGEVTDIKITEQDPLLFFSGKYHQ\r\nLAQNEKVETSS'),
('Q8WVQ1', '1S1D', 1, 1.6, 'A/B', 331, 'HYDROLASE', 'HYDROLASE', 'Soluble calcium-activated nucleotidase 1', 'CANT1', 'A nucleoside diphosphate + H2O = a nucleoside phosphate + phosphate<br />\n', 'adenosine-diphosphatase activity<br />\ncalcium ion binding<br />\nguanosine-diphosphatase activity<br />\nprotein homodimerization activity<br />\nsignal transducer activity<br />\nuridine-diphosphatase activity<br />\n', 'neutrophil degranulation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\nproteoglycan biosynthetic process<br />\n', 'PF06079.', 'MPVQLSEHPEWNESMHSLRISVGGLPVLASMTKAADPRFRPRWKVILTFFVGAAILWLLCSHRPAPGRPPTHNAHNWRLGQAPANWYNDTYPLSPPQRTPAGIRYRIAVIADLDTESRAQEENTWFSYLKKGYLTLSDSGDKVAVEWDKDHGVLESHLAEKGRGMELSDLIVFNGKLYSVDDRTGVVYQIEGSKAVPWVILSDGDGTVEKGFKAEWLAVKDERLYVGGLGKEWTTTTGDVVNENPEWVKVVGYKGSVDHENWVSNYNALRAAAGIQPPGYLIHESACWSDTLQRWFFLPRRASQERYSEKDDERKGANLLLSASPDFGDIAVSHVGAVVPTHGFSSFKFIPNTDDQIIVALKSEEDSGRVASYIMAFTLDGRFLLPETKIGSVKYEGIEFI'),
('Q9UK17', '1S1G', 0, 2.6, 'A/B', 115, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Potassium voltage-gated channel subfamily D member 3', 'KCND3', '', 'A-type (transient outward) potassium channel activity<br />\nion channel binding<br />\nmetal ion binding<br />\n', 'cardiac conduction<br />\nmembrane repolarization<br />\nmembrane repolarization during cardiac muscle cell action potential<br />\nmembrane repolarization during ventricular cardiac muscle cell action potential<br />\npotassium ion export<br />\npotassium ion export across plasma membrane<br />\npotassium ion transport<br />\nprotein homooligomerization<br />\nregulation of heart rate by cardiac conduction<br />\nventricular cardiac muscle cell membrane repolarization<br />\n', 'PF02214.', 'MAAGVAAWLPFARAAAIGWMPVANCPMPLAPADKNKRQDELIVLNVSGRRFQTWRTTLERYPDTLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISAYDDELAFYGILPEIIGDCCYEEYKDRKRENAERLMDDNDSENNQESMPSLSFRQTMWRAFENPHTSTLALVFYYVTGFFIAVSVITNVVETVPCGTVPGSKELPCGERYSVAFFCLDTACVMIFTVEYLLRLFAAPSRYRFIRSVMSIIDVVAIMPYYIGLVMTNNEDVSGAFVTLRVFRVFRIFKFSRHSQGLRILGYTLKSCASELGFLLFSLTMAIIIFATVMFYAEKGSSASKFTSIPASFWYTIVTMTTLGYGDMVPKTIAGKIFGSICSLSGVLVIALPVPVIVSNFSRIYHQNQRADKRRAQKKARLARIRVAKTGSSNAYLHSKRNGLLNEALELTGTPEEEHMGKTTSLIESQHHHLLHCLEKTTGLSYLVDDPLLSVRTSTIKNHEFIDEQMFEQNCMESSMQNYPSTRSPSLSSHPGLTTTCCSRRSKKTTHLPNSNLPATRLRSMQELSTIHIQGSEQPSLTTSRSSLNLKADDGLRPNCKTSQITTAIISIPTPPALTPEGESRPPPASPGPNTNIPSIASNVVKVSAL'),
('P42330', '1S1P', 1, 1.2, 'A', 323, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aldo-keto reductase family 1 member C3', 'AKR1C3', 'Trans-1,2-dihydrobenzene-1,2-diol + NADP+ = catechol + NADPH.<br />\nA 3-alpha-hydroxysteroid + NAD(P)+ = a 3-oxosteroid + NAD(P)H<br />\n(5Z,13E)-(15S)-9-alpha,11-alpha,15-trihydroxyprosta-5,13-dienoate + NADP+ = (5Z,13E)-(15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate + NADPH<br />\nTestosterone + NAD+ = androstenedione + NADH<br />\nTestosterone + NADP+ = androst-4-ene-3,17-dione + NADPH<br />\nIndan-1-ol + NAD(P)+ = indanone + NAD(P)H.<br />\n', '15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity<br />\nalditol:NADP+ 1-oxidoreductase activity<br />\naldo-keto reductase (NADP) activity<br />\nandrosterone dehydrogenase activity<br />\ndelta4-3-oxosteroid 5beta-reductase activity<br />\ndihydrotestosterone 17-beta-dehydrogenase activity<br />\ngeranylgeranyl reductase activity<br />\nindanol dehydrogenase activity<br />\nketoreductase activity<br />\nketosteroid monooxygenase activity<br />\nNADP-retinol dehydrogenase activity<br />\noxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor<br />\nphenanthrene 9,10-monooxygenase activity<br />\nprostaglandin D2 11-ketoreductase activity<br />\nprostaglandin-F synthase activity<br />\nprostaglandin H2 endoperoxidase reductase activity<br />\nretinal dehydrogenase activity<br />\nretinol dehydrogenase activity<br />\ntestosterone 17-beta-dehydrogenase (NADP+) activity<br />\ntestosterone dehydrogenase (NAD+) activity<br />\ntrans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity<br />\n', 'cellular response to cadmium ion<br />\ncellular response to calcium ion<br />\ncellular response to corticosteroid stimulus<br />\ncellular response to jasmonic acid stimulus<br />\ncellular response to prostaglandin D stimulus<br />\ncellular response to prostaglandin stimulus<br />\ncellular response to reactive oxygen species<br />\ncellular response to starvation<br />\ncyclooxygenase pathway<br />\ndaunorubicin metabolic process<br />\ndoxorubicin metabolic process<br />\nfarnesol catabolic process<br />\nG-protein coupled receptor signaling pathway<br />\nkeratinocyte differentiation<br />\nmale gonad development<br />\nmulticellular organismal macromolecule metabolic process<br />\nnegative regulation of retinoic acid biosynthetic process<br />\noxidation-reduction process<br />\npositive regulation of cell death<br />\npositive regulation of cell proliferation<br />\npositive regulation of endothelial cell apoptotic process<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of reactive oxygen species metabolic process<br />\nprogesterone metabolic process<br />\nprostaglandin metabolic process<br />\nprotein import into nucleus, translocation<br />\nregulation of retinoic acid receptor signaling pathway<br />\nregulation of testosterone biosynthetic process<br />\nrenal absorption<br />\nresponse to nutrient<br />\nretinal metabolic process<br />\nretinoid metabolic process<br />\nsteroid metabolic process<br />\ntestosterone biosynthetic process<br />\n', 'PF00248.', 'MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY'),
('Q8RLY5', '1S2D', 1, 2.1, 'A/B/C', 167, 'TRANSFERASE', 'TRANSFERASE', 'Nucleoside 2-deoxyribosyltransferase', 'ptd', NULL, 'deoxyribonucleoside 5''-monophosphate N-glycosidase activity<br />\r\nnucleoside deoxyribosyltransferase activity<br />', 'deoxyribonucleoside monophosphate catabolic process', 'PF05014.', 'MKAVVPTGKIYLGSPFYSDAQRERAAKAKELLAKNPSIAHVFFPFDDGFT\r\nDPDEKNPEIGGIRSMVWRDATYQNDLTGISNATCGVFLYDMDQLDDGSAF\r\nEIGFMRAMHKPVILVPFTEHPEKEKKMNLMIAQGVTTIIDGNTEFEKLAD\r\nYNFNECPSNPVRGYGIY'),
('Q9R381', '1S3Z', 1, 2, 'A/B', 145, 'TRANSFERASE', 'TRANSFERASE', 'Aminoglycoside N(6'')-acetyltransferase type 1', 'N/A', 'Acetyl-CoA + kanamycin-B = CoA + N(6'')-acetylkanamycin-B.', 'aminoglycoside 6''-N-acetyltransferase activity<br />\r\nprotein homodimerization activity<br />', 'acetyl-CoA metabolic process<br />\r\nhistone acetylation<br />\r\nresponse to antibiotic<br />', 'PF00583.', 'MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMA\r\nDGVAIGFADASIRHDYVNGCDSSPVVFLEGIFVLPSFRQRGVAKQLIAAV\r\nQRWGTNKGCREMASDTSPENTISQKVHQALGFEETERVIFYRKRC'),
('P43155', '1S5O', 1, 1.8, 'A', 592, 'TRANSFERASE', 'TRANSFERASE', 'Carnitine O-acetyltransferase', 'CRAT', 'Acetyl-CoA + carnitine = CoA + O-acetylcarnitine.<br />\n', 'carnitine O-acetyltransferase activity<br />\nreceptor binding<br />\n', 'carnitine metabolic process, CoA-linked<br />\nfatty acid beta-oxidation using acyl-CoA oxidase<br />\ntransport<br />\n', 'PF00755.', 'MLAFAARTVVKPLGFLKPFSLMKASSRFKAHQDALPRLPVPPLQQSLDHYLKALQPIVSEEEWAHTKQLVDEFQASGGVGERLQKGLERRARKTENWLSEWWLKTAYLQYRQPVVIYSSPGVMLPKQDFVDLQGQLRFAAKLIEGVLDFKVMIDNETLPVEYLGGKPLCMNQYYQILSSCRVPGPKQDTVSNFSKTKKPPTHITVVHNYQFFELDVYHSDGTPLTADQIFVQLEKIWNSSLQTNKEPVGILTSNHRNSWAKAYNTLIKDKVNRDSVRSIQKSIFTVCLDATMPRVSEDVYRSHVAGQMLHGGGSRLNSGNRWFDKTLQFIVAEDGSCGLVYEHAAAEGPPIVTLLDYVIEYTKKPELVRSPLVPLPMPKKLRFNITPEIKSDIEKAKQNLSIMIQDLDITVMVFHHFGKDFPKSEKLSPDAFIQMALQLAYYRIYGQACATYESASLRMFHLGRTDTIRSASMDSLTFVKAMDDSSVTEHQKVELLRKAVQAHRGYTDRAIRGEAFDRHLLGLKLQAIEDLVSMPDIFMDTSYAIAMHFHLSTSQVPAKTDCVMFFGPVVPDGYGVCYNPMEAHINFSLSAYNSCAETNAARLAHYLEKALLDMRALLQSHPRAKL'),
('Q93CA2', '1S6R', 1, 2.24, 'A', 359, 'HYDROLASE', 'HYDROLASE', 'Beta-lactamase', 'ampC', 'A beta-lactam + H2O = a substituted beta-amino acid.', 'beta-lactamase activity', 'antibiotic catabolic process<br />\r\nresponse to antibiotic<br />', 'PF00144.', 'MMRKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAV\r\nAVIYQGKPHYYTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIAR\r\nGEISLDDPVTRYWPQLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNAS\r\nLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLK\r\nPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDM\r\nANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA\r\nNTVVEGSDSKVALAPLPVVEVNPPAPPVKASWVHKTGSTGGFGSYVAFIP\r\nEKQIGIVMLANTSYPNPARVEAAYHILEALQ'),
('P29466', '1SC3', 1, 1.8, 'A', 178, 'HYDROLASE', 'HYDROLASE', 'Caspase-1', 'CASP1', 'Strict requirement for an Asp residue at position P1 and has a preferred cleavage sequence of Tyr-Val-Ala-Asp-|-.<br />\n', 'CARD domain binding<br />\ncysteine-type endopeptidase activator activity involved in apoptotic process<br />\ncysteine-type endopeptidase activity<br />\ncysteine-type endopeptidase activity involved in apoptotic process<br />\nendopeptidase activity<br />\nidentical protein binding<br />\nkinase binding<br />\n', 'apoptotic process<br />\ncellular response to interferon-gamma<br />\ncellular response to lipopolysaccharide<br />\ncellular response to mechanical stimulus<br />\ncellular response to organic substance<br />\ninterleukin-1 beta production<br />\nmembrane hyperpolarization<br />\nmitochondrial depolarization<br />\npositive regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of interleukin-1 alpha secretion<br />\npositive regulation of interleukin-1 beta secretion<br />\npositive regulation of tumor necrosis factor-mediated signaling pathway<br />\nprogrammed necrotic cell death<br />\nprotein autoprocessing<br />\nproteolysis<br />\npyroptosis<br />\nregulation of apoptotic process<br />\nregulation of autophagy<br />\nregulation of inflammatory response<br />\nresponse to ATP<br />\nresponse to hypoxia<br />\nsignal transduction<br />\ntoxin transport<br />\n', 'PF00619.', 'MADKVLKEKRKLFIRSMGEGTINGLLDELLQTRVLNKEEMEKVKRENATVMDKTRALIDSVIPKGAQACQICITYICEEDSYLAGTLGLSADQTSGNYLNMQDSQGVLSSFPAPQAVQDNPAMPTSSGSEGNVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRTGAEVDITGMTMLLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIREGICGKKHSEQVPDILQLNAIFNMLNTKNCPSLKDKPKVIIIQACRGDSPGVVWFKDSVGVSGNLSLPTTEEFEDDAIKKAHIEKDFIAFCSSTPDNVSWRHPTMGSVFIGRLIEHMQEYACSCDVEEIFRKVRFSFEQPDGRAQMPTTERVTLTRCFYLFPGH'),
('P01552', '1SE3', 1, 2.3, 'A', 239, 'TOXIN', 'OTHERS', 'Enterotoxin type B', 'entB', '', '', 'pathogenesis<br />\n', 'PF02876.', 'MYKRLFISHVILIFALILVISTPNVLAESQPDPKPDELHKSSKFTGLMENMKVLYDDNHVSAINVKSIDQFLYFDLIYSIKDTKLGNYDNVRVEFKNKDLADKYKDKYVDVFGANYYYQCYFSKKTNDINSHQTDKRKTCMYGGVTEHNGNQLDKYRSITVRVFEDGKNLLSFDVQTNKKKVTAQELDYLTRHYLVKNKKLYEFNNSPYETGYIKFIENENSFWYDMMPAPGDKFDQSKYLMMYNDNKMVDSKDVKIEVYLTTKKK'),
('O95881', '1SEN', 0, 1.2, 'A', 150, 'STRUCTURAL GENOMICS', 'OTHERS', 'Thioredoxin domain-containing protein 12', 'TXNDC12', '2 glutathione + protein-disulfide = glutathione disulfide + protein-dithiol.<br />\n', 'peptide disulfide oxidoreductase activity<br />\nprotein-disulfide reductase (glutathione) activity<br />\n', 'cell differentiation<br />\ncell redox homeostasis<br />\nnegative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway<br />\n', '', 'METRPRLGATCLLGFSFLLLVISSDGHNGLGKGFGDHIHWRTLEDGKKEAAASGLPLMVIIHKSWCGACKALKPKFAESTEISELSHNFVMVNLEDEEEPKDEDFSPDGGYIPRILFLDPSGKVHPEIINENGNPSYKYFYVSAEQVVQGMKEAQERLTGDAFRKKHLEDEL'),
('P09619', '1SHA', 0, 1.5, 'B', 5, 'PHOSPHOTRANSFERASE', 'TRANSFERASE', 'Platelet-derived growth factor receptor beta', 'PDGFRB', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nenzyme binding<br />\nphosphatidylinositol 3-kinase binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nplatelet activating factor receptor activity<br />\nplatelet-derived growth factor-activated receptor activity<br />\nplatelet-derived growth factor beta-receptor activity<br />\nplatelet-derived growth factor binding<br />\nplatelet-derived growth factor receptor binding<br />\nprotein kinase binding<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor binding<br />\nvascular endothelial growth factor binding<br />\n', 'aging<br />\naorta morphogenesis<br />\ncardiac myofibril assembly<br />\ncell chemotaxis<br />\ncell migration<br />\ncell migration involved in coronary angiogenesis<br />\ncell migration involved in vasculogenesis<br />\nglycosaminoglycan biosynthetic process<br />\ninner ear development<br />\ninterleukin-7-mediated signaling pathway<br />\nlung growth<br />\nmale gonad development<br />\nMAPK cascade<br />\nmetanephric comma-shaped body morphogenesis<br />\nmetanephric glomerular capillary formation<br />\nmetanephric glomerular mesangial cell proliferation involved in metanephros development<br />\nmetanephric mesenchymal cell migration<br />\nmetanephric mesenchyme development<br />\nmetanephric S-shaped body morphogenesis<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of platelet-derived growth factor receptor-beta signaling pathway<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol metabolic process<br />\nplatelet-derived growth factor receptor-beta signaling pathway<br />\nplatelet-derived growth factor receptor signaling pathway<br />\npositive regulation of apoptotic process<br />\npositive regulation of calcium ion import<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway<br />\npositive regulation of chemotaxis<br />\npositive regulation of collagen biosynthetic process<br />\npositive regulation of DNA biosynthetic process<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of hepatic stellate cell activation<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway<br />\npositive regulation of mitotic nuclear division<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of phospholipase C activity<br />\npositive regulation of phosphoprotein phosphatase activity<br />\npositive regulation of reactive oxygen species metabolic process<br />\npositive regulation of Rho protein signal transduction<br />\npositive regulation of smooth muscle cell migration<br />\npositive regulation of smooth muscle cell proliferation<br />\nprotein autophosphorylation<br />\nregulation of actin cytoskeleton organization<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nresponse to estradiol<br />\nresponse to estrogen<br />\nresponse to fluid shear stress<br />\nresponse to hydrogen peroxide<br />\nresponse to hyperoxia<br />\nresponse to retinoic acid<br />\nresponse to toxic substance<br />\nretina vasculature development in camera-type eye<br />\nsignal transduction<br />\nsmooth muscle cell chemotaxis<br />\nwound healing<br />\n', 'PF07679.', 'MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL'),
('Q92947', '1SIQ', 1, 2.1, 'A', 392, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutaryl-CoA dehydrogenase, mitochondrial', 'GCDH', 'Glutaryl-CoA + electron-transfer flavoprotein = crotonyl-CoA + CO2 + reduced electron-transfer flavoprotein<br />\n', 'fatty-acyl-CoA binding<br />\nflavin adenine dinucleotide binding<br />\nglutaryl-CoA dehydrogenase activity<br />\n', 'fatty acid beta-oxidation using acyl-CoA dehydrogenase<br />\nfatty-acyl-CoA biosynthetic process<br />\nlysine catabolic process<br />\ntryptophan metabolic process<br />\n', 'PF00441.', 'MALRGVSVRLLSRGPGLHVLRTWVSSAAQTEKGGRTQSQLAKSSRPEFDWQDPLVLEEQLTTDEILIRDTFRTYCQERLMPRILLANRNEVFHREIISEMGELGVLGPTIKGYGCAGVSSVAYGLLARELERVDSGYRSAMSVQSSLVMHPIYAYGSEEQRQKYLPQLAKGELLGCFGLTEPNSGSDPSSMETRAHYNSSNKSYTLNGTKTWITNSPMADLFVVWARCEDGCIRGFLLEKGMRGLSAPRIQGKFSLRASATGMIIMDGVEVPEENVLPGASSLGGPFGCLNNARYGIAWGVLGASEFCLHTARQYALDRMQFGVPLARNQLIQKKLADMLTEITLGLHACLQLGRLKDQDKAAPEMVSLLKRNNCGKALDIARQARDMLGGNGISDEYHVIRHAMNLEAVNTYEGTHDIHALILGRAITGIQAFTASK'),
('P06401', '1SQN', 1, 1.45, 'A/B', 261, 'HORMONE / GROWTH FACTOR RECEPTOR', 'HORMONE', 'Progesterone receptor', 'PGR', '', 'ATPase binding<br />\nDNA binding<br />\nenzyme binding<br />\nidentical protein binding<br />\nreceptor binding<br />\nRNA polymerase II core promoter proximal region sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsteroid binding<br />\nsteroid hormone receptor activity<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\nzinc ion binding<br />\n', 'cell-cell signaling<br />\nepithelial cell maturation<br />\nlung alveolus development<br />\nnegative regulation of gene expression<br />\novulation from ovarian follicle<br />\nparacrine signaling<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprogesterone receptor signaling pathway<br />\nregulation of epithelial cell proliferation<br />\nsignal transduction<br />\ntertiary branching involved in mammary gland duct morphogenesis<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'MTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFPGSQTSDTLPEVSAIPISLDGLLFPRPCQGQDPSDEKTQDQQSLSDVEGAYSRAEATRGAGGSSSSPPEKDSGLLDSVLDTLLAPSGPGQSQPSPPACEVTSSWCLFGPELPEDPPAAPATQRVLSPLMSRSGCKVGDSSGTAAAHKVLPRGLSPARQLLLPASESPHWSGAPVKPSPQAAAVEVEEEDGSESEESAGPLLKGKPRALGGAAAGGGAAAVPPGAAAGGVALVPKEDSRFSAPRVALVEQDAPMAPGRSPLATTVMDFIHVPILPLNHALLAARTRQLLEDESYDGGAGAASAFAPPRSSPCASSTPVAVGDFPDCAYPPDAEPKDDAYPLYSDFQPPALKIKEEEEGAEASARSPRSYLVAGANPAAFPDFPLGPPPPLPPRATPSRPGEAAVTAAPASASVSSASSSGSTLECILYKAEGAPPQQGPFAPPPCKAPGASGCLLPRDGLPSTSASAAAAGAAPALYPALGLNGLPQLGYQAAVLKEGLPQVYPPYLNYLRPDSEASQSPQYSFESLPQKICLICGDEASGCHYGVLTCGSCKVFFKRAMEGQHNYLCAGRNDCIVDKIRRKNCPACRLRKCCQAGMVLGGRKFKKFNKVRVVRALDAVALPQPVGVPNESQALSQRFTFSPGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK'),
('P00782', '1SUP', 1, 1.6, 'A', 275, 'HYDROLASE (SERINE PROTEASE)', 'HYDROLASE', 'Subtilisin BPN''', 'apr', 'Hydrolysis of proteins with broad specificity for peptide bonds, and a preference for a large uncharged residue in P1. Hydrolyzes peptide amides.<br />\n', 'metal ion binding<br />\nserine-type endopeptidase activity<br />\n', 'fibrinolysis<br />\nproteolysis<br />\nsporulation resulting in formation of a cellular spore<br />\n', 'PF05922.', 'MRGKKVWISLLFALALIFTMAFGSTSSAQAAGKSNGEKKYIVGFKQTMSTMSAAKKKDVISEKGGKVQKQFKYVDAASATLNEKAVKELKKDPSVAYVEEDHVAHAYAQSVPYGVSQIKAPALHSQGYTGSNVKVAVIDSGIDSSHPDLKVAGGASMVPSETNPFQDNNSHGTHVAGTVAALNNSIGVLGVAPSASLYAVKVLGADGSGQYSWIINGIEWAIANNMDVINMSLGGPSGSAALKAAVDKAVASGVVVVAAAGNEGTSGSSSTVGYPGKYPSVIAVGAVDSSNQRASFSSVGPELDVMAPGVSIQSTLPGNKYGAYNGTSMASPHVAGAAALILSKHPNWTNTQVRSSLENTTTKLGDSFYYGKGLINVQAAAQ'),
('P19838', '1SVC', 0, 2.6, 'P', 364, 'TRANSCRIPTION / DNA', 'TRANSCRIPTION', 'Nuclear factor NF-kappa-B p105 subunit', 'NFKB1', '', 'actinin binding<br />\nchromatin binding<br />\nidentical protein binding<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nregulatory region DNA binding<br />\nRNA polymerase II distal enhancer sequence-specific DNA binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\ntranscriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding<br />\ntranscriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\ntranscription regulatory region DNA binding<br />\ntranscription regulatory region sequence-specific DNA binding<br />\n', 'apoptotic process<br />\ncellular response to dsRNA<br />\ncellular response to interleukin-1<br />\ncellular response to interleukin-6<br />\ncellular response to lipopolysaccharide<br />\ncellular response to mechanical stimulus<br />\ncellular response to nicotine<br />\ncellular response to peptide hormone stimulus<br />\nFc-epsilon receptor signaling pathway<br />\nI-kappaB kinase/NF-kappaB signaling<br />\ninflammatory response<br />\ninnate immune response<br />\nmembrane protein intracellular domain proteolysis<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of calcidiol 1-monooxygenase activity<br />\nnegative regulation of cellular protein metabolic process<br />\nnegative regulation of cholesterol transport<br />\nnegative regulation of gene expression<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of interleukin-12 biosynthetic process<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of vitamin D biosynthetic process<br />\nneutrophil degranulation<br />\nNIK/NF-kappaB signaling<br />\npositive regulation of canonical Wnt signaling pathway<br />\npositive regulation of hyaluronan biosynthetic process<br />\npositive regulation of lipid storage<br />\npositive regulation of macrophage derived foam cell differentiation<br />\npositive regulation of miRNA metabolic process<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of type I interferon production<br />\nresponse to muscle stretch<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nstress-activated MAPK cascade<br />\nT cell receptor signaling pathway<br />\ntranscription from RNA polymerase II promoter<br />\n', 'PF00023.', 'MAEDDPYLGRPEQMFHLDPSLTHTIFNPEVFQPQMALPTDGPYLQILEQPKQRGFRFRYVCEGPSHGGLPGASSEKNKKSYPQVKICNYVGPAKVIVQLVTNGKNIHLHAHSLVGKHCEDGICTVTAGPKDMVVGFANLGILHVTKKKVFETLEARMTEACIRGYNPGLLVHPDLAYLQAEGGGDRQLGDREKELIRQAALQQTKEMDLSVVRLMFTAFLPDSTGSFTRRLEPVVSDAIYDSKAPNASNLKIVRMDRTAGCVTGGEEIYLLCDKVQKDDIQIRFYEEEENGGVWEGFGDFSPTDVHRQFAIVFKTPKYKDINITKPASVFVQLRRKSDLETSEPKPFLYYPEIKDKEEVQRKRQKLMPNFSDSFGGGSGAGAGGGGMFGSGGGGGGTGSTGPGYSFPHYGFPTYGGITFHPGTTKSNAGMKHGTMDTESKKDPEGCDKSDDKNTVNLFGKVIETTEQDQEPSEATVGNGEVTLTYATGTKEESAGVQDNLFLEKAMQLAKRHANALFDYAVTGDVKMLLAVQRHLTAVQDENGDSVLHLAIIHLHSQLVRDLLEVTSGLISDDIINMRNDLYQTPLHLAVITKQEDVVEDLLRAGADLSLLDRLGNSVLHLAAKEGHDKVLSILLKHKKAALLLDHPNGDGLNAIHLAMMSNSLPCLLLLVAAGADVNAQEQKSGRTALHLAVEHDNISLAGCLLLEGDAHVDSTTYDGTTPLHIAAGRGSTRLAALLKAAGADPLVENFEPLYDLDDSWENAGEDEGVVPGTTPLDMATSWQVFDILNGKPYEPEFTSDDLLAQGDMKQLAEDVKLQLYKLLEIPDPDKNWATLAQKLGLGILNNAFRLSPAPSKTLMDNYEVSGGTVRELVEALRQMGYTEAIEVIQAASSPVKTTSQAHSLPLSPASTRQQIDELRDSDSVCDSGVETSFRKLSFTESLTSGASLLTLNKMPHDYGQEGPLEGKI'),
('P10721', '1T46', 1, 1.6, 'A', 129, 'TRANSFERASE ACTIVATOR', 'TRANSFERASE', 'Mast/stem cell growth factor receptor Kit', 'KIT', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncytokine binding<br />\nmetal ion binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotease binding<br />\nprotein homodimerization activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nsignal transducer, downstream of receptor, with protein tyrosine kinase activity<br />\nstem cell factor receptor activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\n', 'actin cytoskeleton reorganization<br />\nactivation of MAPK activity<br />\ncell chemotaxis<br />\ncellular response to thyroid hormone stimulus<br />\ncytokine-mediated signaling pathway<br />\ndendritic cell cytokine production<br />\ndetection of mechanical stimulus involved in sensory perception of sound<br />\ndigestive tract development<br />\nectopic germ cell programmed cell death<br />\nembryonic hemopoiesis<br />\nepithelial cell proliferation<br />\nerythrocyte differentiation<br />\nerythropoietin-mediated signaling pathway<br />\nFc receptor signaling pathway<br />\ngerm cell migration<br />\nglycosphingolipid metabolic process<br />\nhematopoietic stem cell migration<br />\nhemopoiesis<br />\nimmature B cell differentiation<br />\ninflammatory response<br />\ninterleukin-7-mediated signaling pathway<br />\nKit signaling pathway<br />\nlamellipodium assembly<br />\nlymphoid progenitor cell differentiation<br />\nmale gonad development<br />\nMAPK cascade<br />\nmast cell chemotaxis<br />\nmast cell cytokine production<br />\nmast cell degranulation<br />\nmast cell differentiation<br />\nmast cell proliferation<br />\nmegakaryocyte development<br />\nmelanocyte adhesion<br />\nmelanocyte differentiation<br />\nmelanocyte migration<br />\nmyeloid progenitor cell differentiation<br />\nnegative regulation of programmed cell death<br />\novarian follicle development<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\npigmentation<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of colon smooth muscle contraction<br />\npositive regulation of gene expression<br />\npositive regulation of JAK-STAT cascade<br />\npositive regulation of long-term neuronal synaptic plasticity<br />\npositive regulation of MAPK cascade<br />\npositive regulation of Notch signaling pathway<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of phospholipase C activity<br />\npositive regulation of pseudopodium assembly<br />\npositive regulation of pyloric antrum smooth muscle contraction<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of small intestine smooth muscle contraction<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\npositive regulation of vascular smooth muscle cell differentiation<br />\nprotein autophosphorylation<br />\nregulation of bile acid metabolic process<br />\nregulation of cell proliferation<br />\nregulation of cell shape<br />\nregulation of developmental pigmentation<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of transcription from RNA polymerase II promoter<br />\nresponse to cadmium ion<br />\nsignal transduction<br />\nsomatic stem cell division<br />\nsomatic stem cell population maintenance<br />\nspermatid development<br />\nspermatogenesis<br />\nstem cell differentiation<br />\nstem cell population maintenance<br />\nT cell differentiation<br />\ntongue development<br />\nvisual learning<br />\n', 'PF00047.', 'MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVGDEIRLLCTDPGFVKWTFEILDETNENKQNEWITEKAEATNTGKYTCTNKHGLSNSIYVFVRDPAKLFLVDRSLYGKEDNDTLVRCPLTDPEVTNYSLKGCQGKPLPKDLRFIPDPKAGIMIKSVKRAYHRLCLHCSVDQEGKSVLSEKFILKVRPAFKAVPVVSVSKASYLLREGEEFTVTCTIKDVSSSVYSTWKRENSQTKLQEKYNSWHHGDFNYERQATLTISSARVNDSGVFMCYANNTFGSANVTTTLEVVDKGFINIFPMINTTVFVNDGENVDLIVEYEAFPKPEHQQWIYMNRTFTDKWEDYPKSENESNIRYVSELHLTRLKGTEGGTYTFLVSNSDVNAAIAFNVYVNTKPEILTYDRLVNGMLQCVAAGFPEPTIDWYFCPGTEQRCSASVLPVDVQTLNSSGPPFGKLVVQSSIDSSAFKHNGTVECKAYNDVGKTSAYFNFAFKGNNKEQIHPHTLFTPLLIGFVIVAGMMCIIVMILTYKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKQEDHAEAALYKNLLHSKESSCSDSTNEYMDMKPGVSYVVPTKADKRRSVRIGSYIERDVTPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHIYSNLANCSPNRQKPVVDHSVRINSVGSTASSSQPLLVHDDV'),
('Q13838', '1T6N', 1, 1.94, 'A/B', 218, 'pre-mRNA processing protein', 'OTHERS', 'Spliceosome RNA helicase DDX39B', 'DDX39B', 'ATP + H2O = ADP + phosphate<br />\n', 'ATPase activity<br />\nATP binding<br />\nATP-dependent protein binding<br />\nATP-dependent RNA helicase activity<br />\nidentical protein binding<br />\nprotein complex binding<br />\nRNA binding<br />\nRNA-dependent ATPase activity<br />\nU4 snRNA binding<br />\nU6 snRNA binding<br />\n', 'liver development<br />\nmRNA 3''-end processing<br />\nmRNA export from nucleus<br />\nmRNA splicing, via spliceosome<br />\nnegative regulation of DNA damage checkpoint<br />\npositive regulation of cell growth involved in cardiac muscle cell development<br />\npositive regulation of DNA biosynthetic process<br />\npositive regulation of DNA-templated transcription, elongation<br />\npositive regulation of translation<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\nRNA export from nucleus<br />\nRNA secondary structure unwinding<br />\nRNA splicing<br />\nspliceosomal complex assembly<br />\ntermination of RNA polymerase II transcription<br />\nviral mRNA export from host cell nucleus<br />\n', 'PF00270.', 'MAENDVDNELLDYEDDEVETAAGGDGAEAPAKKDVKGSYVSIHSSGFRDFLLKPELLRAIVDCGFEHPSEVQHECIPQAILGMDVLCQAKSGMGKTAVFVLATLQQLEPVTGQVSVLVMCHTRELAFQISKEYERFSKYMPNVKVAVFFGGLSIKKDEEVLKKNCPHIVVGTPGRILALARNKSLNLKHIKHFILDECDKMLEQLDMRRDVQEIFRMTPHEKQVMMFSATLSKEIRPVCRKFMQDPMEIFVDDETKLTLHGLQQYYVKLKDNEKNRKLFDLLDVLEFNQVVIFVKSVQRCIALAQLLVEQNFPAIAIHRGMPQEERLSRYQQFKDFQRRILVATNLFGRGMDIERVNIAFNYDMPEDSDTYLHRVARAGRFGTKGLAITFVSDENDAKILNDVQDRFEVNISELPDEIDISSYIEQTR'),
('O76074', '1TBF', 1, 1.3, 'A', 325, 'HYDROLASE', 'HYDROLASE', 'cGMP-specific 3'',5''-cyclic phosphodiesterase', 'PDE5A', 'Guanosine 3'',5''-cyclic phosphate + H2O = guanosine 5''-phosphate<br />\n', '3'',5''-cyclic-GMP phosphodiesterase activity<br />\n3'',5''-cyclic-nucleotide phosphodiesterase activity<br />\ncGMP binding<br />\nmetal ion binding<br />\n', 'cGMP catabolic process<br />\nnegative regulation of cardiac muscle contraction<br />\nnegative regulation of T cell proliferation<br />\npositive regulation of cardiac muscle hypertrophy<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of oocyte development<br />\nregulation of cGMP metabolic process<br />\nrelaxation of cardiac muscle<br />\nsignal transduction<br />\n', 'PF01590.', 'MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN'),
('P30085', '1TEV', 0, 2.1, 'A', 196, 'TRANSFERASE', 'TRANSFERASE', 'UMP-CMP kinase', 'CMPK1', 'ATP + (d)CMP = ADP + (d)CDP<br />\nATP + UMP = ADP + UDP<br />\nATP + nucleoside diphosphate = ADP + nucleoside triphosphate<br />\n', 'ATP binding<br />\ncytidylate kinase activity<br />\nnucleoside diphosphate kinase activity<br />\nnucleoside phosphate kinase activity<br />\nuridine kinase activity<br />\nuridylate kinase activity<br />\n', '''de novo'' pyrimidine nucleobase biosynthetic process<br />\nnucleobase-containing small molecule interconversion<br />\nnucleoside diphosphate phosphorylation<br />\nnucleoside triphosphate biosynthetic process<br />\npyrimidine ribonucleotide biosynthetic process<br />\n', '', 'MKPLVVFVLGGPGAGKGTQCARIVEKYGYTHLSAGELLRDERKNPDSQYGELIEKYIKEGKIVPVEITISLLKREMDQTMAANAQKNKFLIDGFPRNQDNLQGWNKTMDGKADVSFVLFFDCNNEICIERCLERGKSSGRSDDNRESLEKRIQTYLQSTKPIIDLYEEMGKVKKIDASKSVDEVFDEVVQIFDKEG'),
('Q5PXQ6', '1TMX', 1, 1.75, 'A/B', 293, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Hydroxyquinol 1,2-dioxygenase', 'chqB', 'Hydroxyquinol + O2 = maleylacetate<br />\n', 'catechol 1,2-dioxygenase activity<br />\nferric iron binding<br />\nhydroxyquinol 1,2-dioxygenase activity<br />\n', 'beta-ketoadipate pathway<br />\ncatechol-containing compound metabolic process<br />\n', 'PF00775.', 'MSTPVSAEQQAREQDLVERVLRSFDATADPRLKQVMQALTRHLHAFLREVRLTEAEWETGIGFLTDAGHVTNERRQEFILLSDVLGASMQTIAMNNEAHGDATEATVFGPFFVEGSPRIESGGDIAGGAAGEPCWVEGTVTDTDGNPVPDARIEVWEADDDGFYDVQYDDDRTAARAHLLSGPDGGYAFWAITPTPYPIPHDGPVGRMLAATGRSPMRASHLHFMVTAPGRRTLVTHIFVEGDELLDRDSVFGVKDSLVKSFERQPAGAPTPGGREIDGPWSRVRFDIVLAPA'),
('Q79FX6', '1TPY', 1, 2.2, 'A', 287, 'TRANSFERASE', 'TRANSFERASE', 'Cyclopropane mycolic acid synthase MmaA2', 'mmaA2', 'S-adenosyl-L-methionine + phospholipid olefinic fatty acid = S-adenosyl-L-homocysteine + phospholipid cyclopropane fatty acid.<br />\n', 'cyclopropane-fatty-acyl-phospholipid synthase activity<br />\nmethyltransferase activity<br />\n', 'mycolic acid biosynthetic process<br />\n', '', 'MVNDLTPHFEDVQAHYDLSDDFFRLFLDPTQTYSCAHFEREDMTLEEAQIAKIDLALGKLGLQPGMTLLDIGCGWGATMRRAIAQYDVNVVGLTLSKNQAAHVQKSFDEMDTPRDRRVLLAGWEQFNEPVDRIVSIGAFEHFGHDRHADFFARAHKILPPDGVLLLHTITGLTRQQMVDHGLPLTLWLARFLKFIATEIFPGGQPPTIEMVEEQSAKTGFTLTRRQSLQPHYARTLDLWAEALQEHKSEAIAIQSEEVYERYMKYLTGCAKLFRVGYIDVNQFTLAK'),
('P0A9P4', '1TRB', 1, 2, 'A', 320, 'OXIDOREDUCTASE(FLAVOENZYME)', 'OXIDOREDUCTASE', 'Thioredoxin reductase', 'trxB', 'Thioredoxin + NADP+ = thioredoxin disulfide + NADPH.<br />\n', 'flavin adenine dinucleotide binding<br />\nthioredoxin-disulfide reductase activity<br />\n', 'removal of superoxide radicals<br />\n', 'PF07992.', 'MGTTKHSKLLILGSGPAGYTAAVYAARANLQPVLITGMEKGGQLTTTTEVENWPGDPNDLTGPLLMERMHEHATKFETEIIFDHINKVDLQNRPFRLNGDNGEYTCDALIIATGASARYLGLPSEEAFKGRGVSACATCDGFFYRNQKVAVIGGGNTAVEEALYLSNIASEVHLIHRRDGFRAEKILIKRLMDKVENGNIILHTNRTLEEVTGDQMGVTGVRLRDTQNSDNIESLDVAGLFVAIGHSPNTAIFEGQLELENGYIKVQSGIHGNATQTSIPGVFAAGDVMDHIYRQAITSAGTGCMAALDAERYLDGLADAK'),
('P07327', '1U3T', 1, 2.49, 'A/B', 374, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Alcohol dehydrogenase 1A', 'ADH1A', 'An alcohol + NAD+ = an aldehyde or ketone + NADH.<br />\n', 'alcohol dehydrogenase (NAD) activity<br />\nalcohol dehydrogenase activity, zinc-dependent<br />\nretinol dehydrogenase activity<br />\nzinc ion binding<br />\n', 'alcohol metabolic process<br />\ndrug metabolic process<br />\nethanol oxidation<br />\n', 'PF08240.', 'MSTAGKVIKCKAAVLWELKKPFSIEEVEVAPPKAHEVRIKMVAVGICGTDDHVVSGTMVTPLPVILGHEAAGIVESVGEGVTTVKPGDKVIPLAIPQCGKCRICKNPESNYCLKNDVSNPQGTLQDGTSRFTCRRKPIHHFLGISTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGYGSAVNVAKVTPGSTCAVFGLGGVGLSAIMGCKAAGAARIIAVDINKDKFAKAKELGATECINPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPDSQNLSMNPMLLLTGRTWKGAILGGFKSKECVPKLVADFMAKKFSLDALITHVLPFEKINEGFDLLHSGKSIRTILMF'),
('P00325', '1U3U', 1, 1.6, 'A/B', 374, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Alcohol dehydrogenase 1B', 'ADH1B', 'An alcohol + NAD+ = an aldehyde or ketone + NADH.<br />\n', 'alcohol dehydrogenase activity, zinc-dependent<br />\nethanol binding<br />\nzinc ion binding<br />\n', 'ethanol oxidation<br />\n', 'PF08240.', 'MSTAGKVIKCKAAVLWEVKKPFSIEDVEVAPPKAYEVRIKMVAVGICRTDDHVVSGNLVTPLPVILGHEAAGIVESVGEGVTTVKPGDKVIPLFTPQCGKCRVCKNPESNYCLKNDLGNPRGTLQDGTRRFTCRGKPIHHFLGTSTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGYGSAVNVAKVTPGSTCAVFGLGGVGLSAVMGCKAAGAARIIAVDINKDKFAKAKELGATECINPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPASQNLSINPMLLLTGRTWKGAVYGGFKSKEGIPKLVADFMAKKFSLDALITHVLPFEKINEGFDLLHSGKSIRTVLTF'),
('P00326', '1U3W', 1, 1.45, 'A/B', 374, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Alcohol dehydrogenase 1C', 'ADH1C', 'An alcohol + NAD+ = an aldehyde or ketone + NADH.<br />\n', 'alcohol dehydrogenase (NAD) activity<br />\nalcohol dehydrogenase activity, zinc-dependent<br />\nethanol binding<br />\nretinol dehydrogenase activity<br />\nzinc ion binding<br />\n', 'ethanol oxidation<br />\n', 'PF08240.', 'MSTAGKVIKCKAAVLWELKKPFSIEEVEVAPPKAHEVRIKMVAAGICRSDEHVVSGNLVTPLPVILGHEAAGIVESVGEGVTTVKPGDKVIPLFTPQCGKCRICKNPESNYCLKNDLGNPRGTLQDGTRRFTCSGKPIHHFVGVSTFSQYTVVDENAVAKIDAASPLEKVCLIGCGFSTGYGSAVKVAKVTPGSTCAVFGLGGVGLSVVMGCKAAGAARIIAVDINKDKFAKAKELGATECINPQDYKKPIQEVLKEMTDGGVDFSFEVIGRLDTMMASLLCCHEACGTSVIVGVPPDSQNLSINPMLLLTGRTWKGAIFGGFKSKESVPKLVADFMAKKFSLDALITNILPFEKINEGFDLLRSGKSIRTVLTF'),
('P55792', '1U8V', 1, 1.6, 'A/B/C/D', 490, 'LYASE', 'LYASE', '4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase', 'abfD', '4-hydroxybutanoyl-CoA = (E)-but-2-enoyl-CoA + H2O<br />\nVinylacetyl-CoA = (E)-but-2-enoyl-CoA<br />\n', '4-hydroxybutanoyl-CoA dehydratase activity<br />\n4 iron, 4 sulfur cluster binding<br />\nmetal ion binding<br />\noxidoreductase activity, acting on the CH-CH group of donors<br />\nvinylacetyl-CoA delta-isomerase activity<br />\n', '', 'PF03241.', 'MLMTAEQYIESLRKLNTRVYMFGEKIENWVDHPMIRPSINCVAMTYELAQDPQYADLMTTKSNLIGKTINRFANLHQSTDDLRKKVKMQRLLGQKTASCFQRCVGMDAFNAVFSTTYEIDQKYGTNYHKNFTEYLKYIQENDLIVDGAMTDPKGDRGLAPSAQKDPDLFLRIVEKREDGIVVRGAKAHQTGSINSHEHIIMPTIAMTEADKDYAVSFACPSDADGLFMIYGRQSCDTRKMEEGADIDLGNKQFGGQEALVVFDNVFIPNDRIFLCQEYDFAGMMVERFAGYHRQSYGGCKVGVGDVVIGAAALAADYNGAQKASHVKDKLIEMTHLNETLYCCGIACSAEGYPTAAGNYQIDLLLANVCKQNITRFPYEIVRLAEDIAGGLMVTMPSEADFKSETVVGRDGETIGDFCNKFFAAAPTCTTEERMRVLRFLENICLGASAVGYRTESMHGAGSPQAQRIMIARQGNINAKKELAKAIAGIK');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P96965', '1UK8', 0, 1.6, 'A', 282, 'HYDROLASE', 'HYDROLASE', '2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase', 'cumD', '', 'hydrolase activity', NULL, 'PF00561.', 'MANLEIGKSILAAGVLTNYHDVGEGQPVILIHGSGPGVSAYANWRLTIPA\r\nLSKFYRVIAPDMVGFGFTDRPENYNYSKDSWVDHIIGIMDALEIEKAHIV\r\nGNSFGGGLAIATALRYSERVDRMVLMGAAGTRFDVTEGLNAVWGYTPSIE\r\nNMRNLLDIFAYDRSLVTDELARLRYEASIQPGFQESFSSMFPEPRQRWID\r\nALASSDEDIKTLPNETLIIHGREDQVVPLSSSLRLGELIDRAQLHVFGRC\r\nGHWTQIEQTDRFNRLVVEFFNEANTPKLVGRP'),
('Q72JJ3', '1UKW', 1, 2.4, 'A/B', 378, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Putative acyl-CoA dehydrogenase', 'TT_C0779', NULL, 'acyl-CoA dehydrogenase activity<br />\r\nflavin adenine dinucleotide binding<br />', NULL, 'PF00441.', 'MPIDFSLTEEQRQLQALARRFAKEVILPVAREYDEKEEVPWPVIEKLHEV\r\nGLLNAIIPEEYGGMGLKMLDEVIVGEELAYACMGIYTIPMASDLGITPVL\r\nLAGTEEQKERFLRPLTEKPALAAFALSEPGNGSDAAALKTRAIRQGDHYV\r\nLNGTKMWISNGGEAEWVVVFATVNPELRHKGVVALVVERGTPGFKAIKIH\r\nGKMGQRASGTYELVFEDVKVPVENRLGEEGEGFKIAMQTLNKTRIPVAAG\r\nSVGVARRALDEARKYAKERQAFGQPIANFQAIQFKLADMLIGIETARMYT\r\nYYAAWLADQGLPHAHASAIAKAYASEIAFEAANQAIQIHGGYGYVREFPV\r\nEKLLRDVKLNQIYEGTNEIQRLIIARHILAE'),
('P00387', '1UMK', 1, 1.75, 'A', 275, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'NADH-cytochrome b5 reductase 3', 'CYB5R3', 'NADH + 2 ferricytochrome b5 = NAD+ + H+ + 2 ferrocytochrome b5.<br />\n', 'ADP binding<br />\nAMP binding<br />\ncytochrome-b5 reductase activity, acting on NAD(P)H<br />\nFAD binding<br />\nflavin adenine dinucleotide binding<br />\nNAD binding<br />\noxidoreductase activity<br />\n', 'blood circulation<br />\ncholesterol biosynthetic process<br />\nL-ascorbic acid metabolic process<br />\nneutrophil degranulation<br />\nxenobiotic metabolic process<br />\n', 'PF00970.', 'MGAQLSTLGHMVLFPVWFLYSLLMKLFQRSTPAITLESPDIKYPLRLIDREIISHDTRRFRFALPSPQHILGLPVGQHIYLSARIDGNLVVRPYTPISSDDDKGFVDLVIKVYFKDTHPKFPAGGKMSQYLESMQIGDTIEFRGPSGLLVYQGKGKFAIRPDKKSNPIIRTVKSVGMIAGGTGITPMLQVIRAIMKDPDDHTVCHLLFANQTEKDILLRPELEELRNKHSARFKLWYTLDRAPEAWDYGQGFVNEEMIRDHLPPPEEEPLVLMCGPPPMIQYACLPNLDHVGHPTERCFVF'),
('P31749', '1UNQ', 1, 0.98, 'A', 123, 'TRANSFERASE', 'TRANSFERASE', 'RAC-alpha serine/threonine-protein kinase', 'AKT1', 'ATP + a protein = ADP + a phosphoprotein<br />\n', '14-3-3 protein binding<br />\nATP binding<br />\nenzyme binding<br />\nGTPase activating protein binding<br />\nidentical protein binding<br />\nkinase activity<br />\nnitric-oxide synthase regulator activity<br />\nphosphatidylinositol-3,4,5-trisphosphate binding<br />\nphosphatidylinositol-3,4-bisphosphate binding<br />\nprotein homodimerization activity<br />\nprotein kinase activity<br />\nprotein kinase C binding<br />\nprotein phosphatase 2A binding<br />\nprotein serine/threonine/tyrosine kinase activity<br />\nprotein serine/threonine kinase activity<br />\n', 'activation-induced cell death of T cells<br />\naging<br />\nanoikis<br />\napoptotic mitochondrial changes<br />\ncell differentiation<br />\ncell projection organization<br />\ncell proliferation<br />\ncellular protein modification process<br />\ncellular response to cadmium ion<br />\ncellular response to DNA damage stimulus<br />\ncellular response to epidermal growth factor stimulus<br />\ncellular response to granulocyte macrophage colony-stimulating factor stimulus<br />\ncellular response to hypoxia<br />\ncellular response to insulin stimulus<br />\ncellular response to mechanical stimulus<br />\ncellular response to nerve growth factor stimulus<br />\ncellular response to organic cyclic compound<br />\ncellular response to prostaglandin E stimulus<br />\ncellular response to reactive oxygen species<br />\ncellular response to tumor necrosis factor<br />\ncellular response to vascular endothelial growth factor stimulus<br />\nchemical synaptic transmission, postsynaptic<br />\nendocrine pancreas development<br />\nepidermal growth factor receptor signaling pathway<br />\nestablishment of protein localization to mitochondrion<br />\nexecution phase of apoptosis<br />\nG1/S transition of mitotic cell cycle<br />\ngerm cell development<br />\nglucose homeostasis<br />\nglucose metabolic process<br />\nglucose transport<br />\nglycogen biosynthetic process<br />\nglycogen cell differentiation involved in embryonic placenta development<br />\nG-protein coupled receptor signaling pathway<br />\nhyaluronan metabolic process<br />\nI-kappaB kinase/NF-kappaB signaling<br />\ninflammatory response<br />\ninsulin-like growth factor receptor signaling pathway<br />\ninsulin receptor signaling pathway<br />\ninterleukin-18-mediated signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nintracellular signal transduction<br />\nlabyrinthine layer blood vessel development<br />\nlipopolysaccharide-mediated signaling pathway<br />\nmaintenance of protein location in mitochondrion<br />\nmammary gland epithelial cell differentiation<br />\nmaternal placenta development<br />\nmembrane organization<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of autophagy<br />\nnegative regulation of cell size<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of endopeptidase activity<br />\nnegative regulation of extrinsic apoptotic signaling pathway in absence of ligand<br />\nnegative regulation of fatty acid beta-oxidation<br />\nnegative regulation of gene expression<br />\nnegative regulation of JNK cascade<br />\nnegative regulation of macroautophagy<br />\nnegative regulation of neuron death<br />\nnegative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway<br />\nnegative regulation of plasma membrane long-chain fatty acid transport<br />\nnegative regulation of protein kinase activity<br />\nnegative regulation of protein kinase activity by protein phosphorylation<br />\nnegative regulation of proteolysis<br />\nnegative regulation of release of cytochrome c from mitochondria<br />\nNIK/NF-kappaB signaling<br />\nnitric oxide biosynthetic process<br />\nosteoblast differentiation<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\nperipheral nervous system myelin maintenance<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol-mediated signaling<br />\nphosphorylation<br />\nplatelet activation<br />\npositive regulation of apoptotic process<br />\npositive regulation of blood vessel endothelial cell migration<br />\npositive regulation of cell growth<br />\npositive regulation of cell proliferation<br />\npositive regulation of cellular protein metabolic process<br />\npositive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle<br />\npositive regulation of endodeoxyribonuclease activity<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of epidermal growth factor receptor signaling pathway<br />\npositive regulation of fat cell differentiation<br />\npositive regulation of fibroblast migration<br />\npositive regulation of glucose import<br />\npositive regulation of glucose metabolic process<br />\npositive regulation of glycogen biosynthetic process<br />\npositive regulation of I-kappaB phosphorylation<br />\npositive regulation of lipid biosynthetic process<br />\npositive regulation of mitochondrial membrane potential<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of nitric-oxide synthase activity<br />\npositive regulation of organ growth<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of proteasomal ubiquitin-dependent protein catabolic process<br />\npositive regulation of protein localization to nucleus<br />\npositive regulation of protein localization to plasma membrane<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of sodium ion transport<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of vasoconstriction<br />\nprotein autophosphorylation<br />\nprotein catabolic process<br />\nprotein import into nucleus, translocation<br />\nprotein kinase B signaling<br />\nprotein phosphorylation<br />\nprotein ubiquitination<br />\nregulation of apoptotic process<br />\nregulation of cell cycle checkpoint<br />\nregulation of cell migration<br />\nregulation of glycogen biosynthetic process<br />\nregulation of mRNA stability<br />\nregulation of myelination<br />\nregulation of neuron projection development<br />\nregulation of nitric-oxide synthase activity<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of signal transduction by p53 class mediator<br />\nregulation of translation<br />\nresponse to fluid shear stress<br />\nresponse to food<br />\nresponse to growth hormone<br />\nresponse to heat<br />\nresponse to insulin-like growth factor stimulus<br />\nresponse to oxidative stress<br />\nresponse to UV-A<br />\nsignal transduction<br />\nspinal cord development<br />\nstriated muscle cell differentiation<br />\nT cell costimulation<br />\nTOR signaling<br />\ntranslation<br />\n', 'PF00169.', 'MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA'),
('P15121', '1US0', 1, 0.66, 'A', 316, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aldose reductase', 'AKR1B1', 'Alditol + NAD(P)+ = aldose + NAD(P)H.<br />\n', 'alditol:NADP+ 1-oxidoreductase activity<br />\naldo-keto reductase (NADP) activity<br />\nelectron carrier activity<br />\nglyceraldehyde oxidoreductase activity<br />\n', 'C21-steroid hormone biosynthetic process<br />\ncarbohydrate metabolic process<br />\ncellular response to hydrogen peroxide<br />\ncellular response to methylglyoxal<br />\ncellular response to peptide<br />\ndaunorubicin metabolic process<br />\ndoxorubicin metabolic process<br />\nfructose biosynthetic process<br />\ninner medullary collecting duct development<br />\nmaternal process involved in female pregnancy<br />\nnaphthalene metabolic process<br />\nnegative regulation of apoptotic process<br />\nnorepinephrine metabolic process<br />\npositive regulation of JAK-STAT cascade<br />\npositive regulation of smooth muscle cell proliferation<br />\nregulation of urine volume<br />\nrenal water homeostasis<br />\nresponse to stress<br />\nresponse to thyroid hormone<br />\nresponse to water deprivation<br />\nsorbitol biosynthetic process<br />\nstress-activated protein kinase signaling cascade<br />\ntissue homeostasis<br />\n', 'PF00248.', 'MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF'),
('P24093', '1USQ', 1, 1.9, 'A/B/C/D/E/F', 140, 'ADHESIN', 'CELL_ADHESION', 'Dr hemagglutinin structural subunit', 'draA', '', '', '', 'PF04619.', 'MKKLAIMAAASMVFAVSSAHAGFTPSGTTGTTKLTVTEECQVRVGDLTVAKTRGQLTDAAPIGPVTVQALGCDARQVALKADTDNFEQGKFFLISDNNRDKLYVNIRPTDNSAWTTDNGVFYKNDVGSWGGIIGIYVDGQQTNTPPGNYTLTLTGGYWAK'),
('P08373', '1UXY', 1, 1.8, 'A', 340, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'UDP-N-acetylenolpyruvoylglucosamine reductase', 'murB', 'UDP-N-acetyl-alpha-D-muramate + NADP+ = UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine + NADPH.<br />\n', 'flavin adenine dinucleotide binding<br />\nUDP-N-acetylmuramate dehydrogenase activity<br />\n', 'cell cycle<br />\ncell division<br />\ncell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\n', 'PF01565.', 'MNHSLKPWNTFGIDHNAQHIVCAEDEQQLLNAWQYATAEGQPVLILGEGSNVLFLEDYRGTVIINRIKGIEIHDEPDAWYLHVGAGENWHRLVKYTLQEGMPGLENLALIPGCVGSSPIQNIGAYGVELQRVCAYVDSVELATGKQVRLTAKECRFGYRDSIFKHEYQDRFAIVAVGLRLPKEWQPVLTYGDLTRLDPTTVTPQQVFNAVCHMRTTKLPDPKVNGNAGSFFKNPVVSAETAKALLSQFPTAPNYPQADGSVKLAAGWLIDQCQLKGMQIGGAAVHRQQALVLINEDNAKSEDVVQLAHHVRQKVGEKFNVWLEPEVRFIGASGEVSAVETIS'),
('P27169', '1V04', 0, 2.2, 'A', 353, 'HYDROLASE', 'HYDROLASE', 'Serum paraoxonase/arylesterase 1', 'PON1', 'A phenyl acetate + H2O = a phenol + acetate<br />\nAn aryl dialkyl phosphate + H2O = dialkyl phosphate + an aryl alcohol<br />\nAn N-acyl-L-homoserine lactone + H2O = an N-acyl-L-homoserine<br />\n', 'acyl-L-homoserine-lactone lactonohydrolase activity<br />\naryldialkylphosphatase activity<br />\narylesterase activity<br />\ncalcium ion binding<br />\nphospholipid binding<br />\nprotein homodimerization activity<br />\n', 'aromatic compound catabolic process<br />\ncarboxylic acid catabolic process<br />\ncholesterol metabolic process<br />\nlipoxygenase pathway<br />\norganophosphate catabolic process<br />\nphosphatidylcholine metabolic process<br />\npositive regulation of binding<br />\npositive regulation of cholesterol efflux<br />\npositive regulation of transporter activity<br />\nresponse to external stimulus<br />\nresponse to fatty acid<br />\nresponse to fluoride<br />\nresponse to nutrient levels<br />\nresponse to toxic substance<br />\n', 'PF01731.', 'MAKLIALTLLGMGLALFRNHQSSYQTRLNALREVQPVELPNCNLVKGIETGSEDLEILPNGLAFISSGLKYPGIKSFNPNSPGKILLMDLNEEDPTVLELGITGSKFDVSSFNPHGISTFTDEDNAMYLLVVNHPDAKSTVELFKFQEEEKSLLHLKTIRHKLLPNLNDIVAVGPEHFYGTNDHYFLDPYLQSWEMYLGLAWSYVVYYSPSEVRVVAEGFDFANGINISPDGKYVYIAELLAHKIHVYEKHANWTLTPLKSLDFNTLVDNISVDPETGDLWVGCHPNGMKIFFYDSENPPASEVLRIQNILTEEPKVTQVYAENGTVLQGSTVASVYKGKLLIGTVFHKALYCEL'),
('P26514', '1V0L', 1, 0.98, 'A', 313, 'HYDROLASE', 'HYDROLASE', 'Endo-1,4-beta-xylanase A', 'xlnA', 'Endohydrolysis of (1->4)-beta-D-xylosidic linkages in xylans.<br />\n', 'carbohydrate binding<br />\nendo-1,4-beta-xylanase activity<br />\n', 'xylan catabolic process<br />\n', 'PF00331.', 'MGSYALPRSGVRRSIRVLLLALVVGVLGTATALIAPPGAHAAESTLGAAAAQSGRYFGTAIASGRLSDSTYTSIAGREFNMVTAENEMKIDATEPQRGQFNFSSADRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGSALRQAMIDHINGVMAHYKGKIVQWDVVNEAFADGSSGARRDSNLQRSGNDWIEVAFRTARAADPSAKLCYNDYNVENWTWAKTQAMYNMVRDFKQRGVPIDCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGAPASTYANVTNDCLAVSRCLGITVWGVRDSDSWRSEQTPLLFNNDGSKKAAYTAVLDALNGGDSSEPPADGGQIKGVGSGRCLDVPDASTSDGTQLQLWDCHSGTNQQWAATDAGELRVYGDKCLDAAGTSNGSKVQIYSCWGGDNQKWRLNSDGSVVGVQSGLCLDAVGNGTANGTLIQLYTCSNGSNQRWTRT'),
('Q9RA47', '1V93', 1, 1.9, 'A', 216, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Methylenetetrahydrofolate reductase', 'metF', '5-methyltetrahydrofolate + NAD(P)+ = 5,10-methylenetetrahydrofolate + NAD(P)H.', 'methylenetetrahydrofolate reductase (NAD(P)H) activity<br />\r\nnucleotide binding<br />', 'methionine metabolic process<br />\r\ntetrahydrofolate interconversion<br />', 'PF02219.', 'MKIRDLLKARRGPLFSFEFFPPKDPEGEEALFRTLEELKAFRPAFVSITY\r\nGAMGSTRERSVAWAQRIQSLGLNPLAHLTVAGQSRKEVAEVLHRFVESGV\r\nENLLALRGDPPRGERVFRPHPEGFRYAAELVALIRERYGDRVSVGGAAYP\r\nEGHPESESLEADLRHFKAKVEAGLDFAITQLFFNNAHYFGFLERARRAGI\r\nGIPILPGIMPVTSYRQSAASPRSAGRASP'),
('P19320', '1VCA', 0, 1.8, 'A/B', 202, 'CELL ADHESION PROTEIN', 'CELL_ADHESION', 'Vascular cell adhesion protein 1', 'VCAM1', '', 'cell adhesion molecule binding<br />\nintegrin binding<br />\nprimary amine oxidase activity<br />\n', 'acute inflammatory response<br />\naging<br />\namine metabolic process<br />\nB cell differentiation<br />\ncalcium-mediated signaling using intracellular calcium source<br />\ncell adhesion<br />\ncell chemotaxis<br />\ncell-matrix adhesion<br />\ncellular response to tumor necrosis factor<br />\ncellular response to vascular endothelial growth factor stimulus<br />\nchronic inflammatory response<br />\nextracellular matrix organization<br />\nheterophilic cell-cell adhesion via plasma membrane cell adhesion molecules<br />\ninterferon-gamma-mediated signaling pathway<br />\nleukocyte cell-cell adhesion<br />\nleukocyte tethering or rolling<br />\nmembrane to membrane docking<br />\npositive regulation of T cell proliferation<br />\nregulation of immune response<br />\nresponse to ethanol<br />\nresponse to hypoxia<br />\nresponse to ionizing radiation<br />\nresponse to lipopolysaccharide<br />\nresponse to nicotine<br />\nresponse to nutrient<br />\nresponse to zinc ion<br />\nviral process<br />\n', 'PF05790.', 'MPGKMVVILGASNILWIMFAASQAFKIETTPESRYLAQIGDSVSLTCSTTGCESPFFSWRTQIDSPLNGKVTNEGTTSTLTMNPVSFGNEHSYLCTATCESRKLEKGIQVEIYSFPKDPEIHLSGPLEAGKPITVKCSVADVYPFDRLEIDLLKGDHLMKSQEFLEDADRKSLETKSLEVTFTPVIEDIGKVLVCRAKLHIDEMDSVPTVRQAVKELQVYISPKNTVISVNPSTKLQEGGSVTMTCSSEGLPAPEIFWSKKLDNGNLQHLSGNATLTLIAMRMEDSGIYVCEGVNLIGKNRKEVELIVQEKPFTVEISPGPRIAAQIGDSVMLTCSVMGCESPSFSWRTQIDSPLSGKVRSEGTNSTLTLSPVSFENEHSYLCTVTCGHKKLEKGIQVELYSFPRDPEIEMSGGLVNGSSVTVSCKVPSVYPLDRLEIELLKGETILENIEFLEDTDMKSLENKSLEMTFIPTIEDTGKALVCQAKLHIDDMEFEPKQRQSTQTLYVNVAPRDTTVLVSPSSILEEGSSVNMTCLSQGFPAPKILWSRQLPNGELQPLSENATLTLISTKMEDSGVYLCEGINQAGRSRKEVELIIQVTPKDIKLTAFPSESVKEGDTVIISCTCGNVPETWIILKKKAETGDTVLKSIDGAYTIRKAQLKDAGVYECESKNKVGSQLRSLTLDVQGRENNKDYFSPELLVLYFASSLIIPAIGMIIYFARKANMKGSYSLVEAQKSKV'),
('Q9X0N8', '1VL1', 0, 1.55, 'A', 220, 'HYDROLASE', 'HYDROLASE', '6-phosphogluconolactonase', 'pgl', '6-phospho-D-glucono-1,5-lactone + H2O = 6-phospho-D-gluconate.<br />\n', '6-phosphogluconolactonase activity<br />\n', 'carbohydrate metabolic process<br />\npentose-phosphate shunt, oxidative branch<br />\n', 'PF01182.', 'MEKTVIYLLEDGYVDFVVEKIRTKMEKLLEEKDKIFVVLAGGRTPLPVYEKLAEQKFPWNRIHFFLSDERYVPLDSDQSNFRNINEVLFSRAKIPSGNVHYVDTSLPIEKACEKYEREIRSATDQFDLAILGMGPDGHVASIFDLETGNKDNLVTFTDPSGDPKVPRVTLTFRALNTSLYVLFLIRGKEKINRLTEILKDTPLPAYFVRGKEKTVWFVGK'),
('P29498', '1VYG', 1, 2.4, 'A', 133, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', '14 kDa fatty acid-binding protein', 'N/A', NULL, 'lipid binding<br />\r\ntransporter activity<br />', NULL, 'PF00061.', 'MSSFLGKWKLSESHNFDAVMSKLGVSWATRQIGNTVTPTVTFTMDGDKMT\r\nMLTESTFKNLSCTFKFGEEFDEKTSDGRNVKSVVEKNSESKLTQTQVDPK\r\nNTTVIVREVDGDTMKTTVTVGDVTAIRNYKRLS'),
('Q9RW27', '1W3Q', 1, 1.88, 'A', 195, 'ANTIBIOTIC RESISTANCE', 'OTHERS', 'NimA-related protein', 'DR_0842', NULL, 'cofactor binding', NULL, 'PF12900.', 'MSDFYDPRERDPSVSRRPQNRQSDEWIRELLLRGTIARVATLWQGEDGAA\r\nFPFITPLAYAYRPEQGDLVYHTNVVGRLRANAGQGHPATLEVSEIGQFLP\r\nSNSPLELSVQYRSVMVFGTARVLAGEDARAALTTLSERVFPGLKVGETTR\r\nPISEDDLKRTSVYSLSIDRWSGKENWAEQAIQEEDWPALGPEWLG'),
('Q47PU3', '1W4X', 1, 1.7, 'A', 542, 'OXYGENASE', 'OXIDOREDUCTASE', 'Phenylacetone monooxygenase', 'pamO', 'Phenylacetone + NADPH + O2 = benzyl acetate + NADP+ + H2O<br />\n', 'phenylacetone monooxygenase activity<br />\n', '', '', 'MAGQTTVDSRRQPPEEVDVLVVGAGFSGLYALYRLRELGRSVHVIETAGDVGGVWYWNRYPGARCDIESIEYCYSFSEEVLQEWNWTERYASQPEILRYINFVADKFDLRSGITFHTTVTAAAFDEATNTWTVDTNHGDRIRARYLIMASGQLSVPQLPNFPGLKDFAGNLYHTGNWPHEPVDFSGQRVGVIGTGSSGIQVSPQIAKQAAELFVFQRTPHFAVPARNAPLDPEFLADLKKRYAEFREESRNTPGGTHRYQGPKSALEVSDEELVETLERYWQEGGPDILAAYRDILRDRDANERVAEFIRNKIRNTVRDPEVAERLVPKGYPFGTKRLILEIDYYEMFNRDNVHLVDTLSAPIETITPRGVRTSEREYELDSLVLATGFDALTGALFKIDIRGVGNVALKEKWAAGPRTYLGLSTAGFPNLFFIAGPGSPSALSNMLVSIEQHVEWVTDHIAYMFKNGLTRSEAVLEKEDEWVEHVNEIADETLYPMTASWYTGANVPGKPRVFMLYVGGFHRYRQICDEVAAKGYEGFVLT'),
('P08192', '1W78', 1, 1.82, 'A', 422, 'SYNTHASE', 'OTHERS', 'Dihydrofolate synthase/folylpolyglutamate synthase', 'folC', 'ATP + 7,8-dihydropteroate + L-glutamate = ADP + phosphate + 7,8-dihydropteroylglutamate<br />\nATP + tetrahydropteroyl-(gamma-Glu)(n) + L-glutamate = ADP + phosphate + tetrahydropteroyl-(gamma-Glu)(n+1)<br />\nATP + 10-formyl-tetrahydropteroyl-(gamma-Glu)(n) + L-glutamate = ADP + phosphate + 10-formyl-tetrahydropteroyl-(gamma-Glu)(n+1)<br />\nATP + 5,10-methylene-tetrahydropteroyl-(gamma-Glu)(n) + L-glutamate = ADP + phosphate + 5,10-methylene-tetrahydropteroyl-(gamma-Glu)(n+1)<br />\n', 'ATP binding<br />\ndihydrofolate synthase activity<br />\nmetal ion binding<br />\ntetrahydrofolylpolyglutamate synthase activity<br />\n', 'folic acid biosynthetic process<br />\none-carbon metabolic process<br />\ntetrahydrofolate biosynthetic process<br />\n', 'PF02875.', 'MIIKRTPQAASPLASWLSYLENLHSKTIDLGLERVSLVAARLGVLKPAPFVFTVAGTNGKGTTCRTLESILMAAGYKVGVYSSPHLVRYTERVRVQGQELPESAHTASFAEIESARGDISLTYFEYGTLSALWLFKQAQLDVVILEVGLGGRLDATNIVDADVAVVTSIALDHTDWLGPDRESIGREKAGIFRSEKPAIVGEPEMPSTIADVAQEKGALLQRRGVEWNYSVTDHDWAFSDAHGTLENLPLPLVPQPNAATALAALRASGLEVSENAIRDGIASAILPGRFQIVSESPRVIFDVAHNPHAAEYLTGRMKALPKNGRVLAVIGMLHDKDIAGTLAWLKSVVDDWYCAPLEGPRGATAEQLLEHLGNGKSFDSVAQAWDAAMADAKAEDTVLVCGSFHTVAHVMEVIDARRSGGK'),
('P51151', '1WMS', 1, 1.25, 'A/B', 177, 'PROTEIN TRANSPORT', 'PROTEIN_BINDING', 'Ras-related protein Rab-9A', 'RAB9A', '', 'GDP binding<br />\nGTPase activity<br />\nGTP binding<br />\nidentical protein binding<br />\n', 'membrane organization<br />\nnegative regulation by host of symbiont molecular function<br />\npositive regulation of exocytosis<br />\nprotein transport<br />\nregulation of protein localization<br />\nretrograde transport, endosome to Golgi<br />\n', 'PF00071.', 'MAGKSSLFKVILLGDGGVGKSSLMNRYVTNKFDTQLFHTIGVEFLNKDLEVDGHFVTMQIWDTAGQERFRSLRTPFYRGSDCCLLTFSVDDSQSFQNLSNWKKEFIYYADVKEPESFPFVILGNKIDISERQVSTEEAQAWCRDNGDYPYFETSAKDATNVAAAFEEAVRRVLATEDRSDHLIQTDTVNLHRKPKPSSSCC'),
('P63316', '1WRK', 1, 2.15, 'A/B', 88, 'CONTRACTILE PROTEIN', 'OTHERS', 'Troponin C, slow skeletal and cardiac muscles', 'TNNC1', '', 'actin filament binding<br />\ncalcium-dependent protein binding<br />\ncalcium ion binding<br />\nprotein homodimerization activity<br />\ntroponin I binding<br />\ntroponin T binding<br />\n', 'cardiac muscle contraction<br />\ndiaphragm contraction<br />\nmuscle filament sliding<br />\nregulation of ATPase activity<br />\nregulation of muscle contraction<br />\nregulation of muscle filament sliding speed<br />\nresponse to metal ion<br />\nskeletal muscle contraction<br />\ntransition between fast and slow fiber<br />\nventricular cardiac muscle tissue morphogenesis<br />\n', 'PF13499.', 'MDDIYKAAVEQLTEEQKNEFKAAFDIFVLGAEDGCISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFLVMMVRCMKDDSKGKSEEELSDLFRMFDKNADGYIDLDELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFLEFMKGVE'),
('P48728', '1WSV', 1, 2.6, 'A/B', 375, 'TRANSFERASE', 'TRANSFERASE', 'Aminomethyltransferase, mitochondrial', 'AMT', '[Protein]-S8-aminomethyldihydrolipoyllysine + tetrahydrofolate = [protein]-dihydrolipoyllysine + 5,10-methylenetetrahydrofolate + NH3<br />\n', 'aminomethyltransferase activity<br />\ntransaminase activity<br />\n', 'glycine catabolic process<br />\nglycine decarboxylation via glycine cleavage system<br />\n', 'PF01571.', 'MQRAVSVVARLGFRLQAFPPALCRPLSCAQEVLRRTPLYDFHLAHGGKMVAFAGWSLPVQYRDSHTDSHLHTRQHCSLFDVSHMLQTKILGSDRVKLMESLVVGDIAELRPNQGTLSLFTNEAGGILDDLIVTNTSEGHLYVVSNAGCWEKDLALMQDKVRELQNQGRDVGLEVLDNALLALQGPTAAQVLQAGVADDLRKLPFMTSAVMEVFGVSGCRVTRCGYTGEDGVEISVPVAGAVHLATAILKNPEVKLAGLAARDSLRLEAGLCLYGNDIDEHTTPVEGSLSWTLGKRRRAAMDFPGAKVIVPQLKGRVQRRRVGLMCEGAPMRAHSPILNMEGTKIGTVTSGCPSPSLKKNVAMGYVPCEYSRPGTMLLVEVRRKQQMAVVSKMPFVPTNYYTLK'),
('P09788', '1WVF', 1, 1.3, 'A', 520, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '4-cresol dehydrogenase [hydroxylating] flavoprotein subunit', 'pchF', '4-methylphenol + 2 acceptor + H2O = 4-hydroxybenzaldehyde + 2 reduced acceptor.<br />\n', '4-cresol dehydrogenase (hydroxylating) activity<br />\nflavin adenine dinucleotide binding<br />\noxidoreductase activity, acting on CH-OH group of donors<br />\n', '', 'PF02913.', 'MSEQNNAVLPKGVTQGEFNKAVQKFRALLGDDNVLVESDQLVPYNKIMMPVENAAHAPSAAVTATTVEQVQGVVKICNEHKIPIWTISTGRNFGYGSAAPVQRGQVILDLKKMNKIIKIDPEMCYALVEPGVTFGQMYDYIQENNLPVMLSFSAPSAIAGPVGNTMDRGVGYTPYGEHFMMQCGMEVVLANGDVYRTGMGGVPGSNTWQIFKWGYGPTLDGMFTQANYGICTKMGFWLMPKPPVFKPFEVIFEDEADIVEIVDALRPLRMSNTIPNSVVIASTLWEAGSAHLTRAQYTTEPGHTPDSVIKQMQKDTGMGAWNLYAALYGTQEQVDVNWKIVTDVFKKLGKGRIVTQEEAGDTQPFKYRAQLMSGVPNLQEFGLYNWRGGGGSMWFAPVSEARGSECKKQAAMAKRVLHKYGLDYVAEFIVAPRDMHHVIDVLYDRTNPEETKRADACFNELLDEFEKEGYAVYRVNTRFQDRVAQSYGPVKRKLEHAIKRAVDPNNILAPGRSGIDLNNDF'),
('P12851', '1XIM', 1, 2.2, 'A/B/C/D', 393, 'ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE)', 'OXIDOREDUCTASE', 'Xylose isomerase', 'xylA', 'D-xylopyranose = D-xylulose.<br />\n', 'metal ion binding<br />\nxylose isomerase activity<br />\n', 'D-xylose metabolic process<br />\npentose-phosphate shunt<br />\n', 'PF01261.', 'MSVQATREDKFSFGLWTVGWQARDAFGDATRTALDPVEAVHKLAEIGAYGITFHDDDLVPFGSDAQTRDGIIAGFKKALDETGLIVPMVTTNLFTHPVFKDGGFTSNDRSVRRYAIRKVLRQMDLGAELGAKTLVLWGGREGAEYDSAKDVSAALDRYREALNLLAQYSEDRGYGLRFAIEPKPNEPRGDILLPTAGHAIAFVQELERPELFGINPETGHEQMSNLNFTQGIAQALWHKKLFHIDLNGQHGPKFDQDLVFGHGDLLNAFSLVDLLENGPDGAPAYDGPRHFDYKPSRTEDYDGVWESAKANIRMYLLLKERAKAFRADPEVQEALAASKVAELKTPTLNPGEGYAELLADRSAFEDYDADAVGAKGFGFVKLNQLAIEHLLGAR'),
('P11439', '1XK9', 1, 2.1, 'A/B', 215, 'TRANSFERASE', 'TRANSFERASE', 'Exotoxin A', 'eta', 'NAD+ + diphthamide-[translation elongation factor 2] = nicotinamide + N-(ADP-D-ribosyl)diphthamide-[translation elongation factor 2].<br />\n', 'NAD+-diphthamide ADP-ribosyltransferase activity<br />\n', '', 'PF09101.', 'MHLTPHWIPLVASLGLLAGGSFASAAEEAFDLWNECAKACVLDLKDGVRSSRMSVDPAIADTNGQGVLHYSMVLEGGNDALKLAIDNALSITSDGLTIRLEGGVEPNKPVRYSYTRQARGSWSLNWLVPIGHEKPSNIKVFIHELNAGNQLSHMSPIYTIEMGDELLAKLARDATFFVRAHESNEMQPTLAISHAGVSVVMAQAQPRREKRWSEWASGKVLCLLDPLDGVYNYLAQQRCNLDDTWEGKIYRVLAGNPAKHDLDIKPTVISHRLHFPEGGSLAALTAHQACHLPLETFTRHRQPRGWEQLEQCGYPVQRLVALYLAARLSWNQVDQVIRNALASPGSGGDLGEAIREQPEQARLALTLAAAESERFVRQGTGNDEAGAASADVVSLTCPVAAGECAGPADSGDALLERNYPTGAEFLGDGGDISFSTRGTQNWTVERLLQAHRQLEERGYVFVGYHGTFLEAAQSIVFGGVRARSQDLDAIWRGFYIAGDPALAYGYAQDQEPDARGRIRNGALLRVYVPRSSLPGFYRTGLTLAAPEAAGEVERLIGHPLPLRLDAITGPEEEGGRLETILGWPLAERTVVIPSAIPTDPRNVGGDLDPSSIPDKEQAISALPDYASQPGKPPREDLK'),
('P0AFB1', '1XNF', 0, 1.98, 'A/B', 275, 'Structural genomics', 'OTHERS', 'Lipoprotein NlpI', 'nlpI', '', 'protein binding, bridging<br />\n', 'cell cycle<br />\ncell division<br />\n', 'PF07719.', 'MKPFLRWCFVATALTLAGCSNTSWRKSEVLAVPLQPTLQQEVILARMEQILASRALTDDERAQLLYERGVLYDSLGLRALARNDFSQALAIRPDMPEVFNYLGIYLTQAGNFDAAYEAFDSVLELDPTYNYAHLNRGIALYYGGRDKLAQDDLLAFYQDDPNDPFRSLWLYLAEQKLDEKQAKEVLKQHFEKSDKEQWGWNIVEFYLGNISEQTLMERLKADATDNTSLAEHLSETNFYLGKYYLSLGDLDSATALFKLAVANNVHNFVEHRYALLELSLLGQDQDDLAESDQQ'),
('P09488', '1XW6', 1, 1.9, 'A/B/C/D', 218, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase Mu 1', 'GSTM1', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'enzyme binding<br />\nglutathione binding<br />\nglutathione transferase activity<br />\nprotein homodimerization activity<br />\n', 'cellular detoxification of nitrogen compound<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nnitrobenzene metabolic process<br />\nxenobiotic catabolic process<br />\n', 'PF14497.', 'MPMILGYWDIRGLAHAIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGAHKITQSNAILCYIARKHNLCGETEEEKIRVDILENQTMDNHMQLGMICYNPEFEKLKPKYLEELPEKLKLYSEFLGKRPWFAGNKITFVDFLVYDVLDLHRIFEPKCLDAFPNLKDFISRFEGLEKISAYMKSSRFLPRPVFSKMAVWGNK'),
('P0C278', '1Y0P', 1, 1.5, 'A', 571, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Fumarate reductase flavoprotein subunit', 'fccA', 'Succinate + a quinone = fumarate + a quinol.<br />\n', 'electron carrier activity<br />\nfumarate reductase (menaquinone)<br />\nmetal ion binding<br />\nnucleic acid binding<br />\nsuccinate dehydrogenase activity<br />\n', 'anaerobic electron transport chain<br />\nanaerobic respiration<br />\n', 'PF14537.', 'ADNLAEFHVQNQECDSCHTPDGELSNDSLTYENTQCVSCHGTLEEVAETTKHEHYNAHASHFPGEVACTSCHSAHEKSMVYCDSCHSFDFNMPYAKKWQRDEPTIAELAKDKSERQAALASAPHDTVDVVVVGSGGAGFSAAISATDSGAKVILIEKEPVIGGNAKLAAGGMNAAWTDQQKAKKITDSPELMFEDTMKGGQNINDPALVKVLSSHSKDSVDWMTAMGADLTDVGMMGGASVNRAHRPTGGAGVGAHVVQVLYDNAVKRNIDLRMNTRGIEVLKDDKGTVKGILVKGMYKGYYWVKADAVILATGGFAKNNERVAKLDPSLKGFISTNQPGAVGDGLDVAENAGGALKDMQYIQAHPTLSVKGGVMVTEAVRGNGAILVNREGKRFVNEITTRDKASAAILAQTGKSAYLIFDDSVRKSLSKIDKYIGLGVAPTADSLVKLGKMEGIDGKALTETVARYNSLVSSGKDTDFERPNLPRALNEGNYYAIEVTPGVHHTMGGVMIDTKAEVMNAKKQVIPGLYGAGEVTGGVHGANRLGGNAISDIITFGRLAGEEAAKYSKKN'),
('Q08499', '1Y2K', 1, 1.36, 'A/B', 328, 'HYDROLASE', 'HYDROLASE', 'cAMP-specific 3'',5''-cyclic phosphodiesterase 4D', 'PDE4D', 'Adenosine 3'',5''-cyclic phosphate + H2O = adenosine 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\n3'',5''-cyclic-nucleotide phosphodiesterase activity<br />\nATPase binding<br />\nbeta-2 adrenergic receptor binding<br />\ncAMP binding<br />\ndrug binding<br />\nenzyme binding<br />\nion channel binding<br />\nmetal ion binding<br />\nscaffold protein binding<br />\nubiquitin protein ligase binding<br />\n', 'adrenergic receptor signaling pathway<br />\nadrenergic receptor signaling pathway involved in positive regulation of heart rate<br />\naging<br />\ncAMP catabolic process<br />\ncAMP-mediated signaling<br />\ncellular response to cAMP<br />\ncellular response to epinephrine stimulus<br />\ncellular response to lipopolysaccharide<br />\nestablishment of endothelial barrier<br />\nmulticellular organism growth<br />\nnegative regulation of heart contraction<br />\nnegative regulation of peptidyl-serine phosphorylation<br />\nnegative regulation of relaxation of cardiac muscle<br />\nneutrophil chemotaxis<br />\npositive regulation of interferon-gamma production<br />\npositive regulation of interleukin-2 production<br />\npositive regulation of interleukin-5 production<br />\nregulation of cAMP metabolic process<br />\nregulation of cardiac muscle cell contraction<br />\nregulation of cell communication by electrical coupling involved in cardiac conduction<br />\nregulation of heart rate<br />\nregulation of receptor activity<br />\nregulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum<br />\nregulation of ryanodine-sensitive calcium-release channel activity<br />\nsmooth muscle contraction<br />\nT cell receptor signaling pathway<br />\n', 'PF00233.', 'MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT'),
('P39900', '1Y93', 1, 1.03, 'A', 158, 'HYDROLASE', 'HYDROLASE', 'Macrophage metalloelastase', 'MMP12', 'Hydrolysis of soluble and insoluble elastin. Specific cleavages are also produced at 14-Ala-|-Leu-15 and 16-Tyr-|-Leu-17 in the B chain of insulin.<br />\n', 'calcium ion binding<br />\ncollagen binding<br />\ncore promoter binding<br />\nendopeptidase activity<br />\nmetalloendopeptidase activity<br />\nsequence-specific DNA binding<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'cellular response to virus<br />\ncollagen catabolic process<br />\nextracellular matrix disassembly<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of type I interferon-mediated signaling pathway<br />\npositive regulation of epithelial cell proliferation involved in wound healing<br />\npositive regulation of interferon-alpha secretion<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of type I interferon-mediated signaling pathway<br />\nprotein import into nucleus<br />\nproteolysis<br />\nregulation of defense response to virus by host<br />\nwound healing, spreading of epidermal cells<br />\n', 'PF00045.', 'MKFLLILLLQATASGALPLNSSTSLEKNNVLFGERYLEKFYGLEINKLPVTKMKYSGNLMKEKIQEMQHFLGLKVTGQLDTSTLEMMHAPRCGVPDVHHFREMPGGPVWRKHYITYRINNYTPDMNREDVDYAIRKAFQVWSNVTPLKFSKINTGMADILVVFARGAHGDFHAFDGKGGILAHAFGPGSGIGGDAHFDEDEFWTTHSGGTNLFLTAVHEIGHSLGLGHSSDPKAVMFPTYKYVDINTFRLSADDIRGIQSLYGDPKENQRLPNPDNSEPALCDPNLSFDAVTTVGNKIFFFKDRFFWLKVSERPKTSVNLISSLWPTLPSGIEAAYEIEARNQVFLFKDDKYWLISNLRPEPNYPKSIHSFGFPNFVKKIDAAVFNPRFYRTYFFVDNQYWRYDERRQMMDPGYPKLITKNFQGIGPKIDAVFYSKNKYYYFFQGSNQFEYDFLLQRITKTLKSNSWFGC'),
('Q08257', '1YB5', 1, 1.85, 'A/B', 329, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Quinone oxidoreductase', 'CRYZ', 'NADPH + 2 quinone = NADP+ + 2 semiquinone<br />\n', 'mRNA 3''-UTR binding<br />\nNADPH:quinone reductase activity<br />\nNADPH binding<br />\nzinc ion binding<br />\n', 'protein homotetramerization<br />\nvisual perception<br />\nxenobiotic catabolic process<br />\n', 'PF08240.', 'MATGQKLMRAVRVFEFGGPEVLKLRSDIAVPIPKDHQVLIKVHACGVNPVETYIRSGTYSRKPLLPYTPGSDVAGVIEAVGDNASAFKKGDRVFTSSTISGGYAEYALAADHTVYKLPEKLDFKQGAAIGIPYFTAYRALIHSACVKAGESVLVHGASGGVGLAACQIARAYGLKILGTAGTEEGQKIVLQNGAHEVFNHREVNYIDKIKKYVGEKGIDIIIEMLANVNLSKDLSLLSHGGRVIVVGSRGTIEINPRDTMAKESSIIGVTLFSSTKEEFQQYAAALQAGMEIGWLKPVIGSQYPLEKVAEAHENIIHGSGATGKMILLL'),
('Q9RVD6', '1YI8', 1, 2.1, 'A/B/C', 351, 'LIGASE', 'LIGASE', 'Tryptophan--tRNA ligase 2', 'trpS2', 'ATP + L-tryptophan + tRNA(Trp) = AMP + diphosphate + L-tryptophyl-tRNA(Trp).<br />\n', 'ATP binding<br />\ntryptophan-tRNA ligase activity<br />\n', 'tryptophanyl-tRNA aminoacylation<br />\n', 'PF00579.', 'MPFVDLEVPTMTTPTPAATPARPRVLTGDRPTGALHLGHLAGSLQNRVRLQDEAELFVLLADVQALTDHFDRPEQVRENVLAVALDYLAAGLDPQKTTCVVQSAVPELAELTVYFLNLVTVSHLRQNPTVKAEIAQKGYGERVPAGFFVYPVSQAADIAAFGATLVPVGDDQLPMLEQTREIVRRFNALYAPVLAEPQAQLSRVPRLPGLDGQAKMSKSLGNAIALGDSADEVARKVMGMYTDPGHLRASDPGRVEGNPVFTFLDAFDPDPARVQALKDQYRAGGLGDVKVKKHLIDVLNGVLAPIRTRRAEYERDPDAVLRFVTEGTARGREVAAQTLGQVRRAMRLFGH'),
('P16860', '1YK1', 0, 2.9, 'E', 21, 'HORMONE / GROWTH FACTOR RECEPTOR', 'HORMONE', 'Natriuretic peptides B', 'NPPB', '', 'diuretic hormone activity<br />\nhormone activity<br />\npeptide hormone receptor binding<br />\nreceptor binding<br />\n', 'antimicrobial humoral immune response mediated by antimicrobial peptide<br />\nbody fluid secretion<br />\ncell growth involved in cardiac muscle cell development<br />\ncell surface receptor signaling pathway<br />\ncellular response to mechanical stimulus<br />\ncGMP biosynthetic process<br />\ninflammatory response<br />\nkilling of cells of other organism<br />\nnegative regulation of angiogenesis<br />\nnegative regulation of cell growth<br />\nnegative regulation of smooth muscle cell proliferation<br />\nnegative regulation of systemic arterial blood pressure<br />\npositive regulation of collecting lymphatic vessel constriction<br />\npositive regulation of renal sodium excretion<br />\npositive regulation of urine volume<br />\nprotein folding<br />\nreceptor guanylyl cyclase signaling pathway<br />\nregulation of blood pressure<br />\nregulation of blood vessel diameter<br />\nregulation of vascular permeability<br />\nresponse to calcium ion<br />\nresponse to drug<br />\nresponse to hypoxia<br />\nresponse to lipopolysaccharide<br />\nresponse to organic cyclic compound<br />\nresponse to peptide hormone<br />\n', 'PF00212.', 'MDPQTAPSRALLLLLFLHLAFLGGRSHPLGSPGSASDLETSGLQEQRNHLQGKLSELQVEQTSLEPLQESPRPTGVWKSREVATEGIRGHRKMVLYTLRAPRSPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH'),
('Q9L5C7', '1YLT', 1, 1.1, 'A', 263, 'HYDROLASE', 'HYDROLASE', 'Beta-lactamase', 'blaCTX-M-14', 'A beta-lactam + H2O = a substituted beta-amino acid.', 'beta-lactamase activity', 'beta-lactam antibiotic catabolic process<br />\r\nresponse to antibiotic<br />', NULL, 'MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGV\r\nALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEI\r\nKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGG\r\nVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH\r\nALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIA\r\nVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL'),
('P15555', '1YQS', 1, 1.05, 'A', 349, 'HYDROLASE', 'HYDROLASE', 'D-alanyl-D-alanine carboxypeptidase', 'N/A', 'Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also transpeptidation of peptidyl-alanyl moieties that are N-acyl substituents of D-alanine.', 'serine-type D-Ala-D-Ala carboxypeptidase activity', 'cell wall organization<br />\r\npeptidoglycan biosynthetic process<br />\r\nregulation of cell shape<br />', 'PF00144. ', 'MVSGTVGRGTALGAVLLALLAVPAQAGTAAAADLPAPDDTGLQAVLHTAL\r\nSQGAPGAMVRVDDNGTIHQLSEGVADRATGRAITTTDRFRVGSVTKSFSA\r\nVVLLQLVDEGKLDLDASVNTYLPGLLPDDRITVRQVMSHRSGLYDYTNDM\r\nFAQTVPGFESVRNKVFSYQDLITLSLKHGVTNAPGAAYSYSNTNFVVAGM\r\nLIEKLTGHSVATEYQNRIFTPLNLTDTFYVHPDTVIPGTHANGYLTPDEA\r\nGGALVDSTEQTVSWAQSAGAVISSTQDLDTFFSALMSGQLMSAAQLAQMQ\r\nQWTTVNSTQGYGLGLRRRDLSCGISVYGHTGTVQGYYTYAFASKDGKRSV\r\nTALANTSNNVNVLNTMARTLESAFCGKPTTAKLRSATSSATTVERHEDIA\r\nPGIARD'),
('Q05655', '1YRK', 0, 1.7, 'A', 123, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Protein kinase C delta type', 'PRKCD', 'ATP + a protein = ADP + a phosphoprotein<br />\nATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncalcium-independent protein kinase C activity<br />\nenzyme activator activity<br />\nenzyme binding<br />\ninsulin receptor substrate binding<br />\nkinase binding<br />\nmetal ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\nprotein kinase C activity<br />\nprotein serine/threonine kinase activity<br />\n', 'activation of phospholipase C activity<br />\nactivation of protein kinase activity<br />\napoptotic process<br />\nB cell proliferation<br />\ncell chemotaxis<br />\ncell cycle<br />\ncellular response to angiotensin<br />\ncellular response to hydrogen peroxide<br />\ncellular response to hydroperoxide<br />\ncellular senescence<br />\ndefense response to bacterium<br />\nexecution phase of apoptosis<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nhistone phosphorylation<br />\nimmunoglobulin mediated immune response<br />\ninterferon-gamma-mediated signaling pathway<br />\ninterleukin-10 production<br />\ninterleukin-12 production<br />\nintrinsic apoptotic signaling pathway in response to oxidative stress<br />\nnegative regulation of actin filament polymerization<br />\nnegative regulation of filopodium assembly<br />\nnegative regulation of glial cell apoptotic process<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of insulin receptor signaling pathway<br />\nnegative regulation of MAP kinase activity<br />\nnegative regulation of peptidyl-tyrosine phosphorylation<br />\nnegative regulation of platelet aggregation<br />\nnegative regulation of protein binding<br />\nneutrophil activation<br />\nneutrophil degranulation<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\nplatelet activation<br />\npositive regulation of apoptotic signaling pathway<br />\npositive regulation of ceramide biosynthetic process<br />\npositive regulation of endodeoxyribonuclease activity<br />\npositive regulation of glucosylceramide catabolic process<br />\npositive regulation of phospholipid scramblase activity<br />\npositive regulation of protein dephosphorylation<br />\npositive regulation of protein import into nucleus<br />\npositive regulation of response to DNA damage stimulus<br />\npositive regulation of sphingomyelin catabolic process<br />\npositive regulation of superoxide anion generation<br />\nprotein phosphorylation<br />\nprotein stabilization<br />\nregulation of actin cytoskeleton organization<br />\nregulation of mRNA stability<br />\nregulation of receptor activity<br />\nsignal transduction<br />\nstimulatory C-type lectin receptor signaling pathway<br />\ntermination of signal transduction<br />\n', 'PF00130.', 'MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED'),
('P37288', '1YTV', 0, 1.8, 'M/N', 57, 'SUGAR BINDING PROTEIN', 'OTHERS', 'Vasopressin V1a receptor', 'AVPR1A', '', 'peptide binding<br />\npeptide hormone binding<br />\nprotein kinase C binding<br />\nV1A vasopressin receptor binding<br />\nvasopressin receptor activity<br />\n', 'activation of phospholipase C activity<br />\nblood circulation<br />\ncalcium-mediated signaling<br />\ncellular response to hormone stimulus<br />\ncellular response to water deprivation<br />\ngeneration of precursor metabolites and energy<br />\nG-protein coupled receptor signaling pathway<br />\ngrooming behavior<br />\nmaternal aggressive behavior<br />\nmaternal behavior<br />\nmyotube differentiation<br />\nnegative regulation of female receptivity<br />\nnegative regulation of transmission of nerve impulse<br />\npenile erection<br />\npositive regulation of cell growth<br />\npositive regulation of cell proliferation<br />\npositive regulation of cellular pH reduction<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of glutamate secretion<br />\npositive regulation of heart rate<br />\npositive regulation of prostaglandin biosynthetic process<br />\npositive regulation of renal sodium excretion<br />\npositive regulation of systemic arterial blood pressure<br />\npositive regulation of vasoconstriction<br />\nregulation of systemic arterial blood pressure by vasopressin<br />\nresponse to corticosterone<br />\nresponse to peptide<br />\nsocial behavior<br />\nsperm ejaculation<br />\ntelencephalon development<br />\n', 'PF00001.', 'MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAVTFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGPDWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFVLSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFICYNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAYIVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCVQSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST'),
('Q9BY49', '1YXM', 1, 1.9, 'A/B/C/D', 303, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Peroxisomal trans-2-enoyl-CoA reductase', 'PECR', 'Acyl-CoA + NADP+ = trans-2,3-dehydroacyl-CoA + NADPH<br />\n', 'receptor binding<br />\ntrans-2-enoyl-CoA reductase (NADPH) activity<br />\n', 'fatty acid alpha-oxidation<br />\nfatty acid biosynthetic process<br />\noxidation-reduction process<br />\nphytol metabolic process<br />\n', '', 'MASWAKGRSYLAPGLLQGQVAIVTGGATGIGKAIVKELLELGSNVVIASRKLERLKSAADELQANLPPTKQARVIPIQCNIRNEEEVNNLVKSTLDTFGKINFLVNNGGGQFLSPAEHISSKGWHAVLETNLTGTFYMCKAVYSSWMKEHGGSIVNIIVPTKAGFPLAVHSGAARAGVYNLTKSLALEWACSGIRINCVAPGVIYSQTAVENYGSWGQSFFEGSFQKIPAKRIGVPEEVSSVVCFLLSPAASFITGQSVDVDGGRSLYTHSYEVPDHDNWPKGAGDLSVVKKMKETFKEKAKL'),
('P08546', '1YYP', 0, 2.5, 'B', 22, 'REPLICATION / TRANSFERASE', 'TRANSFERASE', 'DNA polymerase catalytic subunit', 'UL54', 'Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).<br />\n', '3''-5'' exonuclease activity<br />\nDNA binding<br />\nDNA-directed DNA polymerase activity<br />\nnucleotide binding<br />\n', 'bidirectional double-stranded viral DNA replication<br />\nDNA replication<br />\n', 'PF00136.', 'MFFNPYLSGGVTGGAVAGGRRQRSQPGSAQGSGKRPPQKQFLQIVPRGVMFDGQTGLIKHKTGRLPLMFYREIKHLLSHDMVWPCPWRETLVGRVVGPIRFHTYDQTDAVLFFDSPENVSPRYRQHLVPSGNVLRFFGATEHGYSICVNVFGQRSYFYCEYSDTDRLREVIASVGELVPEPRTPYAVSVTPATKTSIYGYGTRPVPDLQCVSISNWTMARKIGEYLLEQGFPVYEVRVDPLTRLVIDRRITTFGWCSVNRYDWRQQGRASTCDIEVDCDVSDLVAVPDDSSWPRYRCLSFDIECMSGEGGFPCAEKSDDIVIQISCVCYETGGNTAVDQGIPNGNDGRGCTSEGVIFGHSGLHLFTIGTCGQVGPDVDVYEFPSEYELLLGFMLFFQRYAPAFVTGYNINSFDLKYILTRLEYLYKVDSQRFCKLPTAQGGRFFLHSPAVGFKRQYAAAFPSASHNNPASTAATKVYIAGSVVIDMYPVCMAKTNSPNYKLNTMAELYLRQRKDDLSYKDIPRCFVANAEGRAQVGRYCLQDAVLVRDLFNTINFHYEAGAIARLAKIPLRRVIFDGQQIRIYTSLLDECACRDFILPNHYSKGTTVPETNSVAVSPNAAIISTAAVPGDAGSVAAMFQMSPPLQSAPSSQDGVSPGSGSNSSSSVGVFSVGSGSSGGVGVSNDNHGAGGTAAVSYQGATVFEPEVGYYNDPVAVFDFASLYPSIIMAHNLCYSTLLVPGGEYPVDPADVYSVTLENGVTHRFVRASVRVSVLSELLNKWVSQRRAVRECMRECQDPVRRMLLDKEQMALKVTCNAFYGFTGVVNGMMPCLPIAASITRIGRDMLERTARFIKDNFSEPCFLHNFFNQEDYVVGTREGDSEESSALPEGLETSSGGSNERRVEARVIYGDTDSVFVRFRGLTPQALVARGPSLAHYVTACLFVEPVKLEFEKVFVSLMMICKKRYIGKVEGASGLSMKGVDLVRKTACEFVKGVTRDVLSLLFEDREVSEAAVRLSRLSLDEVKKYGVPRGFWRILRRLVQARDDLYLHRVRVEDLVLSSVLSKDISLYRQSNLPHIAVIKRLAARSEELPSVGDRVFYVLTAPGVRTAPQGSSDNGDSVTAGVVSRSDAIDGTDDDADGGGVEESNRRGGEPAKKRARKPPSAVCNYEVAEDPSYVREHGVPIHADKYFEQVLKAVTNVLSPVFPGGETARKDKFLHMVLPRRLHLEPAFLPYSVKAHECC'),
('O14727', '1Z6T', 1, 2.21, 'A/B/C/D', 591, 'APOPTOSIS', 'OTHERS', 'Apoptotic protease-activating factor 1', 'APAF1', '', 'ADP binding<br />\nATP binding<br />\ncysteine-type endopeptidase activator activity involved in apoptotic process<br />\nheat shock protein binding<br />\nidentical protein binding<br />\nnucleotide binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nactivation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c<br />\naging<br />\napoptotic process<br />\ncardiac muscle cell apoptotic process<br />\ncell differentiation<br />\ncellular response to transforming growth factor beta stimulus<br />\nforebrain development<br />\nglial cell apoptotic process<br />\nintrinsic apoptotic signaling pathway<br />\nintrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress<br />\nnervous system development<br />\nneural tube closure<br />\nneuron apoptotic process<br />\nneutrophil degranulation<br />\npositive regulation of apoptotic process<br />\npositive regulation of apoptotic signaling pathway<br />\nprotein homooligomerization<br />\nregulation of apoptotic DNA fragmentation<br />\nregulation of apoptotic process<br />\nresponse to G1 DNA damage checkpoint signaling<br />\nresponse to hypoxia<br />\nresponse to nutrient<br />\n', 'PF00619.', 'MDAKARNCLLQHREALEKDIKTSYIMDHMISDGFLTISEEEKVRNEPTQQQRAAMLIKMILKKDNDSYVSFYNALLHEGYKDLAALLHDGIPVVSSSSGKDSVSGITSYVRTVLCEGGVPQRPVVFVTRKKLVNAIQQKLSKLKGEPGWVTIHGMAGCGKSVLAAEAVRDHSLLEGCFPGGVHWVSVGKQDKSGLLMKLQNLCTRLDQDESFSQRLPLNIEEAKDRLRILMLRKHPRSLLILDDVWDSWVLKAFDSQCQILLTTRDKSVTDSVMGPKYVVPVESSLGKEKGLEILSLFVNMKKADLPEQAHSIIKECKGSPLVVSLIGALLRDFPNRWEYYLKQLQNKQFKRIRKSSSYDYEALDEAMSISVEMLREDIKDYYTDLSILQKDVKVPTKVLCILWDMETEEVEDILQEFVNKSLLFCDRNGKSFRYYLHDLQVDFLTEKNCSQLQDLHKKIITQFQRYHQPHTLSPDQEDCMYWYNFLAYHMASAKMHKELCALMFSLDWIKAKTELVGPAHLIHEFVEYRHILDEKDCAVSENFQEFLSLNGHLLGRQPFPNIVQLGLCEPETSEVYQQAKLQAKQEVDNGMLYLEWINKKNITNLSRLVVRPHTDAVYHACFSEDGQRIASCGADKTLQVFKAETGEKLLEIKAHEDEVLCCAFSTDDRFIATCSVDKKVKIWNSMTGELVHTYDEHSEQVNCCHFTNSSHHLLLATGSSDCFLKLWDLNQKECRNTMFGHTNSVNHCRFSPDDKLLASCSADGTLKLWDATSANERKSINVKQFFLNLEDPQEDMEVIVKCCSWSADGARIMVAAKNKIFLFDIHTSGLLGEIHTGHHSTIQYCDFSPQNHLAVVALSQYCVELWNTDSRSKVADCRGHLSWVHGVMFSPDGSSFLTSSDDQTIRLWETKKVCKNSAVMLKQEVDVVFQENEVMVLAVDHIRRLQLINGRTGQIDYLTEAQVSCCCLSPHLQYIAFGDENGAIEILELVNNRIFQSRFQHKKTVWHIQFTADEKTLISSSDDAEIQVWNWQLDKCIFLRGHQETVKDFRLLKNSRLLSWSFDGTVKVWNIITGNKEKDFVCHQGTVLSCDISHDATKFSSTSADKTAKIWSFDLLLPLHELRGHNGCVRCSAFSVDSTLLATGDDNGEIRIWNVSNGELLHLCAPLSEEGAATHGGWVTDLCFSPDGKMLISAGGYIKWWNVVTGESSQTFYTNGTNLKKIHVSPDFKTYVTVDNLGILYILQTLE'),
('Q8YWS4', '1Z8H', 1, 2.02, 'A/B/C/D', 206, 'HYDROLASE', 'HYDROLASE', 'Alr1529 protein', 'alr1529', NULL, NULL, NULL, 'PF13472.', 'MTKQSKTQIRICFVGDSFVNGTGDPECLGWTGRVCVNANKKGYDVTYYNL\r\nGIRRDTSSDIAKRWLQEVSLRLHKEYNSLVVFSFGLNDTTLENGKPRVSI\r\nAETIKNTREILTQAKKLYPVLMISPAPYIEQQDPGRRRRTIDLSQQLALV\r\nCQDLDVPYLDVFPLLEKPSVWLHEAKANDGVHPQAGGYTEFARIVENWDA\r\nWLNWFR'),
('Q13946', '1ZKL', 1, 1.67, 'A', 353, 'HYDROLASE', 'HYDROLASE', 'High affinity cAMP-specific 3'',5''-cyclic phosphodiesterase 7A', 'PDE7A', 'Adenosine 3'',5''-cyclic phosphate + H2O = adenosine 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\nmetal ion binding<br />\n', 'cAMP catabolic process<br />\nsignal transduction<br />\n', 'PF00233.', 'MEVCYQLPVLPLDRPVPQHVLSRRGAISFSSSSALFGCPNPRQLSQRRGAISYDSSDQTALYIRMLGDVRVRSRAGFESERRGSHPYIDFRIFHSQSEIEVSVSARNIRRLLSFQRYLRSSRFFRGTAVSNSLNILDDDYNGQAKCMLEKVGNWNFDIFLFDRLTNGNSLVSLTFHLFSLHGLIEYFHLDMMKLRRFLVMIQEDYHSQNPYHNAVHAADVTQAMHCYLKEPKLANSVTPWDILLSLIAAATHDLDHPGVNQPFLIKTNHYLATLYKNTSVLENHHWRSAVGLLRESGLFSHLPLESRQQMETQIGALILATDISRQNEYLSLFRSHLDRGDLCLEDTRHRHLVLQMALKCADICNPCRTWELSKQWSEKVTEEFFHQGDIEKKYHLGVSPLCDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQTMLGHVGLNKASWKGLQREQSSSEDTDAAFELNSQLLPQENRLS');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P09622', '1ZMD', 1, 2.08, 'A/B/C/D/E/F/G/H', 474, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydrolipoyl dehydrogenase, mitochondrial', 'DLD', 'Protein N6-(dihydrolipoyl)lysine + NAD+ = protein N6-(lipoyl)lysine + NADH<br />\n', 'dihydrolipoyl dehydrogenase activity<br />\nelectron carrier activity<br />\nflavin adenine dinucleotide binding<br />\nlipoamide binding<br />\nNAD binding<br />\n', '2-oxoglutarate metabolic process<br />\naging<br />\nbranched-chain amino acid catabolic process<br />\ncell redox homeostasis<br />\ncellular nitrogen compound metabolic process<br />\ndihydrolipoamide metabolic process<br />\ngastrulation<br />\nlipoate metabolic process<br />\nlysine catabolic process<br />\nmitochondrial acetyl-CoA biosynthetic process from pyruvate<br />\nmitochondrial electron transport, NADH to ubiquinone<br />\nproteolysis<br />\npyruvate metabolic process<br />\nregulation of acetyl-CoA biosynthetic process from pyruvate<br />\nregulation of membrane potential<br />\nsperm capacitation<br />\ntricarboxylic acid cycle<br />\n', 'PF07992.', 'MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF'),
('P0AFI2', '1ZVT', 0, 1.7, 'A/B', 256, 'ISOMERASE', 'ISOMERASE', 'DNA topoisomerase 4 subunit A', 'parC', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\n', 'chromosome segregation<br />\nDNA topological change<br />\nplasmid partitioning<br />\nsister chromatid cohesion<br />\n', 'PF03989.', 'MSDMAERLALHEFTENAYLNYSMYVIMDRALPFIGDGLKPVQRRIVYAMSELGLNASAKFKKSARTVGDVLGKYHPHGDSACYEAMVLMAQPFSYRYPLVDGQGNWGAPDDPKSFAAMRYTESRLSKYSELLLSELGQGTADWVPNFDGTLQEPKMLPARLPNILLNGTTGIAVGMATDIPPHNLREVAQAAIALIDQPKTTLDQLLDIVQGPDYPTEAEIITSRAEIRKIYENGRGSVRMRAVWKKEDGAVVISALPHQVSGARVLEQIAAQMRNKKLPMVDDLRDESDHENPTRLVIVPRSNRVDMDQVMNHLFATTDLEKSYRINLNMIGLDGRPAVKNLLEILSEWLVFRRDTVRRRLNYRLEKVLKRLHILEGLLVAFLNIDEVIEIIRNEDEPKPALMSRFGLTETQAEAILELKLRHLAKLEEMKIRGEQSELEKERDQLQGILASERKMNNLLKKELQADAQAYGDDRRSPLQEREEAKAMSEHDMLPSEPVTIVLSQMGWVRSAKGHDIDAPGLNYKAGDSFKAAVKGKSNQPVVFVDSTGRSYAIDPITLPSARGQGEPLTGKLTLPPGATVDHMLMESDDQKLLMASDAGYGFVCTFNDLVARNRAGKALITLPENAHVMPPVVIEDASDMLLAITQAGRMLMFPVSDLPQLSKGKGNKIINIPSAEAARGEDGLAQLYVLPPQSTLTIHVGKRKIKLRPEELQKVTGERGRRGTLMRGLQRIDRVEIDSPRRASSGDSEE'),
('P11388', '1ZXM', 1, 1.87, 'A/B', 400, 'ISOMERASE', 'ISOMERASE', 'DNA topoisomerase 2-alpha', 'TOP2A', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nchromatin binding<br />\nDNA binding<br />\nDNA binding, bending<br />\nDNA-dependent ATPase activity<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\ndrug binding<br />\nenzyme binding<br />\nhistone deacetylase binding<br />\nmagnesium ion binding<br />\nprotein C-terminus binding<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nprotein kinase C binding<br />\nRNA binding<br />\nubiquitin binding<br />\n', 'apoptotic chromosome condensation<br />\ncellular response to DNA damage stimulus<br />\nchromosome segregation<br />\nDNA ligation<br />\nDNA topological change<br />\nembryonic cleavage<br />\nhematopoietic progenitor cell differentiation<br />\nmitotic DNA integrity checkpoint<br />\nnegative regulation of DNA duplex unwinding<br />\npositive regulation of apoptotic process<br />\npositive regulation of single stranded viral RNA replication via double stranded DNA intermediate<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of viral genome replication<br />\nprotein sumoylation<br />\nregulation of circadian rhythm<br />\nresolution of meiotic recombination intermediates<br />\nrhythmic process<br />\nsister chromatid segregation<br />\n', 'PF00204.', 'MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTYIGSVELVTQQMWVYDEDVGINYREVTFVPGLYKIFDEILVNAADNKQRDPKMSCIRVTIDPENNLISIWNNGKGIPVVEHKVEKMYVPALIFGQLLTSSNYDDDEKKVTGGRNGYGAKLCNIFSTKFTVETASREYKKMFKQTWMDNMGRAGEMELKPFNGEDYTCITFQPDLSKFKMQSLDKDIVALMVRRAYDIAGSTKDVKVFLNGNKLPVKGFRSYVDMYLKDKLDETGNSLKVIHEQVNHRWEVCLTMSEKGFQQISFVNSIATSKGGRHVDYVADQIVTKLVDVVKKKNKGGVAVKAHQVKNHMWIFVNALIENPTFDSQTKENMTLQPKSFGSTCQLSEKFIKAAIGCGIVESILNWVKFKAQVQLNKKCSAVKHNRIKGIPKLDDANDAGGRNSTECTLILTEGDSAKTLAVSGLGVVGRDKYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKNYEDEDSLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLRHRFLEEFITPIVKVSKNKQEMAFYSLPEFEEWKSSTPNHKKWKVKYYKGLGTSTSKEAKEYFADMKRHRIQFKYSGPEDDAAISLAFSKKQIDDRKEWLTNFMEDRRQRKLLGLPEDYLYGQTTTYLTYNDFINKELILFSNSDNERSIPSMVDGLKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSSYHHGEMSLMMTIINLAQNFVGSNNLNLLQPIGQFGTRLHGGKDSASPRYIFTMLSSLARLLFPPKDDHTLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWSCKIPNFDVREIVNNIRRLMDGEEPLPMLPSYKNFKGTIEELAPNQYVISGEVAILNSTTIEISELPVRTWTQTYKEQVLEPMLNGTEKTPPLITDYREYHTDTTVKFVVKMTEEKLAEAERVGLHKVFKLQTSLTCNSMVLFDHVGCLKKYDTVLDILRDFFELRLKYYGLRKEWLLGMLGAESAKLNNQARFILEKIDGKIIIENKPKKELIKVLIQRGYDSDPVKAWKEAQQKVPDEEENEESDNEKETEKSDSVTDSGPTFNYLLDMPLWYLTKEKKDELCRLRNEKEQELDTLKRKSPSDLWKEDLATFIEELEAVEAKEKQDEQVGLPGKGGKAKGKKTQMAEVLPSPRGQRVIPRITIEMKAEAEKKNKKKIKNENTEGSPQEDGVELEGLKQRLEKKQKREPGTKTKKQTTLAFKPIKKGKKRNPWSDSESDRSSDESNFDVPPRETEPRRAATKTKFTMDLDSDEDFSDFDEKTDDEDFVPSDASPPKTKTSPKLSNKELKPQKSVVSDLEADDVKGSVPLSSSPPATHFPDETEITNPVPKKNVTVKKTAAKSQSSTSTTGAKKRAAPKGTKRDPALNSGVSQKPDPAKTKNRRKRKPSTSDDSDSNFEKIVSKAVTSKKSKGESDDFHMDFDSAVAPRAKSVRAKKPIKYLEESDEDDLF'),
('O14832', '2A1X', 1, 2.5, 'A', 308, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Phytanoyl-CoA dioxygenase, peroxisomal', 'PHYH', 'Phytanoyl-CoA + 2-oxoglutarate + O2 = 2-hydroxyphytanoyl-CoA + succinate + CO2.<br />\n', 'carboxylic acid binding<br />\ncofactor binding<br />\nferrous iron binding<br />\nL-ascorbic acid binding<br />\nphytanoyl-CoA dioxygenase activity<br />\n', '2-oxoglutarate metabolic process<br />\nfatty acid alpha-oxidation<br />\nisoprenoid metabolic process<br />\nmethyl-branched fatty acid metabolic process<br />\n', 'PF05721.', 'MEQLRAAARLQIVLGHLGRPSAGAVVAHPTSGTISSASFHPQQFQYTLDNNVLTLEQRKFYEENGFLVIKNLVPDADIQRFRNEFEKICRKEVKPLGLTVMRDVTISKSEYAPSEKMITKVQDFQEDKELFRYCTLPEILKYVECFTGPNIMAMHTMLINKPPDSGKKTSRHPLHQDLHYFPFRPSDLIVCAWTAMEHISRNNGCLVVLPGTHKGSLKPHDYPKWEGGVNKMFHGIQDYEENKARVHLVMEKGDTVFFHPLLIHGSGQNKTQGFRKAISCHFASADCHYIDVKGTSQENIEKEVVGIAHKFFGAENSVNLKDIWMFRARLVKGERTNL'),
('Q91RS4', '2A4Q', 1, 2.45, 'A/C', 181, 'VIRAL PROTEIN', 'OTHERS', 'NS3 protease', 'N/A', NULL, 'metal ion binding<br />\r\nserine-type peptidase activity<br />', 'self proteolysis<br />\r\ntransformation of host cell by virus<br />', 'PF02907.', 'APITAYAQQTRGLLGCIITSLTGRDKNQVEGEVQIVSTAAQTFLATCING\r\nVCWTVYHGAGTRTIASPKGPVIQMYTNVDQDLVGWPAPQGARSLTPCTCG\r\nSSDLYLVTRHADVIPVRRRGDSRGSLLSPRPISYLKGSSGGPLLCPAGHA\r\nVGLFRAAVCTRGVAKAVDFIPVENLETTMRS'),
('P05089', '2AEB', 1, 1.29, 'A/B', 322, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Arginase-1', 'ARG1', 'L-arginine + H2O = L-ornithine + urea<br />\n', 'arginase activity<br />\nmanganese ion binding<br />\n', 'aging<br />\narginine catabolic process<br />\narginine catabolic process to ornithine<br />\ncellular response to dexamethasone stimulus<br />\ncellular response to glucagon stimulus<br />\ncellular response to hydrogen peroxide<br />\ncellular response to interleukin-4<br />\ncellular response to lipopolysaccharide<br />\ncellular response to transforming growth factor beta stimulus<br />\ncollagen biosynthetic process<br />\ndefense response to protozoan<br />\nliver development<br />\nlung development<br />\nmammary gland involution<br />\nmaternal process involved in female pregnancy<br />\nnegative regulation of activated T cell proliferation<br />\nnegative regulation of interferon-gamma-mediated signaling pathway<br />\nnegative regulation of T cell proliferation<br />\nnegative regulation of T-helper 2 cell cytokine production<br />\nneutrophil degranulation<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of neutrophil mediated killing of fungus<br />\nprotein homotrimerization<br />\nregulation of L-arginine import<br />\nresponse to amine<br />\nresponse to amino acid<br />\nresponse to axon injury<br />\nresponse to cadmium ion<br />\nresponse to drug<br />\nresponse to herbicide<br />\nresponse to manganese ion<br />\nresponse to methylmercury<br />\nresponse to selenium ion<br />\nresponse to vitamin A<br />\nresponse to vitamin E<br />\nresponse to zinc ion<br />\nurea cycle<br />\n', 'PF00491.', 'MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK'),
('P17900', '2AG4', 1, 1.8, 'A/B', 162, 'LIPID BINDING PROTEIN', 'OTHERS', 'Ganglioside GM2 activator', 'GM2A', '', 'beta-N-acetylgalactosaminidase activity<br />\nlipid transporter activity<br />\nphospholipase activator activity<br />\nsphingolipid activator protein activity<br />\n', 'ganglioside catabolic process<br />\nglycosphingolipid metabolic process<br />\nlearning or memory<br />\nlipid storage<br />\nneuromuscular process controlling balance<br />\nneutrophil degranulation<br />\noligosaccharide catabolic process<br />\npositive regulation of hydrolase activity<br />\n', 'PF02221.', 'MQSLMQAPLLIALGLLLAAPAQAHLKKPSQLSSFSWDNCDEGKDPAVIRSLTLEPDPIIVPGNVTLSVMGSTSVPLSSPLKVDLVLEKEVAGLWIKIPCTDYIGSCTFEHFCDVLDMLIPTGEPCPEPLRTYGLPCHCPFKEGTYSLPKSEFVVPDLELPSWLTTGNYRIESVLSSSGKRLGCIKIAASLKGI'),
('Q15303', '2AHX', 1, 2.4, 'A/B', 616, 'CELL CYCLE', 'OTHERS', 'Receptor tyrosine-protein kinase erbB-4', 'ERBB4', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nepidermal growth factor receptor binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein homodimerization activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nsignal transducer, downstream of receptor, with protein tyrosine kinase activity<br />\ntranscription regulatory region DNA binding<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\n', 'cardiac muscle tissue regeneration<br />\ncell fate commitment<br />\ncell migration<br />\ncell proliferation<br />\ncellular response to epidermal growth factor stimulus<br />\ncentral nervous system morphogenesis<br />\nembryonic pattern specification<br />\nERBB2 signaling pathway<br />\nheart development<br />\ninterleukin-7-mediated signaling pathway<br />\nlactation<br />\nmammary gland alveolus development<br />\nmammary gland epithelial cell differentiation<br />\nMAPK cascade<br />\nmitochondrial fragmentation involved in apoptotic process<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of ERBB signaling pathway<br />\nnegative regulation of neuron migration<br />\nnervous system development<br />\nneural crest cell migration<br />\nolfactory bulb interneuron differentiation<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of apoptotic process<br />\npositive regulation of cardiac muscle cell proliferation<br />\npositive regulation of cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of protein localization to cell surface<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of STAT protein import into nucleus<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nprotein autophosphorylation<br />\nregulation of cell migration<br />\nregulation of cell motility<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nsignal transduction<br />\ntranscription, DNA-templated<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00757.', 'MKPATGLWVWVSLLVAAGTVQPSDSQSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVMGNLEITSIEHNRDLSFLRSVREVTGYVLVALNQFRYLPLENLRIIRGTKLYEDRYALAIFLNYRKDGNFGLQELGLKNLTEILNGGVYVDQNKFLCYADTIHWQDIVRNPWPSNLTLVSTNGSSGCGRCHKSCTGRCWGPTENHCQTLTRTVCAEQCDGRCYGPYVSDCCHRECAGGCSGPKDTDCFACMNFNDSGACVTQCPQTFVYNPTTFQLEHNFNAKYTYGAFCVKKCPHNFVVDSSSCVRACPSSKMEVEENGIKMCKPCTDICPKACDGIGTGSLMSAQTVDSSNIDKFINCTKINGNLIFLVTGIHGDPYNAIEAIDPEKLNVFRTVREITGFLNIQSWPPNMTDFSVFSNLVTIGGRVLYSGLSLLILKQQGITSLQFQSLKEISAGNIYITDNSNLCYYHTINWTTLFSTINQRIVIRDNRKAENCTAEGMVCNHLCSSDGCWGPGPDQCLSCRRFSRGRICIESCNLYDGEFREFENGSICVECDPQCEKMEDGLLTCHGPGPDNCTKCSHFKDGPNCVEKCPDGLQGANSFIFKYADPDRECHPCHPNCTQGCNGPTSHDCIYYPWTGHSTLPQHARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKRALRRFLETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEEDLEDMMDAEEYLVPQAFNIPPPIYTSRARIDSNRSEIGHSPPPAYTPMSGNQFVYRDGGFAAEQGVSVPYRAPTSTIPEAPVAQGATAEIFDDSCCNGTLRKPVAPHVQEDSSTQRYSADPTVFAPERSPRGELDEEGYMTPMRDKPKQEYLNPVEENPFVSRRKNGDLQALDNPEYHNASNGPPKAEDEYVNEPLYLNTFANTLGKAEYLKNNILSMPEKAKKAFDNPDYWNHSLPPRSTLQHPDYLQEYSTKYFYKQNGRIRPIVAENPEYLSEFSLKPGTVLPPPPYRHRNTVV'),
('P50135', '2AOT', 1, 1.9, 'A/B', 292, 'TRANSFERASE', 'TRANSFERASE', 'Histamine N-methyltransferase', 'HNMT', 'S-adenosyl-L-methionine + histamine = S-adenosyl-L-homocysteine + N(tau)-methylhistamine<br />\n', 'histamine N-methyltransferase activity<br />\n', 'brain development<br />\nhistamine catabolic process<br />\nhistidine catabolic process<br />\nhyperosmotic response<br />\nmethylation<br />\npositive regulation of protein targeting to mitochondrion<br />\nrespiratory gaseous exchange<br />\nresponse to amine<br />\nresponse to cocaine<br />\nresponse to glucocorticoid<br />\nresponse to immobilization stress<br />\nresponse to interleukin-1<br />\nresponse to tumor cell<br />\n', '', 'MASSMRSLFSDHGKYVESFRRFLNHSTEHQCMQEFMDKKLPGIIGRIGDTKSEIKILSIGGGAGEIDLQILSKVQAQYPGVCINNEVVEPSAEQIAKYKELVAKTSNLENVKFAWHKETSSEYQSRMLEKKELQKWDFIHMIQMLYYVKDIPATLKFFHSLLGTNAKMLIIVVSGSSGWDKLWKKYGSRFPQDDLCQYITSDDLTQMLDNLGLKYECYDLLSTMDISDCFIDGNENGDLLWDFLTETCNFNATAPPDLRAELGKDLQEPEFSAKKEGKVLFNNTLSFIVIEA'),
('P01375', '2AZ5', 1, 2.1, 'A/B/C/D', 148, 'CYTOKINE', 'OTHERS', 'Tumor necrosis factor', 'TNF', '', 'cytokine activity<br />\nidentical protein binding<br />\nprotease binding<br />\ntranscription regulatory region DNA binding<br />\ntumor necrosis factor receptor binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nactivation of MAPK activity<br />\nactivation of MAPKKK activity<br />\ncellular response to amino acid stimulus<br />\ncellular response to nicotine<br />\ncellular response to organic cyclic compound<br />\nchronic inflammatory response to antigenic stimulus<br />\ncortical actin cytoskeleton organization<br />\ndeath-inducing signaling complex assembly<br />\ndefense response to Gram-positive bacterium<br />\nembryonic digestive tract development<br />\nendothelial cell apoptotic process<br />\nepithelial cell proliferation involved in salivary gland morphogenesis<br />\nextracellular matrix organization<br />\nextrinsic apoptotic signaling pathway<br />\nextrinsic apoptotic signaling pathway via death domain receptors<br />\nglucose metabolic process<br />\nhumoral immune response<br />\nI-kappaB kinase/NF-kappaB signaling<br />\ninflammatory response<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nJNK cascade<br />\nleukocyte tethering or rolling<br />\nlipopolysaccharide-mediated signaling pathway<br />\nMAPK cascade<br />\nnecroptotic signaling pathway<br />\nnegative regulation of alkaline phosphatase activity<br />\nnegative regulation of bicellular tight junction assembly<br />\nnegative regulation of branching involved in lung morphogenesis<br />\nnegative regulation of cytokine secretion involved in immune response<br />\nnegative regulation of endothelial cell proliferation<br />\nnegative regulation of extrinsic apoptotic signaling pathway in absence of ligand<br />\nnegative regulation of fat cell differentiation<br />\nnegative regulation of gene expression<br />\nnegative regulation of glucose import<br />\nnegative regulation of growth of symbiont in host<br />\nnegative regulation of interleukin-6 production<br />\nnegative regulation of lipid catabolic process<br />\nnegative regulation of lipid storage<br />\nnegative regulation of mitotic cell cycle<br />\nnegative regulation of myoblast differentiation<br />\nnegative regulation of myosin-light-chain-phosphatase activity<br />\nnegative regulation of osteoblast differentiation<br />\nnegative regulation of protein complex disassembly<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of viral genome replication<br />\nosteoclast differentiation<br />\npositive regulation of apoptotic process<br />\npositive regulation of blood microparticle formation<br />\npositive regulation of calcidiol 1-monooxygenase activity<br />\npositive regulation of cell adhesion<br />\npositive regulation of ceramide biosynthetic process<br />\npositive regulation of chemokine (C-X-C motif) ligand 2 production<br />\npositive regulation of chemokine biosynthetic process<br />\npositive regulation of chemokine production<br />\npositive regulation of chronic inflammatory response to antigenic stimulus<br />\npositive regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\npositive regulation of cytokine production<br />\npositive regulation of cytokine secretion<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of fever generation<br />\npositive regulation of gene expression<br />\npositive regulation of hair follicle development<br />\npositive regulation of heterotypic cell-cell adhesion<br />\npositive regulation of humoral immune response mediated by circulating immunoglobulin<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of interferon-gamma production<br />\npositive regulation of interleukin-6 production<br />\npositive regulation of interleukin-8 biosynthetic process<br />\npositive regulation of interleukin-8 production<br />\npositive regulation of JUN kinase activity<br />\npositive regulation of leukocyte adhesion to arterial endothelial cell<br />\npositive regulation of leukocyte adhesion to vascular endothelial cell<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of membrane protein ectodomain proteolysis<br />\npositive regulation of mononuclear cell migration<br />\npositive regulation of NFAT protein import into nucleus<br />\npositive regulation of NF-kappaB import into nucleus<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of NIK/NF-kappaB signaling<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of osteoclast differentiation<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of phagocytosis<br />\npositive regulation of podosome assembly<br />\npositive regulation of programmed cell death<br />\npositive regulation of protein catabolic process<br />\npositive regulation of protein complex assembly<br />\npositive regulation of protein complex disassembly<br />\npositive regulation of protein kinase activity<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of protein localization to cell surface<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of protein transport<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of superoxide dismutase activity<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of translational initiation by iron<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\npositive regulation of vitamin D biosynthetic process<br />\nprotein import into nucleus, translocation<br />\nprotein kinase B signaling<br />\nprotein localization to plasma membrane<br />\nreceptor biosynthetic process<br />\nregulation of branching involved in salivary gland morphogenesis<br />\nregulation of establishment of endothelial barrier<br />\nregulation of I-kappaB kinase/NF-kappaB signaling<br />\nregulation of immunoglobulin secretion<br />\nregulation of insulin secretion<br />\nregulation of tumor necrosis factor-mediated signaling pathway<br />\nresponse to glucocorticoid<br />\nresponse to salt stress<br />\nresponse to virus<br />\nsequestering of triglyceride<br />\ntumor necrosis factor-mediated signaling pathway<br />\n', 'PF00229.', 'MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL'),
('P54965', '2BJF', 1, 1.67, 'A', 329, 'HYDROLASE', 'HYDROLASE', 'Choloylglycine hydrolase', 'cbh', '3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholan-24-oylglycine + H2O = 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholanate + glycine.<br />\n', 'choloylglycine hydrolase activity<br />\n', '', 'PF02275.', 'MCTGLALETKDGLHLFGRNMDIEYSFNQSIIFIPRNFKCVNKSNKKELTTKYAVLGMGTIFDDYPTFADGMNEKGLGCAGLNFPVYVSYSKEDIEGKTNIPVYNFLLWVLANFSSVEEVKEALKNANIVDIPISENIPNTTLHWMISDITGKSIVVEQTKEKLNVFDNNIGVLTNSPTFDWHVANLNQYVGLRYNQVPEFKLGDQSLTALGQGTGLVGLPGDFTPASRFIRVAFLRDAMIKNDKDSIDLIEFFHILNNVAMVRGSTRTVEEKSDLTQYTSCMCLEKGIYYYNTYENNQINAIDMNKENLDGNEIKTYKYNKTLSINHVN'),
('P46925', '2BJU', 1, 1.56, 'A', 453, 'HYDROLASE', 'HYDROLASE', 'Plasmepsin-2', 'N/A', NULL, 'aspartic-type endopeptidase activity', NULL, 'PF00026.', 'MDITVREHDFKHGFIKSNSTFDGLNIDNSKNKKKIQKGFQILYVLLFCSV\r\nMCGLFYYVYENVWLQRDNEMNEILKNSEHLTIGFKVENAHDRILKTIKTH\r\nKLKNYIKESVNFLNSGLTKTNYLGSSNDNIELVDFQNIMFYGDAEVGDNQ\r\nQPFTFILDTGSANLWVPSVKCTTAGCLTKHLYDSSKSRTYEKDGTKVEMN\r\nYVSGTVSGFFSKDLVTVGNLSLPYKFIEVIDTNGFEPTYTASTFDGILGL\r\nGWKDLSIGSVDPIVVELKNQNKIENALFTFYLPVHDKHTGFLTIGGIEER\r\nFYEGPLTYEKLNHDLYWQITLDAHVGNIMLEKANCIVDSGTSAITVPTDF\r\nLNKMLQNLDVIKVPFLPFYVTLCNNSKLPTFEFTSENGKYTLEPEYYLQH\r\nIEDVGPGLCMLNIIGLDFPVPTFILGDPFMRKYFTVFDYDNHSVGIALAK\r\nKNL'),
('P13551', '2BM0', 1, 2.4, 'A', 691, 'ELONGATION FACTOR', 'OTHERS', 'Elongation factor G', 'fusA', '', 'GDP binding<br />\nGTPase activity, coupled<br />\nGTP binding<br />\nmagnesium ion binding<br />\nribosome binding<br />\ntranslation elongation factor activity<br />\n', 'translational elongation<br />\n', 'PF00679.', 'MAVKVEYDLKRLRNIGIAAHIDAGKTTTTERILYYTGRIHKIGEVHEGAATMDFMEQERERGITITAAVTTCFWKDHRINIIDTPGHVDFTIEVERSMRVLDGAIVVFDSSQGVEPQSETVWRQAEKYKVPRIAFANKMDKTGADLWLVIRTMQERLGARPVVMQLPIGREDTFSGIIDVLRMKAYTYGNDLGTDIREIPIPEEYLDQAREYHEKLVEVAADFDENIMLKYLEGEEPTEEELVAAIRKGTIDLKITPVFLGSALKNKGVQLLLDAVVDYLPSPLDIPPIKGTTPEGEVVEIHPDPNGPLAALAFKIMADPYVGRLTFIRVYSGTLTSGSYVYNTTKGRKERVARLLRMHANHREEVEELKAGDLGAVVGLKETITGDTLVGEDAPRVILESIEVPEPVIDVAIEPKTKADQEKLSQALARLAEEDPTFRVSTHPETGQTIISGMGELHLEIIVDRLKREFKVDANVGKPQVAYRETITKPVDVEGKFIRQTGGRGQYGHVKIKVEPLPRGSGFEFVNAIVGGVIPKEYIPAVQKGIEEAMQSGPLIGFPVVDIKVTLYDGSYHEVDSSEMAFKIAGSMAIKEAVQKGDPVILEPIMRVEVTTPEEYMGDVIGDLNARRGQILGMEPRGNAQVIRAFVPLAEMFGYATDLRSKTQGRGSFVMFFDHYQEVPKQVQEKLIKGQ'),
('P71143', '2BM3', 0, 1.8, 'A', 163, 'NUCLEAR PROTEIN', 'OTHERS', 'Scaffolding dockerin binding protein A', 'sdbA', NULL, 'carbohydrate binding', 'polysaccharide catabolic process', 'PF00963.', 'MRKKKRLISLLLAVFIAVACLPAGIARADKASSIELKFDRNKGEVGDILI\r\nGTVRINNIKNFAGFQVNIVYDPKVLMAVDPETGKEFTSSTFPPGRTVLKN\r\nNAYGPIQIADNDPEKGILNFALAYSYIAGYKETGVAEESGIIAKIGFKIL\r\nQKKSTAVKFQDTLSMPGAISGTQLFDWDGEVITGYEVIQPDVLSLGDEPY\r\nETPGTDIPISDNPAATPSSTPSVTPSPEVKPTQTPSPAENSAKVELEPVL\r\nDNATGEAKAAIDEEKLNKALDEAKKSEDDKLVELNIKKVENADAYIQQLP\r\nAKFLIKSDAEYKLRIATEQGIIEVPANMLNTADISKLVKNDSVVEFVIRK\r\nVKVDELGAELKEKIGNRPVIDISVVVDGKKVEWSNYKAKVKISIPYKPDA\r\nKELENHEHIVVLHIDDAGKAVSVPSGKYEPSLGVVTFETNHLSKYAVSYV\r\nYKTFADIGSYAWAKKQIEVLASKGVINGTSDTTFTPQADITRADFMILLV\r\nKALGLTAEVTSNFDDVSEKDYYYEYVGIAKELGITTGVGNNKFNPKAKIT\r\nRQDMMVLTTNALRIAGKISSTGTRADVERFSDKDQIASYAVEGVATLVKE\r\nGIVVGSGDIINPRGNASRAELAAIIYKIYYK'),
('P53848', '2BMB', 1, 2.3, 'A', 528, 'TRANSFERASE', 'TRANSFERASE', 'Folic acid synthesis protein FOL1', 'FOL1', '7,8-dihydroneopterin = 6-hydroxymethyl-7,8-dihydropterin + glycolaldehyde<br />\nATP + 6-hydroxymethyl-7,8-dihydropterin = AMP + 6-hydroxymethyl-7,8-dihydropterin diphosphate<br />\n6-hydroxymethyl-7,8-dihydropterin diphosphate + 4-aminobenzoate = diphosphate + dihydropteroate<br />\n', '2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase activity<br />\n7,8-dihydromonapterin aldolase activity<br />\nATP binding<br />\ndihydroneopterin aldolase activity<br />\ndihydropteroate synthase activity<br />\nkinase activity<br />\nmetal ion binding<br />\n', 'folic acid biosynthetic process<br />\ntetrahydrofolate biosynthetic process<br />\n', 'PF02152.', 'MSKLFSTVNSARHSVPLGGMRDYVHIKKLEMNTVLGPDSWNQLMPQKCLLSLDMGTDFSKSAATDDLKYSLNYAVISRDLTNFVSKKKNWGSVSNLAKSVSQFVMDKYSGVECLNLEVQADTTHIRSDHISCIIQQERGNPESQEFDVVRISELKMLTLIGVFTFERLKKQYVTLDIKLPWPKKAELPPPVQSIIDNVVKFVEESNFKTVEALVESVSAVIAHNEYFQKFPDSPLVVKVLKLNAITATEGVGVSCIREPREIAMVNIPYLSSIHESSDIKFQLSSSQNTPIEGKNTWKRAFLAFGSNIGDRFKHIQMALQLLSREKTVKLRNISSIFESEPMYFKDQTPFMNGCVEVETLLTPSELLKLCKKIEYEELQRVKHFDNGPRTIDLDIVMFLNSAGEDIIVNEPDLNIPHPRMLERTFVLEPLCELISPVHLHPVTAEPIVDHLKQLYDKQHDEDTLWKLVPLPYRSGVEPRFLKFKTATKLDEFTGETNRITVSPTYIMAIFNATPDSFSDGGEHFADIESQLNDIIKLCKDALYLHESVIIDVGGCSTRPNSIQASEEEEIRRSIPLIKAIRESTELPQDKVILSIDTYRSNVAKEAIKVGVDIINDISGGLFDSNMFAVIAENPEICYILSHTRGDISTMNRLAHYENFALGDSIQQEFVHNTDIQQLDDLKDKTVLIRNVGQEIGERYIKAIDNGVKRWQILIDPGLGFAKTWKQNLQIIRHIPILKNYSFTMNSNNSQVYVNLRNMPVLLGPSRKKFIGHITKDVDAKQRDFATGAVVASCIGFGSDMVRVHDVKNCSKSIKLADAIYKGLE'),
('P21890', '2BMW', 1, 1.5, 'A', 304, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Ferredoxin--NADP reductase', 'petH', '2 reduced ferredoxin + NADP+ + H+ = 2 oxidized ferredoxin + NADPH.<br />\n', 'ferredoxin-NADP+ reductase activity<br />\nflavin adenine dinucleotide binding<br />\nNADP binding<br />\n', 'oxidation-reduction process<br />\n', 'PF01383.', 'MSNQGAFDGAANVESGSRVFVYEVVGMRQNEETDQTNYPIRKSGSVFIRVPYNRMNQEMQRITRLGGKIVTIQTVSALQQLNGRTTIATVTDASSEIAKSEGNGKATPVKTDSGAKAFAKPPAEEQLKKKDNKGNTMTQAKAKHADVPVNLYRPNAPFIGKVISNEPLVKEGGIGIVQHIKFDLTGGNLKYIEGQSIGIIPPGVDKNGKPEKLRLYSIASTRHGDDVDDKTISLCVRQLEYKHPESGETVYGVCSTYLTHIEPGSEVKITGPVGKEMLLPDDPEANVIMLATGTGIAPMRTYLWRMFKDAERAANPEYQFKGFSWLVFGVPTTPNILYKEELEEIQQKYPDNFRLTYAISREQKNPQGGRMYIQDRVAEHADELWQLIKNQKTHTYICGLRGMEEGIDAALSAAAAKEGVTWSDYQKDLKKAGRWHVETY'),
('P13686', '2BQ8', 0, 2.2, 'X', 304, 'HYDROLASE', 'HYDROLASE', 'Tartrate-resistant acid phosphatase type 5', 'ACP5', 'A phosphate monoester + H2O = an alcohol + phosphate.<br />\n', 'acid phosphatase activity<br />\nferric iron binding<br />\nferrous iron binding<br />\n', 'bone morphogenesis<br />\nbone resorption<br />\ndefense response to Gram-positive bacterium<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of interleukin-12 production<br />\nnegative regulation of interleukin-1 beta production<br />\nnegative regulation of nitric oxide biosynthetic process<br />\nnegative regulation of superoxide anion generation<br />\nnegative regulation of tumor necrosis factor production<br />\nresponse to cytokine<br />\nresponse to lipopolysaccharide<br />\nriboflavin metabolic process<br />\n', 'PF00149.', 'MDMWTALLILQALLLPSLADGATPALRFVAVGDWGGVPNAPFHTAREMANAKEIARTVQILGADFILSLGDNFYFTGVQDINDKRFQETFEDVFSDRSLRKVPWYVLAGNHDHLGNVSAQIAYSKISKRWNFPSPFYRLHFKIPQTNVSVAIFMLDTVTLCGNSDDFLSQQPERPRDVKLARTQLSWLKKQLAAAREDYVLVAGHYPVWSIAEHGPTHCLVKQLRPLLATYGVTAYLCGHDHNLQYLQDENGVGYVLSGAGNFMDPSKRHQRKVPNGYLRFHYGTEDSLGGFAYVEISSKEMTVTYIEASGKSLFKTRLPRRARP'),
('P51580', '2BZG', 1, 1.58, 'A', 230, 'TRANSFERASE', 'TRANSFERASE', 'Thiopurine S-methyltransferase', 'TPMT', 'S-adenosyl-L-methionine + a thiopurine = S-adenosyl-L-homocysteine + a thiopurine S-methylether<br />\n', 'thiopurine S-methyltransferase activity<br />\n', 'methylation<br />\nnucleobase-containing compound metabolic process<br />\n', 'PF05724.', 'MDGTRTSLDIEEYSDTEVQKNQVLTLEEWQDKWVNGKTAFHQEQGHQLLKKHLDTFLKGKSGLRVFFPLCGKAVEMKWFADRGHSVVGVEISELGIQEFFTEQNLSYSEEPITEIPGTKVFKSSSGNISLYCCSIFDLPRTNIGKFDMIWDRGALVAINPGDRKCYADTMFSLLGKKFQYLLCVLSYDPTKHPGPPFYVPHAEIERLFGKICNIRCLEKVDAFEERHKSWGIDCLFEKLYLLTEK'),
('P30711', '2C3Q', 1, 1.85, 'A/B/C/D', 239, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase theta-1', 'GSTT1', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'glutathione peroxidase activity<br />\nglutathione transferase activity<br />\n', 'glutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\n', 'PF00043.', 'MGLELYLDLLSQPCRAVYIFAKKNDIPFELRIVDLIKGQHLSDAFAQVNPLKKVPALKDGDFTLTESVAILLYLTRKYKVPDYWYPQDLQARARVDEYLAWQHTTLRRSCLRALWHKVMFPVFLGEPVSPQTLAATLAELDVTLQLLEDKFLQNKAFLTGPHISLADLVAITELMHPVGAGCQVFEGRPKLATWRQRVEAAVGEDLFQEAHEVILKAKDFPPADPTIKQKLMPWVLAMIR'),
('P94692', '2C42', 1, 1.78, 'A/B', 1231, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Pyruvate synthase', 'por', 'Pyruvate + CoA + 2 oxidized ferredoxin = acetyl-CoA + CO2 + 2 reduced ferredoxin + 2 H+<br />\n', '4 iron, 4 sulfur cluster binding<br />\niron ion binding<br />\npyruvate synthase activity<br />\nthiamine pyrophosphate binding<br />\n', 'electron transport chain<br />\n', 'PF10371.', 'MGKKMMTTDGNTATAHVAYAMSEVAAIYPITPSSTMGEEADDWAAQGRKNIFGQTLTIREMQSEAGAAGAVHGALAAGALTTTFTASQGLLLMIPNMYKISGELLPGVFHVTARAIAAHALSIFGDHQDIYAARQTGFAMLASSSVQEAHDMALVAHLAAIESNVPFMHFFDGFRTSHEIQKIEVLDYADMASLVNQKALAEFRAKSMNPEHPHVRGTAQNPDIYFQGREAANPYYLKVPGIVAEYMQKVASLTGRSYKLFDYVGAPDAERVIVSMGSSCETIEEVINHLAAKGEKIGLIKVRLYRPFVSEAFFAALPASAKVITVLDRTKEPGAPGDPLYLDVCSAFVERGEAMPKILAGRYGLGSKEFSPAMVKSVYDNMSGAKKNHFTVGIEDDVTGTSLPVDNAFADTTPKGTIQCQFWGLGADGTVGANKQAIKIIGDNTDLFAQGYFSYDSKKSGGITISHLRFGEKPIQSTYLVNRADYVACHNPAYVGIYDILEGIKDGGTFVLNSPWSSLEDMDKHLPSGIKRTIANKKLKFYNIDAVKIATDVGLGGRINMIMQTAFFKLAGVLPFEKAVDLLKKSIHKAYGKKGEKIVKMNTDAVDQAVTSLQEFKYPDSWKDAPAETKAEPMTNEFFKNVVKPILTQQGDKLPVSAFEADGRFPLGTSQFEKRGVAINVPQWVPENCIQCNQCAFVCPHSAILPVLAKEEELVGAPANFTALEAKGKELKGYKFRIQINTLDCMGCGNCADICPPKEKALVMQPLDTQRDAQVPNLEYAARIPVKSEVLPRDSLKGSQFQEPLMEFSGACSGCGETPYVRVITQLFGERMFIANATGCSSIWGASAPSMPYKTNRLGQGPAWGNSLFEDAAEYGFGMNMSMFARRTHLADLAAKALESDASGDVKEALQGWLAGKNDPIKSKEYGDKLKKLLAGQKDGLLGQIAAMSDLYTKKSVWIFGGDGWAYDIGYGGLDHVLASGEDVNVFVMDTEVYSNTGGQSSKATPTGAVAKFAAAGKRTGKKDLARMVMTYGYVYVATVSMGYSKQQFLKVLKEAESFPGPSLVIAYATCINQGLRKGMGKSQDVMNTAVKSGYWPLFRYDPRLAAQGKNPFQLDSKAPDGSVEEFLMAQNRFAVLDRSFPEDAKRLRAQVAHELDVRFKELEHMAATNIFESFAPAGGKADGSVDFGEGAEFCTRDDTPMMARPDSGEACDQNRAGTSEQQGDLSKRTKK'),
('O60942', '2C46', 0, 1.6, 'A/B/C/D', 219, 'TRANSFERASE', 'TRANSFERASE', 'mRNA-capping enzyme', 'RNGTT', 'A 5''-phosphopolynucleotide + H2O = a polynucleotide + phosphate.<br />\nGTP + (5'')pp-Pur-mRNA = diphosphate + G(5'')ppp-Pur-mRNA.<br />\n', 'GTP binding<br />\nmRNA guanylyltransferase activity<br />\npolynucleotide 5''-phosphatase activity<br />\nprotein tyrosine/serine/threonine phosphatase activity<br />\nprotein tyrosine phosphatase activity<br />\nRNA guanylyltransferase activity<br />\ntriphosphatase activity<br />\n', '7-methylguanosine mRNA capping<br />\nRNA processing<br />\ntranscription from RNA polymerase II promoter<br />\nviral process<br />\n', 'PF00782.', 'MAHNKIPPRWLNCPRRGQPVAGRFLPLKTMLGPRYDSQVAEENRFHPSMLSNYLKSLKVKMGLLVDLTNTSRFYDRNDIEKEGIKYIKLQCKGHGECPTTENTETFIRLCERFNERNPPELIGVHCTHGFNRTGFLICAFLVEKMDWSIEAAVATFAQARPPGIYKGDYLKELFRRYGDIEEAPPPPLLPDWCFEDDEDEDEDEDGKKESEPGSSASFGKRRKERLKLGAIFLEGVTVKGVTQVTTQPKLGEVQQKCHQFCGWEGSGFPGAQPVSMDKQNIKLLDLKPYKVSWKADGTRYMMLIDGTNEVFMIDRDNSVFHVSNLEFPFRKDLRMHLSNTLLDGEMIIDRVNGQAVPRYLIYDIIKFNSQPVGDCDFNVRLQCIEREIISPRHEKMKTGLIDKTQEPFSVRNKPFFDICTSRKLLEGNFAKEVSHEMDGLIFQPTGKYKPGRCDDILKWKPPSLNSVDFRLKITRMGGEGLLPQNVGLLYVGGYERPFAQIKVTKELKQYDNKIIECKFENNSWVFMRQRTDKSFPNAYNTAMAVCNSISNPVTKEMLFEFIDRCTAASQGQKRKHHLDPDTELMPPPPPKRPRPLT'),
('P28161', '2C4J', 1, 1.35, 'A/B/C/D', 217, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase Mu 2', 'GSTM2', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'enzyme binding<br />\nglutathione binding<br />\nglutathione peroxidase activity<br />\nglutathione transferase activity<br />\nprotein homodimerization activity<br />\nreceptor binding<br />\n', 'cellular detoxification of nitrogen compound<br />\ncellular response to caffeine<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nlinoleic acid metabolic process<br />\nnegative regulation of ryanodine-sensitive calcium-release channel activity<br />\nnitrobenzene metabolic process<br />\npositive regulation of ryanodine-sensitive calcium-release channel activity<br />\nregulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion<br />\nregulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum<br />\nregulation of skeletal muscle contraction by regulation of release of sequestered calcium ion<br />\nrelaxation of cardiac muscle<br />\nxenobiotic catabolic process<br />\n', 'PF00043.', 'MPMTLGYWNIRGLAHSIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNLPYLIDGTHKITQSNAILRYIARKHNLCGESEKEQIREDILENQFMDSRMQLAKLCYDPDFEKLKPEYLQALPEMLKLYSQFLGKQPWFLGDKITFVDFIAYDVLERNQVFEPSCLDAFPNLKDFISRFEGLEKISAYMKSSRFLPRPVFTKMAVWGNK'),
('P33527', '2CBZ', 1, 1.5, 'A', 230, 'TRANSPORT', 'TRANSPORT_PROT', 'Multidrug resistance-associated protein 1', 'ABCC1', '', 'ATPase activity<br />\nATPase activity, coupled to transmembrane movement of substances<br />\nATPase-coupled anion transmembrane transporter activity<br />\nATP binding<br />\ncobalamin-transporting ATPase activity<br />\nglutathione S-conjugate-exporting ATPase activity<br />\nglutathione transmembrane transporter activity<br />\nphospholipid-translocating ATPase activity<br />\nsphingolipid-translocating ATPase activity<br />\ntransporter activity<br />\nxenobiotic-transporting ATPase activity<br />\n', 'cell chemotaxis<br />\ncobalamin metabolic process<br />\ndrug transmembrane transport<br />\nglutathione transmembrane transport<br />\nleukotriene metabolic process<br />\nphospholipid translocation<br />\nresponse to drug<br />\nsphingolipid translocation<br />\ntransmembrane transport<br />\ntransport<br />\nxenobiotic transport<br />\n', 'PF00664.', 'MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACFPFYFLYLSRHDRGYIQMTPLNKTKTALGFLLWIVCWADLFYSFWERSRGIFLAPVFLVSPTLLGITMLLATFLIQLERRKGVQSSGIMLTFWLVALVCALAILRSKIMTALKEDAQVDLFRDITFYVYFSLLLIQLVLSCFSDRSPLFSETIHDPNPCPESSASFLSRITFWWITGLIVRGYRQPLEGSDLWSLNKEDTSEQVVPVLVKNWKKECAKTRKQPVKVVYSSKDPAQPKESSKVDANEEVEALIVKSPQKEWNPSLFKVLYKTFGPYFLMSFFFKAIHDLMMFSGPQILKLLIKFVNDTKAPDWQGYFYTVLLFVTACLQTLVLHQYFHICFVSGMRIKTAVIGAVYRKALVITNSARKSSTVGEIVNLMSVDAQRFMDLATYINMIWSAPLQVILALYLLWLNLGPSVLAGVAVMVLMVPVNAVMAMKTKTYQVAHMKSKDNRIKLMNEILNGIKVLKLYAWELAFKDKVLAIRQEELKVLKKSAYLSAVGTFTWVCTPFLVALCTFAVYVTIDENNILDAQTAFVSLALFNILRFPLNILPMVISSIVQASVSLKRLRIFLSHEELEPDSIERRPVKDGGGTNSITVRNATFTWARSDPPTLNGITFSIPEGALVAVVGQVGCGKSSLLSALLAEMDKVEGHVAIKGSVAYVPQQAWIQNDSLRENILFGCQLEEPYYRSVIQACALLPDLEILPSGDRTEIGEKGVNLSGGQKQRVSLARAVYSNADIYLFDDPLSAVDAHVGKHIFENVIGPKGMLKNKTRILVTHSMSYLPQVDVIIVMSGGKISEMGSYQELLARDGAFAEFLRTYASTEQEQDAEENGVTGVSGPGKEAKQMENGMLVTDSAGKQLQRQLSSSSSYSGDISRHHNSTAELQKAEAKKEETWKLMEADKAQTGQVKLSVYWDYMKAIGLFISFLSIFLFMCNHVSALASNYWLSLWTDDPIVNGTQEHTKVRLSVYGALGISQGIAVFGYSMAVSIGGILASRCLHVDLLHSILRSPMSFFERTPSGNLVNRFSKELDTVDSMIPEVIKMFMGSLFNVIGACIVILLATPIAAIIIPPLGLIYFFVQRFYVASSRQLKRLESVSRSPVYSHFNETLLGVSVIRAFEEQERFIHQSDLKVDENQKAYYPSIVANRWLAVRLECVGNCIVLFAALFAVISRHSLSAGLVGLSVSYSLQVTTYLNWLVRMSSEMETNIVAVERLKEYSETEKEAPWQIQETAPPSSWPQVGRVEFRNYCLRYREDLDFVLRHINVTINGGEKVGIVGRTGAGKSSLTLGLFRINESAEGEIIIDGINIAKIGLHDLRFKITIIPQDPVLFSGSLRMNLDPFSQYSDEEVWTSLELAHLKDFVSALPDKLDHECAEGGENLSVGQRQLVCLARALLRKTKILVLDEATAAVDLETDDLIQSTIRTQFEDCTVLTIAHRLNTIMDYTRVIVLDKGEIQEYGAPSDLLQQRGLFYSMAKDAGLV'),
('P53608', '2CEV', 1, 2.15, 'A/B/C/D/E/F', 299, 'HYDROLASE', 'HYDROLASE', 'Arginase', 'rocF', 'L-arginine + H2O = L-ornithine + urea<br />\n', 'arginase activity<br />\nmetal ion binding<br />\n', 'arginine metabolic process<br />\nurea cycle<br />\n', 'PF00491.', 'MKPISIIGVPMDLGQTRRGVDMGPSAMRYAGVIERLERLHYDIEDLGDIPIGKAERLHEQGDSRLRNLKAVAEANEKLAAAVDQVVQRGRFPLVLGGDHSIAIGTLAGVAKHYERLGVIWYDAHGDVNTAETSPSGNIHGMPLAASLGFGHPALTQIGGYSPKIKPEHVVLIGVRSLDEGEKKFIREKGIKIYTMHEVDRLGMTRVMEETIAYLKERTDGVHLSLDLDGLDPSDAPGVGTPVIGGLTYRESHLAMEMLAEAQIITSAEFVEVNPILDERNKTASVAVALMGSLFGEKLM'),
('O75891', '2CFI', 1, 1.85, 'A', 307, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytosolic 10-formyltetrahydrofolate dehydrogenase', 'ALDH1L1', '10-formyltetrahydrofolate + NADP+ + H2O = tetrahydrofolate + CO2 + NADPH.<br />\n', 'aldehyde dehydrogenase (NAD) activity<br />\ncatalytic activity<br />\nformyltetrahydrofolate dehydrogenase activity<br />\nhydroxymethyl-, formyl- and related transferase activity<br />\n', '10-formyltetrahydrofolate catabolic process<br />\nbiosynthetic process<br />\nfolic acid metabolic process<br />\none-carbon metabolic process<br />\n', 'PF00171.', 'MKIAVIGQSLFGQEVYCHLRKEGHEVVGVFTVPDKDGKADPLGLEAEKDGVPVFKYSRWRAKGQALPDVVAKYQALGAELNVLPFCSQFIPMEIISAPRHGSIIYHPSLLPRHRGASAINWTLIHGDKKGGFSIFWADDGLDTGDLLLQKECEVLPDDTVSTLYNRFLFPEGIKGMVQAVRLIAEGKAPRLPQPEEGATYEGIQKKETAKINWDQPAEAIHNWIRGNDKVPGAWTEACEQKLTFFNSTLNTSGLVPEGDALPIPGAHRPGVVTKAGLILFGNDDKMLLVKNIQLEDGKMILASNFFKGAASSVLELTEAELVTAEAVRSVWQRILPKVLEVEDSTDFFKSGAASVDVVRLVEEVKELCDGLELENEDVYMASTFGDFIQLLVRKLRGDDEEGECSIDYVEMAVNKRTVRMPHQLFIGGEFVDAEGAKTSETINPTDGSVICQVSLAQVTDVDKAVAAAKDAFENGRWGKISARDRGRLMYRLADLMEQHQEELATIEALDAGAVYTLALKTHVGMSIQTFRYFAGWCDKIQGSTIPINQARPNRNLTLTRKEPVGVCGIIIPWNYPLMMLSWKTAACLAAGNTVVIKPAQVTPLTALKFAELTLKAGIPKGVVNVLPGSGSLVGQRLSDHPDVRKIGFTGSTEVGKHIMKSCAISNVKKVSLELGGKSPLIIFADCDLNKAVQMGMSSVFFNKGENCIAAGRLFVEDSIHDEFVRRVVEEVRKMKVGNPLDRDTDHGPQNHHAHLVKLMEYCQHGVKEGATLVCGGNQVPRPGFFFEPTVFTDVEDHMFIAKEESFGPVMIISRFADGDLDAVLSRANATEFGLASGVFTRDINKALYVSDKLQAGTVFVNTYNKTDVAAPFGGFKQSGFGKDLGEAALNEYLRVKTVTFEY'),
('Q9UJ70', '2CH6', 1, 2.72, 'A/B/C/D', 344, 'TRANSFERASE', 'TRANSFERASE', 'N-acetyl-D-glucosamine kinase', 'NAGK', 'ATP + N-acetyl-D-glucosamine = ADP + N-acetyl-D-glucosamine 6-phosphate<br />\n', 'ATP binding<br />\nN-acetylglucosamine kinase activity<br />\n', 'N-acetylglucosamine metabolic process<br />\nN-acetylmannosamine metabolic process<br />\nN-acetylneuraminate catabolic process<br />\nUDP-N-acetylglucosamine biosynthetic process<br />\n', 'PF01869.', 'MAAIYGGVEGGGTRSEVLLVSEDGKILAEADGLSTNHWLIGTDKCVERINEMVNRAKRKAGVDPLVPLRSLGLSLSGGDQEDAGRILIEELRDRFPYLSESYLITTDAAGSIATATPDGGVVLISGTGSNCRLINPDGSESGCGGWGHMMGDEGSAYWIAHQAVKIVFDSIDNLEAAPHDIGYVKQAMFHYFQVPDRLGILTHLYRDFDKCRFAGFCRKIAEGAQQGDPLSRYIFRKAGEMLGRHIVAVLPEIDPVLFQGKIGLPILCVGSVWKSWELLKEGFLLALTQGREIQAQNFFSSFTLMKLRHSSALGGASLGARHIGHLLPMDYSANAIAFYSYTFS'),
('P54687', '2COI', 1, 1.9, 'A/B', 386, 'TRANSFERASE', 'TRANSFERASE', 'Branched-chain-amino-acid aminotransferase, cytosolic', 'BCAT1', 'L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate.<br />\nL-isoleucine + 2-oxoglutarate = (S)-3-methyl-2-oxopentanoate + L-glutamate.<br />\nL-valine + 2-oxoglutarate = 3-methyl-2-oxobutanoate + L-glutamate.<br />\n', 'branched-chain-amino-acid transaminase activity<br />\nidentical protein binding<br />\nL-isoleucine transaminase activity<br />\nL-leucine transaminase activity<br />\nL-valine transaminase activity<br />\n', 'branched-chain amino acid biosynthetic process<br />\nbranched-chain amino acid catabolic process<br />\ncell proliferation<br />\nG1/S transition of mitotic cell cycle<br />\nleucine biosynthetic process<br />\nvaline biosynthetic process<br />\n', 'PF01063.', 'MKDCSNGCSAECTGEGGSKEVVGTFKAKDLIVTPATILKEKPDPNNLVFGTVFTDHMLTVEWSSEFGWEKPHIKPLQNLSLHPGSSALHYAVELFEGLKAFRGVDNKIRLFQPNLNMDRMYRSAVRATLPVFDKEELLECIQQLVKLDQEWVPYSTSASLYIRPTFIGTEPSLGVKKPTKALLFVLLSPVGPYFSSGTFNPVSLWANPKYVRAWKGGTGDCKMGGNYGSSLFAQCEAVDNGCQQVLWLYGEDHQITEVGTMNLFLYWINEDGEEELATPPLDGIILPGVTRRCILDLAHQWGEFKVSERYLTMDDLTTALEGNRVREMFGSGTACVVCPVSDILYKGETIHIPTMENGPKLASRILSKLTDIQYGREESDWTIVLS'),
('O60760', '2CVD', 1, 1.45, 'A/B/C/D', 198, 'ISOMERASE', 'ISOMERASE', 'Hematopoietic prostaglandin D synthase', 'HPGDS', '(5Z,13E,15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate = (5Z,13E,15S)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate<br />\nRX + glutathione = HX + R-S-glutathione<br />\n', 'calcium ion binding<br />\nglutathione transferase activity<br />\nmagnesium ion binding<br />\nprostaglandin-D synthase activity<br />\nprotein homodimerization activity<br />\n', 'cyclooxygenase pathway<br />\nglutathione derivative biosynthetic process<br />\nlocomotory behavior<br />\nnegative regulation of male germ cell proliferation<br />\nprostaglandin metabolic process<br />\nsignal transduction<br />\n', 'PF14497.', 'MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL'),
('Q7SI98', '2D22', 1, 1.7, 'A/B', 436, 'HYDROLASE', 'HYDROLASE', 'Beta-xylanase', 'N/A', 'Endohydrolysis of (1->4)-beta-D-xylosidic linkages in xylans.', 'endo-1,4-beta-xylanase activity', 'polysaccharide catabolic process', 'PF00331. ', 'AESTLGAAAAQSGRYFGTAIASGKLGDSAYTTIASREFNMVTAENEMKID\r\nATEPQRGQFNFSAGDRVYNWAVQNGKQVRGHTLAWHSQQPGWMQSLSGST\r\nLRQAMIDHINGVMGHYKGKIAQWDVVNEAFSDDGSGGRRDSNLQRTGNDW\r\nIEVAFRTARAADPAAKLCYNDYNIENWTWAKTQGVYNMVRDFKQRGVPID\r\nCVGFQSHFNSGSPYNSNFRTTLQNFAALGVDVAITELDIQGASSSTYAAV\r\nTNDCLAVSRCLGITVWGVRDTDSWRSGDTPLLFNGDGSKKAAYTAVLNAL\r\nNGGSSTPPPSGGGQIKGVGSGRCLDVPNASTTDGTQVQLYDCHSATNQQW\r\nTYTDAGELRVYGDKCLDAAGTGNGTKVQIYSCWGGDNQKWRLNSDGSIVG\r\nVQSGLCLDAVGGGTANGTLIQLYSCSNGSNQRWTRT'),
('P07998', '2E0L', 0, 1.6, 'A/B', 128, 'HYDROLASE', 'HYDROLASE', 'Ribonuclease pancreatic', 'RNASE1', 'Endonucleolytic cleavage to nucleoside 3''-phosphates and 3''-phosphooligonucleotides ending in Cp or Up with 2'',3''-cyclic phosphate intermediates.<br />\n', 'endonuclease activity<br />\nnucleic acid binding<br />\nribonuclease A activity<br />\nribonuclease activity<br />\n', 'RNA phosphodiester bond hydrolysis<br />\n', 'PF00074.', 'MALEKSLVRLLLLVLILLVLGWVQPSLGKESRAKKFQRQHMDSDSSPSSSSTYCNQMMRRRNMTQGRCKPVNTFVHEPLVDVQNVCFQEKVTCKNGQGNCYKSNSSMHITDCRLTNGSRYPNCAYRTSPKERHIIVACEGSPYVPVHFDASVEDST'),
('P47989', '2E1Q', 1, 2.6, 'A/B/C/D', 1333, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Xanthine dehydrogenase/oxidase', 'XDH', 'Xanthine + NAD+ + H2O = urate + NADH<br />\nHypoxanthine + NAD+ + H2O = xanthine + NADH<br />\nXanthine + H2O + O2 = urate + H2O2<br />\n', '2 iron, 2 sulfur cluster binding<br />\nelectron carrier activity<br />\nflavin adenine dinucleotide binding<br />\niron ion binding<br />\nmolybdopterin cofactor binding<br />\noxidoreductase activity, acting on CH-OH group of donors<br />\noxidoreductase activity, acting on the aldehyde or oxo group of donors<br />\nprotein homodimerization activity<br />\nxanthine dehydrogenase activity<br />\nxanthine oxidase activity<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nlactation<br />\nnegative regulation of endothelial cell differentiation<br />\nnegative regulation of endothelial cell proliferation<br />\nnegative regulation of gene expression<br />\nnegative regulation of protein kinase B signaling<br />\nnegative regulation of protein phosphorylation<br />\nnegative regulation of vascular endothelial growth factor signaling pathway<br />\nnegative regulation of vasculogenesis<br />\npositive regulation of p38MAPK cascade<br />\npositive regulation of reactive oxygen species metabolic process<br />\npurine nucleotide catabolic process<br />\nxanthine catabolic process<br />\n', 'PF01315.', 'MTADKLVFFVNGRKVVEKNADPETTLLAYLRRKLGLSGTKLGCGEGGCGACTVMLSKYDRLQNKIVHFSANACLAPICSLHHVAVTTVEGIGSTKTRLHPVQERIAKSHGSQCGFCTPGIVMSMYTLLRNQPEPTMEEIENAFQGNLCRCTGYRPILQGFRTFARDGGCCGGDGNNPNCCMNQKKDHSVSLSPSLFKPEEFTPLDPTQEPIFPPELLRLKDTPRKQLRFEGERVTWIQASTLKELLDLKAQHPDAKLVVGNTEIGIEMKFKNMLFPMIVCPAWIPELNSVEHGPDGISFGAACPLSIVEKTLVDAVAKLPAQKTEVFRGVLEQLRWFAGKQVKSVASVGGNIITASPISDLNPVFMASGAKLTLVSRGTRRTVQMDHTFFPGYRKTLLSPEEILLSIEIPYSREGEYFSAFKQASRREDDIAKVTSGMRVLFKPGTTEVQELALCYGGMANRTISALKTTQRQLSKLWKEELLQDVCAGLAEELHLPPDAPGGMVDFRCTLTLSFFFKFYLTVLQKLGQENLEDKCGKLDPTFASATLLFQKDPPADVQLFQEVPKGQSEEDMVGRPLPHLAADMQASGEAVYCDDIPRYENELSLRLVTSTRAHAKIKSIDTSEAKKVPGFVCFISADDVPGSNITGICNDETVFAKDKVTCVGHIIGAVVADTPEHTQRAAQGVKITYEELPAIITIEDAIKNNSFYGPELKIEKGDLKKGFSEADNVVSGEIYIGGQEHFYLETHCTIAVPKGEAGEMELFVSTQNTMKTQSFVAKMLGVPANRIVVRVKRMGGGFGGKETRSTVVSTAVALAAYKTGRPVRCMLDRDEDMLITGGRHPFLARYKVGFMKTGTVVALEVDHFSNVGNTQDLSQSIMERALFHMDNCYKIPNIRGTGRLCKTNLPSNTAFRGFGGPQGMLIAECWMSEVAVTCGMPAEEVRRKNLYKEGDLTHFNQKLEGFTLPRCWEECLASSQYHARKSEVDKFNKENCWKKRGLCIIPTKFGISFTVPFLNQAGALLHVYTDGSVLLTHGGTEMGQGLHTKMVQVASRALKIPTSKIYISETSTNTVPNTSPTAASVSADLNGQAVYAACQTILKRLEPYKKKNPSGSWEDWVTAAYMDTVSLSATGFYRTPNLGYSFETNSGNPFHYFSYGVACSEVEIDCLTGDHKNLRTDIVMDVGSSLNPAIDIGQVEGAFVQGLGLFTLEELHYSPEGSLHTRGPSTYKIPAFGSIPIEFRVSLLRDCPNKKAIYASKAVGEPPLFLAASIFFAIKDAIRAARAQHTGNNVKELFRLDSPATPEKIRNACVDKFTTLCVTGVPENCKPWSVRV'),
('P62508', '2E2R', 1, 1.6, 'A', 237, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Estrogen-related receptor gamma', 'ESRRG', '', 'AF-2 domain binding<br />\nretinoic acid receptor activity<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nsteroid binding<br />\nsteroid hormone receptor activity<br />\ntranscriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding<br />\nzinc ion binding<br />\n', 'positive regulation of transcription, DNA-templated<br />\nregulation of transcription, DNA-templated<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'MDSVELCLPESFSLHYEEELLCRMSNKDRHIDSSCSSFIKTEPSSPASLTDSVNHHSPGGSSDASGSYSSTMNGHQNGLDSPPLYPSAPILGGSGPVRKLYDDCSSTIVEDPQTKCEYMLNSMPKRLCLVCGDIASGYHYGVASCEACKAFFKRTIQGNIEYSCPATNECEITKRRRKSCQACRFMKCLKVGMLKEGVRLDRVRGGRQKYKRRIDAENSPYLNPQLVQPAKKPYNKIVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDELVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANSDSMHIEDVEAVQKLQDVLHEALQDYEAGQHMEDPRRAGKMLMTLPLLRQTSTKAVQHFYNIKLEGKVPMHKLFLEMLEAKV'),
('Q99584', '2EGD', 0, 1.8, 'A/B', 98, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Protein S100-A13', 'S100A13', '', 'calcium ion binding<br />\ncopper ion binding<br />\nfibroblast growth factor binding<br />\nlipid binding<br />\nprotein homodimerization activity<br />\nRAGE receptor binding<br />\nzinc ion binding<br />\n', 'cytokine secretion<br />\ninterleukin-1 alpha secretion<br />\nmast cell degranulation<br />\npositive regulation of cell proliferation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\nregulation of cell shape<br />\nresponse to copper ion<br />\nresponse to electrical stimulus<br />\n', 'PF01023.', 'MAAEPLTELEESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYWRLIGELAKEIRKKKDLKIRKK'),
('P45877', '2ESL', 0, 1.9, 'A/B/C/D/E/F', 189, 'ISOMERASE / IMMUNOSUPPRESSANT', 'ISOMERASE', 'Peptidyl-prolyl cis-trans isomerase C', 'PPIC', 'Peptidylproline (omega=180) = peptidylproline (omega=0).<br />\n', 'cyclosporin A binding<br />\npeptidyl-prolyl cis-trans isomerase activity<br />\n', 'protein folding<br />\n', 'PF00160.', 'MGPGPRLLLPLVLCVGLGALVFSSGAEGFRKRGPSVTAKVFFDVRIGDKDVGRIVIGLFGKVVPKTVENFVALATGEKGYGYKGSKFHRVIKDFMIQGGDITTGDGTGGVSIYGETFPDENFKLKHYGIGWVSMANAGPDTNGSQFFITLTKPTWLDGKHVVFGKVIDGMTVVHSIELQATDGHDRPLTNCSIINSGKIDVKTPFVVEIADW'),
('P24228', '2EX6', 1, 1.6, 'A', 457, 'HYDROLASE', 'HYDROLASE', 'D-alanyl-D-alanine carboxypeptidase DacB', 'dacB', 'Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also transpeptidation of peptidyl-alanyl moieties that are N-acyl substituents of D-alanine.<br />\n', 'carboxypeptidase activity<br />\nendopeptidase activity<br />\npenicillin binding<br />\nserine-type D-Ala-D-Ala carboxypeptidase activity<br />\n', 'cell wall macromolecule catabolic process<br />\ncell wall organization<br />\nFtsZ-dependent cytokinesis<br />\npeptidoglycan biosynthetic process<br />\npeptidoglycan catabolic process<br />\npeptidoglycan metabolic process<br />\npeptidoglycan turnover<br />\nregulation of cell shape<br />\nresponse to antibiotic<br />\n', 'PF02113.', 'MRFSRFIIGLTSCIAFSVQAANVDEYITQLPAGANLALMVQKVGASAPAIDYHSQQMALPASTQKVITALAALIQLGPDFRFTTTLETKGNVENGVLKGDLVARFGADPTLKRQDIRNMVATLKKSGVNQIDGNVLIDTSIFASHDKAPGWPWNDMTQCFSAPPAAAIVDRNCFSVSLYSAPKPGDMAFIRVASYYPVTMFSQVRTLPRGSAEAQYCELDVVPGDLNRFTLTGCLPQRSEPLPLAFAVQDGASYAGAILKDELKQAGITWSGTLLRQTQVNEPGTVVASKQSAPLHDLLKIMLKKSDNMIADTVFRMIGHARFNVPGTWRAGSDAVRQILRQQAGVDIGNTIIADGSGLSRHNLIAPATMMQVLQYIAQHDNELNFISMLPLAGYDGSLQYRAGLHQAGVDGKVSAKTGSLQGVYNLAGFITTASGQRMAFVQYLSGYAVEPADQRNRRIPLVRFESRLYKDIYQNN');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P37063', '2EZ9', 1, 1.6, 'A/B', 603, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Pyruvate oxidase', 'pox5', 'Pyruvate + phosphate + O2 = acetyl phosphate + CO2 + H2O2.<br />\n', 'magnesium ion binding<br />\npyruvate oxidase activity<br />\nthiamine pyrophosphate binding<br />\n', '', 'PF02775.', 'MVMKQTKQTNILAGAAVIKVLEAWGVDHLYGIPGGSINSIMDALSAERDRIHYIQVRHEEVGAMAAAADAKLTGKIGVCFGSAGPGGTHLMNGLYDAREDHVPVLALIGQFGTTGMNMDTFQEMNENPIYADVADYNVTAVNAATLPHVIDEAIRRAYAHQGVAVVQIPVDLPWQQIPAEDWYASANSYQTPLLPEPDVQAVTRLTQTLLAAERPLIYYGIGARKAGKELEQLSKTLKIPLMSTYPAKGIVADRYPAYLGSANRVAQKPANEALAQADVVLFVGNNYPFAEVSKAFKNTRYFLQIDIDPAKLGKRHKTDIAVLADAQKTLAAILAQVSERESTPWWQANLANVKNWRAYLASLEDKQEGPLQAYQVLRAVNKIAEPDAIYSIDVGDINLNANRHLKLTPSNRHITSNLFATMGVGIPGAIAAKLNYPERQVFNLAGDGGASMTMQDLATQVQYHLPVINVVFTNCQYGFIKDEQEDTNQNDFIGVEFNDIDFSKIADGVHMQAFRVNKIEQLPDVFEQAKAIAQHEPVLIDAVITGDRPLPAEKLRLDSATSSAADIEAFKQRYEAQDLQPLSTYLKQFGLDDLQHQIGQGGF'),
('Q9Y3R4', '2F25', 1, 1.95, 'A/B', 380, 'HYDROLASE', 'HYDROLASE', 'Sialidase-2', 'NEU2', 'Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates<br />\n', 'exo-alpha-(2->3)-sialidase activity<br />\nexo-alpha-(2->6)-sialidase activity<br />\nexo-alpha-(2->8)-sialidase activity<br />\nexo-alpha-sialidase activity<br />\n', 'cellular oligosaccharide catabolic process<br />\nganglioside catabolic process<br />\nglycosphingolipid metabolic process<br />\noligosaccharide catabolic process<br />\n', 'PF13088.', 'MASLPVLQKESVFQSGAHAYRIPALLYLPGQQSLLAFAEQRASKKDEHAELIVLRRGDYDAPTHQVQWQAQEVVAQARLDGHRSMNPCPLYDAQTGTLFLFFIAIPGQVTEQQQLQTRANVTRLCQVTSTDHGRTWSSPRDLTDAAIGPAYREWSTFAVGPGHCLQLHDRARSLVVPAYAYRKLHPIQRPIPSAFCFLSHDHGRTWARGHFVAQDTLECQVAEVETGEQRVVTLNARSHLRARVQAQSTNDGLDFQESQLVKKLVEPPPQGCQGSVISFPSPRSGPGSPAQWLLYTHPTHSWQRADLGAYLNPRPPAPEAWSEPVLLAKGSCAYSDLQSMGTGPDGSPLFGCLYEANDYEEIVFLMFTLKQAFPAEYLPQ'),
('Q13936', '2F3Y', 0, 1.45, 'B', 21, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Voltage-dependent L-type calcium channel subunit alpha-1C', 'CACNA1C', '', 'alpha-actinin binding<br />\ncalmodulin binding<br />\nhigh voltage-gated calcium channel activity<br />\nmetal ion binding<br />\nvoltage-gated calcium channel activity<br />\nvoltage-gated calcium channel activity involved in AV node cell action potential<br />\nvoltage-gated calcium channel activity involved in cardiac muscle cell action potential<br />\n', 'calcium ion transmembrane transport<br />\ncalcium ion transmembrane transport via high voltage-gated calcium channel<br />\ncalcium ion transport into cytosol<br />\ncalcium-mediated signaling using extracellular calcium source<br />\ncamera-type eye development<br />\ncardiac conduction<br />\ncardiac muscle cell action potential involved in contraction<br />\ncell communication by electrical coupling involved in cardiac conduction<br />\nembryonic forelimb morphogenesis<br />\nheart development<br />\nimmune system development<br />\nmembrane depolarization during atrial cardiac muscle cell action potential<br />\nmembrane depolarization during AV node cell action potential<br />\nmembrane depolarization during cardiac muscle cell action potential<br />\npositive regulation of cytosolic calcium ion concentration<br />\nregulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion<br />\nregulation of heart rate by cardiac conduction<br />\nregulation of insulin secretion<br />\nregulation of ventricular cardiac muscle cell action potential<br />\n', 'PF08763.', 'MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTPGAALSWQAAIDAARQAKLMGSAGNATISTVSSTQRKRQQYGKPKKQGSTTATRPPRALLCLTLKNPIRRACISIVEWKPFEIIILLTIFANCVALAIYIPFPEDDSNATNSNLERVEYLFLIIFTVEAFLKVIAYGLLFHPNAYLRNGWNLLDFIIVVVGLFSAILEQATKADGANALGGKGAGFDVKALRAFRVLRPLRLVSGVPSLQVVLNSIIKAMVPLLHIALLVLFVIIIYAIIGLELFMGKMHKTCYNQEGIADVPAEDDPSPCALETGHGRQCQNGTVCKPGWDGPKHGITNFDNFAFAMLTVFQCITMEGWTDVLYWVNDAVGRDWPWIYFVTLIIIGSFFVLNLVLGVLSGEFSKEREKAKARGDFQKLREKQQLEEDLKGYLDWITQAEDIDPENEDEGMDEEKPRNMSMPTSETESVNTENVAGGDIEGENCGARLAHRISKSKFSRYWRRWNRFCRRKCRAAVKSNVFYWLVIFLVFLNTLTIASEHYNQPNWLTEVQDTANKALLALFTAEMLLKMYSLGLQAYFVSLFNRFDCFVVCGGILETILVETKIMSPLGISVLRCVRLLRIFKITRYWNSLSNLVASLLNSVRSIASLLLLLFLFIIIFSLLGMQLFGGKFNFDEMQTRRSTFDNFPQSLLTVFQILTGEDWNSVMYDGIMAYGGPSFPGMLVCIYFIILFICGNYILLNVFLAIAVDNLADAESLTSAQKEEEEEKERKKLARTASPEKKQELVEKPAVGESKEEKIELKSITADGESPPATKINMDDLQPNENEDKSPYPNPETTGEEDEEEPEMPVGPRPRPLSELHLKEKAVPMPEASAFFIFSSNNRFRLQCHRIVNDTIFTNLILFFILLSSISLAAEDPVQHTSFRNHILFYFDIVFTTIFTIEIALKILGNADYVFTSIFTLEIILKMTAYGAFLHKGSFCRNYFNILDLLVVSVSLISFGIQSSAINVVKILRVLRVLRPLRAINRAKGLKHVVQCVFVAIRTIGNIVIVTTLLQFMFACIGVQLFKGKLYTCSDSSKQTEAECKGNYITYKDGEVDHPIIQPRSWENSKFDFDNVLAAMMALFTVSTFEGWPELLYRSIDSHTEDKGPIYNYRVEISIFFIIYIIIIAFFMMNIFVGFVIVTFQEQGEQEYKNCELDKNQRQCVEYALKARPLRRYIPKNQHQYKVWYVVNSTYFEYLMFVLILLNTICLAMQHYGQSCLFKIAMNILNMLFTGLFTVEMILKLIAFKPKGYFSDPWNVFDFLIVIGSIIDVILSETNHYFCDAWNTFDALIVVGSIVDIAITEVNPAEHTQCSPSMNAEENSRISITFFRLFRVMRLVKLLSRGEGIRTLLWTFIKSFQALPYVALLIVMLFFIYAVIGMQVFGKIALNDTTEINRNNNFQTFPQAVLLLFRCATGEAWQDIMLACMPGKKCAPESEPSNSTEGETPCGSSFAVFYFISFYMLCAFLIINLFVAVIMDNFDYLTRDWSILGPHHLDEFKRIWAEYDPEAKGRIKHLDVVTLLRRIQPPLGFGKLCPHRVACKRLVSMNMPLNSDGTVMFNATLFALVRTALRIKTEGNLEQANEELRAIIKKIWKRTSMKLLDQVVPPAGDDEVTVGKFYATFLIQEYFRKFKKRKEQGLVGKPSQRNALSLQAGLRTLHDIGPEIRRAISGDLTAEEELDKAMKEAVSAASEDDIFRRAGGLFGNHVSYYQSDGRSAFPQTFTTQRPLHINKAGSSQGDTESPSHEKLVDSTFTPSSYSSTGSNANINNANNTALGRLPRPAGYPSTVSTVEGHGPPLSPAIRVQEVAWKLSSNRERHVPMCEDLELRRDSGSAGTQAHCLLLRKANPSRCHSRESQAAMAGQEETSQDETYEVKMNHDTEACSEPSLLSTEMLSYQDDENRQLTLPEEDKRDIRQSPKRGFLRSASLGRRASFHLECLKRQKDRGGDISQKTVLPLHLVHHQALAVAGLSPLLQRSHSPASFPRPFATPPATPGSRGWPPQPVPTLRLEGVESSEKLNSSFPSIHCGSWAETTPGGGGSSAARRVRPVSLMVPSQAGAPGRQFHGSASSLVEAVLISEGLGQFAQDPKFIEVTTQELADACDMTIEEMESAADNILSGGAPQSPNGALLPFVNCRDAGQDRAGGEEDAGCVRARGRPSEEELQDSRVYVSSL'),
('P18031', '2F71', 1, 1.55, 'A', 298, 'HYDROLASE', 'HYDROLASE', 'Tyrosine-protein phosphatase non-receptor type 1', 'PTPN1', 'Protein tyrosine phosphate + H2O = protein tyrosine + phosphate<br />\n', 'cadherin binding<br />\nenzyme binding<br />\nephrin receptor binding<br />\ninsulin receptor binding<br />\nprotein kinase binding<br />\nprotein phosphatase 2A binding<br />\nprotein tyrosine phosphatase activity<br />\nreceptor tyrosine kinase binding<br />\nRNA binding<br />\nzinc ion binding<br />\n', 'actin cytoskeleton reorganization<br />\nactivation of JUN kinase activity<br />\nactivation of signaling protein activity involved in unfolded protein response<br />\nendoplasmic reticulum unfolded protein response<br />\ninsulin receptor signaling pathway<br />\nIRE1-mediated unfolded protein response<br />\nJAK-STAT cascade involved in growth hormone signaling pathway<br />\nnegative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway<br />\nnegative regulation of ERK1 and ERK2 cascade<br />\nnegative regulation of insulin receptor signaling pathway<br />\nnegative regulation of MAP kinase activity<br />\nnegative regulation of PERK-mediated unfolded protein response<br />\nnegative regulation of signal transduction<br />\nnegative regulation of vascular endothelial growth factor receptor signaling pathway<br />\npeptidyl-tyrosine dephosphorylation<br />\npeptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity<br />\nplatelet-derived growth factor receptor-beta signaling pathway<br />\npositive regulation of IRE1-mediated unfolded protein response<br />\npositive regulation of protein tyrosine kinase activity<br />\npositive regulation of receptor catabolic process<br />\nprotein dephosphorylation<br />\nregulation of endocytosis<br />\nregulation of hepatocyte growth factor receptor signaling pathway<br />\nregulation of intracellular protein transport<br />\nregulation of signal transduction<br />\nregulation of type I interferon-mediated signaling pathway<br />\n', 'PF00102.', 'MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHNGKCREFFPNHQWVKEETQEDKDCPIKEEKGSPLNAAPYGIESMSQDTEVRSRVVGGSLRGAQAASPAKGEPSLPEKDEDHALSYWKPFLVNMCVATVLTAGAYLCYRFLFNSNT'),
('P07203', '2F8A', 1, 1.5, 'A/B', 185, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutathione peroxidase 1', 'GPX1', '2 glutathione + H2O2 = glutathione disulfide + 2 H2O.<br />\n', 'glutathione peroxidase activity<br />\nSH3 domain binding<br />\n', 'angiogenesis involved in wound healing<br />\nblood vessel endothelial cell migration<br />\ncell redox homeostasis<br />\ncellular response to oxidative stress<br />\nendothelial cell development<br />\nfat cell differentiation<br />\nglutathione metabolic process<br />\nheart contraction<br />\nhydrogen peroxide catabolic process<br />\ninteraction with symbiont<br />\nintrinsic apoptotic signaling pathway in response to oxidative stress<br />\nlipoxygenase pathway<br />\nmyoblast proliferation<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors<br />\nnegative regulation of inflammatory response to antigenic stimulus<br />\nnegative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway<br />\nnegative regulation of release of cytochrome c from mitochondria<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of supramolecular fiber organization<br />\nprotein oxidation<br />\npurine nucleotide catabolic process<br />\nregulation of gene expression, epigenetic<br />\nregulation of mammary gland epithelial cell proliferation<br />\nregulation of neuron apoptotic process<br />\nregulation of proteasomal protein catabolic process<br />\nresponse to gamma radiation<br />\nresponse to hydrogen peroxide<br />\nresponse to hydroperoxide<br />\nresponse to selenium ion<br />\nresponse to symbiotic bacterium<br />\nresponse to xenobiotic stimulus<br />\nsensory perception of sound<br />\nskeletal muscle fiber development<br />\nskeletal muscle tissue regeneration<br />\ntemperature homeostasis<br />\ntriglyceride metabolic process<br />\nUV protection<br />\nvasodilation<br />\n', 'PF00255.', 'MCAARLAAAAAAAQSVYAFSARPLAGGEPVSLGSLRGKVLLIENVASLUGTTVRDYTQMNELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFEKCEVNGAGAHPLFAFLREALPAPSDDATALMTDPKLITWSPVCRNDVAWNFEKFLVGPDGVPLRRYSRRFQTIDIEPDIEALLSQGPSCA'),
('P00811', '2FFY', 1, 1.07, 'A/B', 358, 'HYDROLASE', 'HYDROLASE', 'Beta-lactamase', 'ampC', 'A beta-lactam + H2O = a substituted beta-amino acid<br />\n', 'beta-lactamase activity<br />\n', 'antibiotic catabolic process<br />\nresponse to antibiotic<br />\n', 'PF00144.', 'MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ'),
('P06746', '2FMP', 1, 1.65, 'A', 335, 'TRANSFERASE / DNA', 'TRANSFERASE', 'DNA polymerase beta', 'POLB', 'Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).<br />\n', 'damaged DNA binding<br />\nDNA-(apurinic or apyrimidinic site) lyase activity<br />\nDNA-directed DNA polymerase activity<br />\nenzyme binding<br />\nlyase activity<br />\nmetal ion binding<br />\nmicrotubule binding<br />\n', 'aging<br />\nbase-excision repair<br />\nbase-excision repair, base-free sugar-phosphate removal<br />\nbase-excision repair, DNA ligation<br />\nbase-excision repair, gap-filling<br />\ncellular response to DNA damage stimulus<br />\nDNA-dependent DNA replication<br />\nDNA repair<br />\nhomeostasis of number of cells<br />\nimmunoglobulin heavy chain V-D-J recombination<br />\ninflammatory response<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nlymph node development<br />\nneuron apoptotic process<br />\nprotein deubiquitination<br />\npyrimidine dimer repair<br />\nresponse to ethanol<br />\nresponse to gamma radiation<br />\nresponse to hyperoxia<br />\nsalivary gland morphogenesis<br />\nsomatic hypermutation of immunoglobulin genes<br />\nspleen development<br />\n', 'PF14792.', 'MSKRKAPQETLNGGITDMLTELANFEKNVSQAIHKYNAYRKAASVIAKYPHKIKSGAEAKKLPGVGTKIAEKIDEFLATGKLRKLEKIRQDDTSSSINFLTRVSGIGPSAARKFVDEGIKTLEDLRKNEDKLNHHQRIGLKYFGDFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVCGSFRRGAESSGDMDVLLTHPSFTSESTKQPKLLHQVVEQLQKVHFITDTLSKGETKFMGVCQLPSKNDEKEYPHRRIDIRLIPKDQYYCGVLYFTGSDIFNKNMRAHALEKGFTINEYTIRPLGVTGVAGEPLPVDSEKDIFDYIQWKYREPKDRSE'),
('O14732', '2FVZ', 0, 2.4, 'A/B/C/D', 273, 'HYDROLASE', 'HYDROLASE', 'Inositol monophosphatase 2', 'IMPA2', 'Myo-inositol phosphate + H2O = myo-inositol + phosphate.<br />\n', 'inositol monophosphate 1-phosphatase activity<br />\ninositol monophosphate 3-phosphatase activity<br />\ninositol monophosphate 4-phosphatase activity<br />\nmetal ion binding<br />\nprotein homodimerization activity<br />\n', 'inositol biosynthetic process<br />\ninositol metabolic process<br />\ninositol phosphate dephosphorylation<br />\ninositol phosphate metabolic process<br />\nphosphate-containing compound metabolic process<br />\nphosphatidylinositol phosphorylation<br />\nsignal transduction<br />\n', 'PF00459.', 'MKPSGEDQAALAAGPWEECFQAAVQLALRAGQIIRKALTEEKRVSTKTSAADLVTETDHLVEDLIISELRERFPSHRFIAEEAAASGAKCVLTHSPTWIIDPIDGTCNFVHRFPTVAVSIGFAVRQELEFGVIYHCTEERLYTGRRGRGAFCNGQRLRVSGETDLSKALVLTEIGPKRDPATLKLFLSNMERLLHAKAHGVRVIGSSTLALCHLASGAADAYYQFGLHCWDLAAATVIIREAGGIVIDTSGGPLDLMACRVVAASTREMAMLIAQALQTINYGRDDEK'),
('P28329', '2FY3', 1, 2.27, 'A', 614, 'TRANSFERASE', 'TRANSFERASE', 'Choline O-acetyltransferase', 'CHAT', 'Acetyl-CoA + choline = CoA + O-acetylcholine<br />\n', 'choline O-acetyltransferase activity<br />\n', 'neurotransmitter biosynthetic process<br />\nneurotransmitter secretion<br />\nphosphatidylcholine biosynthetic process<br />\n', 'PF00755.', 'MGLRTAKKRGLGGGGKWKREEGGGTRGRREVRPACFLQSGGRGDPGDVGGPAGNPGCSPHPRAATRPPPLPAHTPAHTPEWCGAASAEAAEPRRAGPHLCIPAPGLTKTPILEKVPRKMAAKTPSSEESGLPKLPVPPLQQTLATYLQCMRHLVSEEQFRKSQAIVQQFGAPGGLGETLQQKLLERQEKTANWVSEYWLNDMYLNNRLALPVNSSPAVIFARQHFPGTDDQLRFAASLISGVLSYKALLDSHSIPTDCAKGQLSGQPLCMKQYYGLFSSYRLPGHTQDTLVAQNSSIMPEPEHVIVACCNQFFVLDVVINFRRLSEGDLFTQLRKIVKMASNEDERLPPIGLLTSDGRSEWAEARTVLVKDSTNRDSLDMIERCICLVCLDAPGGVELSDTHRALQLLHGGGYSKNGANRWYDKSLQFVVGRDGTCGVVCEHSPFDGIVLVQCTEHLLKHVTQSSRKLIRADSVSELPAPRRLRWKCSPEIQGHLASSAEKLQRIVKNLDFIVYKFDNYGKTFIKKQKCSPDAFIQVALQLAFYRLHRRLVPTYESASIRRFQEGRVDNIRSATPEALAFVRAVTDHKAAVPASEKLLLLKDAIRAQTAYTVMAITGMAIDNHLLALRELARAMCKELPEMFMDETYLMSNRFVLSTSQVPTTTEMFCCYGPVVPNGYGACYNPQPETILFCISSFHSCKETSSSKFAKAVEESLIDMRDLCSLLPPTESKPLATKEKATRPSQGHQP'),
('P15291', '2FYB', 1, 1.9, 'A', 273, 'TRANSFERASE', 'TRANSFERASE', 'Beta-1,4-galactosyltransferase 1', 'B4GALT1', 'UDP-alpha-D-galactose + D-glucose = UDP + lactose.<br />\nUDP-alpha-D-galactose + N-acetyl-beta-D-glucosaminylglycopeptide = UDP + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminylglycopeptide.<br />\nUDP-alpha-D-galactose + N-acetyl-D-glucosamine = UDP + N-acetyllactosamine.<br />\n', 'alpha-tubulin binding<br />\nbeta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity<br />\nbeta-tubulin binding<br />\ncytoskeletal protein binding<br />\ngalactosyltransferase activity<br />\nlactose synthase activity<br />\nmanganese ion binding<br />\nN-acetyllactosamine synthase activity<br />\nprotein homodimerization activity<br />\nUDP-galactosyltransferase activity<br />\n', 'acute inflammatory response<br />\nangiogenesis involved in wound healing<br />\nbinding of sperm to zona pellucida<br />\nbranching morphogenesis of an epithelial tube<br />\ncell adhesion<br />\ndevelopment of secondary sexual characteristics<br />\nepithelial cell development<br />\nextracellular matrix organization<br />\ngalactose metabolic process<br />\nkeratan sulfate biosynthetic process<br />\nlactose biosynthetic process<br />\nleukocyte migration<br />\nmammary gland development<br />\nnegative regulation of cell proliferation<br />\nneutrophil degranulation<br />\noligosaccharide biosynthetic process<br />\npenetration of zona pellucida<br />\npositive regulation of apoptotic process involved in mammary gland involution<br />\npositive regulation of epithelial cell proliferation involved in wound healing<br />\nprotein homooligomerization<br />\nprotein N-linked glycosylation<br />\nregulation of acrosome reaction<br />\nregulation of cellular component movement<br />\n', 'PF02709.', 'MRLREPLLSGSAAMPGASLQRACRLLVAVCALHLGVTLVYYLAGRDLSRLPQLVGVSTPLQGGSNSAAAIGQSSGELRTGGARPPPPLGASSQPRPGGDSSPVVDSGPGPASNLTSVPVPHTTALSLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGRCRMIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS'),
('P40859', '2GF3', 1, 1.3, 'A/B', 389, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Monomeric sarcosine oxidase', 'soxA', 'Sarcosine + H2O + O2 = glycine + formaldehyde + H2O2.<br />\n', 'sarcosine oxidase activity<br />\n', 'tetrahydrofolate metabolic process<br />\n', 'PF01266.', 'MSTHFDVIVVGAGSMGMAAGYQLAKQGVKTLLVDAFDPPHTNGSHHGDTRIIRHAYGEGREYVPLALRSQELWYELEKETHHKIFTKTGVLVFGPKGESAFVAETMEAAKEHSLTVDLLEGDEINKRWPGITVPENYNAIFEPNSGVLFSENCIRAYRELAEARGAKVLTHTRVEDFDISPDSVKIETANGSYTADKLIVSMGAWNSKLLSKLNLDIPLQPYRQVVGFFESDESKYSNDIDFPGFMVEVPNGIYYGFPSFGGCGLKLGYHTFGQKIDPDTINREFGVYPEDESNLRAFLEEYMPGANGELKRGAVCMYTKTLDEHFIIDLHPEHSNVVIAAGFSGHGFKFSSGVGEVLSQLALTGKTEHDISIFSINRPALKESLQKTTI'),
('P48443', '2GL8', 0, 2.4, 'A/B/C/D', 237, 'Hormone / Growth factor receptor', 'HORMONE', 'Retinoic acid receptor RXR-gamma', 'RXRG', '', '9-cis retinoic acid receptor activity<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\nzinc ion binding<br />\n', 'positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus<br />\nprotein homotetramerization<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'MYGNYSHFMKFPAGYGGSPGHTGSTSMSPSAALSTGKPMDSHPSYTDTPVSAPRTLSAVGTPLNALGSPYRVITSAMGPPSGALAAPPGINLVAPPSSQLNVVNSVSSSEDIKPLPGLPGIGNMNYPSTSPGSLVKHICAICGDRSSGKHYGVYSCEGCKGFFKRTIRKDLIYTCRDNKDCLIDKRQRNRCQYCRYQKCLVMGMKREAVQEERQRSRERAESEAECATSGHEDMPVERILEAELAVEPKTESYGDMNMENSTNDPVTNICHAADKQLFTLVEWAKRIPHFSDLTLEDQVILLRAGWNELLIASFSHRSVSVQDGILLATGLHVHRSSAHSAGVGSIFDRVLTELVSKMKDMQMDKSELGCLRAIVLFNPDAKGLSNPSEVETLREKVYATLEAYTKQKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLETPLQIT'),
('Q52437', '2GQW', 1, 1.4, 'A', 408, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Ferredoxin reductase', 'bphA4', NULL, 'flavin adenine dinucleotide binding<br />\r\noxidoreductase activity<br />', NULL, 'PF07992.', 'MSQEALKAPVVVLGAGLASVSFVAELRQAGYQGLITVVGDEAERPYDRPP\r\nLSKDFMAHGDAEKIRLDCKRAPEVEWLLGVTAQSFDPQAHTVALSDGRTL\r\nPYGTLVLATGAAPRALPTLQGATMPVHTLRTLEDARRIQAGLRPQSRLLI\r\nVGGGVIGLELAATARTAGVHVSLVETQPRLMSRAAPATLADFVARYHAAQ\r\nGVDLRFERSVTGSVDGVVLLDDGTRIAADMVVVGIGVLANDALARAAGLA\r\nCDDGIFVDAYGRTTCPDVYALGDVTRQRNPLSGRFERIETWSNAQNQGIA\r\nVARHLVDPTAPGYAELPWYWSDQGALRIQVAGLASGDEEIVRGEVSLDAP\r\nKFTLIELQKGRIVGATCVNNARDFAPLRRLLAVGAKPDRAALADPATDLR\r\nKLAAAVAA'),
('Q03736', '2GSM', 1, 2, 'B/D', 255, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome c oxidase subunit 2', 'ctaC', '4 ferrocytochrome c + O2 + 4 H+ = 4 ferricytochrome c + 2 H2O.<br />\n', 'copper ion binding<br />\ncytochrome-c oxidase activity<br />\n', 'electron transport chain<br />\n', 'PF00116.', 'MRHSTTLTGCATGAAGLLAATAAAAQQQSLEIIGRPQPGGTGFQPSASPVATQIHWLDGFILVIIAAITIFVTLLILYAVWRFHEKRNKVPARFTHNSPLEIAWTIVPIVILVAIGAFSLPVLFNQQEIPEADVTVKVTGYQWYWGYEYPDEEISFESYMIGSPATGGDNRMSPEVEQQLIEAGYSRDEFLLATDTAMVVPVNKTVVVQVTGADVIHSWTVPAFGVKQDAVPGRLAQLWFRAEREGIFFGQCSELCGISHAYMPITVKVVSEEAYAAWLEQARGGTYELSSVLPATPAGVSVE'),
('Q13427', '2GW2', 0, 1.8, 'A', 179, 'ISOMERASE', 'ISOMERASE', 'Peptidyl-prolyl cis-trans isomerase G', 'PPIG', 'Peptidylproline (omega=180) = peptidylproline (omega=0).<br />\n', 'cyclosporin A binding<br />\npeptidyl-prolyl cis-trans isomerase activity<br />\nRNA binding<br />\n', 'protein folding<br />\nRNA splicing<br />\n', 'PF00160.', 'MGIKVQRPRCFFDIAINNQPAGRVVFELFSDVCPKTCENFRCLCTGEKGTGKSTQKPLHYKSCLFHRVVKDFMVQGGDFSEGNGRGGESIYGGFFEDESFAVKHNKEFLLSMANRGKDTNGSQFFITTKPTPHLDGHHVVFGQVISGQEVVREIENQKTDAASKPFAEVRILSCGELIPKSKVKKEEKKRHKSSSSSSSSSSDSDSSSDSQSSSDSSDSESATEEKSKKRKKKHRKNSRKHKKEKKKRKKSKKSASSESEAENLEAQPQSTVRPEEIPPIPENRFLMRKSPPKADEKERKNRERERERECNPPNSQPASYQRRLLVTRSGRKIKGRGPRRYRTPSRSRSRDRFRRSETPPHWRQEMQRAQRMRVSSGERWIKGDKSELNEIKENQRSPVRVKERKITDHRNVSESPNRKNEKEKKVKDHKSNSKERDIRRNSEKDDKYKNKVKKRAKSKSRSKSKEKSKSKERDSKHNRNEEKRMRSRSKGRDHENVKEKEKQSDSKGKDQERSRSKEKSKQLESKSNEHDHSKSKEKDRRAQSRSRECDITKGKHSYNSRTRERSRSRDRSRRVRSRTHDRDRSRSKEYHRYREQEYRRRGRSRSRERRTPPGRSRSKDRRRRRRDSRSSEREESQSRNKDKYRNQESKSSHRKENSESEKRMYSKSRDHNSSNNSREKKADRDQSPFSKIKQSSQDNELKSSMLKNKEDEKIRSSVEKENQKSKGQENDHVHEKNKKFDHESSPGTDEDKSG'),
('P22234', '2H31', 0, 2.8, 'A', 425, 'LIGASE', 'LIGASE', 'Multifunctional protein ADE2', 'PAICS', 'ATP + 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate + L-aspartate = ADP + phosphate + (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate.<br />\n5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate = 5-amino-1-(5-phospho-D-ribosyl)imidazole + CO2.<br />\n', 'ATP binding<br />\ncadherin binding<br />\nidentical protein binding<br />\nphosphoribosylaminoimidazole carboxylase activity<br />\nphosphoribosylaminoimidazolesuccinocarboxamide synthase activity<br />\n', '''de novo'' IMP biosynthetic process<br />\npurine nucleobase biosynthetic process<br />\npurine ribonucleoside monophosphate biosynthetic process<br />\n', 'PF00731.', 'MATAEVLNIGKKLYEGKTKEVYELLDSPGKVLLQSKDQITAGNAARKNHLEGKAAISNKITSCIFQLLQEAGIKTAFTRKCGETAFIAPQCEMIPIEWVCRRIATGSFLKRNPGVKEGYKFYPPKVELFFKDDANNDPQWSEEQLIAAKFCFAGLLIGQTEVDIMSHATQAIFEILEKSWLPQNCTLVDMKIEFGVDVTTKEIVLADVIDNDSWRLWPSGDRSQQKDKQSYRDLKEVTPEGLQMVKKNFEWVAERVELLLKSESQCRVVVLMGSTSDLGHCEKIKKACGNFGIPCELRVTSAHKGPDETLRIKAEYEGDGIPTVFVAVAGRSNGLGPVMSGNTAYPVISCPPLTPDWGVQDVWSSLRLPSGLGCSTVLSPEGSAQFAAQIFGLSNHLVWSKLRASILNTWISLKQADKKIRECNL'),
('P23141', '2H7C', 1, 2, 'A/B/C/D/E/F', 543, 'HYDROLASE', 'HYDROLASE', 'Liver carboxylesterase 1', 'CES1', 'A carboxylic ester + H2O = an alcohol + a carboxylate<br />\n4-methylumbelliferyl acetate + H2O = 4-methylumbelliferone + acetate<br />\n', 'carboxylic ester hydrolase activity<br />\nmethylumbelliferyl-acetate deacetylase activity<br />\nsterol esterase activity<br />\n', 'cholesterol biosynthetic process<br />\ncholesterol ester hydrolysis involved in cholesterol transport<br />\nepithelial cell differentiation<br />\nmedium-chain fatty acid metabolic process<br />\nmetabolic process<br />\nresponse to toxic substance<br />\nxenobiotic metabolic process<br />\n', 'PF00135.', 'MWLRAFILATLSASAAWGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGVALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLKMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIPMQLMSYPLSEGQLDQKTAMSLLWKSYPLVCIAKELIPEATEKYLGGTDDTVKKKDLFLDLIADVMFGVPSVIVARNHRDAGAPTYMYEFQYRPSFSSDMKPKTVIGDHGDELFSVFGAPFLKEGASEEEIRLSKMVMKFWANFARNGNPNGEGLPHWPEYNQKEGYLQIGANTQAAQKLKDKEVAFWTNLFAKKAVEKPPQTEHIEL'),
('P07947', '2HDA', 0, 1.9, 'A', 62, 'TRANSFERASE', 'TRANSFERASE', 'Tyrosine-protein kinase Yes', 'YES1', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nenzyme binding<br />\nepidermal growth factor receptor binding<br />\nion channel binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\n', 'cell differentiation<br />\ncell migration<br />\ncellular protein modification process<br />\ncellular response to platelet-derived growth factor stimulus<br />\ncellular response to retinoic acid<br />\ncellular response to transforming growth factor beta stimulus<br />\nephrin receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nglucose transport<br />\ninnate immune response<br />\nleukocyte migration<br />\npeptidyl-tyrosine autophosphorylation<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of cell proliferation<br />\nregulation of vascular permeability<br />\nT cell costimulation<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF07714.', 'MGCIKSKENKSPAIKYRPENTPEPVSTSVSHYGAEPTTVSPCPSSSAKGTAVNFSSLSMTPFGGSSGVTPFGGASSSFSVVPSSYPAGLTGGVTIFVALYDYEARTTEDLSFKKGERFQIINNTEGDWWEARSIATGKNGYIPSNYVAPADSIQAEEWYFGKMGRKDAERLLLNPGNQRGIFLVRESETTKGAYSLSIRDWDEIRGDNVKHYKIRKLDNGGYYITTRAQFDTLQKLVKHYTEHADGLCHKLTTVCPTVKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMSKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGENLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILQTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMNLCWKKDPDERPTFEYIQSFLEDYFTATEPQYQPGENL'),
('P18283', '2HE3', 0, 2.1, 'A', 185, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutathione peroxidase 2', 'GPX2', '2 glutathione + H2O2 = glutathione disulfide + 2 H2O.<br />\n', 'electron carrier activity<br />\nglutathione peroxidase activity<br />\n', 'cellular response to oxidative stress<br />\n', 'PF00255.', 'MAFIAKSFYDLSAISLDGEKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQCRFPRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGYQPTFTLVQKCEVNGQNEHPVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVRRSDVAWNFEKFLIGPEGEPFRRYSRTFPTINIEPDIKRLLKVAI'),
('P48637', '2HGS', 1, 2.1, 'A', 474, 'AMINE / CARBOXYLATE LIGASE', 'LIGASE', 'Glutathione synthetase', 'GSS', 'ATP + gamma-L-glutamyl-L-cysteine + glycine = ADP + phosphate + glutathione.<br />\n', 'ATP binding<br />\nglutathione binding<br />\nglutathione synthase activity<br />\nglycine binding<br />\nidentical protein binding<br />\nmagnesium ion binding<br />\nprotein homodimerization activity<br />\n', 'aging<br />\ncellular amino acid metabolic process<br />\nglutathione biosynthetic process<br />\nnervous system development<br />\nresponse to amino acid<br />\nresponse to cadmium ion<br />\nresponse to nutrient levels<br />\nresponse to oxidative stress<br />\nresponse to tumor necrosis factor<br />\nresponse to xenobiotic stimulus<br />\n', 'PF03917.', 'MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSALLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVFLGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKILSNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFEDISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQLAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSRFVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVVQCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV'),
('P05177', '2HI4', 1, 1.95, 'A', 489, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome P450 1A2', 'CYP1A2', 'RH + [reduced NADPH--hemoprotein reductase] + O2 = ROH + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n', 'aromatase activity<br />\ncaffeine oxidase activity<br />\ndemethylase activity<br />\nelectron carrier activity<br />\nenzyme binding<br />\nheme binding<br />\niron ion binding<br />\nmonooxygenase activity<br />\noxidoreductase activity<br />\noxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen<br />\noxygen binding<br />\n', 'alkaloid metabolic process<br />\ncellular respiration<br />\ncellular response to cadmium ion<br />\ncellular response to copper ion<br />\ndibenzo-p-dioxin metabolic process<br />\ndrug catabolic process<br />\ndrug metabolic process<br />\nepoxygenase P450 pathway<br />\nexogenous drug catabolic process<br />\nheterocycle metabolic process<br />\nhydrogen peroxide biosynthetic process<br />\nlung development<br />\nmethylation<br />\nmonocarboxylic acid metabolic process<br />\nmonoterpenoid metabolic process<br />\nomega-hydroxylase P450 pathway<br />\noxidation-reduction process<br />\noxidative deethylation<br />\noxidative demethylation<br />\nporphyrin-containing compound metabolic process<br />\npost-embryonic development<br />\nregulation of gene expression<br />\nresponse to estradiol<br />\nresponse to immobilization stress<br />\nresponse to lipopolysaccharide<br />\nsteroid catabolic process<br />\ntoxin biosynthetic process<br />\nxenobiotic metabolic process<br />\n', 'PF00067.', 'MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPLLGHVLTLGKNPHLALSRMSQRYGDVLQIRIGSTPVLVLSRLDTIRQALVRQGDDFKGRPDLYTSTLITDGQSLTFSTDSGPVWAARRRLAQNALNTFSIASDPASSSSCYLEEHVSKEAKALISRLQELMAGPGHFDPYNQVVVSVANVIGAMCFGQHFPESSDEMLSLVKNTHEFVETASSGNPLDFFPILRYLPNPALQRFKAFNQRFLWFLQKTVQEHYQDFDKNSVRDITGALFKHSKKGPRASGNLIPQEKIVNLVNDIFGAGFDTVTTAISWSLMYLVTKPEIQRKIQKELDTVIGRERRPRLSDRPQLPYLEAFILETFRHSSFLPFTIPHSTTRDTTLNGFYIPKKCCVFVNQWQVNHDPELWEDPSEFRPERFLTADGTAINKPLSEKMMLFGMGKRRCIGEVLAKWEIFLFLAILLQQLEFSVPPGVKVDLTPIYGLTMKHARCEHVQARRFSIN'),
('P08631', '2HK5', 1, 2, 'A', 268, 'TRANSFERASE', 'TRANSFERASE', 'Tyrosine-protein kinase HCK', 'HCK', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\n', 'cell adhesion<br />\ncell differentiation<br />\ncytokine-mediated signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\ninflammatory response<br />\ninnate immune response-activating signal transduction<br />\nintegrin-mediated signaling pathway<br />\ninterferon-gamma-mediated signaling pathway<br />\nleukocyte degranulation<br />\nleukocyte migration involved in immune response<br />\nlipopolysaccharide-mediated signaling pathway<br />\nmesoderm development<br />\nnegative regulation of apoptotic process<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of actin cytoskeleton reorganization<br />\npositive regulation of actin filament polymerization<br />\npositive regulation of cell proliferation<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of cell shape<br />\nregulation of defense response to virus by virus<br />\nregulation of inflammatory response<br />\nregulation of phagocytosis<br />\nregulation of podosome assembly<br />\nregulation of sequence-specific DNA binding transcription factor activity<br />\nrespiratory burst after phagocytosis<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF07714.', 'MGGRSSCEDPGCPRDEERAPRMGCMKSKFLQVGGNTFSKTETSASPHCPVYVPDPTSTIKPGPNSHNSNTPGIREAGSEDIIVVALYDYEAIHHEDLSFQKGDQMVVLEESGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYQQQP'),
('Q9NS18', '2HT9', 1, 1.9, 'A/B', 124, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutaredoxin-2, mitochondrial', 'GLRX2', '', '2 iron, 2 sulfur cluster binding<br />\narsenate reductase (glutaredoxin) activity<br />\nelectron carrier activity<br />\nglutathione disulfide oxidoreductase activity<br />\nmetal ion binding<br />\nprotein disulfide isomerase activity<br />\nprotein disulfide oxidoreductase activity<br />\n', 'aging<br />\napoptotic process<br />\ncell differentiation<br />\ncell redox homeostasis<br />\ncellular response to superoxide<br />\nDNA protection<br />\nglutathione metabolic process<br />\nregulation of signal transduction<br />\nregulation of transcription, DNA-templated<br />\nresponse to hydrogen peroxide<br />\nresponse to organic substance<br />\nresponse to redox state<br />\nresponse to temperature stimulus<br />\n', 'PF00462.', 'MIWRRAALAGTRLVWSRSGSAGWLDRAAGAAGAAAAAASGMESNTSSSLENLATAPVNQIQETISDNCVVIFSKTSCSYCTMAKKLFHDMNVNYKVVELDLLEYGNQFQDALYKMTGERTVPRIFVNGTFIGGATDTHRLHKEGKLLPLVHQCYLKKSKRKEFQ'),
('P05771', '2I0E', 1, 2.6, 'A/B', 351, 'TRANSFERASE', 'TRANSFERASE', 'Protein kinase C beta type', 'PRKCB', 'ATP + a protein = ADP + a phosphoprotein<br />\n', 'androgen receptor binding<br />\nATP binding<br />\ncalcium channel regulator activity<br />\ncalcium-dependent protein kinase C activity<br />\nchromatin binding<br />\nhistone binding<br />\nhistone kinase activity (H3-T6 specific)<br />\nligand-dependent nuclear receptor transcription coactivator activity<br />\nprotein kinase C activity<br />\nprotein kinase C binding<br />\nprotein serine/threonine kinase activity<br />\nzinc ion binding<br />\n', 'adaptive immune response<br />\napoptotic process<br />\nB cell activation<br />\nB cell receptor signaling pathway<br />\ncalcium ion transport<br />\ncellular calcium ion homeostasis<br />\ncellular response to carbohydrate stimulus<br />\nhistone H3-T6 phosphorylation<br />\nintracellular signal transduction<br />\nlipoprotein transport<br />\nmitotic nuclear envelope disassembly<br />\nnegative regulation of glucose transport<br />\nnegative regulation of insulin receptor signaling pathway<br />\npeptidyl-serine phosphorylation<br />\nplatelet activation<br />\npositive regulation of angiogenesis<br />\npositive regulation of B cell receptor signaling pathway<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of vascular endothelial growth factor receptor signaling pathway<br />\nprotein phosphorylation<br />\nregulation of myeloid cell differentiation<br />\nregulation of transcription from RNA polymerase II promoter<br />\nresponse to hypoxia<br />\nsignal transduction<br />\ntranscription, DNA-templated<br />\n', 'PF00130.', 'MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPTFCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDRDVLIVLVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKCSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKASVDGWFKLLSQEEGEYFNVPVPPEGSEANEELRQKFERAKISQGTKVPEEKTTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKARDKRDTSNFDKEFTRQPVELTPTDKLFIMNLDQNEFAGFSYTNPEFVINV'),
('Q7SID9', '2I0K', 1, 1.6, 'A', 561, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Oxidoreductase', 'N/A', NULL, 'flavin adenine dinucleotide binding<br />\r\nmetal ion binding<br />\r\noxidoreductase activity, acting on CH-OH group of donors<br />', NULL, 'PF09129.', 'STGPVAPLPTPPNFPNDIALFQQAYQNWSKEIMLDATWVCSPKTPQDVVR\r\nLANWAHEHDYKIRPRGAMHGWTPLTVEKGANVEKVILADTMTHLNGITVN\r\nTGGPVATVTAGAGASIEAIVTELQKHDLGWANLPAPGVLSIGGALAVNAH\r\nGAALPAVGQTTLPGHTYGSLSNLVTELTAVVWNGTTYALETYQRNDPRIT\r\nPLLTNLGRCFLTSVTMQAGPNFRQRCQSYTDIPWRELFAPKGADGRTFEK\r\nFVAESGGAEAIWYPFTEKPWMKVWTVSPTKPDSSNEVGSLGSAGSLVGKP\r\nPQAREVSGPYNYIFSDNLPEPITDMIGAINAGNPGIAPLFGPAMYEITKL\r\nGLAATNANDIWGWSKDVQFYIKATTLRLTEGGGAVVTSRANIATVINDFT\r\nEWFHERIEFYRAKGEFPLNGPVEIRCCGLDQAADVKVPSVGPPTISATRP\r\nRPDHPDWDVAIWLNVLGVPGTPGMFEFYREMEQWMRSHYNNDDATFRPEW\r\nSKGWAFGPDPYTDNDIVTNKMRATYIEGVPTTENWDTARARYNQIDPHRV\r\nFTNGFMDKLLP'),
('P07333', '2I1M', 1, 1.8, 'A', 141, 'TRANSFERASE', 'TRANSFERASE', 'Macrophage colony-stimulating factor 1 receptor', 'CSF1R', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncytokine binding<br />\nmacrophage colony-stimulating factor receptor activity<br />\nprotein homodimerization activity<br />\nprotein phosphatase binding<br />\n', 'axon guidance<br />\ncell-cell junction maintenance<br />\ncell proliferation<br />\ncellular response to cytokine stimulus<br />\ncellular response to macrophage colony-stimulating factor stimulus<br />\ncytokine-mediated signaling pathway<br />\nforebrain neuron differentiation<br />\nhemopoiesis<br />\ninflammatory response<br />\ninnate immune response<br />\nmacrophage colony-stimulating factor signaling pathway<br />\nmacrophage differentiation<br />\nmammary gland duct morphogenesis<br />\nmonocyte differentiation<br />\nmulticellular organism development<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell proliferation<br />\nolfactory bulb development<br />\nosteoclast differentiation<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol metabolic process<br />\npositive regulation of cell migration<br />\npositive regulation of cell motility<br />\npositive regulation of cell proliferation<br />\npositive regulation of chemokine secretion<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of protein serine/threonine kinase activity<br />\npositive regulation of protein tyrosine kinase activity<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nprotein autophosphorylation<br />\nregulation of actin cytoskeleton reorganization<br />\nregulation of bone resorption<br />\nregulation of cell shape<br />\nruffle organization<br />\nsignal transduction<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00047.', 'MGPGVLLLLLVATAWHGQGIPVIEPSVPELVVKPGATVTLRCVGNGSVEWDGPPSPHWTLYSDGSSSILSTNNATFQNTGTYRCTEPGDPLGGSAAIHLYVKDPARPWNVLAQEVVVFEDQDALLPCLLTDPVLEAGVSLVRVRGRPLMRHTNYSFSPWHGFTIHRAKFIQSQDYQCSALMGGRKVMSISIRLKVQKVIPGPPALTLVPAELVRIRGEAAQIVCSASSVDVNFDVFLQHNNTKLAIPQQSDFHNNRYQKVLTLNLDQVDFQHAGNYSCVASNVQGKHSTSMFFRVVESAYLNLSSEQNLIQEVTVGEGLNLKVMVEAYPGLQGFNWTYLGPFSDHQPEPKLANATTKDTYRHTFTLSLPRLKPSEAGRYSFLARNPGGWRALTFELTLRYPPEVSVIWTFINGSGTLLCAASGYPQPNVTWLQCSGHTDRCDEAQVLQVWDDPYPEVLSQEPFHKVTVQSLLTVETLEHNQTYECRAHNSVGSGSWAFIPISAGAHTHPPDEFLFTPVVVACMSIMALLLLLLLLLLYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLSPGQDPEGGVDYKNIHLEKKYVRRDSGFSSQGVDTYVEMRPVSTSSNDSFSEQDLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERDYTNLPSSSRSGGSGSSSSELEEESSSEHLTCCEQGDIAQPLLQPNNYQFC'),
('O75715', '2I3Y', 0, 2, 'A', 193, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Epididymal secretory glutathione peroxidase', 'GPX5', '2 glutathione + H2O2 = glutathione disulfide + 2 H2O.<br />\n', 'glutathione peroxidase activity<br />\n', 'cellular response to oxidative stress<br />\nlipid metabolic process<br />\n', 'PF00255.', 'MTTQLRVVHLLPLLLACFVQTSPKQEKMKMDCHKDEKGTIYDYEAIALNKNEYVSFKQYVGKHILFVNVATYCGLTAQYPELNALQEELKPYGLVVLGFPCNQFGKQEPGDNKEILPGLKYVRPGGGFVPSFQLFEKGDVNGEKEQKVFSFLKHSCPHPSEILGTFKSISWDPVKVHDIRWNFEKFLVGPDGIPVMRWSHRATVSSVKTDILAYLKQFKTK'),
('P24752', '2IB8', 1, 1.85, 'A/B/C/D', 394, 'TRANSFERASE', 'TRANSFERASE', 'Acetyl-CoA acetyltransferase, mitochondrial', 'ACAT1', '2 acetyl-CoA = CoA + acetoacetyl-CoA<br />\n', 'acetyl-CoA C-acetyltransferase activity<br />\ncarbon-carbon lyase activity<br />\ncoenzyme binding<br />\nenzyme binding<br />\nligase activity, forming carbon-carbon bonds<br />\nmetal ion binding<br />\nprotein homodimerization activity<br />\n', 'acetyl-CoA biosynthetic process<br />\nacetyl-CoA catabolic process<br />\nadipose tissue development<br />\nbrain development<br />\nbranched-chain amino acid catabolic process<br />\ncoenzyme A biosynthetic process<br />\ncoenzyme A metabolic process<br />\nfatty acid beta-oxidation<br />\nisoleucine catabolic process<br />\nketone body biosynthetic process<br />\nketone body catabolic process<br />\nketone body metabolic process<br />\nliver development<br />\nmetanephric proximal convoluted tubule development<br />\npropionyl-CoA biosynthetic process<br />\nprotein homooligomerization<br />\nresponse to hormone<br />\nresponse to organic cyclic compound<br />\nresponse to starvation<br />\n', 'PF02803.', 'MAVLAALLRSGARSRSPLLRRLVQEIRYVERSYVSKPTLKEVVIVSATRTPIGSFLGSLSLLPATKLGSIAIQGAIEKAGIPKEEVKEAYMGNVLQGGEGQAPTRQAVLGAGLPISTPCTTINKVCASGMKAIMMASQSLMCGHQDVMVAGGMESMSNVPYVMNRGSTPYGGVKLEDLIVKDGLTDVYNKIHMGSCAENTAKKLNIARNEQDAYAINSYTRSKAAWEAGKFGNEVIPVTVTVKGQPDVVVKEDEEYKRVDFSKVPKLKTVFQKENGTVTAANASTLNDGAAALVLMTADAAKRLNVTPLARIVAFADAAVEPIDFPIAPVYAASMVLKDVGLKKEDIAMWEVNEAFSLVVLANIKMLEIDPQKVNINGGAVSLGHPIGMSGARIVGHLTHALKQGEYGLASICNGGGGASAMLIQKL'),
('Q16878', '2IC1', 0, 2.7, 'A', 200, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cysteine dioxygenase type 1', 'CDO1', 'L-cysteine + O2 = 3-sulfinoalanine.<br />\n', 'cysteine dioxygenase activity<br />\nferrous iron binding<br />\n', 'cysteine metabolic process<br />\ninflammatory response<br />\nlactation<br />\nL-cysteine catabolic process<br />\noxidation-reduction process<br />\nresponse to amino acid<br />\nresponse to cAMP<br />\nresponse to ethanol<br />\nresponse to glucagon<br />\nresponse to glucocorticoid<br />\nsulfur amino acid biosynthetic process<br />\ntaurine biosynthetic process<br />\n', 'PF05995.', 'MEQTEVLKPRTLADLIRILHQLFAGDEVNVEEVQAIMEAYESDPTEWAMYAKFDQYRYTRNLVDQGNGKFNLMILCWGEGHGSSIHDHTNSHCFLKMLQGNLKETLFAWPDKKSNEMVKKSERVLRENQCAYINDSIGLHRVENISHTEPAVSLHLYSPPFDTCHAFDQRTGHKNKVTMTFHSKFGIRTPNATSGSLENN'),
('P20701', '2ICA', 1, 1.56, 'A', 179, 'CELL ADHESION', 'CELL_ADHESION', 'Integrin alpha-L', 'ITGAL', '', 'cell adhesion molecule binding<br />\nICAM-3 receptor activity<br />\nmetal ion binding<br />\nprotein complex binding<br />\nprotein heterodimerization activity<br />\n', 'cell adhesion<br />\ncell-matrix adhesion<br />\nextracellular matrix organization<br />\nheterophilic cell-cell adhesion via plasma membrane cell adhesion molecules<br />\ninflammatory response<br />\nintegrin-mediated signaling pathway<br />\nleukocyte cell-cell adhesion<br />\nleukocyte migration<br />\nmovement of cell or subcellular component<br />\nneutrophil degranulation<br />\nphagocytosis<br />\nreceptor clustering<br />\nregulation of immune response<br />\nsignal transduction<br />\nT cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell<br />\n', 'PF01839.', 'MKDSCITVMAMALLSGFFFFAPASSYNLDVRGARSFSPPRAGRHFGYRVLQVGNGVIVGAPGEGNSTGSLYQCQSGTGHCLPVTLRGSNYTSKYLGMTLATDPTDGSILACDPGLSRTCDQNTYLSGLCYLFRQNLQGPMLQGRPGFQECIKGNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKRKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYVIEGTSKQDLTSFNMELSSSGISADLSRGHAVVGAVGAKDWAGGFLDLKADLQDDTFIGNEPLTPEVRAGYLGYTVTWLPSRQKTSLLASGAPRYQHMGRVLLFQEPQGGGHWSQVQTIHGTQIGSYFGGELCGVDVDQDGETELLLIGAPLFYGEQRGGRVFIYQRRQLGFEEVSELQGDPGYPLGRFGEAITALTDINGDGLVDVAVGAPLEEQGAVYIFNGRHGGLSPQPSQRIEGTQVLSGIQWFGRSIHGVKDLEGDGLADVAVGAESQMIVLSSRPVVDMVTLMSFSPAEIPVHEVECSYSTSNKMKEGVNITICFQIKSLIPQFQGRLVANLTYTLQLDGHRTRRRGLFPGGRHELRRNIAVTTSMSCTDFSFHFPVCVQDLISPINVSLNFSLWEEEGTPRDQRAQGKDIPPILRPSLHSETWEIPFEKNCGEDKKCEANLRVSFSPARSRALRLTAFASLSVELSLSNLEEDAYWVQLDLHFPPGLSFRKVEMLKPHSQIPVSCEELPEESRLLSRALSCNVSSPIFKAGHSVALQMMFNTLVNSSWGDSVELHANVTCNNEDSDLLEDNSATTIIPILYPINILIQDQEDSTLYVSFTPKGPKIHQVKHMYQVRIQPSIHDHNIPTLEAVVGVPQPPSEGPITHQWSVQMEPPVPCHYEDLERLPDAAEPCLPGALFRCPVVFRQEILVQVIGTLELVGEIEASSMFSLCSSLSISFNSSKHFHLYGSNASLAQVVMKVDVVYEKQMLYLYVLSGIGGLLLLLLIFIVLYKVGFFKRNLKEKMEAGRGVPNGIPAEDSEQLASGQEAGDPGCLKPLHEKDSESGGGKD'),
('P09110', '2IIK', 0, 2.55, 'A/B', 394, 'TRANSFERASE', 'TRANSFERASE', '3-ketoacyl-CoA thiolase, peroxisomal', 'ACAA1', 'Acyl-CoA + acetyl-CoA = CoA + 3-oxoacyl-CoA.<br />\n', 'acetate CoA-transferase activity<br />\nacetyl-CoA C-acyltransferase activity<br />\npalmitoyl-CoA oxidase activity<br />\n', 'alpha-linolenic acid metabolic process<br />\nbile acid metabolic process<br />\nfatty acid beta-oxidation<br />\nfatty acid beta-oxidation using acyl-CoA oxidase<br />\nneutrophil degranulation<br />\nvery long-chain fatty acid metabolic process<br />\n', 'PF02803.', 'MQRLQVVLGHLRGPADSGWMPQAAPCLSGAPQASAADVVVVHGRRTAICRAGRGGFKDTTPDELLSAVMTAVLKDVNLRPEQLGDICVGNVLQPGAGAIMARIAQFLSDIPETVPLSTVNRQCSSGLQAVASIAGGIRNGSYDIGMACGVESMSLADRGNPGNITSRLMEKEKARDCLIPMGITSENVAERFGISREKQDTFALASQQKAARAQSKGCFQAEIVPVTTTVHDDKGTKRSITVTQDEGIRPSTTMEGLAKLKPAFKKDGSTTAGNSSQVSDGAAAILLARRSKAEELGLPILGVLRSYAVVGVPPDIMGIGPAYAIPVALQKAGLTVSDVDIFEINEAFASQAAYCVEKLRLPPEKVNPLGGAVALGHPLGCTGARQVITLLNELKRRGKRAYGVVSMCIGTGMGAAAVFEYPGN'),
('P40261', '2IIP', 1, 2.05, 'A/B/C/D', 264, 'TRANSFERASE', 'TRANSFERASE', 'Nicotinamide N-methyltransferase', 'NNMT', 'S-adenosyl-L-methionine + nicotinamide = S-adenosyl-L-homocysteine + 1-methylnicotinamide.<br />\n', 'nicotinamide N-methyltransferase activity<br />\npyridine N-methyltransferase activity<br />\n', 'animal organ regeneration<br />\nmethylation<br />\nNAD biosynthesis via nicotinamide riboside salvage pathway<br />\nresponse to drug<br />\nresponse to organonitrogen compound<br />\n', 'PF01234.', 'MESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKKEPEAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL'),
('P25553', '2IMP', 1, 2.1, 'A', 479, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Lactaldehyde dehydrogenase', 'aldA', '(S)-lactaldehyde + NAD+ + H2O = (S)-lactate + NADH.<br />\nGlycolaldehyde + NAD+ + H2O = glycolate + NADH.<br />\n', 'glycolaldehyde dehydrogenase activity<br />\nidentical protein binding<br />\nlactaldehyde dehydrogenase activity<br />\nNAD binding<br />\nsuccinate-semialdehyde dehydrogenase (NAD+) activity<br />\n', 'gamma-aminobutyric acid catabolic process<br />\nglutamate decarboxylation to succinate<br />\nL-fucose catabolic process<br />\nprotein homotetramerization<br />\nrhamnose catabolic process<br />\n', 'PF00171.', 'MSVPVQHPMYIDGQFVTWRGDAWIDVVNPATEAVISRIPDGQAEDARKAIDAAERAQPEWEALPAIERASWLRKISAGIRERASEISALIVEEGGKIQQLAEVEVAFTADYIDYMAEWARRYEGEIIQSDRPGENILLFKRALGVTTGILPWNFPFFLIARKMAPALLTGNTIVIKPSEFTPNNAIAFAKIVDEIGLPRGVFNLVLGRGETVGQELAGNPKVAMVSMTGSVSAGEKIMATAAKNITKVCLELGGKAPAIVMDDADLELAVKAIVDSRVINSGQVCNCAERVYVQKGIYDQFVNRLGEAMQAVQFGNPAERNDIAMGPLINAAALERVEQKVARAVEEGARVAFGGKAVEGKGYYYPPTLLLDVRQEMSIMHEETFGPVLPVVAFDTLEDAISMANDSDYGLTSSIYTQNLNVAMKAIKGLKFGETYINRENFEAMQGFHAGWRKSGIGGADGKHGLHEYLQTQVVYLQS'),
('Q96Q83', '2IUW', 1, 1.5, 'A', 217, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3', 'ALKBH3', 'N1-methyladenine in mRNA + 2-oxoglutarate + O2 = adenine in mRNA + formaldehyde + succinate + CO2<br />\n', 'DNA-N1-methyladenine dioxygenase activity<br />\nferrous iron binding<br />\nL-ascorbic acid binding<br />\nRNA N1-methyladenosine dioxygenase activity<br />\n', 'cell proliferation<br />\nDNA dealkylation involved in DNA repair<br />\nDNA repair<br />\noxidative single-stranded DNA demethylation<br />\noxidative single-stranded RNA demethylation<br />\n', 'PF13532.', 'MEEKRRRARVQGAWAAPVKSQAIAQPATTAKSHLHQKPGQTWKNKEHHLSDREFVFKEPQQVVRRAPEPRVIDREGVYEISLSPTGVSRVCLYPGFVDVKEADWILEQLCQDVPWKQRTGIREDITYQQPRLTAWYGELPYTYSRITMEPNPHWHPVLRTLKNRIEENTGHTFNSLLCNLYRNEKDSVDWHSDDEPSLGRCPIIASLSFGATRTFEMRKKPPPEENGDYTYVERVKIPLDHGTLLIMEGATQADWQHRVPKEYHSREPRVNLTFRTVYPDPRGAPW'),
('P32322', '2IZZ', 1, 1.95, 'A/B/C/D/E', 300, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Pyrroline-5-carboxylate reductase 1, mitochondrial', 'PYCR1', 'L-proline + NAD(P)+ = 1-pyrroline-5-carboxylate + NAD(P)H<br />\n', 'identical protein binding<br />\npyrroline-5-carboxylate reductase activity<br />\n', 'cellular amino acid biosynthetic process<br />\ncellular response to oxidative stress<br />\nL-proline biosynthetic process<br />\nnegative regulation of hydrogen peroxide-induced cell death<br />\nproline biosynthetic process<br />\nregulation of mitochondrial membrane potential<br />\n', 'PF03807.', 'MSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTALSPSGHTKLLPRSLAPAGKD'),
('P61497', '2J07', 1, 1.95, 'A', 420, 'LYASE', 'LYASE', 'Deoxyribodipyrimidine photo-lyase', 'phr', 'Cyclobutadipyrimidine (in DNA) = 2 pyrimidine residues (in DNA).<br />\n', 'deoxyribodipyrimidine photo-lyase activity<br />\nDNA binding<br />\nnucleotide binding<br />\n', 'DNA repair<br />\nprotein-chromophore linkage<br />\n', 'PF00875.', 'MGPLLVWHRGDLRLHDHPALLEALARGPVVGLVVLDPNNLKTTPRRRAWFLENVRALREAYRARGGALWVLEGLPWEKVPEAARRLKAKAVYALTSHTPYGRYRDGRVREALPVPLHLLPAPHLLPPDLPRAYRVYTPFSRLYRGAAPPLPPPEALPKGPEEGEIPREDPGLPLPEPGEEAALAGLRAFLEAKLPRYAEERDRLDGEGGSRLSPYFALGVLSPRLAAWEAERRGGEGARKWVAELLWRDFSYHLLYHFPWMAERPLDPRFQAFPWQEDEALFQAWYEGKTGVPLVDAAMRELHATGFLSNRARMNAAQFAVKHLLLPWKRCEEAFRHLLLDGDRAVNLQGWQWAGGLGVDAAPYFRVFNPVLQGERHDPEGRWLKRWAPEYPSYAPKDPVVDLEEARRRYLRLARDLARG');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('Q15274', '2JBM', 1, 2, 'A/B/C/D/E/F/G/H/I/J/K/L', 297, 'TRANSFERASE', 'TRANSFERASE', 'Nicotinate-nucleotide pyrophosphorylase [carboxylating]', 'QPRT', 'Beta-nicotinate D-ribonucleotide + diphosphate + CO2 = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-diphosphate.<br />\n', 'nicotinate-nucleotide diphosphorylase (carboxylating) activity<br />\nprotein homodimerization activity<br />\n', 'NAD biosynthetic process<br />\nNAD metabolic process<br />\nprotein oligomerization<br />\nquinolinate catabolic process<br />\n', 'PF01729.', 'MDAEGLALLLPPVTLAALVDSWLREDCPGLNYAALVSGAGPSQAALWAKSPGVLAGQPFFDAIFTQLNCQVSWFLPEGSKLVPVARVAEVRGPAHCLLLGERVALNTLARCSGIASAAAAAVEAARGAGWTGHVAGTRKTTPGFRLVEKYGLLVGGAASHRYDLGGLVMVKDNHVVAAGGVEKAVRAARQAADFTLKVEVECSSLQEAVQAAEAGADLVLLDNFKPEELHPTATVLKAQFPSVAVEASGGITLDNLPQFCGPHIDVISMGMLTQAAPALDFSLKLFAKEVAPVPKIH'),
('P49902', '2JC9', 1, 1.5, 'A', 536, 'HYDROLASE', 'HYDROLASE', 'Cytosolic purine 5''-nucleotidase', 'NT5C2', 'A 5''-ribonucleotide + H2O = a ribonucleoside + phosphate.<br />\n', '5''-nucleotidase activity<br />\nmetal ion binding<br />\nnucleoside phosphotransferase activity<br />\nnucleotide binding<br />\n', 'adenosine metabolic process<br />\ndrug metabolic process<br />\nIMP metabolic process<br />\npurine nucleotide catabolic process<br />\n', 'PF05761.', 'MSTSWSDRLQNAADMPANMDKHALKKYRREAYHRVFVNRSLAMEKIKCFGFDMDYTLAVYKSPEYESLGFELTVERLVSIGYPQELLSFAYDSTFPTRGLVFDTLYGNLLKVDAYGNLLVCAHGFNFIRGPETREQYPNKFIQRDDTERFYILNTLFNLPETYLLACLVDFFTNCPRYTSCETGFKDGDLFMSYRSMFQDVRDAVDWVHYKGSLKEKTVENLEKYVVKDGKLPLLLSRMKEVGKVFLATNSDYKYTDKIMTYLFDFPHGPKPGSSHRPWQSYFDLILVDARKPLFFGEGTVLRQVDTKTGKLKIGTYTGPLQHGIVYSGGSSDTICDLLGAKGKDILYIGDHIFGDILKSKKRQGWRTFLVIPELAQELHVWTDKSSLFEELQSLDIFLAELYKHLDSSSNERPDISSIQRRIKKVTHDMDMCYGMMGSLFRSGSRQTLFASQVMRYADLYAASFINLLYYPFSYLFRAAHVLMPHESTVEHTHVDINEMESPLATRNRTSVDFKDTDYKRHQLTRSISEIKPPNLFPLAPQEITHCHDEDDDEEEEEEEE'),
('P45954', '2JIF', 1, 2, 'A/B/C/D', 381, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial', 'ACADSB', 'Acyl-CoA + acceptor = 2,3-dehydroacyl-CoA + reduced acceptor.<br />\n2-methylbutanoyl-CoA + electron-transfer flavoprotein = (E)-2-methylbut-2-enoyl-CoA + reduced electron-transfer flavoprotein + H+.<br />\n', 'acyl-CoA dehydrogenase activity<br />\nflavin adenine dinucleotide binding<br />\n', 'branched-chain amino acid catabolic process<br />\nfatty acid metabolic process<br />\n', 'PF00441.', 'MEGLAVRLLRGSRLLRRNFLTCLSSWKIPPHVSKSSQSEALLNITNNGIHFAPLQTFTDEEMMIKSSVKKFAQEQIAPLVSTMDENSKMEKSVIQGLFQQGLMGIEVDPEYGGTGASFLSTVLVIEELAKVDASVAVFCEIQNTLINTLIRKHGTEEQKATYLPQLTTEKVGSFCLSEAGAGSDSFALKTRADKEGDYYVLNGSKMWISSAEHAGLFLVMANVDPTIGYKGITSFLVDRDTPGLHIGKPENKLGLRASSTCPLTFENVKVPEANILGQIGHGYKYAIGSLNEGRIGIAAQMLGLAQGCFDYTIPYIKERIQFGKRLFDFQGLQHQVAHVATQLEAARLLTYNAARLLEAGKPFIKEASMAKYYASEIAGQTTSKCIEWMGGVGYTKDYPVEKYFRDAKIGTIYEGASNIQLNTIAKHIDAEY'),
('Q9Y600', '2JIS', 1, 1.6, 'A/B', 493, 'LYASE', 'LYASE', 'Cysteine sulfinic acid decarboxylase', 'CSAD', '3-sulfino-L-alanine = hypotaurine + CO2.<br />\n', 'pyridoxal phosphate binding<br />\nsulfinoalanine decarboxylase activity<br />\n', 'carboxylic acid metabolic process<br />\ntaurine biosynthetic process<br />\n', 'PF00282.', 'MADSEALPSLAGDPVAVEALLRAVFGVVVDEAIQKGTSVSQKVCEWKEPEELKQLLDLELRSQGESQKQILERCRAVIRYSVKTGHPRFFNQLFSGLDPHALAGRIITESLNTSQYTYEIAPVFVLMEEEVLRKLRALVGWSSGDGIFCPGGSISNMYAVNLARYQRYPDCKQRGLRTLPPLALFTSKECHYSIQKGAAFLGLGTDSVRVVKADERGKMVPEDLERQIGMAEAEGAVPFLVSATSGTTVLGAFDPLEAIADVCQRHGLWLHVDAAWGGSVLLSQTHRHLLDGIQRADSVAWNPHKLLAAGLQCSALLLQDTSNLLKRCHGSQASYLFQQDKFYDVALDTGDKVVQCGRRVDCLKLWLMWKAQGDQGLERRIDQAFVLARYLVEEMKKREGFELVMEPEFVNVCFWFVPPSLRGKQESPDYHERLSKVAPVLKERMVKEGSMMIGYQPHGTRGNFFRVVVANSALTCADMDFLLNELERLGQDL'),
('P09467', '2JJK', 1, 2, 'A/B/C/D', 338, 'HYDROLASE', 'HYDROLASE', 'Fructose-1,6-bisphosphatase 1', 'FBP1', 'D-fructose 1,6-bisphosphate + H2O = D-fructose 6-phosphate + phosphate.<br />\n', 'AMP binding<br />\nfructose 1,6-bisphosphate 1-phosphatase activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\nmonosaccharide binding<br />\n', 'cellular response to drug<br />\ncellular response to magnesium ion<br />\ndephosphorylation<br />\nfructose 1,6-bisphosphate metabolic process<br />\nfructose 6-phosphate metabolic process<br />\nfructose metabolic process<br />\ngluconeogenesis<br />\nnegative regulation of cell growth<br />\nnegative regulation of glycolytic process<br />\nnegative regulation of Ras protein signal transduction<br />\nprotein homotetramerization<br />\nregulation of gluconeogenesis<br />\nsucrose biosynthetic process<br />\n', 'PF00316.', 'MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ'),
('P00742', '2JKH', 1, 1.25, 'A', 241, 'HYDROLASE', 'HYDROLASE', 'Coagulation factor X', 'F10', 'Selective cleavage of Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.<br />\n', 'calcium ion binding<br />\nphospholipid binding<br />\nserine-type endopeptidase activity<br />\n', 'blood coagulation<br />\nblood coagulation, extrinsic pathway<br />\nblood coagulation, intrinsic pathway<br />\nER to Golgi vesicle-mediated transport<br />\npeptidyl-glutamic acid carboxylation<br />\npositive regulation of cell migration<br />\npositive regulation of protein kinase B signaling<br />\nsignal peptide processing<br />\n', 'PF00008.', 'MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK'),
('P00582', '2KFZ', 0, 2.03, 'A', 605, 'TRANSFERASE / DNA', 'TRANSFERASE', 'DNA polymerase I', 'polA', 'Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).<br />\n', '3''-5'' exonuclease activity<br />\n5''-3'' exonuclease activity<br />\nDNA binding<br />\nDNA-directed DNA polymerase activity<br />\n', 'base-excision repair<br />\nDNA-dependent DNA replication<br />\nDNA repair<br />\nDNA replication<br />\n', 'PF01367.', 'MVQIPQNPLILVDGSSYLYRAYHAFPPLTNSAGEPTGAMYGVLNMLRSLIMQYKPTHAAVVFDAKGKTFRDELFEHYKSHRPPMPDDLRAQIEPLHAMVKAMGLPLLAVSGVEADDVIGTLAREAEKAGRPVLISTGDKDMAQLVTPNITLINTMTNTILGPEEVVNKYGVPPELIIDFLALMGDSSDNIPGVPGVGEKTAQALLQGLGGLDTLYAEPEKIAGLSFRGAKTMAAKLEQNKEVAYLSYQLATIKTDVELELTCEQLEVQQPAAEELLGLFKKYEFKRWTADVEAGKWLQAKGAKPAAKPQETSVADEAPEVTATVISYDNYVTILDEETLKAWIAKLEKAPVFAFDTETDSLDNISANLVGLSFAIEPGVAAYIPVAHDYLDAPDQISRERALELLKPLLEDEKALKVGQNLKYDRGILANYGIELRGIAFDTMLESYILNSVAGRHDMDSLAERWLKHKTITFEEIAGKGKNQLTFNQIALEEAGRYAAEDADVTLQLHLKMWPDLQKHKGPLNVFENIEMPLVPVLSRIERNGVKIDPKVLHNHSEELTLRLAELEKKAHEIAGEEFNLSSTKQLQTILFEKQGIKPLKKTPGGAPSTSEEVLEELALDYPLPKVILEYRGLAKLKSTYTDKLPLMINPKTGRVHTSYHQAVTATGRLSSTDPNLQNIPVRNEEGRRIRQAFIAPEDYVIVSADYSQIELRIMAHLSRDKGLLTAFAEGKDIHRATAAEVFGLPLETVTSEQRRSAKAINFGLIYGMSAFGLARQLNIPRKEAQKYMDLYFERYPGVLEYMERTRAQAKEQGYVETLDGRRLYLPDIKSSNGARRAAAERAAINAPMQGTAADIIKRAMIAVDAWLQAEQPRVRMIMQVHDELVFEVHKDDVDAVAKQIHQLMENCTRLDVPLLVEVGSGENWDQAH'),
('P10632', '2NNJ', 1, 2.28, 'A', 463, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome P450 2C8', 'CYP2C8', 'RH + [reduced NADPH--hemoprotein reductase] + O2 = ROH + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n', 'arachidonic acid epoxygenase activity<br />\naromatase activity<br />\ncaffeine oxidase activity<br />\nestrogen 16-alpha-hydroxylase activity<br />\nheme binding<br />\niron ion binding<br />\nmonooxygenase activity<br />\noxygen binding<br />\n', 'drug metabolic process<br />\nepoxygenase P450 pathway<br />\nexogenous drug catabolic process<br />\nlipid hydroxylation<br />\nomega-hydroxylase P450 pathway<br />\norganic acid metabolic process<br />\noxidation-reduction process<br />\noxidative demethylation<br />\nsteroid metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF00067.', 'MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKVYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRWKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICSVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALTRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTETTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSDLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFKKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLPPSYQICFIPV'),
('Q13564', '2NVU', 1, 2.8, 'A', 534, 'PROTEIN TURNOVER', 'PROTEIN_BINDING', 'NEDD8-activating enzyme E1 regulatory subunit', 'NAE1', '', 'NEDD8 activating enzyme activity<br />\nprotein heterodimerization activity<br />\nubiquitin protein ligase binding<br />\n', 'mitotic DNA replication checkpoint<br />\nneuron apoptotic process<br />\npost-translational protein modification<br />\nprotein neddylation<br />\nregulation of apoptotic process<br />\nregulation of neuron apoptotic process<br />\nsignal transduction<br />\n', 'PF00899.', 'MAQLGKLLKEQKYDRQLRLWGDHGQEALESAHVCLINATATGTEILKNLVLPGIGSFTIIDGNQVSGEDAGNNFFLQRSSIGKNRAEAAMEFLQELNSDVSGSFVEESPENLLDNDPSFFCRFTVVVATQLPESTSLRLADVLWNSQIPLLICRTYGLVGYMRIIIKEHPVIESHPDNALEDLRLDKPFPELREHFQSYDLDHMEKKDHSHTPWIVIIAKYLAQWYSETNGRIPKTYKEKEDFRDLIRQGILKNENGAPEDEENFEEAIKNVNTALNTTQIPSSIEDIFNDDRCINITKQTPSFWILARALKEFVAKEGQGNLPVRGTIPDMIADSGKYIKLQNVYREKAKKDAAAVGNHVAKLLQSIGQAPESISEKELKLLCSNSAFLRVVRCRSLAEEYGLDTINKDEIISSMDNPDNEIVLYLMLRAVDRFHKQQGRYPGVSNYQVEEDIGKLKSCLTGFLQEYGLSVMVKDDYVHEFCRYGAAEPHTIAAFLGGAAAQEVIKIITKQFVIFNNTYIYSGMSQTSATFQL'),
('P00966', '2NZ2', 1, 2.4, 'A', 412, 'LIGASE', 'LIGASE', 'Argininosuccinate synthase', 'ASS1', 'ATP + L-citrulline + L-aspartate = AMP + diphosphate + N(omega)-(L-arginino)succinate<br />\n', 'amino acid binding<br />\nargininosuccinate synthase activity<br />\nATP binding<br />\nidentical protein binding<br />\nRNA binding<br />\n', 'arginine biosynthetic process<br />\nargininosuccinate metabolic process<br />\naspartate metabolic process<br />\ncellular response to laminar fluid shear stress<br />\ncitrulline metabolic process<br />\nnegative regulation of leukocyte cell-cell adhesion<br />\npositive regulation of nitric oxide biosynthetic process<br />\nurea cycle<br />\n', 'PF00764.', 'MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK'),
('P04181', '2OAT', 1, 1.95, 'A/B/C', 439, 'AMINOTRANSFERASE', 'TRANSFERASE', 'Ornithine aminotransferase, mitochondrial', 'OAT', 'L-ornithine + a 2-oxo acid = L-glutamate 5-semialdehyde + an L-amino acid.<br />\n', 'identical protein binding<br />\nornithine-oxo-acid transaminase activity<br />\npyridoxal phosphate binding<br />\n', 'cellular amino acid biosynthetic process<br />\nL-proline biosynthetic process<br />\nprotein hexamerization<br />\nvisual perception<br />\n', 'PF00202.', 'MFSKLAHLQRFAVLSRGVHSSVASATSVATKKTVQGPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF'),
('Q00266', '2OBV', 1, 2.05, 'A', 380, 'TRANSFERASE', 'TRANSFERASE', 'S-adenosylmethionine synthase isoform type-1', 'MAT1A', 'ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\nmethionine adenosyltransferase activity<br />\nselenomethionine adenosyltransferase activity<br />\n', 'methionine catabolic process<br />\nmethylation<br />\none-carbon metabolic process<br />\nprotein homotetramerization<br />\nS-adenosylmethionine biosynthetic process<br />\nselenium compound metabolic process<br />\nsulfur amino acid metabolic process<br />\n', 'PF02773.', 'MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVCKTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQCVHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDSKTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDTVYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVIVRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF'),
('P15104', '2OJW', 1, 2.05, 'A/B/C/D/E', 361, 'LIGASE', 'LIGASE', 'Glutamine synthetase', 'GLUL', 'ATP + L-glutamate + NH3 = ADP + phosphate + L-glutamine.<br />\nL-glutamate = 4-aminobutanoate + CO2.<br />\n', 'ATP binding<br />\ndynein light chain binding<br />\nglutamate-ammonia ligase activity<br />\nglutamate binding<br />\nglutamate decarboxylase activity<br />\nidentical protein binding<br />\nmagnesium ion binding<br />\nmanganese ion binding<br />\n', 'ammonia assimilation cycle<br />\ncell proliferation<br />\ncellular amino acid biosynthetic process<br />\ncellular response to starvation<br />\nglutamate catabolic process<br />\nglutamine biosynthetic process<br />\nneurotransmitter uptake<br />\npositive regulation of epithelial cell proliferation<br />\npositive regulation of insulin secretion<br />\npositive regulation of synaptic transmission, glutamatergic<br />\nprotein homooligomerization<br />\nresponse to glucose<br />\n', 'PF00120.', 'MTTSASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEWNFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRIMDMVSNQHPWFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHYRACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDPKPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLSKRHQYHIRAYDPKGGLDNARRLTGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCLLNETGDEPFQYKN'),
('P11926', '2OO0', 1, 1.9, 'A/B', 461, 'LYASE', 'LYASE', 'Ornithine decarboxylase', 'ODC1', 'L-ornithine = putrescine + CO2<br />\n', 'ornithine decarboxylase activity<br />\nprotein homodimerization activity<br />\n', 'kidney development<br />\npolyamine metabolic process<br />\npositive regulation of cell proliferation<br />\nputrescine biosynthetic process from ornithine<br />\nregulation of cellular amino acid metabolic process<br />\nregulation of protein catabolic process<br />\nresponse to virus<br />\n', 'PF02784.', 'MNNFGNEEFDCHFLDEGFTAKDILDQKINEVSSSDDKDAFYVADLGDILKKHLRWLKALPRVTPFYAVKCNDSKAIVKTLAATGTGFDCASKTEIQLVQSLGVPPERIIYANPCKQVSQIKYAANNGVQMMTFDSEVELMKVARAHPKAKLVLRIATDDSKAVCRLSVKFGATLRTSRLLLERAKELNIDVVGVSFHVGSGCTDPETFVQAISDARCVFDMGAEVGFSMYLLDIGGGFPGSEDVKLKFEEITGVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIIAKKIVLKEQTGSDDEDESSEQTFMYYVNDGVYGSFNCILYDHAHVKPLLQKRPKPDEKYYSSSIWGPTCDGLDRIVERCDLPEMHVGDWMLFENMGAYTVAAASTFNGFQRPTIYYVMSGPAWQLMQQFQNPDFPPEVEEQDASTLPVSCAWESGMKRHRAACASASINV'),
('Q9Y233', '2OUR', 1, 1.45, 'A/B', 328, 'HYDROLASE', 'HYDROLASE', 'cAMP and cAMP-inhibited cGMP 3'',5''-cyclic phosphodiesterase 10A', 'PDE10A', 'Nucleoside 3'',5''-cyclic phosphate + H2O = nucleoside 5''-phosphate.<br />\nGuanosine 3'',5''-cyclic phosphate + H2O = guanosine 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\n3'',5''-cyclic-GMP phosphodiesterase activity<br />\n3'',5''-cyclic-nucleotide phosphodiesterase activity<br />\ncAMP binding<br />\ncGMP binding<br />\ncGMP-stimulated cyclic-nucleotide phosphodiesterase activity<br />\ndrug binding<br />\nmetal ion binding<br />\n', 'cAMP catabolic process<br />\ncGMP catabolic process<br />\nregulation of cAMP-mediated signaling<br />\nregulation of protein kinase A signaling<br />\nsignal transduction<br />\n', 'PF01590.', 'MRIEERKSQHLTGLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED'),
('P11177', '2OZL', 1, 1.9, 'B/D', 328, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Pyruvate dehydrogenase E1 component subunit beta, mitochondrial', 'PDHB', 'Pyruvate + [dihydrolipoyllysine-residue acetyltransferase] lipoyllysine = [dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine + CO2<br />\n', 'pyruvate dehydrogenase (acetyl-transferring) activity<br />\npyruvate dehydrogenase activity<br />\n', 'acetyl-CoA biosynthetic process from pyruvate<br />\ncellular nitrogen compound metabolic process<br />\nglucose metabolic process<br />\nmitochondrial acetyl-CoA biosynthetic process from pyruvate<br />\npyruvate metabolic process<br />\nregulation of acetyl-CoA biosynthetic process from pyruvate<br />\ntricarboxylic acid cycle<br />\n', 'PF02779.', 'MAAVSGLVRRPLREVSGLLKRRFHWTAPAALQVTVRDAINQGMDEELERDEKVFLLGEEVAQYDGAYKVSRGLWKKYGDKRIIDTPISEMGFAGIAVGAAMAGLRPICEFMTFNFSMQAIDQVINSAAKTYYMSGGLQPVPIVFRGPNGASAGVAAQHSQCFAAWYGHCPGLKVVSPWNSEDAKGLIKSAIRDNNPVVVLENELMYGVPFEFPPEAQSKDFLIPIGKAKIERQGTHITVVSHSRPVGHCLEAAAVLSKEGVECEVINMRTIRPMDMETIEASVMKTNHLVTVEGGWPQFGVGAEICARIMEGPAFNFLDAPAVRVTGADVPMPYAKILEDNSIPQVKDIIFAIKKTLNI'),
('P19793', '2P1T', 1, 1.8, 'A', 240, 'HORMONE RECEPTOR', 'HORMONE', 'Retinoic acid receptor RXR-alpha', 'RXRA', '', '9-cis retinoic acid receptor activity<br />\nchromatin DNA binding<br />\nDBD domain binding<br />\nDNA binding<br />\ndouble-stranded DNA binding<br />\nenzyme binding<br />\nLBD domain binding<br />\nligand-dependent nuclear receptor binding<br />\npeptide binding<br />\nprotein heterodimerization activity<br />\nretinoic acid binding<br />\nretinoic acid receptor activity<br />\nretinoic acid-responsive element binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscription coactivator activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\nvitamin D receptor binding<br />\nzinc ion binding<br />\n', 'bile acid and bile salt transport<br />\ncamera-type eye development<br />\ncardiac muscle cell proliferation<br />\ncholesterol metabolic process<br />\nembryo implantation<br />\nin utero embryonic development<br />\nmaternal placenta development<br />\nmodulation by virus of host morphology or physiology<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nperoxisome proliferator activated receptor signaling pathway<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus<br />\npositive regulation of translational initiation by iron<br />\nprotein homotetramerization<br />\nregulation of branching involved in prostate gland morphogenesis<br />\nregulation of lipid metabolic process<br />\nresponse to retinoic acid<br />\nretinoic acid receptor signaling pathway<br />\nsecretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development<br />\ntranscription initiation from RNA polymerase II promoter<br />\nventricular cardiac muscle cell differentiation<br />\nventricular cardiac muscle tissue morphogenesis<br />\nvitamin metabolic process<br />\n', 'PF00104.', 'MDTKHFLPLDFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHICAICGDRSSGKHYGVYSCEGCKGFFKRTVRKDLTYTCRDNKDCLIDKRQRNRCQYCRYQKCLAMGMKREAVQEERQRGKDRNENEVESTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT'),
('Q96SL4', '2P31', 0, 2, 'A/B', 158, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutathione peroxidase 7', 'GPX7', '2 glutathione + H2O2 = glutathione disulfide + 2 H2O.<br />\n', 'catalase activity<br />\nglutathione peroxidase activity<br />\nperoxidase activity<br />\n', 'cellular response to oxidative stress<br />\n', 'PF00255.', 'MVAATVAAAWLLLWAAACAQQEQDFYDFKAVNIRGKLVSLEKYRGSVSLVVNVASECGFTDQHYRALQQLQRDLGPHHFNVLAFPCNQFGQQEPDSNKEIESFARRTYSVSFPMFSKIAVTGTGAHPAFKYLAQTSGKEPTWNFWKYLVAPDGKVVGAWDPTVSVEEVRPQITALVRKLILLKREDL'),
('P12823', '2P41', 1, 1.8, 'A', 293, 'VIRAL PROTEIN', 'OTHERS', 'Genome polyprotein', 'N/A', 'Selective hydrolysis of -Xaa-Xaa-|-Yaa- bonds in which each of the Xaa can be either Arg or Lys and Yaa can be either Ser or Ala.<br />\r\nNucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).<br />\r\nNTP + H2O = NDP + phosphate.<br />\r\nATP + H2O = ADP + phosphate.<br />\r\nS-adenosyl-L-methionine + G(5'')pppR-RNA = S-adenosyl-L-homocysteine + m7G(5'')pppR-RNA.<br />\r\nS-adenosyl-L-methionine + a 5''-(N7-methyl 5''-triphosphoguanosine)-(purine-ribonucleotide)-[mRNA] = S-adenosyl-L-homocysteine + a 5''-(N7-methyl 5''-triphosphoguanosine)-(2''-O-methyl-purine-ribonucleotide)-[mRNA].<br />', 'ATP binding<br />\r\nATP-dependent helicase activity<br />\r\ndouble-stranded RNA binding<br />\r\nion channel activity<br />\r\nmetal ion binding<br />\r\nmRNA (guanine-N7-)-methyltransferase activity<br />\r\nmRNA (nucleoside-2''-O-)-methyltransferase activity<br />\r\nprotein dimerization activity<br />\r\nRNA-directed 5''-3'' RNA polymerase activity<br />\r\nRNA helicase activity<br />\r\nserine-type endopeptidase activity<br />\r\nserine-type exopeptidase activity<br />\r\nstructural molecule activity<br />', 'clathrin-dependent endocytosis of virus by host cell<br />\r\nfusion of virus membrane with host endosome membrane<br />\r\ninduction by virus of host autophagy<br />\r\npore formation by virus in membrane of host cell<br />\r\nprotein oligomerization<br />\r\nregulation of transcription, DNA-templated<br />\r\nsuppression by virus of host STAT2 activity<br />\r\nsuppression by virus of host TYK2 activity<br />\r\nsuppression by virus of host type I interferon-mediated signaling pathway<br />\r\ntranscription, DNA-templated<br />\r\nviral RNA genome replication<br />\r\nvirion attachment to host cell<br />', 'PF01003.', 'MNDQRKKARNTPFNMLKRERNRVSTVQQLTKRFSLGMLQGRGPLKLFMAL\r\nVAFLRFLTIPPTAGILKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR\r\nTAGMIIMLIPTVMAFHLTTRNGEPHMIVSRQEKGKSLLFKTKDGTNMCTL\r\nMAMDLGELCEDTITYKCPFLKQNEPEDIDCWCNSTSTWVTYGTCTTTGEH\r\nRREKRSVALVPHVGMGLETRTETWMSSEGAWKHAQRIETWILRHPGFTIM\r\nAAILAYTIGTTHFQRVLIFILLTAIAPSMTMRCIGISNRDFVEGVSGGSW\r\nVDIVLEHGSCVTTMAKNKPTLDFELIKTEAKQPATLRKYCIEAKLTNTTT\r\nDSRCPTQGEPTLNEEQDKRFVCKHSMVDRGWGNGCGLFGKGGIVTCAMFT\r\nCKKNMEGKIVQPENLEYTVVITPHSGEEHAVGNDTGKHGKEVKITPQSSI\r\nTEAELTGYGTVTMECSPRTGLDFNEMVLLQMKDKAWLVHRQWFLDLPLPW\r\nLPGADTQGSNWIQKETLVTFKNPHAKKQDVVVLGSQEGAMHTALTGATEI\r\nQMSSGNLLFTGHLKCRLRMDKLQLKGMSYSMCTGKFKVVKEIAETQHGTI\r\nVIRVQYEGDGSPCKTPFEIMDLEKRHVLGRLTTVNPIVTEKDSPVNIEAE\r\nPPFGDSYIIIGVEPGQLKLDWFKKGSSIGQMFETTMRGAKRMAILGDTAW\r\nDFGSLGGVFTSIGKALHQVFGAIYGAAFSGVSWTMKILIGVIITWIGMNS\r\nRSTSLSVSLVLVGIVTLYLGVMVQADSGCVVSWKNKELKCGSGIFVTDNV\r\nHTWTEQYKFQPESPSKLASAIQKAHEEGICGIRSVTRLENLMWKQITSEL\r\nNHILSENEVKLTIMTGDIKGIMQVGKRSLRPQPTELRYSWKTWGKAKMLS\r\nTELHNQTFLIDGPETAECPNTNRAWNSLEVEDYGFGVFTTNIWLRLREKQ\r\nDAFCDSKLMSAAIKDNRAVHADMGYWIESALNDTWKIEKASFIEVKSCHW\r\nPKSHTLWSNGVLESEMVIPKNFAGPVSQHNNRPGYHTQTAGPWHLGKLEM\r\nDFDFCEGTTVVVTEDCGNRGPSLRTTTASGKLITEWCCRSCTLPPLRYRG\r\nEDGCWYGMEIRPLKEKEENLVSSLVTAGHGQIDNFSLGILGMALFLEEML\r\nRTRVGTKHAILLVAVSFVTLITGNMSFRDLGRVMVMVGATMTDDIGMGVT\r\nYLALLAAFKVRPTFAAGLLLRKLTSKELMMTTIGIVLLSQSSIPETILEL\r\nTDALALGMMVLKMVRNMEKYQLAVTIMAILCVPNAVILQNAWKVSCTILA\r\nVVSVSPLFLTSSQQKADWIPLALTIKGLNPTAIFLTTLSRTSKKRSWPLN\r\nEAIMAVGMVSILASSLLKNDTPMTGPLVAGGLLTVCYVLTGRSADLELER\r\nATDVKWDDQAEISGSSPILSITISEDGSMSIKNEEEEQTLTILIRTGLLV\r\nISGLFPVSIPITAAAWYLWEVKKQRAGVLWDVPSPPPVGKAELEDGAYRI\r\nKQKGILGYSQIGAGVYKEGTFHTMWHVTRGAVLMHKGKRIEPSWADVKKD\r\nLISYGGGWKLEGEWKEGEEVQVLALEPGKNPRAVQTKPGLFRTNTGTIGA\r\nVSLDFSPGTSGSPIVDKKGKVVGLYGNGVVTRSGAYVSAIAQTEKSIEDN\r\nPEIEDDIFRKRRLTIMDLHPGAGKTKRYLPAIVREAIKRGLRTLILAPTR\r\nVVAAEMEEALRGLPIRYQTPAIRAEHTGREIVDLMCHATFTMRLLSPIRV\r\nPNYNLIIMDEAHFTDPASIAARGYISTRVEMGEAAGIFMTATPPGSRDPF\r\nPQSNAPIMDEEREIPERSWNSGHEWVTDFKGKTVWFVPSIKTGNDIAACL\r\nRKNGKRVIQLSRKTFDSEYVKTRTNDWDFVVTTDISEMGANFKAERVIDP\r\nRRCMKPVILTDGEERVILAGPMPVTHSSAAQRRGRIGRNPRNENDQYIYM\r\nGEPLENDEDCAHWKEAKMLLDNINTPEGIIPSMFEPEREKVDAIDGEYRL\r\nRGEARKTFVDLMRRGDLPVWLAYKVAAEGINYADRRWCFDGTRNNQILEE\r\nNVEVEIWTKEGERKKLKPRWLDARIYSDPLALKEFAAGRKSLTLNLITEM\r\nGRLPTFMTQKARDALDNLAVLHTAEAGGKAYNHALSELPETLETLLLLTL\r\nLATVTGGIFLFLMSGRGIGKMTLGMCCIITASILLWYAQIQPHWIAASII\r\nLEFFLIVLLIPEPEKQRTPQDNQLTYVIIAILTVVAATMANEMGFLEKTK\r\nKDLGLGNIATQQPESNILDIDLRPASAWTLYAVATTFITPMLRHSIENSS\r\nVNVSLTAIANQATVLMGLGKGWPLSKMDIGVPLLAIGCYSQVNPITLTAA\r\nLLLLVAHYAIIGPGLQAKATREAQKRAAAGIMKNPTVDGITVIDLDPIPY\r\nDPKFEKQLGQVMLLVLCVTQVLMMRTTWALCEALTLATGPVSTLWEGNPG\r\nRFWNTTIAVSMANIFRGSYLAGAGLLFSIMKNTTSTRRGTGNIGETLGEK\r\nWKSRLNALGKSEFQIYKKSGIQEVDRTLAKEGIKRGETDHHAVSRGSAKL\r\nRWFVERNLVTPEGKVVDLGCGRGGWSYYCGGLKNVREVKGLTKGGPGHEE\r\nPIPMSTYGWNLVRLQSGVDVFFVPPEKCDTLLCDIGESSPNPTVEAGRTL\r\nRVLNLVENWLNNNTQFCVKVLNPYMPSVIERMETLQRKYGGALVRNPLSR\r\nNSTHEMYWVSNASGNIVSSVNMISRMLINRFTMRHKKATYEPDVDLGSGT\r\nRNIGIESETPNLDIIGKRIEKIKQEHETSWHYDQDHPYKTWAYHGSYETK\r\nQTGSASSMVNGVVRLLTKPWDVVPMVTQMAMTDTTPFGQQRVFKEKVDTR\r\nTQEPKEGTKKLMKITAEWLWKELGKKKTPRMCTREEFTKKVRSNAALGAI\r\nFTDENKWKSAREAVEDSRFWELVDKERNLHLEGKCETCVYNMMGKREKKL\r\nGEFGKAKGSRAIWYMWLGARFLEFEALGFLNEDHWFSRENSLSGVEGEGL\r\nHKLGYILREVSKKEGGAMYADDTAGWDTRITIEDLKNEEMITNHMAGEHK\r\nKLAEAIFKLTYQNKVVRVQRPTPRGTVMDIISRRDQRGSGQVGTYGLNTF\r\nTNMEAQLIRQMEGEGIFKSIQHLTASEEIAVQDWLARVGRERLSRMAISG\r\nDDCVVKPLDDRFARALTALNDMGKVRKDIQQWEPSRGWNDWTQVPFCSHH\r\nFHELIMKDGRTLVVPCRNQDELIGRARISQGAGWSLRETACLGKSYAQMW\r\nSLMYFHRRDLRLAANAICSAVPSHWVPTSRTTWSIHASHEWMTTEDMLTV\r\nWNKVWILENPWMEDKTPVESWEEIPYLGKREDQWCGSLIGLTSRATWAKN\r\nIQTAINQVRSLIGNEEYTDYMPSMKRFRREEEEAGVLW'),
('P01023', '2P9R', 0, 2.3, 'A/B', 102, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Alpha-2-macroglobulin', 'A2M', '', 'calcium-dependent protein binding<br />\nenzyme binding<br />\ngrowth factor binding<br />\nGTPase activator activity<br />\ninterleukin-1 binding<br />\ninterleukin-8 binding<br />\nprotease binding<br />\nreceptor binding<br />\nserine-type endopeptidase inhibitor activity<br />\ntumor necrosis factor binding<br />\n', 'blood coagulation, intrinsic pathway<br />\nextracellular matrix disassembly<br />\nnegative regulation of complement activation, lectin pathway<br />\nplatelet degranulation<br />\nregulation of small GTPase mediated signal transduction<br />\nstem cell differentiation<br />\n', 'PF00207.', 'MGKNKLLHPSLVLLLLVLLPTDASVSGKPQYMVLVPSLLHTETTEKGCVLLSYLNETVTVSASLESVRGNRSLFTDLEAENDVLHCVAFAVPKSSSNEEVMFLTVQVKGPTQEFKKRTTVMVKNEDSLVFVQTDKSIYKPGQTVKFRVVSMDENFHPLNELIPLVYIQDPKGNRIAQWQSFQLEGGLKQFSFPLSSEPFQGSYKVVVQKKSGGRTEHPFTVEEFVLPKFEVQVTVPKIITILEEEMNVSVCGLYTYGKPVPGHVTVSICRKYSDASDCHGEDSQAFCEKFSGQLNSHGCFYQQVKTKVFQLKRKEYEMKLHTEAQIQEEGTVVELTGRQSSEITRTITKLSFVKVDSHFRQGIPFFGQVRLVDGKGVPIPNKVIFIRGNEANYYSNATTDEHGLVQFSINTTNVMGTSLTVRVNYKDRSPCYGYQWVSEEHEEAHHTAYLVFSPSKSFVHLEPMSHELPCGHTQTVQAHYILNGGTLLGLKKLSFYYLIMAKGGIVRTGTHGLLVKQEDMKGHFSISIPVKSDIAPVARLLIYAVLPTGDVIGDSAKYDVENCLANKVDLSFSPSQSLPASHAHLRVTAAPQSVCALRAVDQSVLLMKPDAELSASSVYNLLPEKDLTGFPGPLNDQDNEDCINRHNVYINGITYTPVSSTNEKDMYSFLEDMGLKAFTNSKIRKPKMCPQLQQYEMHGPEGLRVGFYESDVMGRGHARLVHVEEPHTETVRKYFPETWIWDLVVVNSAGVAEVGVTVPDTITEWKAGAFCLSEDAGLGISSTASLRAFQPFFVELTMPYSVIRGEAFTLKATVLNYLPKCIRVSVQLEASPAFLAVPVEKEQAPHCICANGRQTVSWAVTPKSLGNVNFTVSAEALESQELCGTEVPSVPEHGRKDTVIKPLLVEPEGLEKETTFNSLLCPSGGEVSEELSLKLPPNVVEESARASVSVLGDILGSAMQNTQNLLQMPYGCGEQNMVLFAPNIYVLDYLNETQQLTPEIKSKAIGYLNTGYQRQLNYKHYDGSYSTFGERYGRNQGNTWLTAFVLKTFAQARAYIFIDEAHITQALIWLSQRQKDNGCFRSSGSLLNNAIKGGVEDEVTLSAYITIALLEIPLTVTHPVVRNALFCLESAWKTAQEGDHGSHVYTKALLAYAFALAGNQDKRKEVLKSLNEEAVKKDNSVHWERPQKPKAPVGHFYEPQAPSAEVEMTSYVLLAYLTAQPAPTSEDLTSATNIVKWITKQQNAQGGFSSTQDTVVALHALSKYGAATFTRTGKAAQVTIQSSGTFSSKFQVDNNNRLLLQQVSLPELPGEYSMKVTGEGCVYLQTSLKYNILPEKEEFPFALGVQTLPQTCDEPKAHTSFQISLSVSYTGSRSASNMAIVDVKMVSGFIPLKPTVKMLERSNHVSRTEVSSNHVLIYLDKVSNQTLSLFFTVLQDVPVRDLKPAIVKVYDYYETDEFAIAEYNAPCSKDLGNA'),
('O24990', '2PD4', 1, 2.3, 'A/B/C/D', 275, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Enoyl-[acyl-carrier-protein] reductase [NADH] FabI', 'fabI', 'An acyl-[acyl-carrier protein] + NAD+ = a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADH.<br />\n', 'enoyl-[acyl-carrier-protein] reductase (NADH) activity<br />\n', 'fatty acid elongation<br />\nprotein homotetramerization<br />\n', '', 'MGFLKGKKGLIVGVANNKSIAYGIAQSCFNQGATLAFTYLNESLEKRVRPIAQELNSPYVYELDVSKEEHFKSLYNSVKKDLGSLDFIVHSVAFAPKEALEGSLLETSKSAFNTAMEISVYSLIELTNTLKPLLNNGASVLTLSYLGSTKYMAHYNVMGLAKAALESAVRYLAVDLGKHHIRVNALSAGPIRTLASSGIADFRMILKWNEINAPLRKNVSLEEVGNAGMYLLSSLSSGVSGEVHFVDAGYHVMGMGAVEEKDNKATLLWDLHKEQ'),
('P98066', '2PF5', 1, 1.9, 'A/B/C/D/E', 98, 'CELL ADHESION', 'CELL_ADHESION', 'Tumor necrosis factor-inducible gene 6 protein', 'TNFAIP6', '', 'hyaluronic acid binding<br />\n', 'cell adhesion<br />\ncell-cell signaling<br />\ninflammatory response<br />\nnegative regulation of inflammatory response<br />\nneutrophil degranulation<br />\novulation<br />\npositive regulation of cell migration<br />\nsignal transduction<br />\n', 'PF00431.', 'MIILIYLFLLLWEDTQGWGFKDGIFHNSIWLERAAGVYHREARSGKYKLTYAEAKAVCEFEGGHLATYKQLEAARKIGFHVCAAGWMAKGRVGYPIVKPGPNCGFGKTGIIDYGIRLNRSERWDAYCYNPHAKECGGVFTDPKQIFKSPGFPNEYEDNQICYWHIRLKYGQRIHLSFLDFDLEDDPGCLADYVEIYDSYDDVHGFVGRYCGDELPDDIISTGNVMTLKFLSDASVTAGGFQIKYVAMDPVSKSSQGKNTSTTSTGNKNFLAGRFSHL'),
('P51800', '2PFI', 0, 1.6, 'A/B', 155, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Chloride channel protein ClC-Ka', 'CLCNKA', '', 'identical protein binding<br />\nmetal ion binding<br />\nvoltage-gated chloride channel activity<br />\n', 'chloride transmembrane transport<br />\nexcretion<br />\nion transmembrane transport<br />\ntransport<br />\n', 'PF00571.', 'MEELVGLREGFSGDPVTLQELWGPCPHIRRAIQGGLEWLKQKVFRLGEDWYFLMTLGVLMALVSYAMNFAIGCVVRAHQWLYREIGDSHLLRYLSWTVYPVALVSFSSGFSQSITPSSGGSGIPELKTMLAGVILEDYLDIKNFGAKVVGLSCTLATGSTLFLGKVGPFVHLSVMIAAYLGRVRTTTIGEPENKSKQNEMLVAAAAVGVATVFAAPFSGVLFSIEVMSSHFSVRDYWRGFFAATCGAFIFRLLAVFNSEQETITSLYKTSFRVDVPFDLPEIFFFVALGGICGVLSCAYLFCQRTFLSFIKTNRYSSKLLATSKPVYSALATLLLASITYPPGVGHFLASRLSMKQHLDSLFDNHSWALMTQNSSPPWPEELDPQHLWWEWYHPRFTIFGTLAFFLVMKFWMLILATTIPMPAGYFMPIFILGAAIGRLLGEALAVAFPEGIVTGGVTNPIMPGGYALAGAAAFSGAVTHTISTALLAFELTGQIVHALPVLMAVLAANAIAQSCQPSFYDGTIIVKKLPYLPRILGRNIGSHHVRVEHFMNHSITTLAKDTPLEEVVKVVTSTDVTEYPLVESTESQILVGIVQRAQLVQALQAEPPSRAPGHQQCLQDILARGCPTEPVTLTLFSETTLHQAQNLFKLLNLQSLFVTSRGRAVGCVSWVEMKKAISNLTNPPAPK'),
('Q9Y2Z4', '2PID', 1, 2.2, 'A/B', 344, 'LIGASE', 'LIGASE', 'Tyrosine--tRNA ligase, mitochondrial', 'YARS2', 'ATP + L-tyrosine + tRNA(Tyr) = AMP + diphosphate + L-tyrosyl-tRNA(Tyr)<br />\n', 'ATP binding<br />\nprotein homodimerization activity<br />\nRNA binding<br />\ntRNA binding<br />\ntyrosine binding<br />\ntyrosine-tRNA ligase activity<br />\n', 'mitochondrial tyrosyl-tRNA aminoacylation<br />\ntranslation<br />\ntRNA aminoacylation<br />\ntRNA aminoacylation for protein translation<br />\n', 'PF00579.', 'MAAPILRSFSWGRWSGTLNLSVLLPLGLRKAHSGAQGLLAAQKARGLFKDFFPETGTKIELPELFDRGTASFPQTIYCGFDPTADSLHVGHLLALLGLFHLQRAGHNVIALVGGATARLGDPSGRTKEREALETERVRANARALRLGLEALAANHQQLFTDGRSWGSFTVLDNSAWYQKQHLVDFLAAVGGHFRMGTLLSRQSVQLRLKSPEGMSLAEFFYQVLQAYDFYYLFQRYGCRVQLGGSDQLGNIMSGYEFINKLTGEDVFGITVPLITSTTGAKLGKSAGNAVWLNRDKTSPFELYQFFVRQPDDSVERYLKLFTFLPLPEIDHIMQLHVKEPERRGPQKRLAAEVTKLVHGREGLDSAKRCTQALYHSSIDALEVMSDQELKELFKEAPFSEFFLDPGTSVLDTCRKANAIPDGPRGYRMITEGGVSINHQQVTNPESVLIVGQHILKNGLSLLKIGKRNFYIIKWLQL'),
('P12256', '2PVA', 1, 2.5, 'A/B/C/D', 335, 'HYDROLASE', 'HYDROLASE', 'Penicillin acylase', 'N/A', 'Penicillin + H2O = a carboxylate + 6-aminopenicillanate.', 'penicillin amidase activity', 'response to antibiotic', 'PF02275.', 'MLGCSSLSIRTTDDKSLFARTMDFTMEPDSKVIIVPRNYGIRLLEKENVV\r\nINNSYAFVGMGSTDITSPVLYDGVNEKGLMGAMLYYATFATYADEPKKGT\r\nTGINPVYVISQVLGNCVTVDDVIEKLTSYTLLNEANIILGFAPPLHYTFT\r\nDASGESIVIEPDKTGITIHRKTIGVMTNSPGYEWHQTNLRAYIGVTPNPP\r\nQDIMMGDLDLTPFGQGAGGLGLPGDFTPSARFLRVAYWKKYTEKAKNETE\r\nGVTNLFHILSSVNIPKGVVLTNEGKTDYTIYTSAMCAQSKNYYFKLYDNS\r\nRISAVSLMAENLNSQDLITFEWDRKQDIKQLNQVNVMS'),
('P13569', '2PZE', 1, 1.7, 'A/B', 260, 'HYDROLASE', 'HYDROLASE', 'Cystic fibrosis transmembrane conductance regulator', 'CFTR', 'ATP + H2O = ADP + phosphate<br />\n', 'ATPase activity<br />\nATPase activity, coupled to transmembrane movement of substances<br />\nATPase-coupled anion transmembrane transporter activity<br />\nATP binding<br />\nbicarbonate transmembrane transporter activity<br />\nchloride channel activity<br />\nchloride channel inhibitor activity<br />\nchloride channel regulator activity<br />\nchloride transmembrane transporter activity<br />\nenzyme binding<br />\nintracellular ATPase-gated chloride channel activity<br />\nPDZ domain binding<br />\n', 'bicarbonate transport<br />\ncellular response to cAMP<br />\ncellular response to forskolin<br />\nchloride transmembrane transport<br />\ncholesterol biosynthetic process<br />\ncholesterol transport<br />\nintracellular pH elevation<br />\nmembrane hyperpolarization<br />\nmembrane organization<br />\nmulticellular organismal water homeostasis<br />\npositive regulation of cyclic nucleotide-gated ion channel activity<br />\npositive regulation of exocytosis<br />\npositive regulation of insulin secretion involved in cellular response to glucose stimulus<br />\npositive regulation of voltage-gated chloride channel activity<br />\nprotein deubiquitination<br />\nsperm capacitation<br />\ntransepithelial water transport<br />\ntransmembrane transport<br />\nvesicle docking involved in exocytosis<br />\n', 'PF00664.', 'MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL'),
('O95749', '2Q80', 1, 2.7, 'A/B/C/D/E/F', 300, 'TRANSFERASE', 'TRANSFERASE', 'Geranylgeranyl pyrophosphate synthase', 'GGPS1', 'Dimethylallyl diphosphate + isopentenyl diphosphate = diphosphate + geranyl diphosphate<br />\nGeranyl diphosphate + isopentenyl diphosphate = diphosphate + (2E,6E)-farnesyl diphosphate<br />\n(2E,6E)-farnesyl diphosphate + isopentenyl diphosphate = diphosphate + geranylgeranyl diphosphate<br />\n', 'dimethylallyltranstransferase activity<br />\nfarnesyltranstransferase activity<br />\ngeranyltranstransferase activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\n', 'cholesterol biosynthetic process<br />\nfarnesyl diphosphate biosynthetic process<br />\ngeranyl diphosphate biosynthetic process<br />\ngeranylgeranyl diphosphate biosynthetic process<br />\nisoprenoid metabolic process<br />\nregulation of cholesterol biosynthetic process<br />\n', 'PF00348.', 'MEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNASLLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHPDAVKLFTRQLLELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTLGLFFQIRDDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTENIDIKKYCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE'),
('Q9UBK8', '2QTL', 1, 1.9, 'A', 534, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Methionine synthase reductase', 'MTRR', '2 [methionine synthase]-methylcob(I)alamin + 2 S-adenosylhomocysteine + NADP+ = 2 [methionine synthase]-cob(II)alamin + NADPH + 2 S-adenosyl-L-methionine<br />\n', '[methionine synthase] reductase activity<br />\naquacobalamin reductase (NADPH) activity<br />\nFAD binding<br />\nflavin adenine dinucleotide binding<br />\nFMN binding<br />\nNADP binding<br />\nNADPH binding<br />\nNADPH-hemoprotein reductase activity<br />\noxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor<br />\n', 'cobalamin metabolic process<br />\nDNA methylation<br />\nfolic acid metabolic process<br />\nhomocysteine catabolic process<br />\nmethionine biosynthetic process<br />\nmethionine metabolic process<br />\nmethylation<br />\nnegative regulation of cystathionine beta-synthase activity<br />\noxidation-reduction process<br />\nS-adenosylmethionine cycle<br />\nsulfur amino acid metabolic process<br />\n', 'PF00667.', 'MGAASVRAGARLVEVALCSFTVTCLEVMRRFLLLYATQQGQAKAIAEEICEQAVVHGFSADLHCISESDKYDLKTETAPLVVVVSTTGTGDPPDTARKFVKEIQNQTLPVDFFAHLRYGLLGLGDSEYTYFCNGGKIIDKRLQELGARHFYDTGHADDCVGLELVVEPWIAGLWPALRKHFRSSRGQEEISGALPVASPASSRTDLVKSELLHIESQVELLRFDDSGRKDSEVLKQNAVNSNQSNVVIEDFESSLTRSVPPLSQASLNIPGLPPEYLQVHLQESLGQEESQVSVTSADPVFQVPISKAVQLTTNDAIKTTLLVELDISNTDFSYQPGDAFSVICPNSDSEVQSLLQRLQLEDKREHCVLLKIKADTKKKGATLPQHIPAGCSLQFIFTWCLEIRAIPKKAFLRALVDYTSDSAEKRRLQELCSKQGAADYSRFVRDACACLLDLLLAFPSCQPPLSLLLEHLPKLQPRPYSCASSSLFHPGKLHFVFNIVEFLSTATTEVLRKGVCTGWLALLVASVLQPNIHASHEDSGKALAPKISISPRTTNSFHLPDDPSIPIIMVGPGTGIAPFIGFLQHREKLQEQHPDGNFGAMWLFFGCRHKDRDYLFRKELRHFLKHGILTHLKVSFSRDAPVGEEEAPAKYVQDNIQLHGQQVARILLQENGHIYVCGDAKNMAKDVHDALVQIISKEVGVEKLEAMKTLATLKEEKRYLQDIWS'),
('P27815', '2QYK', 1, 2.1, 'A/B', 333, 'HYDROLASE', 'HYDROLASE', 'cAMP-specific 3'',5''-cyclic phosphodiesterase 4A', 'PDE4A', 'Adenosine 3'',5''-cyclic phosphate + H2O = adenosine 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\ncAMP binding<br />\nmetal ion binding<br />\n', 'cAMP catabolic process<br />\ncellular response to drug<br />\nregulation of cAMP-mediated signaling<br />\nregulation of protein kinase A signaling<br />\nsensory perception of smell<br />\nsignal transduction<br />\n', 'PF00233.', 'MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT'),
('Q08493', '2QYM', 0, 1.9, 'A', 358, 'HYDROLASE', 'HYDROLASE', 'cAMP-specific 3'',5''-cyclic phosphodiesterase 4C', 'PDE4C', 'Adenosine 3'',5''-cyclic phosphate + H2O = adenosine 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\nmetal ion binding<br />\n', 'cAMP catabolic process<br />\nsignal transduction<br />\n', 'PF00233.', 'MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT'),
('P22352', '2R37', 0, 1.85, 'A/B', 199, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutathione peroxidase 3', 'GPX3', '2 glutathione + H2O2 = glutathione disulfide + 2 H2O.<br />\n', 'glutathione peroxidase activity<br />\nselenium binding<br />\ntranscription factor binding<br />\n', 'cellular response to oxidative stress<br />\nhydrogen peroxide catabolic process<br />\nprotein homotetramerization<br />\nresponse to lipid hydroperoxide<br />\n', 'PF00255.', 'MARLLQASCLLSLLLAGFVSQSRGQEKSKMDCHGGISGTIYEYGALTIDGEEYIPFKQYAGKYVLFVNVASYUGLTGQYIELNALQEELAPFGLVILGFPCNQFGKQEPGENSEILPTLKYVRPGGGFVPNFQLFEKGDVNGEKEQKFYTFLKNSCPPTSELLGTSDRLFWEPMKVHDIRWNFEKFLVGPDGIPIMRWHHRTTVSNVKMDILSYMRRQAALGVKRK'),
('P04035', '2R4F', 1, 1.7, 'A/B/C/D', 435, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '3-hydroxy-3-methylglutaryl-coenzyme A reductase', 'HMGCR', '(R)-mevalonate + CoA + 2 NADP+ = (S)-3-hydroxy-3-methylglutaryl-CoA + 2 NADPH<br />\n', 'coenzyme binding<br />\nhydroxymethylglutaryl-CoA reductase (NADPH) activity<br />\nhydroxymethylglutaryl-CoA reductase activity<br />\nNADPH binding<br />\nprotein homodimerization activity<br />\nprotein phosphatase 2A binding<br />\n', 'aging<br />\ncholesterol biosynthetic process<br />\ncoenzyme A metabolic process<br />\nisoprenoid biosynthetic process<br />\nmyoblast differentiation<br />\nnegative regulation of blood vessel diameter<br />\nnegative regulation of insulin secretion involved in cellular response to glucose stimulus<br />\nnegative regulation of MAP kinase activity<br />\nnegative regulation of striated muscle cell apoptotic process<br />\nnegative regulation of wound healing<br />\npositive regulation of cardiac muscle cell apoptotic process<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of skeletal muscle tissue development<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of stress-activated MAPK cascade<br />\nprotein tetramerization<br />\nregulation of cholesterol biosynthetic process<br />\nregulation of lipid metabolic process<br />\nresponse to ethanol<br />\nresponse to nutrient<br />\nubiquinone metabolic process<br />\nvisual learning<br />\n', 'PF00368.', 'MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSSDIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTGLNEALPFFLLLIDLSRASTLAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIGVGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFARVLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTADTSKVSLGLDENVSKRIEPSVSLWQFYLSKMISMDIEQVITLSLALLLAVKYIFFEQTETESTLSLKNPITSPVVTQKKVPDNCCRREPMLVRNNQKCDSVEEETGINRERKVEVIKPLVAETDTPNRATFVVGNSSLLDTSSVLVTQEPEIELPREPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLMETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKINLQDLQGACTKKTA'),
('P07550', '2RH1', 1, 2.4, 'A', 230, 'MEMBRANE PROTEIN / HYDROLASE', 'MEMBRANE_PROT', 'Beta-2 adrenergic receptor', 'ADRB2', '', 'adenylate cyclase binding<br />\namyloid-beta binding<br />\nbeta2-adrenergic receptor activity<br />\nepinephrine binding<br />\nnorepinephrine binding<br />\npotassium channel regulator activity<br />\nprotein complex binding<br />\nprotein homodimerization activity<br />\n', 'activation of adenylate cyclase activity<br />\nactivation of transmembrane receptor protein tyrosine kinase activity<br />\nadenylate cyclase-activating adrenergic receptor signaling pathway<br />\nadenylate cyclase-modulating G-protein coupled receptor signaling pathway<br />\nadrenergic receptor signaling pathway<br />\nbone resorption<br />\nbrown fat cell differentiation<br />\ncell-cell signaling<br />\ncell surface receptor signaling pathway<br />\ncellular response to amyloid-beta<br />\ndesensitization of G-protein coupled receptor protein signaling pathway by arrestin<br />\ndiet induced thermogenesis<br />\nendosome to lysosome transport<br />\nheat generation<br />\nmembrane organization<br />\nnegative regulation of multicellular organism growth<br />\nnegative regulation of smooth muscle contraction<br />\nnorepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure<br />\npositive regulation of AMPA receptor activity<br />\npositive regulation of autophagosome maturation<br />\npositive regulation of bone mineralization<br />\npositive regulation of cAMP-dependent protein kinase activity<br />\npositive regulation of lipophagy<br />\npositive regulation of MAPK cascade<br />\npositive regulation of mini excitatory postsynaptic potential<br />\npositive regulation of protein kinase A signaling<br />\npositive regulation of protein serine/threonine kinase activity<br />\npositive regulation of protein ubiquitination<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein deubiquitination<br />\nreceptor-mediated endocytosis<br />\nregulation of sodium ion transport<br />\nresponse to cold<br />\nresponse to psychosocial stress<br />\n', 'PF00001.', 'MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL'),
('Q8DR59', '2V2F', 1, 1.9, 'A', 24, 'TRANSFERASE', 'TRANSFERASE', 'Penicillin-binding protein 1A', 'pbpA', '(GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala))(n)-diphosphoundecaprenol + GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol = (GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala))(n+1)-diphosphoundecaprenol + undecaprenyl diphosphate<br />\nPreferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala<br />\n', 'penicillin binding<br />\npeptidoglycan glycosyltransferase activity<br />\nserine-type D-Ala-D-Ala carboxypeptidase activity<br />\n', 'cell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nresponse to antibiotic<br />\n', 'PF00912.', 'MNKPTILRLIKYLSISFLSLVIAAIVLGGGVFFYYVSKAPSLSESKLVATTSSKIYDNKNQLIADLGSERRVNAQANDIPTDLVKAIVSIEDHRFFDHRGIDTIRILGAFLRNLQSNSLQGGSALTQQLIKLTYFSTSTSDQTISRKAQEAWLAIQLEQKATKQEILTYYINKVYMSNGNYGMQTAAQNYYGKDLNNLSLPQLALLAGMPQAPNQYDPYSHPEAAQDRRNLVLSEMKNQGYISAEQYEKAVNTPITDGLQSLKSASNYPAYMDNYLKEVINQVEEETGYNLLTTGMDVYTNVDQEAQKHLWDIYNTDEYVAYPDDELQVASTIVDVSNGKVIAQLGARHQSSNVSFGINQAVETNRDWGSTMKPITDYAPALEYGVYESTATIVHDEPYNYPGTNTPVYNWDRGYFGNITLQYALQQSRNVPAVETLNKVGLNRAKTFLNGLGIDYPSIHYSNAISSNTTESDKKYGASSEKMAAAYAAFANGGTYYKPMYIHKVVFSDGSEKEFSNVGTRAMKETTAYMMTDMMKTVLSYGTGRNAYLAWLPQAGKTGTSNYTDEEIENHIKTSQFVAPDELFAGYTRKYSMAVWTGYSNRLTPLVGNGLTVAAKVYRSMMTYLSEGSNPEDWNIPEGLYRNGEFVFKNGARSTWSSPAPQQPPSTESSSSSSDSSTSQSSSTTPSTNNSTTTNPNNNTQQSNTTPDQQNQNPQPAQP');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P30520', '2V40', 1, 1.9, 'A', 436, 'LIGASE', 'LIGASE', 'Adenylosuccinate synthetase isozyme 2', 'ADSS', 'GTP + IMP + L-aspartate = GDP + phosphate + N6-(1,2-dicarboxyethyl)-AMP<br />\n', 'adenylosuccinate synthase activity<br />\nGTP binding<br />\nmetal ion binding<br />\nphosphate ion binding<br />\n', '''de novo'' AMP biosynthetic process<br />\nAMP biosynthetic process<br />\naspartate metabolic process<br />\ncellular response to electrical stimulus<br />\nimmune system process<br />\nIMP metabolic process<br />\npurine ribonucleoside monophosphate biosynthetic process<br />\nresponse to ammonium ion<br />\nresponse to purine-containing compound<br />\n', 'PF00709.', 'MAFAETYPAASSLPNGDCGRPRARPGGNRVTVVLGAQWGDEGKGKVVDLLAQDADIVCRCQGGNNAGHTVVVDSVEYDFHLLPSGIINPNVTAFIGNGVVIHLPGLFEEAEKNVQKGKGLEGWEKRLIISDRAHIVFDFHQAADGIQEQQRQEQAGKNLGTTKKGIGPVYSSKAARSGLRMCDLVSDFDGFSERFKVLANQYKSIYPTLEIDIEGELQKLKGYMEKIKPMVRDGVYFLYEALHGPPKKILVEGANAALLDIDFGTYPFVTSSNCTVGGVCTGLGMPPQNVGEVYGVVKAYTTRVGIGAFPTEQDNEIGELLQTRGREFGVTTGRKRRCGWLDLVLLKYAHMINGFTALALTKLDILDMFTEIKVGVAYKLDGEIIPHIPANQEVLNKVEVQYKTLPGWNTDISNARAFKELPVNAQNYVRFIEDELQIPVKWIGVGKSRESMIQLF'),
('Q58L87', '2V57', 1, 1.9, 'A/B/C/D', 189, 'TRANSCRIPTION', 'TRANSCRIPTION', 'TetR family transcriptional regulator', 'lfrR', NULL, 'DNA binding', 'regulation of transcription, DNA-templated<br />\r\ntranscription, DNA-templated<br />', 'PF00440. ', 'MTSPSIESGARERTRRAILDAAMLVLADHPTAALGDIAAAAGVGRSTVHR\r\nYYPERTDLLRALARHVHDLSNAAIERADPTSGPVDAALRRVVESQLDLGP\r\nIVLFVYYEPSILADPELAAYFDIGDEAIVEVLNRASTERPEYPPGWARRV\r\nFWALMQAGYEAAKDGMPRHQIVDAIMTSLTSGIITLPRT'),
('P27338', '2V5Z', 1, 1.6, 'A/B', 519, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Amine oxidase [flavin-containing] B', 'MAOB', 'RCH2NHR'' + H2O + O2 = RCHO + R''NH2 + H2O2.<br />\n', 'electron carrier activity<br />\nflavin adenine dinucleotide binding<br />\nprimary amine oxidase activity<br />\nprotein homodimerization activity<br />\n', 'dopamine catabolic process<br />\nhydrogen peroxide biosynthetic process<br />\nnegative regulation of serotonin secretion<br />\nneurotransmitter catabolic process<br />\npositive regulation of dopamine metabolic process<br />\nresponse to aluminum ion<br />\nresponse to corticosterone<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to lipopolysaccharide<br />\nresponse to selenium ion<br />\nresponse to toxic substance<br />\nsubstantia nigra development<br />\n', 'PF01593.', 'MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV'),
('Q13555', '2V7O', 1, 2.25, 'A', 311, 'TRANSFERASE', 'TRANSFERASE', 'Calcium/calmodulin-dependent protein kinase type II subunit gamma', 'CAMK2G', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\ncalcium-dependent protein serine/threonine phosphatase activity<br />\ncalmodulin binding<br />\ncalmodulin-dependent protein kinase activity<br />\nidentical protein binding<br />\nprotein homodimerization activity<br />\nprotein serine/threonine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\n', 'calcium ion transport<br />\ncell differentiation<br />\nG1/S transition of mitotic cell cycle<br />\ninsulin secretion<br />\ninterferon-gamma-mediated signaling pathway<br />\nintracellular signal transduction<br />\nMAPK cascade<br />\nnervous system development<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\nprotein autophosphorylation<br />\nprotein oligomerization<br />\nregulation of calcium ion transport<br />\nregulation of cellular response to heat<br />\nregulation of relaxation of cardiac muscle<br />\nregulation of skeletal muscle adaptation<br />\n', 'PF08332.', 'MATTATCTRFTDDYQLFEELGKGAFSVVRRCVKKTSTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGAILTTMLVSRNFSAAKSLLNKKSDGGVKKRKSSSSVHLMPQSNNKNSLVSPAQEPAPLQTAMEPQTTVVHNATDGIKGSTESCNTTTEDEDLKARSPEGRSSRDRTAPSAGMQPQPSLCSSAMRKQEIIKITEQLIEAINNGDFEAYTKICDPGLTSFEPEALGNLVEGMDFHKFYFENLLSKNSKPIHTTILNPHVHVIGEDAACIAYIRLTQYIDGQGRPRTSQSEETRVWHRRDGKWLNVHYHCSGAPAAPLQ'),
('O43741', '2V8Q', 1, 2.1, 'B', 86, 'TRANSFERASE', 'TRANSFERASE', '5''-AMP-activated protein kinase subunit beta-2', 'PRKAB2', '', 'identical protein binding<br />\n', 'carnitine shuttle<br />\ncell cycle arrest<br />\nfatty acid biosynthetic process<br />\nmacroautophagy<br />\nprotein phosphorylation<br />\nregulation of fatty acid biosynthetic process<br />\nregulation of macroautophagy<br />\nregulation of signal transduction by p53 class mediator<br />\nsignal transduction<br />\n', 'PF16561.', 'MGNTTSDRVSGERHGAKAARSEGAGGHAPGKEHKIMVGSTDDPSVFSLPDSKLPGDKEFVSWQQDLEDSVKPTQQARPTVIRWSEGGKEVFISGSFNNWSTKIPLIKSHNDFVAILDLPEGEHQYKFFVDGQWVHDPSEPVVTSQLGTINNLIHVKKSDFEVFDALKLDSMESSETSCRDLSSSPPGPYGQEMYAFRSEERFKSPPILPPHLLQVILNKDTNISCDPALLPEPNHVMLNHLYALSIKDSVMVLSATHRYKKKYVTTLLYKPI'),
('Q13698', '2VAY', 0, 1.94, 'B', 21, 'METAL TRANSPORT', 'METAL_BINDING', 'Voltage-dependent L-type calcium channel subunit alpha-1S', 'CACNA1S', '', 'calmodulin binding<br />\nhigh voltage-gated calcium channel activity<br />\nmetal ion binding<br />\nvoltage-gated calcium channel activity<br />\n', 'calcium ion transport<br />\ncardiac conduction<br />\ncellular response to caffeine<br />\nmembrane depolarization during action potential<br />\nmuscle contraction<br />\n', 'PF08763.', 'MEPSSPQDEGLRKKQPKKPVPEILPRPPRALFCLTLENPLRKACISIVEWKPFETIILLTIFANCVALAVYLPMPEDDNNSLNLGLEKLEYFFLIVFSIEAAMKIIAYGFLFHQDAYLRSGWNVLDFTIVFLGVFTVILEQVNVIQSHTAPMSSKGAGLDVKALRAFRVLRPLRLVSGVPSLQVVLNSIFKAMLPLFHIALLVLFMVIIYAIIGLELFKGKMHKTCYFIGTDIVATVENEEPSPCARTGSGRRCTINGSECRGGWPGPNHGITHFDNFGFSMLTVYQCITMEGWTDVLYWVNDAIGNEWPWIYFVTLILLGSFFILNLVLGVLSGEFTKEREKAKSRGTFQKLREKQQLDEDLRGYMSWITQGEVMDVEDFREGKLSLDEGGSDTESLYEIAGLNKIIQFIRHWRQWNRIFRWKCHDIVKSKVFYWLVILIVALNTLSIASEHHNQPLWLTRLQDIANRVLLSLFTTEMLMKMYGLGLRQYFMSIFNRFDCFVVCSGILEILLVESGAMTPLGISVLRCIRLLRIFKITKYWTSLSNLVASLLNSIRSIASLLLLLFLFIVIFALLGMQLFGGRYDFEDTEVRRSNFDNFPQALISVFQVLTGEDWTSMMYNGIMAYGGPSYPGMLVCIYFIILFVCGNYILLNVFLAIAVDNLAEAESLTSAQKAKAEEKKRRKMSKGLPDKSEEEKSTMAKKLEQKPKGEGIPTTAKLKIDEFESNVNEVKDPYPSADFPGDDEEDEPEIPLSPRPRPLAELQLKEKAVPIPEASSFFIFSPTNKIRVLCHRIVNATWFTNFILLFILLSSAALAAEDPIRADSMRNQILKHFDIGFTSVFTVEIVLKMTTYGAFLHKGSFCRNYFNMLDLLVVAVSLISMGLESSAISVVKILRVLRVLRPLRAINRAKGLKHVVQCMFVAISTIGNIVLVTTLLQFMFACIGVQLFKGKFFRCTDLSKMTEEECRGYYYVYKDGDPMQIELRHREWVHSDFHFDNVLSAMMSLFTVSTFEGWPQLLYKAIDSNAEDVGPIYNNRVEMAIFFIIYIILIAFFMMNIFVGFVIVTFQEQGETEYKNCELDKNQRQCVQYALKARPLRCYIPKNPYQYQVWYIVTSSYFEYLMFALIMLNTICLGMQHYNQSEQMNHISDILNVAFTIIFTLEMILKLMAFKARGYFGDPWNVFDFLIVIGSIIDVILSEIDTFLASSGGLYCLGGGCGNVDPDESARISSAFFRLFRVMRLIKLLSRAEGVRTLLWTFIKSFQALPYVALLIVMLFFIYAVIGMQMFGKIALVDGTQINRNNNFQTFPQAVLLLFRCATGEAWQEILLACSYGKLCDPESDYAPGEEYTCGTNFAYYYFISFYMLCAFLVINLFVAVIMDNFDYLTRDWSILGPHHLDEFKAIWAEYDPEAKGRIKHLDVVTLLRRIQPPLGFGKFCPHRVACKRLVGMNMPLNSDGTVTFNATLFALVRTALKIKTEGNFEQANEELRAIIKKIWKRTSMKLLDQVIPPIGDDEVTVGKFYATFLIQEHFRKFMKRQEEYYGYRPKKDIVQIQAGLRTIEEEAAPEICRTVSGDLAAEEELERAMVEAAMEEGIFRRTGGLFGQVDNFLERTNSLPPVMANQRPLQFAEIEMEEMESPVFLEDFPQDPRTNPLARANTNNANANVAYGNSNHSNSHVFSSVHYEREFPEETETPATRGRALGQPCRVLGPHSKPCVEMLKGLLTQRAMPRGQAPPAPCQCPRVESSMPEDRKSSTPGSLHEETPHSRSTRENTSRCSAPATALLIQKALVRGGLGTLAADANFIMATGQALADACQMEPEEVEIMATELLKGREAPEGMASSLGCLNLGSSLGSLDQHQGSQETLIPPRL'),
('P0A953', '2VBA', 1, 1.36, 'A/B/C/D', 406, 'TRANSFERASE', 'TRANSFERASE', '3-oxoacyl-[acyl-carrier-protein] synthase 1', 'fabB', 'Acyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = 3-oxoacyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein].<br />\n', '3-oxoacyl-[acyl-carrier-protein] synthase activity<br />\n', 'fatty acid biosynthetic process<br />\nlipid biosynthetic process<br />\n', 'PF00109.', 'MKRAVITGLGIVSSIGNNQQEVLASLREGRSGITFSQELKDSGMRSHVWGNVKLDTTGLIDRKVVRFMSDASIYAFLSMEQAIADAGLSPEAYQNNPRVGLIAGSGGGSPRFQVFGADAMRGPRGLKAVGPYVVTKAMASGVSACLATPFKIHGVNYSISSACATSAHCIGNAVEQIQLGKQDIVFAGGGEELCWEMACEFDAMGALSTKYNDTPEKASRTYDAHRDGFVIAGGGGMVVVEELEHALARGAHIYAEIVGYGATSDGADMVAPSGEGAVRCMKMAMHGVDTPIDYLNSHGTSTPVGDVKELAAIREVFGDKSPAISATKAMTGHSLGAAGVQEAIYSLLMLEHGFIAPSINIEELDEQAAGLNIVTETTDRELTTVMSNSFGFGGTNATLVMRKLKD'),
('P09210', '2VCT', 1, 2.1, 'A/B/C/D/E/F/G/H', 222, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase A2', 'GSTA2', 'RX + glutathione = HX + R-S-glutathione.<br />\n', 'glutathione transferase activity<br />\n', 'epithelial cell differentiation<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\ninterleukin-12-mediated signaling pathway<br />\n', 'PF14497.', 'MAEKPKLHYSNIRGRMESIRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKEKALIDMYIEGIADLGEMILLLPFSQPEEQDAKLALIQEKTKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPLLKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEESRKIFRF'),
('Q16772', '2VCV', 1, 1.8, 'A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P', 222, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase A3', 'GSTA3', 'RX + glutathione = HX + R-S-glutathione.<br />\n', 'glutathione transferase activity<br />\n', 'glutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\n', 'PF14497.', 'MAGKPKLHYFNGRGRMEPIRWLLAAAGVEFEEKFIGSAEDLGKLRNDGSLMFQQVPMVEIDGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYTEGMADLNEMILLLPLCRPEEKDAKIALIKEKTKSRYFPAFEKVLQSHGQDYLVGNKLSRADISLVELLYYVEELDSSLISNFPLLKALKTRISNLPTVKKFLQPGSPRKPPADAKALEEARKIFRF'),
('Q51911', '2VDB', 1, 2.52, 'B', 53, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Peptostreptococcal albumin-binding protein', 'pab', '', '', 'pathogenesis<br />\n', 'PF17573.', 'MKLNKKLLMAALAGAIVVGGGVNTFAADEPGAIKVDKAPEAPSQELKLTKEEAEKALKKEKPIAKERLRRLGITSEFILNQIDKATSREGLESLVQTIKQSYLKDHPIKEEKTEETPKYNNLFDKHELGGLGKDKGPGRFDENGWENNEHGYETRENAEKAAVKALGDKEINKSYTISQGVDGRYYYVLSREEAETPKKPEEKKPEDKRPKMTIDQWLLKNAKEDAIAELKKAGITSDFYFNAINKAKTVEEVNALKNEILKAHAGKEVNPSTPEVTPSVPQNHYHENDYANIGAGEGTKEDGKKENSKEGIKRKTAREEKPGKEEKPAKEDKKENKKKENTDSPNKKKKEKAALPEAGRRKAEILTLAAASLSSVAGAFISLKKRK'),
('P16219', '2VIG', 1, 1.9, 'A/B/C/D/E/F/G/H', 383, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Short-chain specific acyl-CoA dehydrogenase, mitochondrial', 'ACADS', 'A short-chain acyl-CoA + electron-transfer flavoprotein = a short-chain trans-2,3-dehydroacyl-CoA + reduced electron-transfer flavoprotein<br />\n', 'acyl-CoA dehydrogenase activity<br />\nbutyryl-CoA dehydrogenase activity<br />\nflavin adenine dinucleotide binding<br />\n', 'fatty acid beta-oxidation<br />\nfatty acid beta-oxidation using acyl-CoA dehydrogenase<br />\n', 'PF00441.', 'MAAALLARASGPARRALCPRAWRQLHTIYQSVELPETHQMLLQTCRDFAEKELFPIAAQVDKEHLFPAAQVKKMGGLGLLAMDVPEELGGAGLDYLAYAIAMEEISRGCASTGVIMSVNNSLYLGPILKFGSKEQKQAWVTPFTSGDKIGCFALSEPGNGSDAGAASTTARAEGDSWVLNGTKAWITNAWEASAAVVFASTDRALQNKGISAFLVPMPTPGLTLGKKEDKLGIRGSSTANLIFEDCRIPKDSILGEPGMGFKIAMQTLDMGRIGIASQALGIAQTALDCAVNYAENRMAFGAPLTKLQVIQFKLADMALALESARLLTWRAAMLKDNKKPFIKEAAMAKLAASEAATAISHQAIQILGGMGYVTEMPAERHYRDARITEIYEGTSEIQRLVIAGHLLRSYRS'),
('P17812', '2VO1', 0, 2.8, 'A/B', 273, 'LIGASE', 'LIGASE', 'CTP synthase 1', 'CTPS1', 'ATP + UTP + L-glutamine = ADP + phosphate + CTP + L-glutamate<br />\n', 'ATP binding<br />\nCTP synthase activity<br />\nidentical protein binding<br />\n', '''de novo'' CTP biosynthetic process<br />\nB cell proliferation<br />\nCTP biosynthetic process<br />\nglutamine metabolic process<br />\nnucleobase-containing compound metabolic process<br />\nnucleobase-containing small molecule interconversion<br />\nresponse to drug<br />\nT cell proliferation<br />\n', 'PF06418.', 'MKYILVTGGVISGIGKGIIASSVGTILKSCGLHVTSIKIDPYINIDAGTFSPYEHGEVFVLDDGGEVDLDLGNYERFLDIRLTKDNNLTTGKIYQYVINKERKGDYLGKTVQVVPHITDAIQEWVMRQALIPVDEDGLEPQVCVIELGGTVGDIESMPFIEAFRQFQFKVKRENFCNIHVSLVPQPSSTGEQKTKPTQNSVRELRGLGLSPDLVVCRCSNPLDTSVKEKISMFCHVEPEQVICVHDVSSIYRVPLLLEEQGVVDYFLRRLDLPIERQPRKMLMKWKEMADRYDRLLETCSIALVGKYTKFSDSYASVIKALEHSALAINHKLEIKYIDSADLEPITSQEEPVRYHEAWQKLCSAHGVLVPGGFGVRGTEGKIQAIAWARNQKKPFLGVCLGMQLAVVEFSRNVLGWQDANSTEFDPTTSHPVVVDMPEHNPGQMGGTMRLGKRRTLFQTKNSVMRKLYGDADYLEERHRHRFEVNPVWKKCLEEQGLKFVGQDVEGERMEIVELEDHPFFVGVQYHPEFLSRPIKPSPPYFGLLLASVGRLSHYLQKGCRLSPRDTYSDRSGSSSPDSEITELKFPSINHD'),
('Q5SHN7', '2VQE', 1, 2.5, 'J', 105, 'RIBOSOME', 'OTHERS', '30S ribosomal protein S10', 'rpsJ', '', 'rRNA binding<br />\nstructural constituent of ribosome<br />\n', 'translation<br />\n', 'PF00338.', 'MPKIRIKLRGFDHKTLDASAQKIVEAARRSGAQVSGPIPLPTRVRRFTVIRGPFKHKDSREHFELRTHNRLVDIINPNRKTIEQLMTLDLPTGVEIEIKTVGGGR'),
('P56524', '2VQM', 1, 1.8, 'A', 410, 'HYDROLASE', 'HYDROLASE', 'Histone deacetylase 4', 'HDAC4', 'Hydrolysis of an N6-acetyl-lysine residue of a histone to yield a deacetylated histone.<br />\n', 'activating transcription factor binding<br />\nchromatin binding<br />\ncore promoter binding<br />\nhistone deacetylase activity<br />\nhistone deacetylase binding<br />\nidentical protein binding<br />\nNAD-dependent histone deacetylase activity (H3-K14 specific)<br />\npotassium ion binding<br />\nprotein deacetylase activity<br />\nprotein kinase binding<br />\nrepressing transcription factor binding<br />\nRNA polymerase III transcription factor binding<br />\ntranscription corepressor activity<br />\ntranscription factor binding<br />\nzinc ion binding<br />\n', 'B cell activation<br />\nB cell differentiation<br />\ncardiac muscle hypertrophy in response to stress<br />\ncellular response to mechanical stimulus<br />\ncellular response to parathyroid hormone stimulus<br />\ncellular response to tumor necrosis factor<br />\nchromatin remodeling<br />\nhistone deacetylation<br />\nhistone H3 deacetylation<br />\nhistone H4 deacetylation<br />\ninflammatory response<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of glycolytic process<br />\nnegative regulation of myotube differentiation<br />\nnegative regulation of osteoblast differentiation<br />\nnegative regulation of pri-miRNA transcription from RNA polymerase II promoter<br />\nnegative regulation of sequence-specific DNA binding transcription factor activity<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnervous system development<br />\nosteoblast development<br />\npeptidyl-lysine deacetylation<br />\npositive regulation of cell proliferation<br />\npositive regulation of lamellipodium assembly<br />\npositive regulation of neuron apoptotic process<br />\npositive regulation of protein sumoylation<br />\npositive regulation of reactive oxygen species biosynthetic process<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of smooth muscle cell migration<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein deacetylation<br />\nregulation of cardiac muscle contraction by calcium ion signaling<br />\nregulation of gene expression, epigenetic<br />\nregulation of protein binding<br />\nregulation of skeletal muscle fiber development<br />\nresponse to denervation involved in regulation of muscle adaptation<br />\nresponse to drug<br />\nresponse to interleukin-1<br />\nskeletal system development<br />\ntranscription, DNA-templated<br />\n', 'PF12203.', 'MSSQSHPDGLSGRDQPVELLNPARVNHMPSTVDVATALPLQVAPSAVPMDLRLDHQFSLPVAEPALREQQLQQELLALKQKQQIQRQILIAEFQRQHEQLSRQHEAQLHEHIKQQQEMLAMKHQQELLEHQRKLERHRQEQELEKQHREQKLQQLKNKEKGKESAVASTEVKMKLQEFVLNKKKALAHRNLNHCISSDPRYWYGKTQHSSLDQSSPPQSGVSTSYNHPVLGMYDAKDDFPLRKTASEPNLKLRSRLKQKVAERRSSPLLRRKDGPVVTALKKRPLDVTDSACSSAPGSGPSSPNNSSGSVSAENGIAPAVPSIPAETSLAHRLVAREGSAAPLPLYTSPSLPNITLGLPATGPSAGTAGQQDAERLTLPALQQRLSLFPGTHLTPYLSTSPLERDGGAAHSPLLQHMVLLEQPPAQAPLVTGLGALPLHAQSLVGADRVSPSIHKLRQHRPLGRTQSAPLPQNAQALQHLVIQQQHQQFLEKHKQQFQQQQLQMNKIIPKPSEPARQPESHPEETEEELREHQALLDEPYLDRLPGQKEAHAQAGVQVKQEPIESDEEEAEPPREVEPGQRQPSEQELLFRQQALLLEQQRIHQLRNYQASMEAAGIPVSFGGHRPLSRAQSSPASATFPVSVQEPPTKPRFTTGLVYDTLMLKHQCTCGSSSSHPEHAGRIQSIWSRLQETGLRGKCECIRGRKATLEELQTVHSEAHTLLYGTNPLNRQKLDSKKLLGSLASVFVRLPCGGVGVDSDTIWNEVHSAGAARLAVGCVVELVFKVATGELKNGFAVVRPPGHHAEESTPMGFCYFNSVAVAAKLLQQRLSVSKILIVDWDVHHGNGTQQAFYSDPSVLYMSLHRYDDGNFFPGSGAPDEVGTGPGVGFNVNMAFTGGLDPPMGDAEYLAAFRTVVMPIASEFAPDVVLVSSGFDAVEGHPTPLGGYNLSARCFGYLTKQLMGLAGGRIVLALEGGHDLTAICDASEACVSALLGNELDPLPEKVLQQRPNANAVRSMEKVMEIHSKYWRCLQRTTSTAGRSLIEAQTCENEEAETVTAMASLSVGVKPAEKRPDEEPMEEEPPL'),
('P35219', '2W2J', 0, 1.6, 'A', 290, 'LYASE', 'LYASE', 'Carbonic anhydrase-related protein', 'CA8', '', 'carbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'one-carbon metabolic process<br />\nphosphatidylinositol-mediated signaling<br />\n', 'PF00194.', 'MADLSFIEDTVAFPEKEEDEEEEEEGVEWGYEEGVEWGLVFPDANGEYQSPINLNSREARYDPSLLDVRLSPNYVVCRDCEVTNDGHTIQVILKSKSVLSGGPLPQGHEFELYEVRFHWGRENQRGSEHTVNFKAFPMELHLIHWNSTLFGSIDEAVGKPHGIAIIALFVQIGKEHVGLKAVTEILQDIQYKGKSKTIPCFNPNTLLPDPLLRDYWVYEGSLTIPPCSEGVTWILFRYPLTISQLQIEEFRRLRTHVKGAELVEGCDGILGDNFRPTQPLSDRVIRAAFQ'),
('P51649', '2W8Q', 1, 2.4, 'A', 487, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Succinate-semialdehyde dehydrogenase, mitochondrial', 'ALDH5A1', 'Succinate semialdehyde + NAD+ + H2O = succinate + NADH.<br />\n', 'NAD binding<br />\nprotein homodimerization activity<br />\nsuccinate-semialdehyde dehydrogenase (NAD+) activity<br />\nsuccinate-semialdehyde dehydrogenase [NAD(P)+] activity<br />\n', 'acetate metabolic process<br />\ncentral nervous system development<br />\ngalactosylceramide metabolic process<br />\ngamma-aminobutyric acid catabolic process<br />\nglucose metabolic process<br />\nglucosylceramide metabolic process<br />\nglutamate decarboxylation to succinate<br />\nglutamate metabolic process<br />\nglutamine metabolic process<br />\nglutathione metabolic process<br />\nglycerophospholipid metabolic process<br />\nneurotransmitter catabolic process<br />\npost-embryonic development<br />\nprotein homotetramerization<br />\nrespiratory electron transport chain<br />\nshort-chain fatty acid metabolic process<br />\nsuccinate metabolic process<br />\n', 'PF00171.', 'MATCIWLRSCGARRLGSTFPGCRLRPRAGGLVPASGPAPGPAQLRCYAGRLAGLSAALLRTDSFVGGRWLPAAATFPVQDPASGAALGMVADCGVREARAAVRAAYEAFCRWREVSAKERSSLLRKWYNLMIQNKDDLARIITAESGKPLKEAHGEILYSAFFLEWFSEEARRVYGDIIHTPAKDRRALVLKQPIGVAAVITPWNFPSAMITRKVGAALAAGCTVVVKPAEDTPFSALALAELASQAGIPSGVYNVIPCSRKNAKEVGEAICTDPLVSKISFTGSTTTGKILLHHAANSVKRVSMELGGLAPFIVFDSANVDQAVAGAMASKFRNTGQTCVCSNQFLVQRGIHDAFVKAFAEAMKKNLRVGNGFEEGTTQGPLINEKAVEKVEKQVNDAVSKGATVVTGGKRHQLGKNFFEPTLLCNVTQDMLCTHEETFGPLAPVIKFDTEEEAIAIANAADVGLAGYFYSQDPAQIWRVAEQLEVGMVGVNEGLISSVECPFGGVKQSGLGREGSKYGIDEYLELKYVCYGGL'),
('P11802', '2W96', 0, 2.3, 'B', 303, 'CELL CYCLE', 'OTHERS', 'Cyclin-dependent kinase 4', 'CDK4', 'ATP + a protein = ADP + a phosphoprotein<br />\n', 'ATP binding<br />\ncyclin binding<br />\ncyclin-dependent protein serine/threonine kinase activity<br />\ncyclin-dependent protein serine/threonine kinase regulator activity<br />\nprotein complex binding<br />\n', 'adipose tissue development<br />\nanimal organ regeneration<br />\ncell division<br />\ncellular response to insulin stimulus<br />\ncellular response to interleukin-4<br />\ncellular response to ionomycin<br />\ncellular response to lipopolysaccharide<br />\ncellular response to phorbol 13-acetate 12-myristate<br />\ncircadian rhythm<br />\nG1/S transition of mitotic cell cycle<br />\nlens development in camera-type eye<br />\nmulticellular organism development<br />\nnegative regulation of cell cycle arrest<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell cycle<br />\npositive regulation of cell proliferation<br />\npositive regulation of cell size<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of G2/M transition of mitotic cell cycle<br />\npositive regulation of translation<br />\nprotein phosphorylation<br />\nregulation of gene expression<br />\nregulation of insulin receptor signaling pathway<br />\nregulation of lipid biosynthetic process<br />\nregulation of lipid catabolic process<br />\nregulation of multicellular organism growth<br />\nresponse to drug<br />\nresponse to hyperoxia<br />\nresponse to lead ion<br />\nresponse to organic substance<br />\nresponse to testosterone<br />\nresponse to toxic substance<br />\nsignal transduction<br />\n', 'PF00069.', 'MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE'),
('P24385', '2W96', 0, 2.3, 'A', 271, 'CELL CYCLE', 'OTHERS', 'G1/S-specific cyclin-D1', 'CCND1', '', 'cyclin-dependent protein serine/threonine kinase activity<br />\ncyclin-dependent protein serine/threonine kinase regulator activity<br />\nenzyme binding<br />\nhistone deacetylase binding<br />\nproline-rich region binding<br />\nprotein complex binding<br />\nprotein kinase binding<br />\ntranscription corepressor activity<br />\ntranscription factor binding<br />\n', 'canonical Wnt signaling pathway<br />\ncell division<br />\ncellular response to DNA damage stimulus<br />\nendoplasmic reticulum unfolded protein response<br />\nfat cell differentiation<br />\nG1/S transition of mitotic cell cycle<br />\nlactation<br />\nLeydig cell differentiation<br />\nliver regeneration<br />\nmammary gland alveolus development<br />\nmammary gland epithelial cell proliferation<br />\nmitotic G1 DNA damage checkpoint<br />\nnegative regulation of cell cycle arrest<br />\nnegative regulation of epithelial cell differentiation<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of Wnt signaling pathway<br />\npositive regulation of cell cycle<br />\npositive regulation of cyclin-dependent protein serine/threonine kinase activity<br />\npositive regulation of G2/M transition of mitotic cell cycle<br />\npositive regulation of mammary gland epithelial cell proliferation<br />\npositive regulation of protein phosphorylation<br />\nre-entry into mitotic cell cycle<br />\nresponse to calcium ion<br />\nresponse to corticosterone<br />\nresponse to drug<br />\nresponse to estradiol<br />\nresponse to estrogen<br />\nresponse to ethanol<br />\nresponse to iron ion<br />\nresponse to leptin<br />\nresponse to magnesium ion<br />\nresponse to organonitrogen compound<br />\nresponse to UV-A<br />\nresponse to vitamin E<br />\nresponse to X-ray<br />\ntranscription, DNA-templated<br />\n', 'PF02984.', 'MEHQLLCCEVETIRRAYPDANLLNDRVLRAMLKAEETCAPSVSYFKCVQKEVLPSMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVKKSRLQLLGATCMFVASKMKETIPLTAEKLCIYTDNSIRPEELLQMELLLVNKLKWNLAAMTPHDFIEHFLSKMPEAEENKQIIRKHAQTFVALCATDVKFISNPPSMVAAGSVVAAVQGLNLRSPNNFLSYYRLTRFLSRVIKCDPDCLRACQEQIEALLESSLRQAQQNMDPKAAEEEEEEEEEVDLACTPTDVRDVDI'),
('P0A3M6', '2WAD', 0, 2.18, 'A/B/C', 680, 'PEPTIDE BINDING PROTEIN', 'OTHERS', 'Penicillin-binding protein 2B', 'penA', '', 'penicillin binding<br />\n', 'cell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nresponse to antibiotic<br />\n', 'PF03717.', 'MRKFNSHSIPIRLNLLFSIVILLFMTIIGRLLYMQVLNKDFYEKKLASASQTKITSSSARGEIYDASGKPLVENTLKQVVSFTRSNKMTATDLKETAKKLLTYVSISSPNLTERQLADYYLADPEIYKKIVEALPSEKRLDSDGNRLSESELYNNAVDSVQTSQLNYTEDEKKEIYLFSQLNAVGNFATGTIATDPLNDSQVAVIASISKEMPGISISTSWDRKVLETSLSSIVGSVSSEKAGLPAEEAEAYLKKGYSLNDRVGTSYLEKQYEETLQGKRSVKEIHLDKYGNMESVDTIEEGSKGNNIKLTIDLAFQDSVDALLKSYFNSELENGGAKYSEGVYAVALNPKTGAVLSMSGIKHDLKTGELTPDSLGTVTNVFVPGSVVKAATISSGWENGVLSGNQTLTDQSIVFQGSAPINSWYTQAYGSFPITAVQALEYSSNTYMVQTALGLMGQTYQPNMFVGTSNLESAMEKLRSTFGEYGLGTATGIDLPDESTGFVPKEYSFANYITNAFGQFDNYTPMQLAQYVATIANNGVRVAPRIVEGIYGNNDKGGLGDLIQQLQPTEMNKVNISDSDMSILHQGFYQVAHGTSGLTTGRAFSNGALVSISGKTGTAESYVADGQQATNTNAVAYAPSDNPQIAVAVVFPHNTNLTNGVGPSIARDIINLYQKYHPMN'),
('P80511', '2WCB', 0, 1.73, 'A/B', 91, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Protein S100-A12', 'S100A12', '', 'calcium ion binding<br />\ncopper ion binding<br />\nRAGE receptor binding<br />\nzinc ion binding<br />\n', 'antimicrobial humoral immune response mediated by antimicrobial peptide<br />\ncytokine secretion<br />\ndefense response to bacterium<br />\ndefense response to fungus<br />\ninflammatory response<br />\ninnate immune response<br />\nkilling of cells of other organism<br />\nmast cell activation<br />\nmonocyte chemotaxis<br />\nneutrophil chemotaxis<br />\nneutrophil degranulation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of inflammatory response<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of NF-kappaB transcription factor activity<br />\nxenobiotic metabolic process<br />\n', 'PF01023.', 'MTKLEEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFISLVAIALKAAHYHTHKE'),
('P23921', '2WGH', 1, 2.3, 'A/B', 668, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Ribonucleoside-diphosphate reductase large subunit', 'RRM1', '2''-deoxyribonucleoside diphosphate + thioredoxin disulfide + H2O = ribonucleoside diphosphate + thioredoxin<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor<br />\n', 'deoxyribonucleotide biosynthetic process<br />\nDNA replication<br />\nnucleobase-containing small molecule interconversion<br />\n', 'PF03477.', 'MHVIKRDGRQERVMFDKITSRIQKLCYGLNMDFVDPAQITMKVIQGLYSGVTTVELDTLAAETAATLTTKHPDYAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTRPAANPIQFTLNKEKLKDKEKVSKEEEEKERNTAAMVCSLENRDECLMCGS'),
('Q16832', '2WUH', 0, 1.6, 'A', 165, 'RECEPTOR / PEPTIDE', 'OTHERS', 'Discoidin domain-containing receptor 2', 'DDR2', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncollagen binding<br />\nprotein tyrosine kinase collagen receptor activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\n', 'biomineral tissue development<br />\ncell adhesion<br />\nchondrocyte proliferation<br />\ncollagen-activated tyrosine kinase receptor signaling pathway<br />\ncollagen fibril organization<br />\nendochondral bone growth<br />\nextracellular matrix organization<br />\nossification<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of extracellular matrix disassembly<br />\npositive regulation of fibroblast migration<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of osteoblast differentiation<br />\npositive regulation of protein kinase activity<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\nprotein autophosphorylation<br />\nregulation of bone mineralization<br />\nregulation of extracellular matrix disassembly<br />\nsignal transduction<br />\n', 'PF00754.', 'MILIPRMLLVLFLLLPILSSAKAQVNPAICRYPLGMSGGQIPDEDITASSQWSESTAAKYGRLDSEEGDGAWCPEIPVEPDDLKEFLQIDLHTLHFITLVGTQGRHAGGHGIEFAPMYKINYSRDGTRWISWRNRHGKQVLDGNSNPYDIFLKDLEPPIVARFVRFIPVTDHSMNVCMRVELYGCVWLDGLVSYNAPAGQQFVLPGGSIIYLNDSVYDGAVGYSMTEGLGQLTDGVSGLDDFTQTHEYHVWPGYDYVGWRNESATNGYIEIMFEFDRIRNFTTMKVHCNNMFAKGVKIFKEVQCYFRSEASEWEPNAISFPLVLDDVNPSARFVTVPLHHRMASAIKCQYHFADTWMMFSEITFQSDAAMYNNSEALPTSPMAPTTYDPMLKVDDSNTRILIGCLVAIIFILLAIIVIILWRQFWQKMLEKASRRMLDDEMTVSLSLPSDSSMFNNNRSSSPSEQGSNSTYDRIFPLRPDYQEPSRLIRKLPEFAPGEEESGCSGVVKPVQPSGPEGVPHYAEADIVNLQGVTGGNTYSVPAVTMDLLSGKDVAVEEFPRKLLTFKEKLGEGQFGEVHLCEVEGMEKFKDKDFALDVSANQPVLVAVKMLRADANKNARNDFLKEIKIMSRLKDPNIIHLLAVCITDDPLCMITEYMENGDLNQFLSRHEPPNSSSSDVRTVSYTNLKFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKLMLSCWRRDTKNRPSFQEIHLLLLQQGDE'),
('P78362', '2X7G', 1, 2.5, 'A', 638, 'TRANSFERASE', 'TRANSFERASE', 'SRSF protein kinase 2', 'SRPK2', 'ATP + a protein = ADP + a phosphoprotein<br />\n', '14-3-3 protein binding<br />\nATP binding<br />\nmagnesium ion binding<br />\nprotein serine/threonine kinase activity<br />\nRNA binding<br />\n', 'angiogenesis<br />\ncell differentiation<br />\ninnate immune response<br />\nintracellular signal transduction<br />\nnegative regulation of viral genome replication<br />\nnuclear speck organization<br />\npositive regulation of cell cycle<br />\npositive regulation of cell proliferation<br />\npositive regulation of gene expression<br />\npositive regulation of neuron apoptotic process<br />\npositive regulation of viral genome replication<br />\nprotein phosphorylation<br />\nregulation of mRNA splicing, via spliceosome<br />\nRNA splicing<br />\nspliceosomal complex assembly<br />\n', 'PF00069.', 'MSVNSEKSSSSERPEPQQKAPLVPPPPPPPPPPPPPLPDPTPPEPEEEILGSDDEEQEDPADYCKGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPQQKPIGKISKNKKKKLKKKQKRQAELLEKRLQEIEELEREAERKIIEENITSAAPSNDQDGEYCPEVKLKTTGLEEAAEAETAKDNGEAEDQEEKEDAEKENIEKDEDDVDQELANIDPTWIESPKTNGHIENGPFSLEQQLDDEDDDEEDCPNPEEYNLDEPNAESDYTYSSSYEQFNGELPNGRHKIPESQFPEFSTSLFSGSLEPVACGSVLSEGSPLTEQEESSPSHDRSRTVSASSTGDLPKAKTRAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLNS'),
('P35968', '2XIR', 1, 1.5, 'A', 366, 'TRANSFERASE', 'TRANSFERASE', 'Vascular endothelial growth factor receptor 2', 'KDR', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ngrowth factor binding<br />\nHsp90 protein binding<br />\nidentical protein binding<br />\nintegrin binding<br />\nprotein tyrosine kinase activity<br />\nsignal transducer, downstream of receptor, with protein tyrosine kinase activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\nvascular endothelial growth factor-activated receptor activity<br />\nvascular endothelial growth factor binding<br />\n', 'angiogenesis<br />\ncalcium-mediated signaling using intracellular calcium source<br />\ncell migration involved in sprouting angiogenesis<br />\ncellular response to vascular endothelial growth factor stimulus<br />\nembryonic hemopoiesis<br />\nendothelium development<br />\nERK1 and ERK2 cascade<br />\nextracellular matrix organization<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of endothelial cell apoptotic process<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of angiogenesis<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of focal adhesion assembly<br />\npositive regulation of macroautophagy<br />\npositive regulation of MAPK cascade<br />\npositive regulation of mitochondrial depolarization<br />\npositive regulation of mitochondrial fission<br />\npositive regulation of nitric-oxide synthase biosynthetic process<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of positive chemotaxis<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of vasculogenesis<br />\nprotein autophosphorylation<br />\nprotein kinase B signaling<br />\nregulation of cell shape<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nvasculogenesis<br />\nviral process<br />\n', 'PF07679.', 'MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV'),
('P05893', '2XS1', 0, 2.3, 'B', 20, 'PROTEIN TRANSPORT / VIRAL PROTEIN', 'PROTEIN_BINDING', 'Gag polyprotein', 'gag', '', 'RNA binding<br />\nstructural molecule activity<br />\nzinc ion binding<br />\n', 'viral budding via host ESCRT complex<br />\nviral release from host cell<br />\n', 'PF00540.', 'MGARNAVLSGKKADELEKIRLRPGGKKKYMLKHVVWAANELDRFGLAESLLENKEGCQKILSVLAPLVPTGSENLKSLYNTVCVIWCIHAEEKVKHTEEAKQIVQRHLVVETGTAETMPKTSRPTAPSSGRGGNYPVQQIGGNYVHLPLSPRTLNAWVKLIEEKKFGAEVVPGFQALSEGCTPYDINQMLNCVGDHQAAMQIIRDIINEEAADWDLQHPQPAPQQGQLREPSGSDIAGTTSSVDEQIQWMYRQQNPIPVGNIYRRWIQLRLQKCVRMYNPINILDVKQRPKEPFQSYVDRFYKSLRAEQTDAAVKNWMTQTLLIQNANPDCKLVLKGLGVNPTLEEMLTACQGVGGPGQKARLMAEALKEALRPVPTPFAAAQQRGPRKPIKCWNCGKEGHSARQCRAPRRQRCWKCGKMDHVMAKCPDRQAGFLGLGPWGKKPRNFPMAQVHQGLTPTAPPEDPAVDLLKNYMQLGKQQRESREKPYKEVTEDLLHLNSLFGGDQ'),
('P07101', '2XSN', 0, 2.68, 'A/B/C/D', 336, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Tyrosine 3-monooxygenase', 'TH', 'L-tyrosine + tetrahydrobiopterin + O2 = L-dopa + 4a-hydroxytetrahydrobiopterin.<br />\n', 'amino acid binding<br />\ndopamine binding<br />\nenzyme binding<br />\nferric iron binding<br />\nferrous iron binding<br />\noxygen binding<br />\nprotein domain specific binding<br />\ntetrahydrobiopterin binding<br />\ntyrosine 3-monooxygenase activity<br />\n', 'aminergic neurotransmitter loading into synaptic vesicle<br />\nanatomical structure morphogenesis<br />\nanimal organ morphogenesis<br />\ncatecholamine biosynthetic process<br />\ncellular response to alkaloid<br />\ncellular response to drug<br />\ncellular response to glucose stimulus<br />\ncellular response to growth factor stimulus<br />\ncellular response to manganese ion<br />\ncellular response to nicotine<br />\ncerebral cortex development<br />\ncircadian sleep/wake cycle<br />\ndopamine biosynthetic process<br />\ndopamine biosynthetic process from tyrosine<br />\neating behavior<br />\nembryonic camera-type eye morphogenesis<br />\nepinephrine biosynthetic process<br />\neye photoreceptor cell development<br />\nfatty acid metabolic process<br />\nglycoside metabolic process<br />\nheart development<br />\nheart morphogenesis<br />\nisoquinoline alkaloid metabolic process<br />\nlearning<br />\nlocomotory behavior<br />\nmating behavior<br />\nmemory<br />\nmulticellular organism aging<br />\nneurotransmitter biosynthetic process<br />\nnorepinephrine biosynthetic process<br />\nphthalate metabolic process<br />\nphytoalexin metabolic process<br />\npigmentation<br />\nregulation of heart contraction<br />\nresponse to activity<br />\nresponse to amphetamine<br />\nresponse to corticosterone<br />\nresponse to electrical stimulus<br />\nresponse to estradiol<br />\nresponse to ethanol<br />\nresponse to ether<br />\nresponse to herbicide<br />\nresponse to hypoxia<br />\nresponse to immobilization stress<br />\nresponse to isolation stress<br />\nresponse to light stimulus<br />\nresponse to lipopolysaccharide<br />\nresponse to nutrient levels<br />\nresponse to peptide hormone<br />\nresponse to pyrethroid<br />\nresponse to salt stress<br />\nresponse to water deprivation<br />\nresponse to zinc ion<br />\nsensory perception of sound<br />\nsocial behavior<br />\nsphingolipid metabolic process<br />\nsynaptic transmission, dopaminergic<br />\nterpene metabolic process<br />\nvisual perception<br />\n', 'PF00351.', 'MPTPDATTPQAKGFRRAVSELDAKQAEAIMVRGQGAPGPSLTGSPWPGTAAPAASYTPTPRSPRFIGRRQSLIEDARKEREAAVAAAAAAVPSEPGDPLEAVAFEEKEGKAVLNLLFSPRATKPSALSRAVKVFETFEAKIHHLETRPAQRPRAGGPHLEYFVRLEVRRGDLAALLSGVRQVSEDVRSPAGPKVPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEIAFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNIPQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCCHELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYGAGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYASRIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG'),
('P42574', '2XYG', 1, 1.54, 'A', 146, 'HYDROLASE', 'HYDROLASE', 'Caspase-3', 'CASP3', 'Strict requirement for an Asp residue at positions P1 and P4. It has a preferred cleavage sequence of Asp-Xaa-Xaa-Asp-|- with a hydrophobic amino-acid residue at P2 and a hydrophilic amino-acid residue at P3, although Val or Ala are also accepted at this position.<br />\n', 'aspartic-type endopeptidase activity<br />\ncyclin-dependent protein serine/threonine kinase inhibitor activity<br />\ncysteine-type endopeptidase activator activity involved in apoptotic process<br />\ncysteine-type endopeptidase activity<br />\ncysteine-type endopeptidase activity involved in apoptotic process<br />\ncysteine-type endopeptidase activity involved in execution phase of apoptosis<br />\ndeath receptor binding<br />\npeptidase activity<br />\nphospholipase A2 activator activity<br />\nprotease binding<br />\nprotein complex binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nactivation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c<br />\napoptotic DNA fragmentation<br />\napoptotic process<br />\napoptotic signaling pathway<br />\nB cell homeostasis<br />\ncell fate commitment<br />\ncellular response to DNA damage stimulus<br />\ncellular response to staurosporine<br />\nerythrocyte differentiation<br />\nexecution phase of apoptosis<br />\nextrinsic apoptotic signaling pathway in absence of ligand<br />\nglial cell apoptotic process<br />\nheart development<br />\nhippocampus development<br />\nhippo signaling<br />\nintrinsic apoptotic signaling pathway in response to osmotic stress<br />\nkeratinocyte differentiation<br />\nlearning or memory<br />\nnegative regulation of activated T cell proliferation<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of B cell proliferation<br />\nnegative regulation of cyclin-dependent protein serine/threonine kinase activity<br />\nneuron apoptotic process<br />\nneuron differentiation<br />\nneurotrophin TRK receptor signaling pathway<br />\nplatelet formation<br />\npositive regulation of neuron apoptotic process<br />\nprotein processing<br />\nproteolysis<br />\nregulation of macroautophagy<br />\nresponse to amino acid<br />\nresponse to antibiotic<br />\nresponse to cobalt ion<br />\nresponse to drug<br />\nresponse to estradiol<br />\nresponse to glucocorticoid<br />\nresponse to glucose<br />\nresponse to hydrogen peroxide<br />\nresponse to hypoxia<br />\nresponse to lipopolysaccharide<br />\nresponse to nicotine<br />\nresponse to tumor necrosis factor<br />\nresponse to UV<br />\nresponse to X-ray<br />\nsensory perception of sound<br />\nT cell homeostasis<br />\nwound healing<br />\n', '', 'MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH'),
('Q7CRA4', '2Y2M', 1, 1.62, 'A', 691, 'TRANSFERASE', 'TRANSFERASE', 'Penicillin-binding protein 1b', 'pbp1b', NULL, 'penicillin binding<br />\r\npeptidoglycan glycosyltransferase activity<br />\r\ntransferase activity, transferring acyl groups<br />', NULL, 'PF00912.', 'MQNQLNELKRKMLEFFQQKQKNKKSARPGKKGSSTKKSKTLDKSAIFPAI\r\nLLSIKALFNLLFVLGFLGGMLGAGIALGYGVALFDKVRVPQTEELVNQVK\r\nDISSISEITYSDGTVIASIESDLLRTSISSEQISENLKKAIIATEDEHFK\r\nEHKGVVPKAVIRATLGKFVGLGSSSGGSTLTQQLIKQQVVGDAPTLARKA\r\nAEIVDALALERAMNKDEILTTYLNVAPFGRNNKGQNIAGARQAAEGIFGV\r\nDASQLTVPQAAFLAGLPQSPITYSPYENTGELKSDEDLEIGLRRAKAVLY\r\nSMYRTGALSKDEYSQYKDYDLKQDFLPSGTVTGISRDYLYFTTLAEAQER\r\nMYDYLAQRDNVSAKELKNEATQKFYRDLAAKEIENGGYKITTTIDQKIHS\r\nAMQSAVADYGYLLDDGTGRVEVGNVLMDNQTGAILGFVGGRNYQENQNNH\r\nAFDTKRSPASTTKPLLAYGIAIDQGLMGSETILSNYPTNFANGNPIMYAN\r\nSKGTGMMTLGEALNYSWNIPAYWTYRMLRENGVDVKGYMEKMGYEIPEYG\r\nIESLPMGGGIEVTVAQHTNGYQTLANNGVYHQKHVISKIEAADGRVVYEY\r\nQDKPVQVYSKATATIMQGLLREVLSSRVTTTFKSNLTSLNPTLANADWIG\r\nKTGTTNQDENMWLMLSTPRLTLGGWIGHDDNHSLSRRAGYSNNSNYMAHL\r\nVNAIQQASPSIWGNERFALDPSVVKSEVLKSTGQKPGKVSVEGKEVEVTG\r\nSTVTSYWANKSGAPATSYRFAIGGSDADYQNAWSSIVGSLPTPSSSSSSS\r\nSSSSDSSNSSTTRPSSSRARR'),
('P0AES4', '2Y3P', 1, 2.62, 'A/B', 522, 'ISOMERASE', 'ISOMERASE', 'DNA gyrase subunit A', 'gyrA', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA-dependent ATPase activity<br />\nDNA supercoiling activity<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\nidentical protein binding<br />\n', 'DNA topological change<br />\nresponse to antibiotic<br />\nresponse to drug<br />\ntranscription, DNA-templated<br />\n', 'PF03989.', 'MSDLAREITPVNIEEELKSSYLDYAMSVIVGRALPDVRDGLKPVHRRVLYAMNVLGNDWNKAYKKSARVVGDVIGKYHPHGDSAVYDTIVRMAQPFSLRYMLVDGQGNFGSIDGDSAAAMRYTEIRLAKIAHELMADLEKETVDFVDNYDGTEKIPDVMPTKIPNLLVNGSSGIAVGMATNIPPHNLTEVINGCLAYIDDEDISIEGLMEHIPGPDFPTAAIINGRRGIEEAYRTGRGKVYIRARAEVEVDAKTGRETIIVHEIPYQVNKARLIEKIAELVKEKRVEGISALRDESDKDGMRIVIEVKRDAVGEVVLNNLYSQTQLQVSFGINMVALHHGQPKIMNLKDIIAAFVRHRREVVTRRTIFELRKARDRAHILEALAVALANIDPIIELIRHAPTPAEAKTALVANPWQLGNVAAMLERAGDDAARPEWLEPEFGVRDGLYYLTEQQAQAILDLRLQKLTGLEHEKLLDEYKELLDQIAELLRILGSADRLMEVIREELELVREQFGDKRRTEITANSADINLEDLITQEDVVVTLSHQGYVKYQPLSEYEAQRRGGKGKSAARIKEEDFIDRLLVANTHDHILCFSSRGRVYSMKVYQLPEATRGARGRPIVNLLPLEQDERITAILPVTEFEEGVKVFMATANGTVKKTVLTEFNRLRTAGKVAIKLVDGDELIGVDLTSGEDEVMLFSAEGKVVRFKESSVRAMGCNTTGVRGIRLGEGDKVVSLIVPRGDGAILTATQNGYGKRTAVAEYPTKSRATKGVISIKVTERNGLVVGAVQVDDCDQIMMITDAGTLVRTRVSEISIVGRNTQGVILIRTAEDENVVGLQRVAEPVDEEDLDTIDGSAAEGDDEIAPEVDVDDEPEEE'),
('P09237', '2Y6D', 1, 1.6, 'A', 173, 'HYDROLASE', 'HYDROLASE', 'Matrilysin', 'MMP7', 'Cleavage of 14-Ala-|-Leu-15 and 16-Tyr-|-Leu-17 in B chain of insulin. No action on collagen types I, II, IV, V. Cleaves gelatin chain alpha-2(I) > alpha-1(I).<br />\n', 'heparin binding<br />\nmetalloendopeptidase activity<br />\nmetallopeptidase activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'aging<br />\ncellular response to mechanical stimulus<br />\ncollagen catabolic process<br />\nestrous cycle<br />\nextracellular matrix disassembly<br />\nmaternal process involved in female pregnancy<br />\nproteolysis<br />\nresponse to nutrient levels<br />\n', 'PF00413.', 'MRLTVLCAVCLLPGSLALPLPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHELGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK'),
('Q13332', '2YD9', 1, 2.6, 'A', 305, 'HYDROLASE', 'HYDROLASE', 'Receptor-type tyrosine-protein phosphatase S', 'PTPRS', 'Protein tyrosine phosphate + H2O = protein tyrosine + phosphate<br />\n', 'chondroitin sulfate binding<br />\nheparan sulfate proteoglycan binding<br />\nheparin binding<br />\nphosphoprotein phosphatase activity<br />\nprotein tyrosine phosphatase activity<br />\n', 'cell adhesion<br />\ncerebellum development<br />\ncerebral cortex development<br />\ncorpus callosum development<br />\nestablishment of endothelial intestinal barrier<br />\nhippocampus development<br />\nnegative regulation of axon extension<br />\nnegative regulation of axon regeneration<br />\nnegative regulation of collateral sprouting<br />\nnegative regulation of dendritic spine development<br />\nnegative regulation of interferon-alpha production<br />\nnegative regulation of interferon-beta production<br />\nnegative regulation of neuron projection development<br />\nnegative regulation of toll-like receptor 9 signaling pathway<br />\npeptidyl-tyrosine dephosphorylation<br />\nprotein dephosphorylation<br />\nspinal cord development<br />\n', 'PF00041.', 'MAPTWGPGMVSVVGPMGLLVVLLVGGCAAEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFETIEFDESAGAVLRIQPLRTPRDENVYECVAQNSVGEITVHAKLTVLREDQLPSGFPNIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDPSASNGRIKQLRSETFESTPIRGALQIESSEETDQGKYECVATNSAGVRYSSPANLYVRELREVRRVAPRFSILPMSHEIMPGGNVNITCVAVGSPMPYVKWMQGAEDLTPEDDMPVGRNVLELTDVKDSANYTCVAMSSLGVIEAVAQITVKSLPKAPGTPMVTENTATSITITWDSGNPDPVSYYVIEYKSKSQDGPYQIKEDITTTRYSIGGLSPNSEYEIWVSAVNSIGQGPPSESVVTRTGEQAPASAPRNVQARMLSATTMIVQWEEPVEPNGLIRGYRVYYTMEPEHPVGNWQKHNVDDSLLTTVGSLLEDETYTVRVLAFTSVGDGPLSDPIQVKTQQGVPGQPMNLRAEARSETSITLSWSPPRQESIIKYELLFREGDHGREVGRTFDPTTSYVVEDLKPNTEYAFRLAARSPQGLGAFTPVVRQRTLQSKPSAPPQDVKCVSVRSTAILVSWRPPPPETHNGALVGYSVRYRPLGSEDPEPKEVNGIPPTTTQILLEALEKWTQYRITTVAHTEVGPGPESSPVVVRTDEDVPSAPPRKVEAEALNATAIRVLWRSPAPGRQHGQIRGYQVHYVRMEGAEARGPPRIKDVMLADAQWETDDTAEYEMVITNLQPETAYSITVAAYTMKGDGARSKPKVVVTKGAVLGRPTLSVQQTPEGSLLARWEPPAGTAEDQVLGYRLQFGREDSTPLATLEFPPSEDRYTASGVHKGATYVFRLAARSRGGLGEEAAEVLSIPEDTPRGHPQILEAAGNASAGTVLLRWLPPVPAERNGAIVKYTVAVREAGALGPARETELPAAAEPGAENALTLQGLKPDTAYDLQVRAHTRRGPGPFSPPVRYRTFLRDQVSPKNFKVKMIMKTSVLLSWEFPDNYNSPTPYKIQYNGLTLDVDGRTTKKLITHLKPHTFYNFVLTNRGSSLGGLQQTVTAWTAFNLLNGKPSVAPKPDADGFIMVYLPDGQSPVPVQSYFIVMVPLRKSRGGQFLTPLGSPEDMDLEELIQDISRLQRRSLRHSRQLEVPRPYIAARFSVLPPTFHPGDQKQYGGFDNRGLEPGHRYVLFVLAVLQKSEPTFAASPFSDPFQLDNPDPQPIVDGEEGLIWVIGPVLAVVFIICIVIAILLYKNKPDSKRKDSEPRTKCLLNNADLAPHHPKDPVEMRRINFQTPDSGLRSPLREPGFHFESMLSHPPIPIADMAEHTERLKANDSLKLSQEYESIDPGQQFTWEHSNLEVNKPKNRYANVIAYDHSRVILQPIEGIMGSDYINANYVDGYRCQNAYIATQGPLPETFGDFWRMVWEQRSATIVMMTRLEEKSRIKCDQYWPNRGTETYGFIQVTLLDTIELATFCVRTFSLHKNGSSEKREVRQFQFTAWPDHGVPEYPTPFLAFLRRVKTCNPPDAGPIVVHCSAGVGRTGCFIVIDAMLERIKPEKTVDVYGHVTLMRSQRNYMVQTEDQYSFIHEALLEAVGCGNTEVPARSLYAYIQKLAQVEPGEHVTGMELEFKRLANSKAHTSRFISANLPCNKFKNRLVNIMPYESTRVCLQPIRGVEGSDYINASFIDGYRQQKAYIATQGPLAETTEDFWRMLWENNSTIVVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTVRQFQFTDWPEQGVPKSGEGFIDFIGQVHKTKEQFGQDGPISVHCSAGVGRTGVFITLSIVLERMRYEGVVDIFQTVKMLRTQRPAMVQTEDEYQFCYQAALEYLGSFDHYAT');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P19634', '2YGG', 1, 2.23, 'A', 68, 'METAL BINDING PROTEIN / TRANSPORT PROTEIN', 'METAL_BINDING', 'Sodium/hydrogen exchanger 1', 'SLC9A1', '', 'calcium-dependent protein binding<br />\ncalmodulin binding<br />\nphosphatidylinositol-4,5-bisphosphate binding<br />\npotassium:proton antiporter activity<br />\nprotein binding, bridging<br />\nprotein complex scaffold activity<br />\nprotein phosphatase 2B binding<br />\nsodium:proton antiporter activity<br />\nsodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential<br />\nsolute:proton antiporter activity<br />\n', 'cardiac muscle cell contraction<br />\ncardiac muscle cell differentiation<br />\ncell growth<br />\ncell migration<br />\ncellular response to acidic pH<br />\ncellular response to antibiotic<br />\ncellular response to electrical stimulus<br />\ncellular response to epinephrine stimulus<br />\ncellular response to hypoxia<br />\ncellular response to insulin stimulus<br />\ncellular response to mechanical stimulus<br />\ncellular sodium ion homeostasis<br />\nhyaluronan catabolic process<br />\nhydrogen ion transmembrane transport<br />\nion transport<br />\nmaintenance of cell polarity<br />\nnegative regulation of apoptotic process<br />\nneuron death<br />\npositive regulation of action potential<br />\npositive regulation of apoptotic process<br />\npositive regulation of calcineurin-NFAT signaling cascade<br />\npositive regulation of calcium:sodium antiporter activity<br />\npositive regulation of cardiac muscle hypertrophy<br />\npositive regulation of cell growth<br />\npositive regulation of mitochondrial membrane permeability<br />\npositive regulation of the force of heart contraction<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npotassium ion transmembrane transport<br />\nprotein oligomerization<br />\nregulation of cardiac muscle cell membrane potential<br />\nregulation of cardiac muscle contraction by calcium ion signaling<br />\nregulation of focal adhesion assembly<br />\nregulation of intracellular pH<br />\nregulation of pH<br />\nregulation of sensory perception of pain<br />\nregulation of stress fiber assembly<br />\nregulation of the force of heart contraction by cardiac conduction<br />\nresponse to acidic pH<br />\nresponse to drug<br />\nresponse to muscle stretch<br />\nsodium ion export<br />\nsodium ion import across plasma membrane<br />\n', 'PF00999.', 'MVLRSGICGLSPHRIFPSLLVVVALVGLLPVLRSHGLQLSPTASTIRSSEPPRERSIGDVTTAPPEVTPESRPVNHSVTDHGMKPRKAFPVLGIDYTHVRTPFEISLWILLACLMKIGFHVIPTISSIVPESCLLIVVGLLVGGLIKGVGETPPFLQSDVFFLFLLPPIILDAGYFLPLRQFTENLGTILIFAVVGTLWNAFFLGGLMYAVCLVGGEQINNIGLLDNLLFGSIISAVDPVAVLAVFEEIHINELLHILVFGESLLNDAVTVVLYHLFEEFANYEHVGIVDIFLGFLSFFVVALGGVLVGVVYGVIAAFTSRFTSHIRVIEPLFVFLYSYMAYLSAELFHLSGIMALIASGVVMRPYVEANISHKSHTTIKYFLKMWSSVSETLIFIFLGVSTVAGSHHWNWTFVISTLLFCLIARVLGVLGLTWFINKFRIVKLTPKDQFIIAYGGLRGAIAFSLGYLLDKKHFPMCDLFLTAIITVIFFTVFVQGMTIRPLVDLLAVKKKQETKRSINEEIHTQFLDHLLTGIEDICGHYGHHHWKDKLNRFNKKYVKKCLIAGERSKEPQLIAFYHKMEMKQAIELVESGGMGKIPSAVSTVSMQNIHPKSLPSERILPALSKDKEEEIRKILRNNLQKTRQRLRSYNRHTLVADPYEEAWNQMLLRRQKARQLEQKINNYLTVPAHKLDSPTMSRARIGSDPLAYEPKEDLPVITIDPASPQSPESVDLVNEELKGKVLGLSRDPAKVAEEDEDDDGGIMMRSKETSSPGTDDVFTPAPSDSPSSQRIQRCLSDPGPHPEPGEGEPFFPKGQ'),
('Q13085', '2YL2', 0, 2.3, 'A/B', 540, 'LIGASE', 'LIGASE', 'Acetyl-CoA carboxylase 1', 'ACACA', 'ATP + acetyl-CoA + HCO3- = ADP + phosphate + malonyl-CoA<br />\nATP + biotin-[carboxyl-carrier-protein] + HCO3- = ADP + phosphate + carboxy-biotin-[carboxyl-carrier-protein]<br />\n', 'acetyl-CoA carboxylase activity<br />\nATP binding<br />\nbiotin carboxylase activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\n', 'acetyl-CoA metabolic process<br />\nbiotin metabolic process<br />\ncarnitine shuttle<br />\ncellular response to prostaglandin E stimulus<br />\nfatty acid biosynthetic process<br />\nfatty-acyl-CoA biosynthetic process<br />\nlipid homeostasis<br />\nmalonyl-CoA biosynthetic process<br />\nmulticellular organismal protein metabolic process<br />\npositive regulation of cellular metabolic process<br />\nprotein homotetramerization<br />\nregulation of cholesterol biosynthetic process<br />\ntissue homeostasis<br />\n', 'PF08326.', 'MDEPSPLAQPLELNQHSRFIIGSVSEDNSEDEISNLVKLDLLEEKEGSLSPASVGSDTLSDLGISSLQDGLALHIRSSMSGLHLVKQGRDRKKIDSQRDFTVASPAEFVTRFGGNKVIEKVLIANNGIAAVKCMRSIRRWSYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELILDIAKRIPVQAVWAGWGHASENPKLPELLLKNGIAFMGPPSQAMWALGDKIASSIVAQTAGIPTLPWSGSGLRVDWQENDFSKRILNVPQELYEKGYVKDVDDGLQAAEEVGYPVMIKASEGGGGKGIRKVNNADDFPNLFRQVQAEVPGSPIFVMRLAKQSRHLEVQILADQYGNAISLFGRDCSVQRRHQKIIEEAPATIATPAVFEHMEQCAVKLAKMVGYVSAGTVEYLYSQDGSFYFLELNPRLQVEHPCTEMVADVNLPAAQLQIAMGIPLYRIKDIRMMYGVSPWGDSPIDFEDSAHVPCPRGHVIAARITSENPDEGFKPSSGTVQELNFRSNKNVWGYFSVAAAGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLIKLLETESFQMNRIDTGWLDRLIAEKVQAERPDTMLGVVCGALHVADVSLRNSVSNFLHSLERGQVLPAHTLLNTVDVELIYEGVKYVLKVTRQSPNSYVVIMNGSCVEVDVHRLSDGGLLLSYDGSSYTTYMKEEVDRYRITIGNKTCVFEKENDPSVMRSPSAGKLIQYIVEDGGHVFAGQCYAEIEVMKMVMTLTAVESGCIHYVKRPGAALDPGCVLAKMQLDNPSKVQQAELHTGSLPRIQSTALRGEKLHRVFHYVLDNLVNVMNGYCLPDPFFSSKVKDWVERLMKTLRDPSLPLLELQDIMTSVSGRIPPNVEKSIKKEMAQYASNITSVLCQFPSQQIANILDSHAATLNRKSEREVFFMNTQSIVQLVQRYRSGIRGHMKAVVMDLLRQYLRVETQFQNGHYDKCVFALREENKSDMNTVLNYIFSHAQVTKKNLLVTMLIDQLCGRDPTLTDELLNILTELTQLSKTTNAKVALRARQVLIASHLPSYELRHNQVESIFLSAIDMYGHQFCIENLQKLILSETSIFDVLPNFFYHSNQVVRMAALEVYVRRAYIAYELNSVQHRQLKDNTCVVEFQFMLPTSHPNRGNIPTLNRMSFSSNLNHYGMTHVASVSDVLLDNSFTPPCQRMGGMVSFRTFEDFVRIFDEVMGCFSDSPPQSPTFPEAGHTSLYDEDKVPRDEPIHILNVAIKTDCDIEDDRLAAMFREFTQQNKATLVDHGIRRLTFLVAQKDFRKQVNYEVDRRFHREFPKFFTFRARDKFEEDRIYRHLEPALAFQLELNRMRNFDLTAIPCANHKMHLYLGAAKVEVGTEVTDYRFFVRAIIRHSDLVTKEASFEYLQNEGERLLLEAMDELEVAFNNTNVRTDCNHIFLNFVPTVIMDPSKIEESVRSMVMRYGSRLWKLRVLQAELKINIRLTPTGKAIPIRLFLTNESGYYLDISLYKEVTDSRTAQIMFQAYGDKQGPLHGMLINTPYVTKDLLQSKRFQAQSLGTTYIYDIPEMFRQSLIKLWESMSTQAFLPSPPLPSDMLTYTELVLDDQGQLVHMNRLPGGNEIGMVAWKMTFKSPEYPEGRDIIVIGNDITYRIGSFGPQEDLLFLRASELARAEGIPRIYVSANSGARIGLAEEIRHMFHVAWVDPEDPYKGYRYLYLTPQDYKRVSALNSVHCEHVEDEGESRYKITDIIGKEEGIGPENLRGSGMIAGESSLAYNEIITISLVTCRAIGIGAYLVRLGQRTIQVENSHLILTGAGALNKVLGREVYTSNNQLGGIQIMHNNGVTHCTVCDDFEGVFTVLHWLSYMPKSVHSSVPLLNSKDPIDRIIEFVPTKTPYDPRWMLAGRPHPTQKGQWLSGFFDYGSFSEIMQPWAQTVVVGRARLGGIPVGVVAVETRTVELSIPADPANLDSEAKIIQQAGQVWFPDSAFKTYQAIKDFNREGLPLMVFANWRGFSGGMKDMYDQVLKFGAYIVDGLRECCQPVLVYIPPQAELRGGSWVVIDSSINPRHMEMYADRESRGSVLEPEGTVEIKFRRKDLVKTMRRVDPVYIHLAERLGTPELSTAERKELENKLKEREEFLIPIYHQVAVQFADLHDTPGRMQEKGVISDILDWKTSRTFFYWRLRRLLLEDLVKKKIHNANPELTDGQIQAMLRRWFVEVEGTVKAYVWDNNKDLAEWLEKQLTEEDGVHSVIEENIKCISRDYVLKQIRSLVQANPEVAMDSIIHMTQHISPTQRAEVIRILSTMDSPST'),
('P21397', '2Z5Y', 1, 2.17, 'A', 513, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Amine oxidase [flavin-containing] A', 'MAOA', 'RCH2NHR'' + H2O + O2 = RCHO + R''NH2 + H2O2.<br />\n', 'primary amine oxidase activity<br />\n', 'cellular biogenic amine metabolic process<br />\ndopamine catabolic process<br />\nneurotransmitter catabolic process<br />\nneurotransmitter metabolic process<br />\n', 'PF01593.', 'MENQEKASIAGHMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGGRTYTIRNEHVDYVDVGGAYVGPTQNRILRLSKELGIETYKVNVSERLVQYVKGKTYPFRGAFPPVWNPIAYLDYNNLWRTIDNMGKEIPTDAPWEAQHADKWDKMTMKELIDKICWTKTARRFAYLFVNINVTSEPHEVSALWFLWYVKQCGGTTRIFSVTNGGQERKFVGGSGQVSERIMDLLGDQVKLNHPVTHVDQSSDNIIIETLNHEHYECKYVINAIPPTLTAKIHFRPELPAERNQLIQRLPMGAVIKCMMYYKEAFWKKKDYCGCMIIEDEDAPISITLDDTKPDGSLPAIMGFILARKADRLAKLHKEIRKKKICELYAKVLGSQEALHPVHYEEKNWCEEQYSGGCYTAYFPPGIMTQYGRVIRQPVGRIFFAGTETATKWSGYMEGAVEAGERAAREVLNGLGKVTEKDIWVQEPESKDVPAVEITHTFWERNLPSVSGLLKIIGFSTSVTALGFVLYKYKLLPRS'),
('Q9S427', '2Z72', 0, 1.1, 'A', 340, 'HYDROLASE', 'HYDROLASE', 'Protein-tyrosine-phosphatase', 'PPI', NULL, 'metal ion binding<br />\r\nprotein tyrosine phosphatase activity<br />', NULL, 'PF00149.', 'MNKIYCLAVLSLTLLSPLALANTATEFDGPYVITPISGQSTAYWICDNRL\r\nKTTSIEKLQVNRPEHCGDLPETKLSSEIKQIMPDTYLGIKKVVALSDVHG\r\nQYDVLLTLLKKQKIIDSDGNWAFGEGHMVMTGDIFDRGHQVNEVLWFMYQ\r\nLDQQARDAGGMVHLLMGNHEQMVLGGDLRYVHQRYDIATTLINRPYNKLY\r\nGADTEIGQWLRSKNTIIKINDVLYMHGGISSEWISRELTLDKANALYRAN\r\nVDASKKSLKADDLLNFLFFGNGPTWYRGYFSETFTEAELDTILQHFNVNH\r\nIVVGHTSQERVLGLFHNKVIAVDSSIKVGKSGELLLLENNRLIRGLYDGT\r\nRETLQENSLNQ'),
('P41407', '2Z98', 1, 1.4, 'A', 200, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'FMN-dependent NADH-azoreductase', 'azoR', '', 'azobenzene reductase activity<br />\nFMN binding<br />\noxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor<br />\n', 'response to oxidative stress<br />\n', 'PF02525.', 'MSKVLVLKSSILAGYSQSNQLSDYFVEQWREKHSADEITVRDLAANPIPVLDGELVGALRPSDAPLTPRQQEALALSDELIAELKAHDVIVIAAPMYNFNISTQLKNYFDLVARAGVTFRYTENGPEGLVTGKKAIVITSRGGIHKDGPTDLVTPYLSTFLGFIGITDVKFVFAEGIAYGPEMAAKAQSDAKAAIDSIVSA'),
('Q8N8N7', '2ZB4', 1, 1.63, 'A', 351, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Prostaglandin reductase 2', 'PTGR2', '11-alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+ = (5Z)-(13E)-11-alpha-hydroxy-9,15-dioxoprosta-5,13-dienoate + NAD(P)H<br />\n', '13-prostaglandin reductase activity<br />\n15-oxoprostaglandin 13-oxidase activity<br />\n', 'prostaglandin metabolic process<br />\n', 'PF00107.', 'MIVQRVVLNSRPGKNGNPVAENFRMEEVYLPDNINEGQVQVRTLYLSVDPYMRCRMNEDTGTDYITPWQLSQVVDGGGIGIIEESKHTNLTKGDFVTSFYWPWQTKVILDGNSLEKVDPQLVDGHLSYFLGAIGMPGLTSLIGIQEKGHITAGSNKTMVVSGAAGACGSVAGQIGHFLGCSRVVGICGTHEKCILLTSELGFDAAINYKKDNVAEQLRESCPAGVDVYFDNVGGNISDTVISQMNENSHIILCGQISQYNKDVPYPPPLSPAIEAIQKERNITRERFLVLNYKDKFEPGILQLSQWFKEGKLKIKETVINGLENMGAAFQSMMTGGNIGKQIVCISEEISL'),
('P14677', '2ZC3', 1, 2.5, 'A/D', 168, 'BIOSYNTHETIC PROTEIN', 'OTHERS', 'Penicillin-binding protein 2x', 'pbpX', '', 'penicillin binding<br />\n', 'cell cycle<br />\ncell division<br />\ncell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nresponse to antibiotic<br />\n', 'PF03793.', 'MKWTKRVIRYATKNRKSPAENRRRVGKSLSLLSVFVFAIFLVNFAVIIGTGTRFGTDLAKEAKKVHQTTRTVPAKRGTIYDRNGVPIAEDATSYNVYAVIDENYKSATGKILYVEKTQFNKVAEVFHKYLDMEESYVREQLSQPNLKQVSFGAKGNGITYANMMSIKKELEAAEVKGIDFTTSPNRSYPNGQFASSFIGLAQLHENEDGSKSLLGTSGMESSLNSILAGTDGIITYEKDRLGNIVPGTEQVSQRTMDGKDVYTTISSPLQSFMETQMDAFQEKVKGKYMTATLVSAKTGEILATTQRPTFDADTKEGITEDFVWRDILYQSNYEPGSTMKVMMLAAAIDNNTFPGGEVFNSSELKIADATIRDWDVNEGLTGGRTMTFSQGFAHSSNVGMTLLEQKMGDATWLDYLNRFKFGVPTRFGLTDEYAGQLPADNIVNIAQSSFGQGISVTQTQMIRAFTAIANDGVMLEPKFISAIYDPNDQTARKSQKEIVGNPVSKDAASLTRTNMVLVGTDPVYGTMYNHSTGKPTVTVPGQNVALKSGTAQIADEKNGGYLVGLTDYIFSAVSMSPAENPDFILYVTVQQPEHYSGIQLGEFANPILERASAMKDSLNLQTTAKALEQVSQQSPYPMPSVKDISPGDLAEELRRNLVQPIVVGTGTKIKNSSAEEGKNLAPNQQVLILSDKAEEVPDMYGWTKETAETLAKWLNIELEFQGSGSTVQKQDVRANTAIKDIKKITLTLGD'),
('Q04707', '2ZC6', 0, 2.7, 'A/C', 24, 'BIOSYNTHETIC PROTEIN', 'OTHERS', 'Penicillin-binding protein 1A', 'ponA', '(GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala))(n)-diphosphoundecaprenol + GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol = (GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala))(n+1)-diphosphoundecaprenol + undecaprenyl diphosphate<br />\nPreferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala<br />\n', 'penicillin binding<br />\npeptidoglycan glycosyltransferase activity<br />\nserine-type D-Ala-D-Ala carboxypeptidase activity<br />\n', 'cell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nresponse to antibiotic<br />\n', 'PF00912.', 'MNKPTILRLIKYLSISFLSLVIAAIVLGGGVFFYYVSKAPSLSESKLVATTSSKIYDNKNQLIADLGSERRVNAQANDIPTDLVKAIVSIEDHRFFDHRGIDTIRILGAFLRNLQSNSLQGGSTLTQQLIKLTYFSTSTSDQTISRKAQEAWLAIQLEQKATKQEILTYYINKVYMSNGNYGMQTAAQNYYGKDLNNLSLPQLALLAGMPQAPNQYDPYSHPEAAQDRRNLVLSEMKNQGYISAEQYEKAVNTPITDGLQSLKSASNYPAYMDNYLKEVINQVEEETGYNLLTTGMDVYTNVDQEAQKHLWDIYNTDEYVAYPDDELQVASTIVDVSNGKVIAQLGARHQSSNVSFGINQAVETNRDWGSTMKPITDYAPALEYGVYDSTATIVHDEPYNYPGTNTPVYNWDRGYFGNITLQYALQQSRNVPAVETLNKVGLNRAKTFLNGLGIDYPSIHYSNAISSNTTESDKKYGASSEKMAAAYAAFANGGTYYKPMYIHKVVFSDGSEKEFSNVGTRAMKETTAYMMTDMMKTVLTYGTGRNAYLAWLPQAGKTGTSNYTDEEIENHIKTSQFVAPDELFAGYTRKYSMAVWTGYSNRLTPLVGNGLTVAAKVYRSMMTYLSEGSNPEDWNIPEGLYRNGEFVFKNGARSTWNSPAPQQPPSTESSSSSSDSSTSQSSSTTPSTNNSTTTNPNNNTQQSNTTPDQQNQNPQPAQP'),
('P0AD64', '2ZD8', 1, 1.05, 'A', 265, 'HYDROLASE', 'HYDROLASE', 'Beta-lactamase SHV-1', 'bla', 'A beta-lactam + H2O = a substituted beta-amino acid<br />\n', 'beta-lactamase activity<br />\n', 'beta-lactam antibiotic catabolic process<br />\nresponse to antibiotic<br />\n', '', 'MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR'),
('P41250', '2ZT5', 1, 2.5, 'A', 685, 'LIGASE', 'LIGASE', 'Glycine--tRNA ligase', 'GARS', 'ATP + glycine + tRNA(Gly) = AMP + diphosphate + glycyl-tRNA(Gly)<br />\nP1,P4-bis(5''-guanosyl) tetraphosphate + H2O = GTP + GMP<br />\n', 'ATP binding<br />\nbis(5''-nucleosyl)-tetraphosphatase (asymmetrical) activity<br />\nglycine-tRNA ligase activity<br />\nidentical protein binding<br />\nprotein dimerization activity<br />\n', 'diadenosine tetraphosphate biosynthetic process<br />\nmitochondrial glycyl-tRNA aminoacylation<br />\ntRNA aminoacylation for protein translation<br />\n', 'PF03129.', 'MPSPRPVLLRGARAALLLLLPPRLLARPSLLLRRSLSAASCPPISLPAAASRSSMDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEE'),
('P04839', '3A1F', 0, 2, 'A', 186, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome b-245 heavy chain', 'CYBB', '', 'flavin adenine dinucleotide binding<br />\nheme binding<br />\nmetal ion binding<br />\nprotein heterodimerization activity<br />\nsuperoxide-generating NADPH oxidase activity<br />\nvoltage-gated ion channel activity<br />\n', 'antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\ncell redox homeostasis<br />\ncellular response to cadmium ion<br />\ncellular response to ethanol<br />\ncellular response to L-glutamine<br />\ncellular response to oxidative stress<br />\nhydrogen peroxide biosynthetic process<br />\nhypoxia-inducible factor-1alpha signaling pathway<br />\ninflammatory response<br />\ninnate immune response<br />\nneutrophil degranulation<br />\noxidation-reduction process<br />\npositive regulation of angiogenesis<br />\npositive regulation of tumor necrosis factor biosynthetic process<br />\nrespiratory burst<br />\nresponse to aldosterone<br />\nresponse to angiotensin<br />\nresponse to drug<br />\nresponse to nutrient<br />\nsuperoxide anion generation<br />\nsuperoxide metabolic process<br />\nvascular endothelial growth factor receptor signaling pathway<br />\n', 'PF08022.', 'MGNWAVNEGLSIFVILVWLGLNVFLFVWYYRVYDIPPKFFYTRKLLGSALALARAPAACLNFNCMLILLPVCRNLLSFLRGSSACCSTRVRRQLDRNLTFHKMVAWMIALHSAIHTIAHLFNVEWCVNARVNNSDPYSVALSELGDRQNESYLNFARKRIKNPEGGLYLAVTLLAGITGVVITLCLILIITSSTKTIRRSYFEVFWYTHHLFVIFFIGLAIHGAERIVRGQTAESLAVHNITVCEQKISEWGKIKECPIPQFAGNPPMTWKWIVGPMFLYLCERLVRFWRSQQKVVITKVVTHPFKTIELQMKKKGFKMEVGQYIFVKCPKVSKLEWHPFTLTSAPEEDFFSIHIRIVGDWTEGLFNACGCDKQEFQDAWKLPKIAVDGPFGTASEDVFSYEVVMLVGAGIGVTPFASILKSVWYKYCNNATNLKLKKIYFYWLCRDTHAFEWFADLLQLLESQMQERNNAGFLSYNIYLTGWDESQANHFAVHHDEEKDVITGLKQKTLYGRPNWDNEFKTIASQHPNTRIGVFLCGPEALAETLSKQSISNSESGPRGVHFIFNKENF'),
('P11309', '3A99', 1, 1.6, 'A', 299, 'TRANSFERASE', 'TRANSFERASE', 'Serine/threonine-protein kinase pim-1', 'PIM1', 'ATP + a protein = ADP + a phosphoprotein<br />\n', 'ATP binding<br />\nmanganese ion binding<br />\nprotein serine/threonine kinase activity<br />\nribosomal small subunit binding<br />\ntranscription factor binding<br />\n', 'apoptotic process<br />\ncell cycle<br />\ncell proliferation<br />\nhyaluronan metabolic process<br />\nmulticellular organism development<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of cardiac muscle cell proliferation<br />\npositive regulation of cardioblast proliferation<br />\npositive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of mitotic cell cycle<br />\nvitamin D receptor signaling pathway<br />\n', 'PF00069.', 'MPHEPHEPLTPPFSALPDPAGAPSRRQSRQRPQLSSDSPSAFRASRSHSRNATRSHSHSHSPRHSLRHSPGSGSCGSSSGHRPCADILEVGMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK'),
('P12104', '3AKM', 1, 1.9, 'A/B/C/D', 131, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Fatty acid-binding protein, intestinal', 'FABP2', '', 'fatty acid binding<br />\ntransporter activity<br />\n', 'digestion<br />\ntriglyceride catabolic process<br />\n', 'PF00061.', 'MAFDSTWKVDRSENYDKFMEKMGVNIVKRKLAAHDNLKLTITQEGNKFTVKESSAFRNIEVVFELGVTFNYNLADGTELRGTWSLEGNKLIGKFKRTDNGNELNTVREIIGDELVQTYVYEGVEAKRIFKKD'),
('P08253', '3AYU', 0, 2, 'A', 341, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', '72 kDa type IV collagenase', 'MMP2', 'Cleavage of gelatin type I and collagen types IV, V, VII, X. Cleaves the collagen-like sequence Pro-Gln-Gly-|-Ile-Ala-Gly-Gln.<br />\n', 'metalloendopeptidase activity<br />\nmetallopeptidase activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'angiogenesis<br />\nblood vessel maturation<br />\nbone trabecula formation<br />\ncellular protein metabolic process<br />\ncellular response to amino acid stimulus<br />\ncollagen catabolic process<br />\nembryo implantation<br />\nendodermal cell differentiation<br />\nephrin receptor signaling pathway<br />\nextracellular matrix disassembly<br />\nface morphogenesis<br />\nintramembranous ossification<br />\npositive regulation of innate immune response<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\nproteolysis<br />\nresponse to hypoxia<br />\n', 'PF00040.', 'MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELAVQYLNTFYGCPKESCNLFVLKDTLKKMQKFFGLPQTGDLDQNTIETMRKPRCGNPDVANYNFFPRKPKWDKNQITYRIIGYTPDLDPETVDDAFARAFQVWSDVTPLRFSRIHDGEADIMINFGRWEHGDGYPFDGKDGLLAHAFAPGTGVGGDSHFDDDELWTLGEGQVVRVKYGNADGEYCKFPFLFNGKEYNSCTDTGRSDGFLWCSTTYNFEKDGKYGFCPHEALFTMGGNAEGQPCKFPFRFQGTSYDSCTTEGRTDGYRWCGTTEDYDRDKKYGFCPETAMSTVGGNSEGAPCVFPFTFLGNKYESCTSAGRSDGKMWCATTANYDDDRKWGFCPDQGYSLFLVAAHEFGHAMGLEHSQDPGALMAPIYTYTKNFRLSQDDIKGIQELYGASPDIDLGTGPTPTLGPVTPEICKQDIVFDGIAQIRGEIFFFKDRFIWRTVTPRDKPMGPLLVATFWPELPEKIDAVYEAPQEEKAVFFAGNEYWIYSASTLERGYPKPLTSLGLPPDVQRVDAAFNWSKNKKTYIFAGDKFWRYNEVKKKMDPGFPKLIADAWNAIPDNLDAVVDLQGGGHSYFFKGAYYLKLENQSLKSVKFGSIKSDWLGC'),
('P11473', '3B0T', 1, 1.3, 'A', 304, 'GENE REGULATION', 'OTHERS', 'Vitamin D3 receptor', 'VDR', '', 'calcitriol binding<br />\ncalcitriol receptor activity<br />\nDNA binding<br />\nlithocholic acid binding<br />\nlithocholic acid receptor activity<br />\nretinoid X receptor binding<br />\nsequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\nzinc ion binding<br />\n', 'bile acid signaling pathway<br />\ncalcium ion transport<br />\ncell morphogenesis<br />\ncellular calcium ion homeostasis<br />\ndecidualization<br />\nintestinal absorption<br />\nlactation<br />\nmammary gland branching involved in pregnancy<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of keratinocyte proliferation<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of apoptotic process involved in mammary gland involution<br />\npositive regulation of gene expression<br />\npositive regulation of keratinocyte differentiation<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of vitamin D 24-hydroxylase activity<br />\nregulation of calcidiol 1-monooxygenase activity<br />\nsignal transduction<br />\nskeletal system development<br />\ntranscription initiation from RNA polymerase II promoter<br />\nvitamin D receptor signaling pathway<br />\n', 'PF00104.', 'MEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRRSMKRKALFTCPFNGDCRITKDNRRHCQACRLKRCVDIGMMKEFILTDEEVQRKREMILKRKEEEALKDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSHPSRPNSRHTPSFSGDSSSSCSDHCITSSDMMDSSSFSNLDLSEEDSDDPSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS'),
('P37231', '3B1M', 1, 1.6, 'A', 272, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Peroxisome proliferator-activated receptor gamma', 'PPARG', '', 'activating transcription factor binding<br />\nalpha-actinin binding<br />\narachidonic acid binding<br />\nchromatin binding<br />\ncore promoter sequence-specific DNA binding<br />\nDBD domain binding<br />\nDNA binding<br />\ndouble-stranded DNA binding<br />\ndrug binding<br />\nenzyme binding<br />\nestrogen receptor binding<br />\nidentical protein binding<br />\nLBD domain binding<br />\nligand-dependent nuclear receptor transcription coactivator activity<br />\npeptide binding<br />\nprostaglandin receptor activity<br />\nprotein C-terminus binding<br />\nprotein heterodimerization activity<br />\nprotein phosphatase binding<br />\nprotein self-association<br />\nretinoid X receptor binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\ntranscription regulatory region DNA binding<br />\nzinc ion binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nanimal organ regeneration<br />\ncell fate commitment<br />\ncell maturation<br />\ncellular response to hyperoxia<br />\ncellular response to insulin stimulus<br />\ncellular response to prostaglandin E stimulus<br />\ncellular response to retinoic acid<br />\ncellular response to vitamin E<br />\nepithelial cell differentiation<br />\nfatty acid oxidation<br />\nglucose homeostasis<br />\nheart development<br />\ninnate immune response<br />\nlipid homeostasis<br />\nlipid metabolic process<br />\nlipoprotein transport<br />\nlong-chain fatty acid transport<br />\nlow-density lipoprotein particle receptor biosynthetic process<br />\nmacrophage derived foam cell differentiation<br />\nmonocyte differentiation<br />\nnegative regulation of acute inflammatory response<br />\nnegative regulation of cell growth<br />\nnegative regulation of cholesterol storage<br />\nnegative regulation of collagen biosynthetic process<br />\nnegative regulation of interferon-gamma-mediated signaling pathway<br />\nnegative regulation of macrophage derived foam cell differentiation<br />\nnegative regulation of pancreatic stellate cell proliferation<br />\nnegative regulation of receptor biosynthetic process<br />\nnegative regulation of sequestering of triglyceride<br />\nnegative regulation of smooth muscle cell proliferation<br />\nnegative regulation of telomerase activity<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nperoxisome proliferator activated receptor signaling pathway<br />\nplacenta development<br />\npositive regulation of DNA binding<br />\npositive regulation of fat cell differentiation<br />\npositive regulation of fatty acid oxidation<br />\npositive regulation of oligodendrocyte differentiation<br />\npositive regulation of phagocytosis, engulfment<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of blood pressure<br />\nregulation of cholesterol transporter activity<br />\nregulation of circadian rhythm<br />\nregulation of transcription involved in cell fate commitment<br />\nresponse to caffeine<br />\nresponse to cold<br />\nresponse to drug<br />\nresponse to estrogen<br />\nresponse to immobilization stress<br />\nresponse to lipid<br />\nresponse to low-density lipoprotein particle stimulus<br />\nresponse to mechanical stimulus<br />\nresponse to metformin<br />\nresponse to nutrient<br />\nresponse to retinoic acid<br />\nresponse to starvation<br />\nresponse to vitamin A<br />\nrhythmic process<br />\nsignal transduction<br />\ntranscription initiation from RNA polymerase II promoter<br />\nwhite fat cell differentiation<br />\n', 'PF00104.', 'MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY'),
('Q9UM07', '3B1U', 1, 2.1, 'A', 663, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Protein-arginine deiminase type-4', 'PADI4', 'Protein L-arginine + H2O = protein L-citrulline + NH3<br />\n', 'arginine binding<br />\narginine deiminase activity<br />\ncalcium ion binding<br />\nprotein-arginine deiminase activity<br />\nprotein homodimerization activity<br />\n', 'arginine deiminase pathway<br />\ncellular protein modification process<br />\nchromatin organization<br />\nchromatin remodeling<br />\nhistone citrullination<br />\nhistone H3-R26 citrullination<br />\ninnate immune response<br />\nnucleosome assembly<br />\nprotein citrullination<br />\nregulation of transcription, DNA-templated<br />\nstem cell population maintenance<br />\ntranscription, DNA-templated<br />\n', 'PF03068.', 'MAQGTLIRVTPEQPTHAVCVLGTLTQLDICSSAPEDCTSFSINASPGVVVDIAHGPPAKKKSTGSSTWPLDPGVEVTLTMKVASGSTGDQKVQISYYGPKTPPVKALLYLTGVEISLCADITRTGKVKPTRAVKDQRTWTWGPCGQGAILLVNCDRDNLESSAMDCEDDEVLDSEDLQDMSLMTLSTKTPKDFFTNHTLVLHVARSEMDKVRVFQATRGKLSSKCSVVLGPKWPSHYLMVPGGKHNMDFYVEALAFPDTDFPGLITLTISLLDTSNLELPEAVVFQDSVVFRVAPWIMTPNTQPPQEVYACSIFENEDFLKSVTTLAMKAKCKLTICPEEENMDDQWMQDEMEIGYIQAPHKTLPVVFDSPRNRGLKEFPIKRVMGPDFGYVTRGPQTGGISGLDSFGNLEVSPPVTVRGKEYPLGRILFGDSCYPSNDSRQMHQALQDFLSAQQVQAPVKLYSDWLSVGHVDEFLSFVPAPDRKGFRLLLASPRSCYKLFQEQQNEGHGEALLFEGIKKKKQQKIKNILSNKTLREHNSFVERCIDWNRELLKRELGLAESDIIDIPQLFKLKEFSKAEAFFPNMVNMLVLGKHLGIPKPFGPVINGRCCLEEKVCSLLEPLGLQCTFINDFFTYHIRHGEVHCGTNVRRKPFSFKWWNMVP'),
('Q16647', '3B6H', 1, 1.62, 'A/B', 483, 'ISOMERASE', 'ISOMERASE', 'Prostacyclin synthase', 'PTGIS', '(5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate = (5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate<br />\n', 'heme binding<br />\niron ion binding<br />\nmonooxygenase activity<br />\noxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen<br />\nprostaglandin-I synthase activity<br />\n', 'apoptotic signaling pathway<br />\ncellular response to hypoxia<br />\ncellular response to interleukin-1<br />\ncellular response to interleukin-6<br />\ncyclooxygenase pathway<br />\ndecidualization<br />\nembryo implantation<br />\nicosanoid metabolic process<br />\nNAD biosynthesis via nicotinamide riboside salvage pathway<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of NF-kappaB transcription factor activity<br />\nnegative regulation of nitric oxide biosynthetic process<br />\npositive regulation of angiogenesis<br />\npositive regulation of execution phase of apoptosis<br />\npositive regulation of peroxisome proliferator activated receptor signaling pathway<br />\nprostaglandin biosynthetic process<br />\n', 'PF00067.', 'MAWAALLGLLAALLLLLLLSRRRTRRPGEPPLDLGSIPWLGYALDFGKDAASFLTRMKEKHGDIFTILVGGRYVTVLLDPHSYDAVVWEPRTRLDFHAYAIFLMERIFDVQLPHYSPSDEKARMKLTLLHRELQALTEAMYTNLHAVLLGDATEAGSGWHEMGLLDFSYSFLLRAGYLTLYGIEALPRTHESQAQDRVHSADVFHTFRQLDRLLPKLARGSLSVGDKDHMCSVKSRLWKLLSPARLARRAHRSKWLESYLLHLEEMGVSEEMQARALVLQLWATQGNMGPAAFWLLLFLLKNPEALAAVRGELESILWQAEQPVSQTTTLPQKVLDSTPVLDSVLSESLRLTAAPFITREVVVDLAMPMADGREFNLRRGDRLLLFPFLSPQRDPEIYTDPEVFKYNRFLNPDGSEKKDFYKDGKRLKNYNMPWGAGHNHCLGRSYAVNSIKQFVFLVLVHLDLELINADVEIPEFDLSRYGFGLMQPEHDVPVRYRIRP'),
('P12277', '3B6R', 1, 2, 'A/B', 381, 'TRANSFERASE', 'TRANSFERASE', 'Creatine kinase B-type', 'CKB', 'ATP + creatine = ADP + phosphocreatine<br />\n', 'ATP binding<br />\ncreatine kinase activity<br />\nubiquitin protein ligase binding<br />\n', 'cellular chloride ion homeostasis<br />\ncerebellum development<br />\ncreatine metabolic process<br />\nsubstantia nigra development<br />\n', 'PF00217.', 'MPFSNSHNALKLRFPAEDEFPDLSAHNNHMAKVLTPELYAELRAKSTPSGFTLDDVIQTGVDNPGHPYIMTVGCVAGDEESYEVFKDLFDPIIEDRHGGYKPSDEHKTDLNPDNLQGGDDLDPNYVLSSRVRTGRSIRGFCLPPHCSRGERRAIEKLAVEALSSLDGDLAGRYYALKSMTEAEQQQLIDDHFLFDKPVSPLLLASGMARDWPDARGIWHNDNKTFLVWVNEEDHLRVISMQKGGNMKEVFTRFCTGLTQIETLFKSKDYEFMWNPHLGYILTCPSNLGTGLRAGVHIKLPNLGKHEKFSEVLKRLRLQKRGTGGVDTAAVGGVFDVSNADRLGFSEVELVQMVVDGVKLLIEMEQRLEQGQAIDDLMPAQK'),
('Q02763', '3BEA', 1, 2.02, 'A', 19, 'TRANSFERASE', 'TRANSFERASE', 'Angiopoietin-1 receptor', 'TEK', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ngrowth factor binding<br />\nprotein kinase activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\n', 'angiogenesis<br />\ncell-cell signaling<br />\ndefinitive hemopoiesis<br />\nendochondral ossification<br />\nendothelial cell proliferation<br />\nglomerulus vasculature development<br />\nheart development<br />\nheart trabecula formation<br />\nleukocyte migration<br />\nMAPK cascade<br />\nnegative regulation of angiogenesis<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of inflammatory response<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of actin cytoskeleton reorganization<br />\npositive regulation of angiogenesis<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of focal adhesion assembly<br />\npositive regulation of intracellular signal transduction<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of protein phosphorylation<br />\nprotein autophosphorylation<br />\nprotein oligomerization<br />\nregulation of endothelial cell apoptotic process<br />\nregulation of establishment or maintenance of cell polarity<br />\nregulation of vascular permeability<br />\nresponse to cAMP<br />\nresponse to estrogen<br />\nresponse to hypoxia<br />\nresponse to peptide hormone<br />\nsignal transduction<br />\nsprouting angiogenesis<br />\nsubstrate adhesion-dependent cell spreading<br />\nTie signaling pathway<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00041.', 'MDSLASLVLCGVSLLLSGTVEGAMDLILINSLPLVSDAETSLTCIASGWRPHEPITIGRDFEALMNQHQDPLEVTQDVTREWAKKVVWKREKASKINGAYFCEGRVRGEAIRIRTMKMRQQASFLPATLTMTVDKGDNVNISFKKVLIKEEDAVIYKNGSFIHSVPRHEVPDILEVHLPHAQPQDAGVYSARYIGGNLFTSAFTRLIVRRCEAQKWGPECNHLCTACMNNGVCHEDTGECICPPGFMGRTCEKACELHTFGRTCKERCSGQEGCKSYVFCLPDPYGCSCATGWKGLQCNEACHPGFYGPDCKLRCSCNNGEMCDRFQGCLCSPGWQGLQCEREGIQRMTPKIVDLPDHIEVNSGKFNPICKASGWPLPTNEEMTLVKPDGTVLHPKDFNHTDHFSVAIFTIHRILPPDSGVWVCSVNTVAGMVEKPFNISVKVLPKPLNAPNVIDTGHNFAVINISSEPYFGDGPIKSKKLLYKPVNHYEAWQHIQVTNEIVTLNYLEPRTEYELCVQLVRRGEGGEGHPGPVRRFTTASIGLPPPRGLNLLPKSQTTLNLTWQPIFPSSEDDFYVEVERRSVQKSDQQNIKVPGNLTSVLLNNLHPREQYVVRARVNTKAQGEWSEDLTAWTLSDILPPQPENIKISNITHSSAVISWTILDGYSISSITIRYKVQGKNEDQHVDVKIKNATITQYQLKGLEPETAYQVDIFAENNIGSSNPAFSHELVTLPESQAPADLGGGKMLLIAILGSAGMTCLTVLLAFLIILQLKRANVQRRMAQAFQNVREEPAVQFNSGTLALNRKVKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA'),
('P11498', '3BG3', 1, 2.8, 'A/B/C/D', 697, 'LIGASE', 'LIGASE', 'Pyruvate carboxylase, mitochondrial', 'PC', 'ATP + pyruvate + HCO3- = ADP + phosphate + oxaloacetate.<br />\n', 'ATP binding<br />\nbiotin binding<br />\nbiotin carboxylase activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\npyruvate carboxylase activity<br />\n', 'biotin metabolic process<br />\ngluconeogenesis<br />\nlipid metabolic process<br />\nnegative regulation of gene expression<br />\npositive regulation by host of viral process<br />\npositive regulation by host of viral release from host cell<br />\npyruvate metabolic process<br />\nviral RNA genome packaging<br />\n', 'PF02785.', 'MLKFRTVHGGLRLLGIRRTSTAPAASPNVRRLEYKPIKKVMVANRGEIAIRVFRACTELGIRTVAIYSEQDTGQMHRQKADEAYLIGRGLAPVQAYLHIPDIIKVAKENNVDAVHPGYGFLSERADFAQACQDAGVRFIGPSPEVVRKMGDKVEARAIAIAAGVPVVPGTDAPITSLHEAHEFSNTYGFPIIFKAAYGGGGRGMRVVHSYEELEENYTRAYSEALAAFGNGALFVEKFIEKPRHIEVQILGDQYGNILHLYERDCSIQRRHQKVVEIAPAAHLDPQLRTRLTSDSVKLAKQVGYENAGTVEFLVDRHGKHYFIEVNSRLQVEHTVTEEITDVDLVHAQIHVAEGRSLPDLGLRQENIRINGCAIQCRVTTEDPARSFQPDTGRIEVFRSGEGMGIRLDNASAFQGAVISPHYDSLLVKVIAHGKDHPTAATKMSRALAEFRVRGVKTNIAFLQNVLNNQQFLAGTVDTQFIDENPELFQLRPAQNRAQKLLHYLGHVMVNGPTTPIPVKASPSPTDPVVPAVPIGPPPAGFRDILLREGPEGFARAVRNHPGLLLMDTTFRDAHQSLLATRVRTHDLKKIAPYVAHNFSKLFSMENWGGATFDVAMRFLYECPWRRLQELRELIPNIPFQMLLRGANAVGYTNYPDNVVFKFCEVAKENGMDVFRVFDSLNYLPNMLLGMEAAGSAGGVVEAAISYTGDVADPSRTKYSLQYYMGLAEELVRAGTHILCIKDMAGLLKPTACTMLVSSLRDRFPDLPLHIHTHDTSGAGVAAMLACAQAGADVVDVAADSMSGMTSQPSMGALVACTRGTPLDTEVPMERVFDYSEYWEGARGLYAAFDCTATMKSGNSDVYENEIPGGQYTNLHFQAHSMGLGSKFKEVKKAYVEANQMLGDLIKVTPSSKIVGDLAQFMVQNGLSRAEAEAQAEELSFPRSVVEFLQGYIGVPHGGFPEPFRSKVLKDLPRVEGRPGASLPPLDLQALEKELVDRHGEEVTPEDVLSAAMYPDVFAHFKDFTATFGPLDSLNTRLFLQGPKIAEEFEVELERGKTLHIKALAVSDLNRAGQRQVFFELNGQLRSILVKDTQAMKEMHFHPKALKDVKGQIGAPMPGKVIDIKVVAGAKVAKGQPLCVLSAMKMETVVTSPMEGTVRKVHVTKDMTLEGDDLILEIE'),
('Q16760', '3BQ7', 0, 2.9, 'A/B/C/D/E/F', 68, 'TRANSFERASE', 'TRANSFERASE', 'Diacylglycerol kinase delta', 'DGKD', 'ATP + 1,2-diacyl-sn-glycerol = ADP + 1,2-diacyl-sn-glycerol 3-phosphate.<br />\n', 'ATP binding<br />\ndiacylglycerol binding<br />\ndiacylglycerol kinase activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\nNAD+ kinase activity<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\n', 'cell growth<br />\ndiacylglycerol metabolic process<br />\nendocytosis<br />\nepidermal growth factor receptor signaling pathway<br />\nlipid phosphorylation<br />\nmulticellular organism development<br />\nplatelet activation<br />\nprotein homooligomerization<br />\nprotein kinase C-activating G-protein coupled receptor signaling pathway<br />\nprotein transport<br />\nresponse to organic substance<br />\nsecond-messenger-mediated signaling<br />\nsignal transduction<br />\n', 'PF00130.', 'MAAAAGAPPPGPPQPPPPPPPEESSDSEPEAEPGSPQKLIRKVSTSGQIRQKTIIKEGMLTKQNNSFQRSKRRYFKLRGRTLYYAKTAKSIIFDEVDLTDASVAESSTKNVNNSFTVITPCRKLILCADNRKEMEDWIAALKTVQNREHFEPTQYSMDHFSGMHNWYACSHARPTYCNVCREALSGVTSHGLSCEVCKFKAHKRCAVRATNNCKWTTLASIGKDIIEDADGIAMPHQWLEGNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCPLGLCKVSVIPPTALNSIDSDGFWKASCPPSCTSPLLVFVNSKSGDNQGVKFLRRFKQLLNPAQVFDLMNGGPHLGLRLFQKFDTFRILVCGGDGSVGWVLSEIDSLNLHKQCQLGVLPLGTGNDLARVLGWGSACDDDTQLPQILEKLERASTKMLDRWSVMAYEAKLPRQASSSTVTEDFSEDSEVQQILFYEDSVAAHLSKILTSDQHSVVISSAKVLCETVKDFVARVGKAYEKTTESSEESEVMAKKCSVLKEKLDSLLKTLDDESQASSSLPNPPPTIAEEAEDGDGSGSICGSTGDRLVASACPARPQIFRPREQLMLRANSLKKAIRQIIEHTEKAVDEQNAQTQEQEGFVLGLSESEEKMDHRVCPPLSHSESFGVPKGRSQRKVSKSPCEKLISKGSLSLGSSASLPPQPGSRDGLPALNTKILYPNVRAGMSGSLPGGSVISRLLINADPFNSEPETLEYYTEKCVMNNYFGIGLDAKISLDFNNKRDEHPEKCRSRTKNMMWYGVLGTKELLHRTYKNLEQKVLLECDGRPIPLPSLQGIAVLNIPSYAGGTNFWGGTKEDDTFAAPSFDDKILEVVAVFGSMQMAVSRVIRLQHHRIAQCRTVKISILGDEGVPVQVDGEAWVQPPGYIRIVHKNRAQTLTRDRAFESTLKSWEDKQKCELPRPPSCSLHPEMLSEEEATQMDQFGQAAGVLIHSIREIAQSHRDMEQELAHAVNASSKSMDRVYGKPRTTEGLNCSFVLEMVNNFRALRSETELLLSGKMALQLDPPQKEQLGSALAEMDRQLRRLADTPWLCQSAEPGDEESVMLDLAKRSRSGKFRLVTKFKKEKNNKNKEAHSSLGAPVHLWGTEEVAAWLEHLSLCEYKDIFTRHDIRGSELLHLERRDLKDLGVTKVGHMKRILCGIKELSRSAPAVEA'),
('O15111', '3BRT', 0, 2.25, 'A/C', 14, 'Transferase / Transcription', 'TRANSFERASE', 'Inhibitor of nuclear factor kappa-B kinase subunit alpha', 'CHUK', 'ATP + [I-kappa-B protein] = ADP + [I-kappa-B phosphoprotein].<br />\n', 'ATP binding<br />\nIkappaB kinase activity<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nprotein kinase activity<br />\nscaffold protein binding<br />\n', 'anatomical structure morphogenesis<br />\nantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\ncellular response to cadmium ion<br />\ncellular response to reactive oxygen species<br />\ncellular response to tumor necrosis factor<br />\ncellular response to virus<br />\nFc-epsilon receptor signaling pathway<br />\nI-kappaB kinase/NF-kappaB signaling<br />\nI-kappaB phosphorylation<br />\nimmune response<br />\ninflammatory response<br />\ninnate immune response<br />\nnegative regulation of NF-kappaB transcription factor activity<br />\nNIK/NF-kappaB signaling<br />\nnucleotide-binding oligomerization domain containing signaling pathway<br />\npeptidyl-serine phosphorylation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of interferon-alpha secretion<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein phosphorylation<br />\nregulation of tumor necrosis factor-mediated signaling pathway<br />\nresponse to acetate<br />\nresponse to amino acid<br />\nresponse to drug<br />\nresponse to hydroperoxide<br />\nresponse to lipopolysaccharide<br />\nresponse to toxic substance<br />\nresponse to virus<br />\nRho protein signal transduction<br />\nskeletal muscle contraction<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nstress-activated MAPK cascade<br />\nstriated muscle cell differentiation<br />\nT cell receptor signaling pathway<br />\nTRIF-dependent toll-like receptor signaling pathway<br />\ntumor necrosis factor-mediated signaling pathway<br />\n', 'PF12179.', 'MERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMKKLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLSDIGSGIRYLHENKIIHRDLKPENIVLQDVGGKIIHKIIDLGYAKDVDQGSLCTSFVGTLQYLAPELFENKPYTATVDYWSFGTMVFECIAGYRPFLHHLQPFTWHEKIKKKDPKCIFACEEMSGEVRFSSHLPQPNSLCSLVVEPMENWLQLMLNWDPQQRGGPVDLTLKQPRCFVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGSQELLSETGISLDPRKPASQCVLDGVRGCDSYMVYLFDKSKTVYEGPFASRSLSDCVNYIVQDSKIQLPIIQLRKVWAEAVHYVSGLKEDYSRLFQGQRAAMLSLLRYNANLTKMKNTLISASQQLKAKLEFFHKSIQLDLERYSEQMTYGISSEKMLKAWKEMEEKAIHYAEVGVIGYLEDQIMSLHAEIMELQKSPYGRRQGDLMESLEQRAIDLYKQLKHRPSDHSYSDSTEMVKIIVHTVQSQDRVLKELFGHLSKLLGCKQKIIDLLPKVEVALSNIKEADNTVMFMQGKRQKEIWHLLKIACTQSSARSLVGSSLEGAVTPQTSAWLPPTSAEHDHSLSCVVTPQDGETSAQMIEENLNCLGHLSTIIHEANEEQGNSMMNLDWSWLTE'),
('P51857', '3BUV', 1, 1.35, 'A/B', 326, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '3-oxo-5-beta-steroid 4-dehydrogenase', 'AKR1D1', '5-beta-cholestan-3-one + NADP+ = cholest-4-en-3-one + NADPH<br />\n17,21-dihydroxy-5-beta-pregnane-3,11,20-trione + NADP+ = cortisone + NADPH<br />\n', 'aldo-keto reductase (NADP) activity<br />\ndelta4-3-oxosteroid 5beta-reductase activity<br />\nsteroid binding<br />\n', 'androgen metabolic process<br />\nbile acid biosynthetic process<br />\nbile acid catabolic process<br />\nC21-steroid hormone metabolic process<br />\ncholesterol catabolic process<br />\ndigestion<br />\noxidation-reduction process<br />\n', 'PF00248.', 'MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYRHIDGAYIYQNEHEVGEAIREKIAEGKVRREDIFYCGKLWATNHVPEMVRPTLERTLRVLQLDYVDLYIIEVPMAFKPGDEIYPRDENGKWLYHKSNLCATWEAMEACKDAGLVKSLGVSNFNRRQLELILNKPGLKHKPVSNQVECHPYFTQPKLLKFCQQHDIVITAYSPLGTSRNPIWVNVSSPPLLKDALLNSLGKRYNKTAAQIVLRFNIQRGVVVIPKSFNLERIKENFQIFDFSLTEEEMKDIEALNKNVRFVELLMWRDHPEYPFHDEY'),
('P21964', '3BWY', 1, 1.3, 'A', 214, 'TRANSFERASE', 'TRANSFERASE', 'Catechol O-methyltransferase', 'COMT', 'S-adenosyl-L-methionine + a catechol = S-adenosyl-L-homocysteine + a guaiacol<br />\n', 'catechol O-methyltransferase activity<br />\nL-dopa O-methyltransferase activity<br />\nmagnesium ion binding<br />\nmethyltransferase activity<br />\nO-methyltransferase activity<br />\norcinol O-methyltransferase activity<br />\n', 'cellular response to phosphate starvation<br />\ndevelopmental process<br />\ndopamine catabolic process<br />\nestrogen metabolic process<br />\nfemale pregnancy<br />\nlearning<br />\nmethylation<br />\nmulticellular organismal reproductive process<br />\nnegative regulation of dopamine metabolic process<br />\nnegative regulation of renal sodium excretion<br />\nnegative regulation of smooth muscle cell proliferation<br />\nneurotransmitter catabolic process<br />\npositive regulation of homocysteine metabolic process<br />\nregulation of sensory perception of pain<br />\nresponse to drug<br />\nresponse to lipopolysaccharide<br />\nresponse to organic cyclic compound<br />\nresponse to pain<br />\nshort-term memory<br />\n', 'PF01596.', 'MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLLMGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP'),
('O00555', '3BXK', 0, 2.55, 'B/D', 21, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Voltage-dependent P/Q-type calcium channel subunit alpha-1A', 'CACNA1A', '', 'calcium channel activity<br />\nhigh voltage-gated calcium channel activity<br />\nmetal ion binding<br />\nsyntaxin binding<br />\nvoltage-gated calcium channel activity<br />\n', 'calcium ion transmembrane transport<br />\ncell death<br />\ncellular response to amyloid-beta<br />\nmembrane depolarization<br />\nmembrane depolarization during action potential<br />\npositive regulation of cytosolic calcium ion concentration<br />\nregulation of insulin secretion<br />\nresponse to amyloid-beta<br />\n', 'PF08763.', 'MARFGDEMPARYGGGGSGAAAGVVVGSGGGRGAGGSRQGGQPGAQRMYKQSMAQRARTMALYNPIPVRQNCLTVNRSLFLFSEDNVVRKYAKKITEWPPFEYMILATIIANCIVLALEQHLPDDDKTPMSERLDDTEPYFIGIFCFEAGIKIIALGFAFHKGSYLRNGWNVMDFVVVLTGILATVGTEFDLRTLRAVRVLRPLKLVSGIPSLQVVLKSIMKAMIPLLQIGLLLFFAILIFAIIGLEFYMGKFHTTCFEEGTDDIQGESPAPCGTEEPARTCPNGTKCQPYWEGPNNGITQFDNILFAVLTVFQCITMEGWTDLLYNSNDASGNTWNWLYFIPLIIIGSFFMLNLVLGVLSGEFAKERERVENRRAFLKLRRQQQIERELNGYMEWISKAEEVILAEDETDGEQRHPFDGALRRTTIKKSKTDLLNPEEAEDQLADIASVGSPFARASIKSAKLENSTFFHKKERRMRFYIRRMVKTQAFYWTVLSLVALNTLCVAIVHYNQPEWLSDFLYYAEFIFLGLFMSEMFIKMYGLGTRPYFHSSFNCFDCGVIIGSIFEVIWAVIKPGTSFGISVLRALRLLRIFKVTKYWASLRNLVVSLLNSMKSIISLLFLLFLFIVVFALLGMQLFGGQFNFDEGTPPTNFDTFPAAIMTVFQILTGEDWNEVMYDGIKSQGGVQGGMVFSIYFIVLTLFGNYTLLNVFLAIAVDNLANAQELTKDEQEEEEAANQKLALQKAKEVAEVSPLSAANMSIAVKEQQKNQKPAKSVWEQRTSEMRKQNLLASREALYNEMDPDERWKAAYTRHLRPDMKTHLDRPLVVDPQENRNNNTNKSRAAEPTVDQRLGQQRAEDFLRKQARYHDRARDPSGSAGLDARRPWAGSQEAELSREGPYGRESDHHAREGSLEQPGFWEGEAERGKAGDPHRRHVHRQGGSRESRSGSPRTGADGEHRRHRAHRRPGEEGPEDKAERRARHREGSRPARGGEGEGEGPDGGERRRRHRHGAPATYEGDARREDKERRHRRRKENQGSGVPVSGPNLSTTRPIQQDLGRQDPPLAEDIDNMKNNKLATAESAAPHGSLGHAGLPQSPAKMGNSTDPGPMLAIPAMATNPQNAASRRTPNNPGNPSNPGPPKTPENSLIVTNPSGTQTNSAKTARKPDHTTVDIPPACPPPLNHTVVQVNKNANPDPLPKKEEEKKEEEEDDRGEDGPKPMPPYSSMFILSTTNPLRRLCHYILNLRYFEMCILMVIAMSSIALAAEDPVQPNAPRNNVLRYFDYVFTGVFTFEMVIKMIDLGLVLHQGAYFRDLWNILDFIVVSGALVAFAFTGNSKGKDINTIKSLRVLRVLRPLKTIKRLPKLKAVFDCVVNSLKNVFNILIVYMLFMFIFAVVAVQLFKGKFFHCTDESKEFEKDCRGKYLLYEKNEVKARDREWKKYEFHYDNVLWALLTLFTVSTGEGWPQVLKHSVDATFENQGPSPGYRMEMSIFYVVYFVVFPFFFVNIFVALIIITFQEQGDKMMEEYSLEKNERACIDFAISAKPLTRHMPQNKQSFQYRMWQFVVSPPFEYTIMAMIALNTIVLMMKFYGASVAYENALRVFNIVFTSLFSLECVLKVMAFGILNYFRDAWNIFDFVTVLGSITDILVTEFGNNFINLSFLRLFRAARLIKLLRQGYTIRILLWTFVQSFKALPYVCLLIAMLFFIYAIIGMQVFGNIGIDVEDEDSDEDEFQITEHNNFRTFFQALMLLFRSATGEAWHNIMLSCLSGKPCDKNSGILTRECGNEFAYFYFVSFIFLCSFLMLNLFVAVIMDNFEYLTRDSSILGPHHLDEYVRVWAEYDPAAWGRMPYLDMYQMLRHMSPPLGLGKKCPARVAYKRLLRMDLPVADDNTVHFNSTLMALIRTALDIKIAKGGADKQQMDAELRKEMMAIWPNLSQKTLDLLVTPHKSTDLTVGKIYAAMMIMEYYRQSKAKKLQAMREEQDRTPLMFQRMEPPSPTQEGGPGQNALPSTQLDPGGALMAHESGLKESPSWVTQRAQEMFQKTGTWSPEQGPPTDMPNSQPNSQSVEMREMGRDGYSDSEHYLPMEGQGRAASMPRLPAENQRRRGRPRGNNLSTISDTSPMKRSASVLGPKARRLDDYSLERVPPEENQRHHQRRRDRSHRASERSLGRYTDVDTGLGTDLSMTTQSGDLPSKERDQERGRPKDRKHRQHHHHHHHHHHPPPPDKDRYAQERPDHGRARARDQRWSRSPSEGREHMAHRQGSSSVSGSPAPSTSGTSTPRRGRRQLPQTPSTPRPHVSYSPVIRKAGGSGPPQQQQQQQQQQQAVARPGRAATSGPRRYPGPTAEPLAGDRPPTGGHSSGRSPRMERRVPGPARSESPRACRHGGARWPASGPHVSEGPPGPRHHGYYRGSDYDEADGPGSGGGEEAMAGAYDAPPPVRHASSGATGRSPRTPRASGPACASPSRHGRRLPNGYYPAHGLARPRGPGSRKGLHEPYSESDDDWC'),
('P52788', '3C6K', 1, 1.95, 'A/B/C/D', 362, 'TRANSFERASE', 'TRANSFERASE', 'Spermine synthase', 'SMS', 'S-adenosyl 3-(methylthio)propylamine + spermidine = S-methyl-5''-thioadenosine + spermine.<br />\n', 'spermine synthase activity<br />\n', 'methionine metabolic process<br />\npolyamine metabolic process<br />\nspermine biosynthetic process<br />\n', 'PF17284.', 'MAAARHSTLDFMLGAKADGETILKGLQSIFQEQGMAESVHTWQDHGYLATYTNKNGSFANLRIYPHGLVLLDLQSYDGDAQGKEEIDSILNKVEERMKELSQDSTGRVKRLPPIVRGGAIDRYWPTADGRLVEYDIDEVVYDEDSPYQNIKILHSKQFGNILILSGDVNLAESDLAYTRAIMGSGKEDYTGKDVLILGGGDGGILCEIVKLKPKMVTMVEIDQMVIDGCKKYMRKTCGDVLDNLKGDCYQVLIEDCIPVLKRYAKEGREFDYVINDLTAVPISTSPEEDSTWEFLRLILDLSMKVLKQDGKYFTQGNCVNLTEALSLYEEQLGRLYCPVEFSKEIVCVPSYLELWVFYTVWKKAKP'),
('P29166', '3C8Y', 1, 1.39, 'A', 574, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Iron hydrogenase 1', 'N/A', 'H2 + 2 oxidized ferredoxin = 2 reduced ferredoxin + 2 H+.', '4 iron, 4 sulfur cluster binding<br />\r\nelectron carrier activity<br />\r\nferredoxin hydrogenase activity<br />\r\niron ion binding<br />', NULL, 'PF02906.', 'MKTIIINGVQFNTDEDTTILKFARDNNIDISALCFLNNCNNDINKCEICT\r\nVEVEGTGLVTACDTLIEDGMIINTNSDAVNEKIKSRISQLLDIHEFKCGP\r\nCNRRENCEFLKLVIKYKARASKPFLPKDKTEYVDERSKSLTVDRTKCLLC\r\nGRCVNACGKNTETYAMKFLNKNGKTIIGAEDEKCFDDTNCLLCGQCIIAC\r\nPVAALSEKSHMDRVKNALNAPEKHVIVAMAPSVRASIGELFNMGFGVDVT\r\nGKIYTALRQLGFDKIFDINFGADMTIMEEATELVQRIENNGPFPMFTSCC\r\nPGWVRQAENYYPELLNNLSSAKSPQQIFGTASKTYYPSISGLDPKNVFTV\r\nTVMPCTSKKFEADRPQMEKDGLRDIDAVITTRELAKMIKDAKIPFAKLED\r\nSEADPAMGEYSGAGAIFGATGGVMEAALRSAKDFAENAELEDIEYKQVRG\r\nLNGIKEAEVEINNNKYNVAVINGASNLFKFMKSGMINEKQYHFIEVMACH\r\nGGCVNGGGQPHVNPKDLEKVDIKKVRASVLYNQDEHLSKRKSHENTALVK\r\nMYQNYFGKPGEGRAHEILHFKYKK'),
('P23258', '3CB2', 1, 2.3, 'A/B', 451, 'STRUCTURAL PROTEIN', 'OTHERS', 'Tubulin gamma-1 chain', 'TUBG1', '', 'GTPase activity<br />\nGTP binding<br />\nidentical protein binding<br />\nstructural constituent of cytoskeleton<br />\n', 'ciliary basal body-plasma membrane docking<br />\ncytoplasmic microtubule organization<br />\nG2/M transition of mitotic cell cycle<br />\nmeiotic spindle organization<br />\nmicrotubule cytoskeleton organization<br />\nmicrotubule nucleation<br />\nregulation of G2/M transition of mitotic cell cycle<br />\n', 'PF00091.', 'MPREIITLQLGQCGNQIGFEFWKQLCAEHGISPEGIVEEFATEGTDRKDVFFYQADDEHYIPRAVLLDLEPRVIHSILNSPYAKLYNPENIYLSEHGGGAGNNWASGFSQGEKIHEDIFDIIDREADGSDSLEGFVLCHSIAGGTGSGLGSYLLERLNDRYPKKLVQTYSVFPNQDEMSDVVVQPYNSLLTLKRLTQNADCVVVLDNTALNRIATDRLHIQNPSFSQINQLVSTIMSASTTTLRYPGYMNNDLIGLIASLIPTPRLHFLMTGYTPLTTDQSVASVRKTTVLDVMRRLLQPKNVMVSTGRDRQTNHCYIAILNIIQGEVDPTQVHKSLQRIRERKLANFIPWGPASIQVALSRKSPYLPSAHRVSGLMMANHTSISSLFERTCRQYDKLRKREAFLEQFRKEDMFKDNFDEMDTSREIVQQLIDEYHAATRPDYISWGTQEQ');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P03372', '3CBP', 1, 1.42, 'B', 10, 'TRANSFERASE / TRANSFERASE RECEPTOR', 'TRANSFERASE', 'Estrogen receptor', 'ESR1', '', 'ATPase binding<br />\nbeta-catenin binding<br />\nchromatin binding<br />\ncore promoter sequence-specific DNA binding<br />\nenzyme binding<br />\nestrogen receptor activity<br />\nestrogen receptor binding<br />\nestrogen response element binding<br />\nidentical protein binding<br />\nnitric-oxide synthase regulator activity<br />\nprotein kinase binding<br />\nRNA polymerase II core promoter proximal region sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding<br />\nsteroid binding<br />\nsteroid hormone receptor activity<br />\nTBP-class protein binding<br />\nTFIIB-class transcription factor binding<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\nzinc ion binding<br />\n', 'androgen metabolic process<br />\nantral ovarian follicle growth<br />\ncellular response to estradiol stimulus<br />\ncellular response to estrogen stimulus<br />\nchromatin remodeling<br />\nepithelial cell development<br />\nepithelial cell proliferation involved in mammary gland duct elongation<br />\nintracellular estrogen receptor signaling pathway<br />\nintracellular steroid hormone receptor signaling pathway<br />\nmale gonad development<br />\nmammary gland alveolus development<br />\nmammary gland branching involved in pregnancy<br />\nnegative regulation of gene expression<br />\nnegative regulation of I-kappaB kinase/NF-kappaB signaling<br />\nnegative regulation of production of miRNAs involved in gene silencing by miRNA<br />\nnegative regulation of sequence-specific DNA binding transcription factor activity<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of nitric-oxide synthase activity<br />\npositive regulation of phospholipase C activity<br />\npositive regulation of RNA polymerase II transcriptional preinitiation complex assembly<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprostate epithelial cord arborization involved in prostate glandular acinus morphogenesis<br />\nprostate epithelial cord elongation<br />\nprotein deubiquitination<br />\nprotein localization to chromatin<br />\nregulation of apoptotic process<br />\nregulation of branching involved in prostate gland morphogenesis<br />\nregulation of inflammatory response<br />\nregulation of intracellular estrogen receptor signaling pathway<br />\nregulation of toll-like receptor signaling pathway<br />\nregulation of transcription, DNA-templated<br />\nregulation of transcription from RNA polymerase II promoter<br />\nregulation of Wnt signaling pathway<br />\nresponse to estradiol<br />\nresponse to estrogen<br />\nsignal transduction<br />\nstem cell differentiation<br />\ntranscription, DNA-templated<br />\ntranscription from RNA polymerase II promoter<br />\ntranscription initiation from RNA polymerase II promoter<br />\nuterus development<br />\nvagina development<br />\n', 'PF12743.', 'MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPAVYNYPEGAAYEFNAAAAANAQVYGQTGLPYGPGSEAAAFGSNGLGGFPPLNSVSPSPLMLLHPPPQLSPFLQPHGQQVPYYLENEPSGYTVREAGPPAFYRPNSDNRRQGGRERLASTNDKGSMAMESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDGEGRGEVGSAGDMRAANLWPSPLMIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPTSRGGASVEETDQSHLATAGSTSSHSLQKYYITGEAEGFPATV'),
('P01556', '3CHB', 1, 1.25, 'D/E/F/G/H', 103, 'TOXIN', 'OTHERS', 'Cholera enterotoxin subunit B', 'ctxB', '', 'galactose binding<br />\nhost cell surface binding<br />\n', 'killing of cells of other organism<br />\npathogenesis<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nprotein ADP-ribosylation<br />\n', 'PF01376.', 'MIKLKFGVFFTVLLSSAYAHGTPQNITDLCAEYHNTQIYTLNDKIFSYTESLAGKREMAIITFKNGAIFQVEVPGSQHIDSQKKAIERMKDTLRIAYLTEAKVEKLCVWNNKTPHAIAAISMAN'),
('P00484', '3CLA', 1, 1.75, 'A', 213, 'TRANSFERASE (ACYLTRANSFERASE)', 'TRANSFERASE', 'Chloramphenicol acetyltransferase 3', 'cat3', 'Acetyl-CoA + chloramphenicol = CoA + chloramphenicol 3-acetate<br />\n', 'chloramphenicol O-acetyltransferase activity<br />\n', 'response to antibiotic<br />\n', 'PF00302.', 'MNYTKFDVKNWVRREHFEFYRHRLPCGFSLTSKIDITTLKKSLDDSAYKFYPVMIYLIAQAVNQFDELRMAIKDDELIVWDSVDPQFTVFHQETETFSALSCPYSSDIDQFMVNYLSVMERYKSDTKLFPQGVTPENHLNISALPWVNFDSFNLNVANFTDYFAPIITMAKYQQEGDRLLLPLSVQVHHAVCDGFHVARFINRLQELCNSKLK'),
('O95363', '3CMQ', 1, 2.2, 'A', 414, 'LIGASE', 'LIGASE', 'Phenylalanine--tRNA ligase, mitochondrial', 'FARS2', 'ATP + L-phenylalanine + tRNA(Phe) = AMP + diphosphate + L-phenylalanyl-tRNA(Phe)<br />\n', 'ATP binding<br />\nphenylalanine-tRNA ligase activity<br />\ntRNA binding<br />\n', 'phenylalanyl-tRNA aminoacylation<br />\ntRNA aminoacylation for protein translation<br />\ntRNA processing<br />\n', 'PF03147.', 'MVGSALRRGAHAYVYLVSKASHISRGHQHQAWGSRPPAAECATQRAPGSVVELLGKSYPQDDHSNLTRKVLTRVGRNLHNQQHHPLWLIKERVKEHFYKQYVGRFGTPLFSVYDNLSPVVTTWQNFDSLLIPADHPSRKKGDNYYLNRTHMLRAHTSAHQWDLLHAGLDAFLVVGDVYRRDQIDSQHYPIFHQLEAVRLFSKHELFAGIKDGESLQLFEQSSRSAHKQETHTMEAVKLVEFDLKQTLTRLMAHLFGDELEIRWVDCYFPFTHPSFEMEINFHGEWLEVLGCGVMEQQLVNSAGAQDRIGWAFGLGLERLAMILYDIPDIRLFWCEDERFLKQFCVSNINQKVKFQPLSKYPAVINDISFWLPSENYAENDFYDLVRTIGGDLVEKVDLIDKFVHPKTHKTSHCYRITYRHMERTLSQREVRHIHQALQEAAVQLLGVEGRF'),
('P32929', '3COG', 1, 2, 'A/B/C/D', 402, 'LYASE', 'LYASE', 'Cystathionine gamma-lyase', 'CTH', 'L-cystathionine + H2O = L-cysteine + NH3 + 2-oxobutanoate<br />\n', 'calmodulin binding<br />\ncarbon-sulfur lyase activity<br />\ncystathionine gamma-lyase activity<br />\ncystathionine gamma-synthase activity<br />\nhomocysteine desulfhydrase activity<br />\nidentical protein binding<br />\nL-cysteine desulfhydrase activity<br />\nL-cystine L-cysteine-lyase (deaminating)<br />\npyridoxal phosphate binding<br />\n', '''de novo'' L-methionine biosynthetic process<br />\ncellular response to leukemia inhibitory factor<br />\ncysteine biosynthetic process<br />\ncysteine biosynthetic process via cystathionine<br />\ncysteine metabolic process<br />\nendoplasmic reticulum unfolded protein response<br />\nhydrogen sulfide biosynthetic process<br />\nnegative regulation of apoptotic signaling pathway<br />\npositive regulation of aortic smooth muscle cell differentiation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of NF-kappaB transcription factor activity<br />\nprotein homotetramerization<br />\nprotein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine<br />\nprotein sulfhydration<br />\nsulfur amino acid catabolic process<br />\ntranssulfuration<br />\n', 'PF01053.', 'MQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFEYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNRYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAESLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS'),
('P0A7R5', '3D3B', 1, 1.3, 'J', 45, 'TRANSCRIPTION', 'TRANSCRIPTION', '30S ribosomal protein S10', 'rpsJ', '', 'RNA binding<br />\nstructural constituent of ribosome<br />\ntranscription antitermination factor activity, RNA binding<br />\n', 'transcription antitermination<br />\ntranslation<br />\n', 'PF00338.', 'MQNQRIRIRLKAFDHRLIDQATAEIVETAKRTGAQVRGPIPLPTRKERFTVLISPHVNKDARDQYEIRTHLRLVDIVEPTEKTVDALMRLDLAAGVDVQISLG'),
('Q7Z4W1', '3D3W', 1, 1.87, 'A/B', 244, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'L-xylulose reductase', 'DCXR', 'Xylitol + NADP+ = L-xylulose + NADPH<br />\n', 'identical protein binding<br />\nL-xylulose reductase (NADP+) activity<br />\noxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor<br />\n', 'D-xylose metabolic process<br />\nglucose metabolic process<br />\nglucuronate catabolic process to xylulose 5-phosphate<br />\nNADP metabolic process<br />\noxidation-reduction process<br />\nprotein homotetramerization<br />\nxylulose metabolic process<br />\n', '', 'MELFLAGRRVLVTGAGKGIGRGTVQALHATGARVVAVSRTQADLDSLVRECPGIEPVCVDLGDWEATERALGSVGPVDLLVNNAAVALLQPFLEVTKEAFDRSFEVNLRAVIQVSQIVARGLIARGVPGAIVNVSSQCSQRAVTNHSVYCSTKGALDMLTKVMALELGPHKIRVNAVNPTVVMTSMGQATWSDPHKAKTMLNRIPLGKFAEVEHVVNAILFLLSDRSGMTTGSTLPVEGGFWAC'),
('P06737', '3DDS', 1, 1.8, 'A/B', 846, 'TRANSFERASE', 'TRANSFERASE', 'Glycogen phosphorylase, liver form', 'PYGL', '((1->4)-alpha-D-glucosyl)(n) + phosphate = ((1->4)-alpha-D-glucosyl)(n-1) + alpha-D-glucose 1-phosphate.<br />\n', 'AMP binding<br />\nATP binding<br />\nbile acid binding<br />\ndrug binding<br />\nglucose binding<br />\nglycogen phosphorylase activity<br />\nlinear malto-oligosaccharide phosphorylase activity<br />\nprotein homodimerization activity<br />\npurine nucleobase binding<br />\npyridoxal phosphate binding<br />\nSHG alpha-glucan phosphorylase activity<br />\nvitamin binding<br />\n', '5-phosphoribose 1-diphosphate biosynthetic process<br />\nglucose homeostasis<br />\nglycogen catabolic process<br />\nglycogen metabolic process<br />\nnecroptotic process<br />\nneutrophil degranulation<br />\n', 'PF00343.', 'MAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNESNKVNGN'),
('P50870', '3DHO', 1, 1.8, 'A/B/C/D/E/F', 209, 'TRANSFERASE', 'TRANSFERASE', 'Streptogramin A acetyltransferase', 'vatD', '', 'transferase activity, transferring acyl groups<br />\n', 'response to antibiotic<br />\n', 'PF00132.', 'MGPNPMKMYPIEGNKSVQFIKPILEKLENVEVGEYSYYDSKNGETFDKQILYHYPILNDKLKIGKFCSIGPGVTIIMNGANHRMDGSTYPFNLFGNGWEKHMPKLDQLPIKGDTIIGNDVWIGKDVVIMPGVKIGDGAIVAANSVVVKDIAPYMLAGGNPANEIKQRFDQDTINQLLDIKWWNWPIDIINENIDKILDNSIIREVIWKK'),
('P00390', '3DK9', 1, 0.95, 'A', 478, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Glutathione reductase, mitochondrial', 'GSR', '2 glutathione + NADP+ = glutathione disulfide + NADPH.<br />\n', 'electron carrier activity<br />\nflavin adenine dinucleotide binding<br />\nglutathione-disulfide reductase activity<br />\nNADP binding<br />\n', 'cell redox homeostasis<br />\ncellular response to oxidative stress<br />\nglutathione metabolic process<br />\nnucleobase-containing small molecule interconversion<br />\n', 'PF07992.', 'MALLPRALSAGAGPSWRRAARAFRGFLLLLPEPAALTRALSRAMACRQEPQPQGPPPAAGAVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHSEFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDPKPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAGYIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKKTLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVDEFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPPIGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQGLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR'),
('P55809', '3DLX', 0, 2.2, 'A/B/C/D', 481, 'TRANSFERASE', 'TRANSFERASE', 'Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial', 'OXCT1', 'Succinyl-CoA + a 3-oxo acid = succinate + a 3-oxoacyl-CoA<br />\n', '3-oxoacid CoA-transferase activity<br />\nprotein homodimerization activity<br />\n', 'adipose tissue development<br />\nbrain development<br />\ncellular ketone body metabolic process<br />\nheart development<br />\nketone body catabolic process<br />\nketone catabolic process<br />\npositive regulation of insulin secretion involved in cellular response to glucose stimulus<br />\nresponse to activity<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to hormone<br />\nresponse to nutrient<br />\nresponse to starvation<br />\n', 'PF01144.', 'MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVLVGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENAEFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSVAIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAETTVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDDVRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEADADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMVKGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDKKKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN'),
('P33517', '3DTU', 1, 2.15, 'A/C', 566, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome c oxidase subunit 1', 'ctaD', '4 ferrocytochrome c + O2 + 4 H+ = 4 ferricytochrome c + 2 H2O.<br />\n', 'copper ion binding<br />\ncytochrome-c oxidase activity<br />\nheme binding<br />\niron ion binding<br />\n', 'aerobic respiration<br />\nelectron transport chain<br />\noxidative phosphorylation<br />\n', 'PF00115.', 'MADAAIHGHEHDRRGFFTRWFMSTNHKDIGVLYLFTGGLVGLISVAFTVYMRMELMAPGVQFMCAEHLESGLVKGFFQSLWPSAVENCTPNGHLWNVMITGHGILMMFFVVIPALFGGFGNYFMPLHIGAPDMAFPRMNNLSYWLYVAGTSLAVASLFAPGGNGQLGSGIGWVLYPPLSTSESGYSTDLAIFAVHLSGASSILGAINMITTFLNMRAPGMTMHKVPLFAWSIFVTAWLILLALPVLAGAITMLLTDRNFGTTFFQPSGGGDPVLYQHILWFFGHPEVYIIVLPAFGIVSHVIATFAKKPIFGYLPMVYAMVAIGVLGFVVWAHHMYTAGLSLTQQSYFMMATMVIAVPTGIKIFSWIATMWGGSIELKTPMLWALGFLFLFTVGGVTGIVLSQASVDRYYHDTYYVVAHFHYVMSLGAVFGIFAGIYFWIGKMSGRQYPEWAGKLHFWMMFVGANLTFFPQHFLGRQGMPRRYIDYPEAFATWNFVSSLGAFLSFASFLFFLGVIFYTLTRGARVTANNYWNEHADTLEWTLTSPPPEHTFEQLPKREDWERAPAH'),
('Q03736', '3DTU', 1, 2.15, 'B/D', 256, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome c oxidase subunit 2', 'ctaC', '4 ferrocytochrome c + O2 + 4 H+ = 4 ferricytochrome c + 2 H2O.<br />\n', 'copper ion binding<br />\ncytochrome-c oxidase activity<br />\n', 'electron transport chain<br />\n', 'PF00116.', 'MRHSTTLTGCATGAAGLLAATAAAAQQQSLEIIGRPQPGGTGFQPSASPVATQIHWLDGFILVIIAAITIFVTLLILYAVWRFHEKRNKVPARFTHNSPLEIAWTIVPIVILVAIGAFSLPVLFNQQEIPEADVTVKVTGYQWYWGYEYPDEEISFESYMIGSPATGGDNRMSPEVEQQLIEAGYSRDEFLLATDTAMVVPVNKTVVVQVTGADVIHSWTVPAFGVKQDAVPGRLAQLWFRAEREGIFFGQCSELCGISHAYMPITVKVVSEEAYAAWLEQARGGTYELSSVLPATPAGVSVE'),
('P17735', '3DYD', 1, 2.3, 'A/B', 404, 'TRANSFERASE', 'TRANSFERASE', 'Tyrosine aminotransferase', 'TAT', 'L-tyrosine + 2-oxoglutarate = 4-hydroxyphenylpyruvate + L-glutamate<br />\n', 'amino acid binding<br />\nL-phenylalanine:2-oxoglutarate aminotransferase activity<br />\nL-tyrosine:2-oxoglutarate aminotransferase activity<br />\npyridoxal phosphate binding<br />\n', '2-oxoglutarate metabolic process<br />\nbiosynthetic process<br />\nglutamate metabolic process<br />\nL-phenylalanine catabolic process<br />\nresponse to glucocorticoid<br />\nresponse to mercury ion<br />\nresponse to oxidative stress<br />\ntyrosine catabolic process<br />\n', 'PF00155.', 'MDPYMIQMSSKGNLPSILDVHVNVGGRSSVPGKMKGRKARWSVRPSDMAKKTFNPIRAIVDNMKVKPNPNKTMISLSIGDPTVFGNLPTDPEVTQAMKDALDSGKYNGYAPSIGFLSSREEIASYYHCPEAPLEAKDVILTSGCSQAIDLCLAVLANPGQNILVPRPGFSLYKTLAESMGIEVKLYNLLPEKSWEIDLKQLEYLIDEKTACLIVNNPSNPCGSVFSKRHLQKILAVAARQCVPILADEIYGDMVFSDCKYEPLATLSTDVPILSCGGLAKRWLVPGWRLGWILIHDRRDIFGNEIRDGLVKLSQRILGPCTIVQGALKSILCRTPGEFYHNTLSFLKSNADLCYGALAAIPGLRPVRPSGAMYLMVGIEMEHFPEFENDVEFTERLVAEQSVHCLPATCFEYPNFIRVVITVPEVMMLEACSRIQEFCEQHYHCAEGSQEECDK'),
('P09546', '3E2Q', 1, 1.75, 'A', 545, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Bifunctional protein PutA', 'putA', 'L-proline + a quinone = (S)-1-pyrroline-5-carboxylate + a quinol.<br />\nL-glutamate 5-semialdehyde + NAD+ + H2O = L-glutamate + NADH.<br />\n', '1-pyrroline-5-carboxylate dehydrogenase activity<br />\nbacterial-type RNA polymerase core promoter proximal region sequence-specific DNA binding<br />\nDNA binding<br />\nflavin adenine dinucleotide binding<br />\nidentical protein binding<br />\nproline dehydrogenase activity<br />\nsequence-specific DNA binding<br />\ntranscriptional repressor activity, bacterial-type RNA polymerase core promoter proximal region sequence-specific binding<br />\n', 'proline biosynthetic process<br />\nproline catabolic process to glutamate<br />\ntranscription, DNA-templated<br />\n', 'PF00171.', 'MGTTTMGVKLDDATRERIKSAATRIDRTPHWLIKQAIFSYLEQLENSDTLPELPALLSGAANESDEAPTPAEEPHQPFLDFAEQILPQSVSRAAITAAYRRPETEAVSMLLEQARLPQPVAEQAHKLAYQLADKLRNQKNASGRAGMVQGLLQEFSLSSQEGVALMCLAEALLRIPDKATRDALIRDKISNGNWQSHIGRSPSLFVNAATWGLLFTGKLVSTHNEASLSRSLNRIIGKSGEPLIRKGVDMAMRLMGEQFVTGETIAEALANARKLEEKGFRYSYDMLGEAALTAADAQAYMVSYQQAIHAIGKASNGRGIYEGPGISIKLSALHPRYSRAQYDRVMEELYPRLKSLTLLARQYDIGINIDAEESDRLEISLDLLEKLCFEPELAGWNGIGFVIQAYQKRCPLVIDYLIDLATRSRRRLMIRLVKGAYWDSEIKRAQMDGLEGYPVYTRKVYTDVSYLACAKKLLAVPNLIYPQFATHNAHTLAAIYQLAGQNYYPGQYEFQCLHGMGEPLYEQVTGKVADGKLNRPCRIYAPVGTHETLLAYLVRRLLENGANTSFVNRIADTSLPLDELVADPVTAVEKLAQQEGQTGLPHPKIPLPRDLYGHGRDNSAGLDLANEHRLASLSSALLNSALQKWQALPMLEQPVAAGEMSPVINPAEPKDIVGYVREATPREVEQALESAVNNAPIWFATPPAERAAILHRAAVLMESQMQQLIGILVREAGKTFSNAIAEVREAVDFLHYYAGQVRDDFANETHRPLGPVVCISPWNFPLAIFTGQIAAALAAGNSVLAKPAEQTPLIAAQGIAILLEAGVPPGVVQLLPGRGETVGAQLTGDDRVRGVMFTGSTEVATLLQRNIASRLDAQGRPIPLIAETGGMNAMIVDSSALTEQVVVDVLASAFDSAGQRCSALRVLCLQDEIADHTLKMLRGAMAECRMGNPGRLTTDIGPVIDSEAKANIERHIQTMRSKGRPVFQAVRENSEDAREWQSGTFVAPTLIELDDFAELQKEVFGPVLHVVRYNRNQLPELIEQINASGYGLTLGVHTRIDETIAQVTGSAHVGNLYVNRNMVGAVVGVQPFGGEGLSGTGPKAGGPLYLYRLLANRPESALAVTLARQDAKYPVDAQLKAALTQPLNALREWAANRPELQALCTQYGELAQAGTQRLLPGPTGERNTWTLLPRERVLCIADDEQDALTQLAAVLAVGSQVLWPDDALHRQLVKALPSAVSERIQLAKAENITAQPFDAVIFHGDSDQLRALCEAVAARDGTIVSVQGFARGESNILLERLYIERSLSVNTAAAGGNASLMTIG'),
('P35228', '3E7G', 1, 2.2, 'A/B/C/D', 424, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Nitric oxide synthase, inducible', 'NOS2', '2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O.<br />\n', 'arginine binding<br />\ncalmodulin binding<br />\nflavin adenine dinucleotide binding<br />\nFMN binding<br />\nheme binding<br />\niron ion binding<br />\nNADP binding<br />\nNADPH-hemoprotein reductase activity<br />\nnitric-oxide synthase activity<br />\nprotein homodimerization activity<br />\nreceptor binding<br />\ntetrahydrobiopterin binding<br />\n', 'arginine catabolic process<br />\ncell redox homeostasis<br />\ncellular response to drug<br />\ncellular response to interferon-gamma<br />\ncellular response to lipopolysaccharide<br />\ncircadian rhythm<br />\ndefense response to bacterium<br />\ndefense response to Gram-negative bacterium<br />\ninnate immune response in mucosa<br />\ninterleukin-6 secretion<br />\ninterleukin-8 secretion<br />\nnegative regulation of blood pressure<br />\nnegative regulation of gene expression<br />\nnegative regulation of protein catabolic process<br />\nnitric oxide biosynthetic process<br />\nnitric oxide mediated signal transduction<br />\npeptidyl-cysteine S-nitrosylation<br />\npositive regulation of blood vessel diameter<br />\npositive regulation of guanylate cyclase activity<br />\npositive regulation of killing of cells of other organism<br />\npositive regulation of leukocyte mediated cytotoxicity<br />\nprostaglandin secretion<br />\nregulation of cell proliferation<br />\nregulation of cellular respiration<br />\nregulation of cytokine production involved in inflammatory response<br />\nregulation of insulin secretion<br />\nresponse to bacterium<br />\nresponse to hypoxia<br />\nsuperoxide metabolic process<br />\n', 'PF00667.', 'MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLSKQQNESPQPLVETGKKSPESLVKLDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIMTPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQLTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNIRSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYGRFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVGGLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINIAVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEMLNYVLSPFYYYQVEAWKTHVWQDEKRRPKRREIPLKVLVKAVLFACMLMRKTMASRVRVTILFATETGKSEALAWDLGALFSCAFNPKVVCMDKYRLSCLEEERLLLVVTSTFGNGDCPGNGEKLKKSLFMLKELNNKFRYAVFGLGSSMYPRFCAFAHDIDQKLSHLGASQLTPMGEGDELSGQEDAFRSWAVQTFKAACETFDVRGKQHIQIPKLYTSNVTWDPHHYRLVQDSQPLDLSKALSSMHAKNVFTMRLKSRQNLQSPTSSRATILVELSCEDGQGLNYLPGEHLGVCPGNQPALVQGILERVVDGPTPHQTVRLEALDESGSYWVSDKRLPPCSLSQALTYFLDITTPPTQLLLQKLAQVATEEPERQRLEALCQPSEYSKWKFTNSPTFLEVLEEFPSLRVSAGFLLSQLPILKPRFYSISSSRDHTPTEIHLTVAVVTYHTRDGQGPLHHGVCSTWLNSLKPQDPVPCFVRNASGFHLPEDPSHPCILIGPGTGIAPFRSFWQQRLHDSQHKGVRGGRMTLVFGCRRPDEDHIYQEEMLEMAQKGVLHAVHTAYSRLPGKPKVYVQDILRQQLASEVLRVLHKEPGHLYVCGDVRMARDVAHTLKQLVAAKLKLNEEQVEDYFFQLKSQKRYHEDIFGAVFPYEAKKDRVAVQPSSLEMSAL'),
('Q16719', '3E9K', 1, 1.7, 'A', 465, 'HYDROLASE', 'HYDROLASE', 'Kynureninase', 'KYNU', 'L-kynurenine + H2O = anthranilate + L-alanine<br />\nL-3-hydroxykynurenine + H2O = 3-hydroxyanthranilate + L-alanine<br />\n', 'kynureninase activity<br />\nprotein homodimerization activity<br />\npyridoxal phosphate binding<br />\n', 'anthranilate metabolic process<br />\nL-kynurenine catabolic process<br />\nNAD biosynthetic process<br />\nquinolinate biosynthetic process<br />\nresponse to interferon-gamma<br />\nresponse to vitamin B6<br />\ntryptophan catabolic process<br />\ntryptophan catabolic process to acetyl-CoA<br />\ntryptophan catabolic process to kynurenine<br />\n', 'PF00266.', 'MEPSSLELPADTVQRIAAELKCHPTDERVALHLDEEDKLRHFRECFYIPKIQDLPPVDLSLVNKDENAIYFLGNSLGLQPKMVKTYLEEELDKWAKIAAYGHEVGKRPWITGDESIVGLMKDIVGANEKEIALMNALTVNLHLLMLSFFKPTPKRYKILLEAKAFPSDHYAIESQLQLHGLNIEESMRMIKPREGEETLRIEDILEVIEKEGDSIAVILFSGVHFYTGQHFNIPAITKAGQAKGCYVGFDLAHAVGNVELYLHDWGVDFACWCSYKYLNAGAGGIAGAFIHEKHAHTIKPALVGWFGHELSTRFKMDNKLQLIPGVCGFRISNPPILLVCSLHASLEIFKQATMKALRKKSVLLTGYLEYLIKHNYGKDKAATKKPVVNIITPSHVEERGCQLTITFSVPNKDVFQELEKRGVVCDKRNPNGIRVAPVPLYNSFHDVYKFTNLLTSILDSAETKN'),
('O60658', '3ECN', 1, 2.1, 'A/B', 338, 'HYDROLASE', 'HYDROLASE', 'High affinity cAMP-specific and IBMX-insensitive 3'',5''-cyclic phosphodiesterase 8A', 'PDE8A', 'Adenosine 3'',5''-cyclic phosphate + H2O = adenosine 5''-phosphate<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\n3'',5''-cyclic-nucleotide phosphodiesterase activity<br />\nkinase binding<br />\nmetal ion binding<br />\n', 'cAMP catabolic process<br />\ncellular response to epidermal growth factor stimulus<br />\ncyclic nucleotide metabolic process<br />\nnegative regulation of cell death<br />\nnegative regulation of hydrogen peroxide-induced cell death<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of protein phosphorylation<br />\nregulation of transcription, DNA-templated<br />\nsignal transduction<br />\n', 'PF00989.', 'MGCAPSIHISERLVAEDAPSPAAPPLSSGGPRLPQGQKTAALPRTRGAGLLESELRDGSGKKVAVADVQFGPMRFHQDQLQVLLVFTKEDNQCNGFCRACEKAGFKCTVTKEAQAVLACFLDKHHDIIIIDHRNPRQLDAEALCRSIRSSKLSENTVIVGVVRRVDREELSVMPFISAGFTRRYVENPNIMACYNELLQLEFGEVRSQLKLRACNSVFTALENSEDAIEITSEDRFIQYANPAFETTMGYQSGELIGKELGEVPINEKKADLLDTINSCIRIGKEWQGIYYAKKKNGDNIQQNVKIIPVIGQGGKIRHYVSIIRVCNGNNKAEKISECVQSDTHTDNQTGKHKDRRKGSLDVKAVASRATEVSSQRRHSSMARIHSMTIEAPITKVINIINAAQESSPMPVTEALDRVLEILRTTELYSPQFGAKDDDPHANDLVGGLMSDGLRRLSGNEYVLSTKNTQMVSSNIITPISLDDVPPRIARAMENEEYWDFDIFELEAATHNRPLIYLGLKMFARFGICEFLHCSESTLRSWLQIIEANYHSSNPYHNSTHSADVLHATAYFLSKERIKETLDPIDEVAALIAATIHDVDHPGRTNSFLCNAGSELAILYNDTAVLESHHAALAFQLTTGDDKCNIFKNMERNDYRTLRQGIIDMVLATEMTKHFEHVNKFVNSINKPLATLEENGETDKNQEVINTMLRTPENRTLIKRMLIKCADVSNPCRPLQYCIEWAARISEEYFSQTDEEKQQGLPVVMPVFDRNTCSIPKSQISFIDYFITDMFDAWDAFVDLPDLMQHLDNNFKYWKGLDEMKLRNLRPPPE'),
('P04054', '3ELO', 0, 1.55, 'A', 133, 'HYDROLASE', 'HYDROLASE', 'Phospholipase A2', 'PLA2G1B', 'Phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate<br />\n', 'bile acid binding<br />\ncalcium-dependent phospholipase A2 activity<br />\ncalcium ion binding<br />\nphospholipase A2 activity<br />\nphospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)<br />\nphospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)<br />\nreceptor binding<br />\n', 'actin filament organization<br />\nactivation of MAPK activity<br />\nactivation of phospholipase A2 activity<br />\nantibacterial humoral response<br />\nantimicrobial humoral immune response mediated by antimicrobial peptide<br />\narachidonic acid secretion<br />\ncellular response to insulin stimulus<br />\ndefense response to Gram-positive bacterium<br />\nfatty acid biosynthetic process<br />\nglucose transport<br />\ninnate immune response in mucosa<br />\ninterleukin-8 production<br />\nintracellular signal transduction<br />\nleukotriene biosynthetic process<br />\nmulticellular organismal lipid catabolic process<br />\nneutrophil chemotaxis<br />\nneutrophil mediated immunity<br />\nphosphatidic acid biosynthetic process<br />\nphosphatidylcholine acyl-chain remodeling<br />\nphosphatidylcholine metabolic process<br />\nphosphatidylethanolamine acyl-chain remodeling<br />\nphosphatidylglycerol acyl-chain remodeling<br />\nphosphatidylinositol acyl-chain remodeling<br />\nphosphatidylserine acyl-chain remodeling<br />\npositive regulation of calcium ion transport into cytosol<br />\npositive regulation of DNA replication<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of immune response<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of protein secretion<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nsignal transduction<br />\n', 'PF00068.', 'MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPVDELDKCCQTHDNCYDQAKKLDSCKFLLDNPYTHTYSYSCSGSAITCSSKNKECEAFICNCDRNAAICFSKAPYNKAHKNLDTKKYCQS'),
('P26358', '3EPZ', 1, 2.31, 'A/B', 250, 'TRANSFERASE', 'TRANSFERASE', 'DNA (cytosine-5)-methyltransferase 1', 'DNMT1', 'S-adenosyl-L-methionine + DNA = S-adenosyl-L-homocysteine + DNA containing 5-methylcytosine<br />\n', 'DNA (cytosine-5-)-methyltransferase activity<br />\nDNA binding<br />\nDNA-methyltransferase activity<br />\nmethyl-CpG binding<br />\npromoter-specific chromatin binding<br />\nRNA binding<br />\nzinc ion binding<br />\n', 'cellular response to amino acid stimulus<br />\ncovalent chromatin modification<br />\nDNA methylation<br />\nDNA methylation involved in embryo development<br />\ngene silencing<br />\nmaintenance of DNA methylation<br />\nnegative regulation of gene expression, epigenetic<br />\nnegative regulation of histone H3-K9 methylation<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of gene expression<br />\npositive regulation of histone H3-K4 methylation<br />\npositive regulation of methylation-dependent chromatin silencing<br />\nRas protein signal transduction<br />\nregulation of cell proliferation<br />\ntranscription, DNA-templated<br />\n', 'PF01426.', 'MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLHEFLQTEIKNQLCDLETKLRKEELSEEGYLAKVKSLLNKDLSLENGAHAYNREVNGRLENGNQARSEARRVGMADANSPPKPLSKPRTPRRSKSDGEAKPEPSPSPRITRKSTRQTTITSHFAKGPAKRKPQEESERAKSDESIKEEDKDQDEKRRRVTSRERVARPLPAEEPERAKSGTRTEKEEERDEKEEKRLRSQTKEPTPKQKLKEEPDREARAGVQADEDEDGDEKDEKKHRSQPKDLAAKRRPEEKEPEKVNPQISDEKDEDEKEEKRRKTTPKEPTEKKMARAKTVMNSKTHPPKCIQCGQYLDDPDLKYGQHPPDAVDEPQMLTNEKLSIFDANESGFESYEALPQHKLTCFSVYCKHGHLCPIDTGLIEKNIELFFSGSAKPIYDDDPSLEGGVNGKNLGPINEWWITGFDGGEKALIGFSTSFAEYILMDPSPEYAPIFGLMQEKIYISKIVVEFLQSNSDSTYEDLINKIETTVPPSGLNLNRFTEDSLLRHAQFVVEQVESYDEAGDSDEQPIFLTPCMRDLIKLAGVTLGQRRAQARRQTIRHSTREKDRGPTKATTTKLVYQIFDTFFAEQIEKDDREDKENAFKRRRCGVCEVCQQPECGKCKACKDMVKFGGSGRSKQACQERRCPNMAMKEADDDEEVDDNIPEMPSPKKMHQGKKKKQNKNRISWVGEAVKTDGKKSYYKKVCIDAETLEVGDCVSVIPDDSSKPLYLARVTALWEDSSNGQMFHAHWFCAGTDTVLGATSDPLELFLVDECEDMQLSYIHSKVKVIYKAPSENWAMEGGMDPESLLEGDDGKTYFYQLWYDQDYARFESPPKTQPTEDNKFKFCVSCARLAEMRQKEIPRVLEQLEDLDSRVLYYSATKNGILYRVGDGVYLPPEAFTFNIKLSSPVKRPRKEPVDEDLYPEHYRKYSDYIKGSNLDAPEPYRIGRIKEIFCPKKSNGRPNETDIKIRVNKFYRPENTHKSTPASYHADINLLYWSDEEAVVDFKAVQGRCTVEYGEDLPECVQVYSMGGPNRFYFLEAYNAKSKSFEDPPNHARSPGNKGKGKGKGKGKPKSQACEPSEPEIEIKLPKLRTLDVFSGCGGLSEGFHQAGISDTLWAIEMWDPAAQAFRLNNPGSTVFTEDCNILLKLVMAGETTNSRGQRLPQKGDVEMLCGGPPCQGFSGMNRFNSRTYSKFKNSLVVSFLSYCDYYRPRFFLLENVRNFVSFKRSMVLKLTLRCLVRMGYQCTFGVLQAGQYGVAQTRRRAIILAAAPGEKLPLFPEPLHVFAPRACQLSVVVDDKKFVSNITRLSSGPFRTITVRDTMSDLPEVRNGASALEISYNGEPQSWFQRQLRGAQYQPILRDHICKDMSALVAARMRHIPLAPGSDWRDLPNIEVRLSDGTMARKLRYTHHDRKNGRSSSGALRGVCSCVEAGKACDPAARQFNTLIPWCLPHTGNRHNHWAGLYGRLEWDGFFSTTVTNPEPMGKQGRVLHPEQHRVVSVRECARSQGFPDTYRLFGNILDKHRQVGNAVPPPLAKAIGLEIKLCMLAKARESASAKIKEEEAAKD'),
('Q02750', '3EQC', 1, 1.8, 'A', 359, 'TRANSFERASE', 'TRANSFERASE', 'Dual specificity mitogen-activated protein kinase kinase 1', 'MAP2K1', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nMAP kinase kinase activity<br />\nprotein C-terminus binding<br />\nprotein kinase activity<br />\nprotein N-terminus binding<br />\nprotein serine/threonine/tyrosine kinase activity<br />\nprotein serine/threonine kinase activator activity<br />\nprotein serine/threonine kinase activity<br />\nprotein tyrosine kinase activity<br />\nsignal transducer, downstream of receptor, with protein tyrosine phosphatase activity<br />\n', 'activation of MAPK activity<br />\nBergmann glial cell differentiation<br />\ncell cycle arrest<br />\ncell motility<br />\ncellular senescence<br />\ncerebellar cortex formation<br />\nchemotaxis<br />\nepithelial cell proliferation involved in lung morphogenesis<br />\nERK1 and ERK2 cascade<br />\nface development<br />\nheart development<br />\nkeratinocyte differentiation<br />\nlabyrinthine layer development<br />\nMAPK cascade<br />\nmovement of cell or subcellular component<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of gene expression<br />\nneuron differentiation<br />\nplacenta blood vessel development<br />\npositive regulation of axonogenesis<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of gene expression<br />\npositive regulation of production of miRNAs involved in gene silencing by miRNA<br />\npositive regulation of protein serine/threonine kinase activity<br />\npositive regulation of transcription, DNA-templated<br />\nprotein phosphorylation<br />\nproteolysis in other organism<br />\nregulation of apoptotic process<br />\nregulation of axon regeneration<br />\nregulation of early endosome to late endosome transport<br />\nregulation of Golgi inheritance<br />\nregulation of mitotic cell cycle<br />\nregulation of stress-activated MAPK cascade<br />\nsignal transduction<br />\nthymus development<br />\nthyroid gland development<br />\ntrachea formation<br />\n', 'PF00069.', 'MPKKKPTPIQLNPAPDGSAVNGTSSAETNLEALQKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV'),
('Q07912', '3EQR', 1, 2, 'A/B', 276, 'TRANSFERASE', 'TRANSFERASE', 'Activated CDC42 kinase 1', 'TNK2', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\nATP + a protein = ADP + a phosphoprotein<br />\n', 'ATP binding<br />\nepidermal growth factor receptor binding<br />\nGTPase inhibitor activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nprotein serine/threonine/tyrosine kinase activity<br />\nprotein serine/threonine kinase activity<br />\nprotein tyrosine kinase activity<br />\nubiquitin protein ligase binding<br />\nWW domain binding<br />\n', 'cell differentiation<br />\ncell migration<br />\ncell surface receptor signaling pathway<br />\nendocytosis<br />\ninnate immune response<br />\npeptidyl-tyrosine autophosphorylation<br />\nphosphorylation<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\nregulation of cell proliferation<br />\nregulation of clathrin-dependent endocytosis<br />\nsmall GTPase mediated signal transduction<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF09027.', 'MQPEEGTGWLLELLSEVQLQQYFLRLRDDLNVTRLSHFEYVKNEDLEKIGMGRPGQRRLWEAVKRRKALCKRKSWMSKVFSGKRLEAEFPPHHSQSTFRKTSPAPGGPAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEEPDKLHIQMNDVITVIEGRAENYWWRGQNTRTLCVGPFPRNVVTSVAGLSAQDISQPLQNSFIHTGHGDSDPRHCWGFPDRIDELYLGNPMDPPDLLSVELSTSRPPQHLGGVKKPTYDPVSEDQDPLSSDFKRLGLRKPGLPRGLWLAKPSARVPGTKASRGSGAEVTLIDFGEEPVVPALRPCAPSLAQLAMDACSLLDETPPQSPTRALPRPLHPTPVVDWDARPLPPPPAYDDVAQDEDDFEICSINSTLVGAGVPAGPSQGQTNYAFVPEQARPPPPLEDNLFLPPQGGGKPPSSAQTAEIFQALQQECMRQLQAPAGSPAPSPSPGGDDKPQVPPRVPIPPRPTRPHVQLSPAPPGEEETSQWPGPASPPRVPPREPLSPQGSRTPSPLVPPGSSPLPPRLSSSPGKTMPTTQSFASDPKYATPQVIQAPGPRAGPCILPIVRDGKKVSSTHYYLLPERPSYLERYQRFLREAQSPEEPTPLPVPLLLPPPSTPAPAAPTATVRPMPQAALDPKANFSTNNSNPGARPPPPRATARLPQRGCPGDGPEAGRPADKIQMAMVHGVTTEECQAALQCHGWSVQRAAQYLKVEQLFGLGLRPRGECHKVLEMFDWNLEQAGCHLLGSWGPAHHKR'),
('Q02218', '3ERY', 0, 1.95, 'P/Q', 9, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', '2-oxoglutarate dehydrogenase, mitochondrial', 'OGDH', '2-oxoglutarate + [dihydrolipoyllysine-residue succinyltransferase] lipoyllysine = [dihydrolipoyllysine-residue succinyltransferase] S-succinyldihydrolipoyllysine + CO2.<br />\n', 'chaperone binding<br />\nheat shock protein binding<br />\nmetal ion binding<br />\noxoglutarate dehydrogenase (NAD+) activity<br />\noxoglutarate dehydrogenase (succinyl-transferring) activity<br />\nthiamine pyrophosphate binding<br />\n', '2-oxoglutarate metabolic process<br />\ncellular nitrogen compound metabolic process<br />\ncerebellar cortex development<br />\ngeneration of precursor metabolites and energy<br />\nglycolytic process<br />\nhippocampus development<br />\nlysine catabolic process<br />\nNADH metabolic process<br />\nolfactory bulb mitral cell layer development<br />\npyramidal neuron development<br />\nstriatum development<br />\nsuccinyl-CoA metabolic process<br />\ntangential migration from the subventricular zone to the olfactory bulb<br />\nthalamus development<br />\ntricarboxylic acid cycle<br />\n', 'PF16078.', 'MFHLRTCAAKLRPLTASQTVKTFSQNRPAAARTFQQIRCYSAPVAAEPFLSGTSSNYVEEMYCAWLENPKSVHKSWDIFFRNTNAGAPPGTAYQSPLPLSRGSLAAVAHAQSLVEAQPNVDKLVEDHLAVQSLIRAYQIRGHHVAQLDPLGILDADLDSSVPADIISSTDKLGFYGLDESDLDKVFHLPTTTFIGGQESALPLREIIRRLEMAYCQHIGVEFMFINDLEQCQWIRQKFETPGIMQFTNEEKRTLLARLVRSTRFEEFLQRKWSSEKRFGLEGCEVLIPALKTIIDKSSENGVDYVIMGMPHRGRLNVLANVIRKELEQIFCQFDSKLEAADEGSGDVKYHLGMYHRRINRVTDRNITLSLVANPSHLEAADPVVMGKTKAEQFYCGDTEGKKVMSILLHGDAAFAGQGIVYETFHLSDLPSYTTHGTVHVVVNNQIGFTTDPRMARSSPYPTDVARVVNAPIFHVNSDDPEAVMYVCKVAAEWRSTFHKDVVVDLVCYRRNGHNEMDEPMFTQPLMYKQIRKQKPVLQKYAELLVSQGVVNQPEYEEEISKYDKICEEAFARSKDEKILHIKHWLDSPWPGFFTLDGQPRSMSCPSTGLTEDILTHIGNVASSVPVENFTIHGGLSRILKTRGEMVKNRTVDWALAEYMAFGSLLKEGIHIRLSGQDVERGTFSHRHHVLHDQNVDKRTCIPMNHLWPNQAPYTVCNSSLSEYGVLGFELGFAMASPNALVLWEAQFGDFHNTAQCIIDQFICPGQAKWVRQNGIVLLLPHGMEGMGPEHSSARPERFLQMCNDDPDVLPDLKEANFDINQLYDCNWVVVNCSTPGNFFHVLRRQILLPFRKPLIIFTPKSLLRHPEARSSFDEMLPGTHFQRVIPEDGPAAQNPENVKRLLFCTGKVYYDLTRERKARDMVGQVAITRIEQLSPFPFDLLLKEVQKYPNAELAWCQEEHKNQGYYDYVKPRLRTTISRAKPVWYAGRDPAAAPATGNKKTHLTELQRLLDTAFDLDVFKNFS'),
('P43026', '3EVS', 0, 2.1, 'B', 115, 'CYTOKINE / Transferase Receptor', 'TRANSFERASE', 'Growth/differentiation factor 5', 'GDF5', '', 'BMP binding<br />\ncytokine activity<br />\ngrowth factor activity<br />\nidentical protein binding<br />\ntransforming growth factor beta receptor binding<br />\n', 'cell-cell signaling<br />\ncell development<br />\nchondroblast differentiation<br />\nchondrocyte differentiation<br />\nembryonic limb morphogenesis<br />\nforelimb morphogenesis<br />\nhindlimb morphogenesis<br />\nnegative regulation of chondrocyte differentiation<br />\nnegative regulation of epithelial cell proliferation<br />\nnegative regulation of mesenchymal cell apoptotic process<br />\nnegative regulation of neuron apoptotic process<br />\nossification involved in bone remodeling<br />\npositive regulation of BMP signaling pathway<br />\npositive regulation of chondrocyte differentiation<br />\npositive regulation of neuron differentiation<br />\npositive regulation of pathway-restricted SMAD protein phosphorylation<br />\nregulation of apoptotic process<br />\nregulation of MAPK cascade<br />\nregulation of multicellular organism growth<br />\nresponse to mechanical stimulus<br />\nSMAD protein import into nucleus<br />\nSMAD protein signal transduction<br />\ntransforming growth factor beta receptor signaling pathway<br />\n', 'PF00019.', 'MRLPKLLTFLLWYLAWLDLEFICTVLGAPDLGQRPQGTRPGLAKAEAKERPPLARNVFRPGGHSYGGGATNANARAKGGTGQTGGLTQPKKDEPKKLPPRPGGPEPKPGHPPQTRQATARTVTPKGQLPGGKAPPKAGSVPSSFLLKKAREPGPPREPKEPFRPPPITPHEYMLSLYRTLSDADRKGGNSSVKLEAGLANTITSFIDKGQDDRGPVVRKQRYVFDISALEKDGLLGAELRILRKKPSDTAKPAAPGGGRAAQLKLSSCPSGRQPASLLDVRSVPGLDGSGWEVFDIWKLFRNFKNSAQLCLELEAWERGRAVDLRGLGFDRAARQVHEKALFLVFGRTKKRDLFFNEIKARSGQDDKTVYEYLFSQRRKRRAPLATRQGKRPSKNLKARCSRKALHVNFKDMGWDDWIIAPLEYEAFHCEGLCEFPLRSHLEPTNHAVIQTLMNSMDPESTPPTCCVPTRLSPISILFIDSANNVVYKQYEDMVVESCGCR'),
('P07003', '3EYA', 1, 2.5, 'A/B/C/D/E/F/G/H/I/J/K/L', 549, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Pyruvate dehydrogenase [ubiquinone]', 'poxB', 'Pyruvate + ubiquinone + H2O = acetate + CO2 + ubiquinol<br />\n', 'flavin adenine dinucleotide binding<br />\nidentical protein binding<br />\nlipid binding<br />\nmagnesium ion binding<br />\npyruvate dehydrogenase (quinone) activity<br />\nthiamine pyrophosphate binding<br />\n', 'protein homotetramerization<br />\npyruvate catabolic process<br />\npyruvate metabolic process<br />\n', 'PF02775.', 'MKQTVAAYIAKTLESAGVKRIWGVTGDSLNGLSDSLNRMGTIEWMSTRHEEVAAFAAGAEAQLSGELAVCAGSCGPGNLHLINGLFDCHRNHVPVLAIAAHIPSSEIGSGYFQETHPQELFRECSHYCELVSSPEQIPQVLAIAMRKAVLNRGVSVVVLPGDVALKPAPEGATMHWYHAPQPVVTPEEEELRKLAQLLRYSSNIALMCGSGCAGAHKELVEFAGKIKAPIVHALRGKEHVEYDNPYDVGMTGLIGFSSGFHTMMNADTLVLLGTQFPYRAFYPTDAKIIQIDINPASIGAHSKVDMALVGDIKSTLRALLPLVEEKADRKFLDKALEDYRDARKGLDDLAKPSEKAIHPQYLAQQISHFAADDAIFTCDVGTPTVWAARYLKMNGKRRLLGSFNHGSMANAMPQALGAQATEPERQVVAMCGDGGFSMLMGDFLSVVQMKLPVKIVVFNNSVLGFVAMEMKAGGYLTDGTELHDTNFARIAEACGITGIRVEKASEVDEALQRAFSIDGPVLVDVVVAKEELAIPPQIKLEQAKGFSLYMLRAIISGRGDEVIELAKTNWLR'),
('P22891', '3F1S', 1, 2.3, 'B', 276, 'HYDROLASE INHIBITOR / HYDROLASE', 'HYDROLASE', 'Vitamin K-dependent protein Z', 'PROZ', '', 'calcium ion binding<br />\nserine-type endopeptidase activity<br />\n', 'blood coagulation<br />\nER to Golgi vesicle-mediated transport<br />\nnegative regulation of blood coagulation<br />\npeptidyl-glutamic acid carboxylation<br />\nsignal peptide processing<br />\n', 'PF00008.', 'MAGCVPLLQGLVLVLALHRVEPSVFLPASKANDVLVRWKRAGSYLLEELFEGNLEKECYEEICVYEEAREVFENEVVTDEFWRRYKGGSPCISQPCLHNGSCQDSIWGYTCTCSPGYEGSNCELAKNECHPERTDGCQHFCLPGQESYTCSCAQGYRLGEDHKQCVPHDQCACGVLTSEKRAPDLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSLLHRNITVKTYFNRTSQDPLMIKITHVHVHMRYDADAGENDLSLLELEWPIQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWARNGTDLGNSLTTRPVTLVEGEECGQVLNVTVTTRTYCERSSVAAMHWMDGSVVTREHRGSWFLTGVLGSQPVGGQAHMVLVTKVSRYSLWFKQIMN'),
('P10768', '3FCX', 0, 1.5, 'A/B', 282, 'HYDROLASE', 'HYDROLASE', 'S-formylglutathione hydrolase', 'ESD', 'S-formylglutathione + H2O = glutathione + formate<br />\n4-methylumbelliferyl acetate + H2O = 4-methylumbelliferone + acetate<br />\n', 'carboxylic ester hydrolase activity<br />\nhydrolase activity, acting on ester bonds<br />\nidentical protein binding<br />\nmethylumbelliferyl-acetate deacetylase activity<br />\nS-formylglutathione hydrolase activity<br />\n', 'formaldehyde catabolic process<br />\nglutathione derivative biosynthetic process<br />\n', 'PF00756.', 'MALKQISSNKCFGGLQKVFEHDSVELNCKMKFAVYLPPKAETGKCPALYWLSGLTCTEQNFISKSGYHQSASEHGLVVIAPDTSPRGCNIKGEDESWDFGTGAGFYVDATEDPWKTNYRMYSYVTEELPQLINANFPVDPQRMSIFGHSMGGHGALICALKNPGKYKSVSAFAPICNPVLCPWGKKAFSGYLGTDQSKWKAYDATHLVKSYPGSQLDILIDQGKDDQFLLDGQLLPDNFIAACTEKKIPVVFRLQEGYDHSYYFIATFITDHIRHHAKYLNA'),
('P23280', '3FE4', 0, 1.9, 'A/B', 270, 'LYASE', 'LYASE', 'Carbonic anhydrase 6', 'CA6', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\ndetection of chemical stimulus involved in sensory perception of bitter taste<br />\none-carbon metabolic process<br />\n', 'PF00194.', 'MRALVLLLSLFLLGGQAQHVSDWTYSEGALDEAHWPQHYPACGGQRQSPINLQRTKVRYNPSLKGLNMTGYETQAGEFPMVNNGHTVQISLPSTMRMTVADGTVYIAQQMHFHWGGASSEISGSEHTVDGIRHVIEIHIVHYNSKYKSYDIAQDAPDGLAVLAAFVEVKNYPENTYYSNFISHLANIKYPGQRTTLTGLDVQDMLPRNLQHYYTYHGSLTTPPCTENVHWFVLADFVKLSRTQVWKLENSLLDHRNKTIHNDYRRTQPLNHRVVESNFPNQEYTLGSEFQFYLHKIEEILDYLRRALN'),
('P0AEZ1', '3FST', 1, 1.65, 'A/C/E', 296, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '5,10-methylenetetrahydrofolate reductase', 'metF', '5-methyltetrahydrofolate + NAD(P)+ = 5,10-methylenetetrahydrofolate + NAD(P)H<br />\n', 'FAD binding<br />\nmethylenetetrahydrofolate reductase (NAD(P)H) activity<br />\n', 'methionine biosynthetic process<br />\none-carbon metabolic process<br />\nprotein homotetramerization<br />\ntetrahydrofolate biosynthetic process<br />\ntetrahydrofolate interconversion<br />\n', 'PF02219.', 'MSFFHASQRDALNQSLAEVQGQINVSFEFFPPRTSEMEQTLWNSIDRLSSLKPKFVSVTYGANSGERDRTHSIIKGIKDRTGLEAAPHLTCIDATPDELRTIARDYWNNGIRHIVALRGDLPPGSGKPEMYASDLVTLLKEVADFDISVAAYPEVHPEAKSAQADLLNLKRKVDAGANRAITQFFFDVESYLRFRDRCVSAGIDVEIIPGILPVSNFKQAKKFADMTNVRIPAWMAQMFDGLDDDAETRKLVGANIAMDMVKILSREGVKDFHFYTLNRAEMSYAICHTLGVRPGL'),
('P39086', '3FV2', 1, 1.5, 'A/B', 115, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Glutamate receptor ionotropic, kainate 1', 'GRIK1', '', 'extracellular-glutamate-gated ion channel activity<br />\nkainate selective glutamate receptor activity<br />\nligand-gated ion channel activity<br />\n', 'central nervous system development<br />\nchemical synaptic transmission<br />\nglutamate receptor signaling pathway<br />\nnervous system development<br />\nregulation of synaptic transmission, glutamatergic<br />\ntransport<br />\n', 'PF01094.', 'MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKFAVTSINRNRTLMPNTTLTYDIQRINLFDSFEASRRACDQLALGVAALFGPSHSSSVSAVQSICNALEVPHIQTRWKHPSVDNKDLFYINLYPDYAAISRAILDLVLYYNWKTVTVVYEDSTGLIRLQELIKAPSRYNIKIKIRQLPSGNKDAKPLLKEMKKGKEFYVIFDCSHETAAEILKQILFMGMMTEYYHYFFTTLDLFALDLELYRYSGVNMTGFRLLNIDNPHVSSIIEKWSMERLQAPPRPETGLLDGMMTTEAALMYDAVYMVAIASHRASQLTVSSLQCHRHKPWRLGPRFMNLIKEARWDGLTGHITFNKTNGLRKDFDLDIISLKEEGTEKAAGEVSKHLYKVWKKIGIWNSNSGLNMTDSNKDKSSNITDSLANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCLDLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYVLLACLGVSCVLFVIARFTPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKMWAFMSSRQQTALVRNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYGVGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEDNKEASALGVENIGGIFIVLAAGLVLSVFVAIGEFIYKSRKNNDIEQAFCFFYGLQCKQTHPTNSTSGTTLSTDLECGKLIREERGIRKQSSVHTV'),
('P22748', '3FW3', 1, 1.72, 'A/B', 266, 'LYASE', 'LYASE', 'Carbonic anhydrase 4', 'CA4', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\none-carbon metabolic process<br />\n', 'PF00194.', 'MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKWGGNCQKDRQSPINIVTTKAKVDKKLGRFFFSGYDKKQTWTVQNNGHSVMMLLENKASISGGGLPAPYQAKQLHLHWSDLPYKGSEHSLDGEHFAMEMHIVHEKEKGTSRNVKEAQDPEDEIAVLAFLVEAGTQVNEGFQPLVEALSNIPKPEMSTTMAESSLLDLLPKEEKLRHYFRYLGSLTTPTCDEKVVWTVFREPIQLHREQILAFSQKLYYDKEQTVSMKDNVRPLQQLGQRTVIKSGAPGRPLPWALPALLGPMLACLLAGFLR');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('Q14289', '3FZS', 1, 1.75, 'A', 277, 'TRANSFERASE', 'TRANSFERASE', 'Protein-tyrosine kinase 2-beta', 'PTK2B', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', '3-phosphoinositide-dependent protein kinase binding<br />\nATP binding<br />\ncalmodulin-dependent protein kinase activity<br />\nNMDA glutamate receptor activity<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nprotein complex binding<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\nsignal transducer activity<br />\nubiquitin protein ligase binding<br />\n', 'activation of GTPase activity<br />\nactivation of Janus kinase activity<br />\nadaptive immune response<br />\nangiogenesis<br />\napoptotic process<br />\nblood vessel endothelial cell migration<br />\nbone resorption<br />\ncell surface receptor signaling pathway<br />\ncellular defense response<br />\ncellular response to fluid shear stress<br />\ncellular response to retinoic acid<br />\nchemokine-mediated signaling pathway<br />\nepidermal growth factor receptor signaling pathway<br />\nfocal adhesion assembly<br />\nglial cell proliferation<br />\ninnate immune response<br />\nintegrin-mediated signaling pathway<br />\nionotropic glutamate receptor signaling pathway<br />\nlong term synaptic depression<br />\nlong-term synaptic potentiation<br />\nMAPK cascade<br />\nmarginal zone B cell differentiation<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of bone mineralization<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of muscle cell apoptotic process<br />\nnegative regulation of myeloid cell differentiation<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of potassium ion transport<br />\nneuron projection development<br />\noocyte maturation<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of actin filament polymerization<br />\npositive regulation of angiogenesis<br />\npositive regulation of B cell chemotaxis<br />\npositive regulation of cell growth<br />\npositive regulation of cell-matrix adhesion<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of DNA biosynthetic process<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of excitatory postsynaptic potential<br />\npositive regulation of JNK cascade<br />\npositive regulation of JUN kinase activity<br />\npositive regulation of neuron projection development<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of nitric-oxide synthase activity<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of protein kinase activity<br />\npositive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process<br />\npositive regulation of synaptic transmission, glutamatergic<br />\npositive regulation of translation<br />\nprotein autophosphorylation<br />\nprotein complex assembly<br />\nprotein phosphorylation<br />\nregulation of actin cytoskeleton reorganization<br />\nregulation of calcium-mediated signaling<br />\nregulation of cell adhesion<br />\nregulation of cell shape<br />\nregulation of cGMP biosynthetic process<br />\nregulation of cGMP-mediated signaling<br />\nregulation of establishment of cell polarity<br />\nregulation of inositol trisphosphate biosynthetic process<br />\nregulation of macrophage chemotaxis<br />\nregulation of NMDA receptor activity<br />\nregulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process<br />\nregulation of release of sequestered calcium ion into cytosol<br />\nresponse to calcium ion<br />\nresponse to cAMP<br />\nresponse to cocaine<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to glucose<br />\nresponse to hormone<br />\nresponse to hydrogen peroxide<br />\nresponse to hypoxia<br />\nresponse to immobilization stress<br />\nresponse to lithium ion<br />\nresponse to mechanical stimulus<br />\nresponse to osmotic stress<br />\nresponse to stress<br />\nsignal complex assembly<br />\nsignal transduction<br />\nsprouting angiogenesis<br />\nstress fiber assembly<br />\ntumor necrosis factor-mediated signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\n', 'PF00373.', 'MSGVSEPLSRVKLGTLRRPEGPAEPMVVVPVDVEKEDVRILKVCFYSNSFNPGKNFKLVKCTVQTEIREIITSILLSGRIGPNIRLAECYGLRLKHMKSDEIHWLHPQMTVGEVQDKYECLHVEAEWRYDLQIRYLPEDFMESLKEDRTTLLYFYQQLRNDYMQRYASKVSEGMALQLGCLELRRFFKDMPHNALDKKSNFELLEKEVGLDLFFPKQMQENLKPKQFRKMIQQTFQQYASLREEECVMKFFNTLAGFANIDQETYRCELIQGWNITVDLVIGPKGIRQLTSQDAKPTCLAEFKQIRSIRCLPLEEGQAVLQLGIEGAPQALSIKTSSLAEAENMADLIDGYCRLQGEHQGSLIIHPRKDGEKRNSLPQIPMLNLEARRSHLSESCSIESDIYAEIPDETLRRPGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAMEQERNARYRTPKILEPTAFQEPPPKPSRPKYRPPPQTNLLAPKLQFQVPEGLCASSPTLTSPMEYPSPVNSLHTPPLHRHNVFKRHSMREEDFIQPSSREEAQQLWEAEKVKMRQILDKQQKQMVEDYQWLRQEEKSLDPMVYMNDKSPLTPEKEVGYLEFTGPPQKPPRLGAQSIQPTANLDRTDDLVYLNVMELVRAVLELKNELCQLPPEGYVVVVKNVGLTLRKLIGSVDDLLPSLPSSSRTEIEGTQKLLNKDLAELINKMRLAQQNAVTSLSEECKRQMLTASHTLAVDAKNLLDAVDQAKVLANLAHPPAE'),
('O00763', '3GID', 1, 2.3, 'A/B', 523, 'LIGASE', 'LIGASE', 'Acetyl-CoA carboxylase 2', 'ACACB', 'ATP + acetyl-CoA + HCO3- = ADP + phosphate + malonyl-CoA<br />\nATP + biotin-[carboxyl-carrier-protein] + HCO3- = ADP + phosphate + carboxy-biotin-[carboxyl-carrier-protein]<br />\n', 'acetyl-CoA carboxylase activity<br />\nATP binding<br />\nbiotin binding<br />\nbiotin carboxylase activity<br />\nidentical protein binding<br />\nmetal ion binding<br />\n', 'acetyl-CoA metabolic process<br />\nbiotin metabolic process<br />\ncarnitine shuttle<br />\nenergy homeostasis<br />\nfatty acid biosynthetic process<br />\nmalonyl-CoA biosynthetic process<br />\nnegative regulation of catalytic activity<br />\nnegative regulation of fatty acid beta-oxidation<br />\nnegative regulation of gene expression<br />\npositive regulation of cellular metabolic process<br />\npositive regulation of heart growth<br />\npositive regulation of lipid storage<br />\nprotein homotetramerization<br />\nregulation of cholesterol biosynthetic process<br />\nregulation of glucose metabolic process<br />\nresponse to drug<br />\nresponse to nutrient levels<br />\nresponse to organic cyclic compound<br />\n', 'PF08326.', 'MVLLLCLSCLIFSCLTFSWLKIWGKMTDSKPITKSKSEANLIPSQEPFPASDNSGETPQRNGEGHTLPKTPSQAEPASHKGPKDAGRRRNSLPPSHQKPPRNPLSSSDAAPSPELQANGTGTQGLEATDTNGLSSSARPQGQQAGSPSKEDKKQANIKRQLMTNFILGSFDDYSSDEDSVAGSSRESTRKGSRASLGALSLEAYLTTGEAETRVPTMRPSMSGLHLVKRGREHKKLDLHRDFTVASPAEFVTRFGGDRVIEKVLIANNGIAAVKCMRSIRRWAYEMFRNERAIRFVVMVTPEDLKANAEYIKMADHYVPVPGGPNNNNYANVELIVDIAKRIPVQAVWAGWGHASENPKLPELLCKNGVAFLGPPSEAMWALGDKIASTVVAQTLQVPTLPWSGSGLTVEWTEDDLQQGKRISVPEDVYDKGCVKDVDEGLEAAERIGFPLMIKASEGGGGKGIRKAESAEDFPILFRQVQSEIPGSPIFLMKLAQHARHLEVQILADQYGNAVSLFGRDCSIQRRHQKIVEEAPATIAPLAIFEFMEQCAIRLAKTVGYVSAGTVEYLYSQDGSFHFLELNPRLQVEHPCTEMIADVNLPAAQLQIAMGVPLHRLKDIRLLYGESPWGVTPISFETPSNPPLARGHVIAARITSENPDEGFKPSSGTVQELNFRSSKNVWGYFSVAATGGLHEFADSQFGHCFSWGENREEAISNMVVALKELSIRGDFRTTVEYLINLLETESFQNNDIDTGWLDYLIAEKVQAEKPDIMLGVVCGALNVADAMFRTCMTDFLHSLERGQVLPADSLLNLVDVELIYGGVKYILKVARQSLTMFVLIMNGCHIEIDAHRLNDGGLLLSYNGNSYTTYMKEEVDSYRITIGNKTCVFEKENDPTVLRSPSAGKLTQYTVEDGGHVEAGSSYAEMEVMKMIMTLNVQERGRVKYIKRPGAVLEAGCVVARLELDDPSKVHPAEPFTGELPAQQTLPILGEKLHQVFHSVLENLTNVMSGFCLPEPVFSIKLKEWVQKLMMTLRHPSLPLLELQEIMTSVAGRIPAPVEKSVRRVMAQYASNITSVLCQFPSQQIATILDCHAATLQRKADREVFFINTQSIVQLVQRYRSGIRGYMKTVVLDLLRRYLRVEHHFQQAHYDKCVINLREQFKPDMSQVLDCIFSHAQVAKKNQLVIMLIDELCGPDPSLSDELISILNELTQLSKSEHCKVALRARQILIASHLPSYELRHNQVESIFLSAIDMYGHQFCPENLKKLILSETTIFDVLPTFFYHANKVVCMASLEVYVRRGYIAYELNSLQHRQLPDGTCVVEFQFMLPSSHPNRMTVPISITNPDLLRHSTELFMDSGFSPLCQRMGAMVAFRRFEDFTRNFDEVISCFANVPKDTPLFSEARTSLYSEDDCKSLREEPIHILNVSIQCADHLEDEALVPILRTFVQSKKNILVDYGLRRITFLIAQEKEFPKFFTFRARDEFAEDRIYRHLEPALAFQLELNRMRNFDLTAVPCANHKMHLYLGAAKVKEGVEVTDHRFFIRAIIRHSDLITKEASFEYLQNEGERLLLEAMDELEVAFNNTSVRTDCNHIFLNFVPTVIMDPFKIEESVRYMVMRYGSRLWKLRVLQAEVKINIRQTTTGSAVPIRLFITNESGYYLDISLYKEVTDSRSGNIMFHSFGNKQGPQHGMLINTPYVTKDLLQAKRFQAQTLGTTYIYDFPEMFRQALFKLWGSPDKYPKDILTYTELVLDSQGQLVEMNRLPGGNEVGMVAFKMRFKTQEYPEGRDVIVIGNDITFRIGSFGPGEDLLYLRASEMARAEGIPKIYVAANSGARIGMAEEIKHMFHVAWVDPEDPHKGFKYLYLTPQDYTRISSLNSVHCKHIEEGGESRYMITDIIGKDDGLGVENLRGSGMIAGESSLAYEEIVTISLVTCRAIGIGAYLVRLGQRVIQVENSHIILTGASALNKVLGREVYTSNNQLGGVQIMHYNGVSHITVPDDFEGVYTILEWLSYMPKDNHSPVPIITPTDPIDREIEFLPSRAPYDPRWMLAGRPHPTLKGTWQSGFFDHGSFKEIMAPWAQTVVTGRARLGGIPVGVIAVETRTVEVAVPADPANLDSEAKIIQQAGQVWFPDSAYKTAQAVKDFNREKLPLMIFANWRGFSGGMKDMYDQVLKFGAYIVDGLRQYKQPILIYIPPYAELRGGSWVVIDATINPLCIEMYADKESRGGVLEPEGTVEIKFRKKDLIKSMRRIDPAYKKLMEQLGEPDLSDKDRKDLEGRLKAREDLLLPIYHQVAVQFADFHDTPGRMLEKGVISDILEWKTARTFLYWRLRRLLLEDQVKQEILQASGELSHVHIQSMLRRWFVETEGAVKAYLWDNNQVVVQWLEQHWQAGDGPRSTIRENITYLKHDSVLKTIRGLVEENPEVAVDCVIYLSQHISPAERAQVVHLLSTMDSPAST'),
('P07204', '3GIS', 0, 2.4, 'X/Y/Z', 121, 'BLOOD CLOTTING', 'OTHERS', 'Thrombomodulin', 'THBD', '', 'calcium ion binding<br />\nreceptor activity<br />\ntransmembrane signaling receptor activity<br />\n', 'blood coagulation<br />\nfemale pregnancy<br />\nleukocyte migration<br />\nnegative regulation of blood coagulation<br />\nnegative regulation of fibrinolysis<br />\nnegative regulation of platelet activation<br />\nresponse to cAMP<br />\nresponse to lipopolysaccharide<br />\nresponse to X-ray<br />\n', 'PF12662.', 'MLGVLVLGALALAGLGFPAPAEPQPGGSQCVEHDCFALYPGPATFLNASQICDGLRGHLMTVRSSVAADVISLLLNGDGGVGRRRLWIGLQLPPGCGDPKRLGPLRGFQWVTGDNNTSYSRWARLDLNGAPLCGPLCVAVSAAEATVPSEPIWEEQQCEVKADGFLCEFHFPATCRPLAVEPGAAAAAVSITYGTPFAARGADFQALPVGSSAAVAPLGLQLMCTAPPGAVQGHWAREAPGAWDCSVENGGCEHACNAIPGAPRCQCPAGAALQADGRSCTASATQSCNDLCEHFCVPNPDQPGSYSCMCETGYRLAADQHRCEDVDDCILEPSPCPQRCVNTQGGFECHCYPNYDLVDGECVEPVDPCFRANCEYQCQPLNQTSYLCVCAEGFAPIPHEPHRCQMFCNQTACPADCDPNTQASCECPEGYILDDGFICTDIDECENGGFCSGVCHNLPGTFECICGPDSALARHIGTDCDSGKVDGGDSGSGEPPPSPTPGSTLTPPAVGLVHSGLLIGISIASLCLVVALLALLCHLRKKQGAARAKMEYKCAAPSKEVVLQHVRTERTPQRL'),
('Q15759', '3GP0', 1, 1.9, 'A', 346, 'Transferase / Transferase Inhibitor', 'TRANSFERASE', 'Mitogen-activated protein kinase 11', 'MAPK11', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nMAP kinase activity<br />\nprotein serine/threonine kinase activity<br />\n', 'activation of MAPK activity<br />\ncellular response to virus<br />\nintracellular signal transduction<br />\nnegative regulation of cardiac muscle cell proliferation<br />\npositive regulation of gene expression<br />\npositive regulation of interleukin-12 secretion<br />\npositive regulation of muscle cell differentiation<br />\nRas protein signal transduction<br />\nregulation of sequence-specific DNA binding transcription factor activity<br />\nregulation of signal transduction by p53 class mediator<br />\nresponse to stress<br />\nsignal transduction<br />\ntranscription, DNA-templated<br />\nvascular endothelial growth factor receptor signaling pathway<br />\n', 'PF00069.', 'MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWKELTYQEVLSFKPPEPPKPPGSLEIEQ'),
('P14618', '3GR4', 1, 1.6, 'A/B/C/D', 531, 'TRANSFERASE', 'TRANSFERASE', 'Pyruvate kinase PKM', 'PKM', 'ATP + pyruvate = ADP + phosphoenolpyruvate<br />\n', 'ADP binding<br />\nATP binding<br />\ncadherin binding<br />\nidentical protein binding<br />\nkinase activity<br />\nmagnesium ion binding<br />\nMHC class II protein complex binding<br />\npotassium ion binding<br />\npyruvate kinase activity<br />\nRNA binding<br />\nthyroid hormone binding<br />\n', 'animal organ regeneration<br />\nATP biosynthetic process<br />\ncanonical glycolysis<br />\ncellular response to insulin stimulus<br />\nliver development<br />\nneutrophil degranulation<br />\nprogrammed cell death<br />\nprotein homotetramerization<br />\npyruvate biosynthetic process<br />\nresponse to gravity<br />\nresponse to hypoxia<br />\nresponse to muscle inactivity<br />\nresponse to nutrient<br />\nskeletal muscle tissue regeneration<br />\n', 'PF00224.', 'MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP'),
('P21266', '3GTU', 0, 2.8, 'B/D', 224, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase Mu 3', 'GSTM3', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'enzyme binding<br />\nglutathione binding<br />\nglutathione transferase activity<br />\nidentical protein binding<br />\nprotein homodimerization activity<br />\n', 'cellular detoxification of nitrogen compound<br />\nestablishment of blood-nerve barrier<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nnitrobenzene metabolic process<br />\nresponse to estrogen<br />\nxenobiotic catabolic process<br />\n', 'PF00043.', 'MSCESSMVLGYWDIRGLAHAIRLLLEFTDTSYEEKRYTCGEAPDYDRSQWLDVKFKLDLDFPNLPYLLDGKNKITQSNAILRYIARKHNMCGETEEEKIRVDIIENQVMDFRTQLIRLCYSSDHEKLKPQYLEELPGQLKQFSMFLGKFSWFAGEKLTFVDFLTYDILDQNRIFDPKCLDEFPNLKAFMCRFEALEKIAAYLQSDQFCKMPINNKMAQWGNKPVC'),
('P04271', '3HCM', 1, 2, 'A/B', 92, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Protein S100-B', 'S100B', '', 'calcium-dependent protein binding<br />\ncalcium ion binding<br />\nidentical protein binding<br />\nprotein homodimerization activity<br />\nRAGE receptor binding<br />\nS100 protein binding<br />\ntau protein binding<br />\nzinc ion binding<br />\n', 'astrocyte differentiation<br />\naxonogenesis<br />\ncell proliferation<br />\ncellular response to hypoxia<br />\ncentral nervous system development<br />\ninnate immune response<br />\nlearning or memory<br />\nlong-term synaptic potentiation<br />\nmemory<br />\nnegative regulation of skeletal muscle cell differentiation<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell proliferation<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of myelination<br />\nregulation of cell shape<br />\nregulation of neuronal synaptic plasticity<br />\nresponse to glucocorticoid<br />\nresponse to methylmercury<br />\n', 'PF00036.', 'MSELEKAMVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDNDGDGECDFQEFMAFVAMVTTACHEFFEHE'),
('P22830', '3HCN', 1, 1.6, 'A/B', 359, 'LYASE', 'LYASE', 'Ferrochelatase, mitochondrial', 'FECH', 'Protoheme + 2 H+ = protoporphyrin + Fe2+.<br />\n', '2 iron, 2 sulfur cluster binding<br />\nferrochelatase activity<br />\nferrous iron binding<br />\n', 'cellular response to dexamethasone stimulus<br />\ngeneration of precursor metabolites and energy<br />\nheme biosynthetic process<br />\nprotoporphyrinogen IX metabolic process<br />\nresponse to arsenic-containing substance<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to insecticide<br />\nresponse to lead ion<br />\nresponse to light stimulus<br />\nresponse to methylmercury<br />\nresponse to platinum ion<br />\n', 'PF00762.', 'MRSLGANMAAALRAAGVLLRDPLASSSWRVCQPWRWKSGAAAAAVTTETAQHAQGAKPQVQPQKRKPKTGILMLNMGGPETLGDVHDFLLRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQEQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERDGLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQVGRKPTMKWSTIDRWPTHHLLIQCFADHILKELDHFPLEKRSEVVILFSAHSLPMSVVNRGDPYPQEVSATVQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIETLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSCPLCVNPVCRETKSFFTSQQL'),
('P19801', '3HIG', 1, 2.09, 'A/B', 731, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Amiloride-sensitive amine oxidase [copper-containing]', 'AOC1', 'Histamine + H2O + O2 = (imidazol-4-yl)acetaldehyde + NH3 + H2O2<br />\n', 'calcium ion binding<br />\ncopper ion binding<br />\ndiamine oxidase activity<br />\ndrug binding<br />\nheparin binding<br />\nhistamine oxidase activity<br />\nmethylputrescine oxidase activity<br />\nprimary amine oxidase activity<br />\npropane-1,3-diamine oxidase activity<br />\nprotein complex binding<br />\nprotein homodimerization activity<br />\nquinone binding<br />\nreceptor activity<br />\nzinc ion binding<br />\n', 'amine metabolic process<br />\ncellular response to azide<br />\ncellular response to copper ion<br />\ncellular response to copper ion starvation<br />\ncellular response to heparin<br />\ncellular response to histamine<br />\nneutrophil degranulation<br />\noxidation-reduction process<br />\nresponse to antibiotic<br />\nresponse to drug<br />\nxenobiotic metabolic process<br />\n', 'PF01179.', 'MPALGWAVAAILMLQTAMAEPSPGTLPRKAGVFSDLSNQELKAVHSFLWSKKELRLQPSSTTTMAKNTVFLIEMLLPKKYHVLRFLDKGERHPVREARAVIFFGDQEHPNVTEFAVGPLPGPCYMRALSPRPGYQSSWASRPISTAEYALLYHTLQEATKPLHQFFLNTTGFSFQDCHDRCLAFTDVAPRGVASGQRRSWLIIQRYVEGYFLHPTGLELLVDHGSTDAGHWAVEQVWYNGKFYGSPEELARKYADGEVDVVVLEDPLPGGKGHDSTEEPPLFSSHKPRGDFPSPIHVSGPRLVQPHGPRFRLEGNAVLYGGWSFAFRLRSSSGLQVLNVHFGGERIAYEVSVQEAVALYGGHTPAGMQTKYLDVGWGLGSVTHELAPGIDCPETATFLDTFHYYDADDPVHYPRALCLFEMPTGVPLRRHFNSNFKGGFNFYAGLKGQVLVLRTTSTVYNYDYIWDFIFYPNGVMEAKMHATGYVHATFYTPEGLRHGTRLHTHLIGNIHTHLVHYRVDLDVAGTKNSFQTLQMKLENITNPWSPRHRVVQPTLEQTQYSWERQAAFRFKRKLPKYLLFTSPQENPWGHKRTYRLQIHSMADQVLPPGWQEEQAITWARYPLAVTKYRESELCSSSIYHQNDPWHPPVVFEQFLHNNENIENEDLVAWVTVGFLHIPHSEDIPNTATPGNSVGFLLRPFNFFPEDPSLASRDTVIVWPRDNGPNYVQRWIPEDRDCSMPPPFSYNGTYRPV'),
('P42684', '3HMI', 1, 1.65, 'A', 268, 'TRANSFERASE', 'TRANSFERASE', 'Abelson tyrosine-protein kinase 2', 'ABL2', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'actin filament binding<br />\nactin monomer binding<br />\nATP binding<br />\nmagnesium ion binding<br />\nmanganese ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein kinase activity<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\n', 'cell adhesion<br />\ncellular protein modification process<br />\ncellular response to retinoic acid<br />\ninnate immune response<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of neuron projection development<br />\npositive regulation of oxidoreductase activity<br />\npositive regulation of phospholipase C activity<br />\nregulation of actin cytoskeleton reorganization<br />\nregulation of autophagy<br />\nregulation of cell adhesion<br />\nregulation of cell motility<br />\nregulation of cell proliferation<br />\nregulation of endocytosis<br />\nsignal transduction<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF08919.', 'MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFTQHDHFASCVEDGFEGDKTGGSSPEALHRPYGCDVEPQALNEAIRWSSKENLLGATESDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNQNGEWSEVRSKNGQGWVPSNYITPVNSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRESESSPGQLSISLRYEGRVYHYRINTTADGKVYVTAESRFSTLAELVHHHSTVADGLVTTLHYPAPKCNKPTVYGVSPIHDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDSSISEEVAEELGRAASSSSVVPYLPRLPILPSKTRTLKKQVENKENIEGAQDATENSASSLAPGFIRGAQASSGSPALPRKQRDKSPSSLLEDAKETCFTRDRKGGFFSSFMKKRNAPTPPKRSSSFREMENQPHKKYELTGNFSSVASLQHADGFSFTPAQQEANLVPPKCYGGSFAQRNLCNDDGGGGGGSGTAGGGWSGITGFFTPRLIKKTLGLRAGKPTASDDTSKPFPRSNSTSSMSSGLPEQDRMAMTLPRNCQRSKLQLERTVSTSSQPEENVDRANDMLPKKSEESAAPSRERPKAKLLPRGATALPLRTPSGDLAITEKDPPGVGVAGVAAAPKGKEKNGGARLGMAGVPEDGEQPGWPSPAKAAPVLPTTHNHKVPVLISPTLKHTPADVQLIGTDSQGNKFKLLSEHQVTSSGDKDRPRRVKPKCAPPPPPVMRLLQHPSICSDPTEEPTALTAGQSTSETQEGGKKAALGAVPISGKAGRPVMPPPQVPLPTSSISPAKMANGTAGTKVALRKTKQAAEKISADKISKEALLECADLLSSALTEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQELQVSSAAAGVPGTNPVLNNLLSCVQEISDVVQR'),
('P04958', '3HMY', 1, 2, 'A', 450, 'HYDROLASE', 'HYDROLASE', 'Tetanus toxin', 'tetX', 'Hydrolysis of 76-Gln-|-Phe-77 bond in synaptobrevin 2.<br />\n', 'metalloendopeptidase activity<br />\nprotein transmembrane transporter activity<br />\ntoxin activity<br />\nzinc ion binding<br />\n', 'inhibition of neurotransmitter uptake<br />\nnegative regulation of neurotransmitter secretion<br />\n', 'PF01742.', 'MPITINNFRYSDPVNNDTIIMMEPPYCKGLDIYYKAFKITDRIWIVPERYEFGTKPEDFNPPSSLIEGASEYYDPNYLRTDSDKDRFLQTMVKLFNRIKNNVAGEALLDKIINAIPYLGNSYSLLDKFDTNSNSVSFNLLEQDPSGATTKSAMLTNLIIFGPGPVLNKNEVRGIVLRVDNKNYFPCRDGFGSIMQMAFCPEYVPTFDNVIENITSLTIGKSKYFQDPALLLMHELIHVLHGLYGMQVSSHEIIPSKQEIYMQHTYPISAEELFTFGGQDANLISIDIKNDLYEKTLNDYKAIANKLSQVTSCNDPNIDIDSYKQIYQQKYQFDKDSNGQYIVNEDKFQILYNSIMYGFTEIELGKKFNIKTRLSYFSMNHDPVKIPNLLDDTIYNDTEGFNIESKDLKSEYKGQNMRVNTNAFRNVDGSGLVSKLIGLCKKIIPPTNIRENLYNRTASLTDLGGELCIKIKNEDLTFIAEKNSFSEEPFQDEIVSYNTKNKPLNFNYSLDKIIVDYNLQSKITLPNDRTTPVTKGIPYAPEYKSNAASTIEIHNIDDNTIYQYLYAQKSPTTLQRITMTNSVDDALINSTKIYSYFPSVISKVNQGAQGILFLQWVRDIIDDFTNESSQKTTIDKISDVSTIVPYIGPALNIVKQGYEGNFIGALETTGVVLLLEYIPEITLPVIAALSIAESSTQKEKIIKTIDNFLEKRYEKWIEVYKLVKAKWLGTVNTQFQKRSYQMYRSLEYQVDAIKKIIDYEYKIYSGPDKEQIADEINNLKNKLEEKANKAMININIFMRESSRSFLVNQMINEAKKQLLEFDTQSKNILMQYIKANSKFIGITELKKLESKINKVFSTPIPFSYSKNLDCWVDNEEDIDVILKKSTILNLDINNDIISDISGFNSSVITYPDAQLVPGINGKAIHLVNNESSEVIVHKAMDIEYNDMFNNFTVSFWLRVPKVSASHLEQYGTNEYSIISSMKKHSLSIGSGWSVSLKGNNLIWTLKDSAGEVRQITFRDLPDKFNAYLANKWVFITITNDRLSSANLYINGVLMGSAEITGLGAIREDNNITLKLDRCNNNNQYVSIDKFRIFCKALNPKEIEKLYTSYLSITFLRDFWGNPLRYDTEYYLIPVASSSKDVQLKNITDYMYLTNAPSYTNGKLNIYYRRLYNGLKFIIKRYTPNNEIDSFVKSGDFIKLYVSYNNNEHIVGYPKDGNAFNNLDRILRVGYNAPGIPLYKKMEAVKLRDLKTYSVQLKLYDDKNASLGLVGTHNGQIGNDPNRDILIASNWYFNHLKDKILGCDWYFVPTDEGWTND'),
('P12271', '3HX3', 1, 1.69, 'A', 316, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Retinaldehyde-binding protein 1', 'RLBP1', '', '11-cis retinal binding<br />\nretinol binding<br />\ntransporter activity<br />\n', 'response to stimulus<br />\nretinoid metabolic process<br />\nvisual perception<br />\nvitamin A metabolic process<br />\n', 'PF00650.', 'MSEGVGTFRMVPEEEQELRAQLEQLTTKDHGPVFGPCSQLPRHTLQKAKDELNEREETREEAVRELQEMVQAQAASGEELAVAVAERVQEKDSGFFLRFIRARKFNVGRAYELLRGYVNFRLQYPELFDSLSPEAVRCTIEAGYPGVLSSRDKYGRVVMLFNIENWQSQEITFDEILQAYCFILEKLLENEETQINGFCIIENFKGFTMQQAASLRTSDLRKMVDMLQDSFPARFKAIHFIHQPWYFTTTYNVVKPFLKSKLLERVFVHGDDLSGFYQEIDENILPSDFGGTLPKYDGKAVAEQLFGPQAQAENTAF'),
('Q9L9D7', '3I2K', 1, 1.51, 'A', 574, 'HYDROLASE', 'HYDROLASE', 'Cocaine esterase', 'cocE', 'Cocaine + H2O = ecgonine methyl ester + benzoate<br />\n', 'carboxylic ester hydrolase activity<br />\ndipeptidyl-peptidase activity<br />\n', 'cocaine catabolic process<br />\n', 'PF02129.', 'MVDGNYSVASNVMVPMRDGVRLAVDLYRPDADGPVPVLLVRNPYDKFDVFAWSTQSTNWLEFVRDGYAVVIQDTRGLFASEGEFVPHVDDEADAEDTLSWILEQAWCDGNVGMFGVSYLGVTQWQAAVSGVGGLKAIAPSMASADLYRAPWYGPGGALSVEALLGWSALIGTGLITSRSDARPEDAADFVQLAAILNDVAGAASVTPLAEQPLLGRLIPWVIDQVVDHPDNDESWQSISLFERLGGLATPALITAGWYDGFVGESLRTFVAVKDNADARLVVGPWSHSNLTGRNADRKFGIAATYPIQEATTMHKAFFDRHLRGETDALAGVPKVRLFVMGIDEWRDETDWPLPDTAYTPFYLGGSGAANTSTGGGTLSTSISGTESADTYLYDPADPVPSLGGTLLFHNGDNGPADQRPIHDRDDVLCYSTEVLTDPVEVTGTVSARLFVSSSAVDTDFTAKLVDVFPDGRAIALCDGIVRMRYRETLVNPTLIEAGEIYEVAIDMLATSNVFLPGHRIMVQVSSSNFPKYDRNSNTGGVIAREQLEEMCTAVNRIHRGPEHPSHIVLPIIKR'),
('O94760', '3I4A', 1, 1.9, 'A/B', 285, 'HYDROLASE', 'HYDROLASE', 'N(G),N(G)-dimethylarginine dimethylaminohydrolase 1', 'DDAH1', 'N(omega),N(omega)-dimethyl-L-arginine + H2O = dimethylamine + L-citrulline<br />\n', 'amino acid binding<br />\ncatalytic activity<br />\ndimethylargininase activity<br />\nmetal ion binding<br />\n', 'arginine catabolic process<br />\ncitrulline metabolic process<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of cellular response to hypoxia<br />\nnegative regulation of vascular permeability<br />\nnitric oxide mediated signal transduction<br />\npositive regulation of angiogenesis<br />\npositive regulation of nitric oxide biosynthetic process<br />\nregulation of nitric-oxide synthase activity<br />\nregulation of systemic arterial blood pressure<br />\n', '', 'MAGLGHPAAFGRATHAVVRALPESLGQHALRSAKGEEVDVARAERQHQLYVGVLGSKLGLQVVELPADESLPDCVFVEDVAVVCEETALITRPGAPSRRKEVDMMKEALEKLQLNIVEMKDENATLDGGDVLFTGREFFVGLSKRTNQRGAEILADTFKDYAVSTVPVADGLHLKSFCSMAGPNLIAIGSSESAQKALKIMQQMSDHRYDKLTVPDDIAANCIYLNIPNKGHVLLHRTPEEYPESAKVYEKLKDHMLIPVSMSELEKVDGLLTCCSVLINKKVDS'),
('P0AAI5', '3I8P', 1, 1.9, 'A', 412, 'TRANSFERASE', 'TRANSFERASE', '3-oxoacyl-[acyl-carrier-protein] synthase 2', 'fabF', '(Z)-hexadec-11-enoyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = (Z)-3-oxooctadec-13-enoyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein]<br />\n', '3-oxoacyl-[acyl-carrier-protein] synthase activity<br />\nbeta-ketoacyl-acyl-carrier-protein synthase II activity<br />\n', 'fatty acid biosynthetic process<br />\n', 'PF00109.', 'MSKRRVVVTGLGMLSPVGNTVESTWKALLAGQSGISLIDHFDTSAYATKFAGLVKDFNCEDIISRKEQRKMDAFIQYGIVAGVQAMQDSGLEITEENATRIGAAIGSGIGGLGLIEENHTSLMNGGPRKISPFFVPSTIVNMVAGHLTIMYGLRGPSISIATACTSGVHNIGHAARIIAYGDADVMVAGGAEKASTPLGVGGFGAARALSTRNDNPQAASRPWDKERDGFVLGDGAGMLVLEEYEHAKKRGAKIYAELVGFGMSSDAYHMTSPPENGAGAALAMANALRDAGIEASQIGYVNAHGTSTPAGDKAEAQAVKTIFGEAASRVLVSSTKSMTGHLLGAAGAVESIYSILALRDQAVPPTINLDNPDEGCDLDFVPHEARQVSGMEYTLCNSFGFGGTNGSLIFKKI'),
('P00813', '3IAR', 1, 1.52, 'A', 359, 'HYDROLASE', 'HYDROLASE', 'Adenosine deaminase', 'ADA', 'Adenosine + H2O = inosine + NH3<br />\n', 'adenosine deaminase activity<br />\npurine nucleoside binding<br />\nzinc ion binding<br />\n', 'adenosine catabolic process<br />\naging<br />\ncell adhesion<br />\ndATP catabolic process<br />\ndeoxyadenosine catabolic process<br />\nembryonic digestive tract development<br />\ngerminal center B cell differentiation<br />\nhistamine secretion<br />\nhypoxanthine salvage<br />\ninosine biosynthetic process<br />\nliver development<br />\nlung alveolus development<br />\nnegative regulation of adenosine receptor signaling pathway<br />\nnegative regulation of circadian sleep/wake cycle, non-REM sleep<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of leukocyte migration<br />\nnegative regulation of mature B cell apoptotic process<br />\nnegative regulation of mucus secretion<br />\nnegative regulation of penile erection<br />\nnegative regulation of thymocyte apoptotic process<br />\nPeyer''s patch development<br />\nplacenta development<br />\npositive regulation of alpha-beta T cell differentiation<br />\npositive regulation of B cell proliferation<br />\npositive regulation of calcium-mediated signaling<br />\npositive regulation of germinal center formation<br />\npositive regulation of heart rate<br />\npositive regulation of smooth muscle contraction<br />\npositive regulation of T cell differentiation in thymus<br />\npositive regulation of T cell receptor signaling pathway<br />\npurine-containing compound salvage<br />\npurine nucleotide salvage<br />\npurine ribonucleoside monophosphate biosynthetic process<br />\nregulation of cell-cell adhesion mediated by integrin<br />\nresponse to drug<br />\nresponse to hydrogen peroxide<br />\nresponse to hypoxia<br />\nresponse to morphine<br />\nresponse to vitamin E<br />\nT cell activation<br />\ntrophectodermal cell differentiation<br />\nxanthine biosynthetic process<br />\n', 'PF00962.', 'MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL'),
('P20813', '3IBD', 1, 2, 'A', 462, 'Oxidoreductase / Oxidoreductase Inhibitor', 'OXIDOREDUCTASE', 'Cytochrome P450 2B6', 'CYP2B6', '1,4-cineole + NADPH + O2 = 2-exo-hydroxy-1,4-cineole + NADP+ + H2O<br />\n', 'arachidonic acid epoxygenase activity<br />\nheme binding<br />\niron ion binding<br />\nmonooxygenase activity<br />\noxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen<br />\noxygen binding<br />\nsteroid hydroxylase activity<br />\n', 'cellular ketone metabolic process<br />\ndrug metabolic process<br />\nepoxygenase P450 pathway<br />\nexogenous drug catabolic process<br />\noxidation-reduction process<br />\nsteroid metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF00067.', 'MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKYFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPKDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPR'),
('P23284', '3ICI', 1, 1.7, 'A/B', 183, 'ISOMERASE', 'ISOMERASE', 'Peptidyl-prolyl cis-trans isomerase B', 'PPIB', 'Peptidylproline (omega=180) = peptidylproline (omega=0).<br />\n', 'peptidyl-prolyl cis-trans isomerase activity<br />\nprotein complex binding<br />\nRNA binding<br />\nRNA polymerase binding<br />\nunfolded protein binding<br />\n', 'bone development<br />\nchaperone-mediated protein folding<br />\npositive regulation by host of viral genome replication<br />\npositive regulation by host of viral process<br />\npositive regulation of multicellular organism growth<br />\nprotein peptidyl-prolyl isomerization<br />\nprotein stabilization<br />\n', 'PF00160.', 'MLRLSERNMKVLLAAALIAGSVFFLLLPGPSAADEKKKGPKVTVKVYFDLRIGDEDVGRVIFGLFGKTVPKTVDNFVALATGEKGFGYKNSKFHRVIKDFMIQGGDFTRGDGTGGKSIYGERFPDENFKLKHYGPGWVSMANAGKDTNGSQFFITTVKTAWLDGKHVVFGKVLEGMEVVRKVESTKTDSRDKPLKDVIIADCGKIEVEKPFAIAKE'),
('Q9UIC8', '3IEI', 1, 1.9, 'A/B/C/D/E/F/G/H', 334, 'TRANSFERASE', 'TRANSFERASE', 'Leucine carboxyl methyltransferase 1', 'LCMT1', 'S-adenosyl-L-methionine + [phosphatase 2A protein]-leucine = S-adenosyl-L-homocysteine + [phosphatase 2A protein]-leucine methyl ester<br />\n', 'protein C-terminal carboxyl O-methyltransferase activity<br />\nprotein C-terminal leucine carboxyl O-methyltransferase activity<br />\nS-adenosylmethionine-dependent methyltransferase activity<br />\n', 'cellular protein modification process<br />\nC-terminal protein methylation<br />\nG2/M transition of mitotic cell cycle<br />\nnegative regulation of protein complex assembly<br />\nprotein methylation<br />\nregulation of apoptotic process<br />\nregulation of glucose metabolic process<br />\nregulation of mitotic cell cycle spindle assembly checkpoint<br />\n', 'PF04072.', 'MATRQRESSITSCCSTSSCDADDEGVRGTCEDASLCKRFAVSIGYWHDPYIQHFVRLSKERKAPEINRGYFARVHGVSQLIKAFLRKTECHCQIVNLGAGMDTTFWRLKDEDLLPSKYFEVDFPMIVTRKLHSIKCKPPLSSPILELHSEDTLQMDGHILDSKRYAVIGADLRDLSELEEKLKKCNMNTQLPTLLIAECVLVYMTPEQSANLLKWAANSFERAMFINYEQVNMGDRFGQIMIENLRRRQCDLAGVETCKSLESQKERLLSNGWETASAVDMMELYNRLPRAEVSRIESLEFLDEMELLEQLMRHYCLCWATKGGNELGLKEITY'),
('Q8TD30', '3IHJ', 1, 2.3, 'A', 475, 'TRANSFERASE', 'TRANSFERASE', 'Alanine aminotransferase 2', 'GPT2', 'L-alanine + 2-oxoglutarate = pyruvate + L-glutamate<br />\n', 'L-alanine:2-oxoglutarate aminotransferase activity<br />\npyridoxal phosphate binding<br />\n', '2-oxoglutarate metabolic process<br />\ncellular amino acid biosynthetic process<br />\nL-alanine catabolic process<br />\nL-alanine metabolic process<br />\n', 'PF00155.', 'MQRAAALVRRGCGPRTPSSWGRSQSSAAAEASAVLKVRPERSRRERILTLESMNPQVKAVEYAVRGPIVLKAGEIELELQRGIKKPFTEVIRANIGDAQAMGQQPITFLRQVMALCTYPNLLDSPSFPEDAKKRARRILQACGGNSLGSYSASQGVNCIREDVAAYITRRDGGVPADPDNIYLTTGASDGISTILKILVSGGGKSRTGVMIPIPQYPLYSAVISELDAIQVNYYLDEENCWALNVNELRRAVQEAKDHCDPKVLCIINPGNPTGQVQSRKCIEDVIHFAWEEKLFLLADEVYQDNVYSPDCRFHSFKKVLYEMGPEYSSNVELASFHSTSKGYMGECGYRGGYMEVINLHPEIKGQLVKLLSVRLCPPVSGQAAMDIVVNPPVAGEESFEQFSREKESVLGNLAKKAKLTEDLFNQVPGIHCNPLQGAMYAFPRIFIPAKAVEAAQAHQMAPDMFYCMKLLEETGICVVPGSGFGQREGTYHFRMTILPPVEKLKTVLQKVKDFHINFLEKYA'),
('P17174', '3II0', 1, 2.05, 'A/B/C/D', 399, 'TRANSFERASE', 'TRANSFERASE', 'Aspartate aminotransferase, cytoplasmic', 'GOT1', 'L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate.<br />\nL-cysteine + 2-oxoglutarate = mercaptopyruvate + L-glutamate.<br />\n', 'carboxylic acid binding<br />\nL-aspartate:2-oxoglutarate aminotransferase activity<br />\nL-cysteine:2-oxoglutarate aminotransferase activity<br />\nL-phenylalanine:2-oxoglutarate aminotransferase activity<br />\nphosphatidylserine decarboxylase activity<br />\npyridoxal phosphate binding<br />\n', '2-oxoglutarate metabolic process<br />\naspartate biosynthetic process<br />\naspartate catabolic process<br />\naspartate metabolic process<br />\ncellular amino acid biosynthetic process<br />\ncellular response to insulin stimulus<br />\nfatty acid homeostasis<br />\ngluconeogenesis<br />\nglutamate catabolic process to 2-oxoglutarate<br />\nglutamate catabolic process to aspartate<br />\nglutamate metabolic process<br />\nglycerol biosynthetic process<br />\nNotch signaling pathway<br />\noxaloacetate metabolic process<br />\nresponse to glucocorticoid<br />\n', 'PF00155.', 'MAPPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQKIANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGTGALRIGADFLARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLENAPEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWAIRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPPAQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGMFSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ'),
('O15217', '3IK7', 1, 1.97, 'A/B/C/D', 222, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase A4', 'GSTA4', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'glutathione transferase activity<br />\nidentical protein binding<br />\nprotein homodimerization activity<br />\n', 'glutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF14497.', 'MAARPKLHYPNGRGRMESVRWVLAAAGVEFDEEFLETKEQLYKLQDGNHLLFQQVPMVEIDGMKLVQTRSILHYIADKHNLFGKNLKERTLIDMYVEGTLDLLELLIMHPFLKPDDQQKEVVNMAQKAIIRYFPVFEKILRGHGQSFLVGNQLSLADVILLQTILALEEKIPNILSAFPFLQEYTVKLSNIPTIKRFLEPGSKKKPPPDEIYVRTVYNIFRP'),
('P10827', '3ILZ', 1, 1.85, 'A', 223, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Thyroid hormone receptor alpha', 'THRA', '', 'chromatin DNA binding<br />\nprotein complex binding<br />\nprotein domain specific binding<br />\nsteroid hormone receptor activity<br />\nsteroid receptor RNA activator RNA binding<br />\nTBP-class protein binding<br />\nthyroid hormone binding<br />\nthyroid hormone receptor activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\ntranscription regulatory region DNA binding<br />\ntranscription regulatory region sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'cartilage condensation<br />\ncytoplasmic sequestering of transcription factor<br />\nerythrocyte differentiation<br />\nfemale courtship behavior<br />\nhormone-mediated signaling pathway<br />\nlearning or memory<br />\nnegative regulation of DNA-templated transcription, initiation<br />\nnegative regulation of RNA polymerase II transcriptional preinitiation complex assembly<br />\nnegative regulation of transcription, DNA-templated<br />\nossification<br />\npositive regulation of female receptivity<br />\npositive regulation of myotube differentiation<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of heart contraction<br />\nregulation of lipid catabolic process<br />\nregulation of myeloid cell apoptotic process<br />\nregulation of thyroid hormone mediated signaling pathway<br />\nregulation of transcription from RNA polymerase II promoter<br />\nresponse to cold<br />\nthyroid gland development<br />\ntranscription from RNA polymerase II promoter<br />\ntranscription initiation from RNA polymerase II promoter<br />\nType I pneumocyte differentiation<br />\n', 'PF00104.', 'MEQKPSKVECGSDPEENSARSPDGKRKRKNGQCSLKTSMSGYIPSYLDKDEQCVVCGDKATGYHYRCITCEGCKGFFRRTIQKNLHPTYSCKYDSCCVIDKITRNQCQLCRFKKCIAVGMAMDLVLDDSKRVAKRKLIEQNRERRRKEEMIRSLQQRPEPTPEEWDLIHIATEAHRSTNAQGSHWKQRRKFLPDDIGQSPIVSMPDGDKVDLEAFSEFTKIITPAITRVVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVRYDPESDTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMSTDRSGLLCVDKIEKSQEAYLLAFEHYVNHRKHNIPHFWPKLLMKEREVQSSILYKGAAAEGRPGGSLGVHPEGQQLLGMHVVQGPQVRQLEQQLGEAGSLQGPVLQHQSPKSPQQRLLELLHRSGILHARAVCGEDDSSEADSPSSSEEEPEVCEDLAGNAASP'),
('P04049', '3IQV', 1, 1.2, 'P', 6, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'RAF proto-oncogene serine/threonine-protein kinase', 'RAF1', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nenzyme binding<br />\nidentical protein binding<br />\nkinase activity<br />\nMAP kinase kinase kinase activity<br />\nmetal ion binding<br />\nmitogen-activated protein kinase kinase binding<br />\nprotein heterodimerization activity<br />\nprotein kinase activity<br />\nprotein serine/threonine kinase activity<br />\n', 'activation of adenylate cyclase activity<br />\nactivation of MAPKK activity<br />\napoptotic process<br />\ncell differentiation<br />\ncell proliferation<br />\ndeath-inducing signaling complex assembly<br />\nface development<br />\nheart development<br />\ninsulin secretion involved in cellular response to glucose stimulus<br />\nintermediate filament cytoskeleton organization<br />\nion transmembrane transport<br />\nMAPK cascade<br />\nmulticellular organism development<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors<br />\nnegative regulation of protein complex assembly<br />\nnegative regulation of signal transduction<br />\nneurotrophin TRK receptor signaling pathway<br />\nplatelet activation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein phosphorylation<br />\nregulation of apoptotic process<br />\nregulation of cell differentiation<br />\nregulation of cell motility<br />\nregulation of Rho protein signal transduction<br />\nresponse to hypoxia<br />\nresponse to muscle stretch<br />\nsignal transduction<br />\nsomatic stem cell population maintenance<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nthymus development<br />\nthyroid gland development<br />\nwound healing<br />\n', 'PF00130.', 'MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF'),
('P32754', '3ISQ', 0, 1.75, 'A', 386, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '4-hydroxyphenylpyruvate dioxygenase', 'HPD', '4-hydroxyphenylpyruvate + O2 = homogentisate + CO2.<br />\n', '4-hydroxyphenylpyruvate dioxygenase activity<br />\nmetal ion binding<br />\n', 'L-phenylalanine catabolic process<br />\ntyrosine catabolic process<br />\n', 'PF00903.', 'MTTYSDKGAKPERGRFLHFHSVTFWVGNAKQAASFYCSKMGFEPLAYRGLETGSREVVSHVIKQGKIVFVLSSALNPWNKEMGDHLVKHGDGVKDIAFEVEDCDYIVQKARERGAKIMREPWVEQDKFGKVKFAVLQTYGDTTHTLVEKMNYIGQFLPGYEAPAFMDPLLPKLPKCSLEMIDHIVGNQPDQEMVSASEWYLKNLQFHRFWSVDDTQVHTEYSSLRSIVVANYEESIKMPINEPAPGKKKSQIQEYVDYNGGAGVQHIALKTEDIITAIRHLRERGLEFLSVPSTYYKQLREKLKTAKIKVKENIDALEELKILVDYDEKGYLLQIFTKPVQDRPTLFLEVIQRHNHQGFGAGNFNSLFKAFEEEQNLRGNLTNMETNGVVPGM'),
('P08506', '3ITA', 1, 1.8, 'A/B/C/D', 351, 'HYDROLASE', 'HYDROLASE', 'D-alanyl-D-alanine carboxypeptidase DacC', 'dacC', 'Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also transpeptidation of peptidyl-alanyl moieties that are N-acyl substituents of D-alanine.<br />\n', 'carboxypeptidase activity<br />\nendopeptidase activity<br />\npenicillin binding<br />\nserine-type D-Ala-D-Ala carboxypeptidase activity<br />\n', 'cell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nresponse to drug<br />\n', 'PF07943.', 'MTQYSSLLRGLAAGSAFLFLFAPTAFAAEQTVEAPSVDARAWILMDYASGKVLAEGNADEKLDPASLTKIMTSYVVGQALKADKIKLTDMVTVGKDAWATGNPALRGSSVMFLKPGDQVSVADLNKGVIIQSGNDACIALADYVAGSQESFIGLMNGYAKKLGLTNTTFQTVHGLDAPGQFSTARDMALLGKALIHDVPEEYAIHKEKEFTFNKIRQPNRNRLLWSSNLNVDGMKTGTTAGAGYNLVASATQGDMRLISVVLGAKTDRIRFNESEKLLTWGFRFFETVTPIKPDATFVTQRVWFGDKSEVNLGAGEAGSVTIPRGQLKNLKASYTLTEPQLTAPLKKGQVVGTIDFQLNGKSIEQRPLIVMENVEEGGFFGRVWDFVMMKFHQWFGSWFS'),
('O00408', '3ITU', 1, 1.58, 'A/B/C/D', 341, 'HYDROLASE', 'HYDROLASE', 'cGMP-dependent 3'',5''-cyclic phosphodiesterase', 'PDE2A', 'Nucleoside 3'',5''-cyclic phosphate + H2O = nucleoside 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\n3'',5''-cyclic-GMP phosphodiesterase activity<br />\ncalcium channel activity<br />\ncAMP binding<br />\ncGMP binding<br />\ncGMP-stimulated cyclic-nucleotide phosphodiesterase activity<br />\ncyclic-nucleotide phosphodiesterase activity<br />\ndrug binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\nprotein homodimerization activity<br />\nTPR domain binding<br />\n', 'cAMP catabolic process<br />\ncAMP-mediated signaling<br />\ncellular response to cGMP<br />\ncellular response to drug<br />\ncellular response to granulocyte macrophage colony-stimulating factor stimulus<br />\ncellular response to macrophage colony-stimulating factor stimulus<br />\ncellular response to mechanical stimulus<br />\ncellular response to transforming growth factor beta stimulus<br />\ncGMP catabolic process<br />\ncGMP-mediated signaling<br />\nestablishment of endothelial barrier<br />\nmetabolic process<br />\nmonocyte differentiation<br />\nnegative regulation of cAMP biosynthetic process<br />\nnegative regulation of protein import into nucleus, translocation<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of vascular permeability<br />\npositive regulation of inflammatory response<br />\npositive regulation of vascular permeability<br />\nprotein targeting to mitochondrion<br />\n', 'PF01590.', 'MGQACGHSILCRSQQYPAARPAEPRGQQVFLKPDEPPPPPQPCADSLQDALLSLGSVIDISGLQRAVKEALSAVLPRVETVYTYLLDGESQLVCEDPPHELPQEGKVREAIISQKRLGCNGLGFSDLPGKPLARLVAPLAPDTQVLVMPLADKEAGAVAAVILVHCGQLSDNEEWSLQAVEKHTLVALRRVQVLQQRGPREAPRAVQNPPEGTAEDQKGGAAYTDRDRKILQLCGELYDLDASSLQLKVLQYLQQETRASRCCLLLVSEDNLQLSCKVIGDKVLGEEVSFPLTGCLGQVVEDKKSIQLKDLTSEDVQQLQSMLGCELQAMLCVPVISRATDQVVALACAFNKLEGDLFTDEDEHVIQHCFHYTSTVLTSTLAFQKEQKLKCECQALLQVAKNLFTHLDDVSVLLQEIITEARNLSNAEICSVFLLDQNELVAKVFDGGVVDDESYEIRIPADQGIAGHVATTGQILNIPDAYAHPLFYRGVDDSTGFRTRNILCFPIKNENQEVIGVAELVNKINGPWFSKFDEDLATAFSIYCGISIAHSLLYKKVNEAQYRSHLANEMMMYHMKVSDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEEYEVPDLDGTRAPINGCCSLDAE'),
('P18545', '3JWR', 1, 2.99, 'C/D', 18, 'HYDROLASE', 'HYDROLASE', 'Retinal rod rhodopsin-sensitive cGMP 3'',5''-cyclic phosphodiesterase subunit gamma', 'PDE6G', 'Guanosine 3'',5''-cyclic phosphate + H2O = guanosine 5''-phosphate.<br />\n', '3'',5''-cyclic-GMP phosphodiesterase activity<br />\ncGMP binding<br />\nenzyme inhibitor activity<br />\nspectrin binding<br />\n', 'activation of MAPK activity<br />\npositive regulation of epidermal growth factor receptor signaling pathway<br />\npositive regulation of G-protein coupled receptor protein signaling pathway<br />\nregulation of rhodopsin mediated signaling pathway<br />\nrhodopsin mediated signaling pathway<br />\nvisual perception<br />\nWnt signaling pathway, calcium modulating pathway<br />\n', 'PF04868.', 'MNLEPPKAEFRSATRVAGGPVTPRKGPPKFKQRQTRQFKSKPPKKGVQGFGDDIPGMEGLGTDITVICPWEAFNHLELHELAQYGII'),
('P00797', '3K1W', 1, 1.5, 'A/B', 340, 'HYDROLASE', 'HYDROLASE', 'Renin', 'REN', 'Cleavage of Leu-|-Xaa bond in angiotensinogen to generate angiotensin I.<br />\n', 'aspartic-type endopeptidase activity<br />\ninsulin-like growth factor receptor binding<br />\npeptidase activity<br />\nreceptor binding<br />\n', 'amyloid-beta metabolic process<br />\nangiotensin maturation<br />\ncell maturation<br />\ncellular response to drug<br />\ndrinking behavior<br />\nhormone-mediated signaling pathway<br />\nkidney development<br />\nmale gonad development<br />\nmesonephros development<br />\nproteolysis<br />\nregulation of blood pressure<br />\nregulation of MAPK cascade<br />\nrenin-angiotensin regulation of aldosterone production<br />\nresponse to cAMP<br />\nresponse to cGMP<br />\nresponse to immobilization stress<br />\nresponse to lipopolysaccharide<br />\n', 'PF07966.', 'MDGWRRMPRWGLLLLLWGSCTFGLPTDTTTFKRIFLKRMPSIRESLKERGVDMARLGPEWSQPMKRLTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR'),
('P00918', '3K34', 1, 0.9, 'A', 260, 'LYASE / LYASE INHIBITOR', 'LYASE', 'Carbonic anhydrase 2', 'CA2', 'H2CO3 = CO2 + H2O.<br />\n', 'arylesterase activity<br />\ncarbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'angiotensin-activated signaling pathway<br />\nbicarbonate transport<br />\ncarbon dioxide transport<br />\ncellular response to fluid shear stress<br />\nkidney development<br />\nmorphogenesis of an epithelium<br />\nodontogenesis of dentin-containing tooth<br />\none-carbon metabolic process<br />\npositive regulation of bone resorption<br />\npositive regulation of cellular pH reduction<br />\npositive regulation of dipeptide transmembrane transport<br />\npositive regulation of osteoclast differentiation<br />\npositive regulation of synaptic transmission, GABAergic<br />\nregulation of anion transport<br />\nregulation of chloride transport<br />\nregulation of intracellular pH<br />\nresponse to estrogen<br />\nresponse to pH<br />\nresponse to steroid hormone<br />\nresponse to zinc ion<br />\nsecretion<br />\n', 'PF00194.', 'MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P78352', '3K82', 1, 1.4, 'A', 98, 'CELL ADHESION', 'CELL_ADHESION', 'Disks large homolog 4', 'DLG4', '', 'acetylcholine receptor binding<br />\nbeta-1 adrenergic receptor binding<br />\nD1 dopamine receptor binding<br />\nguanylate kinase activity<br />\nionotropic glutamate receptor binding<br />\nkinase binding<br />\nligand-gated ion channel activity<br />\nneuroligin family protein binding<br />\nP2Y1 nucleotide receptor binding<br />\nPDZ domain binding<br />\nprotein complex binding<br />\nprotein C-terminus binding<br />\nprotein phosphatase binding<br />\nRas guanyl-nucleotide exchange factor activity<br />\nscaffold protein binding<br />\n', 'AMPA glutamate receptor clustering<br />\nchemical synaptic transmission<br />\ndendritic spine morphogenesis<br />\nestablishment of protein localization<br />\nestablishment or maintenance of epithelial cell apical/basal polarity<br />\nlearning<br />\nlocomotory exploration behavior<br />\nMAPK cascade<br />\nnegative regulation of receptor internalization<br />\nnervous system development<br />\nneuromuscular process controlling balance<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of excitatory postsynaptic potential<br />\npositive regulation of synaptic transmission<br />\nprotein complex assembly<br />\nprotein localization to synapse<br />\nreceptor localization to synapse<br />\nregulation of grooming behavior<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of NMDA receptor activity<br />\nsignal transduction<br />\nsocial behavior<br />\nsynaptic vesicle maturation<br />\nvocalization behavior<br />\n', 'PF00625.', 'MDCLCIVTTKKYRYQDEDTPPLEHSPAHLPNQANSPPVIVNTDTLEAPGYELQVNGTEGEMEYEEITLERGNSGLGFSIAGGTDNPHIGDDPSIFITKIIPGGAAAQDGRLRVNDSILFVNEVDVREVTHSAAVEALKEAGSIVRLYVMRRKPPAEKVMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGRLQIGDKILAVNSVGLEDVMHEDAVAALKNTYDVVYLKVAKPSNAYLSDSYAPPDITTSYSQHLDNEISHSSYLGTDYPTAMTPTSPRRYSPVAKDLLGEEDIPREPRRIVIHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAKIHDLREQLMNSSLGSGTASLRSNPKRGFYIRALFDYDKTKDCGFLSQALSFRFGDVLHVIDASDEEWWQARRVHSDSETDDIGFIPSKRRVERREWSRLKAKDWGSSSGSQGREDSVLSYETVTQMEVHYARPIIILGPTKDRANDDLLSEFPDKFGSCVPHTTRPKREYEIDGRDYHFVSSREKMEKDIQAHKFIEAGQYNSHLYGTSVQSVREVAEQGKHCILDVSANAVRRLQAAHLHPIAIFIRPRSLENVLEINKRITEEQARKAFDRATKLEQEFTECFSAIVEGDSFEEIYHKVKRVIEDLSGPYIWVPARERL'),
('Q59961', '3K9F', 1, 2.9, 'C/D', 244, 'ISOMERASE / DNA', 'ISOMERASE', 'DNA topoisomerase 4 subunit B', 'parE', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\nmetal ion binding<br />\n', 'DNA topological change<br />\n', 'PF00204.', 'MSKKEININNYNDDAIQVLEGLDAVRKRPGMYIGSTDGAGLHHLVWEIVDNAVDEALSGFGDRIDVTINKDGSLTVQDHGRGMPTGMHAMGIPTVEVIFTILHAGGKFGQGGYKTSGGLHGVGSSVVNALSSWLEVEITRDGAVYKQRFENGGKPVTTLKKIGTAPKSKTGTKVTFMPDATIFSTTDFKYNTISERLNESAFLLKNVTLSLTDKRTNEAIEFHYENGVQDFVSYLNEDKEILTPVLYFEGEDNGFQVEVALQYNDGFSDNILSFVNNVRTKDGGTHETGLKSAITKVMNDYARKTGLLKEKDKNLEGSDYREGLAAVLSILVPEEHLQFEGQTKDKLGSPLARPVVDGIVADKLTFFLMENGELASNLIRKAIKARDAREAARKARDESRNGKKNKKDKGLLSGKLTPAQSKNPAKNELYLVEGDSAGGSAKQGRDRKFQAILPLRGKVVNTAKAKMADILKNEEINTMIYTIGAGVGADFSIEDANYDKIIIMTDADTDGAHIQTLLLTFFYRYMRPLVEAGHVYIALPPLYKMSKGKGKKEEVAYAWTDGELEELRKQFGKGATLQRYKGLGEMNADQLWETTMNPETRTLIRVTIEDLARAERRVNVLMGDKVEPRRKWIEDNVKFTLEETTVF'),
('P01008', '3KCG', 1, 1.7, 'I', 432, 'HYDROLASE', 'HYDROLASE', 'Antithrombin-III', 'SERPINC1', '', 'heparin binding<br />\nidentical protein binding<br />\nprotease binding<br />\nserine-type endopeptidase inhibitor activity<br />\n', 'acute inflammatory response to antigenic stimulus<br />\nblood coagulation<br />\ncellular protein metabolic process<br />\nlactation<br />\npost-translational protein modification<br />\nregulation of blood coagulation, intrinsic pathway<br />\nresponse to nutrient<br />\n', 'PF00079.', 'MYSNVIGTVTSGKRKVYLLSLLLIGFWDCVTCHGSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK'),
('O00764', '3KEU', 1, 2.1, 'A/B', 312, 'TRANSFERASE', 'TRANSFERASE', 'Pyridoxal kinase', 'PDXK', 'ATP + pyridoxal = ADP + pyridoxal 5''-phosphate.<br />\n', 'ATP binding<br />\nlithium ion binding<br />\nmagnesium ion binding<br />\npotassium ion binding<br />\nprotein homodimerization activity<br />\npyridoxal kinase activity<br />\npyridoxal phosphate binding<br />\nsodium ion binding<br />\nzinc ion binding<br />\n', 'cell proliferation<br />\nneutrophil degranulation<br />\npyridoxal 5''-phosphate salvage<br />\npyridoxal phosphate biosynthetic process<br />\nvitamin B6 metabolic process<br />\n', 'PF08543.', 'MEEECRVLSIQSHVIRGYVGNRAATFPLQVLGFEIDAVNSVQFSNHTGYAHWKGQVLNSDELQELYEGLRLNNMNKYDYVLTGYTRDKSFLAMVVDIVQELKQQNPRLVYVCDPVLGDKWDGEGSMYVPEDLLPVYKEKVVPLADIITPNQFEAELLSGRKIHSQEEALRVMDMLHSMGPDTVVITSSDLPSPQGSNYLIVLGSQRRRNPAGSVVMERIRMDIRKVDAVFVGTGDLFAAMLLAWTHKHPNNLKVACEKTVSTLHHVLQRTIQCAKAQAGEGVRPSPMQLELRMVQSKRDIEDPEIVVQATVL'),
('Q8TED1', '3KIJ', 0, 1.8, 'A/B/C', 172, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Probable glutathione peroxidase 8', 'GPX8', '2 glutathione + H2O2 = glutathione disulfide + 2 H2O.<br />\n', 'glutathione peroxidase activity<br />\nperoxidase activity<br />\n', 'cellular response to oxidative stress<br />\n', 'PF00255.', 'MEPLAAYPLKCSGPRAKVFAVLLSIVLCTVTLFLLQLKFLKPKINSFYAFEVKDAKGRTVSLEKYKGKVSLVVNVASDCQLTDRNYLGLKELHKEFGPSHFSVLAFPCNQFGESEPRPSKEVESFARKNYGVTFPIFHKIKILGSEGEPAFRFLVDSSKKEPRWNFWKYLVNPEGQVVKFWKPEEPIEVIRPDIAALVRQVIIKKKEDL'),
('Q888A4', '3KKJ', 1, 2.5, 'A/B', 328, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Renalase', 'PSPTO_1126', '1,2-dihydro-beta-NAD(P) + H+ + O2 = beta-NAD(P)+ + H2O2<br />\n1,6-dihydro-beta-NAD(P) + H+ + O2 = beta-NAD(P)+ + H2O2<br />\n', 'nucleotide binding<br />\noxidoreductase activity<br />\n', '', 'PF01593.', 'MTVPIAIIGTGIAGLSAAQALTAAGHQVHLFDKSRGSGGRMSSKRSDAGALDMGAQYFTARDRRFATAVKQWQAQGHVAEWTPLLYNFHAGRLSPSPDEQVRWVGKPGMSAITRAMRGDMPVSFSCRITEVFRGEEHWNLLDAEGQNHGPFSHVIIATPAPQASTLLAAAPKLASVVAGVKMDPTWAVALAFETPLQTPMQGCFVQDSPLDWLARNRSKPERDDTLDTWILHATSQWSRQNLDASREQVIEHLHGAFAELIDCTMPAPVFSLAHRWLYARPAGAHEWGALSDADLGIYVCGDWCLSGRVEGAWLSGQEAARRLLEHLQ'),
('P10276', '3KMR', 1, 1.8, 'A', 246, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Retinoic acid receptor alpha', 'RARA', '', 'alpha-actinin binding<br />\nchromatin DNA binding<br />\ndrug binding<br />\nenzyme binding<br />\nhistone deacetylase binding<br />\nmRNA 5''-UTR binding<br />\nprotein domain specific binding<br />\nprotein heterodimerization activity<br />\nprotein kinase A binding<br />\nprotein kinase B binding<br />\nreceptor binding<br />\nretinoic acid binding<br />\nretinoic acid receptor activity<br />\nretinoic acid-responsive element binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscription coactivator activity<br />\ntranscription corepressor activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\ntranslation repressor activity, nucleic acid binding<br />\nzinc ion binding<br />\n', 'apoptotic cell clearance<br />\ncellular response to estrogen stimulus<br />\ncellular response to lipopolysaccharide<br />\ncellular response to retinoic acid<br />\nchondroblast differentiation<br />\nembryonic camera-type eye development<br />\nface development<br />\nfemale pregnancy<br />\ngerm cell development<br />\nglandular epithelial cell development<br />\ngrowth plate cartilage development<br />\nhippocampus development<br />\nlimb development<br />\nliver development<br />\nmulticellular organism growth<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cartilage development<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of granulocyte differentiation<br />\nnegative regulation of interferon-gamma production<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of translational initiation<br />\nnegative regulation of tumor necrosis factor production<br />\nneural tube closure<br />\noutflow tract septum morphogenesis<br />\npositive regulation of binding<br />\npositive regulation of cell cycle<br />\npositive regulation of cell proliferation<br />\npositive regulation of interleukin-13 production<br />\npositive regulation of interleukin-4 production<br />\npositive regulation of interleukin-5 production<br />\npositive regulation of neuron differentiation<br />\npositive regulation of T-helper 2 cell differentiation<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprostate gland development<br />\nprotein phosphorylation<br />\nregulation of myelination<br />\nregulation of synaptic plasticity<br />\nresponse to cytokine<br />\nresponse to estradiol<br />\nresponse to ethanol<br />\nresponse to retinoic acid<br />\nresponse to vitamin A<br />\nretinoic acid receptor signaling pathway<br />\nSertoli cell fate commitment<br />\nsignal transduction<br />\nspermatogenesis<br />\ntrachea cartilage development<br />\ntranscription initiation from RNA polymerase II promoter<br />\nureteric bud development<br />\nventricular cardiac muscle cell differentiation<br />\n', 'PF00104.', 'MASNSSSCPTPGGGHLNGYPVPPYAFFFPPMLGGLSPPGALTTLQHQLPVSGYSTPSPATIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLENSEGLDTLSGQPGGGGRDGGGLAPPPGSCSPSLSPSSNRSSPATHSP'),
('P26447', '3KO0', 1, 2.3, 'A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T', 101, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Protein S100-A4', 'S100A4', '', 'actin binding<br />\ncalcium-dependent protein binding<br />\ncalcium ion binding<br />\nidentical protein binding<br />\nRAGE receptor binding<br />\nRNA binding<br />\ntransition metal ion binding<br />\n', 'epithelial to mesenchymal transition<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\n', 'PF01023.', 'MACPLEKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCIAMMCNEFFEGFPDKQPRKK'),
('P02763', '3KQ0', 1, 1.8, 'A', 183, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Alpha-1-acid glycoprotein 1', 'ORM1', '', '', 'acute-phase response<br />\ninflammatory response<br />\nnegative regulation of interleukin-6 production<br />\nnegative regulation of tumor necrosis factor production<br />\nneutrophil degranulation<br />\nplatelet degranulation<br />\npositive regulation of interleukin-1 beta secretion<br />\npositive regulation of interleukin-1 secretion<br />\npositive regulation of tumor necrosis factor secretion<br />\nregulation of immune system process<br />\n', 'PF00061.', 'MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDQITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQDQCIYNTTYLNVQRENGTISRYVGGQEHFAHLLILRDTKTYMLAFDVNDEKNWGLSVYADKPETTKEQLGEFYEALDCLRIPKSDVVYTDWKKDKCEPLEKQHEKERKQEEGES'),
('P0A749', '3KQJ', 1, 1.7, 'A', 419, 'TRANSFERASE', 'TRANSFERASE', 'UDP-N-acetylglucosamine 1-carboxyvinyltransferase', 'murA', 'Phosphoenolpyruvate + UDP-N-acetyl-alpha-D-glucosamine = phosphate + UDP-N-acetyl-3-O-(1-carboxyvinyl)-alpha-D-glucosamine<br />\n', 'UDP-N-acetylglucosamine 1-carboxyvinyltransferase activity<br />\n', 'cell cycle<br />\ncell division<br />\ncell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nUDP-N-acetylgalactosamine biosynthetic process<br />\n', 'PF00275.', 'MDKFRVQGPTKLQGEVTISGAKNAALPILFAALLAEEPVEIQNVPKLKDVDTSMKLLSQLGAKVERNGSVHIDARDVNVFCAPYDLVKTMRASIWALGPLVARFGQGQVSLPGGCTIGARPVDLHISGLEQLGATIKLEEGYVKASVDGRLKGAHIVMDKVSVGATVTIMCAATLAEGTTIIENAAREPEIVDTANFLITLGAKISGQGTDRIVIEGVERLGGGVYRVLPDRIETGTFLVAAAISRGKIICRNAQPDTLDAVLAKLRDAGADIEVGEDWISLDMHGKRPKAVNVRTAPHPAFPTDMQAQFTLLNLVAEGTGFITETVFENRFMHVPELSRMGAHAEIESNTVICHGVEKLSGAQVMATDLRASASLVLAGCIAEGTTVVDRIYHIDRGYERIEDKLRALGANIERVKGE'),
('O43451', '3L4Y', 1, 1.8, 'A', 868, 'HYDROLASE', 'HYDROLASE', 'Maltase-glucoamylase, intestinal', 'MGAM', 'Hydrolysis of terminal, non-reducing (1->4)-linked alpha-D-glucose residues with release of alpha-D-glucose.<br />\nHydrolysis of terminal (1->4)-linked alpha-D-glucose residues successively from non-reducing ends of the chains with release of beta-D-glucose.<br />\n', 'alpha-1,4-glucosidase activity<br />\namylase activity<br />\ncarbohydrate binding<br />\ncatalytic activity<br />\nglucan 1,4-alpha-glucosidase activity<br />\nmaltose alpha-glucosidase activity<br />\n', 'neutrophil degranulation<br />\npolysaccharide digestion<br />\nstarch catabolic process<br />\n', 'PF01055.', 'MARKKLKKFTTLEIVLSVLLLVLFIISIVLIVLLAKESLKSTAPDPGTTGTPDPGTTGTPDPGTTGTTHARTTGPPDPGTTGTTPVSAECPVVNELERINCIPDQPPTKATCDQRGCCWNPQGAVSVPWCYYSKNHSYHVEGNLVNTNAGFTARLKNLPSSPVFGSNVDNVLLTAEYQTSNRFHFKLTDQTNNRFEVPHEHVQSFSGNAAASLTYQVEISRQPFSIKVTRRSNNRVLFDSSIGPLLFADQFLQLSTRLPSTNVYGLGEHVHQQYRHDMNWKTWPIFNRDTTPNGNGTNLYGAQTFFLCLEDASGLSFGVFLMNSNAMEVVLQPAPAITYRTIGGILDFYVFLGNTPEQVVQEYLELIGRPALPSYWALGFHLSRYEYGTLDNMREVVERNRAAQLPYDVQHADIDYMDERRDFTYDSVDFKGFPEFVNELHNNGQKLVIIVDPAISNNSSSSKPYGPYDRGSDMKIWVNSSDGVTPLIGEVWPGQTVFPDYTNPNCAVWWTKEFELFHNQVEFDGIWIDMNEVSNFVDGSVSGCSTNNLNNPPFTPRILDGYLFCKTLCMDAVQHWGKQYDIHNLYGYSMAVATAEAAKTVFPNKRSFILTRSTFAGSGKFAAHWLGDNTATWDDLRWSIPGVLEFNLFGIPMVGPDICGFALDTPEELCRRWMQLGAFYPFSRNHNGQGYKDQDPASFGADSLLLNSSRHYLNIRYTLLPYLYTLFFRAHSRGDTVARPLLHEFYEDNSTWDVHQQFLWGPGLLITPVLDEGAEKVMAYVPDAVWYDYETGSQVRWRKQKVEMELPGDKIGLHLRGGYIFPTQQPNTTTLASRKNPLGLIIALDENKEAKGELFWDNGETKDTVANKVYLLCEFSVTQNRLEVNISQSTYKDPNNLAFNEIKILGTEEPSNVTVKHNGVPSQTSPTVTYDSNLKVAIITDIDLLLGEAYTVEWSIKIRDEEKIDCYPDENGASAENCTARGCIWEASNSSGVPFCYFVNDLYSVSDVQYNSHGATADISLKSSVYANAFPSTPVNPLRLDVTYHKNEMLQFKIYDPNKNRYEVPVPLNIPSMPSSTPEGQLYDVLIKKNPFGIEIRRKSTGTIIWDSQLLGFTFSDMFIRISTRLPSKYLYGFGETEHRSYRRDLEWHTWGMFSRDQPPGYKKNSYGVHPYYMGLEEDGSAHGVLLLNSNAMDVTFQPLPALTYRTTGGVLDFYVFLGPTPELVTQQYTELIGRPVMVPYWSLGFQLCRYGYQNDSEIASLYDEMVAAQIPYDVQYSDIDYMERQLDFTLSPKFAGFPALINRMKADGMRVILILDPAISGNETQPYPAFTRGVEDDVFIKYPNDGDIVWGKVWPDFPDVVVNGSLDWDSQVELYRAYVAFPDFFRNSTAKWWKREIEELYNNPQNPERSLKFDGMWIDMNEPSSFVNGAVSPGCRDASLNHPPYMPHLESRDRGLSSKTLCMESQQILPDGSLVQHYNVHNLYGWSQTRPTYEAVQEVTGQRGVVITRSTFPSSGRWAGHWLGDNTAAWDQLKKSIIGMMEFSLFGISYTGADICGFFQDAEYEMCVRWMQLGAFYPFSRNHNTIGTRRQDPVSWDVAFVNISRTVLQTRYTLLPYLYTLMHKAHTEGVTVVRPLLHEFVSDQVTWDIDSQFLLGPAFLVSPVLERNARNVTAYFPRARWYDYYTGVDINARGEWKTLPAPLDHINLHVRGGYILPWQEPALNTHLSRQKFMGFKIALDDEGTAGGWLFWDDGQSIDTYGKGLYYLASFSASQNTMQSHIIFNNYITGTNPLKLGYIEIWGVGSVPVTSVSISVSGMVITPSFNNDPTTQVLSIDVTDRNISLHNFTSLTWISTL'),
('Q9GZT4', '3L6B', 1, 1.5, 'A', 340, 'ISOMERASE', 'ISOMERASE', 'Serine racemase', 'SRR', 'L-serine = D-serine<br />\nD-serine = pyruvate + NH3<br />\nL-serine = pyruvate + NH3<br />\n', 'ATP binding<br />\ncalcium ion binding<br />\nD-serine ammonia-lyase activity<br />\nglycine binding<br />\nL-serine ammonia-lyase activity<br />\nmagnesium ion binding<br />\nPDZ domain binding<br />\nprotein homodimerization activity<br />\npyridoxal phosphate binding<br />\nserine racemase activity<br />\nthreonine racemase activity<br />\n', 'aging<br />\nbrain development<br />\nD-serine biosynthetic process<br />\nD-serine metabolic process<br />\nL-serine metabolic process<br />\nprotein homotetramerization<br />\npyruvate biosynthetic process<br />\nresponse to drug<br />\nresponse to lipopolysaccharide<br />\nresponse to morphine<br />\nserine family amino acid metabolic process<br />\n', 'PF00291.', 'MCAQYCISFADVEKAHINIRDSIHLTPVLTSSILNQLTGRNLFFKCELFQKTGSFKIRGALNAVRSLVPDALERKPKAVVTHSSGNHGQALTYAAKLEGIPAYIVVPQTAPDCKKLAIQAYGASIVYCEPSDESRENVAKRVTEETEGIMVHPNQEPAVIAGQGTIALEVLNQVPLVDALVVPVGGGGMLAGIAITVKALKPSVKVYAAEPSNADDCYQSKLKGKLMPNLYPPETIADGVKSSIGLNTWPIIRDLVDDIFTVTEDEIKCATQLVWERMKLLIEPTAGVGVAAVLSQHFQTVSPEVKNICIVLSGGNVDLTSSITWVKQAERPASYQSVSV'),
('P18925', '3LAD', 1, 2.2, 'A/B', 476, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydrolipoyl dehydrogenase', 'N/A', 'Protein N6-(dihydrolipoyl)lysine + NAD+ = protein N6-(lipoyl)lysine + NADH.', 'dihydrolipoyl dehydrogenase activity<br />\r\nelectron carrier activity<br />\r\nflavin adenine dinucleotide binding<br />', 'cell redox homeostasis<br />\r\nglycolytic process<br />', 'PF07992.', 'MSQKFDVIVIGAGPGGYVAAIKSAQLGLKTALIEKYKGKEGKTALGGTCL\r\nNVGCIPSKALLDSSYKFHEAHESFKLHGISTGEVAIDVPTMIARKDQIVR\r\nNLTGGVASLIKANGVTLFEGHGKLLAGKKVEVTAADGSSQVLDTENVILA\r\nSGSKPVEIPPAPVDQDVIVDSTGALDFQNVPGKLGVIGAGVIGLELGSVW\r\nARLGAEVTVLEAMDKFLPAVDEQVAKEAQKILTKQGLKILLGARVTGTEV\r\nKNKQVTVKFVDAEGEKSQAFDKLIVAVGRRPVTTDLLAADSGVTLDERGF\r\nIYVDDYCATSVPGVYAIGDVVRGAMLAHKASEEGVVVAERIAGHKAQMNY\r\nDLIPAVIYTHPEIAGVGKTEQALKAEGVAINVGVFPFAASGRAMAANDTA\r\nGFVKVIADAKTDRVLGVHVIGPSAAELVQQGAIAMEFGTSAEDLGMMVFA\r\nHPALSEALHEAALAVSGHAIHVANRKK'),
('P14410', '3LPP', 1, 2.15, 'A/B/C/D', 870, 'HYDROLASE', 'HYDROLASE', 'Sucrase-isomaltase, intestinal', 'SI', 'Hydrolysis of sucrose and maltose by an alpha-D-glucosidase-type action.<br />\nHydrolysis of (1->6)-alpha-D-glucosidic linkages in some oligosaccharides produced from starch and glycogen by alpha-amylase, and in isomaltose.<br />\n', 'alpha-1,4-glucosidase activity<br />\ncarbohydrate binding<br />\noligo-1,6-glucosidase activity<br />\nsucrose alpha-glucosidase activity<br />\n', 'carbohydrate metabolic process<br />\npolysaccharide digestion<br />\n', 'PF01055.', 'MARKKFSGLEISLIVLFVIVTIIAIALIVVLATKTPAVDEISDSTSTPATTRVTTNPSDSGKCPNVLNDPVNVRINCIPEQFPTEGICAQRGCCWRPWNDSLIPWCFFVDNHGYNVQDMTTTSIGVEAKLNRIPSPTLFGNDINSVLFTTQNQTPNRFRFKITDPNNRRYEVPHQYVKEFTGPTVSDTLYDVKVAQNPFSIQVIRKSNGKTLFDTSIGPLVYSDQYLQISTRLPSDYIYGIGEQVHKRFRHDLSWKTWPIFTRDQLPGDNNNNLYGHQTFFMCIEDTSGKSFGVFLMNSNAMEIFIQPTPIVTYRVTGGILDFYILLGDTPEQVVQQYQQLVGLPAMPAYWNLGFQLSRWNYKSLDVVKEVVRRNREAGIPFDTQVTDIDYMEDKKDFTYDQVAFNGLPQFVQDLHDHGQKYVIILDPAISIGRRANGTTYATYERGNTQHVWINESDGSTPIIGEVWPGLTVYPDFTNPNCIDWWANECSIFHQEVQYDGLWIDMNEVSSFIQGSTKGCNVNKLNYPPFTPDILDKLMYSKTICMDAVQNWGKQYDVHSLYGYSMAIATEQAVQKVFPNKRSFILTRSTFAGSGRHAAHWLGDNTASWEQMEWSITGMLEFSLFGIPLVGADICGFVAETTEELCRRWMQLGAFYPFSRNHNSDGYEHQDPAFFGQNSLLVKSSRQYLTIRYTLLPFLYTLFYKAHVFGETVARPVLHEFYEDTNSWIEDTEFLWGPALLITPVLKQGADTVSAYIPDAIWYDYESGAKRPWRKQRVDMYLPADKIGLHLRGGYIIPIQEPDVTTTASRKNPLGLIVALGENNTAKGDFFWDDGETKDTIQNGNYILYTFSVSNNTLDIVCTHSSYQEGTTLAFQTVKILGLTDSVTEVRVAENNQPMNAHSNFTYDASNQVLLIADLKLNLGRNFSVQWNQIFSENERFNCYPDADLATEQKCTQRGCVWRTGSSLSKAPECYFPRQDNSYSVNSARYSSMGITADLQLNTANARIKLPSDPISTLRVEVKYHKNDMLQFKIYDPQKKRYEVPVPLNIPTTPISTYEDRLYDVEIKENPFGIQIRRRSSGRVIWDSWLPGFAFNDQFIQISTRLPSEYIYGFGEVEHTAFKRDLNWNTWGMFTRDQPPGYKLNSYGFHPYYMALEEEGNAHGVFLLNSNAMDVTFQPTPALTYRTVGGILDFYMFLGPTPEVATKQYHEVIGHPVMPAYWALGFQLCRYGYANTSEVRELYDAMVAANIPYDVQYTDIDYMERQLDFTIGEAFQDLPQFVDKIRGEGMRYIIILDPAISGNETKTYPAFERGQQNDVFVKWPNTNDICWAKVWPDLPNITIDKTLTEDEAVNASRAHVAFPDFFRTSTAEWWAREIVDFYNEKMKFDGLWIDMNEPSSFVNGTTTNQCRNDELNYPPYFPELTKRTDGLHFRTICMEAEQILSDGTSVLHYDVHNLYGWSQMKPTHDALQKTTGKRGIVISRSTYPTSGRWGGHWLGDNYARWDNMDKSIIGMMEFSLFGMSYTGADICGFFNNSEYHLCTRWMQLGAFYPYSRNHNIANTRRQDPASWNETFAEMSRNILNIRYTLLPYFYTQMHEIHANGGTVIRPLLHEFFDEKPTWDIFKQFLWGPAFMVTPVLEPYVQTVNAYVPNARWFDYHTGKDIGVRGQFQTFNASYDTINLHVRGGHILPCQEPAQNTFYSRQKHMKLIVAADDNQMAQGSLFWDDGESIDTYERDLYLSVQFNLNQTTLTSTILKRGYINKSETRLGSLHVWGKGTTPVNAVTLTYNGNKNSLPFNEDTTNMILRIDLTTHNVTLEEPIEINWS'),
('P0A8V2', '3LTI', 0, 1.6, 'A', 292, 'TRANSFERASE', 'TRANSFERASE', 'DNA-directed RNA polymerase subunit beta', 'rpoB', 'Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).<br />\n', 'DNA binding<br />\nDNA-directed 5''-3'' RNA polymerase activity<br />\nribonucleoside binding<br />\n', 'transcription, DNA-templated<br />\n', 'PF04563.', 'MVYSYTEKKRIRKDFGKRPQVLDVPYLLSIQLDSFQKFIEQDPEGQYGLEAAFRSVFPIQSYSGNSELQYVSYRLGEPVFDVQECQIRGVTYSAPLRVKLRLVIYEREAPEGTVKDIKEQEVYMGEIPLMTDNGTFVINGTERVIVSQLHRSPGVFFDSDKGKTHSSGKVLYNARIIPYRGSWLDFEFDPKDNLFVRIDRRRKLPATIILRALNYTTEQILDLFFEKVIFEIRDNKLQMELVPERLRGETASFDIEANGKVYVEKGRRITARHIRQLEKDDVKLIEVPVEYIAGKVVAKDYIDESTGELICAANMELSLDLLAKLSQSGHKRIETLFTNDLDHGPYISETLRVDPTNDRLSALVEIYRMMRPGEPPTREAAESLFENLFFSEDRYDLSAVGRMKFNRSLLREEIEGSGILSKDDIIDVMKKLIDIRNGKGEVDDIDHLGNRRIRSVGEMAENQFRVGLVRVERAVKERLSLGDLDTLMPQDMINAKPISAAVKEFFGSSQLSQFMDQNNPLSEITHKRRISALGPGGLTRERAGFEVRDVHPTHYGRVCPIETPEGPNIGLINSLSVYAQTNEYGFLETPYRKVTDGVVTDEIHYLSAIEEGNYVIAQANSNLDEEGHFVEDLVTCRSKGESSLFSRDQVDYMDVSTQQVVSVGASLIPFLEHDDANRALMGANMQRQAVPTLRADKPLVGTGMERAVAVDSGVTAVAKRGGVVQYVDASRIVIKVNEDEMYPGEAGIDIYNLTKYTRSNQNTCINQMPCVSLGEPVERGDVLADGPSTDLGELALGQNMRVAFMPWNGYNFEDSILVSERVVQEDRFTTIHIQELACVSRDTKLGPEEITADIPNVGEAALSKLDESGIVYIGAEVTGGDILVGKVTPKGETQLTPEEKLLRAIFGEKASDVKDSSLRVPNGVSGTVIDVQVFTRDGVEKDKRALEIEEMQLKQAKKDLSEELQILEAGLFSRIRAVLVAGGVEAEKLDKLPRDRWLELGLTDEEKQNQLEQLAEQYDELKHEFEKKLEAKRRKITQGDDLAPGVLKIVKVYLAVKRRIQPGDKMAGRHGNKGVISKINPIEDMPYDENGTPVDIVLNPLGVPSRMNIGQILETHLGMAAKGIGDKINAMLKQQQEVAKLREFIQRAYDLGADVRQKVDLSTFSDEEVMRLAENLRKGMPIATPVFDGAKEAEIKELLKLGDLPTSGQIRLYDGRTGEQFERPVTVGYMYMLKLNHLVDDKMHARSTGSYSLVTQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLQEMLTVKSDDVNGRTKMYKNIVDGNHQMEPGMPESFNVLLKEIRSLGINIELEDE'),
('P01584', '3LTQ', 0, 2.1, 'A', 153, 'CYTOKINE', 'OTHERS', 'Interleukin-1 beta', 'IL1B', '', 'cytokine activity<br />\ninterleukin-1 receptor binding<br />\nprotein domain specific binding<br />\n', 'activation of MAPK activity<br />\napoptotic process<br />\ncell-cell signaling<br />\ncellular response to drug<br />\ncellular response to mechanical stimulus<br />\ncellular response to organic cyclic compound<br />\ncellular response to organic substance<br />\ncytokine-mediated signaling pathway<br />\nectopic germ cell programmed cell death<br />\nembryo implantation<br />\nextrinsic apoptotic signaling pathway in absence of ligand<br />\nfever generation<br />\nhyaluronan biosynthetic process<br />\nimmune response<br />\ninflammatory response<br />\ninterleukin-1 beta production<br />\nlipopolysaccharide-mediated signaling pathway<br />\nMAPK cascade<br />\nmonocyte aggregation<br />\nnegative regulation of adiponectin secretion<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of extrinsic apoptotic signaling pathway in absence of ligand<br />\nnegative regulation of glucose transport<br />\nnegative regulation of insulin receptor signaling pathway<br />\nnegative regulation of lipid catabolic process<br />\nnegative regulation of lipid metabolic process<br />\nnegative regulation of MAP kinase activity<br />\nnegative regulation of synaptic transmission<br />\nneutrophil chemotaxis<br />\npositive regulation of angiogenesis<br />\npositive regulation of calcidiol 1-monooxygenase activity<br />\npositive regulation of cell adhesion molecule production<br />\npositive regulation of cell division<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of chemokine biosynthetic process<br />\npositive regulation of epithelial to mesenchymal transition<br />\npositive regulation of fever generation<br />\npositive regulation of gene expression<br />\npositive regulation of granulocyte macrophage colony-stimulating factor production<br />\npositive regulation of heterotypic cell-cell adhesion<br />\npositive regulation of histone acetylation<br />\npositive regulation of histone phosphorylation<br />\npositive regulation of interferon-gamma production<br />\npositive regulation of interleukin-2 biosynthetic process<br />\npositive regulation of interleukin-6 biosynthetic process<br />\npositive regulation of interleukin-6 production<br />\npositive regulation of interleukin-6 secretion<br />\npositive regulation of interleukin-8 production<br />\npositive regulation of JNK cascade<br />\npositive regulation of lipid catabolic process<br />\npositive regulation of membrane protein ectodomain proteolysis<br />\npositive regulation of mitotic nuclear division<br />\npositive regulation of monocyte chemotactic protein-1 production<br />\npositive regulation of myosin light chain kinase activity<br />\npositive regulation of NF-kappaB import into nucleus<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of p38MAPK cascade<br />\npositive regulation of phagocytosis<br />\npositive regulation of prostaglandin secretion<br />\npositive regulation of protein export from nucleus<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of T cell mediated immunity<br />\npositive regulation of T cell proliferation<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of vascular endothelial growth factor production<br />\npositive regulation of vascular endothelial growth factor receptor signaling pathway<br />\nprotein kinase B signaling<br />\nregulation of defense response to virus by host<br />\nregulation of ERK1 and ERK2 cascade<br />\nregulation of establishment of endothelial barrier<br />\nregulation of I-kappaB kinase/NF-kappaB signaling<br />\nregulation of insulin secretion<br />\nregulation of nitric-oxide synthase activity<br />\nresponse to ATP<br />\nresponse to carbohydrate<br />\nsequestering of triglyceride<br />\nsignal transduction<br />\nsmooth muscle adaptation<br />\n', 'PF00340.', 'MAEVPELASEMMAYYSGNEDDLFFEADGPKQMKCSFQDLDLCPLDGGIQLRISDHHYSKGFRQAASVVVAMDKLRKMLVPCPQTFQENDLSTFFPFIFEEEPIFFDTWDNEAYVHDAPVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS'),
('Q01668', '3LV3', 0, 1.94, 'C', 9, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Voltage-dependent L-type calcium channel subunit alpha-1D', 'CACNA1D', '', 'alpha-actinin binding<br />\nankyrin binding<br />\nhigh voltage-gated calcium channel activity<br />\nmetal ion binding<br />\nvoltage-gated calcium channel activity<br />\nvoltage-gated calcium channel activity involved in cardiac muscle cell action potential<br />\nvoltage-gated calcium channel activity involved SA node cell action potential<br />\n', 'adenylate cyclase-modulating G-protein coupled receptor signaling pathway<br />\ncalcium ion import<br />\ncalcium ion transmembrane transport<br />\ncalcium ion transport<br />\ncardiac conduction<br />\ncardiac muscle cell action potential involved in contraction<br />\nmembrane depolarization during cardiac muscle cell action potential<br />\nmembrane depolarization during SA node cell action potential<br />\npositive regulation of calcium ion transport<br />\nregulation of atrial cardiac muscle cell membrane repolarization<br />\nregulation of heart rate by cardiac conduction<br />\nregulation of insulin secretion<br />\nregulation of potassium ion transmembrane transport<br />\nregulation of potassium ion transmembrane transporter activity<br />\nsensory perception of sound<br />\n', 'PF08763.', 'MMMMMMMKKMQHQRQQQADHANEANYARGTRLPLSGEGPTSQPNSSKQTVLSWQAAIDAARQAKAAQTMSTSAPPPVGSLSQRKRQQYAKSKKQGNSSNSRPARALFCLSLNNPIRRACISIVEWKPFDIFILLAIFANCVALAIYIPFPEDDSNSTNHNLEKVEYAFLIIFTVETFLKIIAYGLLLHPNAYVRNGWNLLDFVIVIVGLFSVILEQLTKETEGGNHSSGKSGGFDVKALRAFRVLRPLRLVSGVPSLQVVLNSIIKAMVPLLHIALLVLFVIIIYAIIGLELFIGKMHKTCFFADSDIVAEEDPAPCAFSGNGRQCTANGTECRSGWVGPNGGITNFDNFAFAMLTVFQCITMEGWTDVLYWMNDAMGFELPWVYFVSLVIFGSFFVLNLVLGVLSGEFSKEREKAKARGDFQKLREKQQLEEDLKGYLDWITQAEDIDPENEEEGGEEGKRNTSMPTSETESVNTENVSGEGENRGCCGSLCQAISKSKLSRRWRRWNRFNRRRCRAAVKSVTFYWLVIVLVFLNTLTISSEHYNQPDWLTQIQDIANKVLLALFTCEMLVKMYSLGLQAYFVSLFNRFDCFVVCGGITETILVELEIMSPLGISVFRCVRLLRIFKVTRHWTSLSNLVASLLNSMKSIASLLLLLFLFIIIFSLLGMQLFGGKFNFDETQTKRSTFDNFPQALLTVFQILTGEDWNAVMYDGIMAYGGPSSSGMIVCIYFIILFICGNYILLNVFLAIAVDNLADAESLNTAQKEEAEEKERKKIARKESLENKKNNKPEVNQIANSDNKVTIDDYREEDEDKDPYPPCDVPVGEEEEEEEEDEPEVPAGPRPRRISELNMKEKIAPIPEGSAFFILSKTNPIRVGCHKLINHHIFTNLILVFIMLSSAALAAEDPIRSHSFRNTILGYFDYAFTAIFTVEILLKMTTFGAFLHKGAFCRNYFNLLDMLVVGVSLVSFGIQSSAISVVKILRVLRVLRPLRAINRAKGLKHVVQCVFVAIRTIGNIMIVTTLLQFMFACIGVQLFKGKFYRCTDEAKSNPEECRGLFILYKDGDVDSPVVRERIWQNSDFNFDNVLSAMMALFTVSTFEGWPALLYKAIDSNGENIGPIYNHRVEISIFFIIYIIIVAFFMMNIFVGFVIVTFQEQGEKEYKNCELDKNQRQCVEYALKARPLRRYIPKNPYQYKFWYVVNSSPFEYMMFVLIMLNTLCLAMQHYEQSKMFNDAMDILNMVFTGVFTVEMVLKVIAFKPKGYFSDAWNTFDSLIVIGSIIDVALSEADPTESENVPVPTATPGNSEESNRISITFFRLFRVMRLVKLLSRGEGIRTLLWTFIKSFQALPYVALLIAMLFFIYAVIGMQMFGKVAMRDNNQINRNNNFQTFPQAVLLLFRCATGEAWQEIMLACLPGKLCDPESDYNPGEEYTCGSNFAIVYFISFYMLCAFLIINLFVAVIMDNFDYLTRDWSILGPHHLDEFKRIWSEYDPEAKGRIKHLDVVTLLRRIQPPLGFGKLCPHRVACKRLVAMNMPLNSDGTVMFNATLFALVRTALKIKTEGNLEQANEELRAVIKKIWKKTSMKLLDQVVPPAGDDEVTVGKFYATFLIQDYFRKFKKRKEQGLVGKYPAKNTTIALQAGLRTLHDIGPEIRRAISCDLQDDEPEETKREEEDDVFKRNGALLGNHVNHVNSDRRDSLQQTNTTHRPLHVQRPSIPPASDTEKPLFPPAGNSVCHNHHNHNSIGKQVPTSTNANLNNANMSKAAHGKRPSIGNLEHVSENGHHSSHKHDREPQRRSSVKRTRYYETYIRSDSGDEQLPTICREDPEIHGYFRDPHCLGEQEYFSSEECYEDDSSPTWSRQNYGYYSRYPGRNIDSERPRGYHHPQGFLEDDDSPVCYDSRRSPRRRLLPPTPASHRRSSFNFECLRRQSSQEEVPSSPIFPHRTALPLHLMQQQIMAVAGLDSSKAQKYSPSHSTRSWATPPATPPYRDWTPCYTPLIQVEQSEALDQVNGSLPSLHRSSWYTDEPDISYRTFTPASLTVPSSFRNKNSDKQRSADSLVEAVLISEGLGRYARDPKFVSATKHEIADACDLTIDEMESAASTLLNGNVRPRANGDVGPLSHRQDYELQDFGPGYSDEEPDPGRDEEDLADEMICITTL'),
('P43166', '3ML5', 1, 2.05, 'A', 264, 'LYASE', 'LYASE', 'Carbonic anhydrase 7', 'CA7', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\none-carbon metabolic process<br />\npositive regulation of cellular pH reduction<br />\npositive regulation of synaptic transmission, GABAergic<br />\nregulation of chloride transport<br />\n', 'PF00194.', 'MTGHHGWGYGQDDGPSHWHKLYPIAQGDRQSPINIISSQAVYSPSLQPLELSYEACMSLSITNNGHSVQVDFNDSDDRTVVTGGPLEGPYRLKQFHFHWGKKHDVGSEHTVDGKSFPSELHLVHWNAKKYSTFGEAASAPDGLAVVGVFLETGDEHPSMNRLTDALYMVRFKGTKAQFSCFNPKCLLPASRHYWTYPGSLTTPPLSESVTWIVLREPICISERQMGKFRSLLFTSEDDERIHMVNNFRPPQPLKGRVVKASFRA'),
('P30044', '3MNG', 1, 1.45, 'A', 161, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Peroxiredoxin-5, mitochondrial', 'PRDX5', '2 R''-SH + ROOH = R''-S-S-R'' + H2O + ROH<br />\n', 'antioxidant activity<br />\ncysteine-type endopeptidase inhibitor activity involved in apoptotic process<br />\nperoxidase activity<br />\nperoxiredoxin activity<br />\nperoxynitrite reductase activity<br />\nprotein dimerization activity<br />\nreceptor binding<br />\nRNA polymerase III regulatory region DNA binding<br />\nthioredoxin peroxidase activity<br />\n', 'cell redox homeostasis<br />\ncellular response to oxidative stress<br />\ncellular response to reactive oxygen species<br />\nhydrogen peroxide catabolic process<br />\ninflammatory response<br />\nNADPH oxidation<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of oxidoreductase activity<br />\nnegative regulation of transcription from RNA polymerase III promoter<br />\npositive regulation of collagen biosynthetic process<br />\nreactive nitrogen species metabolic process<br />\nregulation of apoptosis involved in tissue homeostasis<br />\nresponse to oxidative stress<br />\n', 'PF08534.', 'MGLAGVCALRRSAGYILVGGAGGQSAAAAARRYSEGEWASGGVRSFSRAAAAMAPIKVGDAIPAVEVFEGEPGNKVNLAELFKGKKGVLFGVPGAFTPGCSKTHLPGFVEQAEALKAKGVQVVACLSVNDAFVTGEWGRAHKAEGKVRLLADPTGAFGKETDLLLDDSLVSIFGNRRLKRFSMVVQDGIVKALNVEPDGTGLTCSLAPNIISQL'),
('P37023', '3MY0', 1, 2.65, 'A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X', 303, 'TRANSFERASE', 'TRANSFERASE', 'Serine/threonine-protein kinase receptor R3', 'ACVRL1', 'ATP + [receptor-protein] = ADP + [receptor-protein] phosphate.<br />\n', 'activin binding<br />\nactivin receptor activity, type I<br />\nATP binding<br />\nBMP receptor activity<br />\nmetal ion binding<br />\nprotein kinase binding<br />\nprotein serine/threonine kinase activity<br />\nsignal transducer, downstream of receptor, with serine/threonine kinase activity<br />\nSMAD binding<br />\ntransforming growth factor beta-activated receptor activity<br />\ntransforming growth factor beta binding<br />\ntransforming growth factor beta receptor activity, type I<br />\ntransmembrane receptor protein serine/threonine kinase activity<br />\n', 'angiogenesis<br />\nartery development<br />\nblood circulation<br />\nblood vessel endothelial cell proliferation involved in sprouting angiogenesis<br />\nblood vessel maturation<br />\nblood vessel remodeling<br />\nBMP signaling pathway<br />\ncellular response to BMP stimulus<br />\ncellular response to transforming growth factor beta stimulus<br />\ndorsal aorta morphogenesis<br />\nendocardial cushion morphogenesis<br />\nendothelial tube morphogenesis<br />\nin utero embryonic development<br />\nlymphangiogenesis<br />\nlymphatic endothelial cell differentiation<br />\nnegative regulation of blood vessel endothelial cell migration<br />\nnegative regulation of cell adhesion<br />\nnegative regulation of cell growth<br />\nnegative regulation of cell migration<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of DNA biosynthetic process<br />\nnegative regulation of endothelial cell differentiation<br />\nnegative regulation of endothelial cell migration<br />\nnegative regulation of endothelial cell proliferation<br />\nnegative regulation of focal adhesion assembly<br />\nnegative regulation of gene expression<br />\npositive regulation of angiogenesis<br />\npositive regulation of BMP signaling pathway<br />\npositive regulation of chondrocyte differentiation<br />\npositive regulation of endothelial cell differentiation<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of pathway-restricted SMAD protein phosphorylation<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein heterooligomerization<br />\nprotein phosphorylation<br />\nregulation of blood pressure<br />\nregulation of blood vessel endothelial cell migration<br />\nregulation of DNA replication<br />\nregulation of endothelial cell proliferation<br />\nregulation of transcription, DNA-templated<br />\nresponse to hypoxia<br />\nretina vasculature development in camera-type eye<br />\nsignal transduction<br />\ntransforming growth factor beta receptor signaling pathway<br />\nvenous blood vessel development<br />\nwound healing, spreading of epidermal cells<br />\n', 'PF07714.', 'MTLGSPRKGLLMLLMALVTQGDPVKPSRGPLVTCTCESPHCKGPTCRGAWCTVVLVREEGRHPQEHRGCGNLHRELCRGRPTEFVNHYCCDSHLCNHNVSLVLEATQPPSEQPGTDGQLALILGPVLALLALVALGVLGLWHVRRRQEKQRGLHSELGESSLILKASEQGDSMLGDLLDSDCTTGSGSGLPFLVQRTVARQVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISNSPEKPKVIQ'),
('P0AEB2', '3MZF', 1, 1.5, 'A', 357, 'HYDROLASE / ANTIBIOTIC', 'HYDROLASE', 'D-alanyl-D-alanine carboxypeptidase DacA', 'dacA', 'Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala. Also transpeptidation of peptidyl-alanyl moieties that are N-acyl substituents of D-alanine.<br />\nA beta-lactam + H2O = a substituted beta-amino acid.<br />\n', 'beta-lactamase activity<br />\ncarboxypeptidase activity<br />\nendopeptidase activity<br />\npenicillin binding<br />\nserine-type D-Ala-D-Ala carboxypeptidase activity<br />\n', 'cell wall macromolecule metabolic process<br />\ncell wall organization<br />\npeptidoglycan biosynthetic process<br />\npeptidoglycan metabolic process<br />\nregulation of cell shape<br />\n', 'PF07943.', 'MNTIFSARIMKRLALTTALCTAFISAAHADDLNIKTMIPGVPQIDAESYILIDYNSGKVLAEQNADVRRDPASLTKMMTSYVIGQAMKAGKFKETDLVTIGNDAWATGNPVFKGSSLMFLKPGMQVPVSQLIRGINLQSGNDACVAMADFAAGSQDAFVGLMNSYVNALGLKNTHFQTVHGLDADGQYSSARDMALIGQALIRDVPNEYSIYKEKEFTFNGIRQLNRNGLLWDNSLNVDGIKTGHTDKAGYNLVASATEGQMRLISAVMGGRTFKGREAESKKLLTWGFRFFETVNPLKVGKEFASEPVWFGDSDRASLGVDKDVYLTIPRGRMKDLKASYVLNSSELHAPLQKNQVVGTINFQLDGKTIEQRPLVVLQEIPEGNFFGKIIDYIKLMFHHWFG'),
('P16471', '3N06', 0, 2, 'B', 209, 'HORMONE / HORMONE RECEPTOR', 'HORMONE', 'Prolactin receptor', 'PRLR', '', 'metal ion binding<br />\nornithine decarboxylase activator activity<br />\npeptide hormone binding<br />\nprolactin receptor activity<br />\nprotein homodimerization activity<br />\n', 'activation of Janus kinase activity<br />\nactivation of transmembrane receptor protein tyrosine kinase activity<br />\ncell surface receptor signaling pathway<br />\nembryo implantation<br />\nJAK-STAT cascade involved in growth hormone signaling pathway<br />\nlactation<br />\nnegative regulation of apoptotic process<br />\nsteroid biosynthetic process<br />\nT cell activation<br />\n', 'PF09067.', 'MKENVASATVFTLLLFLNTCLLNGQLPPGKPEIFKCRSPNKETFTCWWRPGTDGGLPTNYSLTYHREGETLMHECPDYITGGPNSCHFGKQYTSMWRTYIMMVNATNQMGSSFSDELYVDVTYIVQPDPPLELAVEVKQPEDRKPYLWIKWSPPTLIDLKTGWFTLLYEIRLKPEKAAEWEIHFAGQQTEFKILSLHPGQKYLVQVRCKPDHGYWSAWSPATFIQIPSDFTMNDTTVWISVAVLSAVICLIIVWAVALKGYSMVTCIFPPVPGPKIKGFDAHLLEKGKSEELLSALGCQDFPPTSDYEDLLVEYLEVDDSEDQHLMSVHSKEHPSQGMKPTYLDPDTDSGRGSCDSPSLLSEKCEEPQANPSTFYDPEVIEKPENPETTHTWDPQCISMEGKIPYFHAGGSKCSTWPLPQPSQHNPRSSYHNITDVCELAVGPAGAPATLLNEAGKDALKSSQTIKSREEGKATQQREVESFHSETDQDTPWLLPQEKTPFGSAKPLDYVEIHKVNKDGALSLLPKQRENSGKPKKPGTPENNKEYAKVSGVMDNNILVLVPDPHAKNVACFEESAKEAPPSLEQNQAEKALANFTATSSKCRLQLGGLDYLDPACFTHSFH'),
('P0A7Z4', '3N4M', 1, 2.99, 'B/C', 84, 'GENE REGULATION / DNA', 'OTHERS', 'DNA-directed RNA polymerase subunit alpha', 'rpoA', 'Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1).<br />\n', 'DNA binding<br />\nDNA-directed 5''-3'' RNA polymerase activity<br />\nprotein dimerization activity<br />\nzinc ion binding<br />\n', 'DNA-templated transcription, elongation<br />\n', 'PF01000.', 'MQGSVTEFLKPRLVDIEQVSSTHAKVTLEPLERGFGHTLGNALRRILLSSMPGCAVTEVEIDGVLHEYSTKEGVQEDILEILLNLKGLAVRVQGKDEVILTLNKSGIGPVTAADITHDGDVEIVKPQHVICHLTDENASISMRIKVQRGRGYVPASTRIHSEEDERPIGRLLVDACYSPVERIAYNVEAARVEQRTDLDKLVIEMETNGTIDPEEAIRRAATILAEQLEAFVDLRDVRQPEVKEEKPEFDPILLRPVDDLELTVRSANCLKAEAIHYIGDLVQRTEVELLKTPNLGKKSLTEIKDVLASRGLSLGMRLENWPPASIADE'),
('P05108', '3N9Y', 1, 2.1, 'A/B', 481, 'Oxidoreductase', 'OXIDOREDUCTASE', 'Cholesterol side-chain cleavage enzyme, mitochondrial', 'CYP11A1', 'Cholesterol + 6 reduced adrenodoxin + 3 O2 + 6 H+ = pregnenolone + 4-methylpentanal + 6 oxidized adrenodoxin + 4 H2O<br />\n', 'cholesterol monooxygenase (side-chain-cleaving) activity<br />\nheme binding<br />\niron ion binding<br />\n', 'C21-steroid hormone biosynthetic process<br />\ncholesterol metabolic process<br />\nsterol metabolic process<br />\nvitamin D metabolic process<br />\n', 'PF00067.', 'MLAKGLPPRSVLVKGCQTFLSAPREGLGRLRVPTGEGAGISTRSPRPFNEIPSPGDNGWLNLYHFWRETGTHKVHLHHVQNFQKYGPIYREKLGNVESVYVIDPEDVALLFKSEGPNPERFLIPPWVAYHQYYQRPIGVLLKKSAAWKKDRVALNQEVMAPEATKNFLPLLDAVSRDFVSVLHRRIKKAGSGNYSGDISDDLFRFAFESITNVIFGERQGMLEEVVNPEAQRFIDAIYQMFHTSVPMLNLPPDLFRLFRTKTWKDHVAAWDVIFSKADIYTQNFYWELRQKGSVHHDYRGILYRLLGDSKMSFEDIKANVTEMLAGGVDTTSMTLQWHLYEMARNLKVQDMLRAEVLAARHQAQGDMATMLQLVPLLKASIKETLRLHPISVTLQRYLVNDLVLRDYMIPAKTLVQVAIYALGREPTFFFDPENFDPTRWLSKDKNITYFRNLGFGWGVRQCLGRRIAELEMTIFLINMLENFRVEIQHLSDVGTTFNLILMPEKPISFTFWPFNQEATQQ'),
('P10109', '3N9Z', 1, 2.17, 'C/D', 123, 'Oxidoreductase', 'OXIDOREDUCTASE', 'Adrenodoxin, mitochondrial', 'FDX1', '', '2 iron, 2 sulfur cluster binding<br />\nelectron carrier activity<br />\niron ion binding<br />\n', 'C21-steroid hormone biosynthetic process<br />\ncellular response to cAMP<br />\ncellular response to forskolin<br />\ncholesterol metabolic process<br />\nhormone biosynthetic process<br />\noxidation-reduction process<br />\nsmall molecule metabolic process<br />\nsterol metabolic process<br />\n', 'PF00111.', 'MAAAGGARLLRAASAVLGGPAGRWLHHAGSRAGSSGLLRNRGPGGSAEASRSLSVSARARSSSEDKITVHFINRDGETLTTKGKVGDSLLDVVVENNLDIDGFGACEGTLACSTCHLIFEDHIYEKLDAITDEENDMLDLAYGLTDRSRLGCQICLTKSMDNMTVRVPETVADARQSIDVGKTS'),
('P29074', '3NFK', 0, 1.43, 'A/B', 106, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Tyrosine-protein phosphatase non-receptor type 4', 'PTPN4', 'Protein tyrosine phosphate + H2O = protein tyrosine + phosphate<br />\n', 'cytoskeletal protein binding<br />\nnon-membrane spanning protein tyrosine phosphatase activity<br />\n', 'protein dephosphorylation<br />\n', 'PF08736.', 'MTSRFRLPAGRTYNVRASELARDRQHTEVVCNILLLDNTVQAFKVNKHDQGQVLLDVVFKHLDLTEQDYFGLQLADDSTDNPRWLDPNKPIRKQLKRGSPYSLNFRVKFFVSDPNKLQEEYTRYQYFLQIKQDILTGRLPCPSNTAALLASFAVQSELGDYDQSENLSGYLSDYSFIPNQPQDFEKEIAKLHQQHIGLSPAEAEFNYLNTARTLELYGVEFHYARDQSNNEIMIGVMSGGILIYKNRVRMNTFPWLKIVKISFKCKQFFIQLRKELHESRETLLGFNMVNYRACKNLWKACVEHHTFFRLDRPLPPQKNFFAHYFTLGSKFRYCGRTEVQSVQYGKEKANKDRVFARSPSKPLARKLMDWEVVSRNSISDDRLETQSLPSRSPPGTPNHRNSTFTQEGTRLRPSSVGHLVDHMVHTSPSEVFVNQRSPSSTQANSIVLESSPSQETPGDGKPPALPPKQSKKNSWNQIHYSHSQQDLESHINETFDIPSSPEKPTPNGGIPHDNLVLIRMKPDENGRFGFNVKGGYDQKMPVIVSRVAPGTPADLCVPRLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRPNAVYDVVEEKLENEPDFQYIPEKAPLDSVHQDDHSLRESMIQLAEGLITGTVLTQFDQLYRKKPGMTMSCAKLPQNISKNRYRDISPYDATRVILKGNEDYINANYINMEIPSSSIINQYIACQGPLPHTCTDFWQMTWEQGSSMVVMLTTQVERGRVKCHQYWPEPTGSSSYGCYQVTCHSEEGNTAYIFRKMTLFNQEKNESRPLTQIQYIAWPDHGVPDDSSDFLDFVCHVRNKRAGKEEPVVVHCSAGIGRTGVLITMETAMCLIECNQPVYPLDIVRTMRDQRAMMIQTPSQYRFVCEAILKVYEEGFVKPLTTSTNK'),
('P05106', '3NIF', 1, 2.4, 'B/D', 471, 'CELL ADHESION / BLOOD CLOTTING', 'CELL_ADHESION', 'Integrin beta-3', 'ITGB3', '', 'cell adhesion molecule binding<br />\ncoreceptor activity<br />\nenzyme binding<br />\nextracellular matrix binding<br />\nfibronectin binding<br />\nidentical protein binding<br />\nplatelet-derived growth factor receptor binding<br />\nprotease binding<br />\nprotein disulfide isomerase activity<br />\nvascular endothelial growth factor receptor 2 binding<br />\nvirus receptor activity<br />\n', 'activation of protein kinase activity<br />\nangiogenesis involved in wound healing<br />\napolipoprotein A-I-mediated signaling pathway<br />\nblood coagulation<br />\ncell adhesion<br />\ncell adhesion mediated by integrin<br />\ncell growth<br />\ncell-matrix adhesion<br />\ncell migration<br />\ncell-substrate adhesion<br />\ncell-substrate junction assembly<br />\nextracellular matrix organization<br />\nheterotypic cell-cell adhesion<br />\nintegrin-mediated signaling pathway<br />\nleukocyte migration<br />\nmesodermal cell differentiation<br />\nnegative chemotaxis<br />\nnegative regulation of lipid storage<br />\nnegative regulation of lipid transport<br />\nnegative regulation of lipoprotein metabolic process<br />\nnegative regulation of low-density lipoprotein particle receptor biosynthetic process<br />\nnegative regulation of macrophage derived foam cell differentiation<br />\nplatelet activation<br />\nplatelet aggregation<br />\nplatelet degranulation<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of vascular endothelial growth factor receptor signaling pathway<br />\nregulation of bone resorption<br />\nsmooth muscle cell migration<br />\nsubstrate adhesion-dependent cell spreading<br />\ntube development<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nviral entry into host cell<br />\nwound healing<br />\n', 'PF07974.', 'MRARPRPRPLWATVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAPESIEFPVSEARVLEDRPLSDKGSGDSSQVTQVSPQRIALRLRPDDSKNFSIQVRQVEDYPVDIYYLMDLSYSMKDDLWSIQNLGTKLATQMRKLTSNLRIGFGAFVDKPVSPYMYISPPEALENPCYDMKTTCLPMFGYKHVLTLTDQVTRFNEEVKKQSVSRNRDAPEGGFDAIMQATVCDEKIGWRNDASHLLVFTTDAKTHIALDGRLAGIVQPNDGQCHVGSDNHYSASTTMDYPSLGLMTEKLSQKNINLIFAVTENVVNLYQNYSELIPGTTVGVLSMDSSNVLQLIVDAYGKIRSKVELEVRDLPEELSLSFNATCLNNEVIPGLKSCMGLKIGDTVSFSIEAKVRGCPQEKEKSFTIKPVGFKDSLIVQVTFDCDCACQAQAEPNSHRCNNGNGTFECGVCRCGPGWLGSQCECSEEDYRPSQQDECSPREGQPVCSQRGECLCGQCVCHSSDFGKITGKYCECDDFSCVRYKGEMCSGHGQCSCGDCLCDSDWTGYYCNCTTRTDTCMSSNGLLCSGRGKCECGSCVCIQPGSYGDTCEKCPTCPDACTFKKECVECKKFDRGALHDENTCNRYCRDEIESVKELKDTGKDAVNCTYKNEDDCVVRFQYYEDSSGKSILYVVEEPECPKGPDILVVLLSVMGAILLIGLAALLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT'),
('P08514', '3NIF', 1, 2.4, 'A/C', 457, 'CELL ADHESION / BLOOD CLOTTING', 'CELL_ADHESION', 'Integrin alpha-IIb', 'ITGA2B', '', 'extracellular matrix binding<br />\nfibrinogen binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\n', 'cell adhesion<br />\ncell-matrix adhesion<br />\nextracellular matrix organization<br />\nintegrin-mediated signaling pathway<br />\nplatelet aggregation<br />\nplatelet degranulation<br />\npositive regulation of leukocyte migration<br />\nregulation of megakaryocyte differentiation<br />\n', 'PF01839.', 'MARALCPLQALWLLEWVLLLLGPCAAPPAWALNLDPVQLTFYAGPNGSQFGFSLDFHKDSHGRVAIVVGAPRTLGPSQEETGGVFLCPWRAEGGQCPSLLFDLRDETRNVGSQTLQTFKARQGLGASVVSWSDVIVACAPWQHWNVLEKTEEAEKTPVGSCFLAQPESGRRAEYSPCRGNTLSRIYVENDFSWDKRYCEAGFSSVVTQAGELVLGAPGGYYFLGLLAQAPVADIFSSYRPGILLWHVSSQSLSFDSSNPEYFDGYWGYSVAVGEFDGDLNTTEYVVGAPTWSWTLGAVEILDSYYQRLHRLRGEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADRKLAEVGRVYLFLQPRGPHALGAPSLLLTGTQLYGRFGSAIAPLGDLDRDGYNDIAVAAPYGGPSGRGQVLVFLGQSEGLRSRPSQVLDSPFPTGSAFGFSLRGAVDIDDNGYPDLIVGAYGANQVAVYRAQPVVKASVQLLVQDSLNPAVKSCVLPQTKTPVSCFNIQMCVGATGHNIPQKLSLNAELQLDRQKPRQGRRVLLLGSQQAGTTLNLDLGGKHSPICHTTMAFLRDEADFRDKLSPIVLSLNVSLPPTEAGMAPAVVLHGDTHVQEQTRIVLDCGEDDVCVPQLQLTASVTGSPLLVGADNVLELQMDAANEGEGAYEAELAVHLPQGAHYMRALSNVEGFERLICNQKKENETRVVLCELGNPMKKNAQIGIAMLVSVGNLEEAGESVSFQLQIRSKNSQNPNSKIVLLDVPVRAEAQVELRGNSFPASLVVAAEEGEREQNSLDSWGPKVEHTYELHNNGPGTVNGLHLSIHLPGQSQPSDLLYILDIQPQGGLQCFPQPPVNPLKVDWGLPIPSPSPIHPAHHKRDRRQIFLPEPEQPSRLQDPVLVSCDSAPCTVVQCDLQEMARGQRAMVTVLAFLWLPSLYQRPLDQFVLQSHAWFNVSSLPYAVPPLSLPRGEAQVWTQLLRALEERAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNRPPLEEDDEEGE'),
('Q9BTZ2', '3O4R', 1, 1.7, 'A/B/C/D', 260, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dehydrogenase/reductase SDR family member 4', 'DHRS4', 'R-CHOH-R'' + NADP+ = R-CO-R'' + NADPH.<br />\n', '3-keto sterol reductase activity<br />\nalcohol dehydrogenase [NAD(P)+] activity<br />\ncarbonyl reductase (NADPH) activity<br />\nNADP-retinol dehydrogenase activity<br />\noxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor<br />\nreceptor binding<br />\n', 'alcohol metabolic process<br />\ncellular ketone metabolic process<br />\noxidation-reduction process<br />\nprotein tetramerization<br />\nsteroid metabolic process<br />\n', '', 'MHKAGLLGLCARAWNSVRMASSGMTRRDPLANKVALVTASTDGIGFAIARRLAQDGAHVVVSSRKQQNVDQAVATLQGEGLSVTGTVCHVGKAEDRERLVATAVKLHGGIDILVSNAAVNPFFGSIMDVTEEVWDKTLDINVKAPALMTKAVVPEMEKRGGGSVVIVSSIAAFSPSPGFSPYNVSKTALLGLTKTLAIELAPRNIRVNCLAPGLIKTSFSRMLWMDKEKEESMKETLRIRRLGEPEDCAGIVSFLCSEDASYITGETVVVGGGTPSRL'),
('O67987', '3O5U', 1, 2.35, 'A/B', 257, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Chlorocatechol 1,2-dioxygenase', 'clcA', '4-chlorocatechol + O2 = (2E,4Z)-3-chloro-muconate.<br />\n3,5-dichlorocatechol + O2 = (2E,4E)-2,4-dichloromuconate.<br />\n', 'catechol 1,2-dioxygenase activity<br />\nchlorocatechol 1,2-dioxygenase activity<br />\nferric iron binding<br />\n', 'aromatic compound catabolic process<br />\ncatechol-containing compound metabolic process<br />\n', 'PF00775.', 'MANTRVIELFDEFTDLIRDFIVRHEITTPEYETIMQYMISVGEAGEWPLWLDAFFETTVDSVSYGKGNWTSSAIQGPFFKEGAPLLTGKPATLPMRADEPGDRMRFTGSVRDTSGTPITGAVIDVWHSTNDGNYSFFSPALPDQYLLRGRVVPAEDGSIEFHSIRPVPYEIPKAGPTGQLMNSYLGRHSWRPAHIHIRITADGYRPLITQLYFEGDPYLDSDSCSAVKSELVLPVNKIDIDGETWQLVDFNFILQHN');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('O00459', '3O5Z', 0, 2.01, 'A/B', 85, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Phosphatidylinositol 3-kinase regulatory subunit beta', 'PIK3R2', '', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-3-kinase regulator activity<br />\nGTPase activator activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein heterodimerization activity<br />\nprotein phosphatase binding<br />\nreceptor tyrosine kinase binding<br />\n', 'cellular glucose homeostasis<br />\ncellular response to insulin stimulus<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\ninsulin receptor signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nleukocyte migration<br />\nnegative regulation of MAPK cascade<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol phosphorylation<br />\npositive regulation of glucose import in response to insulin stimulus<br />\npositive regulation of transcription factor import into nucleus<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein transport<br />\nregulation of autophagy<br />\nregulation of phosphatidylinositol 3-kinase activity<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of small GTPase mediated signal transduction<br />\nresponse to endoplasmic reticulum stress<br />\nT cell receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\n', 'PF16454.', 'MAGPEGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMPGLNERTRQRGDFPGTYVEFLGPVALARPGPRPRGPRPLPARPRDGAPEPGLTLPDLPEQFSPPDVAPPLLVKLVEAIERTGLDSESHYRPELPAPRTDWSLSDVDQWDTAALADGIKSFLLALPAPLVTPEASAEARRALREAAGPVGPALEPPTLPLHRALTLRFLLQHLGRVASRAPALGPAVRALGATFGPLLLRAPPPPSSPPPGGAPDGSEPSPDFPALLVEKLLQEHLEEQEVAPPALPPKPPKAKPASTVLANGGSPPSLQDAEWYWGDISREEVNEKLRDTPDGTFLVRDASSKIQGEYTLTLRKGGNNKLIKVFHRDGHYGFSEPLTFCSVVDLINHYRHESLAQYNAKLDTRLLYPVSKYQQDQIVKEDSVEAVGAQLKVYHQQYQDKSREYDQLYEEYTRTSQELQMKRTAIEAFNETIKIFEEQGQTQEKCSKEYLERFRREGNEKEMQRILLNSERLKSRIAEIHESRTKLEQQLRAQASDNREIDKRMNSLKPDLMQLRKIRDQYLVWLTQKGARQKKINEWLGIKNETEDQYALMEDEDDLPHHEERTWYVGKINRTQAEEMLSGKRDGTFLIRESSQRGCYACSVVVDGDTKHCVIYRTATGFGFAEPYNLYGSLKELVLHYQHASLVQHNDALTVTLAHPVRAPGPGPPPAAR'),
('P61073', '3ODU', 1, 2.5, 'A/B', 318, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'C-X-C chemokine receptor type 4', 'CXCR4', '', 'actin binding<br />\nC-C chemokine binding<br />\ncoreceptor activity<br />\nC-X-C chemokine receptor activity<br />\nG-protein coupled receptor activity<br />\nmyosin light chain binding<br />\nubiquitin binding<br />\nubiquitin protein ligase binding<br />\nvirus receptor activity<br />\n', 'activation of MAPK activity<br />\napoptotic process<br />\ncalcium-mediated signaling<br />\ncellular response to cytokine stimulus<br />\ndendritic cell chemotaxis<br />\nentry into host cell<br />\nfusion of virus membrane with host plasma membrane<br />\nG-protein coupled receptor signaling pathway<br />\ninflammatory response<br />\nmyelin maintenance<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of oligodendrocyte differentiation<br />\nregulation of chemotaxis<br />\nresponse to hypoxia<br />\nresponse to virus<br />\n', 'PF00001.', 'MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS'),
('P31350', '3OLJ', 0, 2.1, 'A/B/C/D', 285, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Ribonucleoside-diphosphate reductase subunit M2', 'RRM2', '2''-deoxyribonucleoside diphosphate + thioredoxin disulfide + H2O = ribonucleoside diphosphate + thioredoxin<br />\n', 'metal ion binding<br />\nribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor<br />\n', 'deoxyribonucleotide biosynthetic process<br />\nDNA replication<br />\nnucleobase-containing small molecule interconversion<br />\nregulation of transcription involved in G1/S transition of mitotic cell cycle<br />\n', 'PF00268.', 'MLSLRVPLAPITDPQQLQLSPLKGLSLVDKENTPPALSGTRVLASKTARRIFQEPTEPKTKAAAPGVEDEPLLRENPRRFVIFPIEYHDIWQMYKKAEASFWTAEEVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENLVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIETMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFKHLVHKPSEERVREIIINAVRIEQEFLTEALPVKLIGMNCTLMKQYIEFVADRLMLELGFSKVFRVENPFDFMENISLEGKTNFFEKRVGEYQRMGVMSSPTENSFTLDADF'),
('Q92731', '3OLL', 1, 1.5, 'A/B', 240, 'HORMONE RECEPTOR / ACTIVATOR', 'HORMONE', 'Estrogen receptor beta', 'ESR2', '', 'core promoter sequence-specific DNA binding<br />\nDNA binding<br />\nenzyme binding<br />\nestrogen receptor activity<br />\nestrogen response element binding<br />\nidentical protein binding<br />\nreceptor antagonist activity<br />\nRNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsteroid binding<br />\nsteroid hormone receptor activity<br />\ntranscription coactivator activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'cell-cell signaling<br />\ncellular response to estradiol stimulus<br />\nintracellular estrogen receptor signaling pathway<br />\nnegative regulation of cell growth<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of transcription, DNA-templated<br />\nsignal transduction<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF12497.', 'MDIKNSPSSLNSPSSYNCSQSILPLEHGSIYIPSSYVDSHHEYPAMTFYSPAVMNYSIPSNVTNLEGGPGRQTTSPNVLWPTPGHLSPLVVHRQLSHLYAEPQKSPWCEARSLEHTLPVNRETLKRKVSGNRCASPVTGPGSKRDAHFCAVCSDYASGYHYGVWSCEGCKAFFKRSIQGHNDYICPATNQCTIDKNRRKSCQACRLRKCYEVGMVKCGSRRERCGYRLVRRQRSADEQLHCAGKAKRSGGHAPRVRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVLRGCKSSITGSECSPAEDSKSKEGSQNPQSQ'),
('Q14353', '3ORH', 1, 1.86, 'A/B/C/D', 236, 'TRANSFERASE', 'TRANSFERASE', 'Guanidinoacetate N-methyltransferase', 'GAMT', 'S-adenosyl-L-methionine + guanidinoacetate = S-adenosyl-L-homocysteine + creatine<br />\n', 'guanidinoacetate N-methyltransferase activity<br />\nmethyltransferase activity<br />\n', 'animal organ morphogenesis<br />\ncreatine biosynthetic process<br />\ncreatine metabolic process<br />\nmuscle contraction<br />\nregulation of multicellular organism growth<br />\nS-adenosylhomocysteine metabolic process<br />\nS-adenosylmethionine metabolic process<br />\nspermatogenesis<br />\n', '', 'MSAPSATPIFAPGENCSPAWGAAPAAYDAADTHLRILGKPVMERWETPYMHALAAAASSKGGRVLEVGFGMAIAASKVQEAPIDEHWIIECNDGVFQRLRDWAPRQTHKVIPLKGLWEDVAPTLPDGHFDGILYDTYPLSEETWHTHQFNFIKNHAFRLLKPGGVLTYCNLTSWGELMKSKYSDITIMFEETQVPALLEAGFRRENIRTEVMALVPPADCRYYAFPQMITPLVTKG'),
('P34897', '3OU5', 0, 2.04, 'A', 488, 'TRANSFERASE', 'TRANSFERASE', 'Serine hydroxymethyltransferase, mitochondrial', 'SHMT2', '5,10-methylenetetrahydrofolate + glycine + H2O = tetrahydrofolate + L-serine<br />\n', 'amino acid binding<br />\nchromatin binding<br />\nglycine hydroxymethyltransferase activity<br />\nidentical protein binding<br />\nL-allo-threonine aldolase activity<br />\npyridoxal phosphate binding<br />\n', 'folic acid metabolic process<br />\nglycine biosynthetic process from serine<br />\nglycine metabolic process<br />\nL-serine biosynthetic process<br />\nL-serine metabolic process<br />\none-carbon metabolic process<br />\npositive regulation of cell proliferation<br />\nprotein homotetramerization<br />\nprotein K63-linked deubiquitination<br />\nprotein tetramerization<br />\nresponse to type I interferon<br />\ntetrahydrofolate interconversion<br />\ntetrahydrofolate metabolic process<br />\n', '', 'MLYFSLFWAARPLQRCGQLVRMAIRAQHSNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH'),
('Q9Y2I1', '3P0C', 0, 2.27, 'A/B', 107, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Nischarin', 'NISCH', '', 'identical protein binding<br />\nintegrin binding<br />\nphosphatidylinositol binding<br />\n', 'actin cytoskeleton organization<br />\napoptotic process<br />\nglucose metabolic process<br />\nnegative regulation of cell migration<br />\nnorepinephrine secretion<br />\nRac protein signal transduction<br />\nregulation of blood pressure<br />\nregulation of synaptic transmission, GABAergic<br />\n', 'PF00787.', 'MATARTFGPEREAEPAKEARVVGSELVDTYTVYIIQVTDGSHEWTVKHRYSDFHDLHEKLVAERKIDKNLLPPKKIIGKNSRSLVEKREKDLEVYLQKLLAAFPGVTPRVLAHFLHFHFYEINGITAALAEELFEKGEQLLGAGEVFAIGPLQLYAVTEQLQQGKPTCASGDAKTDLGHILDFTCRLKYLKVSGTEGPFGTSNIQEQLLPFDLSIFKSLHQVEISHCDAKHIRGLVASKPTLATLSVRFSATSMKEVLVPEASEFDEWEPEGTTLEGPVTAVIPTWQALTTLDLSHNSVSEIDESVKLIPKIEFLDLSHNGLLVVDNLQHLYNLVHLDLSYNKLSSLEGLHTKLGNIKTLNLAGNLLESLSGLHKLYSLVNLDLRDNRIEQMEEVRSIGSLPCLEHVSLLNNPLSIIPDYRTKVLAQFGERASEVCLDDTVTTEKELDTVEVLKAIQKAKEVKSKLSNPEKKGGEDSRLSAAPCIRPSSSPPTVAPASASLPQPILSNQGIMFVQEEALASSLSSTDSLTPEHQPIAQGCSDSLESIPAGQAASDDLRDVPGAVGGASPEHAEPEVQVVPGSGQIIFLPFTCIGYTATNQDFIQRLSTLIRQAIERQLPAWIEAANQREEGQGEQGEEEDEEEEEEEDVAENRYFEMGPPDVEEEEGGGQGEEEEEEEEDEEAEEERLALEWALGADEDFLLEHIRILKVLWCFLIHVQGSIRQFAACLVLTDFGIAVFEIPHQESRGSSQHILSSLRFVFCFPHGDLTEFGFLMPELCLVLKVRHSENTLFIISDAANLHEFHADLRSCFAPQHMAMLCSPILYGSHTSLQEFLRQLLTFYKVAGGCQERSQGCFPVYLVYSDKRMVQTAAGDYSGNIEWASCTLCSAVRRSCCAPSEAVKSAAIPYWLLLTPQHLNVIKADFNPMPNRGTHNCRNRNSFKLSRVPLSTVLLDPTRSCTQPRGAFADGHVLELLVGYRFVTAIFVLPHEKFHFLRVYNQLRASLQDLKTVVIAKTPGTGGSPQGSFADGQPAERRASNDQRPQEVPAEALAPAPAEVPAPAPAAASASGPAKTPAPAEASTSALVPEETPVEAPAPPPAEAPAQYPSEHLIQATSEENQIPSHLPACPSLRHVASLRGSAIIELFHSSIAEVENEELRHLMWSSVVFYQTPGLEVTACVLLSTKAVYFVLHDGLRRYFSEPLQDFWHQKNTDYNNSPFHISQCFVLKLSDLQSVNVGLFDQHFRLTGSTPMQVVTCLTRDSYLTHCFLQHLMVVLSSLERTPSPEPVDKDFYSEFGNKTTGKMENYELIHSSRVKFTYPSEEEIGDLTFTVAQKMAEPEKAPALSILLYVQAFQVGMPPPGCCRGPLRPKTLLLTSSEIFLLDEDCVHYPLPEFAKEPPQRDRYRLDDGRRVRDLDRVLMGYQTYPQALTLVFDDVQGHDLMGSVTLDHFGEVPGGPARASQGREVQWQVFVPSAESREKLISLLARQWEALCGRELPVELTG'),
('Q9NPC2', '3P1S', 1, 1.65, 'P', 6, 'PEPTIDE BINDING PROTEIN', 'OTHERS', 'Potassium channel subfamily K member 9', 'KCNK9', '', 'potassium channel activity<br />\npotassium ion leak channel activity<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nvoltage-gated potassium channel activity<br />\n', 'potassium ion transmembrane transport<br />\npotassium ion transport<br />\nstabilization of membrane potential<br />\n', 'PF07885.', 'MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV'),
('P35462', '3PBL', 1, 2.89, 'A/B', 220, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'D(3) dopamine receptor', 'DRD3', '', 'D1 dopamine receptor binding<br />\ndopamine binding<br />\ndopamine neurotransmitter receptor activity, coupled via Gi/Go<br />\ndrug binding<br />\nprotein domain specific binding<br />\n', 'acid secretion<br />\nadenylate cyclase-activating dopamine receptor signaling pathway<br />\nadenylate cyclase-inhibiting dopamine receptor signaling pathway<br />\narachidonic acid secretion<br />\nbehavioral response to cocaine<br />\ncellular calcium ion homeostasis<br />\ncircadian regulation of gene expression<br />\ndopamine metabolic process<br />\ngastric emptying<br />\nG-protein coupled receptor internalization<br />\nG-protein coupled receptor signaling pathway<br />\nlearning<br />\nlearning or memory<br />\nlocomotory behavior<br />\nmusculoskeletal movement, spinal reflex action<br />\nnegative regulation of adenylate cyclase activity<br />\nnegative regulation of blood pressure<br />\nnegative regulation of dopamine receptor signaling pathway<br />\nnegative regulation of oligodendrocyte differentiation<br />\nnegative regulation of protein kinase B signaling<br />\nnegative regulation of protein secretion<br />\nnegative regulation of sodium:proton antiporter activity<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of cell proliferation<br />\npositive regulation of cytokinesis<br />\npositive regulation of dopamine receptor signaling pathway<br />\npositive regulation of mitotic nuclear division<br />\npositive regulation of renal sodium excretion<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprepulse inhibition<br />\nregulation of blood volume by renin-angiotensin<br />\nregulation of cAMP metabolic process<br />\nregulation of circadian sleep/wake cycle, sleep<br />\nregulation of dopamine secretion<br />\nregulation of dopamine uptake involved in synaptic transmission<br />\nregulation of lipid metabolic process<br />\nregulation of locomotion involved in locomotory behavior<br />\nregulation of multicellular organism growth<br />\nresponse to amphetamine<br />\nresponse to cocaine<br />\nresponse to drug<br />\nresponse to histamine<br />\nresponse to morphine<br />\nsocial behavior<br />\nsynaptic transmission, dopaminergic<br />\nvisual learning<br />\n', 'PF00001.', 'MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC'),
('Q51504', '3PBQ', 1, 1.7, 'A', 530, 'HYDROLASE / ANTIBIOTIC', 'HYDROLASE', 'Cell division protein', 'pbpB', NULL, 'penicillin binding<br />\r\npeptidoglycan glycosyltransferase activity<br />', 'cell division', 'PF03717.', ' MKLNYFQGALYPWRFCVIVGLLLAMVGAIVWRIVDLHVIDHDFLKGQGDA\r\nRSVRHIAIPAHRGLITDRNGEPLAVSTPVTTLWANPKELMTAKERWPQLA\r\nAALGQDTKLFADRIEQNAEREFIYLVRGLTPEQGEGVIALKVPGVYSIEE\r\nFRRFYPAGEVVAHAVGFTDVDDRGREGIELAFDEWLAGVPGKRQVLKDRR\r\nGRVIKDVQVTKNAKPGKTLALSIDLRLQYLAHRELRNALLENGAKAGSLV\r\nIMDVKTGEILAMTNQPTYNPNNRRNLQPAAMRNRAMIDVFEPGSTVKPFS\r\nMSAALASGRWKPSDIVDVYPGTLQIGRYTIRDVSRNSRQLDLTGILIKSS\r\nNVGISKIAFDIGAESIYSVMQQVGLGQDTGLGFPGERVGNLPNHRKWPKA\r\nETATLAYGYGLSVTAIQLAHAYAALANDGKSVPLSMTRVDRVPDGVQVIS\r\nPEVASTVQGMLQQVVEAQGGVFRAQVPGYHAAGKSGTARKVSVGTKGYRE\r\nNAYRSLFAGFAPATDPRIAMVVVIDEPSKAGYFGGLVSAPVFSKVMAGAL\r\nRLMNVPPDNLPTATEQQQVNAAPAKGGRG'),
('P49916', '3PC7', 0, 1.65, 'A/B', 86, 'LIGASE', 'LIGASE', 'DNA ligase 3', 'LIG3', 'ATP + (deoxyribonucleotide)(n)-3''-hydroxyl + 5''-phospho-(deoxyribonucleotide)(m) = (deoxyribonucleotide)(n+m) + AMP + diphosphate<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA ligase (ATP) activity<br />\nDNA ligase activity<br />\nzinc ion binding<br />\n', 'base-excision repair, DNA ligation<br />\ncell cycle<br />\ncell division<br />\nDNA biosynthetic process<br />\nDNA ligation<br />\nDNA replication<br />\ndouble-strand break repair<br />\ndouble-strand break repair via alternative nonhomologous end joining<br />\ndouble-strand break repair via homologous recombination<br />\nmitochondrial DNA repair<br />\nmitochondrion organization<br />\nnegative regulation of mitochondrial DNA replication<br />\nnucleotide-excision repair, DNA gap filling<br />\ntranscription-coupled nucleotide-excision repair<br />\n', 'PF04679.', 'MSLAFKIFFPQTLRALSRKELCLFRKHHWRDVRQFSQWSETDLLHGHPLFLRRKPVLSFQGSHLRSRATYLVFLPGLHVGLCSGPCEMAEQRFCVDYAKRGTAGCKKCKEKIVKGVCRIGKVVPNPFSESGGDMKEWYHIKCMFEKLERARATTKKIEDLTELEGWEELEDNEKEQITQHIADLSSKAAGTPKKKAVVQAKLTTTGQVTSPVKGASFVTSTNPRKFSGFSAKPNNSGEAPSSPTPKRSLSSSKCDPRHKDCLLREFRKLCAMVADNPSYNTKTQIIQDFLRKGSAGDGFHGDVYLTVKLLLPGVIKTVYNLNDKQIVKLFSRIFNCNPDDMARDLEQGDVSETIRVFFEQSKSFPPAAKSLLTIQEVDEFLLRLSKLTKEDEQQQALQDIASRCTANDLKCIIRLIKHDLKMNSGAKHVLDALDPNAYEAFKASRNLQDVVERVLHNAQEVEKEPGQRRALSVQASLMTPVQPMLAEACKSVEYAMKKCPNGMFSEIKYDGERVQVHKNGDHFSYFSRSLKPVLPHKVAHFKDYIPQAFPGGHSMILDSEVLLIDNKTGKPLPFGTLGVHKKAAFQDANVCLFVFDCIYFNDVSLMDRPLCERRKFLHDNMVEIPNRIMFSEMKRVTKALDLADMITRVIQEGLEGLVLKDVKGTYEPGKRHWLKVKKDYLNEGAMADTADLVVLGAFYGQGSKGGMMSIFLMGCYDPGSQKWCTVTKCAGGHDDATLARLQNELDMVKISKDPSKIPSWLKVNKIYYPDFIVPDPKKAAVWEITGAEFSKSEAHTADGISIRFPRCTRIRDDKDWKSATNLPQLKELYQLSKEKADFTVVAGDEGSSTTGGSSEENKGPSGSAVSRKAPSKPSASTKKAEGKLSNSNSKDGNMQTAKPSAMKVGEKLATKSSPVKVGEKRKAADETLCQTKVLLDIFTGVRLYLPPSTPDFSRLRRYFVAFDGDLVQEFDMTSATHVLGSRDKNPAAQQVSPEWIWACIRKRRLVAPC'),
('Q16873', '3PCV', 1, 1.9, 'A', 150, 'LYASE', 'LYASE', 'Leukotriene C4 synthase', 'LTC4S', 'Leukotriene C4 = leukotriene A4 + glutathione.<br />\n', 'enzyme activator activity<br />\nglutathione peroxidase activity<br />\nglutathione transferase activity<br />\nidentical protein binding<br />\nleukotriene-C4 synthase activity<br />\nlipid binding<br />\n', 'leukotriene biosynthetic process<br />\nleukotriene metabolic process<br />\nlipoxin metabolic process<br />\nlipoxygenase pathway<br />\n', 'PF01124.', 'MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYFPLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVALAALGLLAHFLPAALRAALLGRLRTLLPWA'),
('P04626', '3PP0', 1, 2.25, 'A/B', 307, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Receptor tyrosine-protein kinase erbB-2', 'ERBB2', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nErbB-3 class receptor binding<br />\nidentical protein binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein C-terminus binding<br />\nprotein dimerization activity<br />\nprotein heterodimerization activity<br />\nprotein phosphatase binding<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nRNA polymerase I core binding<br />\nsignal transducer, downstream of receptor, with protein tyrosine kinase activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\ntransmembrane signaling receptor activity<br />\n', 'cell proliferation<br />\ncell surface receptor signaling pathway<br />\ncellular response to epidermal growth factor stimulus<br />\ncellular response to growth factor stimulus<br />\nenzyme linked receptor protein signaling pathway<br />\nERBB2 signaling pathway<br />\nheart development<br />\ninterleukin-7-mediated signaling pathway<br />\nMAPK cascade<br />\nmotor neuron axon guidance<br />\nmyelination<br />\nnegative regulation of ERBB signaling pathway<br />\nnegative regulation of immature T cell proliferation in thymus<br />\nneuromuscular junction development<br />\noligodendrocyte differentiation<br />\nperipheral nervous system development<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of cell adhesion<br />\npositive regulation of cell growth<br />\npositive regulation of epithelial cell proliferation<br />\npositive regulation of GTPase activity<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of protein targeting to membrane<br />\npositive regulation of transcription from RNA polymerase III promoter<br />\npositive regulation of transcription from RNA polymerase I promoter<br />\npositive regulation of translation<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of angiogenesis<br />\nregulation of cell motility<br />\nregulation of ERK1 and ERK2 cascade<br />\nregulation of microtubule-based process<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of transcription from RNA polymerase II promoter<br />\nsignal transduction<br />\ntranscription, DNA-templated<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\nwound healing<br />\n', 'PF00757.', 'MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVGILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEGAGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQGGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV'),
('Q9H4Y5', '3Q19', 1, 1.9, 'A/B', 239, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase omega-2', 'GSTO2', 'RX + glutathione = HX + R-S-glutathione<br />\n2 glutathione + dehydroascorbate = glutathione disulfide + ascorbate<br />\nMethylarsonate + 2 glutathione = methylarsonite + glutathione disulfide + H2O<br />\n', 'glutathione dehydrogenase (ascorbate) activity<br />\nglutathione transferase activity<br />\nidentical protein binding<br />\nmethylarsonate reductase activity<br />\noxidoreductase activity<br />\n', 'cellular response to arsenic-containing substance<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nL-ascorbic acid metabolic process<br />\noxidation-reduction process<br />\ntoxin catabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF13417.', 'MSGDATRTLGKGSQPPGPVPEGLIRIYSMRFCPYSHRTRLVLKAKDIRHEVVNINLRNKPEWYYTKHPFGHIPVLETSQCQLIYESVIACEYLDDAYPGRKLFPYDPYERARQKMLLELFCKVPHLTKECLVALRCGRECTNLKAALRQEFSNLEEILEYQNTTFFGGTCISMIDYLLWPWFERLDVYGILDCVSHTPALRLWISAMKWDPTVCALLMDKSIFQGFLNLYFQNNPNAFDFGLC'),
('Q04771', '3Q4U', 1, 1.82, 'A/B/C/D', 299, 'TRANSFERASE', 'TRANSFERASE', 'Activin receptor type-1', 'ACVR1', 'ATP + [receptor-protein] = ADP + [receptor-protein] phosphate.<br />\n', 'activin binding<br />\nactivin receptor activity, type I<br />\nATP binding<br />\nmetal ion binding<br />\npeptide hormone binding<br />\nprotein homodimerization activity<br />\nprotein kinase activity<br />\nprotein serine/threonine kinase activity<br />\nsignal transducer, downstream of receptor, with serine/threonine kinase activity<br />\nSMAD binding<br />\ntransforming growth factor beta binding<br />\ntransforming growth factor beta receptor activity, type I<br />\ntransmembrane receptor protein serine/threonine kinase activity<br />\n', 'activin receptor signaling pathway<br />\nacute inflammatory response<br />\natrial septum primum morphogenesis<br />\natrioventricular valve morphogenesis<br />\nBMP signaling pathway<br />\nBMP signaling pathway involved in heart development<br />\nbranching involved in blood vessel morphogenesis<br />\ncardiac muscle cell fate commitment<br />\ncellular response to BMP stimulus<br />\ndetermination of left/right symmetry<br />\nembryonic heart tube morphogenesis<br />\nendocardial cushion cell fate commitment<br />\nendocardial cushion fusion<br />\nendocardial cushion morphogenesis<br />\nG1/S transition of mitotic cell cycle<br />\ngastrulation with mouth forming second<br />\ngerm cell development<br />\nin utero embryonic development<br />\nmesoderm formation<br />\nmitral valve morphogenesis<br />\nnegative regulation of activin receptor signaling pathway<br />\nnegative regulation of extrinsic apoptotic signaling pathway<br />\nnegative regulation of signal transduction<br />\nneural crest cell migration<br />\npathway-restricted SMAD protein phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\npharyngeal system development<br />\npositive regulation of bone mineralization<br />\npositive regulation of cell migration<br />\npositive regulation of determination of dorsal identity<br />\npositive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation<br />\npositive regulation of osteoblast differentiation<br />\npositive regulation of pathway-restricted SMAD protein phosphorylation<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein phosphorylation<br />\nregulation of ossification<br />\nsmooth muscle cell differentiation<br />\ntransforming growth factor beta receptor signaling pathway<br />\nventricular septum morphogenesis<br />\n', 'PF01064.', 'MVDGVMILPVLIMIALPSPSMEDEKPKVNPKLYMCVCEGLSCGNEDHCEGQQCFSSLSINDGFHVYQKGCFQVYEQGKMTCKTPPSPGQAVECCQGDWCNRNITAQLPTKGKSFPGTQNFHLEVGLIILSVVFAVCLLACLLGVALRKFKRRNQERLNPRDVEYGTIEGLITTNVGDSTLADLLDHSCTSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKIDNSLDKLKTDC'),
('O25608', '3QDL', 1, 2, 'A/B/C/D', 210, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Oxygen-insensitive NADPH nitroreductase', 'rdxA', 'A 5,6,7,8-tetrahydropteridine + NAD(P)+ = a 6,7-dihydropteridine + NAD(P)H.<br />\n', 'oxidoreductase activity<br />\n', 'response to antibiotic<br />\n', 'PF00881.', 'MKFLDQEKRRQLLNERHSCKMFDSHYEFSSTELEEIAEIARLSPSSYNTQPWHFVMVTDKDLKKQIAAHSYFNEEMIKSASALMVVCSLRPSELLPHGHYMQNLYPESYKVRVIPSFAQMLGVRFNHSMQRLESYILEQCYIAVGQICMGVSLMGLDSCIIGGFDPLKVGEVLEERINKPKIACLIALGKRVAEASQKSRKSKVDAITWL'),
('Q16881', '3QFA', 1, 2.2, 'A/B', 499, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Thioredoxin reductase 1, cytoplasmic', 'TXNRD1', 'Thioredoxin + NADP+ = thioredoxin disulfide + NADPH.<br />\n', 'electron carrier activity<br />\nflavin adenine dinucleotide binding<br />\nmethylseleninic acid reductase activity<br />\nmethylselenol reductase activity<br />\nprotein disulfide oxidoreductase activity<br />\nthioredoxin-disulfide reductase activity<br />\n', 'cell proliferation<br />\ncell redox homeostasis<br />\ncellular response to oxidative stress<br />\nmesoderm formation<br />\nnucleobase-containing small molecule interconversion<br />\nregulation of lipid metabolic process<br />\nresponse to oxygen radical<br />\nselenium compound metabolic process<br />\nsignal transduction<br />\n', 'PF00462.', 'MGCAEGKAVAAAAPTELQTKGKNGDGRRRSAKDHHPGKTLPENPAGFTSTATADSRALLQAYIDGHSVVIFSRSTCTRCTEVKKLFKSLCVPYFVLELDQTEDGRALEGTLSELAAETDLPVVFVKQRKIGGHGPTLKAYQEGRLQKLLKMNGPEDLPKSYDYDLIIIGGGSGGLAAAKEAAQYGKKVMVLDFVTPTPLGTRWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKVEETVKHDWDRMIEAVQNHIGSLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEKIYSAERFLIATGERPRYLGIPGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDVTVMVRSILLRGFDQDMANKIGEHMEEHGIKFIRQFVPIKVEQIEAGTPGRLRVVAQSTNSEEIIEGEYNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKAVEKFGEENIEVYHSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQGFAAALKCGLTKKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCUG'),
('P16435', '3QFS', 1, 1.4, 'A', 437, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'NADPH--cytochrome P450 reductase', 'POR', 'NADPH + n oxidized hemoprotein = NADP+ + n reduced hemoprotein<br />\n', 'cytochrome-b5 reductase activity, acting on NAD(P)H<br />\nelectron carrier activity<br />\nenzyme binding<br />\nflavin adenine dinucleotide binding<br />\nFMN binding<br />\nhydrolase activity<br />\niron-cytochrome-c reductase activity<br />\nNADP binding<br />\nNADPH-hemoprotein reductase activity<br />\nnitric oxide dioxygenase activity<br />\n', 'carnitine metabolic process<br />\ncellular organofluorine metabolic process<br />\ncellular response to follicle-stimulating hormone stimulus<br />\ncellular response to peptide hormone stimulus<br />\ndemethylation<br />\nfatty acid oxidation<br />\nflavonoid metabolic process<br />\ninternal peptidyl-lysine acetylation<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of lipase activity<br />\nnitrate catabolic process<br />\nnitric oxide catabolic process<br />\noxidation-reduction process<br />\npositive regulation of cholesterol biosynthetic process<br />\npositive regulation of chondrocyte differentiation<br />\npositive regulation of monooxygenase activity<br />\npositive regulation of smoothened signaling pathway<br />\npositive regulation of steroid hormone biosynthetic process<br />\nregulation of growth plate cartilage chondrocyte proliferation<br />\nresponse to drug<br />\nresponse to nutrient<br />\nxenobiotic metabolic process<br />\n', 'PF00667.', 'MGDSHVDTSSTVSEAVAEEVSLFSMTDMILFSLIVGLLTYWFLFRKKKEEVPEFTKIQTLTSSVRESSFVEKMKKTGRNIIVFYGSQTGTAEEFANRLSKDAHRYGMRGMSADPEEYDLADLSSLPEIDNALVVFCMATYGEGDPTDNAQDFYDWLQETDVDLSGVKFAVFGLGNKTYEHFNAMGKYVDKRLEQLGAQRIFELGLGDDDGNLEEDFITWREQFWPAVCEHFGVEATGEESSIRQYELVVHTDIDAAKVYMGEMGRLKSYENQKPPFDAKNPFLAAVTTNRKLNQGTERHLMHLELDISDSKIRYESGDHVAVYPANDSALVNQLGKILGADLDVVMSLNNLDEESNKKHPFPCPTSYRTALTYYLDITNPPRTNVLYELAQYASEPSEQELLRKMASSSGEGKELYLSWVVEARRHILAILQDCPSLRPPIDHLCELLPRLQARYYSIASSSKVHPNSVHICAVVVEYETKAGRINKGVATNWLRAKEPAGENGGRALVPMFVRKSQFRLPFKATTPVIMVGPGTGVAPFIGFIQERAWLRQQGKEVGETLLYYGCRRSDEDYLYREELAQFHRDGALTQLNVAFSREQSHKVYVQHLLKQDREHLWKLIEGGAHIYVCGDARNMARDVQNTFYDIVAELGAMEHAQAVDYIKKLMTKGRYSLDVWS'),
('Q72547', '3QIO', 1, 1.4, 'A', 80, 'TRANSFERASE', 'TRANSFERASE', 'Reverse transcriptase/RNaseH', 'pol', 'Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).', 'identical protein binding<br />\r\nmetal ion binding<br />\r\nnucleic acid binding<br />\r\nRNA-directed DNA polymerase activity<br />\r\nRNA-DNA hybrid ribonuclease activity<br />', NULL, 'PF00075.', 'PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKI\r\nGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGL\r\nKKRKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLP\r\nQGWKGSPAIFQSSMTKILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRT\r\nKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKD\r\nSWTVNDIQKLVGKLNWASQIYPGIRVRQLCKLLRGTKALTEVIPLTEEAE\r\nLELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLR\r\nTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWET\r\nWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRET\r\nKLGKAGYVTNRGRQKVVTLTDTTNQKTELQAIYLALQDSGLEVNIVTDSQ\r\nYALGIIQAQPDQSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDK\r\nLVSAGIRKVLFLDGID'),
('Q9UHC9', '3QNT', 0, 2.83, 'A', 263, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Niemann-Pick C1-like protein 1', 'NPC1L1', '', 'drug binding<br />\nmyosin V binding<br />\nRab GTPase binding<br />\n', 'cholesterol biosynthetic process<br />\ncholesterol transport<br />\nintestinal cholesterol absorption<br />\nintestinal lipid absorption<br />\nlipoprotein metabolic process<br />\nresponse to drug<br />\n', 'PF16414.', 'MAEAGLRGWLLWALLLRLAQSEPYTTIHQPGYCAFYDECGKNPELSGSLMTLSNVSCLSNTPARKITGDHLILLQKICPRLYTGPNTQACCSAKQLVSLEASLSITKALLTRCPACSDNFVNLHCHNTCSPNQSLFINVTRVAQLGAGQLPAVVAYEAFYQHSFAEQSYDSCSRVRVPAAATLAVGTMCGVYGSALCNAQRWLNFQGDTGNGLAPLDITFHLLEPGQAVGSGIQPLNEGVARCNESQGDDVATCSCQDCAASCPAIARPQALDSTFYLGQMPGSLVLIIILCSVFAVVTILLVGFRVAPARDKSKMVDPKKGTSLSDKLSFSTHTLLGQFFQGWGTWVASWPLTILVLSVIPVVALAAGLVFTELTTDPVELWSAPNSQARSEKAFHDQHFGPFFRTNQVILTAPNRSSYRYDSLLLGPKNFSGILDLDLLLELLELQERLRHLQVWSPEAQRNISLQDICYAPLNPDNTSLYDCCINSLLQYFQNNRTLLLLTANQTLMGQTSQVDWKDHFLYCANAPLTFKDGTALALSCMADYGAPVFPFLAIGGYKGKDYSEAEALIMTFSLNNYPAGDPRLAQAKLWEEAFLEEMRAFQRRMAGMFQVTFMAERSLEDEINRTTAEDLPIFATSYIVIFLYISLALGSYSSWSRVMVDSKATLGLGGVAVVLGAVMAAMGFFSYLGIRSSLVILQVVPFLVLSVGADNIFIFVLEYQRLPRRPGEPREVHIGRALGRVAPSMLLCSLSEAICFFLGALTPMPAVRTFALTSGLAVILDFLLQMSAFVALLSLDSKRQEASRLDVCCCVKPQELPPPGQGEGLLLGFFQKAYAPFLLHWITRGVVLLLFLALFGVSLYSMCHISVGLDQELALPKDSYLLDYFLFLNRYFEVGAPVYFVTTLGYNFSSEAGMNAICSSAGCNNFSFTQKIQYATEFPEQSYLAIPASSWVDDFIDWLTPSSCCRLYISGPNKDKFCPSTVNSLNCLKNCMSITMGSVRPSVEQFHKYLPWFLNDRPNIKCPKGGLAAYSTSVNLTSDGQVLDTVAILSPRLEYSGTISAHCNLYLLDSTSRFMAYHKPLKNSQDYTEALRAARELAANITADLRKVPGTDPAFEVFPYTITNVFYEQYLTILPEGLFMLSLCLVPTFAVSCLLLGLDLRSGLLNLLSIVMILVDTVGFMALWGISYNAVSLINLVSAVGMSVEFVSHITRSFAISTKPTWLERAKEATISMGSAVFAGVAMTNLPGILVLGLAKAQLIQIFFFRLNLLITLLGLLHGLVFLPVILSYVGPDVNPALALEQKRAEEAVAAVMVASCPNHPSRVSTADNIYVNHSFEGSIKGAGAISNFLPNNGRQF'),
('P07437', '3QNZ', 0, 2.2, 'C', 10, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Tubulin beta chain', 'TUBB', '', 'GTPase activating protein binding<br />\nGTPase activity<br />\nGTP binding<br />\nMHC class I protein binding<br />\nprotein complex binding<br />\nprotein domain specific binding<br />\nstructural constituent of cytoskeleton<br />\nstructural molecule activity<br />\nubiquitin protein ligase binding<br />\n', 'cell division<br />\ncellular process<br />\nciliary basal body-plasma membrane docking<br />\ncytoskeleton-dependent intracellular transport<br />\nG2/M transition of mitotic cell cycle<br />\nmicrotubule-based process<br />\nmovement of cell or subcellular component<br />\nnatural killer cell mediated cytotoxicity<br />\nneutrophil degranulation<br />\nregulation of G2/M transition of mitotic cell cycle<br />\nspindle assembly<br />\n', 'PF00091.', 'MREIVHIQAGQCGNQIGAKFWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPRAILVDLEPGTMDSVRSGPFGQIFRPDNFVFGQSGAGNNWAKGHYTEGAELVDSVLDVVRKEAESCDCLQGFQLTHSLGGGTGSGMGTLLISKIREEYPDRIMNTFSVVPSPKVSDTVVEPYNATLSVHQLVENTDETYCIDNEALYDICFRTLKLTTPTYGDLNHLVSATMSGVTTCLRFPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTSRGSQQYRALTVPELTQQVFDAKNMMAACDPRHGRYLTVAAVFRGRMSMKEVDEQMLNVQNKNSSYFVEWIPNNVKTAVCDIPPRGLKMAVTFIGNSTAIQELFKRISEQFTAMFRRKAFLHWYTGEGMDEMEFTEAESNMNDLVSEYQQYQDATAEEEEDFGEEAEEEA'),
('P05113', '3QT2', 1, 2.55, 'C/D/E/F', 116, 'PROTEIN BINDING / IMMUNE SYSTEM', 'PROTEIN_BINDING', 'Interleukin-5', 'IL5', '', 'cytokine activity<br />\ngrowth factor activity<br />\ninterleukin-5 receptor binding<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\n', 'cytokine-mediated signaling pathway<br />\nimmune response<br />\ninflammatory response<br />\nMAPK cascade<br />\npositive regulation of B cell proliferation<br />\npositive regulation of eosinophil differentiation<br />\npositive regulation of immunoglobulin secretion<br />\npositive regulation of JAK-STAT cascade<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of podosome assembly<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of transcription, DNA-templated<br />\n', 'PF02025.', 'MRMLLHLSLLALGAAYVYAIPTEIPTSALVKETLALLSTHRTLLIANETLRIPVPVHKNHQLCTEEIFQGIGTLESQTVQGGTVERLFKNLSLIKKYIDGQKKKCGEERRRVNQFLDYLQEFLGVMNTEWIIES'),
('Q02880', '3QX3', 1, 2.16, 'A/B', 757, 'ISOMERASE / DNA / ISOMERASE INHIBITOR', 'ISOMERASE', 'DNA topoisomerase 2-beta', 'TOP2B', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nchromatin binding<br />\nDNA binding<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\nenzyme binding<br />\nhistone deacetylase binding<br />\nmetal ion binding<br />\nprotein C-terminus binding<br />\nprotein heterodimerization activity<br />\nprotein kinase C binding<br />\nribonucleoprotein complex binding<br />\n', 'axonogenesis<br />\nDNA topological change<br />\nforebrain development<br />\nmitotic DNA integrity checkpoint<br />\nneuron migration<br />\nprotein sumoylation<br />\nresolution of meiotic recombination intermediates<br />\nsister chromatid segregation<br />\n', 'PF00204.', 'MAKSGGCGAGAGVGGGNGALTWVTLFDQNNAAKKEESETANKNDSSKKLSVERVYQKKTQLEHILLRPDTYIGSVEPLTQFMWVYDEDVGMNCREVTFVPGLYKIFDEILVNAADNKQRDKNMTCIKVSIDPESNIISIWNNGKGIPVVEHKVEKVYVPALIFGQLLTSSNYDDDEKKVTGGRNGYGAKLCNIFSTKFTVETACKEYKHSFKQTWMNNMMKTSEAKIKHFDGEDYTCITFQPDLSKFKMEKLDKDIVALMTRRAYDLAGSCRGVKVMFNGKKLPVNGFRSYVDLYVKDKLDETGVALKVIHELANERWDVCLTLSEKGFQQISFVNSIATTKGGRHVDYVVDQVVGKLIEVVKKKNKAGVSVKPFQVKNHIWVFINCLIENPTFDSQTKENMTLQPKSFGSKCQLSEKFFKAASNCGIVESILNWVKFKAQTQLNKKCSSVKYSKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLKHGFLEEFITPIVKASKNKQELSFYSIPEFDEWKKHIENQKAWKIKYYKGLGTSTAKEAKEYFADMERHRILFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHGLPEQFLYGTATKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTWTQVYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVKMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKKYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWKEAQEKAAEEDETQNQHDDSSSDSGTPSGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVNDLKRKSPSDLWKEDLAAFVEELDKVESQEREDVLAGMSGKAIKGKVGKPKVKKLQLEETMPSPYGRRIIPEITAMKADASKKLLKKKKGDLDTAAVKVEFDEEFSGAPVEGAGEEALTPSVPINKGPKPKREKKEPGTRVRKTPTSSGKPSAKKVKKRNPWSDDESKSESDLEETEPVVIPRDSLLRRAAAERPKYTFDFSEEEDDDADDDDDDNNDLEELKVKASPITNDGEDEFVPSDGLDKDEYTFSPGKSKATPEKSLHDKKSQDFGNLFSFPSYSQKSEDDSAKFDSNEEDSASVFSPSFGLKQTDKVPSKTVAAKKGKPSSDTVPKPKRAPKQKKVVEAVNSDSDSEFGIPKKTTTPKGKGRGAKKRKASGSENEGDYNPGRKTSKTTSKKPKKTSFDQDSDVDIFPSDFPTEPPSLPRTGRARKEVKYFAESDEEEDDVDFAMFN'),
('P72525', '3RAE', 1, 2.9, 'A/B', 488, 'ISOMERASE / DNA / ANTIBIOTIC', 'ISOMERASE', 'DNA topoisomerase 4 subunit A', 'parC', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\n', 'DNA topological change<br />\n', 'PF03989.', 'MSNIQNMSLEDIMGERFGRYSKYIIQDRALPDIRDGLKPVQRRILYSMNKDSNTFDKSYRKSAKSVGNIMGNFHPHGDSSIYDAMVRMSQNWKNREILVEMHGNNGSMDGDPPAAMRYTEARLSEIAGYLLQDIEKKTVPFAWNFDDTEKEPTVLPAAFPNLLVNGSTGISAGYATDIPPHNLAEVIDAAVYMIDHPTAKIDKLMEFLPGPDFPTGAIIQGRDEIKKAYETGKGRVVVRSKTEIEKLKGGKEQIVIIEIPYEINKANLVKKIDDVRVNNKVAGIAEVRDESDRDGLRIAIELKKDANTELVLNYLFKYTDLQINYNFNMVAIDNFTPRQVGIVPILSSYIAHRREVILARSRFDKEKAEKRLHIVEGLIRVISILDEVIALIRASENKADAKENLKVSYDFTEEQAEAIVTLQLYRLTNTDVVVLQEEEAELREKIAMLAAIIGDERTMYNLMKKELREVKKKFATPRLSSLEDTAKAIEIDTASLIAEEDTYVSVTKAGYIKRTSPRSFAASTLEEIGKRDDDRLIFVQSAKTTQHLLMFTSLGNVIYRPIHELADIRWKDIGEHLSQTITNFETNEEILYVEVLDQFDDATTYFAVTRLGQIKRVERKEFTPWRTYRSKSVKYAKLKDDTDQIVAVAPIKLDDVVLVSQNGYALRFNIEEVPVVGAKAAGVKAMNLKEDDVLQSGFICNTSSFYLLTQRGSLKRVSIEEILATSRAKRGLQVLRELKNKPHRVFLAGAVAEQGFVGDFFSTEVDVNDQTLLVQSNKGTIYESRLQDLNLSERTSNGSFISDTISDEEVFDAYLQEVVTEDK'),
('P30405', '3RCG', 1, 0.97, 'A', 165, 'ISOMERASE / ISOMERASE INHIBITOR', 'ISOMERASE', 'Peptidyl-prolyl cis-trans isomerase F, mitochondrial', 'PPIF', 'Peptidylproline (omega=180) = peptidylproline (omega=0).<br />\n', 'cyclosporin A binding<br />\npeptidyl-prolyl cis-trans isomerase activity<br />\n', 'apoptotic mitochondrial changes<br />\ncellular response to arsenic-containing substance<br />\ncellular response to calcium ion<br />\ncellular response to hydrogen peroxide<br />\nnecroptotic process<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of ATPase activity<br />\nnegative regulation of intrinsic apoptotic signaling pathway<br />\nnegative regulation of oxidative phosphorylation<br />\nnegative regulation of oxidative phosphorylation uncoupler activity<br />\nnegative regulation of release of cytochrome c from mitochondria<br />\npositive regulation of release of cytochrome c from mitochondria<br />\nprotein folding<br />\nregulation of mitochondrial membrane permeability<br />\nregulation of mitochondrial membrane permeability involved in programmed necrotic cell death<br />\nregulation of necrotic cell death<br />\nregulation of proton-transporting ATPase activity, rotational mechanism<br />\nresponse to ischemia<br />\n', 'PF00160.', 'MLALRCGSRWLGLLSVPRSVPLRLPAARACSKGSGDPSSSSSSGNPLVYLDVDANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVKEGMDVVKKIESFGSKSGRTSKKIVITDCGQLS'),
('P20711', '3RCH', 1, 2.8, 'A/B', 480, 'LYASE', 'LYASE', 'Aromatic-L-amino-acid decarboxylase', 'DDC', 'L-dopa = dopamine + CO2.<br />\n5-hydroxy-L-tryptophan = 5-hydroxytryptamine + CO2.<br />\n', 'amino acid binding<br />\naromatic-L-amino-acid decarboxylase activity<br />\nenzyme binding<br />\nL-dopa decarboxylase activity<br />\nprotein domain specific binding<br />\npyridoxal phosphate binding<br />\n', 'aminergic neurotransmitter loading into synaptic vesicle<br />\ncatecholamine biosynthetic process<br />\ncellular amino acid metabolic process<br />\ncellular response to alkaloid<br />\ncellular response to drug<br />\ncellular response to growth factor stimulus<br />\ncircadian rhythm<br />\ndopamine biosynthetic process<br />\nindolalkylamine biosynthetic process<br />\nisoquinoline alkaloid metabolic process<br />\nmulticellular organism aging<br />\nphytoalexin metabolic process<br />\nresponse to pyrethroid<br />\nserotonin biosynthetic process<br />\n', 'PF00282.', 'MNASEFRRRGKEMVDYMANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE'),
('P14770', '3REZ', 0, 2.35, 'A/B/C/D', 8, 'CELL ADHESION', 'CELL_ADHESION', 'Platelet glycoprotein IX', 'GP9', '', '', 'blood coagulation<br />\nblood coagulation, intrinsic pathway<br />\ncell adhesion<br />\nplatelet activation<br />\n', 'PF13855.', 'MPAWGALFLLWATAEATKDCPSPCTCRALETMGLWVDCRGHGLTALPALPARTRHLLLANNSLQSVPPGAFDHLPQLQTLDVTQNPWHCDCSLTYLRLWLEDRTPEALLQVRCASPSLAAHGPLGRLTGYQLGSCGWQLQASWVRPGVLWDVALVAVAALGLALLAGLLCATTEALD'),
('Q9NXA8', '3RIY', 1, 1.55, 'A/B', 269, 'HYDROLASE', 'HYDROLASE', 'NAD-dependent protein deacylase sirtuin-5, mitochondrial', 'SIRT5', 'NAD+ + a malonylprotein = nicotinamide + O-malonyl-ADP-ribose + a protein<br />\nNAD+ + a succinylprotein = nicotinamide + O-succinyl-ADP-ribose + a protein<br />\nNAD+ + a glutarylprotein = nicotinamide + O-glutaryl-ADP-ribose + a protein<br />\n', 'NAD+ ADP-ribosyltransferase activity<br />\nNAD+ binding<br />\nNAD-dependent protein deacetylase activity<br />\nprotein-glutaryllysine deglutarylase activity<br />\nprotein-malonyllysine demalonylase activity<br />\nprotein-succinyllysine desuccinylase activity<br />\nzinc ion binding<br />\n', 'chromatin silencing<br />\nmitochondrion organization<br />\nnegative regulation of cardiac muscle cell apoptotic process<br />\nnegative regulation of reactive oxygen species metabolic process<br />\npeptidyl-lysine demalonylation<br />\npeptidyl-lysine desuccinylation<br />\nprotein ADP-ribosylation<br />\nprotein deacetylation<br />\nprotein deglutarylation<br />\nprotein demalonylation<br />\nprotein desuccinylation<br />\nregulation of ketone biosynthetic process<br />\nresponse to nutrient levels<br />\n', 'PF02146.', 'MRPLQIVPSRLISQLYCGLKPPASTRNQICLKMARPSSSMADFRKFFAKAKHIVIISGAGVSAESGVPTFRGAGGYWRKWQAQDLATPLAFAHNPSRVWEFYHYRREVMGSKEPNAGHRAIAECETRLGKQGRRVVVITQNIDELHRKAGTKNLLEIHGSLFKTRCTSCGVVAENYKSPICPALSGKGAPEPGTQDASIPVEKLPRCEEAGCGGLLRPHVVWFGENLDPAILEEVDRELAHCDLCLVVGTSSVVYPAAMFAPQVAARGVPVAEFNTETTPATNRFRFHFQGPCGTTLPEALACHENETVS'),
('P12314', '3RJD', 1, 2.65, 'A', 262, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'High affinity immunoglobulin gamma Fc receptor I', 'FCGR1A', '', 'IgG binding<br />\nsignal transducer activity, downstream of receptor<br />\n', 'antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nimmune response<br />\ninterferon-gamma-mediated signaling pathway<br />\nphagocytosis, engulfment<br />\nreceptor-mediated endocytosis<br />\nregulation of immune response<br />\nsignal transduction<br />\n', 'PF00047.', 'MWFLTTLLLWVPVDGQVDTTKAVITLQPPWVSVFQEETVTLHCEVLHLPGSSSTQWFLNGTATQTSTPSYRITSASVNDSGEYRCQRGLSGRSDPIQLEIHRGWLLLQVSSRVFTEGEPLALRCHAWKDKLVYNVLYYRNGKAFKFFHWNSNLTILKTNISHNGTYHCSGMGKHRYTSAGISVTVKELFPAPVLNASVTSPLLEGNLVTLSCETKLLLQRPGLQLYFSFYMGSKTLRGRNTSSEYQILTARREDSGLYWCEAATEDGNVLKRSPELELQVLGLQLPTPVWFHVLFYLAVGIMFLVNTVLWVTIRKELKRKKKWDLEISLDSGHEKKVISSLQEDRHLEEELKCQEQKEEQLQEGVHRKEPQGAT'),
('P42262', '3RN8', 1, 1.7, 'A/B/C', 115, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor 2', 'GRIA2', '', 'AMPA glutamate receptor activity<br />\namyloid-beta binding<br />\nexcitatory extracellular ligand-gated ion channel activity<br />\nextracellular-glutamate-gated ion channel activity<br />\nionotropic glutamate receptor activity<br />\n', 'chemical synaptic transmission<br />\nionotropic glutamate receptor signaling pathway<br />\nsignal transduction<br />\nsynaptic transmission, glutamatergic<br />\n', 'PF01094.', 'MQKIMHISVLLSPVLWGLIFGVSSNSIQIGGLFPRGADQEYSAFRVGMVQFSTSEFRLTPHIDNLEVANSFAVTNAFCSQFSRGVYAIFGFYDKKSVNTITSFCGTLHVSFITPSFPTDGTHPFVIQMRPDLKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINVGNINNDKKDEMYRSLFQDLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIANLGFTDGDLLKIQFGGANVSGFQIVDYDDSLVSKFIERWSTLEEKEYPGAHTTTIKYTSALTYDAVQVMTEAFRNLRKQRIEISRRGNAGDCLANPAVPWGQGVEIERALKQVQVEGLSGNIKFDQNGKRINYTINIMELKTNGPRKIGYWSEVDKMVVTLTELPSGNDTSGLENKTVVVTTILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKIWNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHTEEFEDGRETQSSESTNEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLSKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGKYAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKEKTSALSLSNVAGVFYILVGGLGLAMLVALIEFCYKSRAEAKRMKVAKNAQNINPSSSQNSQNFATYKEGYNVYGIESVKI'),
('Q9Y2Q3', '3RPN', 1, 1.9, 'A/B/C/D/E/F', 226, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Glutathione S-transferase kappa 1', 'GSTK1', 'RX + glutathione = HX + R-S-glutathione.<br />\n', 'glutathione peroxidase activity<br />\nglutathione transferase activity<br />\nprotein disulfide oxidoreductase activity<br />\nreceptor binding<br />\n', 'epithelial cell differentiation<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\n', 'PF01323.', 'MGPLPRTVELFYDVLSPYSWLGFEILCRYQNIWNINLQLRPSLITGIMKDSGNKPPGLLPRKGLYMANDLKLLRHHLQIPIHFPKDFLSVMLEKGSLSAMRFLTAVNLEHPEMLEKASRELWMRVWSRNEDITEPQSILAAAEKAGMSAEQAQGLLEKIATPKVKNQLKETTEAACRYGAFGLPITVAHVDGQTHMLFGSDRMELLAHLLGEKWMGPIPPAVNARL'),
('Q07021', '3RPX', 0, 2.65, 'A/B/C', 187, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Complement component 1 Q subcomponent-binding protein, mitochondrial', 'C1QBP', '', 'adrenergic receptor binding<br />\ncomplement component C1q binding<br />\nhyaluronic acid binding<br />\nkininogen binding<br />\nmitochondrial ribosome binding<br />\nmRNA binding<br />\nprotein kinase C binding<br />\ntranscription corepressor activity<br />\ntranscription factor binding<br />\n', 'apoptotic process<br />\nblood coagulation, intrinsic pathway<br />\ncomplement activation, classical pathway<br />\nimmune response<br />\ninnate immune response<br />\nmature ribosome assembly<br />\nmRNA processing<br />\nnegative regulation of defense response to virus<br />\nnegative regulation of interferon-gamma production<br />\nnegative regulation of interleukin-12 production<br />\nnegative regulation of MDA-5 signaling pathway<br />\nnegative regulation of mRNA splicing, via spliceosome<br />\nnegative regulation of RIG-I signaling pathway<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nphosphatidylinositol 3-kinase signaling<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell adhesion<br />\npositive regulation of dendritic cell chemotaxis<br />\npositive regulation of mitochondrial translation<br />\npositive regulation of neutrophil chemotaxis<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of substrate adhesion-dependent cell spreading<br />\npositive regulation of trophoblast cell migration<br />\nregulation of complement activation<br />\nRNA splicing<br />\ntranscription, DNA-templated<br />\nviral process<br />\n', 'PF02330.', 'MLPLLRCVPRVLGSSVAGLRAAAPASPFRQLLQPAPRLCTRPFGLLSVRAGSERRPGLLRPRGPCACGCGCGSLHTDGDKAFVDFLSDEIKEERKIQKHKTLPKMSGGWELELNGTEAKLVRKVAGEKITVTFNINNSIPPTFDGEEEPSQGQKVEEQEPELTSTPNFVVEVIKNDDGKKALVLDCHYPEDEVGQEDEAESDIFSIREVSFQSTGESEWKDTNYTLNTDSLDWALYDHLMDFLADRGVDNTFADELVELSTALEHQEYITFLEDLKSFVKSQ');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('Q9F663', '3RXW', 1, 1.26, 'A', 264, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Carbapenem-hydrolyzing beta-lactamase KPC', 'bla', 'A beta-lactam + H2O = a substituted beta-amino acid.<br />\n', 'beta-lactamase activity<br />\n', 'beta-lactam antibiotic catabolic process<br />\nresponse to antibiotic<br />\n', '', 'MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ'),
('Q9NZD2', '3RZN', 1, 1.1, 'A', 209, 'LIPID TRANSPORT', 'OTHERS', 'Glycolipid transfer protein', 'GLTP', '', 'glycolipid binding<br />\nglycolipid transporter activity<br />\nidentical protein binding<br />\nintermembrane lipid transfer activity<br />\nlipid binding<br />\n', 'glycosphingolipid metabolic process<br />\nintermembrane lipid transfer<br />\n', 'PF08718.', 'MALLAEHLLKPLPADKQIETGPFLEAVSHLPPFFDCLGSPVFTPIKADISGNITKIKAVYDTNPAKFRTLQNILEVEKEMYGAEWPKVGATLALMWLKRGLRFIQVFLQSICDGERDENHPNLIRVNATKAYEMALKKYHGWIVQKIFQAALYAAPYKSDFLKALSKGQNVTEEECLEKIRLFLVNYTATIDVIYEMYTQMNAELNYKV'),
('Q9H3S4', '3S4Y', 1, 1.8, 'A/B', 229, 'TRANSFERASE', 'TRANSFERASE', 'Thiamin pyrophosphokinase 1', 'TPK1', 'ATP + thiamine = AMP + thiamine diphosphate.<br />\n', 'ATP binding<br />\nkinase activity<br />\nthiamine binding<br />\nthiamine diphosphokinase activity<br />\n', 'thiamine-containing compound metabolic process<br />\nthiamine diphosphate biosynthetic process<br />\nthiamine metabolic process<br />\n', 'PF04265.', 'MEHAFTPLEPLLSTGNLKYCLVILNQPLDNYFRHLWNKALLRACADGGANRLYDITEGERESFLPEFINGDFDSIRPEVREYYATKGCELISTPDQDHTDFTKCLKMLQKKIEEKDLKVDVIVTLGGLAGRFDQIMASVNTLFQATHITPFPIIIIQEESLIYLLQPGKHRLHVDTGMEGDWCGLIPVGQPCMQVTTTGLKWNLTNDVLAFGTLVSTSNTYDGSGVVTVETDHPLLWTMAIKS'),
('Q6NS38', '3S57', 1, 1.6, 'A', 203, 'OXIDOREDUCTASE / DNA', 'OXIDOREDUCTASE', 'DNA oxidative demethylase ALKBH2', 'ALKBH2', 'DNA-base-CH3 + 2-oxoglutarate + O2 = DNA-base + formaldehyde + succinate + CO2.<br />\n', '1-ethyladenine demethylase activity<br />\ncytosine C-5 DNA demethylase activity<br />\nDNA-N1-methyladenine dioxygenase activity<br />\nferrous iron binding<br />\n', 'DNA dealkylation involved in DNA repair<br />\nDNA demethylation<br />\noxidative demethylation<br />\noxidative DNA demethylation<br />\n', 'PF13532.', 'MDRFLVKGAQGGLLRKQEEQEPTGEEPAVLGGDKESTRKRPRREAPGNGGHSAGPSWRHIRAEGLDCSYTVLFGKAEADEIFQELEKEVEYFTGALARVQVFGKWHSVPRKQATYGDAGLTYTFSGLTLSPKPWIPVLERIRDHVSGVTGQTFNFVLINRYKDGCDHIGEHRDDERELAPGSPIASVSFGACRDFVFRHKDSRGKSPSRRVAVVRLPLAHGSLLMMNHPTNTHWYHSLPVRKKVLAPRVNLTFRKILLTKK'),
('P11511', '3S79', 1, 2.75, 'A', 503, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aromatase', 'CYP19A1', 'Testosterone + 3 [reduced NADPH--hemoprotein reductase] + 3 O2 = 17-beta-estradiol + formate + 4 H2O + 3 [oxidized NADPH--hemoprotein reductase]<br />\nAndrost-4-ene-3,17-dione + 3 [reduced NADPH--hemoprotein reductase] + 3 O2 = estrone + formate + 4 H2O + 3 [oxidized NADPH--hemoprotein reductase]<br />\n', 'aromatase activity<br />\nelectron carrier activity<br />\nheme binding<br />\niron ion binding<br />\noxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen<br />\noxygen binding<br />\nsteroid hydroxylase activity<br />\n', 'androgen catabolic process<br />\nestrogen biosynthetic process<br />\nfemale genitalia development<br />\nfemale gonad development<br />\nmammary gland development<br />\nnegative regulation of chronic inflammatory response<br />\nnegative regulation of macrophage chemotaxis<br />\npositive regulation of estradiol secretion<br />\nprostate gland growth<br />\nsteroid biosynthetic process<br />\nsterol metabolic process<br />\ntestosterone biosynthetic process<br />\nuterus development<br />\n', 'PF00067.', 'MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEH'),
('P53667', '3S95', 1, 1.65, 'A/B', 308, 'TRANSFERASE / ANTIBIOTIC', 'TRANSFERASE', 'LIM domain kinase 1', 'LIMK1', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nheat shock protein binding<br />\nmetal ion binding<br />\nprotein heterodimerization activity<br />\nprotein kinase activity<br />\nprotein serine/threonine kinase activity<br />\nsignal transducer activity<br />\n', 'actin cytoskeleton organization<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nnegative regulation of ubiquitin-protein transferase activity<br />\nnervous system development<br />\npositive regulation of actin filament bundle assembly<br />\npositive regulation of axon extension<br />\npositive regulation of stress fiber assembly<br />\nprotein phosphorylation<br />\nRho protein signal transduction<br />\nsignal transduction<br />\n', 'PF00412.', 'MRLTLLCCTWREERMGEEGSELPVCASCGQRIYDGQYLQALNADWHADCFRCCDCSASLSHQYYEKDGQLFCKKDYWARYGESCHGCSEQITKGLVMVAGELKYHPECFICLTCGTFIGDGDTYTLVEHSKLYCGHCYYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASSHGKRGLSVSIDPPHGPPGCGTEHSHTVRVQGVDPGCMSPDVKNSIHVGDRILEINGTPIRNVPLDEIDLLIQETSRLLQLTLEHDPHDTLGHGLGPETSPLSSPAYTPSGEAGSSARQKPVLRSCSIDRSPGAGSLGSPASQRKDLGRSESLRVVCRPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGESGLPAHPEVPD'),
('P05093', '3SWZ', 1, 2.4, 'A/B/C/D', 485, 'oxidoreductase / oxidoreductase inhibitor', 'OXIDOREDUCTASE', 'Steroid 17-alpha-hydroxylase/17,20 lyase', 'CYP17A1', 'A C(21)-steroid + [reduced NADPH--hemoprotein reductase] + O2 = a 17-alpha-hydroxy-C(21)-steroid + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n17-alpha-hydroxyprogesterone + [reduced NADPH--hemoprotein reductase] + O2 = androstenedione + acetate + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n17-alpha-hydroxypregnenolone + [reduced NADPH--hemoprotein reductase] + O2 = 3-beta-hydroxyandrost-5-en-17-one + acetate + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n', '17-alpha-hydroxyprogesterone aldolase activity<br />\nheme binding<br />\niron ion binding<br />\noxygen binding<br />\nsteroid 17-alpha-monooxygenase activity<br />\n', 'androgen biosynthetic process<br />\nglucocorticoid biosynthetic process<br />\nhormone biosynthetic process<br />\nprogesterone metabolic process<br />\nsex differentiation<br />\nsteroid biosynthetic process<br />\nsteroid metabolic process<br />\nsterol metabolic process<br />\n', 'PF00067.', 'MWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGST'),
('P07900', '3T10', 1, 1.24, 'A', 228, 'CHAPERONE', 'OTHERS', 'Heat shock protein HSP 90-alpha', 'HSP90AA1', '', 'ATPase activity<br />\nATP binding<br />\ndisordered domain specific binding<br />\nDNA polymerase binding<br />\nGTPase binding<br />\nhistone deacetylase binding<br />\nidentical protein binding<br />\nMHC class II protein complex binding<br />\nnitric-oxide synthase regulator activity<br />\nnucleotide binding<br />\nprotein homodimerization activity<br />\nprotein tyrosine kinase activity<br />\nprotein tyrosine kinase binding<br />\nRNA binding<br />\nTPR domain binding<br />\nunfolded protein binding<br />\n', 'chaperone-mediated autophagy<br />\nchaperone-mediated protein complex assembly<br />\nciliary basal body-plasma membrane docking<br />\nERBB2 signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nG2/M transition of mitotic cell cycle<br />\nmitochondrial transport<br />\nneutrophil degranulation<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of telomerase activity<br />\nprotein import into mitochondrial outer membrane<br />\nprotein refolding<br />\nprotein stabilization<br />\nprotein unfolding<br />\nreceptor-mediated endocytosis<br />\nregulation of cellular response to heat<br />\nregulation of G2/M transition of mitotic cell cycle<br />\nregulation of nitric-oxide synthase activity<br />\nregulation of protein complex assembly<br />\nregulation of protein ubiquitination<br />\nresponse to antibiotic<br />\nresponse to cold<br />\nresponse to heat<br />\nresponse to unfolded protein<br />\nsignal transduction<br />\ntelomerase holoenzyme complex assembly<br />\ntelomere maintenance via telomerase<br />\nvascular endothelial growth factor receptor signaling pathway<br />\n', 'PF02518.', 'MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKEDKEEEKEKEEKESEDKPEIEDVGSDEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD'),
('P05106', '3T3M', 1, 2.6, 'B/D', 472, 'CELL ADHESION', 'CELL_ADHESION', 'Integrin beta-3', 'ITGB3', '', 'cell adhesion molecule binding<br />\ncoreceptor activity<br />\nenzyme binding<br />\nextracellular matrix binding<br />\nfibronectin binding<br />\nidentical protein binding<br />\nplatelet-derived growth factor receptor binding<br />\nprotease binding<br />\nprotein disulfide isomerase activity<br />\nvascular endothelial growth factor receptor 2 binding<br />\nvirus receptor activity<br />\n', 'activation of protein kinase activity<br />\nangiogenesis involved in wound healing<br />\napolipoprotein A-I-mediated signaling pathway<br />\nblood coagulation<br />\ncell adhesion<br />\ncell adhesion mediated by integrin<br />\ncell growth<br />\ncell-matrix adhesion<br />\ncell migration<br />\ncell-substrate adhesion<br />\ncell-substrate junction assembly<br />\nextracellular matrix organization<br />\nheterotypic cell-cell adhesion<br />\nintegrin-mediated signaling pathway<br />\nleukocyte migration<br />\nmesodermal cell differentiation<br />\nnegative chemotaxis<br />\nnegative regulation of lipid storage<br />\nnegative regulation of lipid transport<br />\nnegative regulation of lipoprotein metabolic process<br />\nnegative regulation of low-density lipoprotein particle receptor biosynthetic process<br />\nnegative regulation of macrophage derived foam cell differentiation<br />\nplatelet activation<br />\nplatelet aggregation<br />\nplatelet degranulation<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of vascular endothelial growth factor receptor signaling pathway<br />\nregulation of bone resorption<br />\nsmooth muscle cell migration<br />\nsubstrate adhesion-dependent cell spreading<br />\ntube development<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nviral entry into host cell<br />\nwound healing<br />\n', 'PF07974.', 'MRARPRPRPLWATVLALGALAGVGVGGPNICTTRGVSSCQQCLAVSPMCAWCSDEALPLGSPRCDLKENLLKDNCAPESIEFPVSEARVLEDRPLSDKGSGDSSQVTQVSPQRIALRLRPDDSKNFSIQVRQVEDYPVDIYYLMDLSYSMKDDLWSIQNLGTKLATQMRKLTSNLRIGFGAFVDKPVSPYMYISPPEALENPCYDMKTTCLPMFGYKHVLTLTDQVTRFNEEVKKQSVSRNRDAPEGGFDAIMQATVCDEKIGWRNDASHLLVFTTDAKTHIALDGRLAGIVQPNDGQCHVGSDNHYSASTTMDYPSLGLMTEKLSQKNINLIFAVTENVVNLYQNYSELIPGTTVGVLSMDSSNVLQLIVDAYGKIRSKVELEVRDLPEELSLSFNATCLNNEVIPGLKSCMGLKIGDTVSFSIEAKVRGCPQEKEKSFTIKPVGFKDSLIVQVTFDCDCACQAQAEPNSHRCNNGNGTFECGVCRCGPGWLGSQCECSEEDYRPSQQDECSPREGQPVCSQRGECLCGQCVCHSSDFGKITGKYCECDDFSCVRYKGEMCSGHGQCSCGDCLCDSDWTGYYCNCTTRTDTCMSSNGLLCSGRGKCECGSCVCIQPGSYGDTCEKCPTCPDACTFKKECVECKKFDRGALHDENTCNRYCRDEIESVKELKDTGKDAVNCTYKNEDDCVVRFQYYEDSSGKSILYVVEEPECPKGPDILVVLLSVMGAILLIGLAALLIWKLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT'),
('P08514', '3T3M', 1, 2.6, 'A/C', 457, 'CELL ADHESION', 'CELL_ADHESION', 'Integrin alpha-IIb', 'ITGA2B', '', 'extracellular matrix binding<br />\nfibrinogen binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\n', 'cell adhesion<br />\ncell-matrix adhesion<br />\nextracellular matrix organization<br />\nintegrin-mediated signaling pathway<br />\nplatelet aggregation<br />\nplatelet degranulation<br />\npositive regulation of leukocyte migration<br />\nregulation of megakaryocyte differentiation<br />\n', 'PF01839.', 'MARALCPLQALWLLEWVLLLLGPCAAPPAWALNLDPVQLTFYAGPNGSQFGFSLDFHKDSHGRVAIVVGAPRTLGPSQEETGGVFLCPWRAEGGQCPSLLFDLRDETRNVGSQTLQTFKARQGLGASVVSWSDVIVACAPWQHWNVLEKTEEAEKTPVGSCFLAQPESGRRAEYSPCRGNTLSRIYVENDFSWDKRYCEAGFSSVVTQAGELVLGAPGGYYFLGLLAQAPVADIFSSYRPGILLWHVSSQSLSFDSSNPEYFDGYWGYSVAVGEFDGDLNTTEYVVGAPTWSWTLGAVEILDSYYQRLHRLRGEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADRKLAEVGRVYLFLQPRGPHALGAPSLLLTGTQLYGRFGSAIAPLGDLDRDGYNDIAVAAPYGGPSGRGQVLVFLGQSEGLRSRPSQVLDSPFPTGSAFGFSLRGAVDIDDNGYPDLIVGAYGANQVAVYRAQPVVKASVQLLVQDSLNPAVKSCVLPQTKTPVSCFNIQMCVGATGHNIPQKLSLNAELQLDRQKPRQGRRVLLLGSQQAGTTLNLDLGGKHSPICHTTMAFLRDEADFRDKLSPIVLSLNVSLPPTEAGMAPAVVLHGDTHVQEQTRIVLDCGEDDVCVPQLQLTASVTGSPLLVGADNVLELQMDAANEGEGAYEAELAVHLPQGAHYMRALSNVEGFERLICNQKKENETRVVLCELGNPMKKNAQIGIAMLVSVGNLEEAGESVSFQLQIRSKNSQNPNSKIVLLDVPVRAEAQVELRGNSFPASLVVAAEEGEREQNSLDSWGPKVEHTYELHNNGPGTVNGLHLSIHLPGQSQPSDLLYILDIQPQGGLQCFPQPPVNPLKVDWGLPIPSPSPIHPAHHKRDRRQIFLPEPEQPSRLQDPVLVSCDSAPCTVVQCDLQEMARGQRAMVTVLAFLWLPSLYQRPLDQFVLQSHAWFNVSSLPYAVPPLSLPRGEAQVWTQLLRALEERAIPIWWVLVGVLGGLLLLTILVLAMWKVGFFKRNRPPLEEDDEEGE'),
('P10635', '3TBG', 1, 2.1, 'A/B/C/D', 464, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome P450 2D6', 'CYP2D6', 'RH + [reduced NADPH--hemoprotein reductase] + O2 = ROH + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n', 'aromatase activity<br />\ndrug binding<br />\nheme binding<br />\niron ion binding<br />\nmonooxygenase activity<br />\noxidoreductase activity<br />\noxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen<br />\noxygen binding<br />\nsteroid hydroxylase activity<br />\n', 'alkaloid catabolic process<br />\nalkaloid metabolic process<br />\narachidonic acid metabolic process<br />\ncoumarin metabolic process<br />\ndrug catabolic process<br />\ndrug metabolic process<br />\nheterocycle metabolic process<br />\nisoquinoline alkaloid metabolic process<br />\nmonoterpenoid metabolic process<br />\nnegative regulation of binding<br />\nnegative regulation of cellular organofluorine metabolic process<br />\noxidation-reduction process<br />\noxidative demethylation<br />\nsteroid metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF00067.', 'MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPR'),
('P49327', '3TJM', 1, 1.48, 'A', 283, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Fatty acid synthase', 'FASN', 'Acetyl-CoA + n malonyl-CoA + 2n NADPH = a long-chain fatty acid + (n+1) CoA + n CO2 + 2n NADP+<br />\nAcetyl-CoA + [acyl-carrier-protein] = CoA + acetyl-[acyl-carrier-protein]<br />\nMalonyl-CoA + an [acyl-carrier-protein] = CoA + a malonyl-[acyl-carrier-protein]<br />\nAcyl-[acyl-carrier-protein] + malonyl-[acyl-carrier-protein] = 3-oxoacyl-[acyl-carrier-protein] + CO2 + [acyl-carrier-protein]<br />\n(3R)-3-hydroxyacyl-[acyl-carrier-protein] + NADP+ = 3-oxoacyl-[acyl-carrier-protein] + NADPH<br />\nA (3R)-3-hydroxyacyl-[acyl-carrier protein] = a trans-2-enoyl-[acyl-carrier protein] + H2O<br />\nAn acyl-[acyl-carrier protein] + NADP+ = a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADPH<br />\nOleoyl-[acyl-carrier-protein] + H2O = [acyl-carrier-protein] + oleate<br />\n', '[acyl-carrier-protein] S-acetyltransferase activity<br />\n[acyl-carrier-protein] S-malonyltransferase activity<br />\n3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity<br />\n3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity<br />\n3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity<br />\n3-oxoacyl-[acyl-carrier-protein] synthase activity<br />\n3-oxo-glutaryl-[acp] methyl ester reductase activity<br />\n3-oxo-pimeloyl-[acp] methyl ester reductase activity<br />\ncadherin binding<br />\ndrug binding<br />\nenoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity<br />\nenoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity<br />\nfatty acid synthase activity<br />\nmyristoyl-[acyl-carrier-protein] hydrolase activity<br />\nNADPH binding<br />\noleoyl-[acyl-carrier-protein] hydrolase activity<br />\npalmitoyl-[acyl-carrier-protein] hydrolase activity<br />\nphosphopantetheine binding<br />\nprotein homodimerization activity<br />\nRNA binding<br />\n', 'acetyl-CoA metabolic process<br />\ncellular response to interleukin-4<br />\nfatty acid biosynthetic process<br />\nfatty acid metabolic process<br />\nfatty-acyl-CoA biosynthetic process<br />\nmammary gland development<br />\nosteoblast differentiation<br />\npantothenate metabolic process<br />\npositive regulation of cellular metabolic process<br />\nregulation of cholesterol biosynthetic process<br />\n', 'PF00698.', 'MEEVVIAGMSGKLPESENLQEFWDNLIGGVDMVTDDDRRWKAGLYGLPRRSGKLKDLSRFDASFFGVHPKQAHTMDPQLRLLLEVTYEAIVDGGINPDSLRGTHTGVWVGVSGSETSEALSRDPETLVGYSMVGCQRAMMANRLSFFFDFRGPSIALDTACSSSLMALQNAYQAIHSGQCPAAIVGGINVLLKPNTSVQFLRLGMLSPEGTCKAFDTAGNGYCRSEGVVAVLLTKKSLARRVYATILNAGTNTDGFKEQGVTFPSGDIQEQLIRSLYQSAGVAPESFEYIEAHGTGTKVGDPQELNGITRALCATRQEPLLIGSTKSNMGHPEPASGLAALAKVLLSLEHGLWAPNLHFHSPNPEIPALLDGRLQVVDQPLPVRGGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPRLLRASGRTPEAVQKLLEQGLRHSQDLAFLSMLNDIAAVPATAMPFRGYAVLGGERGGPEVQQVPAGERPLWFICSGMGTQWRGMGLSLMRLDRFRDSILRSDEAVKPFGLKVSQLLLSTDESTFDDIVHSFVSLTAIQIGLIDLLSCMGLRPDGIVGHSLGEVACGYADGCLSQEEAVLAAYWRGQCIKEAHLPPGAMAAVGLSWEECKQRCPPGVVPACHNSKDTVTISGPQAPVFEFVEQLRKEGVFAKEVRTGGMAFHSYFMEAIAPPLLQELKKVIREPKPRSARWLSTSIPEAQWHSSLARTSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLKRGLKPSCTIIPLMKKDHRDNLEFFLAGIGRLHLSGIDANPNALFPPVEFPAPRGTPLISPLIKWDHSLAWDVPAAEDFPNGSGSPSAAIYNIDTSSESPDHYLVDHTLDGRVLFPATGYLSIVWKTLARALGLGVEQLPVVFEDVVLHQATILPKTGTVSLEVRLLEASRAFEVSENGNLVVSGKVYQWDDPDPRLFDHPESPTPNPTEPLFLAQAEVYKELRLRGYDYGPHFQGILEASLEGDSGRLLWKDNWVSFMDTMLQMSILGSAKHGLYLPTRVTAIHIDPATHRQKLYTLQDKAQVADVVVSRWLRVTVAGGVHISGLHTESAPRRQQEQQVPILEKFCFTPHTEEGCLSERAALQEELQLCKGLVQALQTKVTQQGLKMVVPGLDGAQIPRDPSQQELPRLLSAACRLQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALKACLDTAVENMPSLKMKVVEVLAGHGHLYSRIPGLLSPHPLLQLSYTATDRHPQALEAAQAELQQHDVAQGQWDPADPAPSALGSADLLVCNCAVAALGDPASALSNMVAALREGGFLLLHTLLRGHPLGDIVAFLTSTEPQYGQGILSQDAWESLFSRVSLRLVGLKKSFYGSTLFLCRRPTPQDSPIFLPVDDTSFRWVESLKGILADEDSSRPVWLKAINCATSGVVGLVNCLRREPGGNRLRCVLLSNLSSTSHVPEVDPGSAELQKVLQGDLVMNVYRDGAWGAFRHFLLEEDKPEEPTAHAFVSTLTRGDLSSIRWVCSSLRHAQPTCPGAQLCTVYYASLNFRDIMLATGKLSPDAIPGKWTSQDSLLGMEFSGRDASGKRVMGLVPAKGLATSVLLSPDFLWDVPSNWTLEEAASVPVVYSTAYYALVVRGRVRPGETLLIHSGSGGVGQAAIAIALSLGCRVFTTVGSAEKRAYLQARFPQLDSTSFANSRDTSFEQHVLWHTGGKGVDLVLNSLAEEKLQASVRCLATHGRFLEIGKFDLSQNHPLGMAIFLKNVTFHGVLLDAFFNESSADWREVWALVQAGIRDGVVRPLKCTVFHGAQVEDAFRYMAQGKHIGKVVVQVLAEEPEAVLKGAKPKLMSAISKTFCPAHKSYIIAGGLGGFGLELAQWLIQRGVQKLVLTSRSGIRTGYQAKQVRRWRRQGVQVQVSTSNISSLEGARGLIAEAAQLGPVGGVFNLAVVLRDGLLENQTPEFFQDVCKPKYSGTLNLDRVTREACPELDYFVVFSSVSCGRGNAGQSNYGFANSAMERICEKRRHEGLPGLAVQWGAIGDVGILVETMSTNDTIVSGTLPQRMASCLEVLDLFLNQPHMVLSSFVLAEKAAAYRDRDSQRDLVEAVAHILGIRDLAAVNLDSSLADLGLDSLMSVEVRQTLERELNLVLSVREVRQLTLRKLQELSSKADEASELACPTPKEDGLAQQQTQLNLRSLLVNPEGPTLMRLNSVQSSERPLFLVHPIEGSTTVFHSLASRLSIPTYGLQCTRAAPLDSIHSLAAYYIDCIRQVQPEGPYRVAGYSYGACVAFEMCSQLQAQQSPAPTHNSLFLFDGSPTYVLAYTQSYRAKLTPGCEAEAETEAICFFVQQFTDMEHNRVLEALLPLKGLEERVAAAVDLIIKSHQGLDRQELSFAARSFYYKLRAAEQYTPKAKYHGNVMLLRAKTGGAYGEDLGADYNLSQVCDGKVSVHVIEGDHRTLLEGSGLESIISIIHSSLAEPRVSVREG'),
('Q03181', '3TKM', 1, 1.95, 'A', 271, 'TRANSCRIPTION / TRANSCRIPTION ACTIVATOR', 'TRANSCRIPTION', 'Peroxisome proliferator-activated receptor delta', 'PPARD', '', 'DNA binding<br />\ndrug binding<br />\nlinoleic acid binding<br />\nlipid binding<br />\nNF-kappaB binding<br />\nprotein heterodimerization activity<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding<br />\ntranscription coactivator activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\nzinc ion binding<br />\n', 'adipose tissue development<br />\napoptotic process<br />\napoptotic signaling pathway<br />\naxon ensheathment<br />\ncell differentiation<br />\ncell proliferation<br />\ncell-substrate adhesion<br />\ncellular response to hypoxia<br />\ncellular response to lipopolysaccharide<br />\ncholesterol metabolic process<br />\ndecidualization<br />\nembryo implantation<br />\nfatty acid beta-oxidation<br />\nfatty acid catabolic process<br />\nfatty acid transport<br />\ngeneration of precursor metabolites and energy<br />\nglucose metabolic process<br />\nglucose transport<br />\nheart development<br />\nkeratinocyte migration<br />\nkeratinocyte proliferation<br />\nlipid metabolic process<br />\nmRNA transcription<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell growth<br />\nnegative regulation of collagen biosynthetic process<br />\nnegative regulation of epithelial cell proliferation<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of myoblast differentiation<br />\nnegative regulation of pri-miRNA transcription from RNA polymerase II promoter<br />\nnegative regulation of smooth muscle cell migration<br />\nnegative regulation of smooth muscle cell proliferation<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nphospholipid biosynthetic process<br />\npositive regulation of blood vessel diameter<br />\npositive regulation of epidermis development<br />\npositive regulation of fat cell differentiation<br />\npositive regulation of insulin secretion<br />\npositive regulation of myoblast proliferation<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of skeletal muscle tissue regeneration<br />\npositive regulation of transcription, DNA-templated<br />\nproteoglycan metabolic process<br />\nregulation of skeletal muscle satellite cell proliferation<br />\nregulation of transcription from RNA polymerase II promoter<br />\nresponse to activity<br />\nresponse to glucose<br />\nresponse to vitamin A<br />\ntranscription initiation from RNA polymerase II promoter<br />\nvitamin A metabolic process<br />\nwound healing<br />\n', 'PF00104.', 'MEQPQEEAPEVREEEEKEEVAEAEGAPELNGGPQHALPSSSYTDLSRSSSPPSLLDQLQMGCDGASCGSLNMECRVCGDKASGFHYGVHACEGCKGFFRRTIRMKLEYEKCERSCKIQKKNRNKCQYCRFQKCLALGMSHNAIRFGRMPEAEKRKLVAGLTANEGSQYNPQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY'),
('P24300', '3U3H', 1, 0.97, 'A', 388, 'ISOMERASE', 'ISOMERASE', 'Xylose isomerase', 'xylA', 'D-xylopyranose = D-xylulose.<br />\n', 'identical protein binding<br />\nmetal ion binding<br />\nxylose isomerase activity<br />\n', 'D-xylose metabolic process<br />\npentose-phosphate shunt<br />\n', 'PF01261.', 'MNYQPTPEDRFTFGLWTVGWQGRDPFGDATRRALDPVESVRRLAELGAHGVTFHDDDLIPFGSSDSEREEHVKRFRQALDDTGMKVPMATTNLFTHPVFKDGGFTANDRDVRRYALRKTIRNIDLAVELGAETYVAWGGREGAESGGAKDVRDALDRMKEAFDLLGEYVTSQGYDIRFAIEPKPNEPRGDILLPTVGHALAFIERLERPELYGVNPEVGHEQMAGLNFPHGIAQALWAGKLFHIDLNGQNGIKYDQDLRFGAGDLRAAFWLVDLLESAGYSGPRHFDFKPPRTEDFDGVWASAAGCMRNYLILKERAAAFRADPEVQEALRASRLDELARPTAADGLQALLDDRSAFEEFDVDAAAARGMAFERLDQLAMDHLLGARG'),
('P55789', '3U5S', 1, 1.5, 'A', 122, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'FAD-linked sulfhydryl oxidase ALR', 'GFER', '2 R''C(R)SH + O2 = R''C(R)S-S(R)CR'' + H2O2<br />\n', 'flavin adenine dinucleotide binding<br />\nflavin-linked sulfhydryl oxidase activity<br />\ngrowth factor activity<br />\nprotein disulfide oxidoreductase activity<br />\n', 'liver development<br />\n', 'PF04777.', 'MAAPGERGRFHGGNLFFLPGGARSEMMDDLATDARGRGAGRRDAAASASTPAQAPTSDSPVAEDASRRRPCRACVDFKTWMRTQQKRDTKFREDCPPDREELGRHSWAVLHTLAAYYPDLPTPEQQQDMAQFIHLFSKFYPCEECAEDLRKRLCRNHPDTRTRACFTQWLCHLHNEVNRKLGKPDFDCSKVDERWRDGWKDGSCD'),
('P09960', '3U9W', 1, 1.25, 'A', 608, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Leukotriene A-4 hydrolase', 'LTA4H', '(7E,9E,11Z,14Z)-(5S,6S)-5,6-epoxyicosa-7,9,11,14-tetraenoate + H2O = (6Z,8E,10E,14Z)-(5S,12R)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate<br />\n', 'aminopeptidase activity<br />\nepoxide hydrolase activity<br />\nleukotriene-A4 hydrolase activity<br />\nmetalloaminopeptidase activity<br />\npeptidase activity<br />\npeptide binding<br />\nRNA binding<br />\nzinc ion binding<br />\n', 'cellular lipid metabolic process<br />\ncellular protein metabolic process<br />\nleukotriene biosynthetic process<br />\nleukotriene metabolic process<br />\nneutrophil degranulation<br />\npeptide catabolic process<br />\n', 'PF09127.', 'MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD'),
('P07237', '3UEM', 1, 2.29, 'A', 343, 'CHAPERONE', 'OTHERS', 'Protein disulfide-isomerase', 'P4HB', 'Catalyzes the rearrangement of -S-S- bonds in proteins.<br />\n', 'enzyme binding<br />\nintegrin binding<br />\npeptide disulfide oxidoreductase activity<br />\nprocollagen-proline 4-dioxygenase activity<br />\nprotein disulfide isomerase activity<br />\nprotein heterodimerization activity<br />\nRNA binding<br />\n', 'cell redox homeostasis<br />\ncellular protein metabolic process<br />\ncellular response to hypoxia<br />\ncellular response to oxidative stress<br />\nchylomicron assembly<br />\ninterleukin-12-mediated signaling pathway<br />\npeptidyl-proline hydroxylation to 4-hydroxy-L-proline<br />\npositive regulation of viral entry into host cell<br />\npost-translational protein modification<br />\nprotein folding<br />\nregulation of oxidative stress-induced intrinsic apoptotic signaling pathway<br />\nresponse to endoplasmic reticulum stress<br />\nvery-low-density lipoprotein particle assembly<br />\n', 'PF00085.', 'MLRRALLCLAVAALVRADAPEEEDHVLVLRKSNFAEALAAHKYLLVEFYAPWCGHCKALAPEYAKAAGKLKAEGSEIRLAKVDATEESDLAQQYGVRGYPTIKFFRNGDTASPKEYTAGREADDIVNWLKKRTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAKQFLQAAEAIDDIPFGITSNSDVFSKYQLDKDGVVLFKKFDEGRNNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPKIFGGEIKTHILLFLPKSVSDYDGKLSNFKTAAESFKGKILFIFIDSDHTDNQRILEFFGLKKEECPAVRLITLEEEMTKYKPESEELTAERITEFCHRFLEGKIKPHLMSQELPEDWDKQPVKVLVGKNFEDVAFDEKKNVFVEFYAPWCGHCKQLAPIWDKLGETYKDHENIVIAKMDSTANEVEAVKVHSFPTLKFFPASADRTVIDYNGERTLDGFKKFLESGGQDGAGDDDDLEDLEEAEEPDMEEDDDQKAVKDEL'),
('O60674', '3UGC', 1, 1.34, 'A', 293, 'Transferase / transferase inhibitor', 'TRANSFERASE', 'Tyrosine-protein kinase JAK2', 'JAK2', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'acetylcholine receptor binding<br />\nATP binding<br />\ngrowth hormone receptor binding<br />\nheme binding<br />\nhistone binding<br />\nhistone kinase activity (H3-Y41 specific)<br />\nidentical protein binding<br />\ninsulin receptor substrate binding<br />\ninterleukin-12 receptor binding<br />\nmetal ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\npeptide hormone receptor binding<br />\nphosphatidylinositol 3-kinase binding<br />\nprotein C-terminus binding<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor binding<br />\nSH2 domain binding<br />\ntype 1 angiotensin receptor binding<br />\n', 'actin filament polymerization<br />\nactivation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nactivation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway<br />\nactivation of Janus kinase activity<br />\nactivation of MAPKK activity<br />\nadaptive immune response<br />\napoptotic process<br />\naxon regeneration<br />\nblood coagulation<br />\ncell differentiation<br />\ncell migration<br />\ncytokine-mediated signaling pathway<br />\nenzyme linked receptor protein signaling pathway<br />\nerythrocyte differentiation<br />\nextrinsic apoptotic signaling pathway<br />\nG-protein coupled receptor signaling pathway<br />\ngrowth hormone receptor signaling pathway<br />\nhistone H3-Y41 phosphorylation<br />\ninnate immune response<br />\ninterferon-gamma-mediated signaling pathway<br />\ninterleukin-12-mediated signaling pathway<br />\nintracellular signal transduction<br />\nintrinsic apoptotic signaling pathway in response to oxidative stress<br />\nJAK-STAT cascade<br />\nJAK-STAT cascade involved in growth hormone signaling pathway<br />\nmammary gland epithelium development<br />\nMAPK cascade<br />\nmesoderm development<br />\nmineralocorticoid receptor signaling pathway<br />\nmovement of cell or subcellular component<br />\nnegative regulation of cardiac muscle cell apoptotic process<br />\nnegative regulation of cell-cell adhesion<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of DNA binding<br />\nnegative regulation of heart contraction<br />\nnegative regulation of neuron apoptotic process<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nplatelet-derived growth factor receptor signaling pathway<br />\npositive regulation of cell activation<br />\npositive regulation of cell differentiation<br />\npositive regulation of cell migration<br />\npositive regulation of cell-substrate adhesion<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of DNA binding<br />\npositive regulation of epithelial cell apoptotic process<br />\npositive regulation of growth factor dependent skeletal muscle satellite cell proliferation<br />\npositive regulation of growth hormone receptor signaling pathway<br />\npositive regulation of inflammatory response<br />\npositive regulation of insulin secretion<br />\npositive regulation of interleukin-1 beta production<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of nitric-oxide synthase biosynthetic process<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of phosphoprotein phosphatase activity<br />\npositive regulation of protein import into nucleus, translocation<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of tumor necrosis factor production<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of apoptotic process<br />\nregulation of cell proliferation<br />\nregulation of inflammatory response<br />\nregulation of interferon-gamma-mediated signaling pathway<br />\nresponse to antibiotic<br />\nresponse to hydroperoxide<br />\nresponse to interleukin-12<br />\nresponse to lipopolysaccharide<br />\nresponse to tumor necrosis factor<br />\nsignal transduction<br />\nSTAT protein import into nucleus<br />\ntumor necrosis factor-mediated signaling pathway<br />\ntyrosine phosphorylation of STAT protein<br />\n', 'PF07714.', 'MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG'),
('O14788', '3URF', 0, 2.7, 'A', 156, 'CYTOKINE', 'OTHERS', 'Tumor necrosis factor ligand superfamily member 11', 'TNFSF11', '', 'cytokine activity<br />\ntumor necrosis factor receptor binding<br />\ntumor necrosis factor receptor superfamily binding<br />\n', 'activation of JUN kinase activity<br />\nanimal organ morphogenesis<br />\nbone resorption<br />\ncalcium ion homeostasis<br />\ncalcium-mediated signaling<br />\ncellular response to leukemia inhibitory factor<br />\ncytokine-mediated signaling pathway<br />\nERK1 and ERK2 cascade<br />\nimmune response<br />\nmammary gland alveolus development<br />\nmammary gland epithelial cell proliferation<br />\nmonocyte chemotaxis<br />\nossification<br />\nosteoclast differentiation<br />\nosteoclast proliferation<br />\nparacrine signaling<br />\npositive regulation of bone resorption<br />\npositive regulation of corticotropin-releasing hormone secretion<br />\npositive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling<br />\npositive regulation of fever generation by positive regulation of prostaglandin secretion<br />\npositive regulation of homotypic cell-cell adhesion<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of intracellular signal transduction<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of osteoclast development<br />\npositive regulation of osteoclast differentiation<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of T cell activation<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein homooligomerization<br />\nTNFSF11-mediated signaling pathway<br />\ntumor necrosis factor-mediated signaling pathway<br />\n', 'PF00229.', 'MRRASRDYTKYLRGSEEMGGGPGAPHEGPLHAPPPPAPHQPPAASRSMFVALLGLGLGQVVCSVALFFYFRAQMDPNRISEDGTHCIYRILRLHENADFQDTTLESQDTKLIPDSCRRIKQAFQGAVQKELQHIVGSQHIRAEKAMVDGSWLDLAKRSKLEAQPFAHLTINATDIPSGSHKVSLSSWYHDRGWAKISNMTFSNGKLIVNQDGFYYLYANICFRHHETSGDLATEYLQLMVYVTKTSIKIPSSHTLMKGGSTKYWSGNSEFHFYSINVGGFFKLRSGEEISIEVSNPSLLDPDQDATYFGAFKVRDID'),
('P07451', '3UYQ', 0, 1.7, 'A', 260, 'LYASE', 'LYASE', 'Carbonic anhydrase 3', 'CA3', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nnickel cation binding<br />\nphosphatase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\none-carbon metabolic process<br />\nresponse to ethanol<br />\nresponse to oxidative stress<br />\n', 'PF00194.', 'MAKEWGYASHNGPDHWHELFPNAKGENQSPVELHTKDIRHDPSLQPWSVSYDGGSAKTILNNGKTCRVVFDDTYDRSMLRGGPLPGPYRLRQFHLHWGSSDDHGSEHTVDGVKYAAELHLVHWNPKYNTFKEALKQRDGIAVIGIFLKIGHENGEFQIFLDALDKIKTKGKEAPFTKFDPSCLFPACRDYWTYQGSFTTPPCEECIVWLLLKEPMTVSSDQMAKLRSLLSSAENEPPVPLVSNWRPPQPINNRVVRASFK'),
('P25098', '3V5W', 1, 2.07, 'A', 689, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Beta-adrenergic receptor kinase 1', 'GRK2', 'ATP + [beta-adrenergic receptor] = ADP + [beta-adrenergic receptor] phosphate.<br />\n', 'alpha-2A adrenergic receptor binding<br />\nATP binding<br />\nbeta-adrenergic receptor kinase activity<br />\nEdg-2 lysophosphatidic acid receptor binding<br />\nG-protein coupled receptor kinase activity<br />\nprotein kinase activity<br />\n', 'cardiac muscle contraction<br />\ndesensitization of G-protein coupled receptor protein signaling pathway<br />\nG-protein coupled acetylcholine receptor signaling pathway<br />\nheart development<br />\nnegative regulation of striated muscle contraction<br />\nnegative regulation of the force of heart contraction by chemical signal<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\npositive regulation of catecholamine secretion<br />\nreceptor internalization<br />\ntachykinin receptor signaling pathway<br />\nviral entry into host cell<br />\nviral genome replication<br />\n', 'PF00169.', 'MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARKKAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQRVPKMKNKPRSPVVELSKVPLVQRGSANGL'),
('P09917', '3V99', 1, 2.25, 'A/B', 674, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Arachidonate 5-lipoxygenase', 'ALOX5', 'Arachidonate + O2 = leukotriene A4 + H2O<br />\n', 'arachidonate 5-lipoxygenase activity<br />\niron ion binding<br />\n', 'leukotriene biosynthetic process<br />\nleukotriene metabolic process<br />\nleukotriene production involved in inflammatory response<br />\nlipoxin metabolic process<br />\nlipoxygenase pathway<br />\nneutrophil degranulation<br />\n', 'PF00305.', 'MPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGAVDSYDVTVDEELGEIQLVRIEKRKYWLNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGCNPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWCSWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNKKKQLPYYYLSPDRIPNSVAI'),
('P09592', '3VE6', 0, 2.83, 'B', 12, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Structural polyprotein', 'N/A', 'Autocatalytic release of the core protein from the N-terminus of the togavirus structural polyprotein by hydrolysis of a -Trp-|-Ser- bond.', 'serine-type endopeptidase activity<br />\r\nstructural molecule activity<br />', 'clathrin-dependent endocytosis of virus by host cell<br />\r\nfusion of virus membrane with host endosome membrane<br />\r\nvirion attachment to host cell<br />', 'PF01589.', 'MFPFQPMYPMQPMPYRNPFAAPRRPWFPRTDPFLAMQVQELTRSMANLTF\r\nKQRRDAPPEGPSAKKPKKEASQKQKGGGQGKKKKNQGKKKAKTGPPNPKA\r\nQNGNKKKTNKKPGKRQRMVMKLESDKTFPIMLEGKINGYACVVGGKLFRP\r\nMHVEGKIDNDVLAALKTKKASKYDLEYADVPQNMRADTFKYTHEKPQGYY\r\nSWHHGAVQYENGRFTVPKGVGAKGDSGRPILDNQGRVVAIVLGGVNEGSR\r\nTALSVVMWNEKGVTVKYTPENCEQWSLVTTMCLLANVTFPCAQPPICYDR\r\nKPAETLAMLSVNVDNPGYDELLEAAVKCPGRKRRSTEELFKEYKLTRPYM\r\nARCIRCAVGSCHSPIAIEAVKSDGHDGYVRLQTSSQYGLDSSGNLKGRTM\r\nRYDMHGTIKEIPLHQVSLHTSRPCHIVDGHGYFLLARCPAGDSITMEFKK\r\nDSVTHSCSVPYEVKFNPVGRELYTHPPEHGVEQACQVYAHDAQNRGAYVE\r\nMHLPGSEVDSSLVSLSGSSVTVTPPVGTSALVECECGGTKISETINKTKQ\r\nFSQCTKKEQCRAYRLQNDKWVYNSDKLPKAAGATLKGKLHVPFLLADGKC\r\nTVPLAPEPMITFGFRSVSLKLHPKNPTYLTTRQLADEPHYTHELISEPAV\r\nRNFTVTEKGWEFVWGNHPPKRFWAQETAPGNPHGLPHEVITHYYHRYPMS\r\nTILGLSICAAIATVSVAASTWLFCRSRVACLTPYRLTPNARIPFCLAVLC\r\nCARTARAETTWESLDHLWNNNQQMFWIQLLIPLAALIVVTRLLRCVCCVV\r\nPFLVMAGAAAGAYEHATTMPSQAGISYNTIVNRAGYAPLPISITPTKIKL\r\nIPTVNLEYVTCHYKTGMDSPAIKCCGSQECTPTYRPDEQCKVFTGVYPFM\r\nWGGAYCFCDTENTQVSKAYVMKSDDCLADHAEAYKAHTASVQAFLNITVG\r\nEHSIVTTVYVNGETPVNFNGVKLTAGPLSTAWTPFDRKIVQYAGEIYNYD\r\nFPEYGAGQPGAFGDIQSRTVSSSDLYANTNLVLQRPKAGAIHVPYTQAPS\r\nGFEQWKKDKAPSLKFTAPFGCEIYTNPIRAENCAVGSIPLAFDIPDALFT\r\nRVSETPTLSAAECTLNECVYSSDFGGIATVKYSASKSGKCAVHVPSGTAT\r\nLKEAAVELTEQGSATIHFSTANIHPEFRLQICTSYVTCKGDCHPPKDHIV\r\nTHPQYHAQTFTAAVSKTAWTWLTSLLGGSAVIIIIGLVLATIVAMYVLTN\r\nQKHN'),
('Q07869', '3VI8', 1, 1.75, 'A', 269, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Peroxisome proliferator-activated receptor alpha', 'PPARA', '', 'DNA binding<br />\ndrug binding<br />\nlipid binding<br />\nMDM2/MDM4 family protein binding<br />\nNFAT protein binding<br />\nphosphatase binding<br />\nprotein complex binding<br />\nprotein domain specific binding<br />\nRNA polymerase II core promoter proximal region sequence-specific DNA binding<br />\nRNA polymerase II repressing transcription factor binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscriptional activator activity, RNA polymerase II transcription factor binding<br />\ntranscriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscription coactivator binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor binding<br />\nubiquitin conjugating enzyme binding<br />\nzinc ion binding<br />\n', 'behavioral response to nicotine<br />\ncircadian regulation of gene expression<br />\nenamel mineralization<br />\nepidermis development<br />\nfatty acid metabolic process<br />\nfatty acid transport<br />\nheart development<br />\nlipid metabolic process<br />\nlipoprotein metabolic process<br />\nnegative regulation of appetite<br />\nnegative regulation of blood pressure<br />\nnegative regulation of cholesterol storage<br />\nnegative regulation of glycolytic process<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of leukocyte cell-cell adhesion<br />\nnegative regulation of macrophage derived foam cell differentiation<br />\nnegative regulation of neuron death<br />\nnegative regulation of pri-miRNA transcription from RNA polymerase II promoter<br />\nnegative regulation of protein binding<br />\nnegative regulation of receptor biosynthetic process<br />\nnegative regulation of sequestering of triglyceride<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of transcription regulatory region DNA binding<br />\npositive regulation of fatty acid beta-oxidation<br />\npositive regulation of fatty acid oxidation<br />\npositive regulation of gluconeogenesis<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter<br />\nregulation of circadian rhythm<br />\nregulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter<br />\nregulation of lipid metabolic process<br />\nregulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter<br />\nresponse to hypoxia<br />\nresponse to insulin<br />\ntranscription initiation from RNA polymerase II promoter<br />\nwound healing<br />\n', 'PF00104.', 'MVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFGFTEYQYLGSCPGSDGSVITDTLSPASSPSSVTYPVVPGSVDESPSGALNIECRICGDKASGYHYGVHACEGCKGFFRRTIRLKLVYDKCDRSCKIQKKNRNKCQYCRFHKCLSVGMSHNAIRFGRMPRSEKAKLKAEILTCEHDIEDSETADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFVIHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANLDLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFDFAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDIFLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY'),
('P78417', '3VLN', 1, 1.7, 'A', 241, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase omega-1', 'GSTO1', 'RX + glutathione = HX + R-S-glutathione<br />\n2 glutathione + dehydroascorbate = glutathione disulfide + ascorbate<br />\nMethylarsonate + 2 glutathione = methylarsonite + glutathione disulfide + H2O<br />\n', 'glutathione dehydrogenase (ascorbate) activity<br />\nglutathione transferase activity<br />\nmethylarsonate reductase activity<br />\noxidoreductase activity<br />\n', 'cellular response to arsenic-containing substance<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\ninterleukin-12-mediated signaling pathway<br />\nL-ascorbic acid metabolic process<br />\nmethylation<br />\nnegative regulation of ryanodine-sensitive calcium-release channel activity<br />\npositive regulation of ryanodine-sensitive calcium-release channel activity<br />\npositive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion<br />\nregulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion<br />\nregulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum<br />\ntoxin catabolic process<br />\nxenobiotic catabolic process<br />\n', 'PF14497.', 'MSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL'),
('P02919', '3VMA', 1, 2.16, 'A', 747, 'TRANSFERASE', 'TRANSFERASE', 'Penicillin-binding protein 1B', 'mrcB', '(GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala))(n)-diphosphoundecaprenol + GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-diphosphoundecaprenol = (GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala))(n+1)-diphosphoundecaprenol + undecaprenyl diphosphate<br />\nPreferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala<br />\n', 'drug binding<br />\nlipopeptide binding<br />\npenicillin binding<br />\npeptidoglycan glycosyltransferase activity<br />\nserine-type D-Ala-D-Ala carboxypeptidase activity<br />\n', 'cell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nresponse to antibiotic<br />\nresponse to X-ray<br />\n', 'PF14812.', 'MAGNDREPIGRKGKPTRPVKQKVSRRRYEDDDDYDDYDDYEDEEPMPRKGKGKGKGRKPRGKRGWLWLLLKLAIVFAVLIAIYGVYLDQKIRSRIDGKVWQLPAAVYGRMVNLEPDMTISKNEMVKLLEATQYRQVSKMTRPGEFTVQANSIEMIRRPFDFPDSKEGQVRARLTFDGDHLATIVNMENNRQFGFFRLDPRLITMISSPNGEQRLFVPRSGFPDLLVDTLLATEDRHFYEHDGISLYSIGRAVLANLTAGRTVQGASTLTQQLVKNLFLSSERSYWRKANEAYMALIMDARYSKDRILELYMNEVYLGQSGDNEIRGFPLASLYYFGRPVEELSLDQQALLVGMVKGASIYNPWRNPKLALERRNLVLRLLQQQQIIDQELYDMLSARPLGVQPRGGVISPQPAFMQLVRQELQAKLGDKVKDLSGVKIFTTFDSVAQDAAEKAAVEGIPALKKQRKLSDLETAIVVVDRFSGEVRAMVGGSEPQFAGYNRAMQARRSIGSLAKPATYLTALSQPKIYRLNTWIADAPIALRQPNGQVWSPQNDDRRYSESGRVMLVDALTRSMNVPTVNLGMALGLPAVTETWIKLGVPKDQLHPVPAMLLGALNLTPIEVAQAFQTIASGGNRAPLSALRSVIAEDGKVLYQSFPQAERAVPAQAAYLTLWTMQQVVQRGTGRQLGAKYPNLHLAGKTGTTNNNVDTWFAGIDGSTVTITWVGRDNNQPTKLYGASGAMSIYQRYLANQTPTPLNLVPPEDIADMGVDYDGNFVCSGGMRILPVWTSDPQSLCQQSEMQQQPSGNPFDQSSQPQQQPQQQPAQQEQKDSDGVAGWIKDMFGSN');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P00403', '3VRJ', 1, 1.9, 'C', 10, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Cytochrome c oxidase subunit 2', 'MT-CO2', '', 'copper ion binding<br />\ncytochrome-c oxidase activity<br />\n', 'ATP synthesis coupled electron transport<br />\nlactation<br />\nmitochondrial electron transport, cytochrome c to oxygen<br />\nresponse to cold<br />\n', 'PF00116.', 'MAHAAQVGLQDATSPIMEELITFHDHALMIIFLICFLVLYALFLTLTTKLTNTNISDAQEMETVWTILPAIILVLIALPSLRILYMTDEVNDPSLTIKSIGHQWYWTYEYTDYGGLIFNSYMLPPLFLEPGDLRLLDVDNRVVLPIEAPIRMMITSQDVLHSWAVPTLGLKTDAIPGRLNQTTFTATRPGVYYGQCSEICGANHSFMPIVLELIPLKIFEMGPVFTL'),
('P25116', '3VW7', 1, 2.2, 'A', 310, 'Signaling protein / antagonist', 'SIGNALING_PROT', 'Proteinase-activated receptor 1', 'F2R', '', 'G-protein alpha-subunit binding<br />\nG-protein beta-subunit binding<br />\nG-protein coupled receptor activity<br />\nreceptor binding<br />\nthrombin-activated receptor activity<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nactivation of MAPKK activity<br />\nanatomical structure morphogenesis<br />\nblood coagulation<br />\nconnective tissue replacement involved in inflammatory response wound healing<br />\nestablishment of synaptic specificity at neuromuscular junction<br />\nG-protein coupled receptor signaling pathway<br />\nhomeostasis of number of cells within a tissue<br />\ninflammatory response<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of glomerular filtration<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of renin secretion into blood stream<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\nplatelet activation<br />\nplatelet dense granule organization<br />\npositive regulation of blood coagulation<br />\npositive regulation of calcium ion transport<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of collagen biosynthetic process<br />\npositive regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of interleukin-6 secretion<br />\npositive regulation of interleukin-8 secretion<br />\npositive regulation of JAK-STAT cascade<br />\npositive regulation of MAPK cascade<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of release of sequestered calcium ion into cytosol<br />\npositive regulation of Rho protein signal transduction<br />\npositive regulation of smooth muscle contraction<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of vasoconstriction<br />\nprotein kinase C-activating G-protein coupled receptor signaling pathway<br />\nregulation of blood coagulation<br />\nregulation of interleukin-1 beta production<br />\nregulation of sensory perception of pain<br />\nrelease of sequestered calcium ion into cytosol<br />\nresponse to lipopolysaccharide<br />\nresponse to wounding<br />\nSTAT protein import into nucleus<br />\ntrans-synaptic signaling by endocannabinoid, modulating synaptic transmission<br />\ntyrosine phosphorylation of STAT protein<br />\n', 'PF00001.', 'MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPLQKQLPAFISEDASGYLTSSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSVLPFKISYYFSGSDWQFGSELCRFVTAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIWALAIAGVVPLLLKEQTIQVPGLNITTCHDVLNETLLEGYYAYYFSAFSAVFFFVPLIISTVCYVSIIRCLSSSAVANRSKKSRALFLSAAVFCIFIICFGPTNVLLIAHYSFLSHTSTTEAAYFAYLLCVCVSSISCCIDPLIYYYASSECQRYVYSILCCKESSDPSSYNSSGQLMASKMDTCSSNLNNSIYKKLLT'),
('Q04760', '3W0T', 1, 1.35, 'A/B/C/D', 184, 'LYASE / LYASE INHIBITOR', 'LYASE', 'Lactoylglutathione lyase', 'GLO1', '(R)-S-lactoylglutathione = glutathione + methylglyoxal<br />\n', 'lactoylglutathione lyase activity<br />\nzinc ion binding<br />\n', 'carbohydrate metabolic process<br />\nglutathione metabolic process<br />\nmethylglyoxal metabolic process<br />\nnegative regulation of apoptotic process<br />\nosteoclast differentiation<br />\npyruvate metabolic process<br />\nregulation of transcription from RNA polymerase II promoter<br />\n', 'PF00903.', 'MAEPQPPSGGLTDEAALSCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQKCDFPIMKFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLELTHNWGTEDDETQSYHNGNSDPRGFGHIGIAVPDVYSACKRFEELGVKFVKKPDDGKMKGLAFIQDPDGYWIEILNPNKMATLM'),
('Q9NR97', '3WN4', 1, 1.81, 'A', 801, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Toll-like receptor 8', 'TLR8', '', 'DNA binding<br />\ndouble-stranded RNA binding<br />\ndrug binding<br />\nidentical protein binding<br />\nreceptor activity<br />\nRNA binding<br />\nsingle-stranded RNA binding<br />\n', 'cellular response to mechanical stimulus<br />\ndefense response to virus<br />\nI-kappaB kinase/NF-kappaB signaling<br />\nimmunoglobulin mediated immune response<br />\ninflammatory response<br />\ninnate immune response<br />\nmicroglial cell activation<br />\nMyD88-dependent toll-like receptor signaling pathway<br />\nnegative regulation of interleukin-12 secretion<br />\npositive regulation of innate immune response<br />\npositive regulation of interferon-alpha biosynthetic process<br />\npositive regulation of interferon-beta biosynthetic process<br />\npositive regulation of interferon-gamma biosynthetic process<br />\npositive regulation of interleukin-1 beta secretion<br />\npositive regulation of interleukin-6 secretion<br />\npositive regulation of interleukin-8 biosynthetic process<br />\nregulation of protein phosphorylation<br />\nresponse to virus<br />\ntoll-like receptor 8 signaling pathway<br />\ntoll-like receptor 9 signaling pathway<br />\ntoll-like receptor signaling pathway<br />\n', 'PF13855.', 'MENMFLQSSMLTCIFLLISGSCELCAEENFSRSYPCDEKKQNDSVIAECSNRRLQEVPQTVGKYVTELDLSDNFITHITNESFQGLQNLTKINLNHNPNVQHQNGNPGIQSNGLNITDGAFLNLKNLRELLLEDNQLPQIPSGLPESLTELSLIQNNIYNITKEGISRLINLKNLYLAWNCYFNKVCEKTNIEDGVFETLTNLELLSLSFNSLSHVPPKLPSSLRKLFLSNTQIKYISEEDFKGLINLTLLDLSGNCPRCFNAPFPCVPCDGGASINIDRFAFQNLTQLRYLNLSSTSLRKINAAWFKNMPHLKVLDLEFNYLVGEIASGAFLTMLPRLEILDLSFNYIKGSYPQHINISRNFSKLLSLRALHLRGYVFQELREDDFQPLMQLPNLSTINLGINFIKQIDFKLFQNFSNLEIIYLSENRISPLVKDTRQSYANSSSFQRHIRKRRSTDFEFDPHSNFYHFTRPLIKPQCAAYGKALDLSLNSIFFIGPNQFENLPDIACLNLSANSNAQVLSGTEFSAIPHVKYLDLTNNRLDFDNASALTELSDLEVLDLSYNSHYFRIAGVTHHLEFIQNFTNLKVLNLSHNNIYTLTDKYNLESKSLVELVFSGNRLDILWNDDDNRYISIFKGLKNLTRLDLSLNRLKHIPNEAFLNLPASLTELHINDNMLKFFNWTLLQQFPRLELLDLRGNKLLFLTDSLSDFTSSLRTLLLSHNRISHLPSGFLSEVSSLKHLDLSSNLLKTINKSALETKTTTKLSMLELHGNPFECTCDIGDFRRWMDEHLNVKIPRLVDVICASPGDQRGKSIVSLELTTCVSDVTAVILFFFTFFITTMVMLAALAHHLFYWDVWFIYNVCLAKVKGYRSLSTSQTFYDAYISYDTKDASVTDWVINELRYHLEESRDKNVLLCLEERDWDPGLAIIDNLMQSINQSKKTVFVLTKKYAKSWNFKTAFYLALQRLMDENMDVIIFILLEPVLQHSQYLRLRQRICKSSILQWPDNPKAEGLFWQTLRNVVLTENDSRYNNMYVDSIKQY'),
('P14920', '3ZNN', 1, 1.9, 'A/B', 347, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'D-amino-acid oxidase', 'DAO', 'A D-amino acid + H2O + O2 = a 2-oxo acid + NH3 + H2O2<br />\n', 'cofactor binding<br />\nD-amino-acid oxidase activity<br />\nFAD binding<br />\nprotein dimerization activity<br />\nreceptor binding<br />\n', 'cellular nitrogen compound metabolic process<br />\nD-alanine catabolic process<br />\ndopamine biosynthetic process<br />\nD-serine catabolic process<br />\nD-serine metabolic process<br />\nproline catabolic process<br />\n', 'PF01266.', 'MRVVVIGAGVIGLSTALCIHERYHSVLQPLDIKVYADRFTPLTTTDVAAGLWQPYLSDPNNPQEADWSQQTFDYLLSHVHSPNAENLGLFLISGYNLFHEAIPDPSWKDTVLGFRKLTPRELDMFPDYGYGWFHTSLILEGKNYLQWLTERLTERGVKFFQRKVESFEEVAREGADVIVNCTGVWAGALQRDPLLQPGRGQIMKVDAPWMKHFILTHDPERGIYNSPYIIPGTQTVTLGGIFQLGNWSELNNIQDHNTIWEGCCRLEPTLKNARIIGERTGFRPVRPQIRLEREQLRTGPSNTEVIHNYGHGGYGLTIHWGCALEAAKLFGRILEEKKLSRMPPSHL'),
('P99999', '3ZOO', 0, 1.35, 'A/B/C/D', 104, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome c', 'CYCS', '', 'electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity<br />\nheme binding<br />\nmetal ion binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c<br />\ncellular respiration<br />\ncellular response to oxidative stress<br />\nintrinsic apoptotic signaling pathway<br />\nmitochondrial electron transport, cytochrome c to oxygen<br />\nmitochondrial electron transport, ubiquinol to cytochrome c<br />\nmitochondrion organization<br />\nprotein dephosphorylation<br />\n', 'PF00034.', 'MGDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE'),
('P27487', '4A5S', 1, 1.62, 'A/B', 728, 'HYDROLASE', 'HYDROLASE', 'Dipeptidyl peptidase 4', 'DPP4', 'Release of an N-terminal dipeptide, Xaa-Yaa-|-Zaa-, from a polypeptide, preferentially when Yaa is Pro, provided Zaa is neither Pro nor hydroxyproline<br />\n', 'dipeptidyl-peptidase activity<br />\nidentical protein binding<br />\nprotease binding<br />\nprotein homodimerization activity<br />\nreceptor binding<br />\nserine-type endopeptidase activity<br />\nserine-type peptidase activity<br />\nvirus receptor activity<br />\n', 'behavioral fear response<br />\ncell adhesion<br />\nendothelial cell migration<br />\nlocomotory exploration behavior<br />\nnegative regulation of extracellular matrix disassembly<br />\npositive regulation of cell proliferation<br />\npsychomotor behavior<br />\nregulation of cell-cell adhesion mediated by integrin<br />\nregulation of insulin secretion<br />\nresponse to hypoxia<br />\nT cell activation<br />\nT cell costimulation<br />\n', 'PF00930.', 'MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP'),
('O15379', '4A69', 1, 2.06, 'A/B', 376, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Histone deacetylase 3', 'HDAC3', 'Hydrolysis of an N6-acetyl-lysine residue of a histone to yield a deacetylated histone.<br />\n', 'chromatin binding<br />\ncyclin binding<br />\nenzyme binding<br />\nhistone deacetylase activity<br />\nhistone deacetylase binding<br />\nNAD-dependent histone deacetylase activity (H3-K14 specific)<br />\nNF-kappaB binding<br />\nprotein deacetylase activity<br />\ntranscription corepressor activity<br />\ntranscription factor binding<br />\n', 'cellular response to fluid shear stress<br />\nchromatin organization<br />\ncircadian rhythm<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of JNK cascade<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of TOR signaling<br />\npositive regulation of transcription factor import into nucleus<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein deacetylation<br />\nregulation of lipid metabolic process<br />\nregulation of protein stability<br />\nspindle assembly<br />\ntranscription, DNA-templated<br />\n', 'PF00850.', 'MAKTVAYFYDPDVGNFHYGAGHPMKPHRLALTHSLVLHYGLYKKMIVFKPYQASQHDMCRFHSEDYIDFLQRVSPTNMQGFTKSLNAFNVGDDCPVFPGLFEFCSRYTGASLQGATQLNNKICDIAINWAGGLHHAKKFEASGFCYVNDIVIGILELLKYHPRVLYIDIDIHHGDGVQEAFYLTDRVMTVSFHKYGNYFFPGTGDMYEVGAESGRYYCLNVPLRDGIDDQSYKHLFQPVINQVVDFYQPTCIVLQCGADSLGCDRLGCFNLSIRGHGECVEYVKSFNIPLLVLGGGGYTVRNVARCWTYETSLLVEEAISEELPYSEYFEYFAPDFTLHPDVSTRIENQNSRQYLDQIRQTIFENLKMLNHAPSVQIHDVPADLLTYDRTDEADAEERGPEENYSRPEAPNEFYDGDHDNDKESDVEI'),
('Q16620', '4AT5', 1, 1.71, 'A', 296, 'TRANSFERASE', 'TRANSFERASE', 'BDNF/NT-3 growth factors receptor', 'NTRK2', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nbrain-derived neurotrophic factor-activated receptor activity<br />\nbrain-derived neurotrophic factor binding<br />\nneurotrophin binding<br />\nprotein homodimerization activity<br />\n', 'brain-derived neurotrophic factor receptor signaling pathway<br />\ncellular response to amino acid stimulus<br />\ncentral nervous system neuron development<br />\ncerebral cortex development<br />\ncircadian rhythm<br />\nfeeding behavior<br />\nglutamate secretion<br />\nlearning<br />\nlong-term synaptic potentiation<br />\nmechanoreceptor differentiation<br />\nnegative regulation of anoikis<br />\nnegative regulation of neuron apoptotic process<br />\nneuromuscular junction development<br />\nneuron differentiation<br />\nneuron migration<br />\noligodendrocyte differentiation<br />\nperipheral nervous system neuron development<br />\npositive regulation of axonogenesis<br />\npositive regulation of cell proliferation<br />\npositive regulation of gene expression<br />\npositive regulation of MAPK cascade<br />\npositive regulation of neuron projection development<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of synapse assembly<br />\nprotein autophosphorylation<br />\nregulation of GTPase activity<br />\nregulation of protein kinase B signaling<br />\nretina development in camera-type eye<br />\nretinal rod cell development<br />\ntrans-synaptic signaling by neuropeptide, modulating synaptic transmission<br />\nvasculogenesis<br />\n', 'PF07679.', 'MSSWIRWHGPAMARLWGFCWLVVGFWRAAFACPTSCKCSASRIWCSDPSPGIVAFPRLEPNSVDPENITEIFIANQKRLEIINEDDVEAYVGLRNLTIVDSGLKFVAHKAFLKNSNLQHINFTRNKLTSLSRKHFRHLDLSELILVGNPFTCSCDIMWIKTLQEAKSSPDTQDLYCLNESSKNIPLANLQIPNCGLPSANLAAPNLTVEEGKSITLSCSVAGDPVPNMYWDVGNLVSKHMNETSHTQGSLRITNISSDDSGKQISCVAENLVGEDQDSVNLTVHFAPTITFLESPTSDHHWCIPFTVKGNPKPALQWFYNGAILNESKYICTKIHVTNHTEYHGCLQLDNPTHMNNGDYTLIAKNEYGKDEKQISAHFMGWPGIDDGANPNYPDVIYEDYGTAANDIGDTTNRSNEIPSTDVTDKTGREHLSVYAVVVIASVVGFCLLVMLFLLKLARHSKFGMKGPASVISNDDDSASPLHHISNGSNTPSSSEGGPDAVIIGMTKIPVIENPQYFGITNSQLKPDTFVQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDILG'),
('P22001', '4BGC', 0, 1.2, 'A', 101, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Potassium voltage-gated channel subfamily A member 3', 'KCNA3', '', 'delayed rectifier potassium channel activity<br />\noutward rectifier potassium channel activity<br />\nvoltage-gated ion channel activity<br />\nvoltage-gated potassium channel activity<br />\n', 'potassium ion transmembrane transport<br />\npotassium ion transport<br />\nprotein homooligomerization<br />\n', 'PF02214.', 'MDERLSLLRSPPPPSARHRAHPPQRPASSGGAHTLVNHGYAEPAAGRELPPDMTVVPGDHLLEPEVADGGGAPPQGGCGGGGCDRYEPLPPSLPAAGEQDCCGERVVINISGLRFETQLKTLCQFPETLLGDPKRRMRYFDPLRNEYFFDRNRPSFDAILYYYQSGGRIRRPVNVPIDIFSEEIRFYQLGEEAMEKFREDEGFLREEERPLPRRDFQRQVWLLFEYPESSGPARGIAIVSVLVILISIVIFCLETLPEFRDEKDYPASTSQDSFEAAGNSTSGSRAGASSFSDPFFVVETLCIIWFSFELLVRFFACPSKATFSRNIMNLIDIVAIIPYFITLGTELAERQGNGQQAMSLAILRVIRLVRVFRIFKLSRHSKGLQILGQTLKASMRELGLLIFFLFIGVILFSSAVYFAEADDPTSGFSSIPDAFWWAVVTMTTVGYGDMHPVTIGGKIVGSLCAIAGVLTIALPVPVIVSNFNYFYHRETEGEEQSQYMHVGSCQHLSSSAEELRKARSNSTLSKSEYMVIEEGGMNHSAFPQTPFKTGNSTATCTTNNNPNSCVNIKKIFTDV'),
('Q08345', '4BKJ', 1, 1.7, 'A/B', 313, 'TRANSFERASE', 'TRANSFERASE', 'Epithelial discoidin domain-containing receptor 1', 'DDR1', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncollagen binding<br />\nmetal ion binding<br />\nprotein tyrosine kinase collagen receptor activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\n', 'axon development<br />\nbranching involved in mammary gland duct morphogenesis<br />\ncell adhesion<br />\ncollagen-activated tyrosine kinase receptor signaling pathway<br />\near development<br />\nembryo implantation<br />\nextracellular matrix organization<br />\nlactation<br />\nmammary gland alveolus development<br />\nnegative regulation of cell proliferation<br />\nneuron projection extension<br />\npeptidyl-tyrosine autophosphorylation<br />\nprotein autophosphorylation<br />\nregulation of cell growth<br />\nregulation of cell-matrix adhesion<br />\nregulation of extracellular matrix disassembly<br />\nsmooth muscle cell-matrix adhesion<br />\nsmooth muscle cell migration<br />\nwound healing, spreading of cells<br />\n', 'PF00754.', 'MGPEALSSLLLLLLVASGDADMKGHFDPAKCRYALGMQDRTIPDSDISASSSWSDSTAARHSRLESSDGDGAWCPAGSVFPKEEEYLQVDLQRLHLVALVGTQGRHAGGLGKEFSRSYRLRYSRDGRRWMGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLRVELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTAILIGCLVAIILLLLLIIALMLWRLHWRRLLSKAERRVLEEELTVHLSVPGDTILINNRPGPREPPPYQEPRPRGNPPHSAPCVPNGSALLLSNPAYRLLLATYARPPRGPGPPTPAWAKPTNTQAYSGDYMEPEKPGAPLLPPPPQNSVPHYAEADIVTLQGVTGGNTYAVPALPPGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQGPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTV'),
('Q9GZT9', '4BQY', 1, 1.53, 'A', 246, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Egl nine homolog 1', 'EGLN1', 'Hypoxia-inducible factor-L-proline + 2-oxoglutarate + O2 = hypoxia-inducible factor-trans-4-hydroxy-L-proline + succinate + CO2<br />\n', 'enzyme binding<br />\niron ion binding<br />\nL-ascorbic acid binding<br />\noxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors<br />\npeptidyl-proline 4-dioxygenase activity<br />\npeptidyl-proline dioxygenase activity<br />\n', 'cardiac muscle tissue morphogenesis<br />\ncellular iron ion homeostasis<br />\nheart trabecula formation<br />\nlabyrinthine layer development<br />\nnegative regulation of cAMP catabolic process<br />\nnegative regulation of cyclic-nucleotide phosphodiesterase activity<br />\nnegative regulation of sequence-specific DNA binding transcription factor activity<br />\noxygen homeostasis<br />\npeptidyl-proline hydroxylation to 4-hydroxy-L-proline<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of angiogenesis<br />\nregulation of neuron death<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nresponse to hypoxia<br />\nresponse to nitric oxide<br />\nventricular septum morphogenesis<br />\n', 'PF13640.', 'MANDSGGPGGPSPSERDRQYCELCGKMENLLRCSRCRSSFYCCKEHQRQDWKKHKLVCQGSEGALGHGVGPHQHSGPAPPAAVPPPRAGAREPRKAAARRDNASGDAAKGKVKAKPPADPAAAASPCRAAAGGQGSAVAAEAEPGKEEPPARSSLFQEKANLYPPSNTPGDALSPGGGLRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF'),
('P35916', '4BSJ', 0, 2.5, 'A', 224, 'TRANSFERASE', 'TRANSFERASE', 'Vascular endothelial growth factor receptor 3', 'FLT4', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ngrowth factor binding<br />\nprotein homodimerization activity<br />\nprotein phosphatase binding<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\nvascular endothelial growth factor-activated receptor activity<br />\nVEGF-C-activated receptor activity<br />\n', 'blood vessel morphogenesis<br />\ncellular response to vascular endothelial growth factor stimulus<br />\nlung alveolus development<br />\nlymphangiogenesis<br />\nlymph vessel development<br />\nnegative regulation of apoptotic process<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of cell proliferation<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of JNK cascade<br />\npositive regulation of MAPK cascade<br />\npositive regulation of protein kinase C signaling<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of vascular endothelial growth factor production<br />\nprotein autophosphorylation<br />\nregulation of blood vessel remodeling<br />\nrespiratory system process<br />\nsprouting angiogenesis<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nvascular endothelial growth factor signaling pathway<br />\nvasculature development<br />\n', 'PF07679.', 'MQRGAALCLRLWLCLGLLDGLVSGYSMTPPTLNITEESHVIDTGDSLSISCRGQHPLEWAWPGAQEAPATGDKDSEDTGVVRDCEGTDARPYCKVLLLHEVHANDTGSYVCYYKYIKARIEGTTAASSYVFVRDFEQPFINKPDTLLVNRKDAMWVPCLVSIPGLNVTLRSQSSVLWPDGQEVVWDDRRGMLVSTPLLHDALYLQCETTWGDQDFLSNPFLVHITGNELYDIQLLPRKSLELLVGEKLVLNCTVWAEFNSGVTFDWDYPGKQAERGKWVPERRSQQTHTELSSILTIHNVSQHDLGSYVCKANNGIQRFRESTEVIVHENPFISVEWLKGPILEATAGDELVKLPVKLAAYPPPEFQWYKDGKALSGRHSPHALVLKEVTEASTGTYTLALWNSAAGLRRNISLELVVNVPPQIHEKEASSPSIYSRHSRQALTCTAYGVPLPLSIQWHWRPWTPCKMFAQRSLRRRQQQDLMPQCRDWRAVTTQDAVNPIESLDTWTEFVEGKNKTVSKLVIQNANVSAMYKCVVSNKVGQDERLIYFYVTTIPDGFTIESKPSEELLEGQPVLLSCQADSYKYEHLRWYRLNLSTLHDAHGNPLLLDCKNVHLFATPLAASLEEVAPGARHATLSLSIPRVAPEHEGHYVCEVQDRRSHDKHCHKKYLSVQALEAPRLTQNLTDLLVNVSDSLEMQCLVAGAHAPSIVWYKDERLLEEKSGVDLADSNQKLSIQRVREEDAGRYLCSVCNAKGCVNSSASVAVEGSEDKGSMEIVILVGTGVIAVFFWVLLLLIFCNMRRPAHADIKTGYLSIIMDPGEVPLEEQCEYLSYDASQWEFPRERLHLGRVLGYGAFGKVVEASAFGIHKGSSCDTVAVKMLKEGATASEHRALMSELKILIHIGNHLNVVNLLGACTKPQGPLMVIVEFCKYGNLSNFLRAKRDAFSPCAEKSPEQRGRFRAMVELARLDRRRPGSSDRVLFARFSKTEGGARRASPDQEAEDLWLSPLTMEDLVCYSFQVARGMEFLASRKCIHRDLAARNILLSESDVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLRDGTRMRAPELATPAIRRIMLNCWSGDPKARPAFSELVEILGDLLQGRGLQEEEEVCMAPRSSQSSEEGSFSQVSTMALHIAQADAEDSPPSLQRHSLAARYYNWVSFPGCLARGAETRGSSRMKTFEEFPMTPTTYKGSVDNQTDSGMVLASEEFEQIESRHRQESGFSCKGPGQNVAVTRAHPDSQGRRRRPERGARGGQVFYNSEYGELSEPSEEDHCSPSARVTFFTDNSY'),
('P13674', '4BT9', 0, 1.9, 'A/B', 238, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Prolyl 4-hydroxylase subunit alpha-1', 'P4HA1', 'L-proline-[procollagen] + 2-oxoglutarate + O2 = trans-4-hydroxy-L-proline-[procollagen] + succinate + CO2.<br />\n', 'identical protein binding<br />\niron ion binding<br />\nL-ascorbic acid binding<br />\noxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen<br />\nprocollagen-proline 4-dioxygenase activity<br />\n', 'collagen fibril organization<br />\npeptidyl-proline hydroxylation to 4-hydroxy-L-proline<br />\n', 'PF13640.', 'MIWYILIIGILLPQSLAHPGFFTSIGQMTDLIHTEKDLVTSLKDYIKAEEDKLEQIKKWAEKLDRLTSTATKDPEGFVGHPVNAFKLMKRLNTEWSELENLVLKDMSDGFISNLTIQRQYFPNDEDQVGAAKALLRLQDTYNLDTDTISKGNLPGVKHKSFLTAEDCFELGKVAYTEADYYHTELWMEQALRQLDEGEISTIDKVSVLDYLSYAVYQQGDLDKALLLTKKLLELDPEHQRANGNLKYFEYIMAKEKDVNKSASDDQSDQKTTPKKKGVAVDYLPERQKYEMLCRGEGIKMTPRRQKKLFCRYHDGNRNPKFILAPAKQEDEWDKPRIIRFHDIISDAEIEIVKDLAKPRLRRATISNPITGDLETVHYRISKSAWLSGYENPVVSRINMRIQDLTGLDVSTAEELQVANYGVGGQYEPHFDFARKDEPDAFKELGTGNRIATWLFYMSDVSAGGATVFPEVGASVWPKKGTAVFWYNLFASGEGDYSTRHAACPVLVGNKWVSNKWLHERGQEFRRPCTLSELE'),
('P08519', '4BVC', 1, 1.6, 'A', 79, 'HYDROLASE', 'HYDROLASE', 'Apolipoprotein(a)', 'LPA', '', 'apolipoprotein binding<br />\nendopeptidase inhibitor activity<br />\nfibronectin binding<br />\nheparin binding<br />\nserine-type endopeptidase activity<br />\n', 'blood circulation<br />\nlipid metabolic process<br />\nlipid transport<br />\nlow-density lipoprotein particle remodeling<br />\n', 'PF00051.', 'MEHKEVVLLLLLFLKSAAPEQSHVVQDCYHGDGQSYRGTYSTTVTGRTCQAWSSMTPHQHNRTTENYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDAVAAPYCYTRDPGVRWEYCNLTQCSDAEGTAVAPPTVTPVPSLEAPSEQAPTEQRPGVQECYHGNGQSYRGTYSTTVTGRTCQAWSSMTPHSHSRTPEYYPNAGLIMNYCRNPDPVAAPYCYTRDPSVRWEYCNLTQCSDAEGTAVAPPTITPIPSLEAPSEQAPTEQRPGVQECYHGNGQSYQGTYFITVTGRTCQAWSSMTPHSHSRTPAYYPNAGLIKNYCRNPDPVAAPWCYTTDPSVRWEYCNLTRCSDAEWTAFVPPNVILAPSLEAFFEQALTEETPGVQDCYYHYGQSYRGTYSTTVTGRTCQAWSSMTPHQHSRTPENYPNAGLTRNYCRNPDAEIRPWCYTMDPSVRWEYCNLTQCLVTESSVLATLTVVPDPSTEASSEEAPTEQSPGVQDCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEISPWCYTMDPNVRWEYCNLTQCPVTESSVLATSTAVSEQAPTEQSPTVQDCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEIRPWCYTMDPSVRWEYCNLTQCPVMESTLLTTPTVVPVPSTELPSEEAPTENSTGVQDCYRGDGQSYRGTLSTTITGRTCQSWSSMTPHWHRRIPLYYPNAGLTRNYCRNPDAEIRPWCYTMDPSVRWEYCNLTRCPVTESSVLTTPTVAPVPSTEAPSEQAPPEKSPVVQDCYHGDGRSYRGISSTTVTGRTCQSWSSMIPHWHQRTPENYPNAGLTENYCRNPDSGKQPWCYTTDPCVRWEYCNLTQCSETESGVLETPTVVPVPSMEAHSEAAPTEQTPVVRQCYHGNGQSYRGTFSTTVTGRTCQSWSSMTPHRHQRTPENYPNDGLTMNYCRNPDADTGPWCFTMDPSIRWEYCNLTRCSDTEGTVVAPPTVIQVPSLGPPSEQDCMFGNGKGYRGKKATTVTGTPCQEWAAQEPHRHSTFIPGTNKWAGLEKNYCRNPDGDINGPWCYTMNPRKLFDYCDIPLCASSSFDCGKPQVEPKKCPGSIVGGCVAHPHSWPWQVSLRTRFGKHFCGGTLISPEWVLTAAHCLKKSSRPSSYKVILGAHQEVNLESHVQEIEVSRLFLEPTQADIALLKLSRPAVITDKVMPACLPSPDYMVTARTECYITGWGETQGTFGTGLLKEAQLLVIENEVCNHYKYICAEHLARGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYARVSRFVTWIEGMMRNN'),
('P02689', '4BVM', 1, 0.93, 'A', 132, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Myelin P2 protein', 'PMP2', '', 'cholesterol binding<br />\nfatty acid binding<br />\ntransporter activity<br />\n', 'membrane organization<br />\n', 'PF00061.', 'MSNKFLGTWKLVSSENFDDYMKALGVGLATRKLGNLAKPTVIISKKGDIITIRTESTFKNTEISFKLGQEFEETTADNRKTKSIVTLQRGSLNQVQRWDGKETTIKRKLVNGKMVAECKMKGVVCTRIYEKV'),
('O75936', '4C5W', 1, 1.7, 'A', 387, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Gamma-butyrobetaine dioxygenase', 'BBOX1', '4-trimethylammoniobutanoate + 2-oxoglutarate + O2 = 3-hydroxy-4-trimethylammoniobutanoate + succinate + CO2<br />\n', 'gamma-butyrobetaine dioxygenase activity<br />\nidentical protein binding<br />\niron ion binding<br />\nzinc ion binding<br />\n', 'carnitine biosynthetic process<br />\n', 'PF06155.', 'MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDVNIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSELQLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHTWQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQKLKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIFDVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISRHLEGAYADWDVVMSRLRILRQRVENGN'),
('P27708', '4C6E', 1, 1.26, 'A', 391, 'HYDROLASE', 'HYDROLASE', 'CAD protein', 'CAD', '2 ATP + L-glutamine + HCO3- + H2O = 2 ADP + phosphate + L-glutamate + carbamoyl phosphate<br />\nCarbamoyl phosphate + L-aspartate = phosphate + N-carbamoyl-L-aspartate<br />\n(S)-dihydroorotate + H2O = N-carbamoyl-L-aspartate<br />\n', 'aspartate binding<br />\naspartate carbamoyltransferase activity<br />\nATP binding<br />\ncarbamoyl-phosphate synthase (ammonia) activity<br />\ncarbamoyl-phosphate synthase (glutamine-hydrolyzing) activity<br />\ndihydroorotase activity<br />\nenzyme binding<br />\nidentical protein binding<br />\nprotein kinase activity<br />\nzinc ion binding<br />\n', '''de novo'' pyrimidine nucleobase biosynthetic process<br />\n''de novo'' UMP biosynthetic process<br />\narginine biosynthetic process<br />\ndrug metabolic process<br />\nglutamine metabolic process<br />\npeptidyl-threonine phosphorylation<br />\nprotein autophosphorylation<br />\npyrimidine nucleoside biosynthetic process<br />\nurea cycle<br />\n', 'PF01979.', 'MAALVLEDGSVLRGQPFGAAVSTAGEVVFQTGMVGYPEALTDPSYKAQILVLTYPLIGNYGIPPDEMDEFGLCKWFESSGIHVAALVVGECCPTPSHWSATRTLHEWLQQHGIPGLQGVDTRELTKKLREQGSLLGKLVQNGTEPSSLPFLDPNARPLVPEVSIKTPRVFNTGGAPRILALDCGLKYNQIRCLCQRGAEVTVVPWDHALDSQEYEGLFLSNGPGDPASYPSVVSTLSRVLSEPNPRPVFGICLGHQLLALAIGAKTYKMRYGNRGHNQPCLLVGSGRCFLTSQNHGFAVETDSLPADWAPLFTNANDGSNEGIVHNSLPFFSVQFHPEHQAGPSDMELLFDIFLETVKEATAGNPGGQTVRERLTERLCPPGIPTPGSGLPPPRKVLILGSGGLSIGQAGEFDYSGSQAIKALKEENIQTLLINPNIATVQTSQGLADKVYFLPITPHYVTQVIRNERPDGVLLTFGGQTALNCGVELTKAGVLARYGVRVLGTPVETIELTEDRRAFAARMAEIGEHVAPSEAANSLEQAQAAAERLGYPVLVRAAFALGGLGSGFASNREELSALVAPAFAHTSQVLVDKSLKGWKEIEYEVVRDAYGNCVTVCNMENLDPLGIHTGESIVVAPSQTLNDREYQLLRQTAIKVTQHLGIVGECNVQYALNPESEQYYIIEVNARLSRSSALASKATGYPLAYVAAKLALGIPLPELRNSVTGGTAAFEPSVDYCVVKIPRWDLSKFLRVSTKIGSCMKSVGEVMGIGRSFEEAFQKALRMVDENCVGFDHTVKPVSDMELETPTDKRIFVVAAALWAGYSVDRLYELTRIDRWFLHRMKRIIAHAQLLEQHRGQPLPPDLLQQAKCLGFSDKQIALAVLSTELAVRKLRQELGICPAVKQIDTVAAEWPAQTNYLYLTYWGTTHDLTFRTPHVLVLGSGVYRIGSSVEFDWCAVGCIQQLRKMGYKTIMVNYNPETVSTDYDMCDRLYFDEISFEVVMDIYELENPEGVILSMGGQLPNNMAMALHRQQCRVLGTSPEAIDSAENRFKFSRLLDTIGISQPQWRELSDLESARQFCQTVGYPCVVRPSYVLSGAAMNVAYTDGDLERFLSSAAAVSKEHPVVISKFIQEAKEIDVDAVASDGVVAAIAISEHVENAGVHSGDATLVTPPQDITAKTLERIKAIVHAVGQELQVTGPFNLQLIAKDDQLKVIECNVRVSRSFPFVSKTLGVDLVALATRVIMGEEVEPVGLMTGSGVVGVKVPQFSFSRLAGADVVLGVEMTSTGEVAGFGESRCEAYLKAMLSTGFKIPKKNILLTIGSYKNKSELLPTVRLLESLGYSLYASLGTADFYTEHGVKVTAVDWHFEEAVDGECPPQRSILEQLAEKNFELVINLSMRGAGGRRLSSFVTKGYRTRRLAADFSVPLIIDIKCTKLFVEALGQIGPAPPLKVHVDCMTSQKLVRLPGLIDVHVHLREPGGTHKEDFASGTAAALAGGITMVCAMPNTRPPIIDAPALALAQKLAEAGARCDFALFLGASSENAGTLGTVAGSAAGLKLYLNETFSELRLDSVVQWMEHFETWPSHLPIVAHAEQQTVAAVLMVAQLTQRSVHICHVARKEEILLIKAAKARGLPVTCEVAPHHLFLSHDDLERLGPGKGEVRPELGSRQDVEALWENMAVIDCFASDHAPHTLEEKCGSRPPPGFPGLETMLPLLLTAVSEGRLSLDDLLQRLHHNPRRIFHLPPQEDTYVEVDLEHEWTIPSHMPFSKAHWTPFEGQKVKGTVRRVVLRGEVAYIDGQVLVPPGYGQDVRKWPQGAVPQLPPSAPATSEMTTTPERPRRGIPGLPDGRFHLPPRIHRASDPGLPAEEPKEKSSRKVAEPELMGTPDGTCYPPPPVPRQASPQNLGTPGLLHPQTSPLLHSLVGQHILSVQQFTKDQMSHLFNVAHTLRMMVQKERSLDILKGKVMASMFYEVSTRTSSSFAAAMARLGGAVLSFSEATSSVQKGESLADSVQTMSCYADVVVLRHPQPGAVELAAKHCRRPVINAGDGVGEHPTQALLDIFTIREELGTVNGMTITMVGDLKHGRTVHSLACLLTQYRVSLRYVAPPSLRMPPTVRAFVASRGTKQEEFESIEEALPDTDVLYMTRIQKERFGSTQEYEACFGQFILTPHIMTRAKKKMVVMHPMPRVNEISVEVDSDPRAAYFRQAENGMYIRMALLATVLGRF'),
('Q9NUB1', '4C78', 1, 2, 'C', 10, 'HYDROLASE', 'HYDROLASE', 'Acetyl-coenzyme A synthetase 2-like, mitochondrial', 'ACSS1', 'ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA.<br />\n', 'acetate-CoA ligase activity<br />\nAMP binding<br />\nATP binding<br />\n', 'acetate biosynthetic process<br />\nacetyl-CoA biosynthetic process<br />\nacetyl-CoA biosynthetic process from acetate<br />\nethanol oxidation<br />\npropionate biosynthetic process<br />\n', 'PF16177.', 'MAARTLGRGVGRLLGSLRGLSGQPARPPCGVSAPRRAASGPSGSAPAVAAAAAQPGSYPALSAQAAREPAAFWGPLARDTLVWDTPYHTVWDCDFSTGKIGWFLGGQLNVSVNCLDQHVRKSPESVALIWERDEPGTEVRITYRELLETTCRLANTLKRHGVHRGDRVAIYMPVSPLAVAAMLACARIGAVHTVIFAGFSAESLAGRINDAKCKVVITFNQGLRGGRVVELKKIVDEAVKHCPTVQHVLVAHRTDNKVHMGDLDVPLEQEMAKEDPVCAPESMGSEDMLFMLYTSGSTGMPKGIVHTQAGYLLYAALTHKLVFDHQPGDIFGCVADIGWITGHSYVVYGPLCNGATSVLFESTPVYPNAGRYWETVERLKINQFYGAPTAVRLLLKYGDAWVKKYDRSSLRTLGSVGEPINCEAWEWLHRVVGDSRCTLVDTWWQTETGGICIAPRPSEEGAEILPAMAMRPFFGIVPVLMDEKGSVVEGSNVSGALCISQAWPGMARTIYGDHQRFVDAYFKAYPGYYFTGDGAYRTEGGYYQITGRMDDVINISGHRLGTAEIEDAIADHPAVPESAVIGYPHDIKGEAAFAFIVVKDSAGDSDVVVQELKSMVATKIAKYAVPDEILVVKRLPKTRSGKVMRRLLRKIITSEAQELGDTTTLEDPSIIAEILSVYQKCKDKQAAAK'),
('Q99707', '4CCZ', 1, 2.7, 'A', 642, 'TRANSFERASE', 'TRANSFERASE', 'Methionine synthase', 'MTR', '5-methyltetrahydrofolate + L-homocysteine = tetrahydrofolate + L-methionine.<br />\n', 'cobalamin binding<br />\nmethionine synthase activity<br />\nzinc ion binding<br />\n', 'axon regeneration<br />\ncellular response to nitric oxide<br />\ncobalamin metabolic process<br />\nmethionine biosynthetic process<br />\nmethylation<br />\nnervous system development<br />\npteridine-containing compound metabolic process<br />\nresponse to axon injury<br />\nsulfur amino acid metabolic process<br />\n', 'PF02310.', 'MSPALQDLSQPEGLKKTLRDEINAILQKRIMVLDGGMGTMIQREKLNEEHFRGQEFKDHARPLKGNNDILSITQPDVIYQIHKEYLLAGADIIETNTFSSTSIAQADYGLEHLAYRMNMCSAGVARKAAEEVTLQTGIKRFVAGALGPTNKTLSVSPSVERPDYRNITFDELVEAYQEQAKGLLDGGVDILLIETIFDTANAKAALFALQNLFEEKYAPRPIFISGTIVDKSGRTLSGQTGEGFVISVSHGEPLCIGLNCALGAAEMRPFIEIIGKCTTAYVLCYPNAGLPNTFGDYDETPSMMAKHLKDFAMDGLVNIVGGCCGSTPDHIREIAEAVKNCKPRVPPATAFEGHMLLSGLEPFRIGPYTNFVNIGERCNVAGSRKFAKLIMAGNYEEALCVAKVQVEMGAQVLDVNMDDGMLDGPSAMTRFCNLIASEPDIAKVPLCIDSSNFAVIEAGLKCCQGKCIVNSISLKEGEDDFLEKARKIKKYGAAMVVMAFDEEGQATETDTKIRVCTRAYHLLVKKLGFNPNDIIFDPNILTIGTGMEEHNLYAINFIHATKVIKETLPGARISGGLSNLSFSFRGMEAIREAMHGVFLYHAIKSGMDMGIVNAGNLPVYDDIHKELLQLCEDLIWNKDPEATEKLLRYAQTQGTGGKKVIQTDEWRNGPVEERLEYALVKGIEKHIIEDTEEARLNQKKYPRPLNIIEGPLMNGMKIVGDLFGAGKMFLPQVIKSARVMKKAVGHLIPFMEKEREETRVLNGTVEEEDPYQGTIVLATVKGDVHDIGKNIVGVVLGCNNFRVIDLGVMTPCDKILKAALDHKADIIGLSGLITPSLDEMIFVAKEMERLAIRIPLLIGGATTSKTHTAVKIAPRYSAPVIHVLDASKSVVVCSQLLDENLKDEYFEEIMEEYEDIRQDHYESLKERRYLPLSQARKSGFQMDWLSEPHPVKPTFIGTQVFEDYDLQKLVDYIDWKPFFDVWQLRGKYPNRGFPKIFNDKTVGGEARKVYDDAHNMLNTLISQKKLRARGVVGFWPAQSIQDDIHLYAEAAVPQAAEPIATFYGLRQQAEKDSASTEPYYCLSDFIAPLHSGIRDYLGLFAVACFGVEELSKAYEDDGDDYSSIMVKALGDRLAEAFAEELHERVRRELWAYCGSEQLDVADLRRLRYKGIRPAPGYPSQPDHTEKLTMWRLADIEQSTGIRLTESLAMAPASAVSGLYFSNLKSKYFAVGKISKDQVEDYALRKNISVAEVEKWLGPILGYDTD'),
('P28472', '4COF', 1, 2.97, 'A/B/C/D/E', 307, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Gamma-aminobutyric acid receptor subunit beta-3', 'GABRB3', '', 'GABA-A receptor activity<br />\nGABA-gated chloride ion channel activity<br />\nidentical protein binding<br />\n', 'cellular response to histamine<br />\nchloride transmembrane transport<br />\ncochlea development<br />\ngamma-aminobutyric acid signaling pathway<br />\ninhibitory postsynaptic potential<br />\ninner ear receptor cell development<br />\ninnervation<br />\nion transmembrane transport<br />\nnegative regulation of neuron apoptotic process<br />\npalate development<br />\nsensory perception of sound<br />\nsignal transduction<br />\ntransport<br />\n', 'PF02931.', 'MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDIRLRPDFGGPPVCVGMNIDIASIDMVSEVNMDYTLTMYFQQYWRDKRLAYSGIPLNLTLDNRVADQLWVPDTYFLNDKKSFVHGVTVKNRMIRLHPDGTVLYGLRITTTAACMMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGGDKAVTGVERIELPQFSIVEHRLVSRNVVFATGAYPRLSLSFRLKRNIGYFILQTYMPSILITILSWVSFWINYDASAARVALGITTVLTMTTINTHLRETLPKIPYVKAIDMYLMGCFVFVFLALLEYAFVNYIFFGRGPQRQKKLAEKTAKAKNDRSKSESNRVDAHGNILLTSLEVHNEMNEVSGGIGDTRNSAISFDNSGIQYRKQSMPREGHGRFLGDRSLPHKKTHLRRRSSQLKIKIPDLTDVNAIDRWSRIVFPFTFSLFNLVYWLYYVN'),
('Q08210', '4CQ8', 1, 1.98, 'A/B', 412, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydroorotate dehydrogenase (quinone), mitochondrial', 'PFF0160c', '(S)-dihydroorotate + a quinone = orotate + a quinol.<br />\n', 'dihydroorotate dehydrogenase activity<br />\n', '''de novo'' pyrimidine nucleobase biosynthetic process<br />\n''de novo'' UMP biosynthetic process<br />\nresponse to drug<br />\n', 'PF01180.', 'MISKLKPQFMFLPKKHILSYCRKDVLNLFEQKFYYTSKRKESNNMKNESLLRLINYNRYYNKIDSNNYYNGGKILSNDRQYIYSPLCEYKKKINDISSYVSVPFKINIRNLGTSNFVNNKKDVLDNDYIYENIKKEKSKHKKIIFLLFVSLFGLYGFFESYNPEFFLYDIFLKFCLKYIDGEICHDLFLLLGKYNILPYDTSNDSIYACTNIKHLDFINPFGVAAGFDKNGVCIDSILKLGFSFIEIGTITPRGQTGNAKPRIFRDVESRSIINSCGFNNMGCDKVTENLILFRKRQEEDKLLSKHIVGVSIGKNKDTVNIVDDLKYCINKIGRYADYIAINVSSPNTPGLRDNQEAGKLKNIILSVKEEIDNLEKNNIMNDESTYNEDNKIVEKKNNFNKNNSHMMKDAKDNFLWFNTTKKKPLVFVKLAPDLNQEQKKEIADVLLETNIDGMIISNTTTQINDIKSFENKKGGVSGAKLKDISTKFICEMYNYTNKQIPIIASGGIFSGLDALEKIEAGASVCQLYSCLVFNGMKSAVQIKRELNHLLYQRGYYNLKEAIGRKHSKS'),
('P29474', '4D1P', 1, 1.73, 'A/B', 440, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Nitric oxide synthase, endothelial', 'NOS3', '2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O.<br />\n', 'actin monomer binding<br />\narginine binding<br />\ncadmium ion binding<br />\ncalmodulin binding<br />\nflavin adenine dinucleotide binding<br />\nFMN binding<br />\nheme binding<br />\niron ion binding<br />\nNADP binding<br />\nNADPH-hemoprotein reductase activity<br />\nnitric-oxide synthase activity<br />\nscaffold protein binding<br />\ntetrahydrobiopterin binding<br />\n', 'angiogenesis<br />\narginine catabolic process<br />\nblood vessel remodeling<br />\ncell redox homeostasis<br />\nendothelial cell migration<br />\nin utero embryonic development<br />\nlipopolysaccharide-mediated signaling pathway<br />\nlung development<br />\nmitochondrion organization<br />\nnegative regulation of blood pressure<br />\nnegative regulation of calcium ion transport<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of extrinsic apoptotic signaling pathway via death domain receptors<br />\nnegative regulation of hydrolase activity<br />\nnegative regulation of muscle hyperplasia<br />\nnegative regulation of platelet activation<br />\nnegative regulation of potassium ion transport<br />\nnitric oxide biosynthetic process<br />\nnitric oxide mediated signal transduction<br />\novulation from ovarian follicle<br />\npositive regulation of angiogenesis<br />\npositive regulation of blood vessel diameter<br />\npositive regulation of guanylate cyclase activity<br />\nregulation of blood pressure<br />\nregulation of blood vessel size<br />\nregulation of nitric-oxide synthase activity<br />\nregulation of sodium ion transport<br />\nregulation of systemic arterial blood pressure by endothelin<br />\nregulation of the force of heart contraction by chemical signal<br />\nremoval of superoxide radicals<br />\nresponse to fluid shear stress<br />\nresponse to heat<br />\nsmooth muscle hyperplasia<br />\nvasodilation<br />\n', 'PF00667.', 'MGNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPWKGSAAKGTGITRKKTFKEVANAVKISASLMGTVMAKRVKATILYGSETGRAQSYAQQLGRLFRKAFDPRVLCMDEYDVVSLEHETLVLVVTSTFGNGDPPENGESFAAALMEMSGPYNSSPRPEQHKSYKIRFNSISCSDPLVSSWRRKRKESSNTDSAGALGTLRFCVFGLGSRAYPHFCAFARAVDTRLEELGGERLLQLGQGDELCGQEEAFRGWAQAAFQAACETFCVGEDAKAAARDIFSPKRSWKRQRYRLSAQAEGLQLLPGLIHVHRRKMFQATIRSVENLQSSKSTRATILVRLDTGGQEGLQYQPGDHIGVCPPNRPGLVEALLSRVEDPPAPTEPVAVEQLEKGSPGGPPPGWVRDPRLPPCTLRQALTFFLDITSPPSPQLLRLLSTLAEEPREQQELEALSQDPRRYEEWKWFRCPTLLEVLEQFPSVALPAPLLLTQLPLLQPRYYSVSSAPSTHPGEIHLTVAVLAYRTQDGLGPLHYGVCSTWLSQLKPGDPVPCFIRGAPSFRLPPDPSLPCILVGPGTGIAPFRGFWQERLHDIESKGLQPTPMTLVFGCRCSQLDHLYRDEVQNAQQRGVFGRVLTAFSREPDNPKTYVQDILRTELAAEVHRVLCLERGHMFVCGDVTMATNVLQTVQRILATEGDMELDEAGDVIGVLRDQQRYHEDIFGLTLRTQEVTSRIRTQSFSLQERQLRGAVPWAFDPPGSDTNSP'),
('P08684', '4D6Z', 1, 1.93, 'A', 481, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome P450 3A4', 'CYP3A4', 'Quinine + NADPH + O2 = 3-hydroxyquinine + NADP+ + H2O<br />\nTaurochenodeoxycholate + NADPH + O2 = taurohyocholate + NADP+ + H2O<br />\nLithocholate + NADPH + O2 = hyodeoxycholate + NADP+ + H2O<br />\nAlbendazole + NADPH + O2 = albendazole S-oxide + NADP+ + H2O<br />\n1,8-cineole + NADPH + O2 = 2-exo-hydroxy-1,8-cineole + NADP+ + H2O<br />\nRH + [reduced NADPH--hemoprotein reductase] + O2 = ROH + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n', '1,8-cineole 2-exo-monooxygenase activity<br />\nalbendazole monooxygenase activity<br />\naromatase activity<br />\ncaffeine oxidase activity<br />\nenzyme binding<br />\nestrogen 16-alpha-hydroxylase activity<br />\nheme binding<br />\niron ion binding<br />\nmonooxygenase activity<br />\noxidoreductase activity<br />\noxygen binding<br />\nquinine 3-monooxygenase activity<br />\nsteroid binding<br />\nsteroid hydroxylase activity<br />\ntaurochenodeoxycholate 6alpha-hydroxylase activity<br />\ntestosterone 6-beta-hydroxylase activity<br />\nvitamin D 24-hydroxylase activity<br />\nvitamin D3 25-hydroxylase activity<br />\n', 'alkaloid catabolic process<br />\nandrogen metabolic process<br />\ndrug catabolic process<br />\ndrug metabolic process<br />\nexogenous drug catabolic process<br />\nheterocycle metabolic process<br />\nlipid hydroxylation<br />\nlipid metabolic process<br />\nmonoterpenoid metabolic process<br />\noxidation-reduction process<br />\noxidative demethylation<br />\nsteroid catabolic process<br />\nsteroid metabolic process<br />\nvitamin D metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF00067.', 'MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGA'),
('Q6TGC4', '4DAT', 0, 1.4, 'B', 9, 'SIGNALING PROTEIN / PROTEIN BINDING', 'SIGNALING_PROT', 'Protein-arginine deiminase type-6', 'PADI6', 'Protein L-arginine + H2O = protein L-citrulline + NH3.<br />\n', 'calcium ion binding<br />\nprotein-arginine deiminase activity<br />\n', 'cytoplasm organization<br />\ncytoskeleton organization<br />\nhistone citrullination<br />\nregulation of translation by machinery localization<br />\n', 'PF03068.', 'MVSVEGRAMSFQSIIHLSLDSPVHAVCVLGTEICLDLSGCAPQKCQCFTIHGSGRVLIDVANTVISEKEDATIWWPLSDPTYATVKMTSPSPSVDADKVSVTYYGPNEDAPVGTAVLYLTGIEVSLEVDIYRNGQVEMSSDKQAKKKWIWGPSGWGAILLVNCNPADVGQQLEDKKTKKVIFSEEITNLSQMTLNVQGPSCILKKYRLVLHTSKEESKKARVYWPQKDNSSTFELVLGPDQHAYTLALLGNHLKETFYVEAIAFPSAEFSGLISYSVSLVEESQDPSIPETVLYKDTVVFRVAPCVFIPCTQVPLEVYLCRELQLQGFVDTVTKLSEKSNSQVASVYEDPNRLGRWLQDEMAFCYTQAPHKTTSLILDTPQAADLDEFPMKYSLSPGIGYMIQDTEDHKVASMDSIGNLMVSPPVKVQGKEYPLGRVLIGSSFYPSAEGRAMSKTLRDFLYAQQVQAPVELYSDWLMTGHVDEFMCFIPTDDKNEGKKGFLLLLASPSACYKLFREKQKEGYGDALLFDELRADQLLSNGREAKTIDQLLADESLKKQNEYVEKCIHLNRDILKTELGLVEQDIIEIPQLFCLEKLTNIPSDQQPKRSFARPYFPDLLRMIVMGKNLGIPKPFGPQIKGTCCLEEKICCLLEPLGFKCTFINDFDCYLTEVGDICACANIRRVPFAFKWWKMVP'),
('P41145', '4DJH', 1, 2.9, 'A/B', 316, 'Hormone receptor / antagonist', 'HORMONE', 'Kappa-type opioid receptor', 'OPRK1', '', 'dynorphin receptor activity<br />\nneuropeptide binding<br />\nopioid receptor activity<br />\n', 'adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway<br />\nadenylate cyclase-inhibiting opioid receptor signaling pathway<br />\nbehavior<br />\nbehavioral response to cocaine<br />\ncellular response to lipopolysaccharide<br />\nchemical synaptic transmission<br />\nconditioned place preference<br />\ndefense response to virus<br />\neating behavior<br />\nestrous cycle<br />\nimmune response<br />\nlocomotory behavior<br />\nmaternal behavior<br />\nnegative regulation of luteinizing hormone secretion<br />\nneuropeptide signaling pathway<br />\nopioid receptor signaling pathway<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\npositive regulation of dopamine secretion<br />\npositive regulation of locomotion<br />\npositive regulation of p38MAPK cascade<br />\npositive regulation of potassium ion transmembrane transport<br />\nregulation of aerobic respiration<br />\nregulation of energy homeostasis<br />\nregulation of saliva secretion<br />\nregulation of sensory perception of pain<br />\nresponse to acrylamide<br />\nresponse to estrogen<br />\nresponse to ethanol<br />\nresponse to insulin<br />\nresponse to morphine<br />\nresponse to radiation<br />\nsensory perception<br />\nsensory perception of pain<br />\nsensory perception of temperature stimulus<br />\n', 'PF00001.', 'MDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLEPAHISPAIPVIITAVYSVVFVVGLVGNSLVMFVIIRYTKMKTATNIYIFNLALADALVTTTMPFQSTVYLMNSWPFGDVLCKIVISIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPLKAKIINICIWLLSSSVGISAIVLGGTKVREDVDVIECSLQFPDDDYSWWDLFMKICVFIFAFVIPVLIIIVCYTLMILRLKSVRLLSGSREKDRNLRRITRLVLVVVAVFVVCWTPIHIFILVEALGSTSHSTAALSSYYFCIALGYTNSSLNPILYAFLDENFKRCFRDFCFPLKMRMERQSTSRVRNTVQDPAYLRDIDGMNKPV'),
('Q7LG56', '4DJN', 0, 2.2, 'A/B', 310, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Ribonucleoside-diphosphate reductase subunit M2 B', 'RRM2B', '2''-deoxyribonucleoside diphosphate + thioredoxin disulfide + H2O = ribonucleoside diphosphate + thioredoxin<br />\n', 'metal ion binding<br />\nribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor<br />\n', 'deoxyribonucleoside triphosphate metabolic process<br />\ndeoxyribonucleotide biosynthetic process<br />\nDNA repair<br />\nkidney development<br />\nmitochondrial DNA replication<br />\nnegative regulation of intrinsic apoptotic signaling pathway by p53 class mediator<br />\nnucleobase-containing small molecule interconversion<br />\nrenal system process<br />\nresponse to amine<br />\nresponse to oxidative stress<br />\n', 'PF00268.', 'MGDPERPEAAGLDQDERSSSDTNESEIKSNEEPLLRKSSRRFVIFPIQYPDIWKMYKQAQASFWTAEEVDLSKDLPHWNKLKADEKYFISHILAFFAASDGIVNENLVERFSQEVQVPEARCFYGFQILIENVHSEMYSLLIDTYIRDPKKREFLFNAIETMPYVKKKADWALRWIADRKSTFGERVVAFAAVEGVFFSGSFAAIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFQYLVNKPSEERVREIIVDAVKIEQEFLTEALPVGLIGMNCILMKQYIEFVADRLLVELGFSKVFQAENPFDFMENISLEGKTNFFEKRVSEYQRFAVMAETTDNVFTLDADF');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P05164', '4DL1', 1, 2, 'A/B/E/F/I/J/M/N', 104, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Myeloperoxidase', 'MPO', 'Cl- + H2O2 + H+ = HClO + H2O<br />\n', 'chromatin binding<br />\nheme binding<br />\nheparin binding<br />\nmetal ion binding<br />\nperoxidase activity<br />\n', 'aging<br />\ndefense response<br />\ndefense response to bacterium<br />\ndefense response to fungus<br />\nhydrogen peroxide catabolic process<br />\nhypochlorous acid biosynthetic process<br />\nlow-density lipoprotein particle remodeling<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of growth of symbiont in host<br />\nneutrophil degranulation<br />\noxidation-reduction process<br />\nremoval of superoxide radicals<br />\nrespiratory burst involved in defense response<br />\nresponse to food<br />\nresponse to gold nanoparticle<br />\nresponse to lipopolysaccharide<br />\nresponse to mechanical stimulus<br />\nresponse to oxidative stress<br />\nresponse to yeast<br />\n', 'PF03098.', 'MGVPFFSSLRCMVDLGPCWAGGLTAEMKLLLALAGLLAILATPQPSEGAAPAVLGEVDTSLVLSSMEEAKQLVDKAYKERRESIKQRLRSGSASPMELLSYFKQPVAATRTAVRAADYLHVALDLLERKLRSLWRRPFNVTDVLTPAQLNVLSKSSGCAYQDVGVTCPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAARASFVTGVNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREAS'),
('P10826', '4DM6', 1, 1.9, 'A/B', 246, 'TRANSCRIPTION / protein binding', 'TRANSCRIPTION', 'Retinoic acid receptor beta', 'RARB', '', 'DNA binding<br />\ndrug binding<br />\nprotein complex binding<br />\nretinoic acid receptor activity<br />\nretinoid X receptor binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\nzinc ion binding<br />\n', 'embryonic digestive tract development<br />\nembryonic eye morphogenesis<br />\nembryonic hindlimb morphogenesis<br />\nglandular epithelial cell development<br />\ngrowth plate cartilage development<br />\nmulticellular organism growth<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of chondrocyte differentiation<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\noutflow tract septum morphogenesis<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell proliferation<br />\npositive regulation of neuron differentiation<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of myelination<br />\nretinal pigment epithelium development<br />\nsignal transduction<br />\nstriatum development<br />\ntranscription initiation from RNA polymerase II promoter<br />\nureteric bud development<br />\nventricular cardiac muscle cell differentiation<br />\n', 'PF00104.', 'MTTSGHACPVPAVNGHMTHYPATPYPLLFPPVIGGLSLPPLHGLHGHPPPSGCSTPSPATIETQSTSSEELVPSPPSPLPPPRVYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMIYTCHRDKNCVINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKETSKQECTESYEMTAELDDLTEKIRKAHQETFPSLCQLGKYTTNSSADHRVRLDLGLWDKFSELATKCIIKIVEFAKRLPGFTGLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFTFANQLLPLEMDDTETGLLSAICLICGDRQDLEEPTKVDKLQEPLLEALKIYIRKRRPSKPHMFPKILMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLENSEGHEPLTPSSSGNTAEHSPSISPSSVENSGVSQSPLVQ'),
('P42345', '4DRI', 1, 1.45, 'B', 90, 'Isomerase / Transferase', 'TRANSFERASE', 'Serine/threonine-protein kinase mTOR', 'MTOR', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nkinase activity<br />\nphosphoprotein binding<br />\nprotein domain specific binding<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\nprotein serine/threonine kinase activity<br />\nribosome binding<br />\nRNA polymerase III type 1 promoter DNA binding<br />\nRNA polymerase III type 2 promoter DNA binding<br />\nRNA polymerase III type 3 promoter DNA binding<br />\nTFIIIC-class transcription factor binding<br />\n', '''de novo'' pyrimidine nucleobase biosynthetic process<br />\nanoikis<br />\nbrain development<br />\ncardiac muscle cell development<br />\ncardiac muscle contraction<br />\ncell aging<br />\ncell cycle arrest<br />\ncell growth<br />\ncellular response to amino acid starvation<br />\ncellular response to amino acid stimulus<br />\ncellular response to hypoxia<br />\ncellular response to leucine<br />\ncellular response to leucine starvation<br />\ncellular response to nutrient levels<br />\ncellular response to starvation<br />\nDNA repair<br />\nenergy reserve metabolic process<br />\ngerm cell development<br />\ngrowth<br />\nheart morphogenesis<br />\nheart valve morphogenesis<br />\ninterleukin-7-mediated signaling pathway<br />\nlong-term memory<br />\nmaternal process involved in female pregnancy<br />\nmRNA stabilization<br />\nmulticellular organism growth<br />\nnegative regulation of autophagy<br />\nnegative regulation of cell size<br />\nnegative regulation of cholangiocyte apoptotic process<br />\nnegative regulation of iodide transmembrane transport<br />\nnegative regulation of macroautophagy<br />\nnegative regulation of muscle atrophy<br />\nnegative regulation of NFAT protein import into nucleus<br />\nnegative regulation of protein phosphorylation<br />\nnegative regulation of protein ubiquitination<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\nphosphorylation<br />\npositive regulation of actin filament polymerization<br />\npositive regulation of cell growth involved in cardiac muscle cell development<br />\npositive regulation of cholangiocyte proliferation<br />\npositive regulation of dendritic spine development<br />\npositive regulation of eating behavior<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of epithelial to mesenchymal transition<br />\npositive regulation of gene expression<br />\npositive regulation of glial cell proliferation<br />\npositive regulation of granulosa cell proliferation<br />\npositive regulation of keratinocyte migration<br />\npositive regulation of lamellipodium assembly<br />\npositive regulation of lipid biosynthetic process<br />\npositive regulation of myotube differentiation<br />\npositive regulation of neuron death<br />\npositive regulation of neuron maturation<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of oligodendrocyte differentiation<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of sensory perception of pain<br />\npositive regulation of skeletal muscle hypertrophy<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of stress fiber assembly<br />\npositive regulation of transcription from RNA polymerase III promoter<br />\npositive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter<br />\npositive regulation of translation<br />\npositive regulation of wound healing, spreading of epidermal cells<br />\npost-embryonic development<br />\nprotein autophosphorylation<br />\nprotein catabolic process<br />\nprotein phosphorylation<br />\nregulation of actin cytoskeleton organization<br />\nregulation of brown fat cell differentiation<br />\nregulation of carbohydrate utilization<br />\nregulation of cell size<br />\nregulation of cellular response to heat<br />\nregulation of fatty acid beta-oxidation<br />\nregulation of glycogen biosynthetic process<br />\nregulation of GTPase activity<br />\nregulation of macroautophagy<br />\nregulation of membrane permeability<br />\nregulation of myelination<br />\nregulation of osteoclast differentiation<br />\nregulation of protein kinase activity<br />\nregulation of response to food<br />\nresponse to amino acid<br />\nresponse to cocaine<br />\nresponse to insulin<br />\nresponse to morphine<br />\nresponse to nutrient<br />\nresponse to stress<br />\nruffle organization<br />\nsignal transduction<br />\nsocial behavior<br />\nspinal cord development<br />\nT cell costimulation<br />\nTORC1 signaling<br />\nTOR signaling<br />\nvisual learning<br />\nvoluntary musculoskeletal movement<br />\nwound healing<br />\n', 'PF11865.', 'MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW'),
('P0AES6', '4DUH', 1, 1.5, 'A/B', 220, 'ISOMERASE / ISOMERASE INHIBITOR', 'ISOMERASE', 'DNA gyrase subunit B', 'gyrB', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA-dependent ATPase activity<br />\nDNA supercoiling activity<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\nmetal ion binding<br />\n', 'chromosome segregation<br />\nDNA topological change<br />\nresponse to antibiotic<br />\nresponse to drug<br />\ntranscription, DNA-templated<br />\n', 'PF00204.', 'MSNSYDSSSIKVLKGLDAVRKRPGMYIGDTDDGTGLHHMVFEVVDNAIDEALAGHCKEIIVTIHADNSVSVQDDGRGIPTGIHPEEGVSAAEVIMTVLHAGGKFDDNSYKVSGGLHGVGVSVVNALSQKLELVIQREGKIHRQIYEHGVPQAPLAVTGETEKTGTMVRFWPSLETFTNVTEFEYEILAKRLRELSFLNSGVSIRLRDKRDGKEDHFHYEGGIKAFVEYLNKNKTPIHPNIFYFSTEKDGIGVEVALQWNDGFQENIYCFTNNIPQRDGGTHLAGFRAAMTRTLNAYMDKEGYSKKAKVSATGDDAREGLIAVVSVKVPDPKFSSQTKDKLVSSEVKSAVEQQMNELLAEYLLENPTDAKIVVGKIIDAARAREAARRAREMTRRKGALDLAGLPGKLADCQERDPALSELYLVEGDSAGGSAKQGRNRKNQAILPLKGKILNVEKARFDKMLSSQEVATLITALGCGIGRDEYNPDKLRYHSIIIMTDADVDGSHIRTLLLTFFYRQMPEIVERGHVYIAQPPLYKVKKGKQEQYIKDDEAMDQYQISIALDGATLHTNASAPALAGEALEKLVSEYNATQKMINRMERRYPKAMLKELIYQPTLTEADLSDEQTVTRWVNALVSELNDKEQHGSQWKFDVHTNAEQNLFEPIVRVRTHGVDTDYPLDHEFITGGEYRRICTLGEKLRGLLEEDAFIERGERRQPVASFEQALDWLVKESRRGLSIQRYKGLGEMNPEQLWETTMDPESRRMLRVTVKDAIAADQLFTTLMGDAVEPRRAFIEENALKAANIDI'),
('P29034', '4DUQ', 0, 1.3, 'A/B', 98, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Protein S100-A2', 'S100A2', '', 'calcium ion binding<br />\nidentical protein binding<br />\ntransition metal ion binding<br />\n', 'endothelial cell migration<br />\n', 'PF01023.', 'MMCSSLEQALAVLVTTFHKYSCQEGDKFKLSKGEMKELLHKELPSFVGEKVDEEGLKKLMGSLDENSDQQVDFQEYAVFLALITVMCNDFFQGCPDRP'),
('P19099', '4DVQ', 1, 2.49, 'A/B/C/D/E/F/G/H/I/J/K/L', 470, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome P450 11B2, mitochondrial', 'CYP11B2', 'A steroid + 2 reduced adrenodoxin + O2 + 2 H+ = an 11-beta- hydroxysteroid + 2 oxidized adrenodoxin + H2O<br />\nCorticosterone + 2 reduced adrenodoxin + O2 + 2 H+ = 18-hydroxycorticosterone + 2 oxidized adrenodoxin + H2O<br />\n', 'corticosterone 18-monooxygenase activity<br />\nheme binding<br />\niron ion binding<br />\nsteroid 11-beta-monooxygenase activity<br />\nsteroid hydroxylase activity<br />\n', 'aldosterone biosynthetic process<br />\nC21-steroid hormone biosynthetic process<br />\ncellular response to hormone stimulus<br />\ncellular response to potassium ion<br />\ncortisol biosynthetic process<br />\nmineralocorticoid biosynthetic process<br />\npotassium ion homeostasis<br />\nregulation of blood volume by renal aldosterone<br />\nrenal water homeostasis<br />\nsodium ion homeostasis<br />\nsterol metabolic process<br />\n', 'PF00067.', 'MALRAKAEVCVAAPWLSLQRARALGTRAARAPRTVLPFEAMPQHPGNRWLRLLQIWREQGYEHLHLEMHQTFQELGPIFRYNLGGPRMVCVMLPEDVEKLQQVDSLHPCRMILEPWVAYRQHRGHKCGVFLLNGPEWRFNRLRLNPDVLSPKAVQRFLPMVDAVARDFSQALKKKVLQNARGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFMPRSLSRWISPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFNRPQHYTGIVAELLLKAELSLEAIKANSMELTAGSVDTTAFPLLMTLFELARNPDVQQILRQESLAAAASISEHPQKATTELPLLRAALKETLRLYPVGLFLERVVSSDLVLQNYHIPAGTLVQVFLYSLGRNAALFPRPERYNPQRWLDIRGSGRNFHHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHFLVETLTQEDIKMVYSFILRPGTSPLLTFRAIN'),
('P19113', '4E1O', 1, 1.8, 'A/B/C/D/E/F', 476, 'LYASE', 'LYASE', 'Histidine decarboxylase', 'HDC', 'L-histidine = histamine + CO2<br />\n', 'histidine decarboxylase activity<br />\npyridoxal phosphate binding<br />\n', 'catecholamine biosynthetic process<br />\nhistamine biosynthetic process<br />\nhistidine catabolic process<br />\nhistidine metabolic process<br />\n', 'PF00282.', 'MMEPEEYRERGREMVDYICQYLSTVRERRVTPDVQPGYLRAQLPESAPEDPDSWDSIFGDIERIIMPGVVHWQSPHMHAYYPALTSWPSLLGDMLADAINCLGFTWASSPACTELEMNVMDWLAKMLGLPEHFLHHHPSSQGGGVLQSTVSESTLIALLAARKNKILEMKTSEPDADESCLNARLVAYASDQAHSSVEKAGLISLVKMKFLPVDDNFSLRGEALQKAIEEDKQRGLVPVFVCATLGTTGVCAFDCLSELGPICAREGLWLHIDAAYAGTAFLCPEFRGFLKGIEYADSFTFNPSKWMMVHFDCTGFWVKDKYKLQQTFSVNPIYLRHANSGVATDFMHWQIPLSRRFRSVKLWFVIRSFGVKNLQAHVRHGTEMAKYFESLVRNDPSFEIPAKRHLGLVVFRLKGPNCLTENVLKEIAKAGRLFLIPATIQDKLIIRFTVTSQFTTRDDILRDWNLIRDAATLILSQHCTSQPSPRVGNLISQIRGARAWACGTSLQSVSGAGDDPVQARKIIKQPQRVGAGPMKRENGLHLETLLDPVDDCFSEEAPDATKHKLSSFLFSYLSVQTKKKTVRSLSCNSVPVSAQKPLPTEASVKNGGSSRVRIFSRFPEDMMMLKKSAFKKLIKFYSVPSFPECSSQCGLQLPCCPLQAMV'),
('P23458', '4E5W', 1, 1.86, 'A/B', 301, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Tyrosine-protein kinase JAK1', 'JAK1', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nCCR5 chemokine receptor binding<br />\ngrowth hormone receptor binding<br />\nmetal ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nprotein phosphatase binding<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor binding<br />\nubiquitin protein ligase binding<br />\n', 'cell differentiation<br />\ncell migration<br />\ninnate immune response<br />\ninterferon-gamma-mediated signaling pathway<br />\ninterleukin-12-mediated signaling pathway<br />\ninterleukin-2-mediated signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nintracellular signal transduction<br />\nMAPK cascade<br />\npeptidyl-tyrosine autophosphorylation<br />\npositive regulation of sprouting angiogenesis<br />\nprotein phosphorylation<br />\nregulation of cell proliferation<br />\nregulation of interferon-gamma-mediated signaling pathway<br />\nregulation of type I interferon-mediated signaling pathway<br />\nresponse to antibiotic<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\ntype I interferon signaling pathway<br />\n', 'PF07714.', 'MQYLNIKEDCNAMAFCAKMRSSKKTEVNLEAPEPGVEVIFYLSDREPLRLGSGEYTAEELCIRAAQACRISPLCHNLFALYDENTKLWYAPNRTITVDDKMSLRLHYRMRFYFTNWHGTNDNEQSVWRHSPKKQKNGYEKKKIPDATPLLDASSLEYLFAQGQYDLVKCLAPIRDPKTEQDGHDIENECLGMAVLAISHYAMMKKMQLPELPKDISYKRYIPETLNKSIRQRNLLTRMRINNVFKDFLKEFNNKTICDSSVSTHDLKVKYLATLETLTKHYGAEIFETSMLLISSENEMNWFHSNDGGNVLYYEVMVTGNLGIQWRHKPNVVSVEKEKNKLKRKKLENKHKKDEEKNKIREEWNNFSYFPEITHIVIKESVVSINKQDNKKMELKLSSHEEALSFVSLVDGYFRLTADAHHYLCTDVAPPLIVHNIQNGCHGPICTEYAINKLRQEGSEEGMYVLRWSCTDFDNILMTVTCFEKSEQVQGAQKQFKNFQIEVQKGRYSLHGSDRSFPSLGDLMSHLKKQILRTDNISFMLKRCCQPKPREISNLLVATKKAQEWQPVYPMSQLSFDRILKKDLVQGEHLGRGTRTHIYSGTLMDYKDDEGTSEEKKIKVILKVLDPSHRDISLAFFEAASMMRQVSHKHIVYLYGVCVRDVENIMVEEFVEGGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNLLLAREGIDSECGPFIKLSDPGIPITVLSRQECIERIPWIAPECVEDSKNLSVAADKWSFGTTLWEICYNGEIPLKDKTLIEKERFYESRCRPVTPSCKELADLMTRCMNYDPNQRPFFRAIMRDINKLEEQNPDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK'),
('P00491', '4EAR', 1, 1.7, 'A/B/C', 289, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Purine nucleoside phosphorylase', 'PNP', 'Purine nucleoside + phosphate = purine + alpha-D-ribose 1-phosphate.<br />\n', 'drug binding<br />\nnucleoside binding<br />\nphosphate ion binding<br />\npurine nucleobase binding<br />\npurine-nucleoside phosphorylase activity<br />\n', 'immune response<br />\ninosine catabolic process<br />\ninterleukin-2 secretion<br />\nNAD biosynthesis via nicotinamide riboside salvage pathway<br />\nneutrophil degranulation<br />\nnicotinamide riboside catabolic process<br />\nnucleobase-containing compound metabolic process<br />\npositive regulation of alpha-beta T cell differentiation<br />\npositive regulation of T cell proliferation<br />\npurine-containing compound salvage<br />\npurine nucleotide catabolic process<br />\nresponse to drug<br />\nurate biosynthetic process<br />\n', 'PF01048.', 'MENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYGEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRFPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANHEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS'),
('P24941', '4EK4', 1, 1.26, 'A', 298, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Cyclin-dependent kinase 2', 'CDK2', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\ncyclin binding<br />\ncyclin-dependent protein kinase activity<br />\ncyclin-dependent protein serine/threonine kinase activity<br />\nkinase activity<br />\nmetal ion binding<br />\nprotein domain specific binding<br />\nprotein serine/threonine kinase activity<br />\n', 'cell division<br />\ncellular response to nitric oxide<br />\ncentriole replication<br />\ncentrosome duplication<br />\nDNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest<br />\nDNA repair<br />\nDNA replication<br />\nG1/S transition of mitotic cell cycle<br />\nG2/M transition of mitotic cell cycle<br />\nhistone phosphorylation<br />\nmeiotic cell cycle<br />\nmitotic G1 DNA damage checkpoint<br />\nmulticellular organism development<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle<br />\npeptidyl-serine phosphorylation<br />\npositive regulation of cell proliferation<br />\npositive regulation of DNA-dependent DNA replication initiation<br />\npositive regulation of transcription, DNA-templated<br />\npotassium ion transport<br />\nprotein phosphorylation<br />\nRas protein signal transduction<br />\nregulation of G2/M transition of mitotic cell cycle<br />\nregulation of gene silencing<br />\nregulation of signal transduction by p53 class mediator<br />\nregulation of ubiquitin-protein ligase activity involved in mitotic cell cycle<br />\nresponse to organic substance<br />\n', 'PF00069.', 'MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL'),
('P16083', '4FGL', 1, 1.2, 'A/B/C/D', 231, 'OXIDOREDUCTASE / OXIDOREDUCTASE inhibitor', 'OXIDOREDUCTASE', 'Ribosyldihydronicotinamide dehydrogenase [quinone]', 'NQO2', '1-(beta-D-ribofuranosyl)-1,4-dihydronicotinamide + a quinone = 1-(beta-D-ribofuranosyl)nicotinamide + a quinol<br />\n', 'chloride ion binding<br />\ndihydronicotinamide riboside quinone reductase activity<br />\nelectron carrier activity<br />\nFAD binding<br />\nmelatonin binding<br />\noxidoreductase activity<br />\noxidoreductase activity, acting on other nitrogenous compounds as donors<br />\nprotein homodimerization activity<br />\nresveratrol binding<br />\nzinc ion binding<br />\n', 'memory<br />\noxidation-reduction process<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of neuron apoptotic process<br />\npositive regulation of reactive oxygen species metabolic process<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\nxenobiotic metabolic process<br />\n', 'PF02525.', 'MAGKKVLIVYAHQEPKSFNGSLKNVAVDELSRQGCTVTVSDLYAMNLEPRATDKDITGTLSNPEVFNYGVETHEAYKQRSLASDITDEQKKVREADLVIFQFPLYWFSVPAILKGWMDRVLCQGFAFDIPGFYDSGLLQGKLALLSVTTGGTAEMYTKTGVNGDSRYFLWPLQHGTLHFCGFKVLAPQISFAPEIASEEERKGMVAAWSQRLQTIWKEEPIPCTAHWHFGQ'),
('Q6GI75', '4FS3', 1, 1.8, 'A', 256, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI', 'fabI', 'An acyl-[acyl-carrier protein] + NADP+ = a trans-2,3-dehydroacyl-[acyl-carrier protein] + NADPH.<br />\n', 'enoyl-[acyl-carrier-protein] reductase (NADH) activity<br />\nenoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity<br />\nNADP binding<br />\n', 'fatty acid elongation<br />\nprotein homotetramerization<br />\n', '', 'MLNLENKTYVIMGIANKRSIAFGVAKVLDQLGAKLVFTYRKERSRKELEKLLEQLNQPEAHLYQIDVQSDEEVINGFEQIGKDVGNIDGVYHSIAFANMEDLRGRFSETSREGFLLAQDISSYSLTIVAHEAKKLMPEGGSIVATTYLGGEFAVQNYNVMGVAKASLEANVKYLALDLGPDNIRVNAISAGPIRTLSAKGVGGFNTILKEIEERAPLKRNVDQVEVGKTAAYLLSDLSSGVTGENIHVDSGFHAIK'),
('P15144', '4FYR', 1, 1.91, 'A', 902, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Aminopeptidase N', 'ANPEP', 'Release of an N-terminal amino acid, Xaa-|-Yaa- from a peptide, amide or arylamide<br />\n', 'aminopeptidase activity<br />\nmetalloaminopeptidase activity<br />\nmetallopeptidase activity<br />\npeptide binding<br />\nreceptor activity<br />\nvirus receptor activity<br />\nzinc ion binding<br />\n', 'angiogenesis<br />\ncell-cell signaling<br />\ncell differentiation<br />\nneutrophil degranulation<br />\npeptide catabolic process<br />\nregulation of blood pressure<br />\nsignal transduction<br />\n', 'PF11838.', 'MAKGFYISKSLGILGILLGVAAVCTIIALSVVYSQEKNKNANSSPVASTTPSASATTNPASATTLDQSKAWNRYRLPNTLKPDSYRVTLRPYLTPNDRGLYVFKGSSTVRFTCKEATDVIIIHSKKLNYTLSQGHRVVLRGVGGSQPPDIDKTELVEPTEYLVVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNMLPKGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPASEINTPAQISELFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNRSIQLPTTVRDIMNRWTLQMGFPVITVDTSTGTLSQEHFLLDPDSNVTRPSEFNYVWIVPITSIRDGRQQQDYWLIDVRAQNDLFSTSGNEWVLLNLNVTGYYRVNYDEENWRKIQTQLQRDHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAALSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWREIPENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQWMENPNNNPIHPNLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQDATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGSFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGSGTRALEQALEKTKANIKWVKENKEVVLQWFTENSK'),
('P12081', '4G84', 1, 2.4, 'A/B', 453, 'LIGASE', 'LIGASE', 'Histidine--tRNA ligase, cytoplasmic', 'HARS', 'ATP + L-histidine + tRNA(His) = AMP + diphosphate + L-histidyl-tRNA(His).<br />\n', 'ATP binding<br />\nhistidine-tRNA ligase activity<br />\nidentical protein binding<br />\n', 'histidyl-tRNA aminoacylation<br />\nmitochondrial translation<br />\ntranslation<br />\ntRNA aminoacylation for protein translation<br />\n', 'PF03129.', 'MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPKGTRDYSPRQMAVREKVFDVIIRCFKRHGAEVIDTPVFELKETLMGKYGEDSKLIYDLKDQGGELLSLRYDLTVPFARYLAMNKLTNIKRYHIAKVYRRDNPAMTRGRYREFYQCDFDIAGNFDPMIPDAECLKIMCEILSSLQIGDFLVKVNDRRILDGMFAICGVSDSKFRTICSSVDKLDKVSWEEVKNEMVGEKGLAPEVADRIGDYVQQHGGVSLVEQLLQDPKLSQNKQALEGLGDLKLLFEYLTLFGIDDKISFDLSLARGLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGRYDGLVGMFDPKGRKVPCVGLSIGVERIFSIVEQRLEALEEKIRTTETQVLVASAQKKLLEERLKLVSELWDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTGQPLCIC'),
('O00206', '4G8A', 1, 2.4, 'A/B', 607, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Toll-like receptor 4', 'TLR4', '', 'lipopolysaccharide binding<br />\nlipopolysaccharide receptor activity<br />\nprotein heterodimerization activity<br />\nreceptor activity<br />\nreceptor binding<br />\ntransmembrane signaling receptor activity<br />\n', 'activation of MAPK activity<br />\napoptotic signaling pathway<br />\nastrocyte development<br />\nB cell proliferation involved in immune response<br />\ncellular response to amyloid-beta<br />\ncellular response to lipopolysaccharide<br />\ncellular response to lipoteichoic acid<br />\ncellular response to mechanical stimulus<br />\ncellular response to oxidised low-density lipoprotein particle stimulus<br />\ndefense response to bacterium<br />\ndefense response to Gram-negative bacterium<br />\ndetection of fungus<br />\ndetection of lipopolysaccharide<br />\nI-kappaB kinase/NF-kappaB signaling<br />\nI-kappaB phosphorylation<br />\nimmune response<br />\ninflammatory response<br />\ninnate immune response<br />\ninterferon-gamma production<br />\ninterleukin-1 beta secretion<br />\nintestinal epithelial structure maintenance<br />\nlipopolysaccharide-mediated signaling pathway<br />\nmacrophage activation<br />\nMyD88-dependent toll-like receptor signaling pathway<br />\nMyD88-independent toll-like receptor signaling pathway<br />\nnecroptotic process<br />\nnegative regulation of ERK1 and ERK2 cascade<br />\nnegative regulation of interferon-gamma production<br />\nnegative regulation of interleukin-17 production<br />\nnegative regulation of interleukin-23 production<br />\nnegative regulation of interleukin-6 production<br />\nnegative regulation of MyD88-independent toll-like receptor signaling pathway<br />\nnegative regulation of osteoclast differentiation<br />\nnegative regulation of tumor necrosis factor production<br />\nnitric oxide production involved in inflammatory response<br />\npositive regulation of B cell proliferation<br />\npositive regulation of chemokine production<br />\npositive regulation of cytokine production involved in inflammatory response<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of gene expression<br />\npositive regulation of inflammatory response<br />\npositive regulation of interferon-alpha production<br />\npositive regulation of interferon-beta biosynthetic process<br />\npositive regulation of interferon-beta production<br />\npositive regulation of interferon-gamma production<br />\npositive regulation of interleukin-10 production<br />\npositive regulation of interleukin-12 biosynthetic process<br />\npositive regulation of interleukin-12 production<br />\npositive regulation of interleukin-1 beta secretion<br />\npositive regulation of interleukin-1 production<br />\npositive regulation of interleukin-6 production<br />\npositive regulation of interleukin-8 biosynthetic process<br />\npositive regulation of interleukin-8 production<br />\npositive regulation of JNK cascade<br />\npositive regulation of macrophage activation<br />\npositive regulation of macrophage cytokine production<br />\npositive regulation of MHC class II biosynthetic process<br />\npositive regulation of NF-kappaB import into nucleus<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of nitric-oxide synthase biosynthetic process<br />\npositive regulation of NLRP3 inflammasome complex assembly<br />\npositive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway<br />\npositive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway<br />\npositive regulation of oxidative stress-induced neuron death<br />\npositive regulation of platelet activation<br />\npositive regulation of reactive oxygen species biosynthetic process<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of tumor necrosis factor biosynthetic process<br />\npositive regulation of tumor necrosis factor production<br />\nregulation of dendritic cell cytokine production<br />\nresponse to lipopolysaccharide<br />\nT-helper 1 type immune response<br />\ntoll-like receptor 4 signaling pathway<br />\ntoll-like receptor signaling pathway<br />\nTRIF-dependent toll-like receptor signaling pathway<br />\n', 'PF13516.', 'MMSASRLAGTLIPAMAFLSCVRPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNITCQMNKTIIGVSVLSVLVVSVVAVLVYKFYFHLMLLAGCIKYGRGENIYDAFVIYSSQDEDWVRNELVKNLEEGVPPFQLCLHYRDFIPGVAIAANIIHEGFHKSRKVIVVVSQHFIQSRWCIFEYEIAQTWQFLSSRAGIIFIVLQKVEKTLLRQQVELYRLLSRNTYLEWEDSVLGRHIFWRRLRKALLDGKSWNPEGTVGTGCNWQEATSI'),
('P04746', '4GQR', 1, 1.2, 'A', 495, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Pancreatic alpha-amylase', 'AMY2A', 'Endohydrolysis of (1->4)-alpha-D-glucosidic linkages in polysaccharides containing three or more (1->4)-alpha-linked D-glucose units<br />\n', 'alpha-amylase activity<br />\nalpha-amylase activity (releasing maltohexaose)<br />\ncalcium ion binding<br />\nchloride ion binding<br />\n', 'carbohydrate catabolic process<br />\ncarbohydrate metabolic process<br />\npolysaccharide digestion<br />\n', 'PF00128.', 'MKFFLLLFTIGFCWAQYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL'),
('P33261', '4GQS', 1, 2.87, 'A/B/C/D', 467, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cytochrome P450 2C19', 'CYP2C19', '+-(R)-limonene + NADPH + O2 = (+)-trans-carveol + NADP+ + H2O.<br />\n--(S)-limonene + NADPH + O2 = (-)-trans-carveol + NADP+ + H2O.<br />\n--(S)-limonene + NADPH + O2 = (-)-perillyl alcohol + NADP+ + H2O.<br />\n', '(R)-limonene 6-monooxygenase activity<br />\n(S)-limonene 6-monooxygenase activity<br />\n(S)-limonene 7-monooxygenase activity<br />\narachidonic acid epoxygenase activity<br />\nenzyme binding<br />\nheme binding<br />\niron ion binding<br />\nmonooxygenase activity<br />\noxidoreductase activity<br />\noxygen binding<br />\nsteroid hydroxylase activity<br />\n', 'drug metabolic process<br />\nepoxygenase P450 pathway<br />\nexogenous drug catabolic process<br />\nheterocycle metabolic process<br />\nmonoterpenoid metabolic process<br />\nomega-hydroxylase P450 pathway<br />\noxidation-reduction process<br />\nsteroid metabolic process<br />\nxenobiotic metabolic process<br />\n', 'PF00067.', 'MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPV'),
('Q9WYT0', '4GT9', 1, 1.39, 'A', 220, 'TRANSFERASE', 'TRANSFERASE', 'Flavin-dependent thymidylate synthase', 'thyX', '5,10-methylenetetrahydrofolate + dUMP + NADPH = dTMP + tetrahydrofolate + NADP+<br />\n', 'flavin adenine dinucleotide binding<br />\nthymidylate synthase (FAD) activity<br />\n', 'dTMP biosynthetic process<br />\ndTTP biosynthetic process<br />\n', 'PF02511.', 'MKIDILDKGFVELVDVMGNDLSAVRAARVSFDMGLKDEERDRHLIEYLMKHGHETPFEHIVFTFHVKAPIFVARQWFRHRIASYNELSGRYSKLSYEFYIPSPERLEGYKTTIPPERVTEKISEIVDKAYRTYLELIESGVPREVARIVLPLNLYTRFFWTVNARSLMNFLNLRADSHAQWEIQQYALAIARIFKEKCPWTFEAFLKYAYKGDILKEVQV'),
('P52209', '4GWG', 1, 1.39, 'A', 482, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', '6-phosphogluconate dehydrogenase, decarboxylating', 'PGD', '6-phospho-D-gluconate + NADP+ = D-ribulose 5-phosphate + CO2 + NADPH.<br />\n', 'phosphogluconate dehydrogenase (decarboxylating) activity<br />\n', 'D-gluconate metabolic process<br />\noxidation-reduction process<br />\npentose biosynthetic process<br />\npentose-phosphate shunt<br />\npentose-phosphate shunt, oxidative branch<br />\n', 'PF00393.', 'MAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQAVDDFIEKLVPLLDTGDIIIDGGNSEYRDTTRRCRDLKAKGILFVGSGVSGGEEGARYGPSLMPGGNKEAWPHIKTIFQGIAAKVGTGEPCCDWVGDEGAGHFVKMVHNGIEYGDMQLICEAYHLMKDVLGMAQDEMAQAFEDWNKTELDSFLIEITANILKFQDTDGKHLLPKIRDSAGQKGTGKWTAISALEYGVPVTLIGEAVFARCLSSLKDERIQASKKLKGPQKFQFDGDKKSFLEDIRKALYASKIISYAQGFMLLRQAATEFGWTLNYGGIALMWRGGCIIRSVFLGKIKDAFDRNPELQNLLLDDFFKSAVENCQDSWRRAVSTGVQAGIPMPCFTTALSFYDGYRHEMLPASLIQAQRDYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA'),
('P21589', '4H2G', 1, 1.55, 'A', 523, 'HYDROLASE', 'HYDROLASE', '5''-nucleotidase', 'NT5E', 'A 5''-ribonucleotide + H2O = a ribonucleoside + phosphate.<br />\n', '5''-nucleotidase activity<br />\nmetal ion binding<br />\nnucleotide binding<br />\n', 'adenosine biosynthetic process<br />\nAMP catabolic process<br />\nDNA metabolic process<br />\nleukocyte cell-cell adhesion<br />\nNAD metabolic process<br />\nnegative regulation of inflammatory response<br />\npurine nucleotide catabolic process<br />\npyrimidine nucleoside catabolic process<br />\n', 'PF02872.', 'MCPRAARAPATLLLALGAVLWPAAGAWELTILHTNDVHSRLEQTSEDSSKCVNASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLNSSIPEDPSIKADINKWRIKLDNYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNNGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSTGSHCHGSFSLIFLSLWAVIFVLYQ'),
('P36507', '4H3Q', 1, 2.2, 'B', 13, 'TRANSFERASE', 'TRANSFERASE', 'Dual specificity mitogen-activated protein kinase kinase 2', 'MAP2K2', 'ATP + a protein = ADP + a phosphoprotein<br />\n', 'ATP binding<br />\nMAP kinase kinase activity<br />\nmetal ion binding<br />\nPDZ domain binding<br />\nprotein serine/threonine/tyrosine kinase activity<br />\nprotein serine/threonine kinase activator activity<br />\nprotein serine/threonine kinase activity<br />\nprotein tyrosine kinase activity<br />\nscaffold protein binding<br />\n', 'activation of MAPK activity<br />\nERK1 and ERK2 cascade<br />\nMAPK cascade<br />\nnegative regulation of gene expression<br />\npeptidyl-serine autophosphorylation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of production of miRNAs involved in gene silencing by miRNA<br />\npositive regulation of protein serine/threonine kinase activity<br />\npositive regulation of transcription, DNA-templated<br />\nproteolysis in other organism<br />\nregulation of apoptotic process<br />\nregulation of early endosome to late endosome transport<br />\nregulation of Golgi inheritance<br />\nregulation of mitotic cell cycle<br />\nregulation of stress-activated MAPK cascade<br />\n', 'PF00069.', 'MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV'),
('Q9EXV5', '4HBU', 1, 1.1, 'A', 263, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Beta-lactamase', 'blaUOE-1', 'A beta-lactam + H2O = a substituted beta-amino acid.', 'beta-lactamase activity', 'beta-lactam antibiotic catabolic process<br />\r\nresponse to antibiotic<br />', NULL, 'MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGV\r\nALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEI\r\nKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPAS\r\nVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK\r\nALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIA\r\nVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL'),
('Q08881', '4HCU', 1, 1.43, 'A', 267, 'transferase / transferase inhibitor', 'TRANSFERASE', 'Tyrosine-protein kinase ITK/TSK', 'ITK', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nmetal ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\n', 'activation of phospholipase C activity<br />\nadaptive immune response<br />\ncellular defense response<br />\ncytokine production<br />\nFc-epsilon receptor signaling pathway<br />\ninnate immune response<br />\ninterferon-gamma production<br />\ninterleukin-4 production<br />\nintracellular signal transduction<br />\nNK T cell differentiation<br />\npeptidyl-tyrosine autophosphorylation<br />\nregulation of cell proliferation<br />\nsignal transduction<br />\nT cell activation<br />\nT cell receptor signaling pathway<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00779.', 'MNNFILLEEQLIKKSQQKRRTSPSNFKVRFFVLTKASLAYFEDRHGKKRTLKGSIELSRIKCVEIVKSDISIPCHYKYPFQVVHDNYLLYVFAPDRESRQRWVLALKEETRNNNSLVPKYHPNFWMDGKWRCCSQLEKLATGCAQYDPTKNASKKPLPPTPEDNRRPLWEPEETVVIALYDYQTNDPQELALRRNEEYCLLDSSEIHWWRVQDRNGHEGYVPSSYLVEKSPNNLETYEWYNKSISRDKAEKLLLDTGKEGAFMVRDSRTAGTYTVSVFTKAVVSENNPCIKHYHIKETNDNPKRYYVAEKYVFDSIPLLINYHQHNGGGLVTRLRYPVCFGRQKAPVTAGLRYGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL'),
('P07814', '4HVC', 1, 2, 'A/B', 510, 'ligase / ligase inhibitor', 'LIGASE', 'Bifunctional glutamate/proline--tRNA ligase', 'EPRS', 'ATP + L-glutamate + tRNA(Glu) = AMP + diphosphate + L-glutamyl-tRNA(Glu).<br />\nATP + L-proline + tRNA(Pro) = AMP + diphosphate + L-prolyl-tRNA(Pro)<br />\n', 'ATP binding<br />\nglutamate-tRNA ligase activity<br />\nGTPase binding<br />\nidentical protein binding<br />\nproline-tRNA ligase activity<br />\nprotein homodimerization activity<br />\nRNA stem-loop binding<br />\nzinc ion binding<br />\n', 'cellular response to interferon-gamma<br />\nglutamyl-tRNA aminoacylation<br />\nnegative regulation of translation<br />\nprolyl-tRNA aminoacylation<br />\nprotein complex assembly<br />\ntRNA aminoacylation for protein translation<br />\n', 'PF00043.', 'MATLSLTVNSGDPPLGALLAVEHVKDDVSISVEEGKENILHVSENVIFTDVNSILRYLARVATTAGLYGSNLMEHTEIDHWLEFSATKLSSCDSFTSTINELNHCLSLRTYLVGNSLSLADLCVWATLKGNAAWQEQLKQKKAPVHVKRWFGFLEAQQAFQSVGTKWDVSTTKARVAPEKKQDVGKFVELPGAEMGKVTVRFPPEASGYLHIGHAKAALLNQHYQVNFKGKLIMRFDDTNPEKEKEDFEKVILEDVAMLHIKPDQFTYTSDHFETIMKYAEKLIQEGKAYVDDTPAEQMKAEREQRIDSKHRKNPIEKNLQMWEEMKKGSQFGQSCCLRAKIDMSSNNGCMRDPTLYRCKIQPHPRTGNKYNVYPTYDFACPIVDSIEGVTHALRTTEYHDRDEQFYWIIEALGIRKPYIWEYSRLNLNNTVLSKRKLTWFVNEGLVDGWDDPRFPTVRGVLRRGMTVEGLKQFIAAQGSSRSVVNMEWDKIWAFNKKVIDPVAPRYVALLKKEVIPVNVPEAQEEMKEVAKHPKNPEVGLKPVWYSPKVFIEGADAETFSEGEMVTFINWGNLNITKIHKNADGKIISLDAKLNLENKDYKKTTKVTWLAETTHALPIPVICVTYEHLITKPVLGKDEDFKQYVNKNSKHEELMLGDPCLKDLKKGDIIQLQRRGFFICDQPYEPVSPYSCKEAPCVLIYIPDGHTKEMPTSGSKEKTKVEATKNETSAPFKERPTPSLNNNCTTSEDSLVLYNRVAVQGDVVRELKAKKAPKEDVDAAVKQLLSLKAEYKEKTGQEYKPGNPPAEIGQNISSNSSASILESKSLYDEVAAQGEVVRKLKAEKSPKAKINEAVECLLSLKAQYKEKTGKEYIPGQPPLSQSSDSSPTRNSEPAGLETPEAKVLFDKVASQGEVVRKLKTEKAPKDQVDIAVQELLQLKAQYKSLIGVEYKPVSATGAEDKDKKKKEKENKSEKQNKPQKQNDGQRKDPSKNQGGGLSSSGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY'),
('P26639', '4HWT', 1, 2.3, 'A/B', 403, 'Ligase / Ligase Inhibitor', 'LIGASE', 'Threonine--tRNA ligase, cytoplasmic', 'TARS', 'ATP + L-threonine + tRNA(Thr) = AMP + diphosphate + L-threonyl-tRNA(Thr).<br />\n', 'ATP binding<br />\nprotein homodimerization activity<br />\nthreonine-tRNA ligase activity<br />\ntRNA binding<br />\n', 'threonyl-tRNA aminoacylation<br />\ntranslation<br />\ntRNA aminoacylation for protein translation<br />\n', 'PF03129.', 'MFEEKASSPSGKMGGEEKPIGAGEEKQKEGGKKKNKEGSGDGGRAELNPWPEYIYTRLEMYNILKAEHDSILAEKAEKDSKPIKVTLPDGKQVDAESWKTTPYQIACGISQGLADNTVIAKVNNVVWDLDRPLEEDCTLELLKFEDEEAQAVYWHSSAHIMGEAMERVYGGCLCYGPPIENGFYYDMYLEEGGVSSNDFSSLEALCKKIIKEKQAFERLEVKKETLLAMFKYNKFKCRILNEKVNTPTTTVYRCGPLIDLCRGPHVRHTGKIKALKIHKNSSTYWEGKADMETLQRIYGISFPDPKMLKEWEKFQEEAKNRDHRKIGRDQELYFFHELSPGSCFFLPKGAYIYNALIEFIRSEYRKRGFQEVVTPNIFNSRLWMTSGHWQHYSENMFSFEVEKELFALKPMNCPGHCLMFDHRPRSWRELPLRLADFGVLHRNELSGALTGLTRVRRFQQDDAHIFCAMEQIEDEIKGCLDFLRTVYSVFGFSFKLNLSTRPEKFLGDIEVWDQAEKQLENSLNEFGEKWELNSGDGAFYGPKIDIQIKDAIGRYHQCATIQLDFQLPIRFNLTYVSHDGDDKKRPVIVHRAILGSVERMIAILTENYGGKWPFWLSPRQVMVVPVGPTCDEYAQKVRQQFHDAKFMADIDLDPGCTLNKKIRNAQLAQYNFILVVGEKEKISGTVNIRTRDNKVHGERTISETIERLQQLKEFRSKQAEEEF'),
('P78540', '4HZE', 1, 1.6, 'A/B/C', 306, 'Hydrolase / Hydrolase Inhibitor', 'HYDROLASE', 'Arginase-2, mitochondrial', 'ARG2', 'L-arginine + H2O = L-ornithine + urea<br />\n', 'arginase activity<br />\nmetal ion binding<br />\n', 'arginine metabolic process<br />\nnegative regulation of activated CD8-positive, alpha-beta T cell apoptotic process<br />\nnegative regulation of CD4-positive, alpha-beta T cell proliferation<br />\nnegative regulation of chemokine (C-C motif) ligand 4 production<br />\nnegative regulation of chemokine (C-C motif) ligand 5 production<br />\nnegative regulation of defense response to bacterium<br />\nnegative regulation of interleukin-13 secretion<br />\nnegative regulation of interleukin-17 secretion<br />\nnegative regulation of macrophage inflammatory protein 1 alpha production<br />\nnegative regulation of tumor necrosis factor production<br />\nnegative regulation of tumor necrosis factor secretion<br />\nnegative regulation of type 2 immune response<br />\nnitric oxide biosynthetic process<br />\npositive regulation of cellular senescence<br />\nregulation of interleukin-1 beta secretion<br />\nregulation of reactive oxygen species biosynthetic process<br />\nstriated muscle contraction<br />\nurea cycle<br />\nureteric bud development<br />\n', 'PF00491.', 'MSLRGSLSRLLQTRVHSILKKSVHSVAVIGAPFSQGQKRKGVEHGPAAIREAGLMKRLSSLGCHLKDFGDLSFTPVPKDDLYNNLIVNPRSVGLANQELAEVVSRAVSDGYSCVTLGGDHSLAIGTISGHARHCPDLCVVWVDAHADINTPLTTSSGNLHGQPVSFLLRELQDKVPQLPGFSWIKPCISSASIVYIGLRDVDPPEHFILKNYDIQYFSMRDIDRLGIQKVMERTFDLLIGKRQRPIHLSFDIDAFDPTLAPATGTPVVGGLTYREGMYIAEEIHNTGLLSALDLVEVNPQLATSEEEAKTTANLAVDVIASSFGQTREGGHIVYDQLPTPSSPDESENQARVRI'),
('P67775', '4I5L', 1, 2.43, 'C/F', 309, 'HYDROLASE / TOXIN', 'HYDROLASE', 'Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform', 'PPP2CA', '[a protein]-serine/threonine phosphate + H2O = [a protein]-serine/threonine + phosphate.<br />\n', 'GABA receptor binding<br />\nmetal ion binding<br />\nphosphoprotein phosphatase activity<br />\nprotein C-terminus binding<br />\n', 'apoptotic process<br />\nceramide metabolic process<br />\ninactivation of MAPK activity<br />\nmeiotic cell cycle<br />\nmesoderm development<br />\nmitotic nuclear envelope reassembly<br />\nnegative regulation of cell growth<br />\nnegative regulation of epithelial to mesenchymal transition<br />\nnegative regulation of tyrosine phosphorylation of STAT protein<br />\nnuclear-transcribed mRNA catabolic process, nonsense-mediated decay<br />\npositive regulation of protein serine/threonine kinase activity<br />\nprotein dephosphorylation<br />\nregulation of cell adhesion<br />\nregulation of cell differentiation<br />\nregulation of DNA replication<br />\nregulation of growth<br />\nregulation of transcription, DNA-templated<br />\nregulation of Wnt signaling pathway<br />\nresponse to organic substance<br />\nRNA splicing<br />\nsecond-messenger-mediated signaling<br />\n', 'PF00149.', 'MDEKVFTKELDQWIEQLNECKQLSESQVKSLCEKAKEILTKESNVQEVRCPVTVCGDVHGQFHDLMELFRIGGKSPDTNYLFMGDYVDRGYYSVETVTLLVALKVRYRERITILRGNHESRQITQVYGFYDECLRKYGNANVWKYFTDLFDYLPLTALVDGQIFCLHGGLSPSIDTLDHIRALDRLQEVPHEGPMCDLLWSDPDDRGGWGISPRGAGYTFGQDISETFNHANGLTLVSRAHQLVMEGYNWCHDRNVVTIFSAPNYCYRCGNQAAIMELDDTLKYSFLQFDPAPRRGEPHVTRRTPDYFL'),
('P28222', '4IAR', 1, 2.7, 'A', 207, 'SIGNALING PROTEIN', 'SIGNALING_PROT', '5-hydroxytryptamine receptor 1B', 'HTR1B', '', 'drug binding<br />\nG-protein coupled serotonin receptor activity<br />\nneurotransmitter receptor activity<br />\nserotonin binding<br />\n', 'adenylate cyclase-inhibiting serotonin receptor signaling pathway<br />\nbone remodeling<br />\ncellular response to alkaloid<br />\ncellular response to drug<br />\ncellular response to temperature stimulus<br />\nchemical synaptic transmission<br />\ndrinking behavior<br />\nG-protein coupled receptor internalization<br />\nG-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger<br />\nnegative regulation of cAMP biosynthetic process<br />\nnegative regulation of serotonin secretion<br />\nnegative regulation of synaptic transmission, GABAergic<br />\nnegative regulation of synaptic transmission, glutamatergic<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\nprotein kinase C-activating G-protein coupled receptor signaling pathway<br />\nregulation of behavior<br />\nregulation of dopamine secretion<br />\nresponse to cocaine<br />\nresponse to ethanol<br />\nresponse to mineralocorticoid<br />\nvasoconstriction<br />\n', 'PF00001.', 'MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P41595', '4IB4', 1, 2.7, 'A', 213, 'SIGNALING PROTEIN', 'SIGNALING_PROT', '5-hydroxytryptamine receptor 2B', 'HTR2B', '', 'drug binding<br />\nG-protein alpha-subunit binding<br />\nG-protein coupled serotonin receptor activity<br />\nGTPase activator activity<br />\nneurotransmitter receptor activity<br />\nserotonin binding<br />\n', 'activation of phospholipase C activity<br />\nbehavior<br />\ncalcium-mediated signaling<br />\ncardiac muscle hypertrophy<br />\ncellular calcium ion homeostasis<br />\ncellular response to temperature stimulus<br />\ncGMP biosynthetic process<br />\nembryonic morphogenesis<br />\nERK1 and ERK2 cascade<br />\nG-protein coupled receptor internalization<br />\nG-protein coupled receptor signaling pathway<br />\nheart morphogenesis<br />\nintestine smooth muscle contraction<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of autophagy<br />\nnegative regulation of cell death<br />\nneural crest cell differentiation<br />\nneural crest cell migration<br />\nphosphatidylinositol 3-kinase signaling<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\nphosphorylation<br />\npositive regulation of cell division<br />\npositive regulation of cell proliferation<br />\npositive regulation of cytokine production<br />\npositive regulation of cytokine secretion<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of nitric-oxide synthase activity<br />\npositive regulation of phosphatidylinositol biosynthetic process<br />\nprotein kinase C-activating G-protein coupled receptor signaling pathway<br />\nprotein kinase C signaling<br />\nregulation of behavior<br />\nrelease of sequestered calcium ion into cytosol<br />\nresponse to drug<br />\nserotonin receptor signaling pathway<br />\nvasoconstriction<br />\n', 'PF00001.', 'MALSYRVSELQSTIPEHILQSTFVHVISSNWSGLQTESIPEEMKQIVEEQGNKLHWAALLILMVIIPTIGGNTLVILAVSLEKKLQYATNYFLMSLAVADLLVGLFVMPIALLTIMFEAMWPLPLVLCPAWLFLDVLFSTASIMHLCAISVDRYIAIKKPIQANQYNSRATAFIKITVVWLISIGIAIPVPIKGIETDVDNPNNITCVLTKERFGDFMLFGSLAAFFTPLAIMIVTYFLTIHALQKKAYLVKNKPPQRLTWLTVSTVFQRDETPCSSPEKVAMLDGSRKDKALPNSGDETLMRRTSTIGKKSVQTISNEQRASKVLGIVFFLFLLMWCPFFITNITLVLCDSCNQTTLQMLLEIFVWIGYVSSGVNPLVYTLFNKTFRDAFGRYITCNYRATKSVKTLRKRSSKIYFRNPMAENSKFFKKHGIRNGINPAMYQSPMRLRSSTIQSSSIILLDTLLLTENEGDKTEEQVSYV'),
('P30613', '4IP7', 1, 1.8, 'A/B/C/D', 541, 'TRANSFERASE', 'TRANSFERASE', 'Pyruvate kinase PKLR', 'PKLR', 'ATP + pyruvate = ADP + phosphoenolpyruvate.<br />\n', 'ATP binding<br />\nkinase activity<br />\nmagnesium ion binding<br />\npotassium ion binding<br />\npyruvate kinase activity<br />\n', 'ATP biosynthetic process<br />\ncanonical glycolysis<br />\ncellular response to epinephrine stimulus<br />\ncellular response to insulin stimulus<br />\nglycolytic process<br />\npyruvate biosynthetic process<br />\nresponse to ATP<br />\nresponse to cAMP<br />\nresponse to glucose<br />\nresponse to heat<br />\nresponse to hypoxia<br />\nresponse to lithium ion<br />\nresponse to nutrient<br />\n', 'PF00224.', 'MSIQENISSLQLRSWVSKSQRDLAKSILIGAPGGPAGYLRRASVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPEIRTGILQGGPESEVELVKGSQVLVTVDPAFRTRGNANTVWVDYPNIVRVVPVGGRIYIDDGLISLVVQKIGPEGLVTQVENGGVLGSRKGVNLPGAQVDLPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS'),
('P0A8T7', '4IQZ', 0, 2.1, 'A/B/C/D/E', 210, 'UNKNOWN FUNCTION', 'OTHERS', 'DNA-directed RNA polymerase subunit beta''', 'rpoC', 'Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1)<br />\n', 'DNA binding<br />\nDNA-directed 5''-3'' RNA polymerase activity<br />\n', 'transcription, DNA-templated<br />\n', 'PF04997.', 'MKDLLKFLKAQTKTEEFDAIKIALASPDMIRSWSFGEVKKPETINYRTFKPERDGLFCARIFGPVKDYECLCGKYKRLKHRGVICEKCGVEVTQTKVRRERMGHIELASPTAHIWFLKSLPSRIGLLLDMPLRDIERVLYFESYVVIEGGMTNLERQQILTEEQYLDALEEFGDEFDAKMGAEAIQALLKSMDLEQECEQLREELNETNSETKRKKLTKRIKLLEAFVQSGNKPEWMILTVLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLDLAAPDIIVRNEKRMLQEAVDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYSGRSVITVGPYLRLHQCGLPKKMALELFKPFIYGKLELRGLATTIKAAKKMVEREEAVVWDILDEVIREHPVLLNRAPTLHRLGIQAFEPVLIEGKAIQLHPLVCAAYNADFDGDQMAVHVPLTLEAQLEARALMMSTNNILSPANGEPIIVPSQDVVLGLYYMTRDCVNAKGEGMVLTGPKEAERLYRSGLASLHARVKVRITEYEKDANGELVAKTSLKDTTVGRAILWMIVPKGLPYSIVNQALGKKAISKMLNTCYRILGLKPTVIFADQIMYTGFAYAARSGASVGIDDMVIPEKKHEIISEAEAEVAEIQEQFQSGLVTAGERYNKVIDIWAAANDRVSKAMMDNLQTETVINRDGQEEKQVSFNSIYMMADSGARGSAAQIRQLAGMRGLMAKPDGSIIETPITANFREGLNVLQYFISTHGARKGLADTALKTANSGYLTRRLVDVAQDLVVTEDDCGTHEGIMMTPVIEGGDVKEPLRDRVLGRVTAEDVLKPGTADILVPRNTLLHEQWCDLLEENSVDAVKVRSVVSCDTDFGVCAHCYGRDLARGHIINKGEAIGVIAAQSIGEPGTQLTMRTFHIGGAASRAAAESSIQVKNKGSIKLSNVKSVVNSSGKLVITSRNTELKLIDEFGRTKESYKVPYGAVLAKGDGEQVAGGETVANWDPHTMPVITEVSGFVRFTDMIDGQTITRQTDELTGLSSLVVLDSAERTAGGKDLRPALKIVDAQGNDVLIPGTDMPAQYFLPGKAIVQLEDGVQISSGDTLARIPQESGGTKDITGGLPRVADLFEARRPKEPAILAEISGIVSFGKETKGKRRLVITPVDGSDPYEEMIPKWRQLNVFEGERVERGDVISDGPEAPHDILRLRGVHAVTRYIVNEVQDVYRLQGVKINDKHIEVIVRQMLRKATIVNAGSSDFLEGEQVEYSRVKIANRELEANGKVGATYSRDLLGITKASLATESFISAASFQETTRVLTEAAVAGKRDELRGLKENVIVGRLIPAGTGYAYHQDRMRRRAAGEAPAAPQVTAEDASASLAELLNAGLGGSDNE'),
('P14868', '4J15', 0, 2.24, 'A/B', 501, 'LIGASE', 'LIGASE', 'Aspartate--tRNA ligase, cytoplasmic', 'DARS', 'ATP + L-aspartate + tRNA(Asp) = AMP + diphosphate + L-aspartyl-tRNA(Asp)<br />\n', 'aminoacylase activity<br />\naspartate-tRNA ligase activity<br />\nATP binding<br />\nRNA binding<br />\n', 'aspartyl-tRNA aminoacylation<br />\nprotein complex assembly<br />\ntranslation<br />\ntRNA aminoacylation for protein translation<br />\n', 'PF00152.', 'MPSASASRKSQEKPREIMDAAEDYAKERYGISSMIQSQEKPDRVLVRVRDLTIQKADEVVWVRARVHTSRAKGKQCFLVLRQQQFNVQALVAVGDHASKQMVKFAANINKESIVDVEGVVRKVNQKIGSCTQQDVELHVQKIYVISLAEPRLPLQLDDAVRPEAEGEEEGRATVNQDTRLDNRVIDLRTSTSQAVFRLQSGICHLFRETLINKGFVEIQTPKIISAASEGGANVFTVSYFKNNAYLAQSPQLYKQMCICADFEKVFSIGPVFRAEDSNTHRHLTEFVGLDIEMAFNYHYHEVMEEIADTMVQIFKGLQERFQTEIQTVNKQFPCEPFKFLEPTLRLEYCEALAMLREAGVEMGDEDDLSTPNEKLLGHLVKEKYDTDFYILDKYPLAVRPFYTMPDPRNPKQSNSYDMFMRGEEILSGAQRIHDPQLLTERALHHGIDLEKIKAYIDSFRFGAPPHAGGGIGLERVTMLFLGLHNVRQTSMFPRDPKRLTP'),
('Q02834', '4J9T', 1, 1.4, 'A', 361, 'Structural Genomics', 'OTHERS', 'Sialidase', 'nedA', 'Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)- glycosidic linkages of terminal sialic acid residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates.<br />\n', 'exo-alpha-(2->3)-sialidase activity<br />\nexo-alpha-(2->6)-sialidase activity<br />\nexo-alpha-(2->8)-sialidase activity<br />\n', 'metabolic process<br />\n', 'PF13088.', 'MTANPYLRRLPRRRAVSFLLAPALAAATVAGASPAQAIAGAPVPPGGEPLYTEQDLAVNGREGFPNYRIPALTVTPDGDLLASYDGRPTGIDAPGPNSILQRRSTDGGRTWGEQQVVSAGQTTAPIKGFSDPSYLVDRETGTIFNFHVYSQRQGFAGSRPGTDPADPNVLHANVATSTDGGLTWSHRTITADITPDPGWRSRFAASGEGIQLRYGPHAGRLIQQYTIINAAGAFQAVSVYSDDHGRTWRAGEAVGVGMDENKTVELSDGRVLLNSRDSARSGYRKVAVSTDGGHSYGPVTIDRDLPDPTNNASIIRAFPDAPAGSARAKVLLFSNAASQTSRSQGTIRMSCDDGQTWPVSKVFQPGSMSYSTLTALPDGTYGLLYEPGTGIRYANFNLAWLGGICAPFTIPDVALEPGQQVTVPVAVTNQSGIAVPKPSLQLDASPDWQVQGSVEPLMPGRQAKGQVTITVPAGTTPGRYRVGATLRTSAGNASTTFTVTVGLLDQARMSIADVDSEETAREDGRASNVIDGNPSTFWHTEWSRADAPGYPHRISLDLGGTHTISGLQYTRRQNSANEQVADYEIYTSLNGTTWDGPVASGRFTTSLAPQRAVFPARDARYIRLVALSEQTGHKYAAVAELEVEGQR'),
('Q92736', '4JKQ', 0, 2.39, 'A', 606, 'UNKNOWN FUNCTION', 'OTHERS', 'Ryanodine receptor 2', 'RYR2', '', 'calcium channel activity<br />\ncalcium-induced calcium release activity<br />\ncalcium ion binding<br />\ncalcium-release channel activity<br />\ncalmodulin binding<br />\nenzyme binding<br />\nidentical protein binding<br />\nion channel binding<br />\nprotein kinase A catalytic subunit binding<br />\nprotein kinase A regulatory subunit binding<br />\nprotein self-association<br />\nryanodine-sensitive calcium-release channel activity<br />\nsuramin binding<br />\n', 'BMP signaling pathway<br />\ncalcium ion transport<br />\ncalcium ion transport into cytosol<br />\ncalcium-mediated signaling<br />\ncalcium-mediated signaling using intracellular calcium source<br />\ncanonical Wnt signaling pathway<br />\ncardiac muscle contraction<br />\ncardiac muscle hypertrophy<br />\ncell communication by electrical coupling involved in cardiac conduction<br />\ncellular calcium ion homeostasis<br />\ncellular response to caffeine<br />\ncellular response to epinephrine stimulus<br />\ndetection of calcium ion<br />\nembryonic heart tube morphogenesis<br />\nestablishment of protein localization to endoplasmic reticulum<br />\nion transmembrane transport<br />\nleft ventricular cardiac muscle tissue morphogenesis<br />\npositive regulation of calcium-transporting ATPase activity<br />\npositive regulation of heart rate<br />\npositive regulation of sequestering of calcium ion<br />\npositive regulation of the force of heart contraction<br />\nPurkinje myocyte to ventricular cardiac muscle cell signaling<br />\nregulation of atrial cardiac muscle cell action potential<br />\nregulation of AV node cell action potential<br />\nregulation of cardiac conduction<br />\nregulation of cardiac muscle contraction<br />\nregulation of cardiac muscle contraction by calcium ion signaling<br />\nregulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion<br />\nregulation of cytosolic calcium ion concentration<br />\nregulation of heart rate<br />\nregulation of SA node cell action potential<br />\nregulation of ventricular cardiac muscle cell action potential<br />\nrelease of sequestered calcium ion into cytosol<br />\nrelease of sequestered calcium ion into cytosol by sarcoplasmic reticulum<br />\nresponse to caffeine<br />\nresponse to hypoxia<br />\nresponse to muscle activity<br />\nresponse to muscle stretch<br />\nresponse to redox state<br />\nsarcoplasmic reticulum calcium ion transport<br />\ntype B pancreatic cell apoptotic process<br />\nventricular cardiac muscle cell action potential<br />\n', 'PF13833.', 'MADGGEGEDEIQFLRTDDEVVLQCTATIHKEQQKLCLAAEGFGNRLCFLESTSNSKNVPPDLSICTFVLEQSLSVRALQEMLANTVEKSEGQVDVEKWKFMMKTAQGGGHRTLLYGHAILLRHSYSGMYLCCLSTSRSSTDKLAFDVGLQEDTTGEACWWTIHPASKQRSEGEKVRVGDDLILVSVSSERYLHLSYGNGSLHVDAAFQQTLWSVAPISSGSEAAQGYLIGGDVLRLLHGHMDECLTVPSGEHGEEQRRTVHYEGGAVSVHARSLWRLETLRVAWSGSHIRWGQPFRLRHVTTGKYLSLMEDKNLLLMDKEKADVKSTAFTFRSSKEKLDVGVRKEVDGMGTSEIKYGDSVCYIQHVDTGLWLTYQSVDVKSVRMGSIQRKAIMHHEGHMDDGISLSRSQHEESRTARVIRSTVFLFNRFIRGLDALSKKAKASTVDLPIESVSLSLQDLIGYFHPPDEHLEHEDKQNRLRALKNRQNLFQEEGMINLVLECIDRLHVYSSAAHFADVAGREAGESWKSILNSLYELLAALIRGNRKNCAQFSGSLDWLISRLERLEASSGILEVLHCVLVESPEALNIIKEGHIKSIISLLDKHGRNHKVLDVLCSLCVCHGVAVRSNQHLICDNLLPGRDLLLQTRLVNHVSSMRPNIFLGVSEGSAQYKKWYYELMVDHTEPFVTAEATHLRVGWASTEGYSPYPGGGEEWGGNGVGDDLFSYGFDGLHLWSGCIARTVSSPNQHLLRTDDVISCCLDLSAPSISFRINGQPVQGMFENFNIDGLFFPVVSFSAGIKVRFLLGGRHGEFKFLPPPGYAPCYEAVLPKEKLKVEHSREYKQERTYTRDLLGPTVSLTQAAFTPIPVDTSQIVLPPHLERIREKLAENIHELWVMNKIELGWQYGPVRDDNKRQHPCLVEFSKLPEQERNYNLQMSLETLKTLLALGCHVGISDEHAEDKVKKMKLPKNYQLTSGYKPAPMDLSFIKLTPSQEAMVDKLAENAHNVWARDRIRQGWTYGIQQDVKNRRNPRLVPYTLLDDRTKKSNKDSLREAVRTLLGYGYNLEAPDQDHAARAEVCSGTGERFRIFRAEKTYAVKAGRWYFEFETVTAGDMRVGWSRPGCQPDQELGSDERAFAFDGFKAQRWHQGNEHYGRSWQAGDVVGCMVDMNEHTMMFTLNGEILLDDSGSELAFKDFDVGDGFIPVCSLGVAQVGRMNFGKDVSTLKYFTICGLQEGYEPFAVNTNRDITMWLSKRLPQFLQVPSNHEHIEVTRIDGTIDSSPCLKVTQKSFGSQNSNTDIMFYRLSMPIECAEVFSKTVAGGLPGAGLFGPKNDLEDYDADSDFEVLMKTAHGHLVPDRVDKDKEATKPEFNNHKDYAQEKPSRLKQRFLLRRTKPDYSTSHSARLTEDVLADDRDDYDFLMQTSTYYYSVRIFPGQEPANVWVGWITSDFHQYDTGFDLDRVRTVTVTLGDEKGKVHESIKRSNCYMVCAGESMSPGQGRNNNGLEIGCVVDAASGLLTFIANGKELSTYYQVEPSTKLFPAVFAQATSPNVFQFELGRIKNVMPLSAGLFKSEHKNPVPQCPPRLHVQFLSHVLWSRMPNQFLKVDVSRISERQGWLVQCLDPLQFMSLHIPEENRSVDILELTEQEELLKFHYHTLRLYSAVCALGNHRVAHALCSHVDEPQLLYAIENKYMPGLLRAGYYDLLIDIHLSSYATARLMMNNEYIVPMTEETKSITLFPDENKKHGLPGIGLSTSLRPRMQFSSPSFVSISNECYQYSPEFPLDILKSKTIQMLTEAVKEGSLHARDPVGGTTEFLFVPLIKLFYTLLIMGIFHNEDLKHILQLIEPSVFKEAATPEEESDTLEKELSVDDAKLQGAGEEEAKGGKRPKEGLLQMKLPEPVKLQMCLLLQYLCDCQVRHRIEAIVAFSDDFVAKLQDNQRFRYNEVMQALNMSAALTARKTKEFRSPPQEQINMLLNFKDDKSECPCPEEIRDQLLDFHEDLMTHCGIELDEDGSLDGNSDLTIRGRLLSLVEKVTYLKKKQAEKPVESDSKKSSTLQQLISETMVRWAQESVIEDPELVRAMFVLLHRQYDGIGGLVRALPKTYTINGVSVEDTINLLASLGQIRSLLSVRMGKEEEKLMIRGLGDIMNNKVFYQHPNLMRALGMHETVMEVMVNVLGGGESKEITFPKMVANCCRFLCYFCRISRQNQKAMFDHLSYLLENSSVGLASPAMRGSTPLDVAAASVMDNNELALALREPDLEKVVRYLAGCGLQSCQMLVSKGYPDIGWNPVEGERYLDFLRFAVFCNGESVEENANVVVRLLIRRPECFGPALRGEGGNGLLAAMEEAIKIAEDPSRDGPSPNSGSSKTLDTEEEEDDTIHMGNAIMTFYSALIDLLGRCAPEMHLIHAGKGEAIRIRSILRSLIPLGDLVGVISIAFQMPTIAKDGNVVEPDMSAGFCPDHKAAMVLFLDRVYGIEVQDFLLHLLEVGFLPDLRAAASLDTAALSATDMALALNRYLCTAVLPLLTRCAPLFAGTEHHASLIDSLLHTVYRLSKGCSLTKAQRDSIEVCLLSICGQLRPSMMQHLLRRLVFDVPLLNEHAKMPLKLLTNHYERCWKYYCLPGGWGNFGAASEEELHLSRKLFWGIFDALSQKKYEQELFKLALPCLSAVAGALPPDYMESNYVSMMEKQSSMDSEGNFNPQPVDTSNITIPEKLEYFINKYAEHSHDKWSMDKLANGWIYGEIYSDSSKVQPLMKPYKLLSEKEKEIYRWPIKESLKTMLAWGWRIERTREGDSMALYNRTRRISQTSQVSVDAAHGYSPRAIDMSNVTLSRDLHAMAEMMAENYHNIWAKKKKMELESKGGGNHPLLVPYDTLTAKEKAKDREKAQDILKFLQINGYAVSRGFKDLELDTPSIEKRFAYSFLQQLIRYVDEAHQYILEFDGGSRGKGEHFPYEQEIKFFAKVVLPLIDQYFKNHRLYFLSAASRPLCSGGHASNKEKEMVTSLFCKLGVLVRHRISLFGNDATSIVNCLHILGQTLDARTVMKTGLESVKSALRAFLDNAAEDLEKTMENLKQGQFTHTRNQPKGVTQIINYTTVALLPMLSSLFEHIGQHQFGEDLILEDVQVSCYRILTSLYALGTSKSIYVERQRSALGECLAAFAGAFPVAFLETHLDKHNIYSIYNTKSSRERAALSLPTNVEDVCPNIPSLEKLMEEIVELAESGIRYTQMPHVMEVILPMLCSYMSRWWEHGPENNPERAEMCCTALNSEHMNTLLGNILKIIYNNLGIDEGAWMKRLAVFSQPIINKVKPQLLKTHFLPLMEKLKKKAATVVSEEDHLKAEARGDMSEAELLILDEFTTLARDLYAFYPLLIRFVDYNRAKWLKEPNPEAEELFRMVAEVFIYWSKSHNFKREEQNFVVQNEINNMSFLITDTKSKMSKAAVSDQERKKMKRKGDRYSMQTSLIVAALKRLLPIGLNICAPGDQELIALAKNRFSLKDTEDEVRDIIRSNIHLQGKLEDPAIRWQMALYKDLPNRTDDTSDPEKTVERVLDIANVLFHLEQKSKRVGRRHYCLVEHPQRSKKAVWHKLLSKQRKRAVVACFRMAPLYNLPRHRAVNLFLQGYEKSWIETEEHYFEDKLIEDLAKPGAEPPEEDEGTKRVDPLHQLILLFSRTALTEKCKLEEDFLYMAYADIMAKSCHDEEDDDGEEEVKSFEEKEMEKQKLLYQQARLHDRGAAEMVLQTISASKGETGPMVAATLKLGIAILNGGNSTVQQKMLDYLKEKKDVGFFQSLAGLMQSCSVLDLNAFERQNKAEGLGMVTEEGSGEKVLQDDEFTCDLFRFLQLLCEGHNSDFQNYLRTQTGNNTTVNIIISTVDYLLRVQESISDFYWYYSGKDVIDEQGQRNFSKAIQVAKQVFNTLTEYIQGPCTGNQQSLAHSRLWDAVVGFLHVFAHMQMKLSQDSSQIELLKELMDLQKDMVVMLLSMLEGNVVNGTIGKQMVDMLVESSNNVEMILKFFDMFLKLKDLTSSDTFKEYDPDGKGVISKRDFHKAMESHKHYTQSETEFLLSCAETDENETLDYEEFVKRFHEPAKDIGFNVAVLLTNLSEHMPNDTRLQTFLELAESVLNYFQPFLGRIEIMGSAKRIERVYFEISESSRTQWEKPQVKESKRQFIFDVVNEGGEKEKMELFVNFCEDTIFEMQLAAQISESDLNERSANKEESEKERPEEQGPRMAFFSILTVRSALFALRYNILTLMRMLSLKSLKKQMKKVKKMTVKDMVTAFFSSYWSIFMTLLHFVASVFRGFFRIICSLLLGGSLVEGAKKIKVAELLANMPDPTQDEVRGDGEEGERKPLEAALPSEDLTDLKELTEESDLLSDIFGLDLKREGGQYKLIPHNPNAGLSDLMSNPVPMPEVQEKFQEQKAKEEEKEEKEETKSEPEKAEGEDGEKEEKAKEDKGKQKLRQLHTHRYGEPEVPESAFWKKIIAYQQKLLNYFARNFYNMRMLALFVAFAINFILLFYKVSTSSVVEGKELPTRSSSENAKVTSLDSSSHRIIAVHYVLEESSGYMEPTLRILAILHTVISFFCIIGYYCLKVPLVIFKREKEVARKLEFDGLYITEQPSEDDIKGQWDRLVINTQSFPNNYWDKFVKRKVMDKYGEFYGRDRISELLGMDKAALDFSDAREKKKPKKDSSLSAVLNSIDVKYQMWKLGVVFTDNSFLYLAWYMTMSVLGHYNNFFFAAHLLDIAMGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRKFYNKSEDGDTPDMKCDDMLTCYMFHMYVGVRAGGGIGDEIEDPAGDEYEIYRIIFDITFFFFVIVILLAIIQGLIIDAFGELRDQQEQVKEDMETKCFICGIGNDYFDTVPHGFETHTLQEHNLANYLFFLMYLINKDETEHTGQESYVWKMYQERCWEFFPAGDCFRKQYEDQLN'),
('Q99835', '4JKV', 1, 2.45, 'A/B', 366, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Smoothened homolog', 'SMO', '', 'drug binding<br />\nG-protein coupled receptor activity<br />\npatched binding<br />\nWnt-protein binding<br />\n', 'anterior/posterior pattern specification<br />\nastrocyte activation<br />\natrial septum morphogenesis<br />\ncell fate specification<br />\ncellular response to cholesterol<br />\ncentral nervous system neuron differentiation<br />\ncerebellar cortex morphogenesis<br />\ncerebral cortex development<br />\ndentate gyrus development<br />\ndetection of cell density by contact stimulus involved in contact inhibition<br />\ndetermination of left/right asymmetry in lateral mesoderm<br />\ndorsal/ventral neural tube patterning<br />\nepithelial-mesenchymal cell signaling<br />\nforebrain morphogenesis<br />\nhair follicle morphogenesis<br />\nheart looping<br />\nhomeostasis of number of cells within a tissue<br />\nin utero embryonic development<br />\nleft/right axis specification<br />\nmammary gland epithelial cell differentiation<br />\nmesenchymal to epithelial transition involved in metanephric renal vesicle formation<br />\nmidgut development<br />\nmulticellular organism growth<br />\nmyoblast migration<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of DNA binding<br />\nnegative regulation of epithelial cell differentiation<br />\nnegative regulation of gene expression<br />\nnegative regulation of hair follicle development<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nneural crest cell migration<br />\nodontogenesis of dentin-containing tooth<br />\nosteoblast differentiation<br />\npancreas morphogenesis<br />\npositive regulation of branching involved in ureteric bud morphogenesis<br />\npositive regulation of epithelial cell proliferation<br />\npositive regulation of gene expression<br />\npositive regulation of hh target transcription factor activity<br />\npositive regulation of mesenchymal cell proliferation<br />\npositive regulation of multicellular organism growth<br />\npositive regulation of neuroblast proliferation<br />\npositive regulation of organ growth<br />\npositive regulation of protein import into nucleus<br />\npositive regulation of smoothened signaling pathway<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein localization to nucleus<br />\nprotein stabilization<br />\nregulation of heart morphogenesis<br />\nregulation of stem cell population maintenance<br />\nrenal system development<br />\nskeletal muscle fiber development<br />\nsmoothened signaling pathway<br />\nsmoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation<br />\nsmoothened signaling pathway involved in ventral spinal cord patterning<br />\nsomite development<br />\nthalamus development<br />\ntype B pancreatic cell development<br />\nvasculogenesis<br />\nventral midline determination<br />\n', 'PF01534.', 'MAAARPARGPELPLLGLLLLLLLGDPGRGAASSGNATGPGPRSAGGSARRSAAVTGPPPPLSHCGRAAPCEPLRYNVCLGSVLPYGATSTLLAGDSDSQEEAHGKLVLWSGLRNAPRCWAVIQPLLCAVYMPKCENDRVELPSRTLCQATRGPCAIVERERGWPDFLRCTPDRFPEGCTNEVQNIKFNSSGQCEVPLVRTDNPKSWYEDVEGCGIQCQNPLFTEAEHQDMHSYIAAFGAVTGLCTLFTLATFVADWRNSNRYPAVILFYVNACFFVGSIGWLAQFMDGARREIVCRADGTMRLGEPTSNETLSCVIIFVIVYYALMAGVVWFVVLTYAWHTSFKALGTTYQPLSGKTSYFHLLTWSLPFVLTVAILAVAQVDGDSVSGICFVGYKNYRYRAGFVLAPIGLVLIVGGYFLIRGVMTLFSIKSNHPGLLSEKAASKINETMLRLGIFGFLAFGFVLITFSCHFYDFFNQAEWERSFRDYVLCQANVTIGLPTKQPIPDCEIKNRPSLLVEKINLFAMFGTGIAMSTWVWTKATLLIWRRTWCRLTGQSDDEPKRIKKSKMIAKAFSKRHELLQNPGQELSFSMHTVSHDGPVAGLAFDLNEPSADVSSAWAQHVTKMVARRGAILPQDISVTPVATPVPPEEQANLWLVEAEISPELQKRLGRKKKRRKRKKEVCPLAPPPELHPPAPAPSTIPRLPQLPRQKCLVAAGAWGAGDSCRQGAWTLVSNPFCPEPSPPQDPFLPSAPAPVAWAHGRRQGLGPIHSRTNLMDTELMDADSDF'),
('P00749', '4JNI', 1, 1.17, 'U', 247, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Urokinase-type plasminogen activator', 'PLAU', 'Specific cleavage of Arg-|-Val bond in plasminogen to form plasmin.<br />\n', 'serine-type endopeptidase activity<br />\n', 'blood coagulation<br />\nchemotaxis<br />\nfibrinolysis<br />\nneutrophil degranulation<br />\nplasminogen activation<br />\npositive regulation of cell migration<br />\nproteolysis<br />\nregulation of cell adhesion mediated by integrin<br />\nregulation of cell proliferation<br />\nregulation of receptor activity<br />\nregulation of smooth muscle cell-matrix adhesion<br />\nregulation of smooth muscle cell migration<br />\nregulation of wound healing<br />\nresponse to hypoxia<br />\nsignal transduction<br />\nsmooth muscle cell migration<br />\n', 'PF00051.', 'MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKPLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL'),
('P00338', '4JNK', 1, 1.9, 'A/B/C/D', 331, 'OXIDOREDUCTASE / OXIDOREDUCTASE INHIBITOR', 'OXIDOREDUCTASE', 'L-lactate dehydrogenase A chain', 'LDHA', '(S)-lactate + NAD+ = pyruvate + NADH.<br />\n', 'cadherin binding<br />\nidentical protein binding<br />\nkinase binding<br />\nL-lactate dehydrogenase activity<br />\nNAD binding<br />\n', 'glycolytic process<br />\nlactate metabolic process<br />\nNAD metabolic process<br />\npositive regulation of apoptotic process<br />\npost-embryonic animal organ development<br />\npyruvate metabolic process<br />\nresponse to cAMP<br />\nresponse to drug<br />\nresponse to estrogen<br />\nresponse to glucose<br />\nresponse to hydrogen peroxide<br />\nresponse to hypoxia<br />\nresponse to nutrient<br />\nsubstantia nigra development<br />\n', 'PF02866.', 'MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF'),
('P27986', '4JPS', 1, 2.2, 'B', 287, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Phosphatidylinositol 3-kinase regulatory subunit alpha', 'PIK3R1', '', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-3-kinase regulator activity<br />\nErbB-3 class receptor binding<br />\ninsulin binding<br />\ninsulin-like growth factor receptor binding<br />\ninsulin receptor binding<br />\ninsulin receptor substrate binding<br />\nneurotrophin TRKA receptor binding<br />\nphosphatidylinositol 3-kinase binding<br />\nphosphatidylinositol 3-kinase regulator activity<br />\nphosphatidylinositol 3-kinase regulatory subunit binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein heterodimerization activity<br />\nprotein phosphatase binding<br />\ntranscription factor binding<br />\ntransmembrane receptor protein tyrosine kinase adaptor activity<br />\n', 'axon guidance<br />\nB cell differentiation<br />\ncellular glucose homeostasis<br />\ncellular response to insulin stimulus<br />\ncellular response to UV<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nextrinsic apoptotic signaling pathway via death domain receptors<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\ngrowth hormone receptor signaling pathway<br />\ninsulin-like growth factor receptor signaling pathway<br />\ninsulin receptor signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nleukocyte migration<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell-matrix adhesion<br />\nnegative regulation of osteoclast differentiation<br />\nNFAT protein import into nucleus<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol phosphorylation<br />\nplatelet activation<br />\npositive regulation of cell migration<br />\npositive regulation of endoplasmic reticulum unfolded protein response<br />\npositive regulation of glucose import<br />\npositive regulation of glucose import in response to insulin stimulus<br />\npositive regulation of protein localization to plasma membrane<br />\npositive regulation of RNA splicing<br />\npositive regulation of transcription factor import into nucleus<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of tumor necrosis factor production<br />\nprotein phosphorylation<br />\nprotein stabilization<br />\nregulation of insulin receptor signaling pathway<br />\nregulation of phosphatidylinositol 3-kinase activity<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of stress fiber assembly<br />\nresponse to endoplasmic reticulum stress<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nviral process<br />\n', 'PF16454.', 'MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR'),
('P42336', '4JPS', 1, 2.2, 'A', 1068, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform', 'PIK3CA', 'ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate<br />\nATP + a protein = ADP + a phosphoprotein<br />\n', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-4-phosphate 3-kinase activity<br />\nATP binding<br />\ninsulin receptor substrate binding<br />\nkinase activity<br />\nphosphatidylinositol 3-kinase activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein kinase activator activity<br />\nprotein serine/threonine kinase activity<br />\n', 'adaptive immune response<br />\nadipose tissue development<br />\nangiogenesis<br />\nanoikis<br />\naxon guidance<br />\ncardiac muscle contraction<br />\ncell chemotaxis<br />\ncellular response to glucose stimulus<br />\nendothelial cell migration<br />\nenergy homeostasis<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nglucose metabolic process<br />\nhypomethylation of CpG island<br />\ninflammatory response<br />\ninnate immune response<br />\ninsulin receptor signaling pathway via phosphatidylinositol 3-kinase<br />\ninterleukin-7-mediated signaling pathway<br />\nleukocyte migration<br />\nliver development<br />\nnegative regulation of anoikis<br />\nnegative regulation of fibroblast apoptotic process<br />\nnegative regulation of macroautophagy<br />\nnegative regulation of neuron apoptotic process<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol phosphorylation<br />\nphosphorylation<br />\nplatelet activation<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of TOR signaling<br />\nprotein kinase B signaling<br />\nprotein phosphorylation<br />\nregulation of cellular respiration<br />\nregulation of gene expression<br />\nregulation of genetic imprinting<br />\nregulation of multicellular organism growth<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nvasculature development<br />\n', 'PF00454.', 'MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN'),
('P30518', '4JQI', 0, 2.6, 'V', 29, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Vasopressin V2 receptor', 'AVPR2', '', 'peptide binding<br />\nvasopressin receptor activity<br />\n', 'activation of adenylate cyclase activity<br />\nadenylate cyclase-modulating G-protein coupled receptor signaling pathway<br />\ncellular response to hormone stimulus<br />\nexcretion<br />\nhemostasis<br />\nI-kappaB kinase/NF-kappaB signaling<br />\ninterferon-gamma production<br />\nmembrane organization<br />\nnegative regulation of renal sodium excretion<br />\nnegative regulation of urine volume<br />\npositive regulation of cell proliferation<br />\npositive regulation of gene expression<br />\npositive regulation of protein ubiquitination<br />\npositive regulation of systemic arterial blood pressure<br />\npositive regulation of vasoconstriction<br />\nregulation of systemic arterial blood pressure by vasopressin<br />\nrenal water homeostasis<br />\nresponse to cytokine<br />\nresponse to peptide<br />\ntelencephalon development<br />\n', 'PF00001.', 'MLMASTTSAVPGHPSLPSLPSNSSQERPLDTRDPLLARAELALLSIVFVAVALSNGLVLAALARRGRRGHWAPIHVFIGHLCLADLAVALFQVLPQLAWKATDRFRGPDALCRAVKYLQMVGMYASSYMILAMTLDRHRAICRPMLAYRHGSGAHWNRPVLVAWAFSLLLSLPQLFIFAQRNVEGGSGVTDCWACFAEPWGRRTYVTWIALMVFVAPTLGIAACQVLIFREIHASLVPGPSERPGGRRRGRRTGSPGEGAHVSAAVAKTVRMTLVIVVVYVLCWAPFFLVQLWAAWDPEAPLEGAPFVLLMLLASLNSCTNPWIYASFSSSVSSELRSLLCCARGRTPPSLGPQDESCTTASSSLAKDTSS'),
('P22607', '4K33', 1, 2.34, 'A', 311, 'TRANSFERASE', 'TRANSFERASE', 'Fibroblast growth factor receptor 3', 'FGFR3', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', '1-phosphatidylinositol-3-kinase activity<br />\nATP binding<br />\nfibroblast growth factor-activated receptor activity<br />\nfibroblast growth factor binding<br />\nidentical protein binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\n', 'bone maturation<br />\nbone mineralization<br />\nbone morphogenesis<br />\ncell-cell signaling<br />\nchondrocyte differentiation<br />\nchondrocyte proliferation<br />\nendochondral bone growth<br />\nendochondral ossification<br />\nfibroblast growth factor receptor apoptotic signaling pathway<br />\nfibroblast growth factor receptor signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nJAK-STAT cascade<br />\nMAPK cascade<br />\nnegative regulation of developmental growth<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of MAPK cascade<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phospholipase activity<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nprotein autophosphorylation<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nskeletal system development<br />\n', 'PF07679.', 'MGAPACALALCVAVAIVAGASSESLGTEQRVVGRAAEVPGPEPGQQEQLVFGSGDAVELSCPPPGGGPMGPTVWVKDGTGLVPSERVLVGPQRLQVLNASHEDSGAYSCRQRLTQRVLCHFSVRVTDAPSSGDDEDGEDEAEDTGVDTGAPYWTRPERMDKKLLAVPAANTVRFRCPAAGNPTPSISWLKNGREFRGEHRIGGIKLRHQQWSLVMESVVPSDRGNYTCVVENKFGSIRQTYTLDVLERSPHRPILQAGLPANQTAVLGSDVEFHCKVYSDAQPHIQWLKHVEVNGSKVGPDGTPYVTVLKTAGANTTDKELEVLSLHNVTFEDAGEYTCLAGNSIGFSHHSAWLVVLPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLRSPPKKGLGSPTVHKISRFPLKRQVSLESNASMSSNTPLVRIARLSSGEGPTLANVSELELPADPKWELSRARLTLGKPLGEGCFGQVVMAEAIGIDKDRAAKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAKGNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSAPFEQYSPGGQDTPSSSSSGDDSVFAHDLLPPAPPSSGGSRT'),
('O14920', '4KIK', 1, 2.83, 'A/B', 663, 'TRANSFERASE', 'TRANSFERASE', 'Inhibitor of nuclear factor kappa-B kinase subunit beta', 'IKBKB', 'ATP + [I-kappa-B protein] = ADP + [I-kappa-B phosphoprotein].<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nIkappaB kinase activity<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\nprotein serine/threonine kinase activity<br />\nscaffold protein binding<br />\n', 'anatomical structure morphogenesis<br />\nantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\ncellular response to tumor necrosis factor<br />\ncortical actin cytoskeleton organization<br />\nFc-epsilon receptor signaling pathway<br />\nI-kappaB kinase/NF-kappaB signaling<br />\ninflammatory response<br />\ninnate immune response<br />\ninterleukin-1-mediated signaling pathway<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of bicellular tight junction assembly<br />\nnegative regulation of myosin-light-chain-phosphatase activity<br />\nnucleotide-binding oligomerization domain containing signaling pathway<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprotein localization to plasma membrane<br />\nprotein phosphorylation<br />\nregulation of establishment of endothelial barrier<br />\nregulation of phosphorylation<br />\nregulation of tumor necrosis factor-mediated signaling pathway<br />\nresponse to virus<br />\nserine phosphorylation of STAT protein<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nstress-activated MAPK cascade<br />\nT cell receptor signaling pathway<br />\nTRIF-dependent toll-like receptor signaling pathway<br />\ntumor necrosis factor-mediated signaling pathway<br />\n', 'PF12179.', 'MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS'),
('P14207', '4KN0', 1, 2.1, 'A', 205, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Folate receptor beta', 'FOLR2', '', 'drug binding<br />\nfolic acid binding<br />\nfolic acid receptor activity<br />\nfolic acid transporter activity<br />\nmethotrexate binding<br />\n', 'C-terminal protein lipidation<br />\nfolic acid metabolic process<br />\nfolic acid transport<br />\ninflammatory response<br />\npositive regulation of cell proliferation<br />\nreceptor-mediated endocytosis<br />\nregulation of thymidylate synthase biosynthetic process<br />\n', 'PF03024.', 'MVWKWMPLLLLLVCVATMCSAQDRTDLLNVCMDAKHHKTKPGPEDKLHDQCSPWKKNACCTASTSQELHKDTSRLYNFNWDHCGKMEPACKRHFIQDTCLYECSPNLGPWIQQVNQSWRKERFLDVPLCKEDCQRWWEDCHTSHTCKSNWHRGWDWTSGVNKCPAGALCRTFESYFPTPAALCEGLWSHSYKVSNYSRGSGRCIQMWFDSAQGNPNEEVARFYAAAMHVNAGEMLHGTGGLLLSLALMLQLWLLG'),
('Q8N1Q1', '4KNN', 1, 1.4, 'A/B', 262, 'LYASE / LYASE INHIBITOR', 'LYASE', 'Carbonic anhydrase 13', 'CA13', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\none-carbon metabolic process<br />\n', 'PF00194.', 'MSRLSWGYREHNGPIHWKEFFPIADGDQQSPIEIKTKEVKYDSSLRPLSIKYDPSSAKIISNSGHSFNVDFDDTENKSVLRGGPLTGSYRLRQVHLHWGSADDHGSEHIVDGVSYAAELHVVHWNSDKYPSFVEAAHEPDGLAVLGVFLQIGEPNSQLQKITDTLDSIKEKGKQTRFTNFDLLSLLPPSWDYWTYPGSLTVPPLLESVTWIVLKQPINISSQQLAKFRSLLCTAEGEAAAFLVSNHRPPQPLKGRKVRASFH'),
('Q07343', '4KP6', 1, 1.5, 'A', 336, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'cAMP-specific 3'',5''-cyclic phosphodiesterase 4B', 'PDE4B', 'Adenosine 3'',5''-cyclic phosphate + H2O = adenosine 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\ncAMP binding<br />\ngamma-tubulin binding<br />\nion channel binding<br />\nmetal ion binding<br />\n', 'cAMP catabolic process<br />\ncellular response to drug<br />\ncellular response to epinephrine stimulus<br />\ncellular response to lipopolysaccharide<br />\nleukocyte migration<br />\nnegative regulation of relaxation of cardiac muscle<br />\nneutrophil chemotaxis<br />\nneutrophil homeostasis<br />\npositive regulation of interferon-gamma production<br />\npositive regulation of interleukin-2 production<br />\nregulation of cardiac muscle cell contraction<br />\nregulation of high voltage-gated calcium channel activity<br />\nT cell receptor signaling pathway<br />\n', 'PF00233.', 'MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT'),
('Q05603', '4KQI', 1, 1.4, 'A', 356, 'TRANSFERASE', 'TRANSFERASE', 'Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase', 'cobT', 'Beta-nicotinate D-ribonucleotide + 5,6-dimethylbenzimidazole = nicotinate + alpha-ribazole 5''-phosphate<br />\n', 'nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity<br />\nnucleotide binding<br />\n', 'cobalamin biosynthetic process<br />\nnucleoside biosynthetic process<br />\n', 'PF02277.', 'MQTLHALLRDIPAPDAEAMARAQQHIDGLLKPPGSLGRLETLAVQLAGMPGLNGTPQVGEKAVLVMCADHGVWDEGVAVSPKIVTAIQAANMTRGTTGVCVLAAQAGAKVHVIDVGIDAEPIPGVVNMRVARGCGNIAVGPAMSRLQAEALLLEVSRYTCDLAQRGVTLFGVGELGMANTTPAAAMVSVFTGSDAKEVVGIGANLPPSRIDNKVDVVRRAIAINQPNPRDGIDVLSKVGGFDLVGMTGVMLGAARCGLPVLLDGFLSYSAALAACQIAPAVRPYLIPSHFSAEKGARIALAHLSMEPYLHMAMRLGEGSGAALAMPIVEAACAMFHNMGELAASNIVLPEGNANAT'),
('Q9NY72', '4L1D', 0, 2.5, 'A/B/C', 121, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Sodium channel subunit beta-3', 'SCN3B', '', 'ion channel binding<br />\nsodium channel regulator activity<br />\nvoltage-gated sodium channel activity<br />\nvoltage-gated sodium channel activity involved in cardiac muscle cell action potential<br />\n', 'atrial cardiac muscle cell action potential<br />\ncardiac muscle cell action potential involved in contraction<br />\ncardiac muscle contraction<br />\nmembrane depolarization<br />\nmembrane depolarization during action potential<br />\nmembrane depolarization during cardiac muscle cell action potential<br />\nnervous system development<br />\npositive regulation of heart rate<br />\npositive regulation of sodium ion transport<br />\nprotein localization to plasma membrane<br />\nregulation of atrial cardiac muscle cell membrane depolarization<br />\nregulation of heart rate by cardiac conduction<br />\nregulation of sodium ion transmembrane transporter activity<br />\nregulation of ventricular cardiac muscle cell membrane depolarization<br />\nSA node cell action potential<br />\nsensory perception of pain<br />\nsodium ion transmembrane transport<br />\nsodium ion transport<br />\nventricular cardiac muscle cell action potential<br />\n', 'PF07686.', 'MPAFNRLFPLASLVLIYWVSVCFPVCVEVPSETEAVQGNPMKLRCISCMKREEVEATTVVEWFYRPEGGKDFLIYEYRNGHQEVESPFQGRLQWNGSKDLQDVSITVLNVTLNDSGLYTCNVSREFEFEAHRPFVKTTRLIPLRVTEEAGEDFTSVVSEIMMYILLVFLTLWLLIEMIYCYRKVSKAEEAAQENASDYLAIPSENKENSAVPVEE'),
('P27986', '4L23', 1, 2.5, 'B', 298, 'signaling Protein / transferase / Inhibitor', 'TRANSFERASE', 'Phosphatidylinositol 3-kinase regulatory subunit alpha', 'PIK3R1', '', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-3-kinase regulator activity<br />\nErbB-3 class receptor binding<br />\ninsulin binding<br />\ninsulin-like growth factor receptor binding<br />\ninsulin receptor binding<br />\ninsulin receptor substrate binding<br />\nneurotrophin TRKA receptor binding<br />\nphosphatidylinositol 3-kinase binding<br />\nphosphatidylinositol 3-kinase regulator activity<br />\nphosphatidylinositol 3-kinase regulatory subunit binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein heterodimerization activity<br />\nprotein phosphatase binding<br />\ntranscription factor binding<br />\ntransmembrane receptor protein tyrosine kinase adaptor activity<br />\n', 'axon guidance<br />\nB cell differentiation<br />\ncellular glucose homeostasis<br />\ncellular response to insulin stimulus<br />\ncellular response to UV<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nextrinsic apoptotic signaling pathway via death domain receptors<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\ngrowth hormone receptor signaling pathway<br />\ninsulin-like growth factor receptor signaling pathway<br />\ninsulin receptor signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nleukocyte migration<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell-matrix adhesion<br />\nnegative regulation of osteoclast differentiation<br />\nNFAT protein import into nucleus<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol phosphorylation<br />\nplatelet activation<br />\npositive regulation of cell migration<br />\npositive regulation of endoplasmic reticulum unfolded protein response<br />\npositive regulation of glucose import<br />\npositive regulation of glucose import in response to insulin stimulus<br />\npositive regulation of protein localization to plasma membrane<br />\npositive regulation of RNA splicing<br />\npositive regulation of transcription factor import into nucleus<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of tumor necrosis factor production<br />\nprotein phosphorylation<br />\nprotein stabilization<br />\nregulation of insulin receptor signaling pathway<br />\nregulation of phosphatidylinositol 3-kinase activity<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of stress fiber assembly<br />\nresponse to endoplasmic reticulum stress<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nviral process<br />\n', 'PF16454.', 'MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR'),
('P42336', '4L23', 1, 2.5, 'A', 1068, 'signaling Protein / transferase / Inhibitor', 'TRANSFERASE', 'Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform', 'PIK3CA', 'ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate<br />\nATP + a protein = ADP + a phosphoprotein<br />\n', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-4-phosphate 3-kinase activity<br />\nATP binding<br />\ninsulin receptor substrate binding<br />\nkinase activity<br />\nphosphatidylinositol 3-kinase activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein kinase activator activity<br />\nprotein serine/threonine kinase activity<br />\n', 'adaptive immune response<br />\nadipose tissue development<br />\nangiogenesis<br />\nanoikis<br />\naxon guidance<br />\ncardiac muscle contraction<br />\ncell chemotaxis<br />\ncellular response to glucose stimulus<br />\nendothelial cell migration<br />\nenergy homeostasis<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nglucose metabolic process<br />\nhypomethylation of CpG island<br />\ninflammatory response<br />\ninnate immune response<br />\ninsulin receptor signaling pathway via phosphatidylinositol 3-kinase<br />\ninterleukin-7-mediated signaling pathway<br />\nleukocyte migration<br />\nliver development<br />\nnegative regulation of anoikis<br />\nnegative regulation of fibroblast apoptotic process<br />\nnegative regulation of macroautophagy<br />\nnegative regulation of neuron apoptotic process<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol phosphorylation<br />\nphosphorylation<br />\nplatelet activation<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of TOR signaling<br />\nprotein kinase B signaling<br />\nprotein phosphorylation<br />\nregulation of cellular respiration<br />\nregulation of gene expression<br />\nregulation of genetic imprinting<br />\nregulation of multicellular organism growth<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nvasculature development<br />\n', 'PF00454.', 'MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN'),
('P00183', '4L4E', 1, 1.26, 'A', 415, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Camphor 5-monooxygenase', 'camC', '+-camphor + reduced putidaredoxin + O2 = (+)-exo-5-hydroxycamphor + oxidized putidaredoxin + H2O.<br />\n', 'camphor 5-monooxygenase activity<br />\nheme binding<br />\niron ion binding<br />\n', '(+)-camphor catabolic process<br />\n', 'PF00067.', 'MTTETIQSNANLAPLPPHVPEHLVFDFDMYNPSNLSAGVQEAWAVLQESNVPDLVWTRCNGGHWIATRGQLIREAYEDYRHFSSECPFIPREAGEAYDFIPTSMDPPEQRQFRALANQVVGMPVVDKLENRIQELACSLIESLRPQGQCNFTEDYAEPFPIRIFMLLAGLPEEDIPHLKYLTDQMTRPDGSMTFAEAKEALYDYLIPIIEQRRQKPGTDAISIVANGQVNGRPITSDEAKRMCGLLLVGGLDTVVNFLSFSMEFLAKSPEHRQELIERPERIPAACEELLRRFSLVADGRILTSDYEFHGVQLKKGDQILLPQMLSGLDERENACPMHVDFSRQKVSHTTFGHGSHLCLGQHLARREIIVTLKEWLTRIPDFSIAPGAQIQHKSGIVSGVQALPLVWDPATTKAV');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P49591', '4L87', 1, 2.9, 'A', 476, 'LIGASE', 'LIGASE', 'Serine--tRNA ligase, cytoplasmic', 'SARS', 'ATP + L-serine + tRNA(Ser) = AMP + diphosphate + L-seryl-tRNA(Ser)<br />\nATP + L-serine + tRNA(Sec) = AMP + diphosphate + L-seryl-tRNA(Sec)<br />\n', 'ATP binding<br />\ncore promoter sequence-specific DNA binding<br />\nprotein homodimerization activity<br />\nRNA binding<br />\nselenocysteine-tRNA ligase activity<br />\nserine-tRNA ligase activity<br />\n', 'negative regulation of angiogenesis<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of vascular endothelial growth factor production<br />\nselenocysteine metabolic process<br />\nselenocysteinyl-tRNA(Sec) biosynthetic process<br />\nseryl-tRNA aminoacylation<br />\ntranscription, DNA-templated<br />\ntranslation<br />\ntRNA aminoacylation for protein translation<br />\ntRNA processing<br />\n', 'PF02403.', 'MVLDLDLFRVDKGGDPALIRETQEKRFKDPGLVDQLVKADSEWRRCRFRADNLNKLKNLCSKTIGEKMKKKEPVGDDESVPENVLSFDDLTADALANLKVSQIKKVRLLIDEAILKCDAERIKLEAERFENLREIGNLLHPSVPISNDEDVDNKVERIWGDCTVRKKYSHVDLVVMVDGFEGEKGAVVAGSRGYFLKGVLVFLEQALIQYALRTLGSRGYIPIYTPFFMRKEVMQEVAQLSQFDEELYKVIGKGSEKSDDNSYDEKYLIATSEQPIAALHRDEWLRPEDLPIKYAGLSTCFRQEVGSHGRDTRGIFRVHQFEKIEQFVYSSPHDNKSWEMFEEMITTAEEFYQSLGIPYHIVNIVSGSLNHAASKKLDLEAWFPGSGAFRELVSCSNCTDYQARRLRIRYGQTKKMMDKVEFVHMLNATMCATTRTICAILENYQTEKGITVPEKLKEFMPPGLQELIPFVKPAPIEQEPSKKQKKQHEGSKKKAAARDVTLENRLQNMEVTDA'),
('P02768', '4L8U', 1, 2.01, 'A', 585, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Serum albumin', 'ALB', '', 'antioxidant activity<br />\nchaperone binding<br />\ncopper ion binding<br />\nDNA binding<br />\ndrug binding<br />\nfatty acid binding<br />\nidentical protein binding<br />\npyridoxal phosphate binding<br />\ntoxic substance binding<br />\n', 'bile acid and bile salt transport<br />\ncellular protein metabolic process<br />\ncellular response to starvation<br />\nhemolysis by symbiont of host erythrocytes<br />\nhigh-density lipoprotein particle remodeling<br />\nmaintenance of mitochondrion location<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of programmed cell death<br />\nplatelet degranulation<br />\npost-translational protein modification<br />\nreceptor-mediated endocytosis<br />\nretina homeostasis<br />\nsodium-independent organic anion transport<br />\ntransport<br />\n', 'PF00273.', 'MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL'),
('P10415', '4LXD', 1, 1.9, 'A', 34, 'APOPTOSIS REGULATOR / INHIBITOR', 'OTHERS', 'Apoptosis regulator Bcl-2', 'BCL2', '', 'BH3 domain binding<br />\nchannel activity<br />\nchannel inhibitor activity<br />\nidentical protein binding<br />\nprotease binding<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nprotein phosphatase 2A binding<br />\nsequence-specific DNA binding<br />\ntranscription factor binding<br />\nubiquitin protein ligase binding<br />\n', 'actin filament organization<br />\napoptotic process<br />\naxonogenesis<br />\naxon regeneration<br />\nB cell homeostasis<br />\nB cell lineage commitment<br />\nB cell proliferation<br />\nB cell receptor signaling pathway<br />\nbehavioral fear response<br />\nbranching involved in ureteric bud morphogenesis<br />\nCD8-positive, alpha-beta T cell lineage commitment<br />\ncell aging<br />\ncell-cell adhesion<br />\ncell growth<br />\ncellular response to DNA damage stimulus<br />\ncellular response to glucose starvation<br />\ncellular response to hypoxia<br />\ncellular response to organic substance<br />\ncochlear nucleus development<br />\ndefense response to virus<br />\ndigestive tract morphogenesis<br />\near development<br />\nendoplasmic reticulum calcium ion homeostasis<br />\nextrinsic apoptotic signaling pathway in absence of ligand<br />\nextrinsic apoptotic signaling pathway via death domain receptors<br />\nfemale pregnancy<br />\nfocal adhesion assembly<br />\ngland morphogenesis<br />\nglomerulus development<br />\nhair follicle morphogenesis<br />\nhomeostasis of number of cells within a tissue<br />\nhumoral immune response<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nintrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress<br />\nintrinsic apoptotic signaling pathway in response to oxidative stress<br />\nlymphoid progenitor cell differentiation<br />\nmale gonad development<br />\nmelanin metabolic process<br />\nmelanocyte differentiation<br />\nmesenchymal cell development<br />\nmetanephros development<br />\nnegative regulation of anoikis<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of apoptotic signaling pathway<br />\nnegative regulation of autophagy<br />\nnegative regulation of calcium ion transport into cytosol<br />\nnegative regulation of cell growth<br />\nnegative regulation of cell migration<br />\nnegative regulation of cellular pH reduction<br />\nnegative regulation of extrinsic apoptotic signaling pathway in absence of ligand<br />\nnegative regulation of G1/S transition of mitotic cell cycle<br />\nnegative regulation of intrinsic apoptotic signaling pathway<br />\nnegative regulation of mitochondrial depolarization<br />\nnegative regulation of myeloid cell apoptotic process<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of ossification<br />\nnegative regulation of osteoblast proliferation<br />\nnegative regulation of reactive oxygen species metabolic process<br />\nnegative regulation of retinal cell programmed cell death<br />\nneuron apoptotic process<br />\noocyte development<br />\norgan growth<br />\nossification<br />\novarian follicle development<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\npigment granule organization<br />\npositive regulation of B cell proliferation<br />\npositive regulation of catalytic activity<br />\npositive regulation of cell growth<br />\npositive regulation of intrinsic apoptotic signaling pathway<br />\npositive regulation of melanocyte differentiation<br />\npositive regulation of multicellular organism growth<br />\npositive regulation of neuron maturation<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway<br />\npositive regulation of skeletal muscle fiber development<br />\npositive regulation of smooth muscle cell migration<br />\npost-embryonic development<br />\nprotein dephosphorylation<br />\nprotein polyubiquitination<br />\nreactive oxygen species metabolic process<br />\nregulation of calcium ion transport<br />\nregulation of cell-matrix adhesion<br />\nregulation of gene expression<br />\nregulation of glycoprotein biosynthetic process<br />\nregulation of mitochondrial membrane permeability<br />\nregulation of mitochondrial membrane potential<br />\nregulation of nitrogen utilization<br />\nregulation of protein heterodimerization activity<br />\nregulation of protein homodimerization activity<br />\nregulation of protein stability<br />\nregulation of transmembrane transporter activity<br />\nregulation of viral genome replication<br />\nrelease of cytochrome c from mitochondria<br />\nrenal system process<br />\nresponse to cytokine<br />\nresponse to drug<br />\nresponse to gamma radiation<br />\nresponse to glucocorticoid<br />\nresponse to hydrogen peroxide<br />\nresponse to iron ion<br />\nresponse to ischemia<br />\nresponse to nicotine<br />\nresponse to radiation<br />\nresponse to toxic substance<br />\nresponse to UV-B<br />\nspleen development<br />\nT cell differentiation in thymus<br />\nT cell homeostasis<br />\nthymus development<br />\n', 'PF00452.', 'MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK'),
('Q92769', '4LY1', 1, 1.57, 'A/B/C', 369, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Histone deacetylase 2', 'HDAC2', 'Hydrolysis of an N6-acetyl-lysine residue of a histone to yield a deacetylated histone.<br />\n', 'chromatin binding<br />\ncore promoter binding<br />\ndeacetylase activity<br />\nenzyme binding<br />\nheat shock protein binding<br />\nhistone deacetylase activity<br />\nhistone deacetylase binding<br />\nNAD-dependent histone deacetylase activity (H3-K14 specific)<br />\nNF-kappaB binding<br />\nprotein deacetylase activity<br />\nRNA binding<br />\nRNA polymerase II repressing transcription factor binding<br />\nsequence-specific DNA binding<br />\ntranscription factor binding<br />\n', 'ATP-dependent chromatin remodeling<br />\nbehavioral response to ethanol<br />\nblood coagulation<br />\ncardiac muscle hypertrophy<br />\ncellular response to dopamine<br />\ncellular response to heat<br />\ncellular response to hydrogen peroxide<br />\ncellular response to retinoic acid<br />\ncellular response to transforming growth factor beta stimulus<br />\nchromatin remodeling<br />\ncircadian regulation of gene expression<br />\ndendrite development<br />\nembryonic digit morphogenesis<br />\nepidermal cell differentiation<br />\neyelid development in camera-type eye<br />\nfungiform papilla formation<br />\nhair follicle placode formation<br />\nhistone deacetylation<br />\nhistone H3 deacetylation<br />\nhistone H4 deacetylation<br />\nmaintenance of chromatin silencing<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of dendritic spine development<br />\nnegative regulation of DNA binding<br />\nnegative regulation of MHC class II biosynthetic process<br />\nnegative regulation of neuron projection development<br />\nnegative regulation of peptidyl-lysine acetylation<br />\nnegative regulation of sequence-specific DNA binding transcription factor activity<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nodontogenesis of dentin-containing tooth<br />\npositive regulation of cell proliferation<br />\npositive regulation of collagen biosynthetic process<br />\npositive regulation of epithelial to mesenchymal transition<br />\npositive regulation of interleukin-1 production<br />\npositive regulation of oligodendrocyte differentiation<br />\npositive regulation of proteolysis<br />\npositive regulation of receptor biosynthetic process<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of tumor necrosis factor production<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nregulation of signal transduction by p53 class mediator<br />\nresponse to amphetamine<br />\nresponse to caffeine<br />\nresponse to cocaine<br />\nresponse to drug<br />\nresponse to hyperoxia<br />\nresponse to lipopolysaccharide<br />\nresponse to nicotine<br />\ntranscription, DNA-templated<br />\n', 'PF00850.', 'MAYSQGGGKKKVCYYYDGDIGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKATAEEMTKYHSDEYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVAGAVKLNRQQTDMAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNFPMRDGIDDESYGQIFKPIISKVMEMYQPSAVVLQCGADSLSGDRLGCFNLTVKGHAKCVEVVKTFNLPLLMLGGGGYTIRNVARCWTYETAVALDCEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTPEYMEKIKQRLFENLRMLPHAPGVQMQAIPEDAVHEDSGDEDGEDPDKRISIRASDKRIACDEEFSDSEDEGEGGRRNVADHKKGAKKARIEEDKKETEDKKTDVKEEDKSKDNSGEKTDTKGTKSEQLSNP'),
('P22303', '4M0E', 1, 2, 'A/B', 542, 'hydrolase / hydrolase inhibitor', 'HYDROLASE', 'Acetylcholinesterase', 'ACHE', 'Acetylcholine + H2O = choline + acetate.<br />\n', 'acetylcholine binding<br />\nacetylcholinesterase activity<br />\namyloid-beta binding<br />\ncholinesterase activity<br />\ncollagen binding<br />\nhydrolase activity<br />\nlaminin binding<br />\nprotein homodimerization activity<br />\nprotein self-association<br />\nserine hydrolase activity<br />\n', 'acetylcholine catabolic process<br />\nacetylcholine catabolic process in synaptic cleft<br />\namyloid precursor protein metabolic process<br />\ncell adhesion<br />\ncell proliferation<br />\nDNA replication<br />\nmuscle organ development<br />\nnegative regulation of synaptic transmission, cholinergic<br />\nnervous system development<br />\nneurotransmitter biosynthetic process<br />\nneurotransmitter receptor biosynthetic process<br />\nosteoblast development<br />\nphosphatidylcholine biosynthetic process<br />\npositive regulation of protein secretion<br />\nprotein tetramerization<br />\nreceptor internalization<br />\nregulation of receptor recycling<br />\nresponse to wounding<br />\nretina development in camera-type eye<br />\nsynapse assembly<br />\n', 'PF08674.', 'MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLDEAERQWKAEFHRWSSYMVHWKNQFDHYSKQDRCSDL'),
('Q93088', '4M3P', 1, 1.9, 'A/B/C/D', 406, 'TRANSFERASE', 'TRANSFERASE', 'Betaine--homocysteine S-methyltransferase 1', 'BHMT', 'Trimethylammonioacetate + L-homocysteine = dimethylglycine + L-methionine.<br />\n', 'betaine-homocysteine S-methyltransferase activity<br />\nzinc ion binding<br />\n', 'amino-acid betaine catabolic process<br />\namino-acid betaine metabolic process<br />\ncholine catabolic process<br />\nL-methionine salvage<br />\nprotein methylation<br />\nregulation of homocysteine metabolic process<br />\nsulfur amino acid metabolic process<br />\n', 'PF02574.', 'MPPVGGKKAKKGILERLNAGEIVIGDGGFVFALEKRGYVKAGPWTPEAAVEHPEAVRQLHREFLRAGSNVMQTFTFYASEDKLENRGNYVLEKISGQEVNEAACDIARQVADEGDALVAGGVSQTPSYLSCKSETEVKKVFLQQLEVFMKKNVDFLIAEYFEHVEEAVWAVETLIASGKPVAATMCIGPEGDLHGVPPGECAVRLVKAGASIIGVNCHFDPTISLKTVKLMKEGLEAARLKAHLMSQPLAYHTPDCNKQGFIDLPEFPFGLEPRVATRWDIQKYAREAYNLGVRYIGGCCGFEPYHIRAIAEELAPERGFLPPASEKHGSWGSGLDMHTKPWVRARARKEYWENLRIASGRPYNPSMSKPDGWGVTKGTAELMQQKEATTEQQLKELFEKQKFKSQ'),
('P51681', '4MBS', 1, 2.71, 'A/B', 351, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'C-C chemokine receptor type 5', 'CCR5', '', 'actin binding<br />\nC-C chemokine binding<br />\nC-C chemokine receptor activity<br />\nchemokine (C-C motif) ligand 5 binding<br />\nchemokine receptor activity<br />\ncoreceptor activity<br />\nphosphatidylinositol phospholipase C activity<br />\nvirus receptor activity<br />\n', 'calcium ion transport<br />\ncalcium-mediated signaling<br />\ncell-cell signaling<br />\ncell surface receptor signaling pathway<br />\ncellular defense response<br />\ncellular response to lipopolysaccharide<br />\nchemotaxis<br />\ndendritic cell chemotaxis<br />\nentry into host cell<br />\nfusion of virus membrane with host plasma membrane<br />\nG-protein coupled receptor signaling pathway<br />\nimmune response<br />\ninflammatory response<br />\nMAPK cascade<br />\npositive regulation of cytosolic calcium ion concentration<br />\nrelease of sequestered calcium ion into cytosol by sarcoplasmic reticulum<br />\nresponse to cholesterol<br />\nsignaling<br />\n', 'PF00001.', 'MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKRLKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFIILLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSSHFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTIMIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFVGEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL'),
('P23945', '4MQW', 1, 2.9, 'X/Y/Z', 351, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Follicle-stimulating hormone receptor', 'FSHR', '', 'follicle-stimulating hormone receptor activity<br />\nG-protein coupled peptide receptor activity<br />\n', 'activation of adenylate cyclase activity<br />\nadenylate cyclase-activating G-protein coupled receptor signaling pathway<br />\ncellular response to follicle-stimulating hormone stimulus<br />\nfemale gamete generation<br />\nfemale gonad development<br />\nfollicle-stimulating hormone signaling pathway<br />\ngonad development<br />\nG-protein coupled receptor signaling pathway<br />\nhormone-mediated signaling pathway<br />\nmale gonad development<br />\npositive regulation of adenylate cyclase activity<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\nprimary ovarian follicle growth<br />\nregulation of osteoclast differentiation<br />\nregulation of protein kinase A signaling<br />\nspermatogenesis<br />\n', 'PF00001.', 'MALLLVSLLAFLSLGSGCHHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNEVVDVTCSPKPDAFNPCEDIMGYNILRVLIWFISILAITGNIIVLVILTTSQYKLTVPRFLMCNLAFADLCIGIYLLLIASVDIHTKSQYHNYAIDWQTGAGCDAAGFFTVFASELSVYTLTAITLERWHTITHAMQLDCKVQLRHAASVMVMGWIFAFAAALFPIFGISSYMKVSICLPMDIDSPLSQLYVMSLLVLNVLAFVVICGCYIHIYLTVRNPNIVSSSSDTRIAKRMAMLIFTDFLCMAPISFFAISASLKVPLITVSKAKILLVLFHPINSCANPFLYAIFTKNFRRDFFILLSKCGCYEMQAQIYRTETSSTVHNTHPRNGHCSSAPRVTNGSTYILVPLSHLAQN'),
('O75899', '4MR7', 1, 2.15, 'A', 412, 'SIGNALING PROTEIN / ANTAGONIST', 'SIGNALING_PROT', 'Gamma-aminobutyric acid type B receptor subunit 1', 'GABBR1', '', 'G-protein coupled GABA receptor activity<br />\n', 'adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway<br />\ngamma-aminobutyric acid signaling pathway<br />\nnegative regulation of adenylate cyclase activity<br />\n', 'PF00003.', 'MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQVKAINFLPVDYEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCVRICSKSYLTLENGKVFLTGGDLPALDGARVDFRCDPDFHLVGSSRSICSQGQWSTPKPHCQVNRTPHSERRAVYIGALFPMSGGWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDSKCDPGQATKYLYELLYNDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHNPTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNLKRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDEMTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAIWALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRMAWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFISVSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHIGRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATVGLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFYGYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAFAFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKENRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGSRVHLLYK'),
('Q9UBS5', '4MS4', 1, 1.9, 'A', 412, 'SIGNALING PROTEIN / AGONIST', 'SIGNALING_PROT', 'Gamma-aminobutyric acid type B receptor subunit 1', 'GABBR1', '', 'G-protein coupled GABA receptor activity<br />\n', 'adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway<br />\ngamma-aminobutyric acid signaling pathway<br />\nnegative regulation of adenylate cyclase activity<br />\n', 'PF00003.', 'MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQVKAINFLPVDYEIEYVCRGEREVVGPKVRKCLANGSWTDMDTPSRCVRICSKSYLTLENGKVFLTGGDLPALDGARVDFRCDPDFHLVGSSRSICSQGQWSTPKPHCQVNRTPHSERRAVYIGALFPMSGGWPGGQACQPAVEMALEDVNSRRDILPDYELKLIHHDSKCDPGQATKYLYELLYNDPIKIILMPGCSSVSTLVAEAARMWNLIVLSYGSSSPALSNRQRFPTFFRTHPSATLHNPTRVKLFEKWGWKKIATIQQTTEVFTSTLDDLEERVKEAGIEITFRQSFFSDPAVPVKNLKRQDARIIVGLFYETEARKVFCEVYKERLFGKKYVWFLIGWYADNWFKIYDPSINCTVDEMTEAVEGHITTEIVMLNPANTRSISNMTSQEFVEKLTKRLKRHPEETGGFQEAPLAYDAIWALALALNKTSGGGGRSGVRLEDFNYNNQTITDQIYRAMNSSSFEGVSGHVVFDASGSRMAWTLIEQLQGGSYKKIGYYDSTKDDLSWSKTDKWIGGSPPADQTLVIKTFRFLSQKLFISVSVLSSLGIVLAVVCLSFNIYNSHVRYIQNSQPNLNNLTAVGCSLALAAVFPLGLDGYHIGRNQFPFVCQARLWLLGLGFSLGYGSMFTKIWWVHTVFTKKEEKKEWRKTLEPWKLYATVGLLVGMDVLTLAIWQIVDPLHRTIETFAKEEPKEDIDVSILPQLEHCSSRKMNTWLGIFYGYKGLLLLLGIFLAYETKSVSTEKINDHRAVGMAIYNVAVLCLITAPVTMILSSQQDAAFAFASLAIVFSSYITLVVLFVPKMRRLITRGEWQSEAQDTMKTGSSTNNNEEEKSRLLEKENRELEKIIAEKEERVSELRHQLQSRQQLRSRRHPPTPPEPSGGLPRGPPEPPDRLSCDGSRVHLLYK'),
('P45381', '4MXU', 1, 2.6, 'A/B', 313, 'HYDROLASE', 'HYDROLASE', 'Aspartoacylase', 'ASPA', 'N-acyl-L-aspartate + H2O = a carboxylate + L-aspartate<br />\n', 'aminoacylase activity<br />\naspartoacylase activity<br />\nhydrolase activity, acting on ester bonds<br />\nidentical protein binding<br />\nmetal ion binding<br />\n', 'aspartate catabolic process<br />\ncellular amino acid biosynthetic process<br />\ncentral nervous system myelination<br />\npositive regulation of oligodendrocyte differentiation<br />\n', 'PF04952.', 'MTSCHIAEEHIQKVAIFGGTHGNELTGVFLVKHWLENGAEIQRTGLEVKPFITNPRAVKKCTRYIDCDLNRIFDLENLGKKMSEDLPYEVRRAQEINHLFGPKDSEDSYDIIFDLHNTTSNMGCTLILEDSRNNFLIQMFHYIKTSLAPLPCYVYLIEHPSLKYATTRSIAKYPVGIEVGPQPQGVLRADILDQMRKMIKHALDFIHHFNEGKEFPPCAIEVYKIIEKVDYPRDENGEIAAIIHPNLQDQDWKPLHPGDPMFLTLDGKTIPLGGDCTVYPVFVNEAAYYEKKEAFAKTTKLTLNAKSIRCCLH'),
('Q8IWT1', '4MZ2', 0, 1.72, 'A', 126, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Sodium channel subunit beta-4', 'SCN4B', '', 'ion channel binding<br />\nsodium channel regulator activity<br />\nvoltage-gated sodium channel activity<br />\nvoltage-gated sodium channel activity involved in cardiac muscle cell action potential<br />\n', 'AV node cell action potential<br />\ncardiac muscle cell action potential involved in contraction<br />\ncardiac muscle contraction<br />\nmembrane depolarization during cardiac muscle cell action potential<br />\npositive regulation of sodium ion transport<br />\nregulation of heart rate by cardiac conduction<br />\nregulation of sodium ion transmembrane transporter activity<br />\nregulation of ventricular cardiac muscle cell membrane repolarization<br />\nsodium ion transmembrane transport<br />\nsodium ion transport<br />\n', 'PF07686.', 'MPGAGDGGKAPARWLGTGLLGLFLLPVTLSLEVSVGKATDIYAVNGTEILLPCTFSSCFGFEDLHFRWTYNSSDAFKILIEGTVKNEKSDPKVTLKDDDRITLVGSTKEKMNNISIVLRDLEFSDTGKYTCHVKNPKENNLQHHATIFLQVVDRLEEVDNTVTLIILAVVGGVIGLLILILLIKKLIIFILKKTREKKKECLVSSSGNDNTENGLPGSKAEEKPPSKV'),
('Q9Y2J8', '4N25', 1, 1.93, 'A', 665, 'HYDROLASE', 'HYDROLASE', 'Protein-arginine deiminase type-2', 'PADI2', 'Protein L-arginine + H2O = protein L-citrulline + NH3.<br />\n', 'calcium ion binding<br />\nestrogen receptor binding<br />\nprotein-arginine deiminase activity<br />\n', 'cellular response to leukemia inhibitory factor<br />\nchromatin-mediated maintenance of transcription<br />\nchromatin organization<br />\nhistone H3-R26 citrullination<br />\nintracellular estrogen receptor signaling pathway<br />\nnegative regulation of chemokine-mediated signaling pathway<br />\nnegative regulation of lymphocyte chemotaxis<br />\nneutrophil degranulation<br />\nprotein citrullination<br />\nregulation of chromatin disassembly<br />\nsubstantia nigra development<br />\n', 'PF03068.', 'MLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVP'),
('P41143', '4N6H', 1, 1.8, 'A', 303, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Delta-type opioid receptor', 'OPRD1', '', 'enkephalin receptor activity<br />\nneuropeptide binding<br />\nopioid receptor activity<br />\n', 'adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway<br />\nadult locomotory behavior<br />\ncellular response to growth factor stimulus<br />\ncellular response to hypoxia<br />\ncellular response to toxic substance<br />\nchemical synaptic transmission<br />\neating behavior<br />\nG-protein coupled receptor signaling pathway<br />\nG-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger<br />\nimmune response<br />\nnegative regulation of gene expression<br />\nnegative regulation of protein oligomerization<br />\nneuropeptide signaling pathway<br />\nopioid receptor signaling pathway<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\npositive regulation of CREB transcription factor activity<br />\npositive regulation of peptidyl-serine phosphorylation<br />\nprotein import into nucleus, translocation<br />\nregulation of calcium ion transport<br />\nregulation of mitochondrial membrane potential<br />\nregulation of sensory perception of pain<br />\nsensory perception of pain<br />\n', 'PF00001.', 'MEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKMKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTRPRDGAVVCMLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDIDRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRKPCGRPDPSSFSRAREATARERVTACTPSDGPGGGAAA'),
('P60568', '4NEJ', 1, 1.92, 'A', 130, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Interleukin-2', 'IL2', '', 'carbohydrate binding<br />\ncytokine activity<br />\nglycosphingolipid binding<br />\ngrowth factor activity<br />\ninterleukin-2 receptor binding<br />\nkappa-type opioid receptor binding<br />\nkinase activator activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\n', 'adaptive immune response<br />\ncell adhesion<br />\ncell-cell signaling<br />\nextrinsic apoptotic signaling pathway in absence of ligand<br />\nimmune response<br />\nleukocyte activation involved in immune response<br />\nMAPK cascade<br />\nnatural killer cell activation<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of B cell apoptotic process<br />\nnegative regulation of heart contraction<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of lymphocyte proliferation<br />\nnegative regulation of protein phosphorylation<br />\nnegative regulation of T-helper 17 cell differentiation<br />\npositive regulation of activated T cell proliferation<br />\npositive regulation of B cell proliferation<br />\npositive regulation of cell growth<br />\npositive regulation of cell proliferation<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of dendritic spine development<br />\npositive regulation of immunoglobulin secretion<br />\npositive regulation of inflammatory response<br />\npositive regulation of interferon-gamma production<br />\npositive regulation of interleukin-17 production<br />\npositive regulation of isotype switching to IgG isotypes<br />\npositive regulation of regulatory T cell differentiation<br />\npositive regulation of tissue remodeling<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nprotein kinase C-activating G-protein coupled receptor signaling pathway<br />\nregulation of regulatory T cell differentiation<br />\nregulation of T cell homeostatic proliferation<br />\nresponse to ethanol<br />\nT cell differentiation<br />\n', 'PF00715.', 'MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT'),
('P14625', '4NH9', 1, 2.77, 'A', 269, 'CHAPERONE', 'OTHERS', 'Endoplasmin', 'HSP90B1', '', 'ATP binding<br />\ncalcium ion binding<br />\nlow-density lipoprotein particle receptor binding<br />\nprotein phosphatase binding<br />\nRNA binding<br />\nunfolded protein binding<br />\nvirion binding<br />\n', 'actin rod assembly<br />\nATF6-mediated unfolded protein response<br />\ncellular protein metabolic process<br />\ncellular response to ATP<br />\nnegative regulation of apoptotic process<br />\npost-translational protein modification<br />\nprotein folding in endoplasmic reticulum<br />\nprotein transport<br />\nreceptor-mediated endocytosis<br />\nregulation of phosphoprotein phosphatase activity<br />\nresponse to endoplasmic reticulum stress<br />\nresponse to hypoxia<br />\nretrograde protein transport, ER to cytosol<br />\nsequestering of calcium ion<br />\ntoll-like receptor signaling pathway<br />\nubiquitin-dependent ERAD pathway<br />\n', 'PF02518.', 'MRALWVLGLCCVLLTFGSVRADDEVDVDGTVEEDLGKSREGSRTDDEVVQREEEAIQLDGLNASQIRELREKSEKFAFQAEVNRMMKLIINSLYKNKEIFLRELISNASDALDKIRLISLTDENALSGNEELTVKIKCDKEKNLLHVTDTGVGMTREELVKNLGTIAKSGTSEFLNKMTEAQEDGQSTSELIGQFGVGFYSAFLVADKVIVTSKHNNDTQHIWESDSNEFSVIADPRGNTLGRGTTITLVLKEEASDYLELDTIKNLVKKYSQFINFPIYVWSSKTETVEEPMEEEEAAKEEKEESDDEAAVEEEEEEKKPKTKKVEKTVWDWELMNDIKPIWQRPSKEVEEDEYKAFYKSFSKESDDPMAYIHFTAEGEVTFKSILFVPTSAPRGLFDEYGSKKSDYIKLYVRRVFITDDFHDMMPKYLNFVKGVVDSDDLPLNVSRETLQQHKLLKVIRKKLVRKTLDMIKKIADDKYNDTFWKEFGTNIKLGVIEDHSNRTRLAKLLRFQSSHHPTDITSLDQYVERMKEKQDKIYFMAGSSRKEAESSPFVERLLKKGYEVIYLTEPVDEYCIQALPEFDGKRFQNVAKEGVKFDESEKTKESREAVEKEFEPLLNWMKDKALKDKIEKAVVSQRLTESPCALVASQYGWSGNMERIMKAQAYQTGKDISTNYYASQKKTFEINPRHPLIRDMLRRIKEDEDDKTVLDLAVVLFETATLRSGYLLPDTKAYGDRIERMLRLSLNIDPDAKVEEEPEEEPEETAEDTTEDTEQDEDEEMDVGTDEEEETAKESTAEKDEL'),
('Q8N543', '4NHY', 1, 2.6, 'A/B/C/D', 542, 'Oxidoreductase / Oxidoreductase inhibitor', 'OXIDOREDUCTASE', 'Prolyl 3-hydroxylase OGFOD1', 'OGFOD1', '[ribosomal protein uS12]-L-proline + 2-oxoglutarate + O2 = [ribosomal protein uS12]-(3S)-3-hydroxy-L-proline + succinate + CO2<br />\n', 'iron ion binding<br />\nL-ascorbic acid binding<br />\npeptidyl-proline 3-dioxygenase activity<br />\npeptidyl-proline dioxygenase activity<br />\n', 'cell proliferation<br />\npeptidyl-proline hydroxylation<br />\nprotein hydroxylation<br />\nregulation of translational termination<br />\nstress granule assembly<br />\n', 'PF10637.', 'MNGKRPAEPGPARVGKKGKKEVMAEFSDAVTEETLKKQVAEAWSRRTPFSHEVIVMDMDPFLHCVIPNFIQSQDFLEGLQKELMNLDFHEKYNDLYKFQQSDDLKKRREPHISTLRKILFEDFRSWLSDISKIDLESTIDMSCAKYEFTDALLCHDDELEGRRIAFILYLVPPWDRSMGGTLDLYSIDEHFQPKQIVKSLIPSWNKLVFFEVSPVSFHQVSEVLSEEKSRLSISGWFHGPSLTRPPNYFEPPIPRSPHIPQDHEILYDWINPTYLDMDYQVQIQEEFEESSEILLKEFLKPEKFTKVCEALEHGHVEWSSRGPPNKRFYEKAEESKLPEILKECMKLFRSEALFLLLSNFTGLKLHFLAPSEEDEMNDKKEAETTDITEEGTSHSPPEPENNQMAISNNSQQSNEQTDPEPEENETKKESSVPMCQGELRHWKTGHYTLIHDHSKAEFALDLILYCGCEGWEPEYGGFTSYIAKGEDEELLTVNPESNSLALVYRDRETLKFVKHINHRSLEQKKTFPNRTGFWDFSFIYYE'),
('Q01064', '4NPW', 1, 1.9, 'A', 366, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Calcium/calmodulin-dependent 3'',5''-cyclic nucleotide phosphodiesterase 1B', 'PDE1B', 'Nucleoside 3'',5''-cyclic phosphate + H2O = nucleoside 5''-phosphate.<br />\n', '3'',5''-cyclic-AMP phosphodiesterase activity<br />\n3'',5''-cyclic-GMP phosphodiesterase activity<br />\ncalcium- and calmodulin-regulated 3'',5''-cyclic-GMP phosphodiesterase activity<br />\ncalmodulin binding<br />\ncalmodulin-dependent cyclic-nucleotide phosphodiesterase activity<br />\nmetal ion binding<br />\n', 'apoptotic process<br />\ncAMP catabolic process<br />\ncellular response to granulocyte macrophage colony-stimulating factor stimulus<br />\ncellular response to macrophage colony-stimulating factor stimulus<br />\ncGMP catabolic process<br />\nlocomotory behavior<br />\nmonocyte differentiation<br />\nregulation of dopamine metabolic process<br />\nregulation of neurotransmitter levels<br />\nresponse to amphetamine<br />\nserotonin metabolic process<br />\nsignal transduction<br />\nvisual learning<br />\n', 'PF00233.', 'MELSPRSPPEMLEESDCPSPLELKSAPSKKMWIKLRSLLRYMVKQLENGEINIEELKKNLEYTASLLEAVYIDETRQILDTEDELQELRSDAVPSEVRDWLASTFTQQARAKGRRAEEKPKFRSIVHAVQAGIFVERMFRRTYTSVGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSVFRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQPSFQWRQPSLDVEVGDPNPDVVSFRSTWVKRIQENKQKWKERAASGITNQMSIDELSPCEEEAPPSPAEDEHNQNGNLD'),
('P14324', '4NUA', 1, 1.43, 'A', 353, 'TRANSFERASE', 'TRANSFERASE', 'Farnesyl pyrophosphate synthase', 'FDPS', 'Dimethylallyl diphosphate + isopentenyl diphosphate = diphosphate + geranyl diphosphate<br />\nGeranyl diphosphate + isopentenyl diphosphate = diphosphate + (2E,6E)-farnesyl diphosphate<br />\n', 'dimethylallyltranstransferase activity<br />\ngeranyltranstransferase activity<br />\nmetal ion binding<br />\nRNA binding<br />\n', 'cholesterol biosynthetic process<br />\nfarnesyl diphosphate biosynthetic process<br />\ngeranyl diphosphate biosynthetic process<br />\nregulation of cholesterol biosynthetic process<br />\nviral process<br />\n', 'PF00348.', 'MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCWCQAWTEEPRALCSSLRMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK'),
('P51812', '4NW6', 1, 1.74, 'A', 321, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Ribosomal protein S6 kinase alpha-3', 'RPS6KA3', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\ncysteine-type endopeptidase inhibitor activity involved in apoptotic process<br />\nkinase activity<br />\nmagnesium ion binding<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\nprotein serine/threonine kinase activity<br />\n', 'cell cycle<br />\ncentral nervous system development<br />\nintracellular signal transduction<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\npeptidyl-serine phosphorylation<br />\npositive regulation of cell differentiation<br />\npositive regulation of cell growth<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of DNA-templated transcription in response to stress<br />\nregulation of translation in response to stress<br />\nresponse to lipopolysaccharide<br />\nsignal transduction<br />\nskeletal system development<br />\ntoll-like receptor signaling pathway<br />\n', 'PF00069.', 'MPLAQLADPWQKMAVESPSDSAENGQQIMDEPMGEEEINPQTEEVSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDPEFTAKTPKDSPGIPPSANAHQLFRGFSFVAITSDDESQAMQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIKKITSTAL'),
('P0ABQ4', '4NX7', 1, 1.15, 'A', 159, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dihydrofolate reductase', 'folA', '5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH<br />\n', 'dihydrofolate reductase activity<br />\ndihydrofolic acid binding<br />\nfolic acid binding<br />\nmethotrexate binding<br />\nNADP+ binding<br />\nNADPH binding<br />\n', 'glycine biosynthetic process<br />\nnucleotide biosynthetic process<br />\none-carbon metabolic process<br />\nresponse to antibiotic<br />\nresponse to drug<br />\nresponse to methotrexate<br />\ntetrahydrofolate biosynthetic process<br />\n', 'PF00186.', 'MISLIAALAVDRVIGMENAMPWNLPADLAWFKRNTLNKPVIMGRHTWESIGRPLPGRKNIILSSQPGTDDRVTWVKSVDEAIAACGDVPEIMVIGGGRVYEQFLPKAQKLYLTHIDAEVEGDTHFPDYEPDDWESVFSEFHDADAQNSHSYCFEILERR'),
('O14646', '4O42', 0, 1.87, 'A', 176, 'DNA BINDING PROTEIN / VIRAL PROTEIN', 'OTHERS', 'Chromodomain-helicase-DNA-binding protein 1', 'CHD1', 'ATP + H2O = ADP + phosphate.<br />\n', 'ATP binding<br />\nATP-dependent DNA helicase activity<br />\nDNA binding<br />\nmethylated histone binding<br />\n', 'chromatin remodeling<br />\ncovalent chromatin modification<br />\npositive regulation by host of viral transcription<br />\nregulation of transcription from RNA polymerase II promoter<br />\ntranscription, DNA-templated<br />\n', 'PF00385.', 'MNGHSDEESVRNSSGESSQSDDDSGSASGSGSGSSSGSSSDGSSSQSGSSDSDSGSESGSQSESESDTSRENKVQAKPPKVDGAEFWKSSPSILAVQRSAILKKQQQQQQQQQHQASSNSGSEEDSSSSEDSDDSSSEVKRKKHKDEDWQMSGSGSPSQSGSDSESEEEREKSSCDETESDYEPKNKVKSRKPQNRSKSKNGKKILGQKKRQIDSSEEDDDEEDYDNDKRSSRRQATVNVSYKEDEEMKTDSDDLLEVCGEDVPQPEEEEFETIERFMDCRIGRKGATGATTTIYAVEADGDPNAGFEKNKEPGEIQYLIKWKGWSHIHNTWETEETLKQQNVRGMKKLDNYKKKDQETKRWLKNASPEDVEYYNCQQELTDDLHKQYQIVERIIAHSNQKSAAGYPDYYCKWQGLPYSECSWEDGALISKKFQACIDEYFSRNQSKTTPFKDCKVLKQRPRFVALKKQPSYIGGHEGLELRDYQLNGLNWLAHSWCKGNSCILADEMGLGKTIQTISFLNYLFHEHQLYGPFLLVVPLSTLTSWQREIQTWASQMNAVVYLGDINSRNMIRTHEWTHHQTKRLKFNILLTTYEILLKDKAFLGGLNWAFIGVDEAHRLKNDDSLLYKTLIDFKSNHRLLITGTPLQNSLKELWSLLHFIMPEKFSSWEDFEEEHGKGREYGYASLHKELEPFLLRRVKKDVEKSLPAKVEQILRMEMSALQKQYYKWILTRNYKALSKGSKGSTSGFLNIMMELKKCCNHCYLIKPPDNNEFYNKQEALQHLIRSSGKLILLDKLLIRLRERGNRVLIFSQMVRMLDILAEYLKYRQFPFQRLDGSIKGELRKQALDHFNAEGSEDFCFLLSTRAGGLGINLASADTVVIFDSDWNPQNDLQAQARAHRIGQKKQVNIYRLVTKGSVEEDILERAKKKMVLDHLVIQRMDTTGKTVLHTGSAPSSSTPFNKEELSAILKFGAEELFKEPEGEEQEPQEMDIDEILKRAETHENEPGPLTVGDELLSQFKVANFSNMDEDDIELEPERNSKNWEEIIPEDQRRRLEEEERQKELEEIYMLPRMRNCAKQISFNGSEGRRSRSRRYSGSDSDSISEGKRPKKRGRPRTIPRENIKGFSDAEIRRFIKSYKKFGGPLERLDAIARDAELVDKSETDLRRLGELVHNGCIKALKDSSSGTERTGGRLGKVKGPTFRISGVQVNAKLVISHEEELIPLHKSIPSDPEERKQYTIPCHTKAAHFDIDWGKEDDSNLLIGIYEYGYGSWEMIKMDPDLSLTHKILPDDPDKKPQAKQLQTRADYLIKLLSRDLAKKEALSGAGSSKRRKARAKKNKAMKSIKVKEEIKSDSSPLPSEKSDEDDDKLSESKSDGRERSKKSSVSDAPVHITASGEPVPISEESEELDQKTFSICKERMRPVKAALKQLDRPEKGLSEREQLEHTRQCLIKIGDHITECLKEYTNPEQIKQWRKNLWIFVSKFTEFDARKLHKLYKHAIKKRQESQQNSDQNSNLNPHVIRNPDVERLKENTNHDDSSRDSYSSDRHLTQYHDHHKDRHQGDSYKKSDSRKRPYSSFSNGKDHRDWDHYKQDSRYYSDREKHRKLDDHRSRDHRSNLEGSLKDRSHSDHRSHSDHRLHSDHRSSSEYTHHKSSRDYRYHSDWQMDHRASSSGPRSPLDQRSPYGSRSPFEHSVEHKSTPEHTWSSRKT'),
('P0A7V3', '4ODQ', 0, 2, 'B', 15, 'ISOMERASE', 'ISOMERASE', '30S ribosomal protein S3', 'rpsC', '', 'rRNA binding<br />\nstructural constituent of ribosome<br />\n', 'cytoplasmic translation<br />\nribosomal small subunit assembly<br />\n', 'PF07650.', 'MGQKVHPNGIRLGIVKPWNSTWFANTKEFADNLDSDFKVRQYLTKELAKASVSRIVIERPAKSIRVTIHTARPGIVIGKKGEDVEKLRKVVADIAGVPAQINIAEVRKPELDAKLVADSITSQLERRVMFRRAMKRAVQNAMRLGAKGIKVEVSGRLGGAEIARTEWYREGRVPLHTLRADIDYNTSEAHTTYGVIGVKVWIFKGEILGGMAAVEQPEKPAAQPKKQQRKGRK'),
('P09038', '4OEE', 1, 1.5, 'A', 155, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Fibroblast growth factor 2', 'FGF2', '', '1-phosphatidylinositol-3-kinase activity<br />\nchemoattractant activity<br />\ncytokine activity<br />\nfibroblast growth factor receptor binding<br />\ngrowth factor activity<br />\nheparin binding<br />\nligand-dependent nuclear receptor transcription coactivator activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor-receptor interaction<br />\n', 'activation of MAPK activity<br />\nanimal organ morphogenesis<br />\nbranching involved in ureteric bud morphogenesis<br />\ncell migration involved in sprouting angiogenesis<br />\nchemotaxis<br />\nchondroblast differentiation<br />\nembryonic morphogenesis<br />\nextracellular matrix organization<br />\nfibroblast growth factor receptor signaling pathway<br />\ngrowth factor dependent regulation of skeletal muscle satellite cell proliferation<br />\nhyaluronan catabolic process<br />\ninositol phosphate biosynthetic process<br />\ninterleukin-7-mediated signaling pathway<br />\nMAPK cascade<br />\nnegative regulation of blood vessel endothelial cell migration<br />\nnegative regulation of cell death<br />\nnegative regulation of fibroblast migration<br />\nnegative regulation of wound healing<br />\nnervous system development<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of angiogenesis<br />\npositive regulation of blood vessel endothelial cell migration<br />\npositive regulation of cardiac muscle cell proliferation<br />\npositive regulation of cell division<br />\npositive regulation of cell fate specification<br />\npositive regulation of cell proliferation<br />\npositive regulation of endothelial cell chemotaxis to fibroblast growth factor<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phospholipase C activity<br />\npositive regulation of sprouting angiogenesis<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nRas protein signal transduction<br />\nregulation of angiogenesis<br />\nregulation of endothelial cell chemotaxis to fibroblast growth factor<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nrelease of sequestered calcium ion into cytosol<br />\nsignal transduction<br />\nsomatic stem cell population maintenance<br />\nstem cell proliferation<br />\nwound healing<br />\n', 'PF00167.', 'MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVNPRSRAAGSPRTRGRRTEERPSGSRLGDRGRGRALPGGRLGGRGRGRAPERVGGRGRGRGTAAPRAAPAARGSRPGPAGTMAAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS'),
('O76054', '4OMJ', 1, 1.6, 'A/B', 275, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'SEC14-like protein 2', 'SEC14L2', '', 'phospholipid binding<br />\ntransporter activity<br />\nvitamin E binding<br />\n', 'positive regulation of transcription, DNA-templated<br />\nregulation of cholesterol biosynthetic process<br />\ntranscription, DNA-templated<br />\n', 'PF00650.', 'MSGRVGDLSPRQKEALAKFRENVQDVLPALPNPDDYFLLRWLRARSFDLQKSEAMLRKHVEFRKQKDIDNIISWQPPEVIQQYLSGGMCGYDLDGCPVWYDIIGPLDAKGLLFSASKQDLLRTKMRECELLLQECAHQTTKLGRKVETITIIYDCEGLGLKHLWKPAVEAYGEFLCMFEENYPETLKRLFVVKAPKLFPVAYNLIKPFLSEDTRKKIMVLGANWKEVLLKHISPDQVPVEYGGTMTDPDGNPKCKSKINYGGDIPRKYYVRDQVKQQYEHSVQISRGSSHQVEYEILFPGCVLRWQFMSDGADVGFGIFLKTKMGERQRAGEMTEVLPNQRYNSHLVPEDGTLTCSDPGIYVLRFDNTYSFIHAKKVNFTVEVLLPDKASEEKMKQLGAGTPK'),
('P41594', '4OO9', 1, 2.6, 'A', 268, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Metabotropic glutamate receptor 5', 'GRM5', '', 'glutamate receptor activity<br />\nG-protein coupled receptor activity<br />\nG-protein coupled receptor activity involved in regulation of postsynaptic membrane potential<br />\nneurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration<br />\nprotein tyrosine kinase activator activity<br />\nprotein tyrosine kinase binding<br />\n', 'adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway<br />\ncalcium-mediated signaling using intracellular calcium source<br />\ncellular response to amyloid-beta<br />\nchemical synaptic transmission<br />\ncognition<br />\nG-protein coupled glutamate receptor signaling pathway<br />\nlearning<br />\nlearning or memory<br />\nlocomotory behavior<br />\nmodulation of age-related behavioral decline<br />\nphospholipase C-activating G-protein coupled glutamate receptor signaling pathway<br />\npositive regulation of protein tyrosine kinase activity<br />\nregulation of intracellular calcium activated chloride channel activity<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of protein phosphorylation<br />\nregulation of synaptic transmission, glutamatergic<br />\nregulation of translation<br />\nregulation of translational elongation<br />\nsynapse organization<br />\n', 'PF00003.', 'MVLLLILSVLLLKEDVRGSAQSSERRVVAHMPGDIIIGALFSVHHQPTVDKVHERKCGAVREQYGIQRVEAMLHTLERINSDPTLLPNITLGCEIRDSCWHSAVALEQSIEFIRDSLISSEEEEGLVRCVDGSSSSFRSKKPIVGVIGPGSSSVAIQVQNLLQLFNIPQIAYSATSMDLSDKTLFKYFMRVVPSDAQQARAMVDIVKRYNWTYVSAVHTEGNYGESGMEAFKDMSAKEGICIAHSYKIYSNAGEQSFDKLLKKLTSHLPKARVVACFCEGMTVRGLLMAMRRLGLAGEFLLLGSDGWADRYDVTDGYQREAVGGITIKLQSPDVKWFDDYYLKLRPETNHRNPWFQEFWQHRFQCRLEGFPQENSKYNKTCNSSLTLKTHHVQDSKMGFVINAIYSMAYGLHNMQMSLCPGYAGLCDAMKPIDGRKLLESLMKTNFTGVSGDTILFDENGDSPGRYEIMNFKEMGKDYFDYINVGSWDNGELKMDDDEVWSKKSNIIRSVCSEPCEKGQIKVIRKGEVSCCWTCTPCKENEYVFDEYTCKACQLGSWPTDDLTGCDLIPVQYLRWGDPEPIAAVVFACLGLLATLFVTVVFIIYRDTPVVKSSSRELCYIILAGICLGYLCTFCLIAKPKQIYCYLQRIGIGLSPAMSYSALVTKTNRIARILAGSKKKICTKKPRFMSACAQLVIAFILICIQLGIIVALFIMEPPDIMHDYPSIREVYLICNTTNLGVVTPLGYNGLLILSCTFYAFKTRNVPANFNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITMCFSVSLSATVALGCMFVPKVYIILAKPERNVRSAFTTSTVVRMHVGDGKSSSAASRSSSLVNLWKRRGSSGETLRYKDRRLAQHKSEIECFTPKGSMGNGGRATMSSSNGKSVTWAQNEKSSRGQHLWQRLSIHINKKENPNQTAVIKPFPKSTESRGLGAGAGAGGSAGGVGATGGAGCAGAGPGGPESPDAGPKALYDVAEAEEHFPAPARPRSPSPISTLSHRAGSASRTDDDVPSLHSEPVARSSSSQGSLMEQISSVVTRFTANISELNSMMLSTAAPSPGVGAPLCSSYLIPKEIQLPTTMTTFAEIQPLPAIEVTGGAQPAAGAQAAGDAARESPAAGPEAAAAKPDLEELVALTPPSPFRDSVDSGSTTPNSPVSESALCIPSSPKYDTLIIRDYTQSSSSL'),
('Q02127', '4OQV', 1, 1.23, 'A', 364, 'OXIDOREDUCTASE / OXIDOREDUCTASE INHIBITOR', 'OXIDOREDUCTASE', 'Dihydroorotate dehydrogenase (quinone), mitochondrial', 'DHODH', '(S)-dihydroorotate + a quinone = orotate + a quinol<br />\n', 'dihydroorotate dehydrogenase activity<br />\ndrug binding<br />\nFMN binding<br />\nubiquinone binding<br />\n', '''de novo'' pyrimidine nucleobase biosynthetic process<br />\n''de novo'' UMP biosynthetic process<br />\nfemale pregnancy<br />\nlactation<br />\npositive regulation of apoptotic process<br />\npyrimidine nucleoside biosynthetic process<br />\nregulation of mitochondrial fission<br />\nresponse to caffeine<br />\nresponse to drug<br />\nresponse to L-arginine<br />\nresponse to starvation<br />\n', 'PF01180.', 'MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSVTPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVNLGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQERDGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSETGGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTFWGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR'),
('P11310', '4P13', 1, 1.73, 'A/B/C/D', 387, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Medium-chain specific acyl-CoA dehydrogenase, mitochondrial', 'ACADM', 'A medium-chain acyl-CoA + electron-transfer flavoprotein = a medium-chain trans-2,3-dehydroacyl-CoA + reduced electron-transfer flavoprotein.<br />\n', 'acyl-CoA dehydrogenase activity<br />\nflavin adenine dinucleotide binding<br />\nidentical protein binding<br />\nmedium-chain-acyl-CoA dehydrogenase activity<br />\n', 'carnitine biosynthetic process<br />\ncarnitine metabolic process, CoA-linked<br />\nfatty acid beta-oxidation<br />\nfatty acid beta-oxidation using acyl-CoA dehydrogenase<br />\nmedium-chain fatty acid catabolic process<br />\nmedium-chain fatty acid metabolic process<br />\noxidation-reduction process<br />\nregulation of lipid metabolic process<br />\n', 'PF00441.', 'MAAGFGRCCRVLRSISRFHWRSQHTKANRQREPGLGFSFEFTEQQKEFQATARKFAREEIIPVAAEYDKTGEYPVPLIRRAWELGLMNTHIPENCGGLGLGTFDACLISEELAYGCTGVQTAIEGNSLGQMPIIIAGNDQQKKKYLGRMTEEPLMCAYCVTEPGAGSDVAGIKTKAEKKGDEYIINGQKMWITNGGKANWYFLLARSDPDPKAPANKAFTGFIVEADTPGIQIGRKELNMGQRCSDTRGIVFEDVKVPKENVLIGDGAGFKVAMGAFDKTRPVVAAGAVGLAQRALDEATKYALERKTFGKLLVEHQAISFMLAEMAMKVELARMSYQRAAWEVDSGRRNTYYASIAKAFAGDIANQLATDAVQILGGNGFNTEYPVEKLMRDAKIYQIYEGTSQIQRLIVAREHIDKYKN');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P50281', '4P3C', 1, 1.94, 'M', 13, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Matrix metalloproteinase-14', 'MMP14', 'Endopeptidase activity. Activates progelatinase A by cleavage of the propeptide at 37-Asn-|-Leu-38. Other bonds hydrolyzed include 35-Gly-|-Ile-36 in the propeptide of collagenase 3, and 341-Asn-|-Phe-342, 441-Asp-|-Leu-442 and 354-Gln-|-Thr-355 in the aggrecan interglobular domain.<br />\n', 'integrin binding<br />\nmetalloaminopeptidase activity<br />\nmetalloendopeptidase activity<br />\npeptidase activator activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'angiogenesis<br />\nastrocyte cell migration<br />\nbranching morphogenesis of an epithelial tube<br />\ncell motility<br />\nchondrocyte proliferation<br />\ncollagen catabolic process<br />\ncraniofacial suture morphogenesis<br />\nembryonic cranial skeleton morphogenesis<br />\nendochondral ossification<br />\nendodermal cell differentiation<br />\nendothelial cell proliferation<br />\nextracellular matrix disassembly<br />\nlung development<br />\nmale gonad development<br />\nnegative regulation of focal adhesion assembly<br />\nnegative regulation of Notch signaling pathway<br />\novarian follicle development<br />\npositive regulation of B cell differentiation<br />\npositive regulation of cell growth<br />\npositive regulation of cell migration<br />\npositive regulation of macrophage migration<br />\npositive regulation of myotube differentiation<br />\nprotein processing<br />\nproteolysis<br />\nresponse to estrogen<br />\nresponse to hormone<br />\nresponse to hypoxia<br />\nresponse to mechanical stimulus<br />\nresponse to odorant<br />\nresponse to organic cyclic compound<br />\nresponse to oxidative stress<br />\ntissue remodeling<br />\nzymogen activation<br />\n', 'PF11857.', 'MSPAPRPPRCLLLPLLTLGTALASLGSAQSSSFSPEAWLQQYGYLPPGDLRTHTQRSPQSLSAAIAAMQKFYGLQVTGKADADTMKAMRRPRCGVPDKFGAEIKANVRRKRYAIQGLKWQHNEITFCIQNYTPKVGEYATYEAIRKAFRVWESATPLRFREVPYAYIREGHEKQADIMIFFAEGFHGDSTPFDGEGGFLAHAYFPGPNIGGDTHFDSAEPWTVRNEDLNGNDIFLVAVHELGHALGLEHSSDPSAIMAPFYQWMDTENFVLPDDDRRGIQQLYGGESGFPTKMPPQPRTTSRPSVPDKPKNPTYGPNICDGNFDTVAMLRGEMFVFKERWFWRVRNNQVMDGYPMPIGQFWRGLPASINTAYERKDGKFVFFKGDKHWVFDEASLEPGYPKHIKELGRGLPTDKIDAALFWMPNGKTYFFRGNKYYRFNEELRAVDSEYPKNIKVWEGIPESPRGSFMGSDEVFTYFYKGNKYWKFNNQKLKVEPGYPKSALRDWMGCPSGGRPDEGTEEETEVIIIEVDEEGGGAVSAAAVVLPVLLLLLVLAVGLAVFFFRRHGTPRRLLYCQRSLLDKV'),
('Q9UJS0', '4P5W', 0, 2.4, 'A/B', 318, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Calcium-binding mitochondrial carrier protein Aralar2', 'SLC25A13', '', 'acidic amino acid transmembrane transporter activity<br />\ncalcium ion binding<br />\nL-aspartate transmembrane transporter activity<br />\nL-glutamate transmembrane transporter activity<br />\ntransporter activity<br />\n', 'aspartate transport<br />\nATP biosynthetic process<br />\ncellular respiration<br />\ngluconeogenesis<br />\nL-glutamate transport<br />\nmalate-aspartate shuttle<br />\nresponse to calcium ion<br />\ntransport<br />\n', 'PF00153.', 'MAAAKVALTKRADPAELRTIFLKYASIEKNGEFFMSPNDFVTRYLNIFGESQPNPKTVELLSGVVDQTKDGLISFQEFVAFESVLCAPDALFMVAFQLFDKAGKGEVTFEDVKQVFGQTTIHQHIPFNWDSEFVQLHFGKERKRHLTYAEFTQFLLEIQLEHAKQAFVQRDNARTGRVTAIDFRDIMVTIRPHVLTPFVEECLVAAAGGTTSHQVSFSYFNGFNSLLNNMELIRKIYSTLAGTRKDVEVTKEEFVLAAQKFGQVTPMEVDILFQLADLYEPRGRMTLADIERIAPLEEGTLPFNLAEAQRQKASGDSARPVLLQVAESAYRFGLGSVAGAVGATAVYPIDLVKTRMQNQRSTGSFVGELMYKNSFDCFKKVLRYEGFFGLYRGLLPQLLGVAPEKAIKLTVNDFVRDKFMHKDGSVPLAAEILAGGCAGGSQVIFTNPLEIVKIRLQVAGEITTGPRVSALSVVRDLGFFGIYKGAKACFLRDIPFSAIYFPCYAHVKASFANEDGQVSPGSLLLAGAIAGMPAASLVTPADVIKTRLQVAARAGQTTYSGVIDCFRKILREEGPKALWKGAGARVFRSSPQFGVTLLTYELLQRWFYIDFGGVKPMGSEPVPKSRINLPAPNPDHVGGYKLAVATFAGIENKFGLYLPLFKPSVSTSKAIGGGP'),
('O75746', '4P5X', 0, 2.26, 'A', 310, 'calcium binding protein', 'METAL_BINDING', 'Calcium-binding mitochondrial carrier protein Aralar1', 'SLC25A12', '', 'acidic amino acid transmembrane transporter activity<br />\ncalcium ion binding<br />\nL-aspartate transmembrane transporter activity<br />\nL-glutamate transmembrane transporter activity<br />\n', 'aspartate transport<br />\ngluconeogenesis<br />\nL-glutamate transport<br />\nmalate-aspartate shuttle<br />\nresponse to calcium ion<br />\n', 'PF00153.', 'MAVKVQTTKRGDPHELRNIFLQYASTEVDGERYMTPEDFVQRYLGLYNDPNSNPKIVQLLAGVADQTKDGLISYQEFLAFESVLCAPDSMFIVAFQLFDKSGNGEVTFENVKEIFGQTIIHHHIPFNWDCEFIRLHFGHNRKKHLNYTEFTQFLQELQLEHARQAFALKDKSKSGMISGLDFSDIMVTIRSHMLTPFVEENLVSAAGGSISHQVSFSYFNAFNSLLNNMELVRKIYSTLAGTRKDVEVTKEEFAQSAIRYGQVTPLEIDILYQLADLYNASGRLTLADIERIAPLAEGALPYNLAELQRQQSPGLGRPIWLQIAESAYRFTLGSVAGAVGATAVYPIDLVKTRMQNQRGSGSVVGELMYKNSFDCFKKVLRYEGFFGLYRGLIPQLIGVAPEKAIKLTVNDFVRDKFTRRDGSVPLPAEVLAGGCAGGSQVIFTNPLEIVKIRLQVAGEITTGPRVSALNVLRDLGIFGLYKGAKACFLRDIPFSAIYFPVYAHCKLLLADENGHVGGLNLLAAGAMAGVPAASLVTPADVIKTRLQVAARAGQTTYSGVIDCFRKILREEGPSAFWKGTAARVFRSSPQFGVTLVTYELLQRWFYIDFGGLKPAGSEPTPKSRIADLPPANPDHIGGYRLATATFAGIENKFGLYLPKFKSPSVAVVQPKAAVAATQ'),
('P14735', '4PES', 1, 2.21, 'A/B', 978, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Insulin-degrading enzyme', 'IDE', 'Degradation of insulin, glucagon and other polypeptides<br />\n', 'amyloid-beta binding<br />\nATPase activity<br />\nATP binding<br />\nbeta-endorphin binding<br />\nidentical protein binding<br />\ninsulin binding<br />\nmetalloendopeptidase activity<br />\npeptide binding<br />\nprotein homodimerization activity<br />\nreceptor binding<br />\nubiquitin-dependent protein binding<br />\nvirus receptor activity<br />\nzinc ion binding<br />\n', 'amyloid-beta clearance<br />\namyloid-beta metabolic process<br />\nbradykinin catabolic process<br />\ndetermination of adult lifespan<br />\nhormone catabolic process<br />\ninsulin catabolic process<br />\ninsulin metabolic process<br />\ninsulin receptor signaling pathway<br />\nnegative regulation of proteolysis<br />\npositive regulation of protein catabolic process<br />\npositive regulation of protein oligomerization<br />\nprotein heterooligomerization<br />\nprotein homooligomerization<br />\nprotein homotetramerization<br />\nproteolysis<br />\nproteolysis involved in cellular protein catabolic process<br />\nubiquitin recycling<br />\n', 'PF00675.', 'MRYRLAWLLHPALPSTFRSVLGARLPPPERLCGFQKKTYSKMNNPAIKRIGNHITKSPEDKREYRGLELANGIKVLLISDPTTDKSSAALDVHIGSLSDPPNIAGLSHFCEHMLFLGTKKYPKENEYSQFLSEHAGSSNAFTSGEHTNYYFDVSHEHLEGALDRFAQFFLCPLFDESCKDREVNAVDSEHEKNVMNDAWRLFQLEKATGNPKHPFSKFGTGNKYTLETRPNQEGIDVRQELLKFHSAYYSSNLMAVCVLGRESLDDLTNLVVKLFSEVENKNVPLPEFPEHPFQEEHLKQLYKIVPIKDIRNLYVTFPIPDLQKYYKSNPGHYLGHLIGHEGPGSLLSELKSKGWVNTLVGGQKEGARGFMFFIINVDLTEEGLLHVEDIILHMFQYIQKLRAEGPQEWVFQECKDLNAVAFRFKDKERPRGYTSKIAGILHYYPLEEVLTAEYLLEEFRPDLIEMVLDKLRPENVRVAIVSKSFEGKTDRTEEWYGTQYKQEAIPDEVIKKWQNADLNGKFKLPTKNEFIPTNFEILPLEKEATPYPALIKDTAMSKLWFKQDDKFFLPKACLNFEFFSPFAYVDPLHCNMAYLYLELLKDSLNEYAYAAELAGLSYDLQNTIYGMYLSVKGYNDKQPILLKKIIEKMATFEIDEKRFEIIKEAYMRSLNNFRAEQPHQHAMYYLRLLMTEVAWTKDELKEALDDVTLPRLKAFIPQLLSRLHIEALLHGNITKQAALGIMQMVEDTLIEHAHTKPLLPSQLVRYREVQLPDRGWFVYQQRNEVHNNCGIEIYYQTDMQSTSENMFLELFCQIISEPCFNTLRTKEQLGYIVFSGPRRANGIQGLRFIIQSEKPPHYLESRVEAFLITMEKSIEDMTEEAFQKHIQALAIRRLDKPKKLSAECAKYWGEIISQQYNFDRDNTEVAYLKTLTKEDIIKFYKEMLAVDAPRRHKVSVHVLAREMDSCPVVGEFPCQNDINLSQAPALPQPEVIQNMTEFKRGLPLFPLVKPHINFMAAKL'),
('P08235', '4PF3', 1, 1.1, 'A', 273, 'TRANSCRIPTION / TRANSCRIPTION INHIBITOR', 'TRANSCRIPTION', 'Mineralocorticoid receptor', 'NR3C2', '', 'sequence-specific DNA binding<br />\nsteroid binding<br />\nsteroid hormone receptor activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'signal transduction<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'METKGYHSLPEGLDMERRWGQVSQAVERSSLGPTERTDENNYMEIVNVSCVSGAIPNNSTQGSSKEKQELLPCLQQDNNRPGILTSDIKTELESKELSATVAESMGLYMDSVRDADYSYEQQNQQGSMSPAKIYQNVEQLVKFYKGNGHRPSTLSCVNTPLRSFMSDSGSSVNGGVMRAIVKSPIMCHEKSPSVCSPLNMTSSVCSPAGINSVSSTTASFGSFPVHSPITQGTPLTCSPNAENRGSRSHSPAHASNVGSPLSSPLSSMKSSISSPPSHCSVKSPVSSPNNVTLRSSVSSPANINNSRCSVSSPSNTNNRSTLSSPAASTVGSICSPVNNAFSYTASGTSAGSSTLRDVVPSPDTQEKGAQEVPFPKTEEVESAISNGVTGQLNIVQYIKPEPDGAFSSSCLGGNSKINSDSSFSVPIKQESTKHSCSGTSFKGNPTVNPFPFMDGSYFSFMDDKDYYSLSGILGPPVPGFDGNCEGSGFPVGIKQEPDDGSYYPEASIPSSAIVGVNSGGQSFHYRIGAQGTISLSRSARDQSFQHLSSFPPVNTLVESWKSHGDLSSRRSDGYPVLEYIPENVSSSTLRSVSTGSSRPSKICLVCGDEASGCHYGVVTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRLQKCLQAGMNLGARKSKKLGKLKGIHEEQPQQQQPPPPPPPPQSPEEGTTYIAPAKEPSVNTALVPQLSTISRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMCLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK'),
('O14842', '4PHU', 1, 2.33, 'A', 211, 'Fatty acid binding protein / Hydrolase', 'OTHERS', 'Free fatty acid receptor 1', 'FFAR1', '', 'bioactive lipid receptor activity<br />\nG-protein coupled receptor activity<br />\nguanyl-nucleotide exchange factor activity<br />\nlipid binding<br />\n', 'glucose homeostasis<br />\nG-protein coupled receptor signaling pathway<br />\ninsulin secretion<br />\npositive regulation of calcium ion transport<br />\npositive regulation of insulin secretion<br />\nresponse to fatty acid<br />\n', 'PF00001.', 'MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK'),
('P04629', '4PMP', 1, 1.8, 'A', 287, 'Transferase / Transferase inhibitor', 'TRANSFERASE', 'High affinity nerve growth factor receptor', 'NTRK1', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nGPI-linked ephrin receptor activity<br />\nkinase binding<br />\nnerve growth factor binding<br />\nnerve growth factor receptor activity<br />\nneurotrophin binding<br />\nneurotrophin p75 receptor binding<br />\nprotein homodimerization activity<br />\nprotein tyrosine kinase activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\n', 'activation of MAPKK activity<br />\naging<br />\naxon guidance<br />\naxonogenesis involved in innervation<br />\nB cell differentiation<br />\nbehavioral response to formalin induced pain<br />\ncellular response to nerve growth factor stimulus<br />\ncellular response to nicotine<br />\ncircadian rhythm<br />\ndetection of mechanical stimulus involved in sensory perception of pain<br />\ndetection of temperature stimulus involved in sensory perception of pain<br />\nlearning or memory<br />\nmechanoreceptor differentiation<br />\nmicrotubule-based movement<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of neuron apoptotic process<br />\nnerve growth factor signaling pathway<br />\nneurotrophin TRK receptor signaling pathway<br />\nolfactory nerve development<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of angiogenesis<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of GTPase activity<br />\npositive regulation of neuron projection development<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of programmed cell death<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of Ras protein signal transduction<br />\npositive regulation of synapse assembly<br />\npositive regulation of synaptic transmission, glutamatergic<br />\nprogrammed cell death involved in cell development<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nresponse to activity<br />\nresponse to axon injury<br />\nresponse to drug<br />\nresponse to electrical stimulus<br />\nresponse to ethanol<br />\nresponse to hydrostatic pressure<br />\nresponse to nutrient levels<br />\nresponse to radiation<br />\nSertoli cell development<br />\nsympathetic nervous system development<br />\n', 'PF13855.', 'MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG'),
('Q7L266', '4PVP', 1, 1.85, 'A/B', 308, 'HYDROLASE', 'HYDROLASE', 'Isoaspartyl peptidase/L-asparaginase', 'ASRGL1', 'L-asparagine + H2O = L-aspartate + NH3<br />\nCleavage of a beta-linked Asp residue from the N-terminus of a polypeptide<br />\n', 'asparaginase activity<br />\nbeta-aspartyl-peptidase activity<br />\n', 'asparagine catabolic process via L-aspartate<br />\nL-phenylalanine catabolic process<br />\n', 'PF01112.', 'MNPIVVVHGGGAGPISKDRKERVHQGMVRAATVGYGILREGGSAVDAVEGAVVALEDDPEFNAGCGSVLNTNGEVEMDASIMDGKDLSAGAVSAVQCIANPIKLARLVMEKTPHCFLTDQGAAQFAAAMGVPEIPGEKLVTERNKKRLEKEKHEKGAQKTDCQKNLGTVGAVALDCKGNVAYATSTGGIVNKMVGRVGDSPCLGAGGYADNDIGAVSTTGHGESILKVNLARLTLFHIEQGKTVEEAADLSLGYMKSRVKGLGGLIVVSKTGDWVAKWTSTSMPWAAAKDGKLHFGIDPDDTTITDLP'),
('Q9H244', '4PXZ', 1, 2.5, 'A', 341, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'P2Y purinoceptor 12', 'P2RY12', '', 'ADP receptor activity<br />\nG-protein coupled adenosine receptor activity<br />\nguanyl-nucleotide exchange factor activity<br />\n', 'adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway<br />\ncalcium ion transmembrane transport<br />\ncellular response to ATP<br />\nglial cell migration<br />\nG-protein coupled receptor signaling pathway<br />\nhemostasis<br />\nnegative regulation of cell differentiation<br />\nnegative regulation of norepinephrine secretion<br />\nplatelet aggregation<br />\npositive regulation of ion transport<br />\npotassium ion transmembrane transport<br />\nprotein kinase B signaling<br />\nregulation of calcium ion transport<br />\nregulation of microglial cell migration<br />\nsubstrate-dependent cell migration, cell extension<br />\n', 'PF00001.', 'MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIFFQIRSKSNFIIFLKNTVISDLLMILTFPFKILSDAKLGTGPLRTFVCQVTSVIFYFTMYISISFLGLITIDRYQKTTRPFKTSNPKNLLGAKILSVVIWAFMFLLSLPNMILTNRQPRDKNVKKCSFLKSEFGLVWHEIVNYICQVIFWINFLIVIVCYTLITKELYRSYVRTRGVGKVPRKKVNVKVFIIIAVFFICFVPFHFARIPYTLSQTRDVFDCTAENTLFYVKESTLWLTSLNACLDPFIYFFLCKSFRNSLISMLKCPNSATSLSQDNRKKEQDGGDPNEETPM'),
('P16070', '4PZ3', 1, 1.08, 'A/B', 153, 'CELL ADHESION', 'CELL_ADHESION', 'CD44 antigen', 'CD44', '', 'collagen binding<br />\nhyaluronic acid binding<br />\n', 'cartilage development<br />\ncell-cell adhesion<br />\ncell-matrix adhesion<br />\ncellular response to fibroblast growth factor stimulus<br />\nextracellular matrix disassembly<br />\nextracellular matrix organization<br />\nhyaluronan catabolic process<br />\ninterferon-gamma-mediated signaling pathway<br />\nleukocyte migration<br />\nmonocyte aggregation<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of DNA damage response, signal transduction by p53 class mediator<br />\nnegative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator<br />\nneutrophil degranulation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of heterotypic cell-cell adhesion<br />\npositive regulation of monocyte aggregation<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\nregulation of lamellipodium morphogenesis<br />\nwound healing, spreading of cells<br />\n', 'PF00193.', 'MDKFWWHAAWGLCLVPLSLAQIDLNITCRFAGVFHVEKNGRYSISRTEAADLCKAFNSTLPTMAQMEKALSIGFETCRYGFIEGHVVIPRIHPNSICAANNTGVYILTSNTSQYDTYCFNASAPPEEDCTSVTDLPNAFDGPITITIVNRDGTRYVQKGEYRTNPEDIYPSNPTDDDVSSGSSSERSSTSGGYIFYTFSTVHPIPDEDSPWITDSTDRIPATTLMSTSATATETATKRQETWDWFSWLFLPSESKNHLHTTTQMAGTSSNTISAGWEPNEENEDERDRHLSFSGSGIDDDEDFISSTISTTPRAFDHTKQNQDWTQWNPSHSNPEVLLQTTTRMTDVDRNGTTAYEGNWNPEAHPPLIHHEHHEEEETPHSTSTIQATPSSTTEETATQKEQWFGNRWHEGYRQTPKEDSHSTTGTAAASAHTSHPMQGRTTPSPEDSSWTDFFNPISHPMGRGHQAGRRMDMDSSHSITLQPTANPNTGLVEDLDRTGPLSMTTQQSNSQSFSTSHEGLEEDKDHPTTSTLTSSNRNDVTGGRRDPNHSEGSTTLLEGYTSHYPHTKESRTFIPVTSAKTGSFGVTAVTVGDSNSNVNRSLSGDQDTFHPSGGSHTTHGSESDGHSHGSQEGGANTTSGPIRTPQIPEWLIILASLLALALILAVCIAVNSRRRCGQKKKLVINSGNGAVEDRKPSGLNGEASKSQEMVHLVNKESSETPDQFMTADETRNLQNVDMKIGV'),
('P15692', '4QAF', 1, 1.8, 'C/D', 102, 'TRANSPORT PROTEIN / SIGNALING PROTEIN', 'TRANSPORT_PROT', 'Vascular endothelial growth factor A', 'VEGFA', '', 'chemoattractant activity<br />\ncytokine activity<br />\nextracellular matrix binding<br />\nfibronectin binding<br />\ngrowth factor activity<br />\nheparin binding<br />\nidentical protein binding<br />\nneuropilin binding<br />\nplatelet-derived growth factor receptor binding<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nreceptor agonist activity<br />\nvascular endothelial growth factor receptor 1 binding<br />\nvascular endothelial growth factor receptor 2 binding<br />\nvascular endothelial growth factor receptor binding<br />\n', 'activation of protein kinase activity<br />\nangiogenesis<br />\nartery morphogenesis<br />\nbasophil chemotaxis<br />\nbranching involved in blood vessel morphogenesis<br />\nbranching morphogenesis of an epithelial tube<br />\ncamera-type eye morphogenesis<br />\ncardiac muscle fiber development<br />\ncardiac vascular smooth muscle cell development<br />\ncell maturation<br />\ncell migration involved in sprouting angiogenesis<br />\ncellular response to hypoxia<br />\ncellular response to vascular endothelial growth factor stimulus<br />\ncommissural neuron axon guidance<br />\ncoronary artery morphogenesis<br />\ncoronary vein morphogenesis<br />\ndopaminergic neuron differentiation<br />\nendothelial cell chemotaxis<br />\nepithelial cell differentiation<br />\neye photoreceptor cell development<br />\ngrowth<br />\nheart morphogenesis<br />\ninduction of positive chemotaxis<br />\nin utero embryonic development<br />\nkidney development<br />\nlactation<br />\nlung development<br />\nlymph vessel morphogenesis<br />\nmacrophage differentiation<br />\nmammary gland alveolus development<br />\nmesoderm development<br />\nmonocyte differentiation<br />\nmotor neuron migration<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnervous system development<br />\noutflow tract morphogenesis<br />\novarian follicle development<br />\nplatelet degranulation<br />\npositive chemotaxis<br />\npositive regulation of angiogenesis<br />\npositive regulation of axon extension involved in axon guidance<br />\npositive regulation of blood vessel endothelial cell migration<br />\npositive regulation of branching involved in ureteric bud morphogenesis<br />\npositive regulation of cell adhesion<br />\npositive regulation of cell division<br />\npositive regulation of cell migration<br />\npositive regulation of cell migration involved in sprouting angiogenesis<br />\npositive regulation of cell proliferation<br />\npositive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway<br />\npositive regulation of cellular component movement<br />\npositive regulation of CREB transcription factor activity<br />\npositive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of epithelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of focal adhesion assembly<br />\npositive regulation of gene expression<br />\npositive regulation of histone deacetylase activity<br />\npositive regulation of leukocyte migration<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of mast cell chemotaxis<br />\npositive regulation of mesenchymal cell proliferation<br />\npositive regulation of neuroblast proliferation<br />\npositive regulation of p38MAPK cascade<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of peptidyl-tyrosine autophosphorylation<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of phosphorylation<br />\npositive regulation of positive chemotaxis<br />\npositive regulation of protein autophosphorylation<br />\npositive regulation of protein complex assembly<br />\npositive regulation of protein kinase C signaling<br />\npositive regulation of protein kinase D signaling<br />\npositive regulation of protein localization to early endosome<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of receptor internalization<br />\npositive regulation of retinal ganglion cell axon guidance<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\npositive regulation of vascular endothelial growth factor receptor signaling pathway<br />\npositive regulation of vascular permeability<br />\npost-embryonic camera-type eye development<br />\nprimitive erythrocyte differentiation<br />\nregulation of cell shape<br />\nregulation of cGMP metabolic process<br />\nregulation of retinal ganglion cell axon guidance<br />\nregulation of transcription from RNA polymerase II promoter<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nresponse to hypoxia<br />\nsurfactant homeostasis<br />\ntube formation<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nvascular endothelial growth factor signaling pathway<br />\nvasculogenesis<br />\nVEGF-activated neuropilin signaling pathway<br />\n', 'PF00341.', 'MNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR'),
('P05230', '4QC4', 1, 1.49, 'A/B', 140, 'PROTEIN BINDING', 'PROTEIN_BINDING', 'Fibroblast growth factor 1', 'FGF1', '', '1-phosphatidylinositol-3-kinase activity<br />\nfibroblast growth factor receptor binding<br />\ngrowth factor activity<br />\nheparin binding<br />\nHsp70 protein binding<br />\nintegrin binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nS100 protein binding<br />\n', 'activation of MAPK activity<br />\nactivation of protein kinase B activity<br />\nanatomical structure morphogenesis<br />\nangiogenesis<br />\nbranch elongation involved in ureteric bud branching<br />\ncell differentiation<br />\ncell proliferation<br />\ncellular response to heat<br />\nfibroblast growth factor receptor signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nlung development<br />\nMAPK cascade<br />\nmesonephric epithelium development<br />\nmulticellular organism development<br />\norgan induction<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of angiogenesis<br />\npositive regulation of cell division<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of cholesterol biosynthetic process<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of epithelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of intracellular signal transduction<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of sprouting angiogenesis<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of endothelial cell chemotaxis to fibroblast growth factor<br />\nregulation of endothelial tube morphogenesis<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nsignal transduction<br />\n', 'PF00167.', 'MAEGEITTFTALTEKFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD'),
('P09884', '4QCL', 1, 2.2, 'A', 922, 'TRANSFERASE / DNA / RNA', 'TRANSFERASE', 'DNA polymerase alpha catalytic subunit', 'POLA1', 'Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1).<br />\n', '3''-5'' exonuclease activity<br />\n4 iron, 4 sulfur cluster binding<br />\nchromatin binding<br />\nDNA binding<br />\nDNA-directed DNA polymerase activity<br />\nmetal ion binding<br />\nnucleoside binding<br />\nnucleotide binding<br />\nprotein kinase binding<br />\n', 'cell proliferation<br />\nDNA replication<br />\nDNA replication, synthesis of RNA primer<br />\nDNA replication initiation<br />\nDNA strand elongation involved in DNA replication<br />\ndouble-strand break repair via nonhomologous end joining<br />\nG1/S transition of mitotic cell cycle<br />\nlagging strand elongation<br />\nleading strand elongation<br />\nregulation of transcription involved in G1/S transition of mitotic cell cycle<br />\ntelomere maintenance via semi-conservative replication<br />\nviral process<br />\n', 'PF12254.', 'MAPVHGDDSLSDSGSFVSSRARREKKSKKGRQEALERLKKAKAGEKYKYEVEDFTGVYEEVDEEQYSKLVQARQDDDWIVDDDGIGYVEDGREIFDDDLEDDALDADEKGKDGKARNKDKRNVKKLAVTKPNNIKSMFIACAGKKTADKAVDLSKDGLLGDILQDLNTETPQITPPPVMILKKKRSIGASPNPFSVHTATAVPSGKIASPVSRKEPPLTPVPLKRAEFAGDDVQVESTEEEQESGAMEFEDGDFDEPMEVEEVDLEPMAAKAWDKESEPAEEVKQEADSGKGTVSYLGSFLPDVSCWDIDQEGDSSFSVQEVQVDSSHLPLVKGADEEQVFHFYWLDAYEDQYNQPGVVFLFGKVWIESAETHVSCCVMVKNIERTLYFLPREMKIDLNTGKETGTPISMKDVYEEFDEKIATKYKIMKFKSKPVEKNYAFEIPDVPEKSEYLEVKYSAEMPQLPQDLKGETFSHVFGTNTSSLELFLMNRKIKGPCWLEVKSPQLLNQPVSWCKVEAMALKPDLVNVIKDVSPPPLVVMAFSMKTMQNAKNHQNEIIAMAALVHHSFALDKAAPKPPFQSHFCVVSKPKDCIFPYAFKEVIEKKNVKVEVAATERTLLGFFLAKVHKIDPDIIVGHNIYGFELEVLLQRINVCKAPHWSKIGRLKRSNMPKLGGRSGFGERNATCGRMICDVEISAKELIRCKSYHLSELVQQILKTERVVIPMENIQNMYSESSQLLYLLEHTWKDAKFILQIMCELNVLPLALQITNIAGNIMSRTLMGGRSERNEFLLLHAFYENNYIVPDKQIFRKPQQKLGDEDEEIDGDTNKYKKGRKKAAYAGGLVLDPKVGFYDKFILLLDFNSLYPSIIQEFNICFTTVQRVASEAQKVTEDGEQEQIPELPDPSLEMGILPREIRKLVERRKQVKQLMKQQDLNPDLILQYDIRQKALKLTANSMYGCLGFSYSRFYAKPLAALVTYKGREILMHTKEMVQKMNLEVIYGDTDSIMINTNSTNLEEVFKLGNKVKSEVNKLYKLLEIDIDGVFKSLLLLKKKKYAALVVEPTSDGNYVTKQELKGLDIVRRDWCDLAKDTGNFVIGQILSDQSRDTIVENIQKRLIEIGENVLNGSVPVSQFEINKALTKDPQDYPDKKSLPHVHVALWINSQGGRKVKAGDTVSYVICQDGSNLTASQRAYAPEQLQKQDNLTIDTQYYLAQQIHPVVARICEPIDGIDAVLIATWLGLDPTQFRVHHYHKDEENDALLGGPAQLTDEEKYRDCERFKCPCPTCGTENIYDNVFDGSGTDMEPSLYRCSNIDCKASPLTFTVQLSNKLIMDIRRFIKKYYDGWLICEEPTCRNRTRHLPLQFSRTGPLCPACMKATLQPEYSDKSLYTQLCFYRYIFDAECALEKLTTDHEKDKLKKQFFTPKVLQDYRKLKNTAEQFLSRSGYSEVNLSKLFAGCAVKS'),
('Q96RI1', '4QE6', 1, 1.65, 'A', 229, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Bile acid receptor', 'NR1H4', '', 'bile acid binding<br />\nbile acid receptor activity<br />\nchenodeoxycholic acid binding<br />\nligand-dependent nuclear receptor binding<br />\nretinoid X receptor binding<br />\nRNA polymerase II distal enhancer sequence-specific DNA binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\nthyroid hormone receptor activity<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscriptional activator activity, RNA polymerase II transcription factor binding<br />\ntranscription coactivator activity<br />\ntranscription corepressor activity<br />\ntranscription factor activity, RNA polymerase II distal enhancer sequence-specific binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription regulatory region sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'bile acid and bile salt transport<br />\nbile acid metabolic process<br />\nbile acid signaling pathway<br />\ncell-cell junction assembly<br />\ncellular response to fatty acid<br />\ncellular response to lipopolysaccharide<br />\ncellular response to organonitrogen compound<br />\ncellular triglyceride homeostasis<br />\ndefense response to bacterium<br />\nfatty acid homeostasis<br />\nglucose homeostasis<br />\nhistone H3-R17 methylation<br />\ninflammatory response<br />\ninnate immune response<br />\ninterleukin-17 secretion<br />\nintracellular bile acid receptor signaling pathway<br />\nintracellular receptor signaling pathway<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of bile acid biosynthetic process<br />\nnegative regulation of I-kappaB kinase/NF-kappaB signaling<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of interferon-gamma secretion<br />\nnegative regulation of interleukin-1 production<br />\nnegative regulation of interleukin-2 production<br />\nnegative regulation of interleukin-6 production<br />\nnegative regulation of monocyte chemotactic protein-1 production<br />\nnegative regulation of NF-kappaB transcription factor activity<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnegative regulation of tumor necrosis factor-mediated signaling pathway<br />\nnegative regulation of tumor necrosis factor secretion<br />\nnitrogen catabolite activation of transcription from RNA polymerase II promoter<br />\nNotch signaling pathway<br />\npositive regulation of adipose tissue development<br />\npositive regulation of ammonia assimilation cycle<br />\npositive regulation of glucose import in response to insulin stimulus<br />\npositive regulation of glutamate metabolic process<br />\npositive regulation of insulin receptor signaling pathway<br />\npositive regulation of insulin secretion involved in cellular response to glucose stimulus<br />\npositive regulation of phosphatidic acid biosynthetic process<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of bile acid biosynthetic process<br />\nregulation of cholesterol homeostasis<br />\nregulation of cholesterol metabolic process<br />\nregulation of insulin secretion involved in cellular response to glucose stimulus<br />\nregulation of low-density lipoprotein particle clearance<br />\nregulation of transcription, DNA-templated<br />\nregulation of urea metabolic process<br />\nsignal transduction<br />\ntoll-like receptor 4 signaling pathway<br />\ntoll-like receptor 9 signaling pathway<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'MVMQFQGLENPIQISPHCSCTPSGFFMEMMSMKPAKGVLTEQVAGPLGQNLEVEPYSQYSNVQFPQVQPQISSSSYYSNLGFYPQQPEEWYSPGIYELRRMPAETLYQGETEVAEMPVTKKPRMGASAGRIKGDELCVVCGDRASGYHYNALTCEGCKGFFRRSITKNAVYKCKNGGNCVMDMYMRRKCQECRLRKCKEMGMLAECMYTGLLTEIQCKSKRLRKNVKQHADQTVNEDSEGRDLRQVTSTTKSCREKTELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEEFSAEENFLILTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSDLLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEKLQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLCEIWDVQ'),
('P27695', '4QHE', 0, 1.4, 'A', 281, 'LYASE', 'LYASE', 'DNA-(apurinic or apyrimidinic site) lyase', 'APEX1', 'The C-O-P bond 3'' to the apurinic or apyrimidinic site in DNA is broken by a beta-elimination reaction, leaving a 3''-terminal unsaturated sugar and a product with a terminal 5''-phosphate<br />\n', '3''-5'' exonuclease activity<br />\nchromatin DNA binding<br />\nclass I DNA-(apurinic or apyrimidinic site) lyase activity<br />\nclass III/IV DNA-(apurinic or apyrimidinic site) lyase activity<br />\ndamaged DNA binding<br />\nDNA-(apurinic or apyrimidinic site) lyase activity<br />\nDNA binding<br />\ndouble-stranded DNA 3''-5'' exodeoxyribonuclease activity<br />\ndouble-stranded DNA exodeoxyribonuclease activity<br />\ndouble-stranded telomeric DNA binding<br />\nendodeoxyribonuclease activity<br />\nendonuclease activity<br />\nmetal ion binding<br />\nNF-kappaB binding<br />\noxidoreductase activity<br />\nphosphodiesterase I activity<br />\nphosphoric diester hydrolase activity<br />\nprotein complex binding<br />\nRNA binding<br />\nRNA-DNA hybrid ribonuclease activity<br />\nsite-specific endodeoxyribonuclease activity, specific for altered base<br />\ntranscription coactivator activity<br />\ntranscription corepressor activity<br />\nuracil DNA N-glycosylase activity<br />\n', 'aging<br />\nbase-excision repair<br />\nbase-excision repair, base-free sugar-phosphate removal<br />\ncell redox homeostasis<br />\ncellular response to cAMP<br />\ncellular response to hydrogen peroxide<br />\ncellular response to peptide hormone stimulus<br />\nDNA demethylation<br />\nDNA recombination<br />\nDNA repair<br />\nnegative regulation of smooth muscle cell migration<br />\npositive regulation of G1/S transition of mitotic cell cycle<br />\nregulation of apoptotic process<br />\nregulation of mRNA stability<br />\nregulation of transcription, DNA-templated<br />\nresponse to drug<br />\ntelomere maintenance<br />\ntelomere maintenance via base-excision repair<br />\ntranscription, DNA-templated<br />\n', 'PF03372.', 'MPKRGKKGAVAEDGDELRTEPEAKKSKTAAKKNDKEAAGEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQCPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL'),
('P22894', '4QKZ', 1, 1.2, 'A', 163, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Neutrophil collagenase', 'MMP8', 'Cleavage of interstitial collagens in the triple helical domain. Unlike EC 3.4.24.7, this enzyme cleaves type III collagen more slowly than type I.<br />\n', 'metalloendopeptidase activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'collagen catabolic process<br />\nendodermal cell differentiation<br />\nextracellular matrix disassembly<br />\nneutrophil degranulation<br />\nproteolysis<br />\n', 'PF00045.', 'MFSLKTLPFLLLLHVQISKAFPVSSKEKNTKTVQDYLEKFYQLPSNQYQSTRKNGTNVIVEKLKEMQRFFGLNVTGKPNEETLDMMKKPRCGVPDSGGFMLTPGNPKWERTNLTYRIRNYTPQLSEAEVERAIKDAFELWSVASPLIFTRISQGEADINIAFYQRDHGDNSPFDGPNGILAHAFQPGQGIGGDAHFDAEETWTNTSANYNLFLVAAHEFGHSLGLAHSSDPGALMYPNYAFRETSNYSLPQDDIDGIQAIYGLSSNPIQPTGPSTPKPCDPSLTFDAITTLRGEILFFKDRYFWRRHPQLQRVEMNFISLFWPSLPTGIQAAYEDFDRDLIFLFKGNQYWALSGYDILQGYPKDISNYGFPSSVQAIDAAVFYRSKTYFFVNDQFWRYDNQRQFMEPGYPKSISGAFPGIESKVDAVFQQEHFFHVFSGPRYYAFDLIAQRVTRVARGNKWLNCRYG'),
('P27361', '4QTB', 1, 1.4, 'A/B', 379, 'Transferase / transferase inhibitor', 'TRANSFERASE', 'Mitogen-activated protein kinase 3', 'MAPK3', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nkinase activity<br />\nMAP kinase activity<br />\nMAP kinase kinase activity<br />\nphosphatase binding<br />\nphosphotyrosine residue binding<br />\nprotein serine/threonine kinase activity<br />\nscaffold protein binding<br />\n', 'activation of MAPK activity<br />\napoptotic process<br />\narachidonic acid metabolic process<br />\naxon guidance<br />\nBergmann glial cell differentiation<br />\nBMP signaling pathway<br />\ncardiac neural crest cell development involved in heart development<br />\ncartilage development<br />\ncaveolin-mediated endocytosis<br />\ncell cycle<br />\ncellular response to amino acid starvation<br />\ncellular response to cadmium ion<br />\ncellular response to dopamine<br />\ncellular response to mechanical stimulus<br />\ncellular response to reactive oxygen species<br />\nDNA damage induced protein phosphorylation<br />\nERK1 and ERK2 cascade<br />\nface development<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nfibroblast growth factor receptor signaling pathway<br />\ninterleukin-1-mediated signaling pathway<br />\nJAK-STAT cascade involved in growth hormone signaling pathway<br />\nlipopolysaccharide-mediated signaling pathway<br />\nlung morphogenesis<br />\nMAPK cascade<br />\nMAPK import into nucleus<br />\nnegative regulation of apolipoprotein binding<br />\nouter ear morphogenesis<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-tyrosine autophosphorylation<br />\nphosphorylation<br />\nplatelet activation<br />\npositive regulation of cyclase activity<br />\npositive regulation of cytokine secretion involved in immune response<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of gene expression<br />\npositive regulation of histone acetylation<br />\npositive regulation of histone phosphorylation<br />\npositive regulation of macrophage chemotaxis<br />\npositive regulation of metallopeptidase activity<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of telomerase activity<br />\npositive regulation of telomere capping<br />\npositive regulation of telomere maintenance via telomerase<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of translation<br />\npositive regulation of xenophagy<br />\nprotein complex assembly<br />\nprotein phosphorylation<br />\nregulation of cellular pH<br />\nregulation of cellular response to heat<br />\nregulation of cytoskeleton organization<br />\nregulation of early endosome to late endosome transport<br />\nregulation of Golgi inheritance<br />\nregulation of ossification<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of sequence-specific DNA binding transcription factor activity<br />\nregulation of stress-activated MAPK cascade<br />\nresponse to epidermal growth factor<br />\nresponse to exogenous dsRNA<br />\nresponse to toxic substance<br />\nsensory perception of pain<br />\nstress-activated MAPK cascade<br />\nthymus development<br />\nthyroid gland development<br />\ntrachea formation<br />\ntranscription initiation from RNA polymerase I promoter<br />\nviral process<br />\n', 'PF00069.', 'MAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP'),
('P08581', '4R1V', 1, 1.2, 'A', 291, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Hepatocyte growth factor receptor', 'MET', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nhepatocyte growth factor-activated receptor activity<br />\nidentical protein binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein phosphatase binding<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\n', 'branching morphogenesis of an epithelial tube<br />\ncell proliferation<br />\ncell surface receptor signaling pathway<br />\nendothelial cell morphogenesis<br />\nentry of bacterium into host cell<br />\nestablishment of skin barrier<br />\ninterleukin-7-mediated signaling pathway<br />\nMAPK cascade<br />\nnegative regulation of autophagy<br />\nnegative regulation of guanyl-nucleotide exchange factor activity<br />\nnegative regulation of hydrogen peroxide-mediated programmed cell death<br />\nnegative regulation of Rho protein signal transduction<br />\nnegative regulation of stress fiber assembly<br />\nnegative regulation of thrombin-activated receptor signaling pathway<br />\nphosphatidylinositol-mediated signaling<br />\npositive chemotaxis<br />\npositive regulation of endothelial cell chemotaxis<br />\npositive regulation of microtubule polymerization<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nsemaphorin-plexin signaling pathway<br />\nsignal transduction<br />\n', 'PF07714.', 'MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEHHIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQDCSSKANLSGGVWKDNINMALVVDTYYDDQLISCGSVNRGTCQRHVFPHNHTADIQSEVHCIFSPQIEEPSQCPDCVVSALGAKVLSSVKDRFINFFVGNTINSSYFPDHPLHSISVRRLKETKDGFMFLTDQSYIDVLPEFRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRIIRFCSINSGLHSYMEMPLECILTEKRKKRSTKKEVFNILQAAYVSKPGAQLARQIGASLNDDILFGVFAQSKPDSAEPMDRSAMCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFNRTLLRNSSGCEARRDEYRTEFTTALQRVDLFMGQFSEVLLTSISTFIKGDLTIANLGTSEGRFMQVVVSRSGPSTPHVNFLLDSHPVSPEVIVEHTLNQNGYTLVITGKKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGWCHDKCVRSEECLSGTWTQQICLPAIYKVFPNSAPLEGGTRLTICGWDFGFRRNNKFDLKKTRVLLGNESCTLTLSESTMNTLKCTVGPAMNKHFNMSIIISNGHGTTQYSTFSYVDPVITSISPKYGPMAGGTLLTLTGNYLNSGNSRHISIGGKTCTLKSVSNSILECYTPAQTISTEFAVKLKIDLANRETSIFSYREDPIVYEIHPTKSFISGGSTITGVGKNLNSVSVPRMVINVHEAGRNFTVACQHRSNSEIICCTTPSLQQLNLQLPLKTKAFFMLDGILSKYFDLIYVHNPVFKPFEKPVMISMGNENVLEIKGNDIDPEAVKGEVLKVGNKSCENIHLHSEAVLCTVPNDLLKLNSELNIEWKQAISSTVLGKVIVQPDQNFTGLIAGVVSISTALLLLLGFFLWLKKRKQIKDLGSELVRYDARVHTPHLDRLVSARSVSPTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKCVAPYPSLLSSEDNADDEVDTRPASFWETS'),
('P17252', '4RA4', 1, 2.63, 'A', 355, 'Transferase / transferase inhibitor', 'TRANSFERASE', 'Protein kinase C alpha type', 'PRKCA', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\ncalcium-dependent protein kinase C activity<br />\nenzyme binding<br />\nhistone kinase activity (H3-T6 specific)<br />\nprotein kinase activity<br />\nprotein kinase C activity<br />\nprotein serine/threonine kinase activity<br />\nzinc ion binding<br />\n', 'activation of adenylate cyclase activity<br />\nangiogenesis<br />\napoptotic signaling pathway<br />\naxon guidance<br />\ncell adhesion<br />\ndesmosome assembly<br />\nERBB2 signaling pathway<br />\nhistone H3-T6 phosphorylation<br />\nintracellular signal transduction<br />\nmitotic nuclear envelope disassembly<br />\nnegative regulation of adenylate cyclase activity<br />\nnegative regulation of glial cell apoptotic process<br />\npeptidyl-serine phosphorylation<br />\nplatelet activation<br />\npositive regulation of angiogenesis<br />\npositive regulation of blood vessel endothelial cell migration<br />\npositive regulation of cardiac muscle hypertrophy<br />\npositive regulation of cell adhesion<br />\npositive regulation of cell migration<br />\npositive regulation of dense core granule biogenesis<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of lipopolysaccharide-mediated signaling pathway<br />\npositive regulation of macrophage differentiation<br />\npositive regulation of mitotic cell cycle<br />\nprotein phosphorylation<br />\nregulation of insulin secretion<br />\nregulation of mRNA stability<br />\nregulation of platelet aggregation<br />\nresponse to interleukin-1<br />\n', 'PF00130.', 'MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSVCKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV'),
('P12676', '4REK', 1, 0.74, 'A', 499, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Cholesterol oxidase', 'choA', 'Cholesterol + O2 = cholest-5-en-3-one + H2O2<br />\nA 3-oxo-Delta5-steroid = a 3-oxo-Delta4-steroid<br />\n', 'cholesterol oxidase activity<br />\nflavin adenine dinucleotide binding<br />\nsteroid delta-isomerase activity<br />\n', 'cholesterol metabolic process<br />\n', 'PF05199.', 'MTAQQHLSRRRMLGMAAFGAAALAGGTTIAAPRAAAAAKSAADNGGYVPAVVIGTGYGAAVSALRLGEAGVQTLMLEMGQLWNQPGPDGNIFCGMLNPDKRSSWFKNRTEAPLGSFLWLDVVNRNIDPYAGVLDRVNYDQMSVYVGRGVGGGSLVNGGMAVEPKRSYFEEILPRVDSSEMYDRYFPRANSMLRVNHIDTKWFEDTEWYKFARVSREQAGKAGLGTVFVPNVYDFGYMQREAAGEVPKSALATEVIYGNNHGKQSLDKTYLAAALGTGKVTIQTLHQVKTIRQTKDGGYALTVEQKDTDGKLLATKEISCRYLFLGAGSLGSTELLVRARDTGTLPNLNSEVGAGWGPNGNIMTARANHMWNPTGAHQSSIPALGIDAWDNSDSSVFAEIAPMPAGLETWVSLYLAITKNPQRGTFVYDAATDRAKLNWTRDQNAPAVNAAKALFDRINKANGTIYRYDLFGTQLKAFADDFCYHPLGGCVLGKATDDYGRVAGYKNLYVTDGSLIPGSVGVNPFVTITALAERNVERIIKQDVTAS'),
('Q06187', '4RFZ', 1, 1.17, 'A', 282, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Tyrosine-protein kinase BTK', 'BTK', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nphosphatidylinositol-3,4,5-trisphosphate binding<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\n', 'adaptive immune response<br />\napoptotic signaling pathway<br />\nB cell activation<br />\nB cell affinity maturation<br />\nB cell receptor signaling pathway<br />\ncalcium-mediated signaling<br />\ncell maturation<br />\ncellular response to interleukin-7<br />\ncellular response to molecule of fungal origin<br />\ncellular response to reactive oxygen species<br />\nFc-epsilon receptor signaling pathway<br />\nhistamine secretion by mast cell<br />\nI-kappaB kinase/NF-kappaB signaling<br />\ninnate immune response<br />\nintracellular signal transduction<br />\nmesoderm development<br />\nMyD88-dependent toll-like receptor signaling pathway<br />\nnegative regulation of B cell proliferation<br />\nnegative regulation of cytokine production<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of B cell differentiation<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of type I hypersensitivity<br />\npositive regulation of type III hypersensitivity<br />\nprotein phosphorylation<br />\nregulation of B cell apoptotic process<br />\nregulation of B cell cytokine production<br />\nregulation of cell proliferation<br />\ntranscription, DNA-templated<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00779.', 'MAAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILENRNGSLKPGSSHRKTKKPLPPTPEEDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDSSKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELINYHQHNSAGLISRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES'),
('P35754', '4RQR', 1, 1.08, 'A', 105, 'ELECTRON TRANSPORT', 'OTHERS', 'Glutaredoxin-1', 'GLRX', '', 'electron carrier activity<br />\nglutathione disulfide oxidoreductase activity<br />\nglutathione oxidoreductase activity<br />\nprotein N-terminus binding<br />\n', 'cell redox homeostasis<br />\nnucleobase-containing small molecule interconversion<br />\npositive regulation of membrane potential<br />\npositive regulation of sodium ion transmembrane transporter activity<br />\nprotein deglutathionylation<br />\n', 'PF00462.', 'MAQEFVNCKIQPGKVVVFIKPTCPYCRRAQEILSQLPIKQGLLEFVDITATNHTNEIQDYLQQLTGARTVPRVFIGKDCIGGCSDLVSLQQSGELLTRLKQIGALQ');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P51843', '4RWV', 1, 1.86, 'B', 15, 'TRANSCRIPTION', 'TRANSCRIPTION', 'Nuclear receptor subfamily 0 group B member 1', 'NR0B1', '', 'AF-2 domain binding<br />\nDNA binding<br />\nDNA hairpin binding<br />\nprotein domain specific binding<br />\nprotein homodimerization activity<br />\nRNA binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\nsteroid hormone receptor binding<br />\ntranscription corepressor activity<br />\ntranscription factor binding<br />\n', 'adrenal gland development<br />\ngonad development<br />\nhypothalamus development<br />\nLeydig cell differentiation<br />\nmale gonad development<br />\nmale sex determination<br />\nnegative regulation of cell differentiation<br />\nnegative regulation of intracellular steroid hormone receptor signaling pathway<br />\nnegative regulation of sequence-specific DNA binding transcription factor activity<br />\nnegative regulation of transcription, DNA-templated<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npituitary gland development<br />\nprotein localization<br />\nresponse to immobilization stress<br />\nSertoli cell differentiation<br />\nspermatogenesis<br />\nsteroid biosynthetic process<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'MAGENHQWQGSILYNMLMSAKQTRAAPEAPETRLVDQCWGCSCGDEPGVGREGLLGGRNVALLYRCCFCGKDHPRQGSILYSMLTSAKQTYAAPKAPEATLGPCWGCSCGSDPGVGRAGLPGGRPVALLYRCCFCGEDHPRQGSILYSLLTSSKQTHVAPAAPEARPGGAWWDRSYFAQRPGGKEALPGGRATALLYRCCFCGEDHPQQGSTLYCVPTSTNQAQAAPEERPRAPWWDTSSGALRPVALKSPQVVCEAASAGLLKTLRFVKYLPCFQVLPLDQQLVLVRNCWASLLMLELAQDRLQFETVEVSEPSMLQKILTTRRRETGGNEPLPVPTLQHHLAPPAEARKVPSASQVQAIKCFLSKCWSLNISTKEYAYLKGTVLFNPDVPGLQCVKYIQGLQWGTQQILSEHTRMTHQGPHDRFIELNSTLFLLRFINANVIAELFFRPIIGTVSMDDMMLEMLCTKI'),
('O43614', '4S0V', 1, 2.5, 'A', 252, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Orexin receptor type 2', 'HCRTR2', '', 'neuropeptide receptor activity<br />\norexin receptor activity<br />\npeptide binding<br />\npeptide hormone binding<br />\n', 'cellular response to hormone stimulus<br />\nchemical synaptic transmission<br />\ncircadian sleep/wake cycle process<br />\nfeeding behavior<br />\nneuropeptide signaling pathway<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\nregulation of circadian sleep/wake cycle, sleep<br />\nregulation of circadian sleep/wake cycle, wakefulness<br />\nregulation of cytosolic calcium ion concentration<br />\nresponse to peptide<br />\n', 'PF00001.', 'MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW'),
('Q9UDX3', '4TLG', 1, 1.77, 'A/B', 406, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'SEC14-like protein 4', 'SEC14L4', '', 'lipid binding<br />\ntransporter activity<br />\n', '', 'PF00650.', 'MSSRVGDLSPQQQEALARFRENLQDLLPILPNADDYFLLRWLRARNFDLQKSEDMLRRHMEFRKQQDLDNIVTWQPPEVIQLYDSGGLCGYDYEGCPVYFNIIGSLDPKGLLLSASKQDMIRKRIKVCELLLHECELQTQKLGRKIEMALMVFDMEGLSLKHLWKPAVEVYQQFFSILEANYPETLKNLIVIRAPKLFPVAFNLVKSFMSEETRRKIVILGDNWKQELTKFISPDQLPVEFGGTMTDPDGNPKCLTKINYGGEVPKSYYLCEQVRLQYEHTRSVGRGSSLQVENEILFPGCVLRWQFASDGGDIGFGVFLKTKMGEQQSAREMTEVLPSQRYNAHMVPEDGSLTCLQAGVYVLRFDNTYSRMHAKKLSYTVEVLLPDKASEETLQSLKAMRPSPTQ'),
('O95069', '4TWK', 1, 2.6, 'A/B', 275, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Potassium channel subfamily K member 2', 'KCNK2', '', 'outward rectifier potassium channel activity<br />\npotassium channel inhibitor activity<br />\npotassium ion leak channel activity<br />\n', 'cardiac ventricle development<br />\ncellular response to hypoxia<br />\ncochlea development<br />\nG-protein coupled receptor signaling pathway<br />\nmemory<br />\nnegative regulation of cardiac muscle cell proliferation<br />\nnegative regulation of DNA biosynthetic process<br />\npositive regulation of cell death<br />\npositive regulation of cellular response to hypoxia<br />\npotassium ion transmembrane transport<br />\nresponse to axon injury<br />\nresponse to mechanical stimulus<br />\nstabilization of membrane potential<br />\n', 'PF07885.', 'MLPSASRERPGYRAGVAAPDLLDPKSAAQNSKPRLSFSTKPTVLASRVESDTTINVMKWKTVSTIFLVVVLYLIIGATVFKALEQPHEISQRTTIVIQKQTFISQHSCVNSTELDELIQQIVAAINAGIIPLGNTSNQISHWDLGSSFFFAGTVITTIGFGNISPRTEGGKIFCIIYALLGIPLFGFLLAGVGDQLGTIFGKGIAKVEDTFIKWNVSQTKIRIISTIIFILFGCVLFVALPAIIFKHIEGWSALDAIYFVVITLTTIGFGDYVAGGSDIEYLDFYKPVVWFWILVGLAYFAAVLSMIGDWLRVISKKTKEEVGEFRAHAAEWTANVTAEFKETRRRLSVEIYDKFQRATSIKRKLSAELAGNHNQELTPCRRTLSVNHLTSERDVLPPLLKTESIYLNGLTPHCAGEEIAVIENIK'),
('P08149', '4U3T', 0, 2.2, 'A/B', 338, 'HYDROLASE', 'HYDROLASE', 'Probable peptidoglycan D,D-transpeptidase PenA', 'penA', 'Preferential cleavage: (Ac)2-L-Lys-D-Ala-|-D-Ala<br />\n', 'penicillin binding<br />\nserine-type D-Ala-D-Ala carboxypeptidase activity<br />\n', 'cell cycle<br />\ncell division<br />\ncell wall organization<br />\npeptidoglycan biosynthetic process<br />\nregulation of cell shape<br />\nresponse to antibiotic<br />\n', 'PF03717.', 'MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAMAVLFACLIARGLYLQTVTYNFLKEQGDNRIVRTQALPATRGTVSDRNGAVLALSAPTESLFAVPKDMKEMPSAAQLERLSELVDVPVDVLRNKLEQKGKSFIWIKRQLDPKVAEEVKALGLENFVFEKELKRHYPMGNLFAHVIGFTDIDGKGQEGLELSLEDSLYGEDGAEVVLRDRQGNIVDSLDSPRNKAPQNGKDIILSLDQRIQTLAYEELNKAVEYHQAKAGTVVVLDARTGEILALANTPAYDPNRPGRADSEQRRNRAVTDMIEPGSAIKPFVIAKALDAGKTDLNERLNTQPYKIGPSPVRDTHVYPSLDVRGIMQKSSNVGTSKLSARFGAEEMYDFYHELGIGVRMHSGFPGETAGLLRNWRRWRPIEQATMSFGYGLQLSLLQLARAYTALTHDGVLLPLSFEKQAVAPQGKRIFKESTAREVRNLMVSVTEPGGTGTAGAVDGFDVGAKTGTARKFVNGRYADNKHVATFIGFAPAKNPRVIVAVTIDEPTAHGYYGGVVAGPPFKKIMGGSLNILGISPTKPLTAAAVKTPS'),
('P00734', '4UD9', 1, 1.12, 'H', 259, 'HYDROLASE', 'HYDROLASE', 'Prothrombin', 'F2', 'Selective cleavage of Arg-|-Gly bonds in fibrinogen to form fibrin and release fibrinopeptides A and B.<br />\n', 'calcium ion binding<br />\ngrowth factor activity<br />\nheparin binding<br />\nlipopolysaccharide binding<br />\nreceptor binding<br />\nserine-type endopeptidase activity<br />\nthrombospondin receptor activity<br />\n', 'acute-phase response<br />\nantimicrobial humoral immune response mediated by antimicrobial peptide<br />\nblood coagulation<br />\nblood coagulation, intrinsic pathway<br />\ncell surface receptor signaling pathway<br />\ncellular protein metabolic process<br />\ncytolysis by host of symbiont cells<br />\nER to Golgi vesicle-mediated transport<br />\nfibrinolysis<br />\nleukocyte migration<br />\nmulticellular organism development<br />\nnegative regulation of astrocyte differentiation<br />\nnegative regulation of cytokine production involved in inflammatory response<br />\nnegative regulation of fibrinolysis<br />\nnegative regulation of platelet activation<br />\nnegative regulation of proteolysis<br />\nneutrophil mediated killing of gram-negative bacterium<br />\npeptidyl-glutamic acid carboxylation<br />\nplatelet activation<br />\npositive regulation of blood coagulation<br />\npositive regulation of cell growth<br />\npositive regulation of cell proliferation<br />\npositive regulation of collagen biosynthetic process<br />\npositive regulation of lipid kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway<br />\npositive regulation of protein localization to nucleus<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of reactive oxygen species metabolic process<br />\npositive regulation of release of sequestered calcium ion into cytosol<br />\nproteolysis<br />\nregulation of blood coagulation<br />\nregulation of cell shape<br />\nregulation of complement activation<br />\nregulation of cytosolic calcium ion concentration<br />\nresponse to wounding<br />\nsignal peptide processing<br />\n', 'PF00594.', 'MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE'),
('P04150', '4UDD', 1, 1.8, 'A', 278, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Glucocorticoid receptor', 'NR3C1', '', 'core promoter binding<br />\nglucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity<br />\nglucocorticoid receptor activity<br />\nHsp90 protein binding<br />\nRNA binding<br />\nRNA polymerase II core promoter proximal region sequence-specific DNA binding<br />\nsteroid binding<br />\nsteroid hormone binding<br />\nSUMO binding<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'apoptotic process<br />\ncell cycle<br />\ncell division<br />\ncellular response to dexamethasone stimulus<br />\ncellular response to glucocorticoid stimulus<br />\ncellular response to steroid hormone stimulus<br />\ncellular response to transforming growth factor beta stimulus<br />\nchromosome segregation<br />\ncovalent chromatin modification<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of transcription, DNA-templated<br />\nsignal transduction<br />\ntranscription, DNA-templated<br />\ntranscription from RNA polymerase II promoter<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF02155.', 'MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSKAVSLSMGLYMGETETKVMGNDLGFPQQGQISLSSGETDLKLLEESIANLNRSTSVPENPKSSASTAVSAAPTEKEFPKTHSDVSSEQQHLKGQTGTNGGNVKLYTTDQSTFDILQDLEFSSGSPGKETNESPWRSDLLIDENCLLSPLAGEDDSFLLEGNSNEDCKPLILPDTKPKIKDNGDLVLSSPSNVTLPQVKTEKEDFIELCTPGVIKQEKLGTVYCQASFPGANIIGNKMSAISVHGVSTSGGQMYHYDMNTASLSQQQDQKPIFNVIPPIPVGSENWNRCQGSGDDNLTSLGTLNFPGRTVFSNGYSSPSMRPDVSSPPSSSSTATTGPPPKLCLVCSDEASGCHYGVLTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRYRKCLQAGMNLEARKTKKKIKGIQQATTGVSQETSENPGNKTIVPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK'),
('Q16850', '4UHI', 1, 2.04, 'A/B/C/D', 443, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Lanosterol 14-alpha demethylase', 'CYP51A1', 'A 14-alpha-methylsteroid + 3 O2 + 3 NADPH = a Delta(14)-steroid + formate + 3 NADP+ + 4 H2O<br />\n', 'heme binding<br />\niron ion binding<br />\nsterol 14-demethylase activity<br />\n', 'cholesterol biosynthetic process<br />\ncholesterol biosynthetic process via 24,25-dihydrolanosterol<br />\nregulation of cholesterol biosynthetic process<br />\nsteroid biosynthetic process<br />\nsterol metabolic process<br />\n', 'PF00067.', 'MLLLGLLQAGGSVLGQAMEKVTGGNLLSMLLIACAFTLSLVYLIRLAAGHLVQLPAGVKSPPYIFSPIPFLGHAIAFGKSPIEFLENAYEKYGPVFSFTMVGKTFTYLLGSDAAALLFNSKNEDLNAEDVYSRLTTPVFGKGVAYDVPNPVFLEQKKMLKSGLNIAHFKQHVSIIEKETKEYFESWGESGEKNVFEALSELIILTASHCLHGKEIRSQLNEKVAQLYADLDGGFSHAAWLLPGWLPLPSFRRRDRAHREIKDIFYKAIQKRRQSQEKIDDILQTLLDATYKDGRPLTDDEVAGMLIGLLLAGQHTSSTTSAWMGFFLARDKTLQKKCYLEQKTVCGENLPPLTYDQLKDLNLLDRCIKETLRLRPPIMIMMRMARTPQTVAGYTIPPGHQVCVSPTVNQRLKDSWVERLDFNPDRYLQDNPASGEKFAYVPFGAGRHRCIGENFAYVQIKTIWSTMLRLYEFDLIDGYFPTVNYTTMIHTPENPVIRYKRRSK'),
('Q46509', '4USA', 1, 1.13, 'A', 907, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aldehyde oxidoreductase', 'mop', 'An aldehyde + H2O + acceptor = a carboxylate + reduced acceptor.<br />\n', '2 iron, 2 sulfur cluster binding<br />\naldehyde dehydrogenase (FAD-independent) activity<br />\nelectron carrier activity<br />\nmetal ion binding<br />\n', '', 'PF01315.', 'MIQKVITVNGIEQNLFVDAEALLSDVLRQQLGLTGVKVGCEQGQCGACSVILDGKVVRACVTKMKRVADGAQITTIEGVGQPENLHPLQKAWVLHGGAQCGFCSPGFIVSAKGLLDTNADPSREDVRDWFQKHRNACRCTGYKPLVDAVMDAAAVINGKKPETDLEFKMPADGRIWGSKYPRPTAVAKVTGTLDYGADLGLKMPAGTLHLAMVQAKVSHANIKGIDTSEALTMPGVHSVITHKDVKGKNRITGLITFPTNKGDGWDRPILCDEKVFQYGDCIALVCADSEANARAAAEKVKVDLEELPAYMSGPAAAAEDAIEIHPGTPNVYFEQPIVKGEDTGPIFASADVTVEGDFYVGRQPHMPIEPDVAFAYMGDDGKCYIHSKSIGVHLHLYMIAPGVGLEPDQLVLVANPMGGTFGYKFSPTSEALVAVAAMATGRPVHLRYNYQQQQQYTGKRSPWEMNVKFAAKKDGTLLAMESDWLVDHGPYSEFGDLLTLRGAQFIGAGYNIPNIRGLGRTVATNHVWGSAFRGYGAPQSMFASECLMDMLAEKLGMDPLELRYKNAYRPGDTNPTGQEPEVFSLPDMIDQLRPKYQAALEKAQKESTATHKKGVGISIGVYGSGLDGPDASEAWAELNADGTITVHTAWEDHGQGADIGCVGTAHEALRPMGVAPEKIKFTWPNTATTPNSGPSGGSRQQVMTGNAIRVACENLLKACEKPGGGYYTYDELKAADKPTKITGNWTASGATHCDAVTGLGKPFVVYMYGVFMAEVTVDVATGQTTVDGMTLMADLGSLCNQLATDGQIYGGLAQGIGLALSEDFEDIKKHATLVGAGFPFIKQIPDKLDIVYVNHPRPDGPFGASGVGELPLTSPHAAIINAIKSATGVRIYRLPAYPEKVLEALKA'),
('P35520', '4UUU', 1, 1.71, 'A/B', 142, 'LYASE', 'LYASE', 'Cystathionine beta-synthase', 'CBS', 'L-serine + L-homocysteine = L-cystathionine + H2O<br />\n', 'carbon monoxide binding<br />\ncystathionine beta-synthase activity<br />\nenzyme binding<br />\nheme binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\nmodified amino acid binding<br />\nnitric oxide binding<br />\nnitrite reductase (NO-forming) activity<br />\noxygen binding<br />\nprotein homodimerization activity<br />\npyridoxal phosphate binding<br />\nS-adenosyl-L-methionine binding<br />\nubiquitin protein ligase binding<br />\n', 'cysteine biosynthetic process<br />\ncysteine biosynthetic process from serine<br />\ncysteine biosynthetic process via cystathionine<br />\nDNA protection<br />\nhomocysteine catabolic process<br />\nhomocysteine metabolic process<br />\nhydrogen sulfide biosynthetic process<br />\nL-cysteine catabolic process<br />\nL-serine catabolic process<br />\nL-serine metabolic process<br />\ntranssulfuration<br />\n', 'PF00571.', 'MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPASESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKDRISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDVLRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEILQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTTYEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKAAQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLSAPLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVGKVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLLNFVAAQERDQK'),
('Q9UGM1', '4UXU', 1, 1.71, 'A/B', 212, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Neuronal acetylcholine receptor subunit alpha-9', 'CHRNA9', '', 'acetylcholine-gated cation-selective channel activity<br />\ncalcium channel activity<br />\nligand-gated ion channel activity<br />\n', 'detection of mechanical stimulus involved in sensory perception of sound<br />\ninner ear morphogenesis<br />\npositive regulation of cytosolic calcium ion concentration<br />\n', 'PF02931.', 'MNWSHSCISFCWIYFAASRLRAAETADGKYAQKLFNDLFEDYSNALRPVEDTDKVLNVTLQITLSQIKDMDERNQILTAYLWIRQIWHDAYLTWDRDQYDGLDSIRIPSDLVWRPDIVLYNKADDESSEPVNTNVVLRYDGLITWDAPAITKSSCVVDVTYFPFDNQQCNLTFGSWTYNGNQVDIFNALDSGDLSDFIEDVEWEVHGMPAVKNVISYGCCSEPYPDVTFTLLLKRRSSFYIVNLLIPCVLISFLAPLSFYLPAASGEKVSLGVTILLAMTVFQLMVAEIMPASENVPLIGKYYIATMALITASTALTIMVMNIHFCGAEARPVPHWARVVILKYMSRVLFVYDVGESCLSPHHSRERDHLTKVYSKLPESNLKAARNKDLSRKKDMNKRLKNDLGCQGKNPQEAESYCAQYKVLTRNIEYIAKCLKDHKATNSKGSEWKKVAKVIDRFFMWIFFIMVFVMTILIIARAD'),
('Q9UDX4', '4UYB', 1, 1.5, 'A', 400, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'SEC14-like protein 3', 'SEC14L3', '', 'lipid binding<br />\ntransporter activity<br />\n', '', 'PF00650.', 'MSGRVGDLSPKQAETLAKFRENVQDVLPALPNPDDYFLLRWLRARNFDLQKSEALLRKYMEFRKTMDIDHILDWQPPEVIQKYMPGGLCGYDRDGCPVWYDIIGPLDPKGLLFSVTKQDLLKTKMRDCERILHECDLQTERLGKKIETIVMIFDCEGLGLKHFWKPLVEVYQEFFGLLEENYPETLKFMLIVKATKLFPVGYNLMKPFLSEDTRRKIIVLGNNWKEGLLKLISPEELPAQFGGTLTDPDGNPKCLTKINYGGEIPKSMYVRDQVKTQYEHSVQINRGSSHQVEYEILFPGCVLRWQFSSDGADIGFGVFLKTKMGERQRAGEMTDVLPSQRYNAHMVPEDGNLTCSEAGVYVLRFDNTYSFVHAKKVSFTVEVLLPDEGMQKYDKELTPV'),
('Q7L0J3', '4V11', 0, 1.95, 'B', 10, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Synaptic vesicle glycoprotein 2A', 'SV2A', '', 'protein kinase binding<br />\nreceptor activity<br />\ntransmembrane transporter activity<br />\n', 'cellular calcium ion homeostasis<br />\nneurotransmitter transport<br />\nregulation of gamma-aminobutyric acid secretion<br />\n', 'PF07690.', 'MEEGFRDRAAFIRGAKDIAKEVKKHAAKKVVKGLDRVQDEYSRRSYSRFEEEDDDDDFPAPSDGYYRGEGTQDEEEGGASSDATEGHDEDDEIYEGEYQGIPRAESGGKGERMADGAPLAGVRGGLSDGEGPPGGRGEAQRRKEREELAQQYEAILRECGHGRFQWTLYFVLGLALMADGVEVFVVGFVLPSAEKDMCLSDSNKGMLGLIVYLGMMVGAFLWGGLADRLGRRQCLLISLSVNSVFAFFSSFVQGYGTFLFCRLLSGVGIGGSIPIVFSYFSEFLAQEKRGEHLSWLCMFWMIGGVYAAAMAWAIIPHYGWSFQMGSAYQFHSWRVFVLVCAFPSVFAIGALTTQPESPRFFLENGKHDEAWMVLKQVHDTNMRAKGHPERVFSVTHIKTIHQEDELIEIQSDTGTWYQRWGVRALSLGGQVWGNFLSCFGPEYRRITLMMMGVWFTMSFSYYGLTVWFPDMIRHLQAVDYASRTKVFPGERVEHVTFNFTLENQIHRGGQYFNDKFIGLRLKSVSFEDSLFEECYFEDVTSSNTFFRNCTFINTVFYNTDLFEYKFVNSRLINSTFLHNKEGCPLDVTGTGEGAYMVYFVSFLGTLAVLPGNIVSALLMDKIGRLRMLAGSSVMSCVSCFFLSFGNSESAMIALLCLFGGVSIASWNALDVLTVELYPSDKRTTAFGFLNALCKLAAVLGISIFTSFVGITKAAPILFASAALALGSSLALKLPETRGQVLQ'),
('P27986', '4WAF', 1, 2.39, 'B', 312, 'transferase / transferase inhibitor', 'TRANSFERASE', 'Phosphatidylinositol 3-kinase regulatory subunit alpha', 'PIK3R1', '', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-3-kinase regulator activity<br />\nErbB-3 class receptor binding<br />\ninsulin binding<br />\ninsulin-like growth factor receptor binding<br />\ninsulin receptor binding<br />\ninsulin receptor substrate binding<br />\nneurotrophin TRKA receptor binding<br />\nphosphatidylinositol 3-kinase binding<br />\nphosphatidylinositol 3-kinase regulator activity<br />\nphosphatidylinositol 3-kinase regulatory subunit binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nphosphotyrosine residue binding<br />\nprotein heterodimerization activity<br />\nprotein phosphatase binding<br />\ntranscription factor binding<br />\ntransmembrane receptor protein tyrosine kinase adaptor activity<br />\n', 'axon guidance<br />\nB cell differentiation<br />\ncellular glucose homeostasis<br />\ncellular response to insulin stimulus<br />\ncellular response to UV<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nextrinsic apoptotic signaling pathway via death domain receptors<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\ngrowth hormone receptor signaling pathway<br />\ninsulin-like growth factor receptor signaling pathway<br />\ninsulin receptor signaling pathway<br />\ninterleukin-7-mediated signaling pathway<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nleukocyte migration<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cell-matrix adhesion<br />\nnegative regulation of osteoclast differentiation<br />\nNFAT protein import into nucleus<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol phosphorylation<br />\nplatelet activation<br />\npositive regulation of cell migration<br />\npositive regulation of endoplasmic reticulum unfolded protein response<br />\npositive regulation of glucose import<br />\npositive regulation of glucose import in response to insulin stimulus<br />\npositive regulation of protein localization to plasma membrane<br />\npositive regulation of RNA splicing<br />\npositive regulation of transcription factor import into nucleus<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of tumor necrosis factor production<br />\nprotein phosphorylation<br />\nprotein stabilization<br />\nregulation of insulin receptor signaling pathway<br />\nregulation of phosphatidylinositol 3-kinase activity<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of stress fiber assembly<br />\nresponse to endoplasmic reticulum stress<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nviral process<br />\n', 'PF16454.', 'MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR'),
('P42336', '4WAF', 1, 2.39, 'A', 1067, 'transferase / transferase inhibitor', 'TRANSFERASE', 'Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform', 'PIK3CA', 'ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate<br />\nATP + a protein = ADP + a phosphoprotein<br />\n', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-4-phosphate 3-kinase activity<br />\nATP binding<br />\ninsulin receptor substrate binding<br />\nkinase activity<br />\nphosphatidylinositol 3-kinase activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein kinase activator activity<br />\nprotein serine/threonine kinase activity<br />\n', 'adaptive immune response<br />\nadipose tissue development<br />\nangiogenesis<br />\nanoikis<br />\naxon guidance<br />\ncardiac muscle contraction<br />\ncell chemotaxis<br />\ncellular response to glucose stimulus<br />\nendothelial cell migration<br />\nenergy homeostasis<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nglucose metabolic process<br />\nhypomethylation of CpG island<br />\ninflammatory response<br />\ninnate immune response<br />\ninsulin receptor signaling pathway via phosphatidylinositol 3-kinase<br />\ninterleukin-7-mediated signaling pathway<br />\nleukocyte migration<br />\nliver development<br />\nnegative regulation of anoikis<br />\nnegative regulation of fibroblast apoptotic process<br />\nnegative regulation of macroautophagy<br />\nnegative regulation of neuron apoptotic process<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphatidylinositol phosphorylation<br />\nphosphorylation<br />\nplatelet activation<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of TOR signaling<br />\nprotein kinase B signaling<br />\nprotein phosphorylation<br />\nregulation of cellular respiration<br />\nregulation of gene expression<br />\nregulation of genetic imprinting<br />\nregulation of multicellular organism growth<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\nvasculature development<br />\n', 'PF00454.', 'MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN'),
('Q13231', '4WKA', 1, 0.95, 'A', 365, 'HYDROLASE', 'HYDROLASE', 'Chitotriosidase-1', 'CHIT1', 'Random endo-hydrolysis of N-acetyl-beta-D-glucosaminide (1->4)-beta-linkages in chitin and chitodextrins<br />\n', 'chitinase activity<br />\nchitin binding<br />\nendochitinase activity<br />\nhydrolase activity, hydrolyzing O-glycosyl compounds<br />\n', 'chitin catabolic process<br />\nimmune response<br />\nneutrophil degranulation<br />\npolysaccharide catabolic process<br />\npolysaccharide digestion<br />\nresponse to bacterium<br />\n', 'PF01607.', 'MVRSVAWAGFMVLLMIPWGSAAKLVCYFTNWAQYRQGEARFLPKDLDPSLCTHLIYAFAGMTNHQLSTTEWNDETLYQEFNGLKKMNPKLKTLLAIGGWNFGTQKFTDMVATANNRQTFVNSAIRFLRKYSFDGLDLDWEYPGSQGSPAVDKERFTTLVQDLANAFQQEAQTSGKERLLLSAAVPAGQTYVDAGYEVDKIAQNLDFVNLMAYDFHGSWEKVTGHNSPLYKRQEESGAAASLNVDAAVQQWLQKGTPASKLILGMPTYGRSFTLASSSDTRVGAPATGSGTPGPFTKEGGMLAYYEVCSWKGATKQRIQDQKVPYIFRDNQWVGFDDVESFKTKVSYLKQKGLGGAMVWALDLDDFAGFSCNQGRYPLIQTLRQELSLPYLPSGTPELEVPKPGQPSEPEHGPSPGQDTFCQGKADGLYPNPRERSSFYSCAAGRLFQQSCPTGLVFSNSCKCCTWN'),
('P0AF12', '4WKC', 1, 1.64, 'A', 232, 'hydrolase / hydrolase inhibitor', 'HYDROLASE', '5''-methylthioadenosine/S-adenosylhomocysteine nucleosidase', 'mtnN', 'S-adenosyl-L-homocysteine + H2O = S-(5-deoxy-D-ribos-5-yl)-L-homocysteine + adenine<br />\nS-methyl-5''-thioadenosine + H2O = S-methyl-5-thio-D-ribose + adenine<br />\n', 'adenosylhomocysteine nucleosidase activity<br />\nidentical protein binding<br />\nmethylthioadenosine nucleosidase activity<br />\n', 'L-methionine salvage from methylthioadenosine<br />\nL-methionine salvage from S-adenosylmethionine<br />\nnucleoside catabolic process<br />\n', 'PF01048.', 'MKIGIIGAMEEEVTLLRDKIENRQTISLGGCEIYTGQLNGTEVALLKSGIGKVAAALGATLLLEHCKPDVIINTGSAGGLAPTLKVGDIVVSDEARYHDADVTAFGYEYGQLPGCPAGFKADDKLIAAAEACIAELNLNAVRGLIVSGDAFINGSVGLAKIRHNFPQAIAVEMEATAIAHVCHNFNVPFVVVRAISDVADQQSHLSFDEFLAVAAKQSSLMVESLVQKLAHG'),
('P00352', '4WP7', 1, 1.8, 'A', 501, 'OXIDOREDUCTASE / OXIDOREDUCTASE INHIBITOR', 'OXIDOREDUCTASE', 'Retinal dehydrogenase 1', 'ALDH1A1', 'Retinal + NAD+ + H2O = retinoate + NADH<br />\n', 'aldehyde dehydrogenase (NAD) activity<br />\nandrogen binding<br />\nbenzaldehyde dehydrogenase (NAD+) activity<br />\nGTPase activator activity<br />\nNAD binding<br />\nretinal dehydrogenase activity<br />\n', 'cellular aldehyde metabolic process<br />\nethanol oxidation<br />\nfructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate<br />\noxidation-reduction process<br />\nretinoid metabolic process<br />\nretinol metabolic process<br />\n', 'PF00171.', 'MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLNDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS'),
('O43570', '4WW8', 1, 1.42, 'A/B/C/D', 262, 'LYASE', 'LYASE', 'Carbonic anhydrase 12', 'CA12', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\nchloride ion homeostasis<br />\none-carbon metabolic process<br />\n', 'PF00194.', 'MPRRSLHAAAVLLLVILKEQPSSPAPVNGSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQVQVCTAAGLSLGIILSLALAGILGICIVVVVSIWLFRRKSIKKGDNKGVIYKPATKMETEAHA'),
('O94788', '4X2Q', 1, 2.94, 'A/B/C/D', 498, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Retinal dehydrogenase 2', 'ALDH1A2', 'Retinal + NAD+ + H2O = retinoate + NADH.<br />\n', '3-chloroallyl aldehyde dehydrogenase activity<br />\naldehyde dehydrogenase (NAD) activity<br />\nretinal binding<br />\nretinal dehydrogenase activity<br />\n', '9-cis-retinoic acid biosynthetic process<br />\nanterior/posterior pattern specification<br />\nblood vessel development<br />\ncardiac muscle tissue development<br />\ncellular response to retinoic acid<br />\ndetermination of bilateral symmetry<br />\nembryonic camera-type eye development<br />\nembryonic digestive tract development<br />\nembryonic forelimb morphogenesis<br />\nface development<br />\nheart morphogenesis<br />\nhindbrain development<br />\nkidney development<br />\nliver development<br />\nlung development<br />\nmidgut development<br />\nmorphogenesis of embryonic epithelium<br />\nnegative regulation of cell proliferation<br />\nneural crest cell development<br />\nneural tube development<br />\nneuron differentiation<br />\npancreas development<br />\npituitary gland development<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell proliferation<br />\npositive regulation of gene expression<br />\nproximal/distal pattern formation<br />\nregulation of endothelial cell proliferation<br />\nresponse to cytokine<br />\nresponse to estradiol<br />\nresponse to vitamin A<br />\nretinal metabolic process<br />\nretinoic acid metabolic process<br />\nretinoic acid receptor signaling pathway<br />\nretinol metabolic process<br />\nureter maturation<br />\nvitamin A metabolic process<br />\n', 'PF00171.', 'MTSSKIEMPGEVKADPAALMASLHLLPSPTPNLEIKYTKIFINNEWQNSESGRVFPVYNPATGEQVCEVQEADKADIDKAVQAARLAFSLGSVWRRMDASERGRLLDKLADLVERDRAVLATMESLNGGKPFLQAFYVDLQGVIKTFRYYAGWADKIHGMTIPVDGDYFTFTRHEPIGVCGQIIPWNFPLLMFAWKIAPALCCGNTVVIKPAEQTPLSALYMGALIKEAGFPPGVINILPGYGPTAGAAIASHIGIDKIAFTGSTEVGKLIQEAAGRSNLKRVTLELGGKSPNIIFADADLDYAVEQAHQGVFFNQGQCCTAGSRIFVEESIYEEFVRRSVERAKRRVVGSPFDPTTEQGPQIDKKQYNKILELIQSGVAEGAKLECGGKGLGRKGFFIEPTVFSNVTDDMRIAKEEIFGPVQEILRFKTMDEVIERANNSDFGLVAAVFTNDINKALTVSSAMQAGTVWINCYNALNAQSPFGGFKMSGNGREMGEFGLREYSEVKTVTVKIPQKNS'),
('P07741', '4X45', 1, 1.75, 'A/B', 180, 'TRANSFERASE', 'TRANSFERASE', 'Adenine phosphoribosyltransferase', 'APRT', 'AMP + diphosphate = adenine + 5-phospho-alpha-D-ribose 1-diphosphate.<br />\n', 'adenine binding<br />\nadenine phosphoribosyltransferase activity<br />\nAMP binding<br />\n', 'adenine salvage<br />\nAMP salvage<br />\ncellular response to insulin stimulus<br />\ngrooming behavior<br />\nlactation<br />\nneutrophil degranulation<br />\npurine-containing compound salvage<br />\npurine ribonucleoside salvage<br />\n', 'PF00156.', 'MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDYIAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPGQRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE'),
('O00264', '4X8Y', 0, 1.95, 'A/B', 124, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Membrane-associated progesterone receptor component 1', 'PGRMC1', '', 'heme binding<br />\nsteroid binding<br />\n', 'neutrophil degranulation<br />\n', 'PF00173.', 'MAAEDVVATGADPSDLESGGLLHEIFTSPLNLLLLGLCIFLLYKIVRGDQPAASGDSDDDEPPPLPRLKRRDFTPAELRRFDGVQDPRILMAINGKVFDVTKGRKFYGPEGPYGVFAGRDASRGLATFCLDKEALKDEYDDLSDLTAAQQETLSDWESQFTFKYHHVGKLLKEGEEPTVYSDEEEPKDESARKND'),
('P14780', '4XCT', 1, 1.3, 'A', 332, 'HYDROLASE', 'HYDROLASE', 'Matrix metalloproteinase-9', 'MMP9', 'Cleavage of gelatin types I and V and collagen types IV and V<br />\n', 'collagen binding<br />\nendopeptidase activity<br />\nidentical protein binding<br />\nmetalloendopeptidase activity<br />\nmetallopeptidase activity<br />\nserine-type endopeptidase activity<br />\nzinc ion binding<br />\n', 'cellular response to cadmium ion<br />\ncellular response to reactive oxygen species<br />\ncollagen catabolic process<br />\nembryo implantation<br />\nendodermal cell differentiation<br />\nephrin receptor signaling pathway<br />\nextracellular matrix disassembly<br />\nleukocyte migration<br />\nmacrophage differentiation<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cation channel activity<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway<br />\nnegative regulation of intrinsic apoptotic signaling pathway<br />\nneutrophil degranulation<br />\nossification<br />\npositive regulation of cell migration<br />\npositive regulation of DNA binding<br />\npositive regulation of epidermal growth factor receptor signaling pathway<br />\npositive regulation of keratinocyte migration<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of receptor binding<br />\npositive regulation of release of cytochrome c from mitochondria<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\nproteolysis<br />\nskeletal system development<br />\n', 'PF00040.', 'MSLWQPLVLVLLVLGCCFAAPRQRQSTLVLFPGDLRTNLTDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVVVPTRFGNADGAACHFPFIFEGRSYSACTTDGRSDGLPWCSTTANYDTDDRFGFCPSERLYTQDGNADGKPCQFPFIFQGQSYSACTTDGRSDGYRWCATTANYDRDKLFGFCPTRADSTVMGGNSAGELCVFPFTFLGKEYSTCTSEGRGDGRLWCATTSNFDSDKKWGFCPDQGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYGPRPEPEPRPPTTTTPQPTAPPTVCPTGPPTVHPSERPTAGPTGPPSAGPTGPPTAGPSTATTVPLSPVDDACNVNIFDAIAEIGNQLYLFKDGKYWRFSEGRGSRPQGPFLIADKWPALPRKLDSVFEERLSKKLFFFSGRQVWVYTGASVLGPRRLDKLGLGADVAQVTGALRSGRGKMLLFSGRRLWRFDVKAQMVDPRSASEVDRMFPGVPLDTHDVFQYREKAYFCQDRFYWRVSSRSELNQVDQVGYVTYDILQCPED'),
('P22455', '4XCU', 1, 1.71, 'A', 303, 'Transferase / Transferase Inhibitor', 'TRANSFERASE', 'Fibroblast growth factor receptor 4', 'FGFR4', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', '1-phosphatidylinositol-3-kinase activity<br />\nATP binding<br />\nfibroblast growth factor-activated receptor activity<br />\nfibroblast growth factor binding<br />\nheparin binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\n', 'cell migration<br />\nfibroblast growth factor receptor signaling pathway<br />\nglucose homeostasis<br />\ninterleukin-7-mediated signaling pathway<br />\nMAPK cascade<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphate ion homeostasis<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of catalytic activity<br />\npositive regulation of cell proliferation<br />\npositive regulation of DNA biosynthetic process<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of gene expression<br />\npositive regulation of proteolysis<br />\nprotein autophosphorylation<br />\nregulation of bile acid biosynthetic process<br />\nregulation of cholesterol homeostasis<br />\nregulation of extracellular matrix disassembly<br />\nregulation of lipid metabolic process<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\n', 'PF07679.', 'MRLLLALLGVLLSVPGPPVLSLEASEEVELEPCLAPSLEQQEQELTVALGQPVRLCCGRAERGGHWYKEGSRLAPAGRVRGWRGRLEIASFLPEDAGRYLCLARGSMIVLQNLTLITGDSLTSSNDDEDPKSHRDPSNRHSYPQQAPYWTHPQRMEKKLHAVPAGNTVKFRCPAAGNPTPTIRWLKDGQAFHGENRIGGIRLRHQHWSLVMESVVPSDRGTYTCLVENAVGSIRYNYLLDVLERSPHRPILQAGLPANTTAVVGSDVELLCKVYSDAQPHIQWLKHIVINGSSFGADGFPYVQVLKTADINSSEVEVLYLRNVSAEDAGEYTCLAGNSIGLSYQSAWLTVLPEEDPTWTAAAPEARYTDIILYASGSLALAVLLLLAGLYRGQALHGRHPRPPATVQKLSRFPLARQFSLESGSSGKSSSSLVRGVRLSSSGPALLAGLVSLDLPLDPLWEFPRDRLVLGKPLGEGCFGQVVRAEAFGMDPARPDQASTVAVKMLKDNASDKDLADLVSEMEVMKLIGRHKNIINLLGVCTQEGPLYVIVECAAKGNLREFLRARRPPGPDLSPDGPRSSEGPLSFPVLVSCAYQVARGMQYLESRKCIHRDLAARNVLVTEDNVMKIADFGLARGVHHIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILLWEIFTLGGSPYPGIPVEELFSLLREGHRMDRPPHCPPELYGLMRECWHAAPSQRPTFKQLVEALDKVLLAVSEEYLDLRLTFGPYSPSGGDASSTCSSSDSVFSHDPLPLGSSSFPFGSGVQT'),
('P00748', '4XDE', 1, 2.14, 'A', 243, 'BLOOD CLOTTING', 'OTHERS', 'Coagulation factor XII', 'F12', 'Selective cleavage of Arg-|-Ile bonds in factor VII to form factor VIIa and factor XI to form factor XIa.<br />\n', 'calcium ion binding<br />\nmisfolded protein binding<br />\nserine-type endopeptidase activity<br />\n', 'blood coagulation, intrinsic pathway<br />\nFactor XII activation<br />\nfibrinolysis<br />\ninnate immune response<br />\nplasma kallikrein-kinin cascade<br />\npositive regulation of blood coagulation<br />\npositive regulation of fibrinolysis<br />\npositive regulation of plasminogen activation<br />\nprotein autoprocessing<br />\nprotein processing<br />\nresponse to misfolded protein<br />\nzymogen activation<br />\n', 'PF00008.', 'MRALLLLGFLLVSLESTLSIPPWEAPKEHKYKAEEHTVVLTVTGEPCHFPFQYHRQLYHKCTHKGRPGPQPWCATTPNFDQDQRWGYCLEPKKVKDHCSKHSPCQKGGTCVNMPSGPHCLCPQHLTGNHCQKEKCFEPQLLRFFHKNEIWYRTEQAAVARCQCKGPDAHCQRLASQACRTNPCLHGGRCLEVEGHRLCHCPVGYTGAFCDVDTKASCYDGRGLSYRGLARTTLSGAPCQPWASEATYRNVTAEQARNWGLGGHAFCRNPDNDIRPWCFVLNRDRLSWEYCDLAQCQTPTQAAPPTPVSPRLHVPLMPAQPAPPKPQPTTRTPPQSQTPGALPAKREQPPSLTRNGPLSCGQRLRKSLSSMTRVVGGLVALRGAHPYIAALYWGHSFCAGSLIAPCWVLTAAHCLQDRPAPEDLTVVLGQERRNHSCEPCQTLAVRSYRLHEAFSPVSYQHDLALLRLQEDADGSCALLSPYVQPVCLPSGAARPSETTLCQVAGWGHQFEGAEEYASFLQEAQVPFLSLERCSAPDVHGSSILPGMLCAGFLEGGTDACQGDSGGPLVCEDQAAERRLTLQGIISWGSGCGDRNKPGVYTDVAYYLAWIREHTVS'),
('P49588', '4XEM', 1, 1.28, 'A', 455, 'LIGASE', 'LIGASE', 'Alanine--tRNA ligase, cytoplasmic', 'AARS', 'ATP + L-alanine + tRNA(Ala) = AMP + diphosphate + L-alanyl-tRNA(Ala)<br />\n', 'alanine-tRNA ligase activity<br />\namino acid binding<br />\naminoacyl-tRNA editing activity<br />\nATP binding<br />\nmetal ion binding<br />\ntRNA binding<br />\n', 'alanyl-tRNA aminoacylation<br />\ncerebellar Purkinje cell layer development<br />\nnegative regulation of neuron apoptotic process<br />\nneuromuscular process controlling balance<br />\ntRNA aminoacylation for protein translation<br />\ntRNA modification<br />\ntRNA processing<br />\n', 'PF02272.', 'MDSTLTASEIRQRFIDFFKRNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAKLSRAANTQKCIRAGGKHNDLDDVGKDVYHHTFFEMLGSWSFGDYFKELACKMALELLTQEFGIPIERLYVTYFGGDEAAGLEADLECKQIWQNLGLDDTKILPGNMKDNFWEMGDTGPCGPCSEIHYDRIGGRDAAHLVNQDDPNVLEIWNLVFIQYNREADGILKPLPKKSIDTGMGLERLVSVLQNKMSNYDTDLFVPYFEAIQKGTGARPYTGKVGAEDADGIDMAYRVLADHARTITVALADGGRPDNTGRGYVLRRILRRAVRYAHEKLNASRGFFATLVDVVVQSLGDAFPELKKDPDMVKDIINEEEVQFLKTLSRGRRILDRKIQSLGDSKTIPGDTAWLLYDTYGFPVDLTGLIAEEKGLVVDMDGFEEERKLAQLKSQGKGAGGEDLIMLDIYAIEELRARGLEVTDDSPKYNYHLDSSGSYVFENTVATVMALRREKMFVEEVSTGQECGVVLDKTCFYAEQGGQIYDEGYLVKVDDSSEDKTEFTVKNAQVRGGYVLHIGTIYGDLKVGDQVWLFIDEPRRRPIMSNHTATHILNFALRSVLGEADQKGSLVAPDRLRFDFTAKGAMSTQQIKKAEEIANEMIEAAKAVYTQDCPLAAAKAIQGLRAVFDETYPDPVRVVSIGVPVSELLDDPSGPAGSLTSVEFCGGTHLRNSSHAGAFVIVTEEAIAKGIRRIVAVTGAEAQKALRKAESLKKCLSVMEAKVKAQTAPNKDVQREIADLGEALATAVIPQWQKDELRETLKSLKKVMDDLDRASKADVQKRVLEKTKQFIDSNPNQPLVILEMESGASAKALNEALKLFKMHSPQTSAMLFTVDNEAGKITCLCQVPQNAANRGLKASEWVQQVSGLMDGKGGGKDVSAQATGKNVGCLQEALQLATSFAQLRLGDVKN'),
('P12070', '4XIA', 1, 2.3, 'A/B', 393, 'ISOMERASE(INTRAMOLECULAR OXIDOREDUCTASE)', 'OXIDOREDUCTASE', 'Xylose isomerase', 'xylA', 'D-xylopyranose = D-xylulose.<br />\n', 'metal ion binding<br />\nxylose isomerase activity<br />\n', 'D-xylose metabolic process<br />\npentose-phosphate shunt<br />\n', 'PF01261.', 'MSVQPTPADHFTFGLWTVGWTGADPFGVATRKNLDPVEAVHKLAELGAYGITFHDNDLIPFDATEAEREKILGDFNQALKDTGLKVPMVTTNLFSHPVFKDGGFTSNDRSIRRFALAKVLHNIDLAAEMGAETFVMWGGREGSEYDGSKDLAAALDRMREGVDTAAGYIKDKGYNLRIALEPKPNEPRGDIFLPTVGHGLAFIEQLEHGDIVGLNPETGHEQMAGLNFTHGIAQALWAEKLFHIDLNGQRGIKYDQDLVFGHGDLTSAFFTVDLLENGFPNGGPKYTGPRHFDYKPSRTDGYDGVWDSAKANMSMYLLLKERALAFRADPEVQEAMKTSGVFELGETTLNAGESAADLMNDSASFAGFDAEAAAERNFAFIRLNQLAIEHLLGSR'),
('P01189', '4XNH', 1, 2.1, 'F', 8, 'TRANSFERASE', 'TRANSFERASE', 'Pro-opiomelanocortin', 'POMC', '', 'G-protein coupled receptor binding<br />\nhormone activity<br />\nneuropeptide hormone activity<br />\nreceptor binding<br />\ntype 1 melanocortin receptor binding<br />\ntype 3 melanocortin receptor binding<br />\ntype 4 melanocortin receptor binding<br />\n', 'antimicrobial humoral immune response mediated by antimicrobial peptide<br />\ncell-cell signaling<br />\ncellular pigmentation<br />\ngeneration of precursor metabolites and energy<br />\nglucose homeostasis<br />\nkilling of cells of other organism<br />\nmodification of morphology or physiology of other organism<br />\nnegative regulation of tumor necrosis factor production<br />\nneuropeptide signaling pathway<br />\npeptide hormone processing<br />\npositive regulation of neutrophil mediated killing of fungus<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of appetite<br />\nregulation of blood pressure<br />\nregulation of corticosterone secretion<br />\nregulation of glycogen metabolic process<br />\nsignal transduction<br />\n', 'PF00976.', 'MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPDLSAETPMFPGNGDEQPLTENPRKYVMGHFRWDRFGRRNSSSSGSSGAGQKREDVSAGEDCGPLPEGGPEPRSDGAKPGPREGKRSYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEFKRELTGQRLREGDGPDGPADDGAGAQADLEHSLLVAAEKKDEGPYRMEHFRWGSPPKDKRYGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE'),
('P52895', '4XO6', 1, 1.2, 'A/B', 322, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aldo-keto reductase family 1 member C2', 'AKR1C2', 'Trans-1,2-dihydrobenzene-1,2-diol + NADP+ = catechol + NADPH<br />\nA 3-alpha-hydroxysteroid + NAD(P)+ = a 3-oxosteroid + NAD(P)H<br />\n', 'alditol:NADP+ 1-oxidoreductase activity<br />\nbile acid binding<br />\ncarboxylic acid binding<br />\nketosteroid monooxygenase activity<br />\noxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor<br />\nphenanthrene 9,10-monooxygenase activity<br />\ntrans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity<br />\n', 'cellular response to jasmonic acid stimulus<br />\ncellular response to prostaglandin D stimulus<br />\ndaunorubicin metabolic process<br />\ndigestion<br />\ndoxorubicin metabolic process<br />\nepithelial cell differentiation<br />\nG-protein coupled receptor signaling pathway<br />\noxidation-reduction process<br />\npositive regulation of cell proliferation<br />\npositive regulation of protein kinase B signaling<br />\nprogesterone metabolic process<br />\nprostaglandin metabolic process<br />\nsteroid metabolic process<br />\n', 'PF00248.', 'MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHIDSAHVYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSNSHRPELVRPALERSLKNLQLDYVDLYLIHFPVSVKPGEEVIPKDENGKILFDTVDLCATWEAMEKCKDAGLAKSIGVSNFNHRLLEMILNKPGLKYKPVCNQVECHPYFNQRKLLDFCKSKDIVLVAYSALGSHREEPWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTSEEMKAIDGLNRNVRYLTLDIFAGPPNYPFSDEY'),
('P54802', '4XWH', 1, 2.32, 'A', 720, 'HYDROLASE', 'HYDROLASE', 'Alpha-N-acetylglucosaminidase', 'NAGLU', 'Hydrolysis of terminal non-reducing N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides.<br />\n', 'alpha-N-acetylglucosaminidase activity<br />\n', 'cerebellar Purkinje cell layer development<br />\nglycosaminoglycan catabolic process<br />\ninner ear receptor cell development<br />\nlocomotor rhythm<br />\nlysosome organization<br />\nmiddle ear morphogenesis<br />\nnervous system development<br />\nretinal rod cell development<br />\n', 'PF05089.', 'MEAVAVAAAVGVLLLAGAGGAAGDEAREAAAVRALVARLLGPGPAADFSVSVERALAAKPGLDTYSLGGGGAARVRVRGSTGVAAAAGLHRYLRDFCGCHVAWSGSQLRLPRPLPAVPGELTEATPNRYRYYQNVCTQSYSFVWWDWARWEREIDWMALNGINLALAWSGQEAIWQRVYLALGLTQAEINEFFTGPAFLAWGRMGNLHTWDGPLPPSWHIKQLYLQHRVLDQMRSFGMTPVLPAFAGHVPEAVTRVFPQVNVTKMGSWGHFNCSYSCSFLLAPEDPIFPIIGSLFLRELIKEFGTDHIYGADTFNEMQPPSSEPSYLAAATTAVYEAMTAVDTEAVWLLQGWLFQHQPQFWGPAQIRAVLGAVPRGRLLVLDLFAESQPVYTRTASFQGQPFIWCMLHNFGGNHGLFGALEAVNGGPEAARLFPNSTMVGTGMAPEGISQNEVVYSLMAELGWRKDPVPDLAAWVTSFAARRYGVSHPDAGAAWRLLLRSVYNCSGEACRGHNRSPLVRRPSLQMNTSIWYNRSDVFEAWRLLLTSAPSLATSPAFRYDLLDLTRQAVQELVSLYYEEARSAYLSKELASLLRAGGVLAYELLPALDEVLASDSRFLLGSWLEQARAAAVSEAEADFYEQNSRYQLTLWGPEGNILDYANKQLAGLVANYYTPRWRLFLEALVDSVAQGIPFQQHQFDKNVFQLEQAFVLSKQRYPSQPRGDTVDLAKKIFLKYYPRWVAGSW'),
('P10636', '4Y32', 1, 1.7, 'C/D', 7, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Microtubule-associated protein tau', 'MAPT', '', 'actin binding<br />\napolipoprotein binding<br />\nDNA binding<br />\ndynactin binding<br />\nenzyme binding<br />\nHsp90 protein binding<br />\nidentical protein binding<br />\nlipoprotein particle binding<br />\nmicrotubule binding<br />\nmicrotubule lateral binding<br />\nprotein homodimerization activity<br />\nprotein phosphatase 2A binding<br />\nreceptor agonist activity<br />\nSH3 domain binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\namyloid fibril formation<br />\nastrocyte activation<br />\naxonal transport<br />\naxonal transport of mitochondrion<br />\ncellular response to heat<br />\ncytoplasmic microtubule organization<br />\ngeneration of neurons<br />\nintracellular distribution of mitochondria<br />\nlearning or memory<br />\nmemory<br />\nmicroglial cell activation<br />\nmicrotubule cytoskeleton organization<br />\nnegative regulation of establishment of protein localization to mitochondrion<br />\nnegative regulation of gene expression<br />\nnegative regulation of kinase activity<br />\nnegative regulation of mitochondrial fission<br />\nnegative regulation of mitochondrial membrane potential<br />\nneurofibrillary tangle assembly<br />\nneuron projection development<br />\nplus-end-directed organelle transport along microtubule<br />\npositive regulation of axon extension<br />\npositive regulation of cellular protein localization<br />\npositive regulation of diacylglycerol kinase activity<br />\npositive regulation of microtubule polymerization<br />\npositive regulation of neuron death<br />\npositive regulation of protein localization to synapse<br />\npositive regulation of superoxide anion generation<br />\nprotein homooligomerization<br />\nprotein oligomerization<br />\nregulation of autophagy<br />\nregulation of calcium-mediated signaling<br />\nregulation of cellular response to heat<br />\nregulation of microtubule cytoskeleton organization<br />\nregulation of microtubule polymerization<br />\nregulation of microtubule polymerization or depolymerization<br />\nregulation of mitochondrial fission<br />\nregulation of response to DNA damage stimulus<br />\nsupramolecular fiber organization<br />\nsynapse assembly<br />\nsynapse organization<br />\n', 'PF00418.', 'MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQEPESGKVVQEGFLREPGPPGLSHQLMSGMPGAPLLPEGPREATRQPSGTGPEDTEGGRHAPELLKHQLLGDLHQEGPPLKGAGGKERPGSKEEVDEDRDVDESSPQDSPPSKASPAQDGRPPQTAAREATSIPGFPAEGAIPLPVDFLSKVSTEIPASEPDGPSVGRAKGQDAPLEFTFHVEITPNVQKEQAHSEEHLGRAAFPGAPGEGPEARGPSLGEDTKEADLPEPSEKQPAAAPRGKPVSRVPQLKARMVSKSKDGTGSDDKKAKTSTRSSAKTLKNRPCLSPKHPTPGSSDPLIQPSSPAVCPEPPSSPKYVSSVTSRTGSSGAKEMKLKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL'),
('P08686', '4Y8W', 1, 2.64, 'A/B/C', 466, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Steroid 21-hydroxylase', 'CYP21A2', 'A C(21) steroid + [reduced NADPH--hemoprotein reductase] + O2 = a 21-hydroxy-C(21)-steroid + [oxidized NADPH--hemoprotein reductase] + H2O<br />\n', 'heme binding<br />\niron ion binding<br />\nsteroid 21-monooxygenase activity<br />\nsteroid binding<br />\nsteroid hydroxylase activity<br />\n', 'glucocorticoid biosynthetic process<br />\nmineralocorticoid biosynthetic process<br />\nsteroid biosynthetic process<br />\nsteroid metabolic process<br />\nsterol metabolic process<br />\n', 'PF00067.', 'MLLLGLLLLPLLAGARLLWNWWKLRSLHLPPLAPGFLHLLQPDLPIYLLGLTQKFGPIYRLHLGLQDVVVLNSKRTIEEAMVKKWADFAGRPEPLTYKLVSKNYPDLSLGDYSLLWKAHKKLTRSALLLGIRDSMEPVVEQLTQEFCERMRAQPGTPVAIEEEFSLLTCSIICYLTFGDKIKDDNLMPAYYKCIQEVLKTWSHWSIQIVDVIPFLRFFPNPGLRRLKQAIEKRDHIVEMQLRQHKESLVAGQWRDMMDYMLQGVAQPSMEEGSGQLLEGHVHMAAVDLLIGGTETTANTLSWAVVFLLHHPEIQQRLQEELDHELGPGASSSRVPYKDRARLPLLNATIAEVLRLRPVVPLALPHRTTRPSSISGYDIPEGTVIIPNLQGAHLDETVWERPHEFWPDRFLEPGKNSRALAFGCGARVCLGEPLARLELFVVLTRLLQAFTLLPSGDALPSLQPLPHCSVILKMQPFQVRLQPRGMGAHSPGQNQ');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('Q14181', '4Y97', 0, 2.51, 'A/C/E/G', 598, 'TRANSFERASE', 'TRANSFERASE', 'DNA polymerase alpha subunit B', 'POLA2', '', 'DNA binding<br />\nDNA-directed DNA polymerase activity<br />\nprotein heterodimerization activity<br />\n', 'DNA replication<br />\nDNA replication initiation<br />\nG1/S transition of mitotic cell cycle<br />\nprotein import into nucleus, translocation<br />\ntelomere maintenance via semi-conservative replication<br />\n', 'PF04042.', 'MSASAQQLAEELQIFGLDCEEALIEKLVELCVQYGQNEEGMVGELIAFCTSTHKVGLTSEILNSFEHEFLSKRLSKARHSTCKDSGHAGARDIVSIQELIEVEEEEEILLNSYTTPSKGSQKRAISTPETPLTKRSVSTRSPHQLLSPSSFSPSATPSQKYNSRSNRGEVVTSFGLAQGVSWSGRGGAGNISLKVLGCPEALTGSYKSMFQKLPDIREVLTCKIEELGSELKEHYKIEAFTPLLAPAQEPVTLLGQIGCDSNGKLNNKSVILEGDREHSSGAQIPVDLSELKEYSLFPGQVVIMEGINTTGRKLVATKLYEGVPLPFYQPTEEDADFEQSMVLVACGPYTTSDSITYDPLLDLIAVINHDRPDVCILFGPFLDAKHEQVENCLLTSPFEDIFKQCLRTIIEGTRSSGSHLVFVPSLRDVHHEPVYPQPPFSYSDLSREDKKQVQFVSEPCSLSINGVIFGLTSTDLLFHLGAEEISSSSGTSDRFSRILKHILTQRSYYPLYPPQEDMAIDYESFYVYAQLPVTPDVLIIPSELRYFVKDVLGCVCVNPGRLTKGQVGGTFARLYLRRPAADGAERQSPCIAVQVVRI'),
('Q15046', '4YCU', 1, 2.1, 'A/B', 512, 'ligase / ligase inhibitor', 'LIGASE', 'Lysine--tRNA ligase', 'KARS', 'ATP + L-lysine + tRNA(Lys) = AMP + diphosphate + L-lysyl-tRNA(Lys)<br />\n', 'amino acid binding<br />\nATP adenylyltransferase activity<br />\nATP binding<br />\nidentical protein binding<br />\nlysine-tRNA ligase activity<br />\nprotein homodimerization activity<br />\ntRNA binding<br />\n', 'activation of MAPK activity<br />\nbasophil activation involved in immune response<br />\ndiadenosine tetraphosphate biosynthetic process<br />\nERK1 and ERK2 cascade<br />\nlysyl-tRNA aminoacylation<br />\nnegative regulation of cell proliferation<br />\npositive regulation of cytokine production involved in inflammatory response<br />\npositive regulation of cytokine secretion involved in immune response<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of macrophage activation<br />\npositive regulation of macrophage chemotaxis<br />\npositive regulation of metallopeptidase activity<br />\npositive regulation of p38MAPK cascade<br />\npositive regulation of transcription, DNA-templated<br />\nresponse to X-ray<br />\ntRNA aminoacylation for protein translation<br />\ntRNA processing<br />\ntumor necrosis factor-mediated signaling pathway<br />\nviral process<br />\n', 'PF00152.', 'MAAVQAAEVKVDGSEPKLSKNELKRRLKAEKKVAEKEAKQKELSEKQLSQATAAATNHTTDNGVGPEEESVDPNQYYKIRSQAIHQLKVNGEDPYPHKFHVDISLTDFIQKYSHLQPGDHLTDITLKVAGRIHAKRASGGKLIFYDLRGEGVKLQVMANSRNYKSEEEFIHINNKLRRGDIIGVQGNPGKTKKGELSIIPYEITLLSPCLHMLPHLHFGLKDKETRYRQRYLDLILNDFVRQKFIIRSKIITYIRSFLDELGFLEIETPMMNIIPGGAVAKPFITYHNELDMNLYMRIAPELYHKMLVVGGIDRVYEIGRQFRNEGIDLTHNPEFTTCEFYMAYADYHDLMEITEKMVSGMVKHITGSYKVTYHPDGPEGQAYDVDFTPPFRRINMVEELEKALGMKLPETNLFETEETRKILDDICVAKAVECPPPRTTARLLDKLVGEFLEVTCINPTFICDHPQIMSPLAKWHRSKEGLTERFELFVMKKEICNAYTELNDPMRQRQLFEEQAKAKAAGDDEAMFIDENFCTALEYGLPPTAGWGMGIDRVAMFLTDSNNIKEVLLFPAMKPEDKKENVATTDTLESTTVGTSV'),
('P08709', '4YLQ', 1, 1.4, 'H', 254, 'HYDROLASE', 'HYDROLASE', 'Coagulation factor VII', 'F7', 'Selective cleavage of Arg-|-Ile bond in factor X to form factor Xa.<br />\n', 'calcium ion binding<br />\nreceptor binding<br />\nserine-type endopeptidase activity<br />\nserine-type peptidase activity<br />\n', 'animal organ regeneration<br />\nblood coagulation<br />\nblood coagulation, extrinsic pathway<br />\ncircadian rhythm<br />\nER to Golgi vesicle-mediated transport<br />\npeptidyl-glutamic acid carboxylation<br />\npositive regulation of blood coagulation<br />\npositive regulation of cell migration<br />\npositive regulation of leukocyte chemotaxis<br />\npositive regulation of platelet-derived growth factor receptor signaling pathway<br />\npositive regulation of positive chemotaxis<br />\npositive regulation of protein kinase B signaling<br />\nprotein processing<br />\nresponse to 2,3,7,8-tetrachlorodibenzodioxine<br />\nresponse to anticoagulant<br />\nresponse to astaxanthin<br />\nresponse to carbon dioxide<br />\nresponse to cholesterol<br />\nresponse to estradiol<br />\nresponse to estrogen<br />\nresponse to genistein<br />\nresponse to growth hormone<br />\nresponse to hypoxia<br />\nresponse to Thyroid stimulating hormone<br />\nresponse to thyrotropin-releasing hormone<br />\nresponse to thyroxine<br />\nresponse to vitamin K<br />\nsignal peptide processing<br />\n', 'PF00008.', 'MVSQALRLLCLLLGLQGCLAAGGVAKASGGETRDMPWKPGPHRVFVTQEEAHGVLHRRRRANAFLEELRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP'),
('Q9UM73', '4Z55', 1, 1.55, 'A', 339, 'Transferase / Transferase Inhibitor', 'TRANSFERASE', 'ALK tyrosine kinase receptor', 'ALK', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nNF-kappaB-inducing kinase activity<br />\nprotein tyrosine kinase activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\n', 'activation of MAPK activity<br />\nadult behavior<br />\ncell proliferation<br />\nhippocampus development<br />\nneuron development<br />\nphosphorylation<br />\npositive regulation of NF-kappaB transcription factor activity<br />\nprotein autophosphorylation<br />\nregulation of apoptotic process<br />\nregulation of cell proliferation<br />\nregulation of dopamine receptor signaling pathway<br />\nresponse to environmental enrichment<br />\nsignal transduction<br />\nswimming behavior<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00629.', 'MGAIGLLWLLPLLLSTAAVGSGMGTGQRAGSPAAGPPLQPREPLSYSRLQRKSLAVDFVVPSLFRVYARDLLLPPSSSELKAGRPEARGSLALDCAPLLRLLGPAPGVSWTAGSPAPAEARTLSRVLKGGSVRKLRRAKQLVLELGEEAILEGCVGPPGEAAVGLLQFNLSELFSWWIRQGEGRLRIRLMPEKKASEVGREGRLSAAIRASQPRLLFQIFGTGHSSLESPTNMPSPSPDYFTWNLTWIMKDSFPFLSHRSRYGLECSFDFPCELEYSPPLHDLRNQSWSWRRIPSEEASQMDLLDGPGAERSKEMPRGSFLLLNTSADSKHTILSPWMRSSSEHCTLAVSVHRHLQPSGRYIAQLLPHNEAAREILLMPTPGKHGWTVLQGRIGRPDNPFRVALEYISSGNRSLSAVDFFALKNCSEGTSPGSKMALQSSFTCWNGTVLQLGQACDFHQDCAQGEDESQMCRKLPVGFYCNFEDGFCGWTQGTLSPHTPQWQVRTLKDARFQDHQDHALLLSTTDVPASESATVTSATFPAPIKSSPCELRMSWLIRGVLRGNVSLVLVENKTGKEQGRMVWHVAAYEGLSLWQWMVLPLLDVSDRFWLQMVAWWGQGSRAIVAFDNISISLDCYLTISGEDKILQNTAPKSRNLFERNPNKELKPGENSPRQTPIFDPTVHWLFTTCGASGPHGPTQAQCNNAYQNSNLSVEVGSEGPLKGIQIWKVPATDTYSISGYGAAGGKGGKNTMMRSHGVSVLGIFNLEKDDMLYILVGQQGEDACPSTNQLIQKVCIGENNVIEEEIRVNRSVHEWAGGGGGGGGATYVFKMKDGVPVPLIIAAGGGGRAYGAKTDTFHPERLENNSSVLGLNGNSGAAGGGGGWNDNTSLLWAGKSLQEGATGGHSCPQAMKKWGWETRGGFGGGGGGCSSGGGGGGYIGGNAASNNDPEMDGEDGVSFISPLGILYTPALKVMEGHGEVNIKHYLNCSHCEVDECHMDPESHKVICFCDHGTVLAEDGVSCIVSPTPEPHLPLSLILSVVTSALVAALVLAFSGIMIVYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKVPVRPKDPEGVPPLLVSQQAKREEERSPAAPPPLPTTSSGKAAKKPTAAEISVRVPRGPAVEGGHVNMAFSQSNPPSELHKVHGSRNKPTSLWNPTYGSWFTEKPTKKNNPIAKKEPHDRGNLGLEGSCTVPPNVATGRLPGASLLLEPSSLTANMKEVPLFRLRHFPCGNVNYGYQQQGLPLEAATAPGAGHYEDTILKSKNSMNQPGP'),
('P17540', '4Z9M', 1, 2.1, 'A/B/C/D/E/F/G/H', 390, 'TRANSFERASE', 'TRANSFERASE', 'Creatine kinase S-type, mitochondrial', 'CKMT2', 'ATP + creatine = ADP + phosphocreatine<br />\n', 'ATP binding<br />\ncreatine kinase activity<br />\n', 'creatine metabolic process<br />\nmuscle contraction<br />\n', 'PF00217.', 'MASIFSKLLTGRNASLLFATMGTSVLTTGYLLNRQKVCAEVREQPRLFPPSADYPDLRKHNNCMAECLTPAIYAKLRNKVTPNGYTLDQCIQTGVDNPGHPFIKTVGMVAGDEESYEVFADLFDPVIKLRHNGYDPRVMKHTTDLDASKITQGQFDEHYVLSSRVRTGRSIRGLSLPPACTRAERREVENVAITALEGLKGDLAGRYYKLSEMTEQDQQRLIDDHFLFDKPVSPLLTCAGMARDWPDARGIWHNYDKTFLIWINEEDHTRVISMEKGGNMKRVFERFCRGLKEVERLIQERGWEFMWNERLGYILTCPSNLGTGLRAGVHVRIPKLSKDPRFSKILENLRLQKRGTGGVDTAAVADVYDISNIDRIGRSEVELVQIVIDGVNYLVDCEKKLERGQDIKVPPPLPQFGKK'),
('P01138', '4ZBN', 1, 2.45, 'A/B', 120, 'Immune system / DNA', 'IMMUNE_SYS_PROT', 'Beta-nerve growth factor', 'NGF', '', 'growth factor activity<br />\nmetalloendopeptidase inhibitor activity<br />\nnerve growth factor receptor binding<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nactivation of MAPKK activity<br />\ncell-cell signaling<br />\nextrinsic apoptotic signaling pathway via death domain receptors<br />\nmicrotubule-based movement<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of neuron apoptotic process<br />\nnerve growth factor processing<br />\nneuron projection morphogenesis<br />\nneurotrophin TRK receptor signaling pathway<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of apoptotic process<br />\npositive regulation of axonogenesis<br />\npositive regulation of gene expression<br />\npositive regulation of Ras protein signal transduction<br />\nregulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nregulation of neuron differentiation<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\n', 'PF00243.', 'MSMLFYTLITAFLIGIQAEPHSESNVPAGHTIPQAHWTKLQHSLDTALRRARSAPAAAIAARVAGQTRNITVDPRLFKKRRLRSPRVLFSTQPPREAADTQDLDFEVGGAAPFNRTHRSKRSSSHPIFHRGEFSVCDSVSVWVGDKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDPNPVDSGCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSRKAVRRA'),
('P19440', '4ZC6', 1, 2.1, 'A', 353, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Glutathione hydrolase 1 proenzyme', 'GGT1', 'A (5-L-glutamyl)-peptide + an amino acid = a peptide + a 5-L-glutamyl amino acid<br />\nGlutathione + H2O = L-cysteinylglycine + L-glutamate<br />\nLeukotriene C4 + H2O = leukotriene D4 + L-glutamate<br />\n', 'glutathione hydrolase activity<br />\nhypoglycin A gamma-glutamyl transpeptidase activity<br />\nleukotriene-C(4) hydrolase<br />\npeptidyltransferase activity<br />\n', 'cellular amino acid metabolic process<br />\ncysteine biosynthetic process<br />\nfatty acid metabolic process<br />\nglutamate metabolic process<br />\nglutathione biosynthetic process<br />\nglutathione catabolic process<br />\nleukotriene D4 biosynthetic process<br />\nleukotriene metabolic process<br />\nproteolysis<br />\nregulation of immune system process<br />\nregulation of inflammatory response<br />\nspermatogenesis<br />\nxenobiotic metabolic process<br />\nzymogen activation<br />\n', 'PF01019.', 'MKKKLVVLGLLAVVLVLVIVGLCLWLPSASKEPDNHVYTRAAVAADAKQCSKIGRDALRDGGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNSTTRKAEVINAREVAPRLAFATMFNSSEQSQKGGLSVAVPGEIRGYELAHQRHGRLPWARLFQPSIQLARQGFPVGKGLAAALENKRTVIEQQPVLCEVFCRDRKVLREGERLTLPQLADTYETLAIEGAQAFYNGSLTAQIVKDIQAAGGIVTAEDLNNYRAELIEHPLNISLGDVVLYMPSAPLSGPVLALILNILKGYNFSRESVESPEQKGLTYHRIVEAFRFAYAKRTLLGDPKFVDVTEVVRNMTSEFFAAQLRAQISDDTTHPISYYKPEFYTPDDGGTAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILFNNEMDDFSSPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITTATALAIIYNLWFGYDVKRAVEEPRLHNQLLPNVTTVERNIDQAVTAALETRHHHTQIASTFIAVVQAIVRTAGGWAAASDSRKGGEPAGY'),
('P09172', '4ZEL', 0, 2.9, 'A/B', 578, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Dopamine beta-hydroxylase', 'DBH', '3,4-dihydroxyphenethylamine + ascorbate + O2 = noradrenaline + dehydroascorbate + H2O<br />\n', 'catalytic activity<br />\ncopper ion binding<br />\ndopamine beta-monooxygenase activity<br />\nL-ascorbic acid binding<br />\n', 'behavioral response to ethanol<br />\nblood vessel remodeling<br />\ncatecholamine biosynthetic process<br />\nchemical synaptic transmission<br />\ncytokine production<br />\ndopamine catabolic process<br />\nfear response<br />\nglucose homeostasis<br />\nhomoiothermy<br />\nleukocyte mediated immunity<br />\nleukocyte migration<br />\nlocomotory behavior<br />\nmaternal behavior<br />\nmemory<br />\nnorepinephrine biosynthetic process<br />\noctopamine biosynthetic process<br />\npositive regulation of vasoconstriction<br />\nregulation of cell proliferation<br />\nregulation of extrinsic apoptotic signaling pathway<br />\nresponse to amphetamine<br />\nresponse to pain<br />\nvisual learning<br />\n', 'PF03712.', 'MPALSRWASLPGPSMREAAFMYSTAVAIFLVILVAALQGSAPRESPLPYHIPLDPEGSLELSWNVSYTQEAIHFQLLVRRLKAGVLFGMSDRGELENADLVVLWTDGDTAYFADAWSDQKGQIHLDPQQDYQLLQVQRTPEGLTLLFKRPFGTCDPKDYLIEDGTVHLVYGILEEPFRSLEAINGSGLQMGLQRVQLLKPNIPEPELPSDACTMEVQAPNIQIPSQETTYWCYIKELPKGFSRHHIIKYEPIVTKGNEALVHHMEVFQCAPEMDSVPHFSGPCDSKMKPDRLNYCRHVLAAWALGAKAFYYPEEAGLAFGGPGSSRYLRLEVHYHNPLVIEGRNDSSGIRLYYTAKLRRFNAGIMELGLVYTPVMAIPPRETAFILTGYCTDKCTQLALPPSGIHIFASQLHTHLTGRKVVTVLVRDGREWEIVNQDNHYSPHFQEIRMLKKVVSVHPGDVLITSCTYNTEDRELATVGGFGILEEMCVNYVHYYPQTQLELCKSAVDAGFLQKYFHLINRFNNEDVCTCPQASVSQQFTSVPWNSFNRDVLKALYSFAPISMHCNKSSAVRFQGEWNLQPLPKVISTLEEPTPQCPTSQGRSPAGPTVVSIGGGKG'),
('P54368', '4ZGY', 1, 2.63, 'B', 125, 'LYASE / LYASE INHIBITOR', 'LYASE', 'Ornithine decarboxylase antizyme 1', 'OAZ1', '', 'ornithine decarboxylase inhibitor activity<br />\n', 'negative regulation of polyamine transmembrane transport<br />\npolyamine biosynthetic process<br />\npolyamine metabolic process<br />\npositive regulation of intracellular protein transport<br />\npositive regulation of protein catabolic process<br />\nregulation of cellular amino acid metabolic process<br />\ntransport<br />\n', 'PF02100.', 'MVKSSLQRILNSHCFAREKEGDKPSATIHASRTMPLLSLHSRGGSSSESSRVSLHCCSNPGPGPRWCSDAPHPPLKIPGGRGNSQRDHNLSANLFYSDDRLNVTEELTSNDKTRILNVQSRLTDAKRINWRTVLSGGSLYIEIPGGALPEGSKDSFAVLLEFAEEQLRADHVFICFHKNREDRAALLRTFSFLGFEIVRPGHPLVPKRPDACFMAYTFERESSGEEEE'),
('Q9Y478', '4ZHX', 1, 2.99, 'B/D', 270, 'TRANSFERASE', 'TRANSFERASE', '5''-AMP-activated protein kinase subunit beta-1', 'PRKAB1', '', 'AMP-activated protein kinase activity<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\n', 'cell cycle arrest<br />\nfatty acid biosynthetic process<br />\nmacroautophagy<br />\nnail development<br />\npositive regulation of gene expression<br />\nprotein heterooligomerization<br />\nprotein phosphorylation<br />\nregulation of catalytic activity<br />\nregulation of macroautophagy<br />\nregulation of signal transduction by p53 class mediator<br />\nsignal transduction<br />\n', 'PF16561.', 'MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSEEIKAPEKEEFLAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNWSKLPLTRSHNNFVAILDLPEGEHQYKFFVDGQWTHDPSEPIVTSQLGTVNNIIQVKKTDFEVFDALMVDSQKCSDVSELSSSPPGPYHQEPYVCKPEERFRAPPILPPHLLQVILNKDTGISCDPALLPEPNHVMLNHLYALSIKDGVMVLSATHRYKKKYVTTLLYKPI'),
('O43613', '4ZJ8', 1, 2.75, 'A', 246, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Orexin receptor type 1', 'HCRTR1', '', 'G-protein coupled receptor activity<br />\norexin receptor activity<br />\npeptide binding<br />\npeptide hormone binding<br />\n', 'cellular response to hormone stimulus<br />\nchemical synaptic transmission<br />\nfeeding behavior<br />\nneuropeptide signaling pathway<br />\npositive regulation of ERK1 and ERK2 cascade<br />\nregulation of circadian sleep/wake cycle, sleep<br />\nregulation of cytosolic calcium ion concentration<br />\nresponse to peptide<br />\n', 'PF00001.', 'MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP'),
('P02708', '4ZJS', 1, 2.23, 'A/B/C/D/E', 30, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Acetylcholine receptor subunit alpha', 'CHRNA1', '', 'acetylcholine binding<br />\nacetylcholine-gated cation-selective channel activity<br />\nacetylcholine receptor activity<br />\nion channel activity<br />\nligand-gated ion channel activity<br />\n', 'muscle cell cellular homeostasis<br />\nmusculoskeletal movement<br />\nneuromuscular junction development<br />\nneuromuscular process<br />\nneuromuscular synaptic transmission<br />\nneuronal action potential<br />\nneuron cellular homeostasis<br />\nregulation of membrane potential<br />\nresponse to nicotine<br />\nsignal transduction<br />\nskeletal muscle contraction<br />\nskeletal muscle tissue growth<br />\nsynaptic transmission, cholinergic<br />\ntransport<br />\n', 'PF02931.', 'MEPWPLLLLFSLCSAGLVLGSEHETRLVAKLFKDYSSVVRPVEDHRQVVEVTVGLQLIQLINVDEVNQIVTTNVRLKQGDMVDLPRPSCVTLGVPLFSHLQNEQWVDYNLKWNPDDYGGVKKIHIPSEKIWRPDLVLYNNADGDFAIVKFTKVLLQYTGHITWTPPAIFKSYCEIIVTHFPFDEQNCSMKLGTWTYDGSVVAINPESDQPDLSNFMESGEWVIKESRGWKHSVTYSCCPDTPYLDITYHFVMQRLPLYFIVNVIIPCLLFSFLTGLVFYLPTDSGEKMTLSISVLLSLTVFLLVIVELIPSTSSAVPLIGKYMLFTMVFVIASIIITVIVINTHHRSPSTHVMPNWVRKVFIDTIPNIMFFSTMKRPSREKQDKKIFTEDIDISDISGKPGPPPMGFHSPLIKHPEVKSAIEGIKYIAETMKSDQESNNAAAEWKYVAMVMDHILLGVFMLVCIIGTLAVFAGRLIELNQQG'),
('P32297', '4ZK4', 1, 1.9, 'A/B/C/D/E', 16, 'ACETYLCHOLINE BINDING PROTEIN', 'OTHERS', 'Neuronal acetylcholine receptor subunit alpha-3', 'CHRNA3', '', 'acetylcholine binding<br />\nacetylcholine-gated cation-selective channel activity<br />\nacetylcholine receptor activity<br />\nligand-gated ion channel activity<br />\nserotonin-gated cation-selective channel activity<br />\n', 'acetylcholine receptor signaling pathway<br />\nactivation of transmembrane receptor protein tyrosine kinase activity<br />\nbehavioral response to nicotine<br />\nexcitatory postsynaptic potential<br />\nion transport<br />\nlocomotory behavior<br />\nnervous system development<br />\nregulation of acetylcholine secretion, neurotransmission<br />\nregulation of dendrite morphogenesis<br />\nregulation of membrane potential<br />\nregulation of smooth muscle contraction<br />\nresponse to acetylcholine<br />\nsignal transduction<br />\nsynaptic transmission, cholinergic<br />\nsynaptic transmission involved in micturition<br />\n', 'PF02931.', 'MGSGPLSLPLALSPPRLLLLLLLSLLPVARASEAEHRLFERLFEDYNEIIRPVANVSDPVIIHFEVSMSQLVKVDEVNQIMETNLWLKQIWNDYKLKWNPSDYGGAEFMRVPAQKIWKPDIVLYNNAVGDFQVDDKTKALLKYTGEVTWIPPAIFKSSCKIDVTYFPFDYQNCTMKFGSWSYDKAKIDLVLIGSSMNLKDYWESGEWAIIKAPGYKHDIKYNCCEEIYPDITYSLYIRRLPLFYTINLIIPCLLISFLTVLVFYLPSDCGEKVTLCISVLLSLTVFLLVITETIPSTSLVIPLIGEYLLFTMIFVTLSIVITVFVLNVHYRTPTTHTMPSWVKTVFLNLLPRVMFMTRPTSNEGNAQKPRPLYGAELSNLNCFSRAESKGCKEGYPCQDGMCGYCHHRRIKISNFSANLTRSSSSESVDAVLSLSALSPEIKEAIQSVKYIAENMKAQNEAKEIQDDWKYVAMVIDRIFLWVFTLVCILGTAGLFLQPLMAREDA'),
('P30556', '4ZUD', 1, 2.8, 'A', 314, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Type-1 angiotensin II receptor', 'AGTR1', '', 'angiotensin type II receptor activity<br />\nangiotensin type I receptor activity<br />\nbradykinin receptor binding<br />\nprotein heterodimerization activity<br />\n', 'angiotensin-activated signaling pathway<br />\ncalcium-mediated signaling<br />\ncell chemotaxis<br />\nG-protein coupled receptor signaling pathway<br />\nkidney development<br />\nlow-density lipoprotein particle remodeling<br />\nphospholipase C-activating angiotensin-activated signaling pathway<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\npositive regulation of cellular protein metabolic process<br />\npositive regulation of cholesterol esterification<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway<br />\npositive regulation of inflammatory response<br />\npositive regulation of macrophage derived foam cell differentiation<br />\npositive regulation of NAD(P)H oxidase activity<br />\npositive regulation of phospholipase A2 activity<br />\npositive regulation of reactive oxygen species metabolic process<br />\nregulation of blood vessel diameter<br />\nregulation of blood vessel diameter by renin-angiotensin<br />\nregulation of cell growth<br />\nregulation of cell proliferation<br />\nregulation of inflammatory response<br />\nregulation of renal sodium excretion<br />\nregulation of systemic arterial blood pressure by renin-angiotensin<br />\nregulation of vasoconstriction<br />\nrenin-angiotensin regulation of aldosterone production<br />\nRho protein signal transduction<br />\n', 'PF00001.', 'MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE'),
('Q8MU52', '4ZXG', 1, 1.7, 'A/B', 205, 'TRANSFERASE', 'TRANSFERASE', 'Glutathione S-transferase', 'GST', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'glutathione transferase activity<br />\n', '', 'PF14497.', 'MGDNIVLYYFDARGKAELIRLIFAYLGIEYTDKRFGVNGDAFVEFKNFKKEKDTPFEQVPILQIGDLILAQSQAIVRYLSKKYNICGESELNEFYADMIFCGVQDIHYKFNNTNLFKQNETTFLNEDLPKWSGYFEKLLKKNHTNNNNDKYYFVGNNLTYADLAVFNLYDDIETKYPSSLKNFPLLKAHNEFISNLPNIKNYITNRKESVY'),
('O43776', '4ZYA', 0, 1.65, 'A/B', 74, 'LIGASE', 'LIGASE', 'Asparagine--tRNA ligase, cytoplasmic', 'NARS', 'ATP + L-asparagine + tRNA(Asn) = AMP + diphosphate + L-asparaginyl-tRNA(Asn).<br />\n', 'asparagine-tRNA ligase activity<br />\nATP binding<br />\nnucleic acid binding<br />\n', 'asparaginyl-tRNA aminoacylation<br />\ntRNA aminoacylation for protein translation<br />\n', 'PF00152.', 'MVLAELYVSDREGSDATGDGTKEKPFKTGLKALMTVGKEPFPTIYVDSQKENERWNVISKSQLKNIKKMWHREQMKSESREKKEAEDSLRREKNLEEAKKITIKNDPSLPEPKCVKIGALEGYRGQRVKVFGWVHRLRRQGKNLMFLVLRDGTGYLQCVLADELCQCYNGVLLSTESSVAVYGMLNLTPKGKQAPGGHELSCDFWELIGLAPAGGADNLINEESDVDVQLNNRHMMIRGENMSKILKARSMVTRCFRDHFFDRGYYEVTPPTLVQTQVEGGATLFKLDYFGEEAFLTQSSQLYLETCLPALGDVFCIAQSYRAEQSRTRRHLAEYTHVEAECPFLTFDDLLNRLEDLVCDVVDRILKSPAGSIVHELNPNFQPPKRPFKRMNYSDAIVWLKEHDVKKEDGTFYEFGEDIPEAPERLMTDTINEPILLCRFPVEIKSFYMQRCPEDSRLTESVDVLMPNVGEIVGGSMRIFDSEEILAGYKREGIDPTPYYWYTDQRKYGTCPHGGYGLGLERFLTWILNRYHIRDVCLYPRFVQRCTP'),
('P22102', '4ZZ1', 1, 1.35, 'A', 203, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Trifunctional purine biosynthetic protein adenosine-3', 'GART', 'ATP + 5-phospho-D-ribosylamine + glycine = ADP + phosphate + N1-(5-phospho-D-ribosyl)glycinamide.<br />\nATP + 2-(formamido)-N1-(5-phospho-D-ribosyl)acetamidine = ADP + phosphate + 5-amino-1-(5-phospho-D-ribosyl)imidazole.<br />\n10-formyltetrahydrofolate + N1-(5-phospho-D-ribosyl)glycinamide = tetrahydrofolate + N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide.<br />\n', 'ATP binding<br />\nmetal ion binding<br />\nphosphoribosylamine-glycine ligase activity<br />\nphosphoribosylformylglycinamidine cyclo-ligase activity<br />\nphosphoribosylglycinamide formyltransferase activity<br />\n', '''de novo'' IMP biosynthetic process<br />\nbrainstem development<br />\ncerebellum development<br />\ncerebral cortex development<br />\nglycine metabolic process<br />\npurine nucleobase biosynthetic process<br />\npurine ribonucleoside monophosphate biosynthetic process<br />\nresponse to inorganic substance<br />\nresponse to organic substance<br />\ntetrahydrofolate biosynthetic process<br />\n', 'PF00586.', 'MAARVLIIGSGGREHTLAWKLAQSHHVKQVLVAPGNAGTACSEKISNTAISISDHTALAQFCKEKKIEFVVVGPEAPLAAGIVGNLRSAGVQCFGPTAEAAQLESSKRFAKEFMDRHGIPTAQWKAFTKPEEACSFILSADFPALVVKASGLAAGKGVIVAKSKEEACKAVQEIMQEKAFGAAGETIVIEELLDGEEVSCLCFTDGKTVAPMPPAQDHKRLLEGDGGPNTGGMGAYCPAPQVSNDLLLKIKDTVLQRTVDGMQQEGTPYTGILYAGIMLTKNGPKVLEFNCRFGDPECQVILPLLKSDLYEVIQSTLDGLLCTSLPVWLENHTALTVVMASKGYPGDYTKGVEITGFPEAQALGLEVFHAGTALKNGKVVTHGGRVLAVTAIRENLISALEEAKKGLAAIKFEGAIYRKDVGFRAIAFLQQPRSLTYKESGVDIAAGNMLVKKIQPLAKATSRSGCKVDLGGFAGLFDLKAAGFKDPLLASGTDGVGTKLKIAQLCNKHDTIGQDLVAMCVNDILAQGAEPLFFLDYFSCGKLDLSVTEAVVAGIAKACGKAGCALLGGETAEMPDMYPPGEYDLAGFAVGAMERDQKLPHLERITEGDVVVGIASSGLHSNGFSLVRKIVAKSSLQYSSPAPDGCGDQTLGDLLLTPTRIYSHSLLPVLRSGHVKAFAHITGGGLLENIPRVLPEKLGVDLDAQTWRIPRVFSWLQQEGHLSEEEMARTFNCGVGAVLVVSKEQTEQILRDIQQHKEEAWVIGSVVARAEGSPRVKVKNLIESMQINGSVLKNGSLTNHFSFEKKKARVAVLISGTGSNLQALIDSTREPNSSAQIDIVISNKAAVAGLDKAERAGIPTRVINHKLYKNRVEFDSAIDLVLEEFSIDIVCLAGFMRILSGPFVQKWNGKMLNIHPSLLPSFKGSNAHEQALETGVTVTGCTVHFVAEDVDAGQIILQEAVPVKRGDTVATLSERVKLAEHKIFPAALQLVASGTVQLGENGKICWVKEE'),
('P28482', '4ZZN', 1, 1.33, 'A', 350, 'TRANSFERASE', 'TRANSFERASE', 'Mitogen-activated protein kinase 1', 'MAPK1', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nDNA binding<br />\nidentical protein binding<br />\nkinase activity<br />\nMAP kinase activity<br />\nMAP kinase kinase activity<br />\nmitogen-activated protein kinase kinase kinase binding<br />\nphosphatase binding<br />\nphosphotyrosine residue binding<br />\nprotein serine/threonine kinase activity<br />\nRNA polymerase II carboxy-terminal domain kinase activity<br />\ntranscription factor binding<br />\n', 'activation of MAPK activity<br />\napoptotic process<br />\naxon guidance<br />\nB cell receptor signaling pathway<br />\nBergmann glial cell differentiation<br />\ncardiac neural crest cell development involved in heart development<br />\ncaveolin-mediated endocytosis<br />\ncell cycle<br />\ncellular response to amino acid starvation<br />\ncellular response to cadmium ion<br />\ncellular response to DNA damage stimulus<br />\ncellular response to dopamine<br />\ncellular response to granulocyte macrophage colony-stimulating factor stimulus<br />\ncellular response to reactive oxygen species<br />\nchemical synaptic transmission<br />\nchemotaxis<br />\ncytosine metabolic process<br />\ndiadenosine tetraphosphate biosynthetic process<br />\nERBB signaling pathway<br />\nERK1 and ERK2 cascade<br />\nface development<br />\nFc-epsilon receptor signaling pathway<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\nfibroblast growth factor receptor signaling pathway<br />\nJAK-STAT cascade involved in growth hormone signaling pathway<br />\nlabyrinthine layer blood vessel development<br />\nlearning or memory<br />\nlipopolysaccharide-mediated signaling pathway<br />\nlong-term synaptic potentiation<br />\nlung morphogenesis<br />\nmammary gland epithelial cell proliferation<br />\nMAPK cascade<br />\nMAPK import into nucleus<br />\nnegative regulation of cell differentiation<br />\nneutrophil degranulation<br />\nouter ear morphogenesis<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\nplatelet activation<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of gene expression<br />\npositive regulation of peptidyl-threonine phosphorylation<br />\npositive regulation of protein import into nucleus, translocation<br />\npositive regulation of telomerase activity<br />\npositive regulation of telomere capping<br />\npositive regulation of telomere maintenance via telomerase<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of translation<br />\nprotein phosphorylation<br />\nregulation of cellular pH<br />\nregulation of cellular response to heat<br />\nregulation of cytoskeleton organization<br />\nregulation of early endosome to late endosome transport<br />\nregulation of Golgi inheritance<br />\nregulation of ossification<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of protein stability<br />\nregulation of sequence-specific DNA binding transcription factor activity<br />\nregulation of stress-activated MAPK cascade<br />\nresponse to epidermal growth factor<br />\nresponse to estrogen<br />\nresponse to exogenous dsRNA<br />\nresponse to nicotine<br />\nresponse to stress<br />\nresponse to toxic substance<br />\nsensory perception of pain<br />\nsignal transduction<br />\nstress-activated MAPK cascade<br />\nT cell receptor signaling pathway<br />\nthymus development<br />\nthyroid gland development<br />\ntrachea formation<br />\ntranscription, DNA-templated<br />\nviral process<br />\n', 'PF00069.', 'MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS'),
('P31153', '5A1I', 1, 1.09, 'A', 395, 'TRANSFERASE', 'TRANSFERASE', 'S-adenosylmethionine synthase isoform type-2', 'MAT2A', 'ATP + L-methionine + H2O = phosphate + diphosphate + S-adenosyl-L-methionine<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\nmethionine adenosyltransferase activity<br />\n', 'cellular response to leukemia inhibitory factor<br />\nmethylation<br />\none-carbon metabolic process<br />\nprotein heterooligomerization<br />\nprotein hexamerization<br />\nS-adenosylmethionine biosynthetic process<br />\n', 'PF02773.', 'MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY'),
('P29475', '5ADF', 1, 1.97, 'A/B', 421, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Nitric oxide synthase, brain', 'NOS1', '2 L-arginine + 3 NADPH + 4 O2 = 2 L-citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O.<br />\n', 'arginine binding<br />\ncadmium ion binding<br />\ncalmodulin binding<br />\nflavin adenine dinucleotide binding<br />\nFMN binding<br />\nheme binding<br />\nion channel binding<br />\niron ion binding<br />\nNADP binding<br />\nNADPH-hemoprotein reductase activity<br />\nnitric-oxide synthase activity<br />\nscaffold protein binding<br />\nsodium channel regulator activity<br />\ntetrahydrobiopterin binding<br />\n', 'arginine catabolic process<br />\ncell redox homeostasis<br />\ncellular response to growth factor stimulus<br />\nexogenous drug catabolic process<br />\nmulticellular organismal response to stress<br />\nmyoblast fusion<br />\nnegative regulation of adrenergic receptor signaling pathway involved in heart process<br />\nnegative regulation of blood pressure<br />\nnegative regulation of calcium ion transport<br />\nnegative regulation of calcium ion transport into cytosol<br />\nnegative regulation of hydrolase activity<br />\nnegative regulation of potassium ion transport<br />\nnegative regulation of serotonin uptake<br />\nneurotransmitter biosynthetic process<br />\nnitric oxide biosynthetic process<br />\nnitric oxide mediated signal transduction<br />\npeptidyl-cysteine S-nitrosylation<br />\npositive regulation of adrenergic receptor signaling pathway involved in heart process<br />\npositive regulation of guanylate cyclase activity<br />\npositive regulation of histone acetylation<br />\npositive regulation of sodium ion transmembrane transport<br />\npositive regulation of the force of heart contraction<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nregulation of calcium ion transmembrane transport via high voltage-gated calcium channel<br />\nregulation of cardiac conduction<br />\nregulation of cardiac muscle contraction<br />\nregulation of neurogenesis<br />\nregulation of ryanodine-sensitive calcium-release channel activity<br />\nregulation of sodium ion transport<br />\nresponse to heat<br />\nresponse to hypoxia<br />\nretrograde trans-synaptic signaling by nitric oxide<br />\nstriated muscle contraction<br />\nvasodilation<br />\n', 'PF00667.', 'MEDHMFGVQQIQPNVISVRLFKRKVGGLGFLVKERVSKPPVIISDLIRGGAAEQSGLIQAGDIILAVNGRPLVDLSYDSALEVLRGIASETHVVLILRGPEGFTTHLETTFTGDGTPKTIRVTQPLGPPTKAVDLSHQPPAGKEQPLAVDGASGPGNGPQHAYDDGQEAGSLPHANGLAPRPPGQDPAKKATRVSLQGRGENNELLKEIEPVLSLLTSGSRGVKGGAPAKAEMKDMGIQVDRDLDGKSHKPLPLGVENDRVFNDLWGKGNVPVVLNNPYSEKEQPPTSGKQSPTKNGSPSKCPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVRTKGQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWKGTNGTPTKRRAIGFKKLAEAVKFSAKLMGQAMAKRVKATILYATETGKSQAYAKTLCEIFKHAFDAKVMSMEEYDIVHLEHETLVLVVTSTFGNGDPPENGEKFGCALMEMRHPNSVQEERKSYKVRFNSVSSYSDSQKSSGDGPDLRDNFESAGPLANVRFSVFGLGSRAYPHFCAFGHAVDTLLEELGGERILKMREGDELCGQEEAFRTWAKKVFKAACDVFCVGDDVNIEKANNSLISNDRSWKRNKFRLTFVAEAPELTQGLSNVHKKRVSAARLLSRQNLQSPKSSRSTIFVRLHTNGSQELQYQPGDHLGVFPGNHEDLVNALIERLEDAPPVNQMVKVELLEERNTALGVISNWTDELRLPPCTIFQAFKYYLDITTPPTPLQLQQFASLATSEKEKQRLLVLSKGLQEYEEWKWGKNPTIVEVLEEFPSIQMPATLLLTQLSLLQPRYYSISSSPDMYPDEVHLTVAIVSYRTRDGEGPIHHGVCSSWLNRIQADELVPCFVRGAPSFHLPRNPQVPCILVGPGTGIAPFRSFWQQRQFDIQHKGMNPCPMVLVFGCRQSKIDHIYREETLQAKNKGVFRELYTAYSREPDKPKKYVQDILQEQLAESVYRALKEQGGHIYVCGDVTMAADVLKAIQRIMTQQGKLSAEDAGVFISRMRDDNRYHEDIFGVTLRTYEVTNRLRSESIAFIEESKKDTDEVFSS'),
('P14416', '5AER', 0, 2.19, 'B/C', 14, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'D(2) dopamine receptor', 'DRD2', '', 'dopamine binding<br />\ndopamine neurotransmitter receptor activity, coupled via Gi/Go<br />\ndrug binding<br />\nidentical protein binding<br />\nionotropic glutamate receptor binding<br />\npotassium channel regulator activity<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\n', 'activation of protein kinase activity<br />\nadenohypophysis development<br />\nadenylate cyclase-inhibiting dopamine receptor signaling pathway<br />\nadult walking behavior<br />\narachidonic acid secretion<br />\nassociative learning<br />\nauditory behavior<br />\naxonogenesis<br />\nbehavioral response to cocaine<br />\nbehavioral response to ethanol<br />\nbranching morphogenesis of a nerve<br />\ncellular calcium ion homeostasis<br />\ncerebral cortex GABAergic interneuron migration<br />\nchemical synaptic transmission, postsynaptic<br />\ncircadian regulation of gene expression<br />\ndopamine metabolic process<br />\nfeeding behavior<br />\nG-protein coupled receptor internalization<br />\ngrooming behavior<br />\nintracellular signal transduction<br />\nlocomotory behavior<br />\nlong-term memory<br />\nnegative regulation of adenylate cyclase activity<br />\nnegative regulation of blood pressure<br />\nnegative regulation of cell migration<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of circadian sleep/wake cycle, sleep<br />\nnegative regulation of cytosolic calcium ion concentration<br />\nnegative regulation of dopamine receptor signaling pathway<br />\nnegative regulation of dopamine secretion<br />\nnegative regulation of innate immune response<br />\nnegative regulation of insulin secretion<br />\nnegative regulation of protein kinase B signaling<br />\nnegative regulation of protein secretion<br />\nnegative regulation of synaptic transmission, glutamatergic<br />\nnegative regulation of voltage-gated calcium channel activity<br />\nneurological system process involved in regulation of systemic arterial blood pressure<br />\nneuron-neuron synaptic transmission<br />\norbitofrontal cortex development<br />\nperistalsis<br />\nphosphatidylinositol metabolic process<br />\nphospholipase C-activating dopamine receptor signaling pathway<br />\npigmentation<br />\npositive regulation of cytokinesis<br />\npositive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway<br />\npositive regulation of dopamine uptake involved in synaptic transmission<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of glial cell-derived neurotrophic factor secretion<br />\npositive regulation of G-protein coupled receptor protein signaling pathway<br />\npositive regulation of growth hormone secretion<br />\npositive regulation of long-term synaptic potentiation<br />\npositive regulation of multicellular organism growth<br />\npositive regulation of neuroblast proliferation<br />\npositive regulation of receptor internalization<br />\npositive regulation of renal sodium excretion<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of urine volume<br />\nprepulse inhibition<br />\nprotein localization<br />\nregulation of cAMP metabolic process<br />\nregulation of dopamine secretion<br />\nregulation of dopamine uptake involved in synaptic transmission<br />\nregulation of heart rate<br />\nregulation of locomotion involved in locomotory behavior<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of phosphoprotein phosphatase activity<br />\nregulation of potassium ion transport<br />\nregulation of sodium ion transport<br />\nregulation of synapse structural plasticity<br />\nregulation of synaptic transmission, GABAergic<br />\nrelease of sequestered calcium ion into cytosol<br />\nresponse to amphetamine<br />\nresponse to axon injury<br />\nresponse to cocaine<br />\nresponse to drug<br />\nresponse to histamine<br />\nresponse to hypoxia<br />\nresponse to inactivity<br />\nresponse to iron ion<br />\nresponse to light stimulus<br />\nresponse to morphine<br />\nresponse to nicotine<br />\nresponse to toxic substance<br />\nsensory perception of smell<br />\nstriatum development<br />\nsynapse assembly<br />\nsynaptic transmission, dopaminergic<br />\ntemperature homeostasis<br />\nvisual learning<br />\nWnt signaling pathway<br />\n', 'PF00001.', 'MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC'),
('P36544', '5AFN', 1, 2.15, 'A/B/C/D/E', 205, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Neuronal acetylcholine receptor subunit alpha-7', 'CHRNA7', '', 'acetylcholine binding<br />\nacetylcholine-gated cation-selective channel activity<br />\nacetylcholine receptor activity<br />\namyloid-beta binding<br />\ncalcium channel activity<br />\nchloride channel regulator activity<br />\nion channel activity<br />\nligand-gated ion channel activity<br />\nprotein homodimerization activity<br />\ntoxic substance binding<br />\n', 'acetylcholine receptor signaling pathway<br />\nactivation of MAPK activity<br />\nassociative learning<br />\nB cell activation<br />\nbehavioral response to ethanol<br />\nbehavioral response to nicotine<br />\ncalcium ion transport<br />\ncellular calcium ion homeostasis<br />\ncognition<br />\ndendrite arborization<br />\ndendritic spine organization<br />\nendocytosis<br />\nflagellated sperm motility<br />\ngeneration of ovulation cycle rhythm<br />\nion transmembrane transport<br />\nion transport<br />\nlearning or memory<br />\nmemory<br />\nmodulation of excitatory postsynaptic potential<br />\nnegative regulation of amyloid-beta formation<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of interleukin-1 beta production<br />\nnegative regulation of interleukin-6 production<br />\nnegative regulation of protein phosphorylation<br />\nnegative regulation of tumor necrosis factor production<br />\npositive regulation of amyloid-beta formation<br />\npositive regulation of angiogenesis<br />\npositive regulation of cell proliferation<br />\npositive regulation of CoA-transferase activity<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of excitatory postsynaptic potential<br />\npositive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure<br />\npositive regulation of long-term synaptic potentiation<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of protein metabolic process<br />\npositive regulation of protein phosphorylation<br />\nregulation of amyloid fibril formation<br />\nregulation of amyloid precursor protein catabolic process<br />\nregulation of neuron death<br />\nregulation of norepinephrine secretion<br />\nregulation of synaptic transmission, dopaminergic<br />\nresponse to acetylcholine<br />\nresponse to amyloid-beta<br />\nresponse to cold<br />\nresponse to food<br />\nresponse to hypoxia<br />\nresponse to nicotine<br />\nsensory processing<br />\nshort-term memory<br />\nsignal transduction<br />\nsynapse organization<br />\nsynaptic transmission, cholinergic<br />\nT cell activation<br />\n', 'PF02931.', 'MRCSPGGVWLALAASLLHVSLQGEFQRKLYKELVKNYNPLERPVANDSQPLTVYFSLSLLQIMDVDEKNQVLTTNIWLQMSWTDHYLQWNVSEYPGVKTVRFPDGQIWKPDILLYNSADERFDATFHTNVLVNSSGHCQYLPPGIFKSSCYIDVRWFPFDVQHCKLKFGSWSYGGWSLDLQMQEADISGYIPNGEWDLVGIPGKRSERFYECCKEPYPDVTFTVTMRRRTLYYGLNLLIPCVLISALALLVFLLPADSGEKISLGITVLLSLTVFMLLVAEIMPATSDSVPLIAQYFASTMIIVGLSVVVTVIVLQYHHHDPDGGKMPKWTRVILLNWCAWFLRMKRPGEDKVRPACQHKQRRCSLASVEMSAVAPPPASNGNLLYIGFRGLDGVHCVPTPDSGVVCGRMACSPTHDEHLLHGGQPPEGDPDLAKILEEVRYIANRFRCQDESEAVCSEWKFAACVVDRLCLMAFSVFTIICTIGILMSAPNFVEAVSKDFA'),
('P12821', '5AMC', 1, 1.65, 'A/B', 629, 'HYDROLASE', 'HYDROLASE', 'Angiotensin-converting enzyme', 'ACE', 'Release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of angiotensin I to angiotensin II, with increase in vasoconstrictor activity, but no action on angiotensin II.<br />\n', 'actin binding<br />\nbradykinin receptor binding<br />\ncarboxypeptidase activity<br />\nchloride ion binding<br />\ndrug binding<br />\nendopeptidase activity<br />\nexopeptidase activity<br />\nmetallodipeptidase activity<br />\nmetallopeptidase activity<br />\nmitogen-activated protein kinase binding<br />\nmitogen-activated protein kinase kinase binding<br />\npeptidyl-dipeptidase activity<br />\ntripeptidyl-peptidase activity<br />\nzinc ion binding<br />\n', 'amyloid-beta metabolic process<br />\nangiotensin catabolic process in blood<br />\nangiotensin maturation<br />\nantigen processing and presentation of peptide antigen via MHC class I<br />\narachidonic acid secretion<br />\nblood vessel remodeling<br />\ncell proliferation in bone marrow<br />\nheart contraction<br />\nhematopoietic stem cell differentiation<br />\nhormone catabolic process<br />\nkidney development<br />\nmononuclear cell proliferation<br />\nnegative regulation of gap junction assembly<br />\nnegative regulation of gene expression<br />\nnegative regulation of protein binding<br />\nneutrophil mediated immunity<br />\npeptide catabolic process<br />\npositive regulation of peptidyl-cysteine S-nitrosylation<br />\npositive regulation of peptidyl-tyrosine autophosphorylation<br />\npositive regulation of protein binding<br />\npositive regulation of protein tyrosine kinase activity<br />\npositive regulation of systemic arterial blood pressure<br />\nposttranscriptional regulation of gene expression<br />\nproteolysis<br />\nregulation of angiotensin metabolic process<br />\nregulation of blood pressure<br />\nregulation of blood vessel diameter<br />\nregulation of hematopoietic stem cell proliferation<br />\nregulation of renal output by angiotensin<br />\nregulation of smooth muscle cell migration<br />\nregulation of systemic arterial blood pressure by renin-angiotensin<br />\nregulation of vasoconstriction<br />\nspermatogenesis<br />\n', 'PF01401.', 'MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFAQSYNSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQNFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSNMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWNATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLQAGSSRPWQEVLKDMVGLDALDAQPLLKYFQPVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSARSEGPLPDSGRVSFLGLDLDAQQARVGQWLLLFLGIALLVATLGLSQRLFSIRHRSLHRHSHGPQFGSEVELRHS'),
('Q12797', '5APA', 1, 2.05, 'A', 197, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aspartyl/asparaginyl beta-hydroxylase', 'ASPH', 'Peptide L-aspartate + 2-oxoglutarate + O2 = peptide 3-hydroxy-L-aspartate + succinate + CO2<br />\n', 'calcium ion binding<br />\nelectron carrier activity<br />\nion channel binding<br />\npeptide-aspartate beta-dioxygenase activity<br />\nstructural constituent of muscle<br />\nstructural molecule activity<br />\n', 'activation of cysteine-type endopeptidase activity<br />\nactivation of store-operated calcium channel activity<br />\ncalcium ion transmembrane transport<br />\ncellular response to calcium ion<br />\ndetection of calcium ion<br />\nface morphogenesis<br />\nion transmembrane transport<br />\nlimb morphogenesis<br />\nmuscle contraction<br />\nnegative regulation of cell proliferation<br />\npalate development<br />\npattern specification process<br />\npeptidyl-aspartic acid hydroxylation<br />\npositive regulation of calcium ion transport into cytosol<br />\npositive regulation of intracellular protein transport<br />\npositive regulation of proteolysis<br />\npositive regulation of ryanodine-sensitive calcium-release channel activity<br />\npositive regulation of transcription, DNA-templated<br />\nregulation of cardiac conduction<br />\nregulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion<br />\nregulation of cell communication by electrical coupling<br />\nregulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity<br />\nregulation of protein depolymerization<br />\nregulation of protein stability<br />\nregulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum<br />\nregulation of ryanodine-sensitive calcium-release channel activity<br />\nresponse to ATP<br />\n', 'PF05279.', 'MAQRKNAKSSGNSSSSGSGSGSTSAGSSSPGARRETKHGGHKNGRKGGLSGTSFFTWFMVIALLGVWTSVAVVWFDLVDYEEVLGKLGIYDADGDGDFDVDDAKVLLGLKERSTSEPAVPPEEAEPHTEPEEQVPVEAEPQNIEDEAKEQIQSLLHEMVHAEHVEGEDLQQEDGPTGEPQQEDDEFLMATDVDDRFETLEPEVSHEETEHSYHVEETVSQDCNQDMEEMMSEQENPDSSEPVVEDERLHHDTDDVTYQVYEEQAVYEPLENEGIEITEVTAPPEDNPVEDSQVIVEEVSIFPVEEQQEVPPETNRKTDDPEQKAKVKKKKPKLLNKFDKTIKAELDAAEKLRKRGKIEEAVNAFKELVRKYPQSPRARYGKAQCEDDLAEKRRSNEVLRGAIETYQEVASLPDVPADLLKLSLKRRSDRQQFLGHMRGSLLTLQRLVQLFPNDTSLKNDLGVGYLLIGDNDNAKKVYEEVLSVTPNDGFAKVHYGFILKAQNKIAESIPYLKEGIESGDPGTDDGRFYFHLGDAMQRVGNKEAYKWYELGHKRGHFASVWQRSLYNVNGLKAQPWWTPKETGYTELVKSLERNWKLIRDEGLAVMDKAKGLFLPEDENLREKGDWSQFTLWQQGRRNENACKGAPKTCTLLEKFPETTGCRRGQIKYSIMHPGTHVWPHTGPTNCRLRMHLGLVIPKEGCKIRCANETKTWEEGKVLIFDDSFEHEVWQDASSFRLIFIVDVWHPELTPQQRRSLPAI'),
('P00505', '5AX8', 0, 2.99, 'A/B/C/D', 401, 'TRANSFERASE', 'TRANSFERASE', 'Aspartate aminotransferase, mitochondrial', 'GOT2', 'L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate<br />\nL-kynurenine + 2-oxoglutarate = 4-(2-aminophenyl)-2,4-dioxobutanoate + L-glutamate.<br />\n', '4-hydroxyglutamate transaminase activity<br />\namino acid binding<br />\nenzyme binding<br />\nkynurenine-oxoglutarate transaminase activity<br />\nL-aspartate:2-oxoglutarate aminotransferase activity<br />\nL-phenylalanine:2-oxoglutarate aminotransferase activity<br />\nphospholipid binding<br />\nprotein homodimerization activity<br />\npyridoxal phosphate binding<br />\nRNA binding<br />\n', '2-oxoglutarate metabolic process<br />\n4-hydroxyproline catabolic process<br />\naspartate biosynthetic process<br />\naspartate catabolic process<br />\naspartate metabolic process<br />\ncellular amino acid biosynthetic process<br />\nfatty acid transport<br />\ngluconeogenesis<br />\nglutamate catabolic process to 2-oxoglutarate<br />\nglutamate catabolic process to aspartate<br />\nglutamate metabolic process<br />\nglyoxylate metabolic process<br />\noxaloacetate metabolic process<br />\nresponse to ethanol<br />\n', 'PF00155.', 'MALLHSGRVLPGIAAAFHPGLAAAASARASSWWTHVEMGPPDPILGVTEAFKRDTNSKKMNLGVGAYRDDNGKPYVLPSVRKAEAQIAAKNLDKEYLPIGGLAEFCKASAELALGENSEVLKSGRFVTVQTISGTGALRIGASFLQRFFKFSRDVFLPKPTWGNHTPIFRDAGMQLQGYRYYDPKTCGFDFTGAVEDISKIPEQSVLLLHACAHNPTGVDPRPEQWKEIATVVKKRNLFAFFDMAYQGFASGDGDKDAWAVRHFIEQGINVCLCQSYAKNMGLYGERVGAFTMVCKDADEAKRVESQLKILIRPMYSNPPLNGARIAAAILNTPDLRKQWLQEVKVMADRIIGMRTQLVSNLKKEGSTHNWQHITDQIGMFCFTGLKPEQVERLIKEFSIYMTKDGRISVAGVTSSNVGYLAHAIHQVTK');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('Q9UBN7', '5B8D', 1, 1.05, 'A', 105, 'HYDROLASE', 'HYDROLASE', 'Histone deacetylase 6', 'HDAC6', 'Hydrolysis of an N6-acetyl-lysine residue of a histone to yield a deacetylated histone.<br />\n', 'actin binding<br />\nalpha-tubulin binding<br />\nbeta-catenin binding<br />\nbeta-tubulin binding<br />\ncore promoter binding<br />\ndynein complex binding<br />\nenzyme binding<br />\nhistone deacetylase activity<br />\nhistone deacetylase binding<br />\nHsp90 protein binding<br />\nmicrotubule binding<br />\nmisfolded protein binding<br />\nNAD-dependent histone deacetylase activity (H3-K14 specific)<br />\npolyubiquitin modification-dependent protein binding<br />\ntau protein binding<br />\ntubulin deacetylase activity<br />\nubiquitin binding<br />\nubiquitin protein ligase binding<br />\nzinc ion binding<br />\n', 'aggresome assembly<br />\nautophagy<br />\ncellular response to hydrogen peroxide<br />\ncellular response to misfolded protein<br />\ncellular response to topologically incorrect protein<br />\ncilium assembly<br />\ncollateral sprouting<br />\ndendritic spine morphogenesis<br />\nhistone deacetylation<br />\nHsp90 deacetylation<br />\nintracellular protein transport<br />\nlysosome localization<br />\nmitochondrion localization<br />\nnegative regulation of hydrogen peroxide metabolic process<br />\nnegative regulation of microtubule depolymerization<br />\nnegative regulation of oxidoreductase activity<br />\nnegative regulation of protein complex disassembly<br />\nnegative regulation of proteolysis<br />\nnegative regulation of transcription, DNA-templated<br />\nparkin-mediated stimulation of mitophagy in response to mitochondrial depolarization<br />\npeptidyl-lysine deacetylation<br />\npolyubiquitinated misfolded protein transport<br />\npositive regulation of chaperone-mediated protein complex assembly<br />\npositive regulation of epithelial cell migration<br />\npositive regulation of hydrogen peroxide-mediated programmed cell death<br />\npositive regulation of receptor biosynthetic process<br />\npositive regulation of signal transduction<br />\nprotein complex disassembly<br />\nprotein deacetylation<br />\nprotein polyubiquitination<br />\nprotein quality control by the ubiquitin-proteasome system<br />\nregulation of androgen receptor signaling pathway<br />\nregulation of autophagy<br />\nregulation of autophagy of mitochondrion<br />\nregulation of establishment of protein localization<br />\nregulation of fat cell differentiation<br />\nregulation of gene expression, epigenetic<br />\nregulation of macroautophagy<br />\nregulation of microtubule-based movement<br />\nregulation of protein stability<br />\nregulation of receptor activity<br />\nresponse to growth factor<br />\nresponse to misfolded protein<br />\nresponse to organic substance<br />\nresponse to toxic substance<br />\ntranscription, DNA-templated<br />\ntubulin deacetylation<br />\nubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway<br />\n', 'PF00850.', 'MTSTGQDSTTTRQRRSRQNPQSPPQDSSVTSKRNIKKGAVPRSIPNLAEVKKKGKMKKLGQAMEEDLIVGLQGMDLNLEAEALAGTGLVLDEQLNEFHCLWDDSFPEGPERLHAIKEQLIQEGLLDRCVSFQARFAEKEELMLVHSLEYIDLMETTQYMNEGELRVLADTYDSVYLHPNSYSCACLASGSVLRLVDAVLGAEIRNGMAIIRPPGHHAQHSLMDGYCMFNHVAVAARYAQQKHRIRRVLIVDWDVHHGQGTQFTFDQDPSVLYFSIHRYEQGRFWPHLKASNWSTTGFGQGQGYTINVPWNQVGMRDADYIAAFLHVLLPVALEFQPQLVLVAAGFDALQGDPKGEMAATPAGFAQLTHLLMGLAGGKLILSLEGGYNLRALAEGVSASLHTLLGDPCPMLESPGAPCRSAQASVSCALEALEPFWEVLVRSTETVERDNMEEDNVEESEEEGPWEPPVLPILTWPVLQSRTGLVYDQNMMNHCNLWDSHHPEVPQRILRIMCRLEELGLAGRCLTLTPRPATEAELLTCHSAEYVGHLRATEKMKTRELHRESSNFDSIYICPSTFACAQLATGAACRLVEAVLSGEVLNGAAVVRPPGHHAEQDAACGFCFFNSVAVAARHAQTISGHALRILIVDWDVHHGNGTQHMFEDDPSVLYVSLHRYDHGTFFPMGDEGASSQIGRAAGTGFTVNVAWNGPRMGDADYLAAWHRLVLPIAYEFNPELVLVSAGFDAARGDPLGGCQVSPEGYAHLTHLLMGLASGRIILILEGGYNLTSISESMAACTRSLLGDPPPLLTLPRPPLSGALASITETIQVHRRYWRSLRVMKVEDREGPSSSKLVTKKAPQPAKPRLAERMTTREKKVLEAGMGKVTSASFGEESTPGQTNSETAVVALTQDQPSEAATGGATLAQTISEAAIGGAMLGQTTSEEAVGGATPDQTTSEETVGGAILDQTTSEDAVGGATLGQTTSEEAVGGATLAQTTSEAAMEGATLDQTTSEEAPGGTELIQTPLASSTDHQTPPTSPVQGTTPQISPSTLIGSLRTLELGSESQGASESQAPGEENLLGEAAGGQDMADSMLMQGSRGLTDQAIFYAVTPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPHPH'),
('P20831', '5BS3', 1, 2.65, 'B/D', 490, 'Isomerase / DNA / RNA', 'ISOMERASE', 'DNA gyrase subunit A', 'gyrA', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\n', 'DNA topological change<br />\nresponse to antibiotic<br />\n', 'PF03989.', 'MAELPQSRINERNITSEMRESFLDYAMSVIVARALPDVRDGLKPVHRRILYGLNEQGMTPDKSYKKSARIVGDVMGKYHPHGDSSIYEAMVRMAQDFSYRYPLVDGQGNFGSMDGDGAAAMRYTEARMTKITLELLRDINKDTIDFIDNYDGNEREPSVLPARFPNLLANGASGIAVGMATNIPPHNLTELINGVLSLSKNPDISIAELMEDIEGPDFPTAGLILGKSGIRRAYETGRGSIQMRSRAVIEERGGGRQRIVVTEIPFQVNKARMIEKIAELVRDKKIDGITDLRDETSLRTGVRVVIDVRKDANASVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKEALVHYLEHQKTVVRRRTQYNLRKAKDRAHILEGLRIALDHIDEIISTIRESDTDKVAMESLQQRFKLSEKQAQAILDMRLRRLTGLERDKIEAEYNELLNYISELEAILADEEVLLQLVRDELTEIRDRFGDDRRTEIQLGGFEDLEDEDLIPEEQIVITLSHNNYIKRLPVSTYRAQNRGGRGVQGMNTLEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVVNAIELENDEVISTMIAVKDLESEDNFLVFATKRGVVKRSALSNFSRINRNGKIAISFREDDELIAVRLTSGQEDILIGTSHASLIRFPESTLRPLGRTATGVKGITLREGDEVVGLDVAHANSVDEVLVVTENGYGKRTPVNDYRLSNRGGKGIKTATITERNGNVVCITTVTGEEDLMIVTNAGVIIRLDVADISQNGRAAQGVRLIRLGDDQFVSTVAKVKEDAEDETNEDEQSTSTVSEDGTEQQREAVVNDETPGNAIHTEVIDSEENDEDGRIEVRQDFMDRVEEDIQQSLDEDEE'),
('Q9BY41', '5BWZ', 1, 1.59, 'A/B', 377, 'Hydrolase / Hydrolase Inhibitor', 'HYDROLASE', 'Histone deacetylase 8', 'HDAC8', 'Hydrolysis of an N6-acetyl-lysine residue of a histone to yield a deacetylated histone.<br />\n', 'chromatin binding<br />\nhistone deacetylase activity<br />\nHsp70 protein binding<br />\nHsp90 protein binding<br />\nmetal ion binding<br />\nNAD-dependent histone deacetylase activity (H3-K14 specific)<br />\ntranscription factor binding<br />\n', 'cellular response to forskolin<br />\ncellular response to trichostatin A<br />\nchromatin assembly or disassembly<br />\nchromatin organization<br />\nnegative regulation of histone H3-K9 acetylation<br />\nnegative regulation of osteoblast differentiation<br />\nnegative regulation of protein ubiquitination<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nregulation of cohesin loading<br />\nregulation of protein stability<br />\nregulation of telomere maintenance<br />\nsister chromatid cohesion<br />\ntranscription, DNA-templated<br />\n', 'PF00850.', 'MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVV'),
('Q9ULX7', '5CJF', 1, 1.83, 'A', 276, 'LYASE', 'LYASE', 'Carbonic anhydrase 14', 'CA14', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nmetal ion binding<br />\n', 'bicarbonate transport<br />\n', 'PF00194.', 'MLFSALLLEVIWILAADGGQHWTYEGPHGQDHWPASYPECGNNAQSPIDIQTDSVTFDPDLPALQPHGYDQPGTEPLDLHNNGHTVQLSLPSTLYLGGLPRKYVAAQLHLHWGQKGSPGGSEHQINSEATFAELHIVHYDSDSYDSLSEAAERPQGLAVLGILIEVGETKNIAYEHILSHLHEVRHKDQKTSVPPFNLRELLPKQLGQYFRYNGSLTTPPCYQSVLWTVFYRRSQISMEQLEKLQGTLFSTEEEPSKLLVQNYRALQPLNQRMVFASFIQAGSSYTTGEMLSLGVGILVGCLCLLLAVYFIARKIRKKRLENRKSVVFTSAQATTEA'),
('Q13002', '5CMM', 1, 1.27, 'A', 140, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, kainate 2', 'GRIK2', '', 'extracellular-glutamate-gated ion channel activity<br />\nkainate selective glutamate receptor activity<br />\nligand-gated ion channel activity<br />\nPDZ domain binding<br />\nprotein homodimerization activity<br />\nubiquitin conjugating enzyme binding<br />\nubiquitin protein ligase binding<br />\n', 'behavioral fear response<br />\ncellular calcium ion homeostasis<br />\nchemical synaptic transmission<br />\nglutamate receptor signaling pathway<br />\ninhibitory postsynaptic potential<br />\nintracellular protein transport<br />\nmodulation of chemical synaptic transmission<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of synaptic transmission, glutamatergic<br />\nneuronal action potential<br />\nneuron apoptotic process<br />\npositive regulation of neuron apoptotic process<br />\npositive regulation of synaptic transmission<br />\nreceptor clustering<br />\nregulation of JNK cascade<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of short-term neuronal synaptic plasticity<br />\nsynaptic transmission, glutamatergic<br />\ntransport<br />\n', 'PF01094.', 'MKIIFPILSNPVFRRTVKLLLCLLWIGYSQGTTHVLRFGGIFEYVESGPMGAEELAFRFAVNTINRNRTLLPNTTLTYDTQKINLYDSFEASKKACDQLSLGVAAIFGPSHSSSANAVQSICNALGVPHIQTRWKHQVSDNKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTKDAKPLLKEMKRGKEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMERLQAPPKPDSGLLDGFMTTDAALMYDAVHVVSVAVQQFPQMTVSSLQCNRHKPWRFGTRFMSLIKEAHWEGLTGRITFNKTNGLRTDFDLDVISLKEEGLEKIGTWDPASGLNMTESQKGKPANITDSLSNRSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKSNEEGIQRVLTSDYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEESKEASALGVQNIGGIFIVLAAGLVLSVFVAVGEFLYKSKKNAQLEKRSFCSAMVEELRMSLKCQRRLKHKPQAPVIVKTEEVINMHTFNDRRLPGKETMA'),
('P0A0K8', '5CPH', 1, 1.2, 'A/B', 233, 'ISOMERASE / ISOMERASE INHIBITOR', 'ISOMERASE', 'DNA gyrase subunit B', 'gyrB', 'ATP-dependent breakage, passage and rejoining of double-stranded DNA<br />\n', 'ATP binding<br />\nDNA binding<br />\nDNA topoisomerase type II (ATP-hydrolyzing) activity<br />\nmetal ion binding<br />\n', 'DNA topological change<br />\nresponse to antibiotic<br />\n', 'PF00204.', 'MVTALSDVNNTDNYGAGQIQVLEGLEAVRKRPGMYIGSTSERGLHHLVWEIVDNSIDEALAGYANQIEVVIEKDNWIKVTDNGRGIPVDIQEKMGRPAVEVILTVLHAGGKFGGGGYKVSGGLHGVGSSVVNALSQDLEVYVHRNETIYHQAYKKGVPQFDLKEVGTTDKTGTVIRFKADGEIFTETTVYNYETLQQRIRELAFLNKGIQITLRDERDEENVREDSYHYEGGIKSYVELLNENKEPIHDEPIYIHQSKDDIEVEIAIQYNSGYATNLLTYANNIHTYEGGTHEDGFKRALTRVLNSYGLSSKIMKEEKDRLSGEDTREGMTAIISIKHGDPQFEGQTKTKLGNSEVRQVVDKLFSEHFERFLYENPQVARTVVEKGIMAARARVAAKKAREVTRRKSALDVASLPGKLADCSSKSPEECEIFLVEGDSAGGSTKSGRDSRTQAILPLRGKILNVEKARLDRILNNNEIRQMITAFGTGIGGDFDLAKARYHKIVIMTDADVDGAHIRTLLLTFFYRFMRPLIEAGYVYIAQPPLYKLTQGKQKYYVYNDRELDKLKSELNPTPKWSIARYKGLGEMNADQLWETTMNPEHRALLQVKLEDAIEADQTFEMLMGDVVENRRQFIEDNAVYANLDF'),
('O15382', '5CR5', 1, 1.61, 'A/B', 365, 'TRANSFERASE', 'TRANSFERASE', 'Branched-chain-amino-acid aminotransferase, mitochondrial', 'BCAT2', 'L-leucine + 2-oxoglutarate = 4-methyl-2-oxopentanoate + L-glutamate.<br />\nL-isoleucine + 2-oxoglutarate = (S)-3-methyl-2-oxopentanoate + L-glutamate.<br />\nL-valine + 2-oxoglutarate = 3-methyl-2-oxobutanoate + L-glutamate.<br />\n', 'branched-chain-amino-acid transaminase activity<br />\nL-isoleucine transaminase activity<br />\nL-leucine transaminase activity<br />\nL-valine transaminase activity<br />\n', 'branched-chain amino acid biosynthetic process<br />\nbranched-chain amino acid catabolic process<br />\ncellular response to leukemia inhibitory factor<br />\nisoleucine catabolic process<br />\nleucine biosynthetic process<br />\nregulation of hormone levels<br />\nvaline biosynthetic process<br />\n', 'PF01063.', 'MAAAALGQIWARKLLSVPWLLCGPRRYASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKTFTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRPWLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSLGVSQPTRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLVQQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQSLLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTACQVCPVHRILYKDRNLHIPTMENGPELILRFQKELKEIQYGIRAHEWMFPV'),
('P06653', '5CTV', 1, 1.05, 'A', 180, 'HYDROLASE', 'HYDROLASE', 'Autolysin', 'lytA', 'Hydrolyzes the link between N-acetylmuramoyl residues and L-amino acid residues in certain cell-wall glycopeptides.<br />\n', 'N-acetylmuramoyl-L-alanine amidase activity<br />\n', 'cell wall organization<br />\nestablishment of competence for transformation<br />\npeptidoglycan catabolic process<br />\nsporulation resulting in formation of a cellular spore<br />\n', 'PF01510.', 'MEINVSKLRTDLPQVGVQPYRQVHAHSTGNPHSTVQNEADYHWRKDPELGFFSHIVGNGCIMQVGPVDNGAWDVGGGWNAETYAAVELIESHSTKEEFMTDYRLYIELLRNLADEAGLPKTLDTGSLAGIKTHEYCTNNQPNNHSDHVDPYPYLAKWGISREQFKHDIENGLTIETGWQKNDTGYWYVHSDGSYPKDKFEKINGTWYYFDSSGYMLADRWRKHTDGNWYWFDNSGEMATGWKKIADKWYYFNEEGAMKTGWVKYKDTWYYLDAKEGAMVSNAFIQSADGTGWYYLKPDGTLADKPEFTVEPDGLITVK'),
('P11229', '5CXV', 1, 2.7, 'A', 217, 'HYDROLASE', 'HYDROLASE', 'Muscarinic acetylcholine receptor M1', 'CHRM1', '', 'drug binding<br />\nG-protein coupled acetylcholine receptor activity<br />\nphosphatidylinositol phospholipase C activity<br />\n', 'adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway<br />\ncell proliferation<br />\ncellular protein modification process<br />\ncognition<br />\nG-protein coupled acetylcholine receptor signaling pathway<br />\nG-protein coupled receptor signaling pathway<br />\nnervous system development<br />\nneuromuscular synaptic transmission<br />\nphospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway<br />\npositive regulation of cell proliferation<br />\npositive regulation of intracellular protein transport<br />\npositive regulation of ion transport<br />\nprotein kinase C-activating G-protein coupled receptor signaling pathway<br />\nregulation of locomotion<br />\nregulation of vascular smooth muscle contraction<br />\nsaliva secretion<br />\nsignal transduction<br />\nsynaptic transmission, cholinergic<br />\n', 'PF00001.', 'MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISFKVNTELKTVNNYFLLSLACADLIIGTFSMNLYTTYLLMGHWALGTLACDLWLALDYVASNASVMNLLLISFDRYFSVTRPLSYRAKRTPRRAALMIGLAWLVSFVLWAPAILFWQYLVGERTVLAGQCYIQFLSQPIITFGTAMAAFYLPVTVMCTLYWRIYRETENRARELAALQGSETPGKGGGSSSSSERSQPGAEGSPETPPGRCCRCCRAPRLLQAYSWKEEEEEDEGSMESLTSSEGEEPGSEVVIKMPMVDPEAQAPTKQPPRSSPNTVKRPTKKGRDRAGKGQKPRGKEQLAKRKTFSLVKEKKAARTLSAILLAFILTWTPYNIMVLVSTFCKDCVPETLWELGYWLCYVNSTINPMCYALCNKAFRDTFRLLLLCRWDKRRWRKIPKRPGSVHRTPSRQC'),
('P50579', '5D6E', 1, 1.49, 'A', 371, 'HYDROLASE', 'HYDROLASE', 'Methionine aminopeptidase 2', 'METAP2', 'Release of N-terminal amino acids, preferentially methionine, from peptides and arylamides<br />\n', 'aminopeptidase activity<br />\nmetal ion binding<br />\nmetalloexopeptidase activity<br />\nRNA binding<br />\n', 'N-terminal protein amino acid modification<br />\npeptidyl-methionine modification<br />\nprotein processing<br />\nregulation of rhodopsin mediated signaling pathway<br />\n', 'PF00557.', 'MAGVEEVAASGSHLNGDLDPDDREEGAASTAEEAAKKKRRKKKKSKGPSAAGEQEPDKESGASVDEVARQLERSALEDKERDEDDEDGDGDGDGATGKKKKKKKKKRGPKVQTDPPSVPICDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVRKYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTTVLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDVGEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEVYAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWLDRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY'),
('Q13882', '5DA3', 1, 1.7, 'A', 262, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Protein-tyrosine kinase 6', 'PTK6', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nidentical protein binding<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\n', 'cell migration<br />\ncellular response to retinoic acid<br />\nERBB2 signaling pathway<br />\ninnate immune response<br />\nintestinal epithelial cell differentiation<br />\nnegative regulation of growth<br />\nnegative regulation of protein tyrosine kinase activity<br />\nnegative regulation of signal transduction<br />\npeptidyl-tyrosine autophosphorylation<br />\npositive regulation of cell cycle<br />\npositive regulation of epidermal growth factor receptor signaling pathway<br />\npositive regulation of neuron projection development<br />\npositive regulation of tyrosine phosphorylation of STAT protein<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of cell proliferation<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\ntyrosine phosphorylation of STAT protein<br />\n', 'PF07714.', 'MVSRDQAHLGPKYVGLWDFKSRTDEELSFRAGDVFHVARKEEQWWWATLLDEAGGAVAQGYVPHNYLAERETVESEPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRRAGGRLHLNEAVSFLSLPELVNYHRAQSLSHGLRLAAPCRKHEPEPLPHWDDWERPREEFTLCRKLGSGYFGEVFEGLWKDRVQVAIKVISRDNLLHQQMLQSEIQAMKKLRHKHILALYAVVSVGDPVYIITELMAKGSLLELLRDSDEKVLPVSELLDIAWQVAEGMCYLESQNYIHRDLAARNILVGENTLCKVGDFGLARLIKEDVYLSHDHNIPYKWTAPEALSRGHYSTKSDVWSFGILLHEMFSRGQVPYPGMSNHEAFLRVDAGYRMPCPLECPPSVHKLMLTCWCRDPEQRPCFKALRERLSSFTSYENPT'),
('P43133', '5DLH', 0, 2.25, 'A', 316, 'HYDROLASE', 'HYDROLASE', 'Thermolysin', 'nprS', 'Preferential cleavage: Xaa-|-Leu > Xaa-|-Phe.<br />\n', 'metal ion binding<br />\nmetalloendopeptidase activity<br />\n', '', 'PF07504.', 'MKRKMKMKLVRFGLAAGLAAQVFFLPYNALASTEHVTWNQQFQTPQFISGDLLKVNGTSPEELVYQYVEKNENKFKFHENAKDTLQLKEKKNDNLGFTFMRFQQTYKGIPVFGAVVTAHVKDGTLTALSGTLIPNLDTKGSLKSGKKLSEKQARDIAEKDLVANVTKEVPEYEQGKDTEFVVYVNGDEASLAYVVNLNFLTPEPGNWLYIIDAVDGKILNKFNQLDAAKPGDVKSITGTSTVGVGRGVLGDQKNINTTYSTYYYLQDNTRGNGIFTYDAKYRTTLPGSLWADADNQFFASYDAPAVDAHYYAGVTYDYYKNVHNRLSYDGNNAAIRSSVHYSQGYNNAFWNGSQMVYGDGDGQTFIPLSGGIDVVAHELTHAVTDYTAGLIYQNESGAINEAISDIFGTLVEFYANKNPDWEIGEDVYTPGISGDSLRSMSDPAKYGDPDHYSKRYTGTQDNGGVHINSGIINKAAYLISQGGTHYGVSVVGIGRDKLGKIFYRALTQYLTPTSNFSQLRAAAVQSATDLYGSTSQEVASVKQAFDAVGVK'),
('P08173', '5DSG', 1, 2.6, 'A/B', 205, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Muscarinic acetylcholine receptor M4', 'CHRM4', '', 'G-protein coupled acetylcholine receptor activity<br />\n', 'adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway<br />\ncell proliferation<br />\ncell surface receptor signaling pathway<br />\nG-protein coupled acetylcholine receptor signaling pathway<br />\nphospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway<br />\nregulation of locomotion<br />\nsignal transduction<br />\nsynaptic transmission, cholinergic<br />\n', 'PF00001.', 'MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGNILVMLSIKVNRQLQTVNNYFLFSLACADLIIGAFSMNLYTVYIIKGYWPLGAVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPARRTTKMAGLMIAAAWVLSFVLWAPAILFWQFVVGKRTVPDNQCFIQFLSNPAVTFGTAIAAFYLPVVIMTVLYIHISLASRSRVHKHRPEGPKEKKAKTLAFLKSPLMKQSVKKPPPGEAAREELRNGKLEEAPPPALPPPPRPVADKDTSNESSSGSATQNTKERPATELSTTEATTPAMPAPPLQPRALNPASRWSKIQIVTKQTGNECVTAIEIVPATPAGMRPAANVARKFASIARNQVRKKRQMAARERKVTRTIFAILLAFILTWTPYNVMVLVNTFCQSCIPDTVWSIGYWLCYVNSTINPACYALCNATFKKTFRHLLLCQYRNIGTAR'),
('O00329', '5DXU', 1, 2.64, 'A', 1043, 'Transferase / Inhibitor', 'TRANSFERASE', 'Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform', 'PIK3CD', 'ATP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate.<br />\n', '1-phosphatidylinositol-3-kinase activity<br />\n1-phosphatidylinositol-4-phosphate 3-kinase activity<br />\nATP binding<br />\nkinase activity<br />\nphosphatidylinositol 3-kinase activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\n', 'adaptive immune response<br />\naxon guidance<br />\nB cell activation<br />\nB cell chemotaxis<br />\nB cell receptor signaling pathway<br />\ncytokine production<br />\ninflammatory response<br />\ninnate immune response<br />\ninterleukin-7-mediated signaling pathway<br />\nmast cell chemotaxis<br />\nmast cell degranulation<br />\nmast cell differentiation<br />\nnatural killer cell activation<br />\nnatural killer cell chemotaxis<br />\nnatural killer cell differentiation<br />\nneutrophil chemotaxis<br />\nneutrophil extravasation<br />\nphosphatidylinositol 3-kinase signaling<br />\nphosphatidylinositol biosynthetic process<br />\nphosphatidylinositol-mediated signaling<br />\nphosphorylation<br />\nplatelet activation<br />\npositive regulation of cell migration<br />\npositive regulation of gene expression<br />\npositive regulation of neutrophil apoptotic process<br />\nprotein phosphorylation<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nrespiratory burst involved in defense response<br />\nsignal transduction<br />\nT cell activation<br />\nT cell chemotaxis<br />\nT cell differentiation<br />\nT cell receptor signaling pathway<br />\n', 'PF00454.', 'MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ'),
('P00915', '5E2M', 1, 1.41, 'A/B', 259, 'LYASE', 'LYASE', 'Carbonic anhydrase 1', 'CA1', 'H2CO3 = CO2 + H2O.<br />\n', 'arylesterase activity<br />\ncarbonate dehydratase activity<br />\nhydro-lyase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\ninterleukin-12-mediated signaling pathway<br />\none-carbon metabolic process<br />\n', 'PF00194.', 'MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF'),
('P05107', '5E6X', 0, 1.75, 'A', 513, 'CELL ADHESION', 'CELL_ADHESION', 'Integrin beta-2', 'ITGB2', '', 'cell adhesion molecule binding<br />\ncomplement component C3b binding<br />\nheat shock protein binding<br />\nICAM-3 receptor activity<br />\nmetal ion binding<br />\nprotein complex binding<br />\nprotein heterodimerization activity<br />\nprotein kinase binding<br />\n', 'aging<br />\namyloid-beta clearance<br />\napoptotic process<br />\ncell adhesion<br />\ncell-cell adhesion via plasma-membrane adhesion molecules<br />\ncell-cell signaling<br />\ncell-matrix adhesion<br />\ncellular extravasation<br />\ncellular response to low-density lipoprotein particle stimulus<br />\nendodermal cell differentiation<br />\nendothelial cell migration<br />\nextracellular matrix organization<br />\nheterotypic cell-cell adhesion<br />\ninflammatory response<br />\nintegrin-mediated signaling pathway<br />\nleukocyte cell-cell adhesion<br />\nleukocyte migration<br />\nleukocyte migration involved in inflammatory response<br />\nnatural killer cell activation<br />\nneutrophil chemotaxis<br />\nneutrophil degranulation<br />\nphagocytosis, engulfment<br />\npositive regulation of angiogenesis<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of nitric oxide biosynthetic process<br />\nreceptor clustering<br />\nreceptor internalization<br />\nregulation of cell shape<br />\nregulation of immune response<br />\nregulation of peptidyl-tyrosine phosphorylation<br />\ntoll-like receptor 4 signaling pathway<br />\n', 'PF08725.', 'MLGLRPPLLALVGLLSLGCVLSQECTKFKVSSCRECIESGPGCTWCQKLNFTGPGDPDSIRCDTRPQLLMRGCAADDIMDPTSLAETQEDHNGGQKQLSPQKVTLYLRPGQAAAFNVTFRRAKGYPIDLYYLMDLSYSMLDDLRNVKKLGGDLLRALNEITESGRIGFGSFVDKTVLPFVNTHPDKLRNPCPNKEKECQPPFAFRHVLKLTNNSNQFQTEVGKQLISGNLDAPEGGLDAMMQVAACPEEIGWRNVTRLLVFATDDGFHFAGDGKLGAILTPNDGRCHLEDNLYKRSNEFDYPSVGQLAHKLAENNIQPIFAVTSRMVKTYEKLTEIIPKSAVGELSEDSSNVVQLIKNAYNKLSSRVFLDHNALPDTLKVTYDSFCSNGVTHRNQPRGDCDGVQINVPITFQVKVTATECIQEQSFVIRALGFTDIVTVQVLPQCECRCRDQSRDRSLCHGKGFLECGICRCDTGYIGKNCECQTQGRSSQELEGSCRKDNNSIICSGLGDCVCGQCLCHTSDVPGKLIYGQYCECDTINCERYNGQVCGGPGRGLCFCGKCRCHPGFEGSACQCERTTEGCLNPRRVECSGRGRCRCNVCECHSGYQLPLCQECPGCPSPCGKYISCAECLKFEKGPFGKNCSAACPGLQLSNNPVKGRTCKERDSEGCWVAYTLEQQDGMDRYLIYVDESRECVAGPNIAAIVGGTVAGIVLIGILLLVIWKALIHLSDLREYRRFEKEKLKSQWNNDNPLFKSATTTVMNPKFAES'),
('Q9UGM6', '5EKD', 1, 1.82, 'A/B', 343, 'LIGASE / ANTIBIOTIC', 'LIGASE', 'Tryptophan--tRNA ligase, mitochondrial', 'WARS2', 'ATP + L-tryptophan + tRNA(Trp) = AMP + diphosphate + L-tryptophyl-tRNA(Trp).<br />\n', 'ATP binding<br />\ntryptophan-tRNA ligase activity<br />\n', 'tRNA aminoacylation for protein translation<br />\ntryptophanyl-tRNA aminoacylation<br />\nvasculogenesis<br />\n', 'PF00579.', 'MALHSMRKARERWSFIRALHKGSAAAPALQKDSKKRVFSGIQPTGILHLGNYLGAIESWVRLQDEYDSVLYSIVDLHSITVPQDPAVLRQSILDMTAVLLACGINPEKSILFQQSQVSEHTQLSWILSCMVRLPRLQHLHQWKAKTTKQKHDGTVGLLTYPVLQAADILLYKSTHVPVGEDQVQHMELVQDLAQGFNKKYGEFFPVPESILTSMKKVKSLRDPSAKMSKSDPDKLATVRITDSPEEIVQKFRKAVTDFTSEVTYDPAGRAGVSNIVAVHAAVTGLSVEEVVRRSAGMNTARYKLAVADAVIEKFAPIKREIEKLKLDKDHLEKVLQIGSAKAKELAYTVCQEVKKLVGFL'),
('P31224', '5ENQ', 1, 1.8, 'A/B/C', 291, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Multidrug efflux pump subunit AcrB', 'acrB', '', 'drug:proton antiporter activity<br />\ndrug transmembrane transporter activity<br />\nidentical protein binding<br />\n', 'drug transmembrane transport<br />\nresponse to drug<br />\n', 'PF00873.', 'MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH'),
('P11362', '5EW8', 1, 1.63, 'A/B', 308, 'TRANSFERASE', 'TRANSFERASE', 'Fibroblast growth factor receptor 1', 'FGFR1', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', '1-phosphatidylinositol-3-kinase activity<br />\nATP binding<br />\nfibroblast growth factor-activated receptor activity<br />\nfibroblast growth factor binding<br />\nheparin binding<br />\nidentical protein binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein homodimerization activity<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor-receptor interaction<br />\n', 'angiogenesis<br />\nauditory receptor cell development<br />\nbranching involved in salivary gland morphogenesis<br />\ncell maturation<br />\ncell migration<br />\nchondrocyte differentiation<br />\nchordate embryonic development<br />\nembryonic limb morphogenesis<br />\nfibroblast growth factor receptor signaling pathway<br />\nfibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development<br />\ninner ear morphogenesis<br />\ninterleukin-7-mediated signaling pathway<br />\nin utero embryonic development<br />\nlung-associated mesenchyme development<br />\nMAPK cascade<br />\nmesenchymal cell differentiation<br />\nmidbrain development<br />\nmiddle ear morphogenesis<br />\nnegative regulation of fibroblast growth factor production<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nneuron migration<br />\norgan induction<br />\nouter ear morphogenesis<br />\nparaxial mesoderm development<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of cardiac muscle cell proliferation<br />\npositive regulation of cell proliferation<br />\npositive regulation of endothelial cell chemotaxis to fibroblast growth factor<br />\npositive regulation of MAPK cascade<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway<br />\npositive regulation of mesenchymal cell proliferation<br />\npositive regulation of mitotic cell cycle DNA replication<br />\npositive regulation of neuron differentiation<br />\npositive regulation of neuron projection development<br />\npositive regulation of parathyroid hormone secretion<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of phospholipase activity<br />\npositive regulation of phospholipase C activity<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling<br />\nregulation of cell differentiation<br />\nregulation of extrinsic apoptotic signaling pathway in absence of ligand<br />\nregulation of lateral mesodermal cell fate specification<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nsensory perception of sound<br />\nskeletal system development<br />\nskeletal system morphogenesis<br />\ntranscription, DNA-templated<br />\nureteric bud development<br />\nvacuolar phosphate transport<br />\nventricular zone neuroblast division<br />\nvitamin D3 metabolic process<br />\n', 'PF07679.', 'MWSWKCLLFWAVLVTATLCTARPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDDVQSINWLRDGVQLAESNRTRITGEEVEVQDSVPADSGLYACVTSSPSGSDTTYFSVNVSDALPSSEDDDDDDDSSSEEKETDNTKPNRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMVGSVIVYKMKSGTKKSDFHSQMAVHKLAKSIPLRRQVTVSADSSASMNSGVLLVRPSRLSSSGTPMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMPLDQYSPSFPDTRSSTCSSGEDSVFSHEPLPEEPCLPRHPAQLANGGLKRR'),
('Q13224', '5EWM', 1, 2.76, 'B/D', 364, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, NMDA 2B', 'GRIN2B', '', 'extracellular-glutamate-gated ion channel activity<br />\nglutamate binding<br />\nglycine binding<br />\nNMDA glutamate receptor activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nzinc ion binding<br />\n', 'chemical synaptic transmission<br />\nephrin receptor signaling pathway<br />\nglutamate receptor signaling pathway<br />\nlearning or memory<br />\nMAPK cascade<br />\nprotein heterotetramerization<br />\nresponse to ethanol<br />\ntransport<br />\n', 'PF01094.', 'MKPRAECCSPKFWLVLAVLAVSGSRARSQKSPPSIGIAVILVGTSDEVAIKDAHEKDDFHHLSVVPRVELVAMNETDPKSIITRICDLMSDRKIQGVVFADDTDQEAIAQILDFISAQTLTPILGIHGGSSMIMADKDESSMFFQFGPSIEQQASVMLNIMEEYDWYIFSIVTTYFPGYQDFVNKIRSTIENSFVGWELEEVLLLDMSLDDGDSKIQNQLKKLQSPIILLYCTKEEATYIFEVANSVGLTGYGYTWIVPSLVAGDTDTVPAEFPTGLISVSYDEWDYGLPARVRDGIAIITTAASDMLSEHSFIPEPKSSCYNTHEKRIYQSNMLNRYLINVTFEGRNLSFSEDGYQMHPKLVIILLNKERKWERVGKWKDKSLQMKYYVWPRMCPETEEQEDDHLSIVTLEEAPFVIVESVDPLSGTCMRNTVPCQKRIVTENKTDEEPGYIKKCCKGFCIDILKKISKSVKFTYDLYLVTNGKHGKKINGTWNGMIGEVVMKRAYMAVGSLTINEERSEVVDFSVPFIETGISVMVSRSNGTVSPSAFLEPFSADVWVMMFVMLLIVSAVAVFVFEYFSPVGYNRCLADGREPGGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEYVDQVSGLSDKKFQRPNDFSPPFRFGTVPNGSTERNIRNNYAEMHAYMGKFNQRGVDDALLSLKTGKLDAFIYDAAVLNYMAGRDEGCKLVTIGSGKVFASTGYGIAIQKDSGWKRQVDLAILQLFGDGEMEELEALWLTGICHNEKNEVMSSQLDIDNMAGVFYMLGAAMALSLITFICEHLFYWQFRHCFMGVCSGKPGMVFSISRGIYSCIHGVAIEERQSVMNSPTATMNNTHSNILRLLRTAKNMANLSGVNGSPQSALDFIRRESSVYDISEHRRSFTHSDCKSYNNPPCEENLFSDYISEVERTFGNLQLKDSNVYQDHYHHHHRPHSIGSASSIDGLYDCDNPPFTTQSRSISKKPLDIGLPSSKHSQLSDLYGKFSFKSDRYSGHDDLIRSDVSDISTHTVTYGNIEGNAAKRRKQQYKDSLKKRPASAKSRREFDEIELAYRRRPPRSPDHKRYFRDKEGLRDFYLDQFRTKENSPHWEHVDLTDIYKERSDDFKRDSVSGGGPCTNRSHIKHGTGDKHGVVSGVPAPWEKNLTNVEWEDRSGGNFCRSCPSKLHNYSTTVTGQNSGRQACIRCEACKKAGNLYDISEDNSLQELDQPAAPVAVTSNASTTKYPQSPTNSKAQKKNRNKLRRQHSYDTFVDLQKEEAALAPRSVSLKDKGRFMDGSPYAHMFEMSAGESTFANNKSSVPTAGHHHHNNPGGGYMLSKSLYPDRVTQNPFIPTFGDDQCLLHGSKSYFFRQPTVAGASKARPDFRALVTNKPVVSALHGAVPARFQKDICIGNQSNPCVPNNKNPRAFNGSSNGHVYEKLSSIESDV'),
('P17948', '5EX3', 1, 2.41, 'D', 9, 'TRANSFERASE', 'TRANSFERASE', 'Vascular endothelial growth factor receptor 1', 'FLT1', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ngrowth factor binding<br />\nplacental growth factor-activated receptor activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\nvascular endothelial growth factor-activated receptor activity<br />\nVEGF-A-activated receptor activity<br />\nVEGF-B-activated receptor activity<br />\n', 'angiogenesis<br />\nblood vessel morphogenesis<br />\ncell differentiation<br />\ncell migration<br />\ncellular response to vascular endothelial growth factor stimulus<br />\nembryonic morphogenesis<br />\nmonocyte chemotaxis<br />\npeptidyl-tyrosine phosphorylation<br />\npositive regulation of angiogenesis<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of MAPK cascade<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of phospholipase C activity<br />\npositive regulation of vascular endothelial growth factor receptor signaling pathway<br />\nprotein autophosphorylation<br />\ntransmembrane receptor protein tyrosine kinase signaling pathway<br />\nvascular endothelial growth factor receptor-1 signaling pathway<br />\nvascular endothelial growth factor receptor signaling pathway<br />\n', 'PF07679.', 'MVSYWDTGVLLCALLSCLLLTGSSSGSKLKDPELSLKGTQHIMQAGQTLHLQCRGEAAHKWSLPEMVSKESERLSITKSACGRNGKQFCSTLTLNTAQANHTGFYSCKYLAVPTSKKKETESAIYIFISDTGRPFVEMYSEIPEIIHMTEGRELVIPCRVTSPNITVTLKKFPLDTLIPDGKRIIWDSRKGFIISNATYKEIGLLTCEATVNGHLYKTNYLTHRQTNTIIDVQISTPRPVKLLRGHTLVLNCTATTPLNTRVQMTWSYPDEKNKRASVRRRIDQSNSHANIFYSVLTIDKMQNKDKGLYTCRVRSGPSFKSVNTSVHIYDKAFITVKHRKQQVLETVAGKRSYRLSMKVKAFPSPEVVWLKDGLPATEKSARYLTRGYSLIIKDVTEEDAGNYTILLSIKQSNVFKNLTATLIVNVKPQIYEKAVSSFPDPALYPLGSRQILTCTAYGIPQPTIKWFWHPCNHNHSEARCDFCSNNEESFILDADSNMGNRIESITQRMAIIEGKNKMASTLVVADSRISGIYICIASNKVGTVGRNISFYITDVPNGFHVNLEKMPTEGEDLKLSCTVNKFLYRDVTWILLRTVNNRTMHYSISKQKMAITKEHSITLNLTIMNVSLQDSGTYACRARNVYTGEEILQKKEITIRDQEAPYLLRNLSDHTVAISSSTTLDCHANGVPEPQITWFKNNHKIQQEPGIILGPGSSTLFIERVTEEDEGVYHCKATNQKGSVESSAYLTVQGTSDKSNLELITLTCTCVAATLFWLLLTLFIRKMKRSSSEIKTDYLSIIMDPDEVPLDEQCERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDLLQANVQQDGKDYIPINAILTGNSGFTYSTPAFSEDFFKESISAPKFNSGSSDDVRYVNAFKFMSLERIKTFEELLPNATSMFDDYQGDSSTLLASPMLKRFTWTDSKPKASLKIDLRVTSKSKESGLSDVSRPSFCHSSCGHVSEGKRRFTYDHAELERKIACCSPPPDYNSVVLYSTPPI'),
('Q13131', '5EZV', 1, 2.99, 'A/C', 43, 'TRANSFERASE', 'TRANSFERASE', '5''-AMP-activated protein kinase catalytic subunit alpha-1', 'PRKAA1', 'ATP + a protein = ADP + a phosphoprotein<br />\nATP + [acetyl-CoA carboxylase] = ADP + [acetyl-CoA carboxylase] phosphate<br />\nATP + [hydroxymethylglutaryl-CoA reductase (NADPH)] = ADP + [hydroxymethylglutaryl-CoA reductase (NADPH)] phosphate<br />\nATP + [tau protein] = ADP + [tau protein] phosphate.<br />\n', '[acetyl-CoA carboxylase] kinase activity<br />\n[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity<br />\nAMP-activated protein kinase activity<br />\nATP binding<br />\ncAMP-dependent protein kinase activity<br />\nchromatin binding<br />\nhistone serine kinase activity<br />\nkinase binding<br />\nmetal ion binding<br />\nprotein C-terminus binding<br />\nprotein kinase activity<br />\ntau-protein kinase activity<br />\n', 'activation of MAPK activity<br />\nCAMKK-AMPK signaling cascade<br />\ncell cycle arrest<br />\ncellular response to ethanol<br />\ncellular response to glucose starvation<br />\ncellular response to hydrogen peroxide<br />\ncellular response to hypoxia<br />\ncellular response to nutrient levels<br />\ncellular response to organonitrogen compound<br />\ncellular response to prostaglandin E stimulus<br />\ncholesterol biosynthetic process<br />\ncold acclimation<br />\nfatty acid biosynthetic process<br />\nfatty acid homeostasis<br />\nfatty acid oxidation<br />\nglucose homeostasis<br />\nglucose metabolic process<br />\nlipid biosynthetic process<br />\nmacroautophagy<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of glucose import in response to insulin stimulus<br />\nnegative regulation of glucosylceramide biosynthetic process<br />\nnegative regulation of lipid catabolic process<br />\nnegative regulation of TOR signaling<br />\npositive regulation of autophagy<br />\npositive regulation of cell proliferation<br />\npositive regulation of cholesterol biosynthetic process<br />\npositive regulation of gene expression<br />\npositive regulation of glycolytic process<br />\npositive regulation of skeletal muscle tissue development<br />\nprotein heterooligomerization<br />\nprotein phosphorylation<br />\nregulation of circadian rhythm<br />\nregulation of energy homeostasis<br />\nregulation of macroautophagy<br />\nregulation of peptidyl-serine phosphorylation<br />\nregulation of signal transduction by p53 class mediator<br />\nregulation of transcription, DNA-templated<br />\nregulation of vesicle-mediated transport<br />\nresponse to activity<br />\nresponse to caffeine<br />\nresponse to camptothecin<br />\nresponse to gamma radiation<br />\nresponse to hypoxia<br />\nresponse to UV<br />\nrhythmic process<br />\nsignal transduction<br />\ntranscription, DNA-templated<br />\nWnt signaling pathway<br />\n', 'PF16579.', 'MRRLSSWRKMATAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTYSKMSLQLYQVDSRTYLLDFRSIDDEITEAKSGTATPQRSGSVSNYRSCQRSDSDAEAQGKSSEVSLTSSVTSLDSSPVDLTPRPGSHTIEFFEMCANLIKILAQ'),
('P11021', '5F0X', 1, 1.6, 'A/B', 382, 'CHAPERONE', 'OTHERS', '78 kDa glucose-regulated protein', 'HSPA5', '', 'ATPase activity<br />\nATP binding<br />\ncadherin binding<br />\ncalcium ion binding<br />\nchaperone binding<br />\nenzyme binding<br />\nmisfolded protein binding<br />\nprotein domain specific binding<br />\nribosome binding<br />\nubiquitin protein ligase binding<br />\nunfolded protein binding<br />\n', 'activation of signaling protein activity involved in unfolded protein response<br />\nATF6-mediated unfolded protein response<br />\ncellular response to antibiotic<br />\ncellular response to calcium ion<br />\ncellular response to cAMP<br />\ncellular response to drug<br />\ncellular response to glucose starvation<br />\ncellular response to interleukin-4<br />\ncellular response to manganese ion<br />\ncellular response to nerve growth factor stimulus<br />\ncerebellar Purkinje cell layer development<br />\ncerebellum structural organization<br />\nendoplasmic reticulum unfolded protein response<br />\nER overload response<br />\nIRE1-mediated unfolded protein response<br />\nmaintenance of protein localization in endoplasmic reticulum<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of protein homodimerization activity<br />\nnegative regulation of transforming growth factor beta receptor signaling pathway<br />\nneuron apoptotic process<br />\nneuron differentiation<br />\nPERK-mediated unfolded protein response<br />\npositive regulation of cell migration<br />\npositive regulation of neuron projection development<br />\npositive regulation of protein ubiquitination<br />\npositive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress<br />\nprotein folding in endoplasmic reticulum<br />\nregulation of ATF6-mediated unfolded protein response<br />\nregulation of IRE1-mediated unfolded protein response<br />\nregulation of PERK-mediated unfolded protein response<br />\nregulation of protein folding in endoplasmic reticulum<br />\nresponse to cocaine<br />\nresponse to methamphetamine hydrochloride<br />\nresponse to radiation<br />\nstress response to metal ion<br />\nsubstantia nigra development<br />\ntoxin transport<br />\nubiquitin-dependent ERAD pathway<br />\n', 'PF00012.', 'MKLSLVAAMLLLLSAARAEEEDKKEDVGTVVGIDLGTTYSCVGVFKNGRVEIIANDQGNRITPSYVAFTPEGERLIGDAAKNQLTSNPENTVFDAKRLIGRTWNDPSVQQDIKFLPFKVVEKKTKPYIQVDIGGGQTKTFAPEEISAMVLTKMKETAEAYLGKKVTHAVVTVPAYFNDAQRQATKDAGTIAGLNVMRIINEPTAAAIAYGLDKREGEKNILVFDLGGGTFDVSLLTIDNGVFEVVATNGDTHLGGEDFDQRVMEHFIKLYKKKTGKDVRKDNRAVQKLRREVEKAKRALSSQHQARIEIESFYEGEDFSETLTRAKFEELNMDLFRSTMKPVQKVLEDSDLKKSDIDEIVLVGGSTRIPKIQQLVKEFFNGKEPSRGINPDEAVAYGAAVQAGVLSGDQDTGDLVLLDVCPLTLGIETVGGVMTKLIPRNTVVPTKKSQIFSTASDNQPTVTIKVYEGERPLTKDNHLLGTFDLTGIPPAPRGVPQIEVTFEIDVNGILRVTAEDKGTGNKNKITITNDQNRLTPEEIERMVNDAEKFAEEDKKLKERIDTRNELESYAYSLKNQIGDKEKLGGKLSSEDKETMEKAVEEKIEWLESHQDADIEDFKAKKKELEEIVQPIISKLYGSAGPPPTGEEDTAEKDEL'),
('P35354', '5F19', 1, 2.04, 'A/B', 551, 'OXIDOREDUCTASE / INHIBITOR', 'OXIDOREDUCTASE', 'Prostaglandin G/H synthase 2', 'PTGS2', 'Arachidonate + AH2 + 2 O2 = prostaglandin H2 + A + H2O<br />\n', 'arachidonate 15-lipoxygenase activity<br />\nenzyme binding<br />\nheme binding<br />\nmetal ion binding<br />\nperoxidase activity<br />\nprostaglandin-endoperoxide synthase activity<br />\nprotein homodimerization activity<br />\n', 'aging<br />\nangiogenesis<br />\nbone mineralization<br />\nbrown fat cell differentiation<br />\ncellular response to ATP<br />\ncellular response to fluid shear stress<br />\ncellular response to heat<br />\ncellular response to hypoxia<br />\ncellular response to lead ion<br />\ncellular response to mechanical stimulus<br />\ncellular response to non-ionic osmotic stress<br />\ncellular response to UV<br />\ncyclooxygenase pathway<br />\ndecidualization<br />\nembryo implantation<br />\nhair cycle<br />\ninflammatory response<br />\nlearning<br />\nlipoxygenase pathway<br />\nmaintenance of permeability of blood-brain barrier<br />\nmemory<br />\nmovement of cell or subcellular component<br />\nNAD biosynthesis via nicotinamide riboside salvage pathway<br />\nnegative regulation of calcium ion transport<br />\nnegative regulation of cell cycle<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress<br />\nnegative regulation of smooth muscle contraction<br />\nnegative regulation of synaptic transmission, dopaminergic<br />\novulation<br />\npositive regulation of apoptotic process<br />\npositive regulation of brown fat cell differentiation<br />\npositive regulation of cell migration involved in sprouting angiogenesis<br />\npositive regulation of fever generation<br />\npositive regulation of fibroblast growth factor production<br />\npositive regulation of NF-kappaB import into nucleus<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of platelet-derived growth factor production<br />\npositive regulation of prostaglandin biosynthetic process<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of smooth muscle contraction<br />\npositive regulation of synaptic plasticity<br />\npositive regulation of synaptic transmission, glutamatergic<br />\npositive regulation of transforming growth factor beta production<br />\npositive regulation of vascular endothelial growth factor production<br />\npositive regulation of vasoconstriction<br />\nprostaglandin biosynthetic process<br />\nprostaglandin metabolic process<br />\nregulation of blood pressure<br />\nregulation of inflammatory response<br />\nresponse to angiotensin<br />\nresponse to drug<br />\nresponse to estradiol<br />\nresponse to fatty acid<br />\nresponse to fructose<br />\nresponse to glucocorticoid<br />\nresponse to lipopolysaccharide<br />\nresponse to lithium ion<br />\nresponse to manganese ion<br />\nresponse to oxidative stress<br />\nresponse to tumor necrosis factor<br />\nresponse to vitamin D<br />\nsensory perception of pain<br />\n', 'PF03098.', 'MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFYGENCSTPEFLTRIKLFLKPTPNTVHYILTHFKGFWNVVNNIPFLRNAIMSYVLTSRSHLIDSPPTYNADYGYKSWEAFSNLSYYTRALPPVPDDCPTPLGVKGKKQLPDSNEIVEKLLLRRKFIPDPQGSNMMFAFFAQHFTHQFFKTDHKRGPAFTNGLGHGVDLNHIYGETLARQRKLRLFKDGKMKYQIIDGEMYPPTVKDTQAEMIYPPQVPEHLRFAVGQEVFGLVPGLMMYATIWLREHNRVCDVLKQEHPEWGDEQLFQTSRLILIGETIKIVIEDYVQHLSGYHFKLKFDPELLFNKQFQYQNRIAAEFNTLYHWHPLLPDTFQIHDQKYNYQQFIYNNSILLEHGITQFVESFTRQIAGRVAGGRNVPPAVQKVSQASIDQSRQMKYQSFNEYRKRFMLKPYESFEELTGEKEMSAELEALYGDIDAVELYPALLVEKPRPDAIFGETMVEVGAPFSLKGLMGNVICSPAYWKPSTFGGEVGFQIINTASIQSLICNNVKGCPFTSFSVPDPELIKTVTINASSSRSGLDDINPTVLLKERSTEL'),
('P41180', '5FBK', 1, 2.1, 'A/B', 522, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Extracellular calcium-sensing receptor', 'CASR', '', 'amino acid binding<br />\ncalcium ion binding<br />\ndrug binding<br />\nG-protein coupled receptor activity<br />\nintegrin binding<br />\nion channel binding<br />\nmagnesium ion binding<br />\nphosphatidylinositol phospholipase C activity<br />\npolyamine binding<br />\nprotein homodimerization activity<br />\nprotein kinase binding<br />\n', 'adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway<br />\nanatomical structure morphogenesis<br />\napoptotic process<br />\nbranching morphogenesis of an epithelial tube<br />\ncalcium ion import<br />\ncellular calcium ion homeostasis<br />\ncellular response to glucose stimulus<br />\ncellular response to hepatocyte growth factor stimulus<br />\ncellular response to hypoxia<br />\ncellular response to low-density lipoprotein particle stimulus<br />\ncellular response to peptide<br />\ncellular response to vitamin D<br />\nchemosensory behavior<br />\ndetection of calcium ion<br />\nfat pad development<br />\nG-protein coupled receptor signaling pathway<br />\nJNK cascade<br />\nossification<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\npositive regulation of ATPase activity<br />\npositive regulation of calcium ion import<br />\npositive regulation of cell proliferation<br />\npositive regulation of gene expression<br />\npositive regulation of insulin secretion<br />\npositive regulation of positive chemotaxis<br />\npositive regulation of vasoconstriction<br />\nresponse to fibroblast growth factor<br />\nresponse to ischemia<br />\nvasodilation<br />\n', 'PF00003.', 'MAFYSCCWVLLALTWHTSAYGPDQRAQKKGDIILGGLFPIHFGVAAKDQDLKSRPESVECIRYNFRGFRWLQAMIFAIEEINSSPALLPNLTLGYRIFDTCNTVSKALEATLSFVAQNKIDSLNLDEFCNCSEHIPSTIAVVGATGSGVSTAVANLLGLFYIPQVSYASSSRLLSNKNQFKSFLRTIPNDEHQATAMADIIEYFRWNWVGTIAADDDYGRPGIEKFREEAEERDICIDFSELISQYSDEEEIQHVVEVIQNSTAKVIVVFSSGPDLEPLIKEIVRRNITGKIWLASEAWASSSLIAMPQYFHVVGGTIGFALKAGQIPGFREFLKKVHPRKSVHNGFAKEFWEETFNCHLQEGAKGPLPVDTFLRGHEESGDRFSNSSTAFRPLCTGDENISSVETPYIDYTHLRISYNVYLAVYSIAHALQDIYTCLPGRGLFTNGSCADIKKVEAWQVLKHLRHLNFTNNMGEQVTFDECGDLVGNYSIINWHLSPEDGSIVFKEVGYYNVYAKKGERLFINEEKILWSGFSREVPFSNCSRDCLAGTRKGIIEGEPTCCFECVECPDGEYSDETDASACNKCPDDFWSNENHTSCIAKEIEFLSWTEPFGIALTLFAVLGIFLTAFVLGVFIKFRNTPIVKATNRELSYLLLFSLLCCFSSSLFFIGEPQDWTCRLRQPAFGISFVLCISCILVKTNRVLLVFEAKIPTSFHRKWWGLNLQFLLVFLCTFMQIVICVIWLYTAPPSSYRNQELEDEIIFITCHEGSLMALGFLIGYTCLLAAICFFFAFKSRKLPENFNEAKFITFSMLIFFIVWISFIPAYASTYGKFVSAVEVIAILAASFGLLACIFFNKIYIILFKPSRNTIEEVRCSTAAHAFKVAARATLRRSNVSRKRSSSLGGSTGSTPSSSISSKSNSEDPFPQPERQKQQQPLALTQQEQQQQPLTLPQQQRSQQQPRCKQKVIFGSGTVTFSLSFDEPQKNAMAHRNSTHQNSLEAQKSSDTLTRHEPLLPLQCGETDLDLTVQETGLQGPVGGDQRPEVEDPEELSPALVVSSSQSFVISGGGSTVTENVVNS');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('O60939', '5FEB', 0, 1.35, 'A', 122, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Sodium channel subunit beta-2', 'SCN2B', '', 'sodium channel regulator activity<br />\nvoltage-gated sodium channel activity involved in cardiac muscle cell action potential<br />\n', 'cardiac muscle cell action potential involved in contraction<br />\ncardiac muscle contraction<br />\nchemical synaptic transmission<br />\nmembrane depolarization during cardiac muscle cell action potential<br />\nnervous system development<br />\nregulation of atrial cardiac muscle cell membrane depolarization<br />\nregulation of heart rate by cardiac conduction<br />\nregulation of sodium ion transmembrane transporter activity<br />\nresponse to pyrethroid<br />\nsodium ion transmembrane transport<br />\n', 'PF07686.', 'MHRDAWLPRPAFSLTGLSLFFSLVPPGRSMEVTVPATLNVLNGSDARLPCTFNSCYTVNHKQFSLNWTYQECNNCSEEMFLQFRMKIINLKLERFQDRVEFSGNPSKYDVSVMLRNVQPEDEGIYNCYIMNPPDRHRGHGKIHLQVLMEEPPERDSTVAVIVGASVGGFLAVVILVLMVVKCVRRKKEQKLSTDDLKTEEEGKTDGEGNPDDGAK'),
('P47895', '5FHZ', 1, 2.9, 'A/B/C/D/E/F/G/H', 512, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Aldehyde dehydrogenase family 1 member A3', 'ALDH1A3', 'An aldehyde + NAD(P)+ + H2O = a carboxylate + NAD(P)H<br />\n', 'aldehyde dehydrogenase (NAD) activity<br />\naldehyde dehydrogenase [NAD(P)+] activity<br />\nNAD+ binding<br />\nprotein homodimerization activity<br />\nretinal dehydrogenase activity<br />\nthyroid hormone binding<br />\n', 'embryonic camera-type eye development<br />\nembryonic eye morphogenesis<br />\nface development<br />\nHarderian gland development<br />\ninner ear morphogenesis<br />\nlocomotory behavior<br />\nneuromuscular process controlling balance<br />\nnucleus accumbens development<br />\nolfactory pit development<br />\noptic cup morphogenesis involved in camera-type eye development<br />\npositive regulation of apoptotic process<br />\nprotein homotetramerization<br />\nretinal metabolic process<br />\nretinoic acid biosynthetic process<br />\nretinoic acid metabolic process<br />\nretinol metabolic process<br />\nrighting reflex<br />\n', 'PF00171.', 'MATANGAVENGQPDRKPPALPRPIRNLEVKFTKIFINNEWHESKSGKKFATCNPSTREQICEVEEGDKPDVDKAVEAAQVAFQRGSPWRRLDALSRGRLLHQLADLVERDRATLAALETMDTGKPFLHAFFIDLEGCIRTLRYFAGWADKIQGKTIPTDDNVVCFTRHEPIGVCGAITPWNFPLLMLVWKLAPALCCGNTMVLKPAEQTPLTALYLGSLIKEAGFPPGVVNIVPGFGPTVGAAISSHPQINKIAFTGSTEVGKLVKEAASRSNLKRVTLELGGKNPCIVCADADLDLAVECAHQGVFFNQGQCCTAASRVFVEEQVYSEFVRRSVEYAKKRPVGDPFDVKTEQGPQIDQKQFDKILELIESGKKEGAKLECGGSAMEDKGLFIKPTVFSEVTDNMRIAKEEIFGPVQPILKFKSIEEVIKRANSTDYGLTAAVFTKNLDKALKLASALESGTVWINCYNALYAQAPFGGFKMSGNGRELGEYALAEYTEVKTVTIKLGDKNP'),
('Q89ZI2', '5FKY', 1, 1.8, 'A/B', 716, 'HYDROLASE', 'HYDROLASE', 'O-GlcNAcase BT_4395', 'BT_4395', '[Protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-serine + H2O = [protein]-L-serine + N-acetyl-D-glucosamine<br />\n[Protein]-3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonine + H2O = [protein]-L-threonine + N-acetyl-D-glucosamine<br />\nHydrolysis of terminal non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides<br />\n', '[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity<br />\n[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity<br />\n[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity<br />\nbeta-N-acetylglucosaminidase activity<br />\nidentical protein binding<br />\nN-acetyl-beta-D-galactosaminidase activity<br />\n', 'carbohydrate metabolic process<br />\nprotein deglycosylation<br />\n', 'PF02838.', 'MKNNKIYLLGACLLCAVTTFAQNVSLQPPPQQLIVQNKTIDLPAVYQLNGGEEANPHAVKVLKELLSGKQSSKKGMLISIGEKGDKSVRKYSRQIPDHKEGYYLSVNEKEIVLAGNDERGTYYALQTFAQLLKDGKLPEVEIKDYPSVRYRGVVEGFYGTPWSHQARLSQLKFYGKNKMNTYIYGPKDDPYHSAPNWRLPYPDKEAAQLQELVAVANENEVDFVWAIHPGQDIKWNKEDRDLLLAKFEKMYQLGVRSFAVFFDDISGEGTNPQKQAELLNYIDEKFAQVKPDINQLVMCPTEYNKSWSNPNGNYLTTLGDKLNPSIQIMWTGDRVISDITRDGISWINERIKRPAYIWWNFPVSDYVRDHLLLGPVYGNDTTIAKEMSGFVTNPMEHAESSKIAIYSVASYAWNPAKYDTWQTWKDAIRTILPSAAEELECFAMHNSDLGPNGHGYRREESMDIQPAAERFLKAFKEGKNYDKADFETLQYTFERMKESADILLMNTENKPLIVEITPWVHQFKLTAEMGEEVLKMVEGRNESYFLRKYNHVKALQQQMFYIDQTSNQNPYQPGVKTATRVIKPLIDRTFATVVKFFNQKFNAHLDATTDYMPHKMISNVEQIKNLPLQVKANRVLISPANEVVKWAAGNSVEIELDAIYPGENIQINFGKDAPCTWGRLEISTDGKEWKTVDLKQKESRLSAGLQKAPVKFVRFTNVSDEEQQVYLRQFVLTIEKK'),
('Q16790', '5FL4', 1, 1.82, 'A/B/C/D', 255, 'LYASE', 'LYASE', 'Carbonic anhydrase 9', 'CA9', 'H2CO3 = CO2 + H2O.<br />\n', 'carbonate dehydratase activity<br />\nzinc ion binding<br />\n', 'bicarbonate transport<br />\nmorphogenesis of an epithelium<br />\none-carbon metabolic process<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nresponse to drug<br />\nresponse to testosterone<br />\nsecretion<br />\n', 'PF00194.', 'MAPLCPSPWLPLLIPAPAPGLTVQLLLSLLLLVPVHPQRLPRMQEDSPLGGGSSGEDDPLGEEDLPSEEDSPREEDPPGEEDLPGEEDLPGEEDLPEVKPKSEEEGSLKLEDLPTVEAPGDPQEPQNNAHRDKEGDDQSHWRYGGDPPWPRVSPACAGRFQSPVDIRPQLAAFCPALRPLELLGFQLPPLPELRLRNNGHSVQLTLPPGLEMALGPGREYRALQLHLHWGAAGRPGSEHTVEGHRFPAEIHVVHLSTAFARVDEALGRPGGLAVLAAFLEEGPEENSAYEQLLSRLEEIAEEGSETQVPGLDISALLPSDFSRYFQYEGSLTTPPCAQGVIWTVFNQTVMLSAKQLHTLSDTLWGPGDSRLQLNFRATQPLNGRVIEASFPAGVDSSPRAAEPVQLNSCLAAGDILALVFGLLFAVTSVAFLVQMRRQHRRGTKGGVSYRPAEVAETGA'),
('Q96SW2', '5FQD', 1, 2.45, 'B/E', 402, 'LIGASE', 'LIGASE', 'Protein cereblon', 'CRBN', '', 'metal ion binding<br />\n', 'negative regulation of ion transmembrane transport<br />\nnegative regulation of protein homooligomerization<br />\npositive regulation of protein homodimerization activity<br />\nproteasome-mediated ubiquitin-dependent protein catabolic process<br />\nprotein ubiquitination<br />\n', 'PF02190.', 'MAGEGDQQDAAHNMGNHLPLLPAESEEEDEMEVEDQDSKEAKKPNIINFDTSLPTSHTYLGADMEEFHGRTLHDDDSCQVIPVLPQVMMILIPGQTLPLQLFHPQEVSMVRNLIQKDRTFAVLAYSNVQEREAQFGTTAEIYAYREEQDFGIEIVKVKAIGRQRFKVLELRTQSDGIQQAKVQILPECVLPSTMSAVQLESLNKCQIFPSKPVSREDQCSYKWWQKYQKRKFHCANLTSWPRWLYSLYDAETLMDRIKKQLREWDENLKDDSLPSNPIDFSYRVAACLPIDDVLRIQLLKIGSAIQRLRCELDIMNKCTSLCCKQCQETEITTKNEIFSLSLCGPMAAYVNPHGYVHETLTVYKACNLNLIGRPSTEHSWFPGYAWTVAQCKICASHIGWKFTATKKDMSPQKFWGLTRSALLPTIPDTEDEISPDKVILCL'),
('O95831', '5FS8', 1, 1.4, 'A', 511, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Apoptosis-inducing factor 1, mitochondrial', 'AIFM1', '', 'DNA binding<br />\nFAD binding<br />\nNAD(P)H oxidase activity<br />\noxidoreductase activity, acting on NAD(P)H<br />\nprotein dimerization activity<br />\n', 'activation of cysteine-type endopeptidase activity involved in apoptotic process<br />\napoptotic process<br />\ncellular response to aldosterone<br />\ncellular response to estradiol stimulus<br />\ncellular response to hydrogen peroxide<br />\ncellular response to nitric oxide<br />\ncellular response to oxygen-glucose deprivation<br />\nchromosome condensation<br />\nintrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress<br />\nmitochondrial respiratory chain complex I assembly<br />\nneuron apoptotic process<br />\nneuron differentiation<br />\npositive regulation of apoptotic process<br />\npositive regulation of neuron apoptotic process<br />\nregulation of apoptotic DNA fragmentation<br />\nresponse to ischemia<br />\nresponse to L-glutamate<br />\nresponse to toxic substance<br />\n', 'PF14721.', 'MFRCGGLAAGALKQKLVPLVRTVCVRSPRQRNRLPGNLFQRWHVPLELQMTRQMASSGASGGKIDNSVLVLIVGLSTVGAGAYAYKTMKEDEKRYNERISGLGLTPEQKQKKAALSASEGEEVPQDKAPSHVPFLLIGGGTAAFAAARSIRARDPGARVLIVSEDPELPYMRPPLSKELWFSDDPNVTKTLRFKQWNGKERSIYFQPPSFYVSAQDLPHIENGGVAVLTGKKVVQLDVRDNMVKLNDGSQITYEKCLIATGGTPRSLSAIDRAGAEVKSRTTLFRKIGDFRSLEKISREVKSITIIGGGFLGSELACALGRKARALGTEVIQLFPEKGNMGKILPEYLSNWTMEKVRREGVKVMPNAIVQSVGVSSGKLLIKLKDGRKVETDHIVAAVGLEPNVELAKTGGLEIDSDFGGFRVNAELQARSNIWVAGDAACFYDIKLGRRRVEHHDHAVVSGRLAGENMTGAAKPYWHQSMFWSDLGPDVGYEAIGLVDSSLPTVGVFAKATAQDNPKSATEQSGTGIRSESETESEASEITIPPSTPAVPQAPVQGEDYGKGVIFYLRDKVVVGIVLWNIFNRMPIARKIIKDGEQHEDLNEVAKLFNIHED'),
('P14555', '5G3N', 1, 1.8, 'A/B', 124, 'HYDROLASE', 'HYDROLASE', 'Phospholipase A2, membrane associated', 'PLA2G2A', 'Phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate<br />\n', 'calcium-dependent phospholipase A2 activity<br />\ncalcium ion binding<br />\nphospholipase A2 activity<br />\nphospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)<br />\nphospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)<br />\nphospholipid binding<br />\n', 'antimicrobial humoral response<br />\narachidonic acid secretion<br />\ndefense response to Gram-positive bacterium<br />\nlipid catabolic process<br />\nlow-density lipoprotein particle remodeling<br />\nphosphatidic acid biosynthetic process<br />\nphosphatidic acid metabolic process<br />\nphosphatidylcholine acyl-chain remodeling<br />\nphosphatidylethanolamine acyl-chain remodeling<br />\nphosphatidylglycerol acyl-chain remodeling<br />\nphosphatidylinositol acyl-chain remodeling<br />\nphosphatidylserine acyl-chain remodeling<br />\nphospholipid metabolic process<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of inflammatory response<br />\npositive regulation of macrophage derived foam cell differentiation<br />\n', 'PF00068.', 'MKTLLLLAVIMIFGLLQAHGNLVNFHRMIKLTTGKEAALSYGFYGCHCGVGGRGSPKDATDRCCVTHDCCYKRLEKRGCGTKFLSYKFSNSGSRITCAKQDSCRSQLCECDKAAATCFARNKTTYNKKYQYYSNKHCRGSTPRC'),
('P24530', '5GLI', 0, 2.5, 'A', 238, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Endothelin receptor type B', 'EDNRB', '', 'endothelin receptor activity<br />\npeptide hormone binding<br />\ntype 1 angiotensin receptor binding<br />\n', 'aging<br />\ncalcium-mediated signaling<br />\ncell surface receptor signaling pathway<br />\ncellular response to lipopolysaccharide<br />\ncGMP-mediated signaling<br />\nendothelin receptor signaling pathway<br />\nenteric nervous system development<br />\nenteric smooth muscle cell differentiation<br />\nepithelial fluid transport<br />\nmacrophage chemotaxis<br />\nmelanocyte differentiation<br />\nnegative regulation of adenylate cyclase activity<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cellular protein metabolic process<br />\nnegative regulation of neuron maturation<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnervous system development<br />\nneural crest cell migration<br />\nperipheral nervous system development<br />\nphospholipase C-activating G-protein coupled receptor signaling pathway<br />\npositive regulation of cell proliferation<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of penile erection<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of renal sodium excretion<br />\npositive regulation of urine volume<br />\nposterior midgut development<br />\nregulation of blood pressure<br />\nregulation of epithelial cell proliferation<br />\nregulation of fever generation<br />\nregulation of pH<br />\nregulation of sensory perception of pain<br />\nresponse to organic cyclic compound<br />\nresponse to pain<br />\nsensory perception of pain<br />\nvasoconstriction<br />\nvasodilation<br />\nvein smooth muscle contraction<br />\n', 'PF00001.', 'MQPPPSLCGRALVALVLACGLSRIWGEERGFPPDRATPLLQTAEIMTPPTKTLWPKGSNASLARSLAPAEVPKGDRTAGSPPRTISPPPCQGPIEIKETFKYINTVVSCLVFVLGIIGNSTLLRIIYKNKCMRNGPNILIASLALGDLLHIVIDIPINVYKLLAEDWPFGAEMCKLVPFIQKASVGITVLSLCALSIDRYRAVASWSRIKGIGVPKWTAVEIVLIWVVSVVLAVPEAIGFDIITMDYKGSYLRICLLHPVQKTAFMQFYKTAKDWWLFSFYFCLPLAITAFFYTLMTCEMLRKKSGMQIALNDHLKQRREVAKTVFCLVLVFALCWLPLHLSRILKLTLYNQNDPNRCELLSFLLVLDYIGINMASLNSCINPIALYLVSKRFKNCFKSCLCCWCQSFEEKQSLEEKQSCLKFKANDHGYDNFRSSNKYSSS'),
('P36969', '5H5Q', 0, 1.1, 'A', 169, 'OXIDOREDUCTASE / OXIDOREDUCTASE INHIBITOR', 'OXIDOREDUCTASE', 'Phospholipid hydroperoxide glutathione peroxidase, mitochondrial', 'GPX4', '2 glutathione + a hydroperoxy-fatty-acyl-[lipid] = glutathione disulfide + a hydroxy-fatty-acyl-[lipid] + H2O<br />\n', 'glutathione peroxidase activity<br />\nidentical protein binding<br />\nphospholipid-hydroperoxide glutathione peroxidase activity<br />\n', 'lipoxygenase pathway<br />\nmulticellular organism development<br />\noxidation-reduction process<br />\nphospholipid metabolic process<br />\nprotein polymerization<br />\nresponse to oxidative stress<br />\n', 'PF00255.', 'MSLGRLCRLLKPALLCGALAAPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVNLDKYRGFVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSNEEIKEFAAGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRYGPMEEPLVIEKDLPHYF'),
('Q05586', '5H8Q', 1, 1.9, 'B', 151, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, NMDA 1', 'GRIN1', '', 'calcium channel activity<br />\ncalcium ion binding<br />\ncalmodulin binding<br />\nextracellular-glutamate-gated ion channel activity<br />\nglutamate binding<br />\nglycine binding<br />\nneurotransmitter binding<br />\nNMDA glutamate receptor activity<br />\nprotein complex binding<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor binding<br />\ntransmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential<br />\n', 'adult locomotory behavior<br />\ncalcium ion homeostasis<br />\ncation transport<br />\ncerebral cortex development<br />\nconditioned taste aversion<br />\nephrin receptor signaling pathway<br />\nexcitatory postsynaptic potential<br />\nionotropic glutamate receptor signaling pathway<br />\nlong-term memory<br />\nmale mating behavior<br />\nMAPK cascade<br />\nnegative regulation of neuron apoptotic process<br />\nolfactory learning<br />\npons maturation<br />\npositive regulation of apoptotic process<br />\npositive regulation of calcium ion transport into cytosol<br />\npositive regulation of excitatory postsynaptic potential<br />\npositive regulation of reactive oxygen species biosynthetic process<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprepulse inhibition<br />\npropylene metabolic process<br />\nprotein heterotetramerization<br />\nregulation of axonogenesis<br />\nregulation of dendrite morphogenesis<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of membrane potential<br />\nregulation of respiratory gaseous exchange<br />\nregulation of synapse assembly<br />\nrespiratory gaseous exchange<br />\nresponse to amphetamine<br />\nresponse to ethanol<br />\nresponse to morphine<br />\nsensory perception of pain<br />\nsocial behavior<br />\nsuckling behavior<br />\nsynaptic transmission, glutamatergic<br />\nvisual learning<br />\n', 'PF01094.', 'MSTMRLLTLALLFSCSVARAACDPKIVNIGAVLSTRKHEQMFREAVNQANKRHGSWKIQLNATSVTHKPNAIQMALSVCEDLISSQVYAILVSHPPTPNDHFTPTPVSYTAGFYRIPVLGLTTRMSIYSDKSIHLSFLRTVPPYSHQSSVWFEMMRVYSWNHIILLVSDDHEGRAAQKRLETLLEERESKAEKVLQFDPGTKNVTALLMEAKELEARVIILSASEDDAATVYRAAAMLNMTGSGYVWLVGEREISGNALRYAPDGILGLQLINGKNESAHISDAVGVVAQAVHELLEKENITDPPRGCVGNTNIWKTGPLFKRVLMSSKYADGVTGRVEFNEDGDRKFANYSIMNLQNRKLVQVGIYNGTHVIPNDRKIIWPGGETEKPRGYQMSTRLKIVTIHQEPFVYVKPTLSDGTCKEEFTVNGDPVKKVICTGPNDTSPGSPRHTVPQCCYGFCIDLLIKLARTMNFTYEVHLVADGKFGTQERVNNSNKKEWNGMMGELLSGQADMIVAPLTINNERAQYIEFSKPFKYQGLTILVKKEIPRSTLDSFMQPFQSTLWLLVGLSVHVVAVMLYLLDRFSPFGRFKVNSEEEEEDALTLSSAMWFSWGVLLNSGIGEGAPRSFSARILGMVWAGFAMIIVASYTANLAAFLVLDRPEERITGINDPRLRNPSDKFIYATVKQSSVDIYFRRQVELSTMYRHMEKHNYESAAEAIQAVRDNKLHAFIWDSAVLEFEASQKCDLVTTGELFFRSGFGIGMRKDSPWKQNVSLSILKSHENGFMEDLDKTWVRYQECDSRSNAPATLTFENMAGVFMLVAGGIVAGIFLIFIEIAYKRHKDARRKQMQLAFAAVNVWRKNLQDRKSGRAEPDPKKKATFRAITSTLASSFKRRRSSKDTSTGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES'),
('Q12879', '5H8Q', 1, 1.9, 'A', 139, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, NMDA 2A', 'GRIN2A', '', 'calcium channel activity<br />\nextracellular-glutamate-gated ion channel activity<br />\nNMDA glutamate receptor activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nzinc ion binding<br />\n', 'chemical synaptic transmission<br />\ndirectional locomotion<br />\ndopamine metabolic process<br />\nglutamate receptor signaling pathway<br />\nlearning or memory<br />\nlong-term synaptic potentiation<br />\nMAPK cascade<br />\nmemory<br />\nnegative regulation of protein catabolic process<br />\nneurogenesis<br />\npositive regulation of apoptotic process<br />\npositive regulation of long-term synaptic potentiation<br />\nprotein localization<br />\nregulation of sensory perception of pain<br />\nresponse to amphetamine<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to wounding<br />\nsensory perception of pain<br />\nserotonin metabolic process<br />\nsleep<br />\nstartle response<br />\ntransport<br />\nvisual learning<br />\n', 'PF01094.', 'MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQAAGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHTFVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGYREFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLILSEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILTTAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPRLVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVEDIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLVTNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRSNGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVDQVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSLKTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALLQFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHLFYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRSAKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNMNELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDSIRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNHKTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVTLPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPHSETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGNPATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLLEGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIGRCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYSTPRVLNSCSNRRVYKKMPSIESDV'),
('P09455', '5HBS', 1, 0.89, 'A', 134, 'RETINOL-BINDING PROTEIN', 'OTHERS', 'Retinol-binding protein 1', 'RBP1', '', 'retinal binding<br />\nretinoid binding<br />\nretinol binding<br />\ntransporter activity<br />\n', 'retinoic acid biosynthetic process<br />\nretinoid metabolic process<br />\nvitamin A metabolic process<br />\n', 'PF00061.', 'MPVDFTGYWKMLVNENFEEYLRALDVNVALRKIANLLKPDKEIVQDGDHMIIRTLSTFRNYIMDFQVGKEFEEDLTGIDDRKCMTTVSWDGDKLQCVQKGEKEGRGWTQWIEGDELHLEMRVEGVVCKQVFKKVQ'),
('P59768', '5HE0', 1, 2.56, 'G', 71, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2', 'GNG2', '', 'G-protein beta-subunit binding<br />\nsignal transducer activity<br />\n', 'adenylate cyclase-activating dopamine receptor signaling pathway<br />\ncell proliferation<br />\ncellular response to catecholamine stimulus<br />\ncellular response to glucagon stimulus<br />\ncellular response to prostaglandin E stimulus<br />\nplatelet activation<br />\nprotein folding<br />\nWnt signaling pathway, calcium modulating pathway<br />\n', 'PF00631.', 'MASNNTASIAQARKLVEQLKMEANIDRIKVSKAAADLMAYCEAHAKEDPLLTPVPASENPFREKKFFCAIL'),
('P00533', '5HG8', 1, 1.42, 'A', 328, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Epidermal growth factor receptor', 'EGFR', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'actin filament binding<br />\nATP binding<br />\ncadherin binding<br />\ncalmodulin binding<br />\nchromatin binding<br />\ndouble-stranded DNA binding<br />\nenzyme binding<br />\nepidermal growth factor-activated receptor activity<br />\nepidermal growth factor binding<br />\nidentical protein binding<br />\nintegrin binding<br />\nMAP kinase kinase kinase activity<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nprotein heterodimerization activity<br />\nprotein kinase binding<br />\nprotein phosphatase binding<br />\nprotein tyrosine kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nsignal transducer, downstream of receptor, with protein tyrosine kinase activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\ntransmembrane signaling receptor activity<br />\nubiquitin protein ligase binding<br />\nvirus receptor activity<br />\n', 'activation of phospholipase A2 activity by calcium-mediated signaling<br />\nactivation of phospholipase C activity<br />\nastrocyte activation<br />\ncell-cell adhesion<br />\ncell proliferation<br />\ncell surface receptor signaling pathway<br />\ncellular response to amino acid stimulus<br />\ncellular response to cadmium ion<br />\ncellular response to dexamethasone stimulus<br />\ncellular response to drug<br />\ncellular response to epidermal growth factor stimulus<br />\ncellular response to estradiol stimulus<br />\ncellular response to mechanical stimulus<br />\ncellular response to reactive oxygen species<br />\ncerebral cortex cell migration<br />\ncircadian rhythm<br />\ndigestive tract morphogenesis<br />\nditerpenoid metabolic process<br />\nembryonic placenta development<br />\nepidermal growth factor receptor signaling pathway<br />\nERBB2 signaling pathway<br />\neyelid development in camera-type eye<br />\nhair follicle development<br />\nhydrogen peroxide metabolic process<br />\ninterleukin-7-mediated signaling pathway<br />\nlearning or memory<br />\nliver regeneration<br />\nlung development<br />\nmagnesium ion homeostasis<br />\nMAPK cascade<br />\nmembrane organization<br />\nmidgut development<br />\nmorphogenesis of an epithelial fold<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of cardiocyte differentiation<br />\nnegative regulation of epidermal growth factor receptor signaling pathway<br />\nnegative regulation of ERBB signaling pathway<br />\nnegative regulation of mitotic cell cycle<br />\nnegative regulation of protein catabolic process<br />\nneuron projection morphogenesis<br />\nossification<br />\novulation cycle<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\npositive regulation of blood vessel diameter<br />\npositive regulation of bone resorption<br />\npositive regulation of catenin import into nucleus<br />\npositive regulation of cell growth<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle<br />\npositive regulation of DNA repair<br />\npositive regulation of DNA replication<br />\npositive regulation of epithelial cell proliferation<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of inflammatory response<br />\npositive regulation of MAP kinase activity<br />\npositive regulation of NIK/NF-kappaB signaling<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of phosphorylation<br />\npositive regulation of production of miRNAs involved in gene silencing by miRNA<br />\npositive regulation of prolactin secretion<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of protein kinase C activity<br />\npositive regulation of protein localization to plasma membrane<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of smooth muscle cell proliferation<br />\npositive regulation of superoxide anion generation<br />\npositive regulation of synaptic transmission, glutamatergic<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of vasoconstriction<br />\nprotein autophosphorylation<br />\nprotein insertion into membrane<br />\nregulation of cell motility<br />\nregulation of ERK1 and ERK2 cascade<br />\nregulation of JNK cascade<br />\nregulation of nitric-oxide synthase activity<br />\nregulation of peptidyl-tyrosine phosphorylation<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nregulation of transcription from RNA polymerase II promoter<br />\nresponse to calcium ion<br />\nresponse to cobalamin<br />\nresponse to hydroxyisoflavone<br />\nresponse to osmotic stress<br />\nresponse to stress<br />\nresponse to UV-A<br />\nsalivary gland morphogenesis<br />\nsignal transduction<br />\ntongue development<br />\ntranslation<br />\nwound healing<br />\n', 'PF00757.', 'MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA'),
('P21549', '5HHY', 1, 1.7, 'A/B', 386, 'TRANSFERASE', 'TRANSFERASE', 'Serine--pyruvate aminotransferase', 'AGXT', 'L-serine + pyruvate = 3-hydroxypyruvate + L-alanine.<br />\nL-alanine + glyoxylate = pyruvate + glycine.<br />\n', 'alanine-glyoxylate transaminase activity<br />\namino acid binding<br />\nidentical protein binding<br />\nprotein homodimerization activity<br />\nprotein self-association<br />\npyridoxal phosphate binding<br />\nreceptor binding<br />\nserine-pyruvate transaminase activity<br />\ntransaminase activity<br />\n', 'cellular nitrogen compound metabolic process<br />\nglycine biosynthetic process, by transamination of glyoxylate<br />\nglyoxylate catabolic process<br />\nglyoxylate metabolic process<br />\nL-alanine catabolic process<br />\nL-cysteine catabolic process<br />\nNotch signaling pathway<br />\noxalic acid secretion<br />\npyruvate biosynthetic process<br />\nresponse to cAMP<br />\nresponse to glucocorticoid<br />\n', 'PF00266.', 'MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEIKEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIGARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLLLVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSFYLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHGRLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLRIGLLGCNATRENVDRVTEALRAALQHCPKKKL'),
('P00492', '5HIA', 1, 1.77, 'A/B/C/D', 218, 'TRANSFERASE', 'TRANSFERASE', 'Hypoxanthine-guanine phosphoribosyltransferase', 'HPRT1', 'IMP + diphosphate = hypoxanthine + 5-phospho-alpha-D-ribose 1-diphosphate.<br />\nGMP + diphosphate = guanine + 5-phospho-alpha-D-ribose 1-diphosphate.<br />\n', 'guanine phosphoribosyltransferase activity<br />\nhypoxanthine phosphoribosyltransferase activity<br />\nidentical protein binding<br />\nmagnesium ion binding<br />\nnucleotide binding<br />\nprotein homodimerization activity<br />\n', 'adenine salvage<br />\ncentral nervous system neuron development<br />\ncerebral cortex neuron differentiation<br />\ncytolysis<br />\ndendrite morphogenesis<br />\ndopamine metabolic process<br />\nGMP catabolic process<br />\ngrooming behavior<br />\nguanine salvage<br />\nhypoxanthine metabolic process<br />\nhypoxanthine salvage<br />\nIMP metabolic process<br />\nIMP salvage<br />\nlocomotory behavior<br />\nlymphocyte proliferation<br />\npositive regulation of dopamine metabolic process<br />\nprotein homotetramerization<br />\npurine-containing compound salvage<br />\npurine nucleotide biosynthetic process<br />\npurine ribonucleoside salvage<br />\nresponse to amphetamine<br />\nstriatum development<br />\n', 'PF00156.', 'MATRSPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA'),
('P28702', '5HJP', 1, 2.6, 'A/C', 235, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Retinoic acid receptor RXR-beta', 'RXRB', '', '9-cis retinoic acid receptor activity<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nRNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding<br />\nsteroid hormone receptor activity<br />\ntranscriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding<br />\ntranscription coactivator activity<br />\ntranscription factor activity, sequence-specific DNA binding<br />\nzinc ion binding<br />\n', 'positive regulation of transcription from RNA polymerase II promoter<br />\ntranscription initiation from RNA polymerase II promoter<br />\n', 'PF00104.', 'MSWAARPPFLPQRHAAGQCGPVGVRKEMHCGVASRWRRRRPWLDPAAAAAAAVAGGEQQTPEPEPGEAGRDGMGDSGRDSRSPDSSSPNPLPQGVPPPSPPGPPLPPSTAPSLGGSGAPPPPPMPPPPLGSPFPVISSSMGSPGLPPPAPPGFSGPVSSPQINSTVSLPGGGSGPPEDVKPPVLGVRGLHCPPPPGGPGAGKRLCAICGDRSSGKHYGVYSCEGCKGFFKRTIRKDLTYSCRDNKDCTVDKRQRNRCQYCRYQKCLATGMKREAVQEERQRGKDKDGDGEGAGGAPEEMPVDRILEAELAVEQKSDQGVEGPGGTGGSGSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMRMDKTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYASLETYCKQKYPEQQGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQLA'),
('Q99720', '5HK1', 1, 2.51, 'A/B/C', 223, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Sigma non-opioid intracellular receptor 1', 'SIGMAR1', '', 'drug binding<br />\nidentical protein binding<br />\nopioid receptor activity<br />\n', 'lipid transport<br />\nnervous system development<br />\nprotein homotrimerization<br />\nregulation of neuron apoptotic process<br />\n', 'PF04622.', 'MQWAVGRRWAWAALLLAVAAVLTQVVWLWLGTQSFVFQREEIAQLARQYAGLDHELAFSRLIVELRRLHPGHVLPDEELQWVFVNAGGWMGAMCLLHASLSEYVLLFGTALGSRGHSGRYWAEISDTIISGTFHQWREGTTKSEVFYPGETVVHGPGEATAVEWGPNTWMVEYGRGVIPSTLAFALADTVFSTQDFLTLFYTLRSYARGLRLELTTYLFGQDP'),
('Q9Y2U5', '5HQ8', 1, 1.72, 'I/J', 15, 'TRANSFERASE', 'TRANSFERASE', 'Mitogen-activated protein kinase kinase kinase 2', 'MAP3K2', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\nMAP kinase kinase kinase activity<br />\nmetal ion binding<br />\nprotein kinase activity<br />\nprotein kinase binding<br />\nprotein serine/threonine kinase activity<br />\n', 'activation of JUN kinase activity<br />\nactivation of MAPK activity<br />\ncellular response to mechanical stimulus<br />\npositive regulation of transcription, DNA-templated<br />\nprotein phosphorylation<br />\nregulation of apoptotic process<br />\nregulation of mitotic cell cycle<br />\n', 'PF00564.', 'MDDQQALNSIMQDLAVLHKASRPALSLQETRKAKSSSPKKQNDVRVKFEHRGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYTNNELVIPLTTQDDLDKAVELLDRSIHMKSLKILLVINGSTQATNLEPLPSLEDLDNTVFGAERKKRLSIIGPTSRDRSSPPPGYIPDELHQVARNGSFTSINSEGEFIPESMDQMLDPLSLSSPENSGSGSCPSLDSPLDGESYPKSRMPRAQSYPDNHQEFSDYDNPIFEKFGKGGTYPRRYHVSYHHQEYNDGRKTFPRARRTQGTSLRSPVSFSPTDHSLSTSSGSSIFTPEYDDSRIRRRGSDIDNPTLTVMDISPPSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGALTENVTRKYTRQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVACTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPKLPPHVSDYTRDFLKRIFVEAKLRPSADELLRHMFVHYH'),
('P00519', '5HU9', 1, 1.53, 'A', 272, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Tyrosine-protein kinase ABL1', 'ABL1', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'actin filament binding<br />\nactin monomer binding<br />\nATP binding<br />\nDNA binding<br />\nephrin receptor binding<br />\nmagnesium ion binding<br />\nmanganese ion binding<br />\nmitogen-activated protein kinase binding<br />\nneuropilin binding<br />\nnicotinate-nucleotide adenylyltransferase activity<br />\nnon-membrane spanning protein tyrosine kinase activity<br />\nphosphotyrosine residue binding<br />\nproline-rich region binding<br />\nprotein C-terminus binding<br />\nprotein kinase activity<br />\nprotein kinase C binding<br />\nprotein tyrosine kinase activity<br />\nreceptor binding<br />\nSH2 domain binding<br />\nSH3 domain binding<br />\nsyntaxin binding<br />\n', 'actin cytoskeleton organization<br />\nactin filament branching<br />\nactivated T cell proliferation<br />\nactivation of protein kinase C activity<br />\nalpha-beta T cell differentiation<br />\nautophagy<br />\nB-1 B cell homeostasis<br />\nB cell proliferation involved in immune response<br />\nB cell receptor signaling pathway<br />\nBergmann glial cell differentiation<br />\ncardiovascular system development<br />\ncell cycle arrest<br />\ncellular protein modification process<br />\ncellular response to DNA damage stimulus<br />\ncellular response to dopamine<br />\ncellular response to hydrogen peroxide<br />\ncellular response to lipopolysaccharide<br />\ncellular response to oxidative stress<br />\ncerebellum morphogenesis<br />\ncollateral sprouting<br />\nDNA damage induced protein phosphorylation<br />\nendothelial cell migration<br />\nepidermal growth factor receptor signaling pathway<br />\nestablishment of protein localization<br />\nFc-gamma receptor signaling pathway involved in phagocytosis<br />\ninnate immune response<br />\nintegrin-mediated signaling pathway<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nmicrospike assembly<br />\nmismatch repair<br />\nmitochondrial depolarization<br />\nmitotic cell cycle<br />\nnegative regulation of BMP signaling pathway<br />\nnegative regulation of cell-cell adhesion<br />\nnegative regulation of cellular senescence<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of ERK1 and ERK2 cascade<br />\nnegative regulation of I-kappaB kinase/NF-kappaB signaling<br />\nnegative regulation of long-term synaptic potentiation<br />\nnegative regulation of mitotic cell cycle<br />\nnegative regulation of phospholipase C activity<br />\nnegative regulation of protein serine/threonine kinase activity<br />\nnegative regulation of ubiquitin-protein transferase activity<br />\nneural tube closure<br />\nneuroepithelial cell differentiation<br />\nneuromuscular process controlling balance<br />\nneuropilin signaling pathway<br />\npeptidyl-tyrosine autophosphorylation<br />\npeptidyl-tyrosine phosphorylation<br />\nplatelet-derived growth factor receptor-beta signaling pathway<br />\npositive regulation blood vessel branching<br />\npositive regulation of actin cytoskeleton reorganization<br />\npositive regulation of actin filament binding<br />\npositive regulation of apoptotic process<br />\npositive regulation of cell migration involved in sprouting angiogenesis<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of endothelial cell migration<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of focal adhesion assembly<br />\npositive regulation of I-kappaB kinase/NF-kappaB signaling<br />\npositive regulation of interferon-gamma secretion<br />\npositive regulation of interleukin-2 secretion<br />\npositive regulation of microtubule binding<br />\npositive regulation of mitotic cell cycle<br />\npositive regulation of muscle cell differentiation<br />\npositive regulation of neuron death<br />\npositive regulation of osteoblast proliferation<br />\npositive regulation of oxidoreductase activity<br />\npositive regulation of peptidyl-tyrosine phosphorylation<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of release of sequestered calcium ion into cytosol<br />\npositive regulation of stress fiber assembly<br />\npositive regulation of substrate adhesion-dependent cell spreading<br />\npositive regulation of Wnt signaling pathway, planar cell polarity pathway<br />\npost-embryonic development<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of actin cytoskeleton organization<br />\nregulation of actin cytoskeleton reorganization<br />\nregulation of autophagy<br />\nregulation of axon extension<br />\nregulation of Cdc42 protein signal transduction<br />\nregulation of cell adhesion<br />\nregulation of cell motility<br />\nregulation of cell proliferation<br />\nregulation of endocytosis<br />\nregulation of extracellular matrix organization<br />\nregulation of hematopoietic stem cell differentiation<br />\nregulation of microtubule polymerization<br />\nregulation of modification of synaptic structure<br />\nregulation of response to DNA damage stimulus<br />\nregulation of transcription, DNA-templated<br />\nresponse to oxidative stress<br />\nsignal transduction in response to DNA damage<br />\nspleen development<br />\nsubstrate adhesion-dependent cell spreading<br />\nthymus development<br />\ntransitional one stage B cell differentiation<br />\n', 'PF08919.', 'MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSASCVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGSALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPPPPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVLPATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR'),
('P49773', '5I2F', 1, 1.25, 'A/B', 126, 'Hydrolase / Hydrolase Inhibitor', 'HYDROLASE', 'Histidine triad nucleotide-binding protein 1', 'HINT1', '', 'hydrolase activity<br />\nnucleotide binding<br />\nprotein kinase C binding<br />\n', 'intrinsic apoptotic signaling pathway by p53 class mediator<br />\npositive regulation of calcium-mediated signaling<br />\npurine ribonucleotide catabolic process<br />\nregulation of transcription, DNA-templated<br />\nsignal transduction<br />\ntranscription, DNA-templated<br />\n', 'PF01230.', 'MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG'),
('Q05586', '5I2N', 1, 2.12, 'B', 151, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, NMDA 1', 'GRIN1', '', 'calcium channel activity<br />\ncalcium ion binding<br />\ncalmodulin binding<br />\nextracellular-glutamate-gated ion channel activity<br />\nglutamate binding<br />\nglycine binding<br />\nneurotransmitter binding<br />\nNMDA glutamate receptor activity<br />\nprotein complex binding<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor binding<br />\ntransmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential<br />\n', 'adult locomotory behavior<br />\ncalcium ion homeostasis<br />\ncation transport<br />\ncerebral cortex development<br />\nconditioned taste aversion<br />\nephrin receptor signaling pathway<br />\nexcitatory postsynaptic potential<br />\nionotropic glutamate receptor signaling pathway<br />\nlong-term memory<br />\nmale mating behavior<br />\nMAPK cascade<br />\nnegative regulation of neuron apoptotic process<br />\nolfactory learning<br />\npons maturation<br />\npositive regulation of apoptotic process<br />\npositive regulation of calcium ion transport into cytosol<br />\npositive regulation of excitatory postsynaptic potential<br />\npositive regulation of reactive oxygen species biosynthetic process<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprepulse inhibition<br />\npropylene metabolic process<br />\nprotein heterotetramerization<br />\nregulation of axonogenesis<br />\nregulation of dendrite morphogenesis<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of membrane potential<br />\nregulation of respiratory gaseous exchange<br />\nregulation of synapse assembly<br />\nrespiratory gaseous exchange<br />\nresponse to amphetamine<br />\nresponse to ethanol<br />\nresponse to morphine<br />\nsensory perception of pain<br />\nsocial behavior<br />\nsuckling behavior<br />\nsynaptic transmission, glutamatergic<br />\nvisual learning<br />\n', 'PF01094.', 'MSTMRLLTLALLFSCSVARAACDPKIVNIGAVLSTRKHEQMFREAVNQANKRHGSWKIQLNATSVTHKPNAIQMALSVCEDLISSQVYAILVSHPPTPNDHFTPTPVSYTAGFYRIPVLGLTTRMSIYSDKSIHLSFLRTVPPYSHQSSVWFEMMRVYSWNHIILLVSDDHEGRAAQKRLETLLEERESKAEKVLQFDPGTKNVTALLMEAKELEARVIILSASEDDAATVYRAAAMLNMTGSGYVWLVGEREISGNALRYAPDGILGLQLINGKNESAHISDAVGVVAQAVHELLEKENITDPPRGCVGNTNIWKTGPLFKRVLMSSKYADGVTGRVEFNEDGDRKFANYSIMNLQNRKLVQVGIYNGTHVIPNDRKIIWPGGETEKPRGYQMSTRLKIVTIHQEPFVYVKPTLSDGTCKEEFTVNGDPVKKVICTGPNDTSPGSPRHTVPQCCYGFCIDLLIKLARTMNFTYEVHLVADGKFGTQERVNNSNKKEWNGMMGELLSGQADMIVAPLTINNERAQYIEFSKPFKYQGLTILVKKEIPRSTLDSFMQPFQSTLWLLVGLSVHVVAVMLYLLDRFSPFGRFKVNSEEEEEDALTLSSAMWFSWGVLLNSGIGEGAPRSFSARILGMVWAGFAMIIVASYTANLAAFLVLDRPEERITGINDPRLRNPSDKFIYATVKQSSVDIYFRRQVELSTMYRHMEKHNYESAAEAIQAVRDNKLHAFIWDSAVLEFEASQKCDLVTTGELFFRSGFGIGMRKDSPWKQNVSLSILKSHENGFMEDLDKTWVRYQECDSRSNAPATLTFENMAGVFMLVAGGIVAGIFLIFIEIAYKRHKDARRKQMQLAFAAVNVWRKNLQDRKSGRAEPDPKKKATFRAITSTLASSFKRRRSSKDTSTGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES'),
('Q12879', '5I2N', 1, 2.12, 'A', 139, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, NMDA 2A', 'GRIN2A', '', 'calcium channel activity<br />\nextracellular-glutamate-gated ion channel activity<br />\nNMDA glutamate receptor activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nzinc ion binding<br />\n', 'chemical synaptic transmission<br />\ndirectional locomotion<br />\ndopamine metabolic process<br />\nglutamate receptor signaling pathway<br />\nlearning or memory<br />\nlong-term synaptic potentiation<br />\nMAPK cascade<br />\nmemory<br />\nnegative regulation of protein catabolic process<br />\nneurogenesis<br />\npositive regulation of apoptotic process<br />\npositive regulation of long-term synaptic potentiation<br />\nprotein localization<br />\nregulation of sensory perception of pain<br />\nresponse to amphetamine<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to wounding<br />\nsensory perception of pain<br />\nserotonin metabolic process<br />\nsleep<br />\nstartle response<br />\ntransport<br />\nvisual learning<br />\n', 'PF01094.', 'MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQAAGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHTFVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGYREFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLILSEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILTTAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPRLVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVEDIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLVTNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRSNGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVDQVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSLKTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALLQFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHLFYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRSAKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNMNELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDSIRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNHKTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVTLPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPHSETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGNPATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLLEGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIGRCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYSTPRVLNSCSNRRVYKKMPSIESDV'),
('P17405', '5I85', 1, 2.5, 'A', 583, 'HYDROLASE', 'HYDROLASE', 'Sphingomyelin phosphodiesterase', 'SMPD1', 'Sphingomyelin + H2O = N-acylsphingosine + phosphocholine<br />\n', 'acid sphingomyelin phosphodiesterase activity<br />\nhydrolase activity, acting on glycosyl bonds<br />\nsphingomyelin phosphodiesterase activity<br />\nzinc ion binding<br />\n', 'ceramide biosynthetic process<br />\nglycosphingolipid metabolic process<br />\nnegative regulation of MAP kinase activity<br />\nnervous system development<br />\npositive regulation of apoptotic process<br />\npositive regulation of protein dephosphorylation<br />\nresponse to cocaine<br />\nresponse to drug<br />\nsignal transduction<br />\nsphingomyelin catabolic process<br />\nsphingomyelin metabolic process<br />\ntermination of signal transduction<br />\n', 'PF00149.', 'MPRYGASLRQSCPRSGREQGQDGTAGAPGLLWMGLVLALALALALALSDSRVLWAPAEAHPLSPQGHPARLHRIVPRLRDVFGWGNLTCPICKGLFTAINLGLKKEPNVARVGSVAIKLCNLLKIAPPAVCQSIVHLFEDDMVEVWRRSVLSPSEACGLLLGSTCGHWDIFSSWNISLPTVPKPPPKPPSPPAPGAPVSRILFLTDLHWDHDYLEGTDPDCADPLCCRRGSGLPPASRPGAGYWGEYSKCDLPLRTLESLLSGLGPAGPFDMVYWTGDIPAHDVWHQTRQDQLRALTTVTALVRKFLGPVPVYPAVGNHESTPVNSFPPPFIEGNHSSRWLYEAMAKAWEPWLPAEALRTLRIGGFYALSPYPGLRLISLNMNFCSRENFWLLINSTDPAGQLQWLVGELQAAEDRGDKVHIIGHIPPGHCLKSWSWNYYRIVARYENTLAAQFFGHTHVDEFEVFYDEETLSRPLAVAFLAPSATTYIGLNPGYRVYQIDGNYSGSSHVVLDHETYILNLTQANIPGAIPHWQLLYRARETYGLPNTLPTAWHNLVYRMRGDMQLFQTFWFLYHKGHPPSEPCGTPCRLATLCAQLSARADSPALCRHLMPDGSLPEAQSLWPRPLFC'),
('P29317', '5I9Y', 1, 1.23, 'A', 305, 'TRANSFERASE', 'TRANSFERASE', 'Ephrin type-A receptor 2', 'EPHA2', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\ncadherin binding<br />\nephrin receptor activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\nvirus receptor activity<br />\n', 'activation of GTPase activity<br />\naxial mesoderm formation<br />\nblood vessel endothelial cell proliferation involved in sprouting angiogenesis<br />\nbone remodeling<br />\nbranching involved in mammary gland duct morphogenesis<br />\ncAMP metabolic process<br />\ncell adhesion<br />\ncell chemotaxis<br />\ncell migration<br />\ncell motility<br />\ndefense response to Gram-positive bacterium<br />\nephrin receptor signaling pathway<br />\ninflammatory response<br />\nintrinsic apoptotic signaling pathway in response to DNA damage<br />\nkeratinocyte differentiation<br />\nlens fiber cell morphogenesis<br />\nmammary gland epithelial cell proliferation<br />\nmulticellular organism development<br />\nnegative regulation of angiogenesis<br />\nnegative regulation of chemokine production<br />\nnegative regulation of lymphangiogenesis<br />\nnegative regulation of protein kinase B signaling<br />\nneural tube development<br />\nneuron differentiation<br />\nnotochord cell development<br />\nnotochord formation<br />\nosteoblast differentiation<br />\nosteoclast differentiation<br />\npericyte cell differentiation<br />\npositive regulation of protein localization to plasma membrane<br />\npost-anal tail morphogenesis<br />\nprotein kinase B signaling<br />\nregulation of angiogenesis<br />\nregulation of blood vessel endothelial cell migration<br />\nregulation of cell adhesion mediated by integrin<br />\nregulation of ERK1 and ERK2 cascade<br />\nregulation of lamellipodium assembly<br />\nresponse to growth factor<br />\nskeletal system development<br />\nvasculogenesis<br />\n', 'PF14575.', 'MELQAARACFALLWGCALAAAAAAQGKEVVLLDFAAAGGELGWLTHPYGKGWDLMQNIMNDMPIYMYSVCNVMSGDQDNWLRTNWVYRGEAERIFIELKFTVRDCNSFPGGASSCKETFNLYYAESDLDYGTNFQKRLFTKIDTIAPDEITVSSDFEARHVKLNVEERSVGPLTRKGFYLAFQDIGACVALLSVRVYYKKCPELLQGLAHFPETIAGSDAPSLATVAGTCVDHAVVPPGGEEPRMHCAVDGEWLVPIGQCLCQAGYEKVEDACQACSPGFFKFEASESPCLECPEHTLPSPEGATSCECEEGFFRAPQDPASMPCTRPPSAPHYLTAVGMGAKVELRWTPPQDSGGREDIVYSVTCEQCWPESGECGPCEASVRYSEPPHGLTRTSVTVSDLEPHMNYTFTVEARNGVSGLVTSRSFRTASVSINQTEPPKVRLEGRSTTSLSVSWSIPPPQQSRVWKYEVTYRKKGDSNSYNVRRTEGFSVTLDDLAPDTTYLVQVQALTQEGQGAGSKVHEFQTLSPEGSGNLAVIGGVAVGVVLLLVLAGVGFFIHRRRKNQRARQSPEDVYFSKSEQLKPLKTYVDPHTYEDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDPRVSIRLPSTSGSEGVPFRTVSEWLESIKMQQYTEHFMAAGYTAIEKVVQMTNDDIKRIGVRLPGHQKRIAYSLLGLKDQVNTVGIPI');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P15056', '5ITA', 1, 1.95, 'A/B', 276, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Serine/threonine-protein kinase B-raf', 'BRAF', 'ATP + a protein = ADP + a phosphoprotein<br />\n', 'ATP binding<br />\ncalcium ion binding<br />\nidentical protein binding<br />\nMAP kinase kinase kinase activity<br />\nmitogen-activated protein kinase kinase binding<br />\nprotein heterodimerization activity<br />\nprotein kinase activity<br />\nprotein serine/threonine kinase activity<br />\n', 'animal organ morphogenesis<br />\nCD4-positive, alpha-beta T cell differentiation<br />\nCD4-positive or CD8-positive, alpha-beta T cell lineage commitment<br />\ncell differentiation<br />\ncellular response to calcium ion<br />\ncellular response to drug<br />\ncellular response to nerve growth factor stimulus<br />\nestablishment of protein localization to membrane<br />\nface development<br />\nglucose transport<br />\nhead morphogenesis<br />\nlong-term synaptic potentiation<br />\nMAPK cascade<br />\nmyeloid progenitor cell differentiation<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of fibroblast migration<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of signal transduction<br />\nnegative regulation of synaptic vesicle exocytosis<br />\npositive regulation of axonogenesis<br />\npositive regulation of axon regeneration<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of gene expression<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of stress fiber assembly<br />\npositive regulation of substrate adhesion-dependent cell spreading<br />\nprotein heterooligomerization<br />\nprotein phosphorylation<br />\nregulation of cell proliferation<br />\nregulation of T cell differentiation<br />\nresponse to cAMP<br />\nresponse to peptide hormone<br />\nsomatic stem cell population maintenance<br />\nT cell receptor signaling pathway<br />\nthymus development<br />\nthyroid gland development<br />\nvisual learning<br />\n', 'PF00130.', 'MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSSASMDTVTSSSSSSLSVLPSSLSVFQNPTDVARSNPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDSLKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPLTTHNFVRKTFFTLAFCDFCRKLLFQGFRCQTCGYKFHQRCSTEVPLMCVNYDQLDLLFVSKFFEHHPIPQEEASLAETALTSGSSPSAPASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQRDRSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSATPPASLPGSLTNVKALQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH'),
('Q96FI4', '5ITQ', 0, 1.48, 'A', 290, 'DNA BINDING PROTEIN / DNA', 'OTHERS', 'Endonuclease 8-like 1', 'NEIL1', 'The C-O-P bond 3'' to the apurinic or apyrimidinic site in DNA is broken by a beta-elimination reaction, leaving a 3''-terminal unsaturated sugar and a product with a terminal 5''-phosphate<br />\n', 'class I DNA-(apurinic or apyrimidinic site) lyase activity<br />\nclass III/IV DNA-(apurinic or apyrimidinic site) lyase activity<br />\ndamaged DNA binding<br />\nDNA-(apurinic or apyrimidinic site) lyase activity<br />\nDNA N-glycosylase activity<br />\nhydrolase activity, acting on glycosyl bonds<br />\nprotein C-terminus binding<br />\nzinc ion binding<br />\n', 'base-excision repair<br />\ndepyrimidination<br />\nnegative regulation of nuclease activity<br />\nnucleotide-excision repair<br />\nresponse to oxidative stress<br />\n', 'PF01149.', 'MPEGPELHLASQFVNEACRALVFGGCVEKSSVSRNPEVPFESSAYRISASARGKELRLILSPLPGAQPQQEPLALVFRFGMSGSFQLVPREELPRHAHLRFYTAPPGPRLALCFVDIRRFGRWDLGGKWQPGRGPCVLQEYQQFRENVLRNLADKAFDRPICEALLDQRFFNGIGNYLRAEILYRLKIPPFEKARSVLEALQQHRPSPELTLSQKIRTKLQNPDLLELCHSVPKEVVQLGGKGYGSESGEEDFAAFRAWLRCYGMPGMSSLQDRHGRTIWFQGDPGPLAPKGRKSRKKKSKATQLSPEDRVEDALPPSKAPSRTRRAKRDLPKRTATQRPEGTSLQQDPEAPTVPKKGRRKGRQAASGHCRPRKVKADIPSLEPEGTSAS'),
('P29274', '5IU4', 1, 1.72, 'A', 207, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Adenosine receptor A2a', 'ADORA2A', '', 'alpha-actinin binding<br />\nenzyme binding<br />\nG-protein coupled adenosine receptor activity<br />\nidentical protein binding<br />\nprotein heterodimerization activity<br />\ntype 5 metabotropic glutamate receptor binding<br />\n', 'adenylate cyclase-modulating G-protein coupled receptor signaling pathway<br />\napoptotic process<br />\nastrocyte activation<br />\nblood circulation<br />\nblood coagulation<br />\ncAMP biosynthetic process<br />\ncell-cell signaling<br />\ncellular defense response<br />\ncellular protein metabolic process<br />\ncentral nervous system development<br />\neating behavior<br />\nexcitatory postsynaptic potential<br />\ninflammatory response<br />\ninhibitory postsynaptic potential<br />\nlocomotory behavior<br />\nmembrane depolarization<br />\nnegative regulation of alpha-beta T cell activation<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\nnegative regulation of inflammatory response<br />\nnegative regulation of locomotion<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of protein kinase activity<br />\nnegative regulation of vascular permeability<br />\nneuron projection morphogenesis<br />\nphagocytosis<br />\npositive regulation of acetylcholine secretion, neurotransmission<br />\npositive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway<br />\npositive regulation of apoptotic signaling pathway<br />\npositive regulation of circadian sleep/wake cycle, sleep<br />\npositive regulation of glutamate secretion<br />\npositive regulation of protein secretion<br />\npositive regulation of renal sodium excretion<br />\npositive regulation of synaptic transmission, GABAergic<br />\npositive regulation of synaptic transmission, glutamatergic<br />\npositive regulation of urine volume<br />\nprepulse inhibition<br />\nprotein kinase C-activating G-protein coupled receptor signaling pathway<br />\nregulation of calcium ion transport<br />\nregulation of mitochondrial membrane potential<br />\nregulation of norepinephrine secretion<br />\nregulation of synaptic plasticity<br />\nregulation of transcription, DNA-templated<br />\nresponse to amphetamine<br />\nresponse to caffeine<br />\nresponse to drug<br />\nsensory perception<br />\nsynaptic transmission, cholinergic<br />\nsynaptic transmission, dopaminergic<br />\nsynaptic transmission, glutamatergic<br />\nvasodilation<br />\n', 'PF00001.', 'MPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS'),
('O43525', '5J03', 0, 2, 'A', 56, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Potassium voltage-gated channel subfamily KQT member 3', 'KCNQ3', '', 'calmodulin binding<br />\nvoltage-gated potassium channel activity<br />\n', 'chemical synaptic transmission<br />\nmembrane hyperpolarization<br />\npotassium ion transmembrane transport<br />\n', 'PF00520.', 'MGLKARRAAGAAGGGGDGGGGGGGAANPAGGDAAAAGDEERKVGLAPGDVEQVTLALGAGADKDGTLLLEGGGRDEGQRRTPQGIGLLAKTPLSRPVKRNNAKYRRIQTLIYDALERPRGWALLYHALVFLIVLGCLILAVLTTFKEYETVSGDWLLLLETFAIFIFGAEFALRIWAAGCCCRYKGWRGRLKFARKPLCMLDIFVLIASVPVVAVGNQGNVLATSLRSLRFLQILRMLRMDRRGGTWKLLGSAICAHSKELITAWYIGFLTLILSSFLVYLVEKDVPEVDAQGEEMKEEFETYADALWWGLITLATIGYGDKTPKTWEGRLIAATFSLIGVSFFALPAGILGSGLALKVQEQHRQKHFEKRRKPAAELIQAAWRYYATNPNRIDLVATWRFYESVVSFPFFRKEQLEAASSQKLGLLDRVRLSNPRGSNTKGKLFTPLNVDAIEESPSKEPKPVGLNNKERFRTAFRMKAYAFWQSSEDAGTGDPMAEDRGYGNDFPIEDMIPTLKAAIRAVRILQFRLYKKKFKETLRPYDVKDVIEQYSAGHLDMLSRIKYLQTRIDMIFTPGPPSTPKHKKSQKGSAFTFPSQQSPRNEPYVARPSTSEIEDQSMMGKFVKVERQVQDMGKKLDFLVDMHMQHMERLQVQVTEYYPTKGTSSPAEAEKKEDNRYSDLKTIICNYSETGPPEPPYSFHQVTIDKVSPYGFFAHDPVNLPRGGPSSGKVQATPPSSATTYVERPTVLPILTLLDSRVSCHSQADLQGPYSDRISPRQRRSITRDSDTPLSLMSVNHEELERSPSGFSISQDRDDYVFGPNGGSSWMREKRYLAEGETDTDTDPFTPSGSMPLSSTGDGISDSVWTPSNKPI'),
('O43526', '5J03', 0, 2, 'A', 28, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Potassium voltage-gated channel subfamily KQT member 2', 'KCNQ2', '', 'ankyrin binding<br />\ncalmodulin binding<br />\nvoltage-gated potassium channel activity<br />\n', 'chemical synaptic transmission<br />\nnervous system development<br />\npotassium ion transmembrane transport<br />\n', 'PF00520.', 'MVQKSRNGGVYPGPSGEKKLKVGFVGLDPGAPDSTRDGALLIAGSEAPKRGSILSKPRAGGAGAGKPPKRNAFYRKLQNFLYNVLERPRGWAFIYHAYVFLLVFSCLVLSVFSTIKEYEKSSEGALYILEIVTIVVFGVEYFVRIWAAGCCCRYRGWRGRLKFARKPFCVIDIMVLIASIAVLAAGSQGNVFATSALRSLRFLQILRMIRMDRRGGTWKLLGSVVYAHSKELVTAWYIGFLCLILASFLVYLAEKGENDHFDTYADALWWGLITLTTIGYGDKYPQTWNGRLLAATFTLIGVSFFALPAGILGSGFALKVQEQHRQKHFEKRRNPAAGLIQSAWRFYATNLSRTDLHSTWQYYERTVTVPMYSSQTQTYGASRLIPPLNQLELLRNLKSKSGLAFRKDPPPEPSPSKGSPCRGPLCGCCPGRSSQKVSLKDRVFSSPRGVAAKGKGSPQAQTVRRSPSADQSLEDSPSKVPKSWSFGDRSRARQAFRIKGAASRQNSEEASLPGEDIVDDKSCPCEFVTEDLTPGLKVSIRAVCVMRFLVSKRKFKESLRPYDVMDVIEQYSAGHLDMLSRIKSLQSRVDQIVGRGPAITDKDRTKGPAEAELPEDPSMMGRLGKVEKQVLSMEKKLDFLVNIYMQRMGIPPTETEAYFGAKEPEPAPPYHSPEDSREHVDRHGCIVKIVRSSSSTGQKNFSAPPAAPPVQCPPSTSWQPQSHPRQGHGTSPVGDHGSLVRIPPPPAHERSLSAYGGGNRASMEFLRQEDTPGCRPPEGNLRDSDTSISIPSVDHEELERSFSGFSISQSKENLDALNSCYAAVAPCAKVRPYIAEGESDTDSDLCTPCGPPPRSATGEGPFGDVGWAGPRK'),
('P09211', '5J41', 1, 1.19, 'A/B', 209, 'transferase / transferase inhibitor', 'TRANSFERASE', 'Glutathione S-transferase P', 'GSTP1', 'RX + glutathione = HX + R-S-glutathione<br />\n', 'dinitrosyl-iron complex binding<br />\ndrug binding<br />\nglutathione binding<br />\nglutathione peroxidase activity<br />\nglutathione transferase activity<br />\nJUN kinase binding<br />\nkinase regulator activity<br />\nnitric oxide binding<br />\nS-nitrosoglutathione binding<br />\n', 'animal organ regeneration<br />\ncellular response to cell-matrix adhesion<br />\ncellular response to epidermal growth factor stimulus<br />\ncellular response to glucocorticoid stimulus<br />\ncellular response to insulin stimulus<br />\ncellular response to lipopolysaccharide<br />\ncellular response to oxidative stress<br />\ncentral nervous system development<br />\ncommon myeloid progenitor cell proliferation<br />\nglutathione derivative biosynthetic process<br />\nglutathione metabolic process<br />\nlinoleic acid metabolic process<br />\nnegative regulation of acute inflammatory response<br />\nnegative regulation of apoptotic process<br />\nnegative regulation of biosynthetic process<br />\nnegative regulation of ERK1 and ERK2 cascade<br />\nnegative regulation of extrinsic apoptotic signaling pathway<br />\nnegative regulation of fibroblast proliferation<br />\nnegative regulation of I-kappaB kinase/NF-kappaB signaling<br />\nnegative regulation of interleukin-1 beta production<br />\nnegative regulation of JUN kinase activity<br />\nnegative regulation of leukocyte proliferation<br />\nnegative regulation of MAPK cascade<br />\nnegative regulation of MAP kinase activity<br />\nnegative regulation of monocyte chemotactic protein-1 production<br />\nnegative regulation of nitric-oxide synthase biosynthetic process<br />\nnegative regulation of protein kinase activity<br />\nnegative regulation of smooth muscle cell chemotaxis<br />\nnegative regulation of stress-activated MAPK cascade<br />\nnegative regulation of tumor necrosis factor-mediated signaling pathway<br />\nnegative regulation of tumor necrosis factor production<br />\nnegative regulation of vascular smooth muscle cell proliferation<br />\nneutrophil degranulation<br />\nnitric oxide storage<br />\noligodendrocyte development<br />\npositive regulation of superoxide anion generation<br />\nregulation of ERK1 and ERK2 cascade<br />\nregulation of stress-activated MAPK cascade<br />\nresponse to amino acid<br />\nresponse to estradiol<br />\nresponse to ethanol<br />\nresponse to L-ascorbic acid<br />\nresponse to reactive oxygen species<br />\nxenobiotic metabolic process<br />\n', 'PF14497.', 'MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ'),
('P00720', '5JDT', 1, 1, 'A', 164, 'HYDROLASE', 'HYDROLASE', 'Endolysin', 'E', 'Hydrolysis of (1->4)-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrins<br />\n', 'lysozyme activity<br />\n', 'cell wall macromolecule catabolic process<br />\ncytolysis<br />\ndefense response to bacterium<br />\npeptidoglycan catabolic process<br />\nviral release from host cell<br />\n', 'PF00959.', 'MNIFEMLRIDERLRLKIYKDTEGYYTIGIGHLLTKSPSLNAAKSELDKAIGRNCNGVITKDEAEKLFNQDVDAAVRGILRNAKLKPVYDSLDAVRRCALINMVFQMGETGVAGFTNSLRMLQQKRWDEAAVNLAKSIWYNQTPNRAKRVITTFRTGTWDAYKNL'),
('P50859', '5JLC', 1, 2.4, 'A', 514, 'OXIDOREDUCTASE / OXIDOREDUCATSE INHIBITOR', 'OXIDOREDUCTASE', 'Lanosterol 14-alpha demethylase', 'ERG11', 'A 14-alpha-methylsteroid + 3 O2 + 3 NADPH = a Delta(14)-steroid + formate + 3 NADP+ + 4 H2O.<br />\n', 'drug binding<br />\nheme binding<br />\niron ion binding<br />\nsterol 14-demethylase activity<br />\n', 'ergosterol biosynthetic process<br />\n', 'PF00067.', 'MSTENTSLVVELLEYVKLGLSYFQALPLAQRVSIMVALPFVYTITWQLLYSLRKDRPPLVFYWIPWVGSAIPYGTKPYEFFEDCQKKYGDIFSFMLLGRIMTVYLGPKGHEFIFNAKLADVSAEAAYSHLTTPVFGKGVIYDCPNHRLMEQKKFVKGALTKEAFVRYVPLIAEEIYKYFRNSKNFKINENNSGIVDVMVSQPEMTIFTASRSLLGKEMRDKLDTDFAYLYSDLDKGFTPINFVFPNLPLEHYRKRDHAQQAISGTYMSLIKERREKNDIQNRDLIDELMKNSTYKDGTKMTDQEIANLLIGVLMGGQHTSAATSAWCLLHLAERPDVQEELYQEQMRVLNNDTKELTYDDLQNMPLLNQMIKETLRLHHPLHSLFRKVMRDVAIPNTSYVVPRDYHVLVSPGYTHLQEEFFPKPNEFNIHRWDGDAASSSAAGGDEVDYGFGAISKGVSSPYLPFGGGRHRCIGELFAYCQLGVLMSIFIRTMKWRYPTEGETVPPSDFTSMVTLPTAPAKIYWEKRHPEQKY'),
('P16234', '5K5X', 0, 2.17, 'A', 424, 'TRANSFERASE', 'TRANSFERASE', 'Platelet-derived growth factor receptor alpha', 'PDGFRA', 'ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate<br />\n', 'ATP binding<br />\nphosphatidylinositol-4,5-bisphosphate 3-kinase activity<br />\nplatelet-derived growth factor alpha-receptor activity<br />\nplatelet-derived growth factor binding<br />\nplatelet-derived growth factor receptor binding<br />\nprotein complex binding<br />\nprotein homodimerization activity<br />\nprotein kinase activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\ntransmembrane receptor protein tyrosine kinase activity<br />\nvascular endothelial growth factor-activated receptor activity<br />\nvascular endothelial growth factor binding<br />\n', 'adrenal gland development<br />\ncardiac myofibril assembly<br />\ncell activation<br />\ncell chemotaxis<br />\ncellular response to amino acid stimulus<br />\ncellular response to reactive oxygen species<br />\nembryonic cranial skeleton morphogenesis<br />\nembryonic digestive tract morphogenesis<br />\nembryonic skeletal system morphogenesis<br />\nestrogen metabolic process<br />\nextracellular matrix organization<br />\nface morphogenesis<br />\nhematopoietic progenitor cell differentiation<br />\ninterleukin-7-mediated signaling pathway<br />\nin utero embryonic development<br />\nLeydig cell differentiation<br />\nlung development<br />\nluteinization<br />\nmale genitalia development<br />\nMAPK cascade<br />\nmetanephric glomerular capillary formation<br />\nnegative regulation of platelet activation<br />\nnegative regulation of platelet-derived growth factor receptor-beta signaling pathway<br />\nodontogenesis of dentin-containing tooth<br />\npalate development<br />\npeptidyl-tyrosine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\nplatelet aggregation<br />\nplatelet-derived growth factor receptor-alpha signaling pathway<br />\nplatelet-derived growth factor receptor signaling pathway<br />\npositive regulation of cell migration<br />\npositive regulation of cell proliferation<br />\npositive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of DNA replication<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of phosphatidylinositol 3-kinase activity<br />\npositive regulation of phosphatidylinositol 3-kinase signaling<br />\npositive regulation of phospholipase C activity<br />\nprotein autophosphorylation<br />\nregulation of actin cytoskeleton reorganization<br />\nregulation of chemotaxis<br />\nregulation of mesenchymal stem cell differentiation<br />\nregulation of phosphatidylinositol 3-kinase signaling<br />\nretina vasculature development in camera-type eye<br />\nsignal transduction involved in regulation of gene expression<br />\nviral process<br />\nwound healing<br />\n', 'PF07679.', 'MGTSHPAFLVLGCLLTGLSLILCQLSLPSILPNENEKVVQLNSSFSLRCFGESEVSWQYPMSEEESSDVEIRNEENNSGLFVTVLEVSSASAAHTGLYTCYYNHTQTEENELEGRHIYIYVPDPDVAFVPLGMTDYLVIVEDDDSAIIPCRTTDPETPVTLHNSEGVVPASYDSRQGFNGTFTVGPYICEATVKGKKFQTIPFNVYALKATSELDLEMEALKTVYKSGETIVVTCAVFNNEVVDLQWTYPGEVKGKGITMLEEIKVPSIKLVYTLTVPEATVKDSGDYECAARQATREVKEMKKVTISVHEKGFIEIKPTFSQLEAVNLHEVKHFVVEVRAYPPPRISWLKNNLTLIENLTEITTDVEKIQEIRYRSKLKLIRAKEEDSGHYTIVAQNEDAVKSYTFELLTQVPSSILDLVDDHHGSTGGQTVRCTAEGTPLPDIEWMICKDIKKCNNETSWTILANNVSNIITEIHSRDRSTVEGRVTFAKVEETIAVRCLAKNLLGAENRELKLVAPTLRSELTVAAAVLVLLVIVIISLIVLVVIWKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHHPEKPKKELDIFGLNPADESTRSYVILSFENNGDYMDMKQADTTQYVPMLERKEVSKYSDIQRSLYDRPASYKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSDHPAVARMRVDSDNAYIGVTYKNEEDKLKDWEGGLDEQRLSADSGYIIPLPDIDPVPEEEDLGKRNRHSSQTSEESAIETGSSSSTFIKREDETIEDIDMMDDIGIDSSDLVEDSFL'),
('Q72874', '5KAO', 1, 1.8, 'A/B', 99, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Pol polyprotein', 'pol', NULL, 'aspartic-type endopeptidase activity', NULL, 'PF00077.', 'PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGI\r\nGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF'),
('Q05586', '5KCJ', 1, 2.09, 'B', 151, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, NMDA 1', 'GRIN1', '', 'calcium channel activity<br />\ncalcium ion binding<br />\ncalmodulin binding<br />\nextracellular-glutamate-gated ion channel activity<br />\nglutamate binding<br />\nglycine binding<br />\nneurotransmitter binding<br />\nNMDA glutamate receptor activity<br />\nprotein complex binding<br />\nRas guanyl-nucleotide exchange factor activity<br />\nreceptor binding<br />\ntransmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential<br />\n', 'adult locomotory behavior<br />\ncalcium ion homeostasis<br />\ncation transport<br />\ncerebral cortex development<br />\nconditioned taste aversion<br />\nephrin receptor signaling pathway<br />\nexcitatory postsynaptic potential<br />\nionotropic glutamate receptor signaling pathway<br />\nlong-term memory<br />\nmale mating behavior<br />\nMAPK cascade<br />\nnegative regulation of neuron apoptotic process<br />\nolfactory learning<br />\npons maturation<br />\npositive regulation of apoptotic process<br />\npositive regulation of calcium ion transport into cytosol<br />\npositive regulation of excitatory postsynaptic potential<br />\npositive regulation of reactive oxygen species biosynthetic process<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\nprepulse inhibition<br />\npropylene metabolic process<br />\nprotein heterotetramerization<br />\nregulation of axonogenesis<br />\nregulation of dendrite morphogenesis<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of membrane potential<br />\nregulation of respiratory gaseous exchange<br />\nregulation of synapse assembly<br />\nrespiratory gaseous exchange<br />\nresponse to amphetamine<br />\nresponse to ethanol<br />\nresponse to morphine<br />\nsensory perception of pain<br />\nsocial behavior<br />\nsuckling behavior<br />\nsynaptic transmission, glutamatergic<br />\nvisual learning<br />\n', 'PF01094.', 'MSTMRLLTLALLFSCSVARAACDPKIVNIGAVLSTRKHEQMFREAVNQANKRHGSWKIQLNATSVTHKPNAIQMALSVCEDLISSQVYAILVSHPPTPNDHFTPTPVSYTAGFYRIPVLGLTTRMSIYSDKSIHLSFLRTVPPYSHQSSVWFEMMRVYSWNHIILLVSDDHEGRAAQKRLETLLEERESKAEKVLQFDPGTKNVTALLMEAKELEARVIILSASEDDAATVYRAAAMLNMTGSGYVWLVGEREISGNALRYAPDGILGLQLINGKNESAHISDAVGVVAQAVHELLEKENITDPPRGCVGNTNIWKTGPLFKRVLMSSKYADGVTGRVEFNEDGDRKFANYSIMNLQNRKLVQVGIYNGTHVIPNDRKIIWPGGETEKPRGYQMSTRLKIVTIHQEPFVYVKPTLSDGTCKEEFTVNGDPVKKVICTGPNDTSPGSPRHTVPQCCYGFCIDLLIKLARTMNFTYEVHLVADGKFGTQERVNNSNKKEWNGMMGELLSGQADMIVAPLTINNERAQYIEFSKPFKYQGLTILVKKEIPRSTLDSFMQPFQSTLWLLVGLSVHVVAVMLYLLDRFSPFGRFKVNSEEEEEDALTLSSAMWFSWGVLLNSGIGEGAPRSFSARILGMVWAGFAMIIVASYTANLAAFLVLDRPEERITGINDPRLRNPSDKFIYATVKQSSVDIYFRRQVELSTMYRHMEKHNYESAAEAIQAVRDNKLHAFIWDSAVLEFEASQKCDLVTTGELFFRSGFGIGMRKDSPWKQNVSLSILKSHENGFMEDLDKTWVRYQECDSRSNAPATLTFENMAGVFMLVAGGIVAGIFLIFIEIAYKRHKDARRKQMQLAFAAVNVWRKNLQDRKSGRAEPDPKKKATFRAITSTLASSFKRRRSSKDTSTGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES'),
('Q12879', '5KCJ', 1, 2.09, 'A', 139, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glutamate receptor ionotropic, NMDA 2A', 'GRIN2A', '', 'calcium channel activity<br />\nextracellular-glutamate-gated ion channel activity<br />\nNMDA glutamate receptor activity<br />\nRas guanyl-nucleotide exchange factor activity<br />\nzinc ion binding<br />\n', 'chemical synaptic transmission<br />\ndirectional locomotion<br />\ndopamine metabolic process<br />\nglutamate receptor signaling pathway<br />\nlearning or memory<br />\nlong-term synaptic potentiation<br />\nMAPK cascade<br />\nmemory<br />\nnegative regulation of protein catabolic process<br />\nneurogenesis<br />\npositive regulation of apoptotic process<br />\npositive regulation of long-term synaptic potentiation<br />\nprotein localization<br />\nregulation of sensory perception of pain<br />\nresponse to amphetamine<br />\nresponse to drug<br />\nresponse to ethanol<br />\nresponse to wounding<br />\nsensory perception of pain<br />\nserotonin metabolic process<br />\nsleep<br />\nstartle response<br />\ntransport<br />\nvisual learning<br />\n', 'PF01094.', 'MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQAAGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHTFVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGYREFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLILSEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILTTAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPRLVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVEDIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLVTNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRSNGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVDQVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSLKTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALLQFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHLFYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRSAKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNMNELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDSIRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNHKTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVTLPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPHSETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGNPATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLLEGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIGRCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYSTPRVLNSCSNRRVYKKMPSIESDV'),
('P61889', '5KKA', 1, 1.75, 'A/B', 312, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Malate dehydrogenase', 'mdh', '(S)-malate + NAD+ = oxaloacetate + NADH<br />\n', 'L-malate dehydrogenase activity<br />\nmalate dehydrogenase activity<br />\noxidoreductase activity<br />\n', 'anaerobic respiration<br />\nfermentation<br />\nglycolytic process<br />\nmalate metabolic process<br />\ntricarboxylic acid cycle<br />\n', 'PF02866.', 'MKVAVLGAAGGIGQALALLLKTQLPSGSELSLYDIAPVTPGVAVDLSHIPTAVKIKGFSGEDATPALEGADVVLISAGVARKPGMDRSDLFNVNAGIVKNLVQQVAKTCPKACIGIITNPVNTTVAIAAEVLKKAGVYDKNKLFGVTTLDIIRSNTFVAELKGKQPGEVEVPVIGGHSGVTILPLLSQVPGVSFTEQEVADLTKRIQNAGTEVVEAKAGGGSATLSMGQAAARFGLSLVRALQGEQGVVECAYVEGDGQYARFFSQPLLLGKNGVEERKSIGTLSAFEQNALEGMLDTLKKDIALGEEFVNK'),
('P24666', '5KQL', 1, 1.45, 'A', 158, 'hydrolase / hydrolase inhibitor', 'HYDROLASE', 'Low molecular weight phosphotyrosine protein phosphatase', 'ACP1', 'Protein tyrosine phosphate + H2O = protein tyrosine + phosphate.<br />\nA phosphate monoester + H2O = an alcohol + phosphate.<br />\n', 'acid phosphatase activity<br />\nnon-membrane spanning protein tyrosine phosphatase activity<br />\n', '', 'PF01451.', 'MAEQATKSVLFVCLGNICRSPIAEAVFRKLVTDQNISENWRVDSAATSGYEIGNPPDYRGQSCMKRHGIPMSHVARQITKEDFATFDYILCMDESNLRDLNRKSNQVKTCKAKIELLGSYDPQKQLIIEDPYYGNDSDFETVYQQCVRCCRAFLEKAH'),
('Q00534', '5L2S', 1, 2.27, 'A', 301, 'Transferase / Transferase Inhibitor', 'TRANSFERASE', 'Cyclin-dependent kinase 6', 'CDK6', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', 'ATP binding<br />\ncyclin binding<br />\ncyclin-dependent protein serine/threonine kinase activity<br />\nFBXO family protein binding<br />\n', 'astrocyte development<br />\ncell cycle arrest<br />\ncell dedifferentiation<br />\ncell division<br />\ncellular response to phorbol 13-acetate 12-myristate<br />\ndentate gyrus development<br />\nG1/S transition of mitotic cell cycle<br />\ngeneration of neurons<br />\ngliogenesis<br />\nhematopoietic stem cell differentiation<br />\nlateral ventricle development<br />\nnegative regulation of cell cycle<br />\nnegative regulation of cell differentiation<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of cellular senescence<br />\nnegative regulation of epithelial cell proliferation<br />\nnegative regulation of monocyte differentiation<br />\nnegative regulation of myeloid cell differentiation<br />\nnegative regulation of osteoblast differentiation<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nNotch signaling pathway<br />\npositive regulation of cell-matrix adhesion<br />\npositive regulation of fibroblast proliferation<br />\npositive regulation of gene expression<br />\nprotein phosphorylation<br />\nregulation of cell motility<br />\nregulation of erythrocyte differentiation<br />\nregulation of G2/M transition of mitotic cell cycle<br />\nregulation of gene expression<br />\nregulation of hematopoietic stem cell differentiation<br />\nresponse to virus<br />\nsignal transduction<br />\nT cell differentiation in thymus<br />\ntype B pancreatic cell development<br />\n', 'PF00069.', 'MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSELNTA'),
('P28062', '5L5F', 1, 2.5, 'K/Y', 138, 'HYDROLASE / HYDROLASE INHIBITOR', 'HYDROLASE', 'Proteasome subunit beta type-8', 'PSMB8', 'Cleavage of peptide bonds with very broad specificity.<br />\n', 'threonine-type endopeptidase activity<br />\n', 'anaphase-promoting complex-dependent catabolic process<br />\nantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\nfat cell differentiation<br />\nFc-epsilon receptor signaling pathway<br />\nMAPK cascade<br />\nnegative regulation of canonical Wnt signaling pathway<br />\nnegative regulation of G2/M transition of mitotic cell cycle<br />\nnegative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle<br />\nNIK/NF-kappaB signaling<br />\npositive regulation of canonical Wnt signaling pathway<br />\npositive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition<br />\npost-translational protein modification<br />\nproteasome-mediated ubiquitin-dependent protein catabolic process<br />\nprotein deubiquitination<br />\nprotein polyubiquitination<br />\nregulation of cellular amino acid metabolic process<br />\nregulation of endopeptidase activity<br />\nregulation of hematopoietic stem cell differentiation<br />\nregulation of mRNA stability<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nSCF-dependent proteasomal ubiquitin-dependent protein catabolic process<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nT cell receptor signaling pathway<br />\ntransmembrane transport<br />\ntumor necrosis factor-mediated signaling pathway<br />\ntype I interferon signaling pathway<br />\nviral process<br />\nWnt signaling pathway, planar cell polarity pathway<br />\n', 'PF00227.', 'MALLDVCGAPRGQRPESALPVAGSGRRSDPGHYSFSMRSPELALPRGMQPTEFFQSLGGDGERNVQIEMAHGTTTLAFKFQHGVIAAVDSRASAGSYISALRVNKVIEINPYLLGTMSGCAADCQYWERLLAKECRLYYLRNGERISVSAASKLLSNMMCQYRGMGLSMGSMICGWDKKGPGLYYVDEHGTRLSGNMFSTGSGNTYAYGVMDSGYRPNLSPEEAYDLGRRAIAYATHRDSYSGGVVNMYHMKEDGWVKVESTDVSDLLHQYREANQ'),
('P51161', '5L8I', 1, 1.88, 'A/B/C', 128, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'Gastrotropin', 'FABP6', '', 'bile acid binding<br />\nlipid binding<br />\ntransporter activity<br />\n', 'bile acid and bile salt transport<br />\nlipid metabolic process<br />\nnegative regulation of cell proliferation<br />\ntriglyceride catabolic process<br />\n', '', 'MAFTGKFEMESEKNYDEFMKLLGISSDVIEKARNFKIVTEVQQDGQDFTWSQHYSGGHTMTNKFTVGKESNIQTMGGKTFKATVQMEGGKLVVNFPNYHQTSEIVGDKLVEVSTIGGVTYERVSKRLA'),
('Q16665', '5L9B', 1, 1.95, 'C/D', 19, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Hypoxia-inducible factor 1-alpha', 'HIF1A', '', 'E-box binding<br />\nenzyme binding<br />\nhistone acetyltransferase binding<br />\nhistone deacetylase binding<br />\nHsp90 protein binding<br />\nnuclear hormone receptor binding<br />\np53 binding<br />\nprotein domain specific binding<br />\nprotein heterodimerization activity<br />\nprotein kinase binding<br />\nsequence-specific DNA binding<br />\ntranscriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding<br />\ntranscriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding<br />\ntranscription factor activity, RNA polymerase II distal enhancer sequence-specific binding<br />\ntranscription factor activity, RNA polymerase II transcription factor binding<br />\ntranscription factor activity, sequence-specific DNA binding<br />\ntranscription factor activity, transcription factor binding<br />\ntranscription factor binding<br />\nubiquitin protein ligase binding<br />\n', 'angiogenesis<br />\naxonal transport of mitochondrion<br />\nB-1 B cell homeostasis<br />\ncardiac ventricle morphogenesis<br />\ncartilage development<br />\ncellular iron ion homeostasis<br />\ncellular response to hypoxia<br />\ncellular response to interleukin-1<br />\ncerebral cortex development<br />\ncollagen metabolic process<br />\nconnective tissue replacement involved in inflammatory response wound healing<br />\ndigestive tract morphogenesis<br />\ndopaminergic neuron differentiation<br />\nelastin metabolic process<br />\nembryonic hemopoiesis<br />\nembryonic placenta development<br />\nepithelial cell differentiation involved in mammary gland alveolus development<br />\nepithelial to mesenchymal transition<br />\nglucose homeostasis<br />\nheart looping<br />\nhemoglobin biosynthetic process<br />\nhypoxia-inducible factor-1alpha signaling pathway<br />\nintestinal epithelial cell maturation<br />\niris morphogenesis<br />\nlactate metabolic process<br />\nlactation<br />\nmRNA transcription from RNA polymerase II promoter<br />\nmuscle cell cellular homeostasis<br />\nnegative regulation of bone mineralization<br />\nnegative regulation of growth<br />\nnegative regulation of mesenchymal cell apoptotic process<br />\nnegative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway<br />\nnegative regulation of reactive oxygen species metabolic process<br />\nnegative regulation of thymocyte apoptotic process<br />\nnegative regulation of TOR signaling<br />\nneural crest cell migration<br />\nneural fold elevation formation<br />\noutflow tract morphogenesis<br />\noxygen homeostasis<br />\npositive regulation of angiogenesis<br />\npositive regulation of autophagy of mitochondrion<br />\npositive regulation of chemokine-mediated signaling pathway<br />\npositive regulation of chemokine production<br />\npositive regulation of endothelial cell proliferation<br />\npositive regulation of epithelial cell migration<br />\npositive regulation of erythrocyte differentiation<br />\npositive regulation of gene expression<br />\npositive regulation of glycolytic process<br />\npositive regulation of hormone biosynthetic process<br />\npositive regulation of insulin secretion involved in cellular response to glucose stimulus<br />\npositive regulation of macroautophagy<br />\npositive regulation of neuroblast proliferation<br />\npositive regulation of nitric-oxide synthase activity<br />\npositive regulation of pri-miRNA transcription from RNA polymerase II promoter<br />\npositive regulation of receptor biosynthetic process<br />\npositive regulation of transcription, DNA-templated<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\npositive regulation of vascular endothelial growth factor production<br />\npositive regulation of vascular endothelial growth factor receptor signaling pathway<br />\npost-translational protein modification<br />\nprotein deubiquitination<br />\nprotein ubiquitination<br />\nregulation of aerobic respiration<br />\nregulation of gene expression<br />\nregulation of transcription, DNA-templated<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nregulation of transcription from RNA polymerase II promoter in response to oxidative stress<br />\nregulation of transforming growth factor beta2 production<br />\nresponse to hypoxia<br />\nresponse to iron ion<br />\nresponse to muscle activity<br />\nretina vasculature development in camera-type eye<br />\nsignal transduction<br />\ntranscription from RNA polymerase II promoter<br />\nvascular endothelial growth factor production<br />\nvisual learning<br />\n', 'PF11413.', 'MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNVSSHLDKASVMRLTISYLRVRKLLDAGDLDIEDDMKAQMNCFYLKALDGFVMVLTDDGDMIYISDNVNKYMGLTQFELTGHSVFDFTHPCDHEEMREMLTHRNGLVKKGKEQNTQRSFFLRMKCTLTSRGRTMNIKSATWKVLHCTGHIHVYDTNSNQPQCGYKKPPMTCLVLICEPIPHPSNIEIPLDSKTFLSRHSLDMKFSYCDERITELMGYEPEELLGRSIYEYYHALDSDHLTKTHHDMFTKGQVTTGQYRMLAKRGGYVWVETQATVIYNTKNSQPQCIVCVNYVVSGIIQHDLIFSLQQTECVLKPVESSDMKMTQLFTKVESEDTSSLFDKLKKEPDALTLLAPAAGDTIISLDFGSNDTETDDQQLEEVPLYNDVMLPSPNEKLQNINLAMSPLPTAETPKPLRSSADPALNQEVALKLEPNPESLELSFTMPQIQDQTPSPSDGSTRQSSPEPNSPSEYCFYVDSDMVNEFKLELVEKLFAEDTEAKNPFSTQDTDLDLEMLAPYIPMDDDFQLRSFDQLSPLESSSASPESASPQSTVTVFQQTQIQEPTANATTTTATTDELKTVTKDRMEDIKILIASPSPTHIHKETTSATSSPYRDTQSRTASPNRAGKGVIEQTEKSHPRSPNVLSVALSQRTTVPEEELNPKILALQNAQRKRKMEHDGSLFQAVGIGTLLQQPDDHAATTSLSWKRVKGCKSSEQNGMEQKTIILIPSDLACRLLGQSMDESGLPQLTSYDCEVNAPIQGSRNLLQGEELLRALDQVN'),
('P20618', '5LF1', 1, 2, 'L/Z', 213, 'HYDROLASE', 'HYDROLASE', 'Proteasome subunit beta type-1', 'PSMB1', 'Cleavage of peptide bonds with very broad specificity<br />\n', 'threonine-type endopeptidase activity<br />\n', 'anaphase-promoting complex-dependent catabolic process<br />\nantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\nFc-epsilon receptor signaling pathway<br />\nMAPK cascade<br />\nnegative regulation of canonical Wnt signaling pathway<br />\nnegative regulation of G2/M transition of mitotic cell cycle<br />\nnegative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle<br />\nneutrophil degranulation<br />\nNIK/NF-kappaB signaling<br />\npositive regulation of canonical Wnt signaling pathway<br />\npositive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition<br />\npost-translational protein modification<br />\nproteasome-mediated ubiquitin-dependent protein catabolic process<br />\nprotein deubiquitination<br />\nprotein polyubiquitination<br />\nregulation of cellular amino acid metabolic process<br />\nregulation of hematopoietic stem cell differentiation<br />\nregulation of mRNA stability<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nSCF-dependent proteasomal ubiquitin-dependent protein catabolic process<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nT cell receptor signaling pathway<br />\ntransmembrane transport<br />\ntumor necrosis factor-mediated signaling pathway<br />\nviral process<br />\nWnt signaling pathway, planar cell polarity pathway<br />\n', 'PF00227.', 'MLSSTAMYSAPGRDLGMEPHRAAGPLQLRFSPYVFNGGTILAIAGEDFAIVASDTRLSEGFSIHTRDSPKCYKLTDKTVIGCSGFHGDCLTLTKIIEARLKMYKHSNNKAMTTGAIAAMLSTILYSRRFFPYYVYNIIGGLDEEGKGAVYSFDPVGSYQRDSFKAGGSASAMLQPLLDNQVGFKNMQNVEHVPLSLDRAMRLVKDVFISAAERDVYTGDALRICIVTKEGIREETVSLRKD'),
('P28074', '5LF4', 1, 1.99, 'K/Y', 204, 'HYDROLASE', 'HYDROLASE', 'Proteasome subunit beta type-5', 'PSMB5', 'Cleavage of peptide bonds with very broad specificity<br />\n', 'peptidase activity<br />\nthreonine-type endopeptidase activity<br />\n', 'anaphase-promoting complex-dependent catabolic process<br />\nantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\nFc-epsilon receptor signaling pathway<br />\nMAPK cascade<br />\nnegative regulation of canonical Wnt signaling pathway<br />\nnegative regulation of G2/M transition of mitotic cell cycle<br />\nnegative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle<br />\nNIK/NF-kappaB signaling<br />\npositive regulation of canonical Wnt signaling pathway<br />\npositive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition<br />\npost-translational protein modification<br />\nproteasome-mediated ubiquitin-dependent protein catabolic process<br />\nprotein deubiquitination<br />\nprotein polyubiquitination<br />\nproteolysis<br />\nregulation of cellular amino acid metabolic process<br />\nregulation of hematopoietic stem cell differentiation<br />\nregulation of mRNA stability<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nresponse to oxidative stress<br />\nSCF-dependent proteasomal ubiquitin-dependent protein catabolic process<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nT cell receptor signaling pathway<br />\ntransmembrane transport<br />\ntumor necrosis factor-mediated signaling pathway<br />\nviral process<br />\nWnt signaling pathway, planar cell polarity pathway<br />\n', 'PF00227.', 'MALASVLERPLPVNQRGFFGLGGRADLLDLGPGSLSDGLSLAAPGWGVPEEPGIEMLHGTTTLAFKFRHGVIVAADSRATAGAYIASQTVKKVIEINPYLLGTMAGGAADCSFWERLLARQCRIYELRNKERISVAAASKLLANMVYQYKGMGLSMGTMICGWDKRGPGLYYVDSEGNRISGATFSVGSGSVYAYGVMDRGYSYDLEVEQAYDLARRAIYQATYRDAYSGGAVNLYHVREDGWIRVSSDNVADLHEKYSGSTP'),
('P49721', '5LF7', 1, 2, 'J/X', 201, 'HYDROLASE', 'HYDROLASE', 'Proteasome subunit beta type-2', 'PSMB2', 'Cleavage of peptide bonds with very broad specificity<br />\n', 'threonine-type endopeptidase activity<br />\n', 'anaphase-promoting complex-dependent catabolic process<br />\nantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent<br />\nFc-epsilon receptor signaling pathway<br />\nMAPK cascade<br />\nnegative regulation of canonical Wnt signaling pathway<br />\nnegative regulation of G2/M transition of mitotic cell cycle<br />\nnegative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle<br />\nNIK/NF-kappaB signaling<br />\npositive regulation of canonical Wnt signaling pathway<br />\npositive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition<br />\npost-translational protein modification<br />\nproteasome-mediated ubiquitin-dependent protein catabolic process<br />\nprotein deubiquitination<br />\nprotein polyubiquitination<br />\nregulation of cellular amino acid metabolic process<br />\nregulation of hematopoietic stem cell differentiation<br />\nregulation of mRNA stability<br />\nregulation of transcription from RNA polymerase II promoter in response to hypoxia<br />\nresponse to organic cyclic compound<br />\nresponse to organonitrogen compound<br />\nSCF-dependent proteasomal ubiquitin-dependent protein catabolic process<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nT cell receptor signaling pathway<br />\ntransmembrane transport<br />\ntumor necrosis factor-mediated signaling pathway<br />\nviral process<br />\nWnt signaling pathway, planar cell polarity pathway<br />\n', 'PF00227.', 'MEYLIGIQGPDYVLVASDRVAASNIVQMKDDHDKMFKMSEKILLLCVGEAGDTVQFAEYIQKNVQLYKMRNGYELSPTAAANFTRRNLADCLRSRTPYHVNLLLAGYDEHEGPALYYMDYLAALAKAPFAAHGYGAFLTLSILDRYYTPTISRERAVELLRKCLEELQKRFILNLPTFSVRIIDKNGIHDLDNISFPKQGS'),
('O15530', '5LVO', 1, 1.09, 'A', 310, 'TRANSFERASE', 'TRANSFERASE', '3-phosphoinositide-dependent protein kinase 1', 'PDPK1', 'ATP + a protein = ADP + a phosphoprotein.<br />\n', '3-phosphoinositide-dependent protein kinase activity<br />\nATP binding<br />\ninsulin receptor binding<br />\nkinase activity<br />\nphospholipase activator activity<br />\nphospholipase binding<br />\nprotein kinase binding<br />\nprotein serine/threonine kinase activity<br />\n', 'actin cytoskeleton organization<br />\nactivation of protein kinase B activity<br />\ncalcium-mediated signaling<br />\ncell migration<br />\ncellular response to brain-derived neurotrophic factor stimulus<br />\ncellular response to epidermal growth factor stimulus<br />\ncellular response to insulin stimulus<br />\nepidermal growth factor receptor signaling pathway<br />\nextrinsic apoptotic signaling pathway<br />\nFc-epsilon receptor signaling pathway<br />\nfocal adhesion assembly<br />\nhyperosmotic response<br />\ninterleukin-7-mediated signaling pathway<br />\nintracellular signal transduction<br />\nnegative regulation of cardiac muscle cell apoptotic process<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of protein kinase activity<br />\nnegative regulation of toll-like receptor signaling pathway<br />\nnegative regulation of transforming growth factor beta receptor signaling pathway<br />\npeptidyl-serine phosphorylation<br />\npeptidyl-threonine phosphorylation<br />\nphosphatidylinositol-mediated signaling<br />\nplatelet activation<br />\npositive regulation of phospholipase activity<br />\npositive regulation of protein localization to plasma membrane<br />\npositive regulation of release of sequestered calcium ion into cytosol<br />\nprotein autophosphorylation<br />\nprotein phosphorylation<br />\nregulation of endothelial cell migration<br />\nregulation of I-kappaB kinase/NF-kappaB signaling<br />\nregulation of mast cell degranulation<br />\nregulation of transcription, DNA-templated<br />\nstimulatory C-type lectin receptor signaling pathway<br />\nT cell costimulation<br />\nT cell receptor signaling pathway<br />\ntranscription, DNA-templated<br />\ntype B pancreatic cell development<br />\n', 'PF14593.', 'MARTTSQLYDAVPIQSSVVLCSCPSPSMVRTQTESSTPPGIPGGSRQGPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDEDCYGNYDNLLSQFGCMQVSSSSSSHSLSASDTGLPQRSGSNIEQYIHDLDSNSFELDLQFSEDEKRLLLEKQAGGNPWHQFVENNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEVWRQRYQSHPDAAVQ'),
('O14746', '5MER', 1, 1.88, 'C/F', 7, 'IMMUNE SYSTEM', 'IMMUNE_SYS_PROT', 'Telomerase reverse transcriptase', 'TERT', 'Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1)<br />\n', 'chaperone binding<br />\nDNA binding<br />\nidentical protein binding<br />\nmetal ion binding<br />\nnucleotidyltransferase activity<br />\nprotein C-terminus binding<br />\nprotein homodimerization activity<br />\nprotein N-terminus binding<br />\nRNA binding<br />\nRNA-directed DNA polymerase activity<br />\ntelomerase activity<br />\ntelomerase RNA binding<br />\ntelomerase RNA reverse transcriptase activity<br />\ntelomeric DNA binding<br />\ntranscription coactivator binding<br />\ntRNA binding<br />\n', 'beta-catenin-TCF complex assembly<br />\ncellular response to hypoxia<br />\nDNA biosynthetic process<br />\nDNA strand elongation<br />\nestablishment of protein localization to telomere<br />\nmitochondrion organization<br />\nnegative regulation of cellular senescence<br />\nnegative regulation of endothelial cell apoptotic process<br />\nnegative regulation of extrinsic apoptotic signaling pathway in absence of ligand<br />\nnegative regulation of gene expression<br />\nnegative regulation of glial cell proliferation<br />\nnegative regulation of neuron apoptotic process<br />\nnegative regulation of production of siRNA involved in RNA interference<br />\npositive regulation of angiogenesis<br />\npositive regulation of G1/S transition of mitotic cell cycle<br />\npositive regulation of glucose import<br />\npositive regulation of hair cycle<br />\npositive regulation of nitric-oxide synthase activity<br />\npositive regulation of pri-miRNA transcription from RNA polymerase II promoter<br />\npositive regulation of protein binding<br />\npositive regulation of protein localization to nucleolus<br />\npositive regulation of stem cell proliferation<br />\npositive regulation of transdifferentiation<br />\npositive regulation of vascular associated smooth muscle cell migration<br />\npositive regulation of vascular smooth muscle cell proliferation<br />\npositive regulation of Wnt signaling pathway<br />\nproduction of siRNA involved in RNA interference<br />\nregulation of protein stability<br />\nreplicative senescence<br />\nresponse to cadmium ion<br />\nRNA biosynthetic process<br />\nRNA-dependent DNA biosynthetic process<br />\ntelomere maintenance<br />\ntelomere maintenance via telomerase<br />\ntranscription, RNA-templated<br />\n', 'PF00078.', 'MPRAPRCRAVRSLLRSHYREVLPLATFVRRLGPQGWRLVQRGDPAAFRALVAQCLVCVPWDARPPPAAPSFRQVSCLKELVARVLQRLCERGAKNVLAFGFALLDGARGGPPEAFTTSVRSYLPNTVTDALRGSGAWGLLLRRVGDDVLVHLLARCALFVLVAPSCAYQVCGPPLYQLGAATQARPPPHASGPRRRLGCERAWNHSVREAGVPLGLPAPGARRRGGSASRSLPLPKRPRRGAAPEPERTPVGQGSWAHPGRTRGPSDRGFCVVSPARPAEEATSLEGALSGTRHSHPSVGRQHHAGPPSTSRPPRPWDTPCPPVYAETKHFLYSSGDKEQLRPSFLLSSLRPSLTGARRLVETIFLGSRPWMPGTPRRLPRLPQRYWQMRPLFLELLGNHAQCPYGVLLKTHCPLRAAVTPAAGVCAREKPQGSVAAPEEEDTDPRRLVQLLRQHSSPWQVYGFVRACLRRLVPPGLWGSRHNERRFLRNTKKFISLGKHAKLSLQELTWKMSVRDCAWLRRSPGVGCVPAAEHRLREEILAKFLHWLMSVYVVELLRSFFYVTETTFQKNRLFFYRKSVWSKLQSIGIRQHLKRVQLRELSEAEVRQHREARPALLTSRLRFIPKPDGLRPIVNMDYVVGARTFRREKRAERLTSRVKALFSVLNYERARRPGLLGASVLGLDDIHRAWRTFVLRVRAQDPPPELYFVKVDVTGAYDTIPQDRLTEVIASIIKPQNTYCVRRYAVVQKAAHGHVRKAFKSHVSTLTDLQPYMRQFVAHLQETSPLRDAVVIEQSSSLNEASSGLFDVFLRFMCHHAVRIRGKSYVQCQGIPQGSILSTLLCSLCYGDMENKLFAGIRRDGLLLRLVDDFLLVTPHLTHAKTFLRTLVRGVPEYGCVVNLRKTVVNFPVEDEALGGTAFVQMPAHGLFPWCGLLLDTRTLEVQSDYSSYARTSIRASLTFNRGFKAGRNMRRKLFGVLRLKCHSLFLDLQVNSLQTVCTNIYKILLLQAYRFHACVLQLPFHQQVWKNPTFFLRVISDTASLCYSILKAKNAGMSLGAKGAAGPLPSEAVQWLCHQAFLLKLTRHRVTYVPLLGSLRTAQTQLSRKLPGTTLTALEAAANPALPSDFKTILD'),
('P62937', '5T9Z', 1, 1.4, 'A', 163, 'isomerase / isomerase inhibitor', 'ISOMERASE', 'Peptidyl-prolyl cis-trans isomerase A', 'PPIA', 'Peptidylproline (omega=180) = peptidylproline (omega=0).<br />\n', 'cyclosporin A binding<br />\npeptidyl-prolyl cis-trans isomerase activity<br />\nRNA binding<br />\nunfolded protein binding<br />\nvirion binding<br />\n', 'entry into host cell<br />\nestablishment of integrated proviral latency<br />\nfusion of virus membrane with host plasma membrane<br />\ninterleukin-12-mediated signaling pathway<br />\nleukocyte migration<br />\nlipid particle organization<br />\nneutrophil degranulation<br />\npositive regulation of protein secretion<br />\npositive regulation of viral genome replication<br />\nprotein folding<br />\nprotein peptidyl-prolyl isomerization<br />\nregulation of viral genome replication<br />\nRNA-dependent DNA biosynthetic process<br />\nuncoating of virus<br />\nviral life cycle<br />\nviral release from host cell<br />\nvirion assembly<br />\n', 'PF00160.', 'MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE');
INSERT INTO `targets` (`protID`, `pdbID`, `hasLig`, `resolu`, `chain`, `resiNum`, `classification`, `class`, `prot_name`, `gene_name`, `catalytics`, `mol_func`, `bio_process`, `pfam`, `sequence`) VALUES
('P13995', '5TC4', 1, 1.89, 'A', 315, 'OXIDOREDUCTASE', 'OXIDOREDUCTASE', 'Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial', 'MTHFD2', '5,10-methylenetetrahydrofolate + NAD+ = 5,10-methenyltetrahydrofolate + NADH<br />\n5,10-methenyltetrahydrofolate + H2O = 10-formyltetrahydrofolate.<br />\n', 'magnesium ion binding<br />\nmethenyltetrahydrofolate cyclohydrolase activity<br />\nmethylenetetrahydrofolate dehydrogenase (NAD+) activity<br />\nmethylenetetrahydrofolate dehydrogenase (NADP+) activity<br />\nphosphate ion binding<br />\n', 'folic acid metabolic process<br />\none-carbon metabolic process<br />\ntetrahydrofolate metabolic process<br />\n', 'PF00763.', 'MAATSLMSALAARLLQPAHSCSLRLRPFHLAAVRNEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEEREVLKSKELGVATN'),
('O75311', '5TIN', 1, 2.61, 'A/B/C/D/E', 309, 'TRANSPORT PROTEIN', 'TRANSPORT_PROT', 'Glycine receptor subunit alpha-3', 'GLRA3', '', 'extracellular-glycine-gated chloride channel activity<br />\nglycine binding<br />\nglycine-gated chloride ion channel activity<br />\nmetal ion binding<br />\n', 'chloride transmembrane transport<br />\nion transmembrane transport<br />\nneuropeptide signaling pathway<br />\nprotein homooligomerization<br />\nresponse to amino acid<br />\nsynaptic transmission, glycinergic<br />\n', 'PF02931.', 'MAHVRHFRTLVSGFYFWEAALLLSLVATKETDSARSRSAPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKFTCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRQHKELLRFRRKRKNKTEAFALEKFYRFSDMDDEVRESRFSFTAYGMGPCLQAKDGMTPKGPNHPVQVMPKSPDEMRKVFIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHQQQD'),
('P17752', '5TPG', 1, 1.5, 'A', 299, 'OXIDOREDUCTASE / OXIDOREDUCTASE inhibitor', 'OXIDOREDUCTASE', 'Tryptophan 5-hydroxylase 1', 'TPH1', 'L-tryptophan + tetrahydrobiopterin + O2 = 5-hydroxy-L-tryptophan + 4a-hydroxytetrahydrobiopterin.<br />\n', 'iron ion binding<br />\ntryptophan 5-monooxygenase activity<br />\n', 'aromatic amino acid family metabolic process<br />\nbone remodeling<br />\ncircadian rhythm<br />\nindolalkylamine biosynthetic process<br />\nmammary gland alveolus development<br />\nnegative regulation of ossification<br />\npositive regulation of fat cell differentiation<br />\nresponse to immobilization stress<br />\nserotonin biosynthetic process<br />\n', 'PF00351.', 'MIEDNKENKDHSLERGRASLIFSLKNEVGGLIKALKIFQEKHVNLLHIESRKSKRRNSEFEIFVDCDINREQLNDIFHLLKSHTNVLSVNLPDNFTLKEDGMETVPWFPKKISDLDHCANRVLMYGSELDADHPGFKDNVYRKRRKYFADLAMNYKHGDPIPKVEFTEEEIKTWGTVFQELNKLYPTHACREYLKNLPLLSKYCGYREDNIPQLEDVSNFLKERTGFSIRPVAGYLSPRDFLSGLAFRVFHCTQYVRHSSDPFYTPEPDTCHELLGHVPLLAEPSFAQFSQEIGLASLGASEEAVQKLATCYFFTVEFGLCKQDGQLRVFGAGLLSSISELKHALSGHAKVKPFDPKITCKQECLITTFQDVYFVSESFEDAKEKMREFTKTIKRPFGVKYNPYTRSIQILKDTKSITSAMNELQHDLDVVSDALAKVSRKPSI'),
('P21554', '5U09', 1, 2.6, 'A', 212, 'MEMBRANE PROTEIN', 'MEMBRANE_PROT', 'Cannabinoid receptor 1', 'CNR1', '', 'cannabinoid receptor activity<br />\ndrug binding<br />\n', 'adenylate cyclase-modulating G-protein coupled receptor signaling pathway<br />\naging<br />\naxonal fasciculation<br />\nglucose homeostasis<br />\nG-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger<br />\nmaternal process involved in female pregnancy<br />\nmemory<br />\nnegative regulation of action potential<br />\nnegative regulation of blood pressure<br />\nnegative regulation of dopamine secretion<br />\nnegative regulation of fatty acid beta-oxidation<br />\nnegative regulation of mast cell activation<br />\nnegative regulation of nitric-oxide synthase activity<br />\npositive regulation of acute inflammatory response to antigenic stimulus<br />\npositive regulation of apoptotic process<br />\npositive regulation of blood pressure<br />\npositive regulation of fever generation<br />\npositive regulation of neuron projection development<br />\nregulation of feeding behavior<br />\nregulation of insulin secretion<br />\nregulation of penile erection<br />\nregulation of synaptic transmission, GABAergic<br />\nregulation of synaptic transmission, glutamatergic<br />\nresponse to cocaine<br />\nresponse to ethanol<br />\nresponse to lipopolysaccharide<br />\nresponse to morphine<br />\nresponse to nicotine<br />\nresponse to nutrient<br />\nsensory perception of pain<br />\nspermatogenesis<br />\ntrans-synaptic signaling by endocannabinoid, modulating synaptic transmission<br />\n', 'PF00001.', 'MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVFHRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLMWTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWKAHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLLAIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL'),
('P09874', '5WS1', 1, 1.9, 'A/B', 350, 'TRANSFERASE / TRANSFERASE INHIBITOR', 'TRANSFERASE', 'Poly [ADP-ribose] polymerase 1', 'PARP1', 'NAD+ + (ADP-D-ribosyl)(n)-acceptor = nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor<br />\n', 'DNA binding<br />\nDNA ligase (ATP) activity<br />\nenzyme binding<br />\nestrogen receptor binding<br />\nhistone deacetylase binding<br />\nidentical protein binding<br />\nNAD+ ADP-ribosyltransferase activity<br />\nNAD binding<br />\nprotein ADP-ribosylase activity<br />\nprotein kinase binding<br />\nprotein N-terminus binding<br />\nRNA binding<br />\nRNA polymerase II regulatory region sequence-specific DNA binding<br />\nR-SMAD binding<br />\ntranscriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding<br />\ntranscription factor binding<br />\nzinc ion binding<br />\n', 'apoptotic process<br />\nATP generation from poly-ADP-D-ribose<br />\ncellular response to amyloid-beta<br />\ncellular response to DNA damage stimulus<br />\ncellular response to insulin stimulus<br />\ncellular response to oxidative stress<br />\ncellular response to zinc ion<br />\nDNA damage response, detection of DNA damage<br />\nDNA ligation involved in DNA repair<br />\nDNA repair<br />\ndouble-strand break repair<br />\ndouble-strand break repair via homologous recombination<br />\nglobal genome nucleotide-excision repair<br />\nlagging strand elongation<br />\nmacrophage differentiation<br />\nmitochondrial DNA metabolic process<br />\nmitochondrial DNA repair<br />\nmitochondrion organization<br />\nnegative regulation of ATP biosynthetic process<br />\nnegative regulation of telomere maintenance via telomere lengthening<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nnucleotide-excision repair, DNA damage recognition<br />\nnucleotide-excision repair, DNA duplex unwinding<br />\nnucleotide-excision repair, DNA incision<br />\nnucleotide-excision repair, DNA incision, 3''-to lesion<br />\nnucleotide-excision repair, DNA incision, 5''-to lesion<br />\nnucleotide-excision repair, preincision complex assembly<br />\nnucleotide-excision repair, preincision complex stabilization<br />\npeptidyl-serine ADP-ribosylation<br />\npositive regulation of cardiac muscle hypertrophy<br />\npositive regulation of intracellular estrogen receptor signaling pathway<br />\npositive regulation of mitochondrial depolarization<br />\npositive regulation of myofibroblast differentiation<br />\npositive regulation of neuron death<br />\npositive regulation of SMAD protein import into nucleus<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npositive regulation of transcription regulatory region DNA binding<br />\nprotein ADP-ribosylation<br />\nprotein autoprocessing<br />\nprotein modification process<br />\nprotein poly-ADP-ribosylation<br />\nregulation of catalytic activity<br />\nregulation of cellular protein localization<br />\nregulation of DNA methylation<br />\nregulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway<br />\nregulation of SMAD protein complex assembly<br />\nresponse to aldosterone<br />\nresponse to gamma radiation<br />\nsignal transduction involved in regulation of gene expression<br />\ntelomere maintenance<br />\ntranscription from RNA polymerase II promoter<br />\ntransforming growth factor beta receptor signaling pathway<br />\n', 'PF00533.', 'MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKGQDGIGSKAEKTLGDFAAEYAKSNRSTCKGCMEKIEKGQVRLSKKMVDPEKPQLGMIDRWYHPGCFVKNREELGFRPEYSASQLKGFSLLATEDKEALKKQLPGVKSEGKRKGDEVDGVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVAATPPPSTASAPAAVNSSASADKPLSNMKILTLGKLSRNKDEVKAMIEKLGGKLTGTANKASLCISTKKEVEKMNKKMEEVKEANIRVVSEDFLQDVSASTKSLQELFLAHILSPWGAEVKAEPVEVVAPRGKSGAALSKKSKGQVKEEGINKSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLW'),
('P50440', '7JDW', 1, 2.37, 'A', 386, 'TRANSFERASE', 'TRANSFERASE', 'Glycine amidinotransferase, mitochondrial', 'GATM', 'L-arginine + glycine = L-ornithine + guanidinoacetate<br />\n', 'glycine amidinotransferase activity<br />\n', 'creatine biosynthetic process<br />\ncreatine metabolic process<br />\nlearning or memory<br />\nmulticellular organism development<br />\nmuscle atrophy<br />\n', '', 'MLRVRCLRGGSRGAEAVHYIGSRLGRTLTGWVQRTFQSTQAATASSRNSCAADDKATEPLPKDCPVSSYNEWDPLEEVIVGRAENACVPPFTIEVKANTYEKYWPFYQKQGGHYFPKDHLKKAVAEIEEMCNILKTEGVTVRRPDPIDWSLKYKTPDFESTGLYSAMPRDILIVVGNEIIEAPMAWRSRFFEYRAYRSIIKDYFHRGAKWTTAPKPTMADELYNQDYPIHSVEDRHKLAAQGKFVTTEFEPCFDAADFIRAGRDIFAQRSQVTNYLGIEWMRRHLAPDYRVHIISFKDPNPMHIDATFNIIGPGIVLSNPDRPCHQIDLFKKAGWTIITPPTPIIPDDHPLWMSSKWLSMNVLMLDEKRVMVDANEVPIQKMFEKLGITTIKVNIRNANSLGGGFHCWTCDVRRRGTLQSYLD'),
('P05067', '2FK1', 1, 1.6, 'A', 56, 'METAL BINDING PROTEIN', 'METAL_BINDING', 'Amyloid-beta A4 protein', 'APP', '', 'acetylcholine receptor activator activity<br />\nacetylcholine receptor binding<br />\namylin binding<br />\napolipoprotein binding<br />\nchaperone binding<br />\nchemoattractant activity<br />\nDNA binding<br />\nenzyme binding<br />\nephrin receptor binding<br />\nfrizzled binding<br />\ngrowth factor receptor binding<br />\nheparan sulfate binding<br />\nheparan sulfate proteoglycan binding<br />\nheparin binding<br />\nidentical protein binding<br />\ninsulin receptor binding<br />\nintegrin binding<br />\nlow-density lipoprotein particle receptor binding<br />\npeptidase activator activity<br />\nprotein dimerization activity<br />\nprotein heterodimerization activity<br />\nprotein homodimerization activity<br />\nPTB domain binding<br />\nreceptor activator activity<br />\nreceptor binding<br />\nserine-type endopeptidase inhibitor activity<br />\ntransition metal ion binding<br />\n', 'activation of MAPK activity<br />\nactivation of MAPKKK activity<br />\nadult locomotory behavior<br />\namyloid fibril formation<br />\nantibacterial humoral response<br />\nantifungal humoral response<br />\nantimicrobial humoral immune response mediated by antimicrobial peptide<br />\nassociative learning<br />\nastrocyte activation<br />\nastrocyte activation involved in immune response<br />\naxo-dendritic transport<br />\naxon midline choice point recognition<br />\naxonogenesis<br />\ncalcium-mediated signaling<br />\ncell adhesion<br />\ncellular copper ion homeostasis<br />\ncellular process<br />\ncellular protein metabolic process<br />\ncellular response to amyloid-beta<br />\ncellular response to cAMP<br />\ncellular response to nerve growth factor stimulus<br />\ncellular response to norepinephrine stimulus<br />\ncholesterol metabolic process<br />\ncollateral sprouting in absence of injury<br />\ndefense response to Gram-negative bacterium<br />\ndefense response to Gram-positive bacterium<br />\ndendrite development<br />\nendocytosis<br />\nextracellular matrix organization<br />\nforebrain development<br />\nG-protein coupled receptor signaling pathway<br />\ninnate immune response<br />\nionotropic glutamate receptor signaling pathway<br />\nlearning<br />\nlearning or memory<br />\nlipoprotein metabolic process<br />\nlocomotory behavior<br />\nmating behavior<br />\nmemory<br />\nmicroglia development<br />\nmicroglial cell activation<br />\nmodulation of age-related behavioral decline<br />\nmodulation of excitatory postsynaptic potential<br />\nmRNA polyadenylation<br />\nnegative regulation of adenylate cyclase activity<br />\nnegative regulation of canonical Wnt signaling pathway<br />\nnegative regulation of cell proliferation<br />\nnegative regulation of gene expression<br />\nnegative regulation of long-term synaptic potentiation<br />\nnegative regulation of mitochondrion organization<br />\nnegative regulation of neuron death<br />\nnegative regulation of neuron differentiation<br />\nnegative regulation of protein localization to nucleus<br />\nnegative regulation of transcription from RNA polymerase II promoter<br />\nneuromuscular process controlling balance<br />\nneuron apoptotic process<br />\nneuron projection development<br />\nneuron projection maintenance<br />\nneuron remodeling<br />\nNotch signaling pathway<br />\nplatelet degranulation<br />\npositive regulation of 1-phosphatidylinositol-3-kinase activity<br />\npositive regulation of amyloid-beta formation<br />\npositive regulation of amyloid fibril formation<br />\npositive regulation of apoptotic process<br />\npositive regulation of cAMP metabolic process<br />\npositive regulation of cell activation<br />\npositive regulation of cellular response to thapsigargin<br />\npositive regulation of cellular response to tunicamycin<br />\npositive regulation of cysteine-type endopeptidase activity involved in apoptotic process<br />\npositive regulation of cytosolic calcium ion concentration<br />\npositive regulation of ERK1 and ERK2 cascade<br />\npositive regulation of excitatory postsynaptic potential<br />\npositive regulation of G2/M transition of mitotic cell cycle<br />\npositive regulation of gene expression<br />\npositive regulation of G-protein coupled receptor internalization<br />\npositive regulation of G-protein coupled receptor protein signaling pathway<br />\npositive regulation of JNK cascade<br />\npositive regulation of long-term synaptic potentiation<br />\npositive regulation of MAPK cascade<br />\npositive regulation of membrane protein ectodomain proteolysis<br />\npositive regulation of mitotic cell cycle<br />\npositive regulation of monocyte chemotaxis<br />\npositive regulation of neuron death<br />\npositive regulation of neuron differentiation<br />\npositive regulation of NF-kappaB transcription factor activity<br />\npositive regulation of nitric oxide biosynthetic process<br />\npositive regulation of oxidative stress-induced neuron death<br />\npositive regulation of peptidyl-serine phosphorylation<br />\npositive regulation of peptidyl-threonine phosphorylation<br />\npositive regulation of protein binding<br />\npositive regulation of protein import<br />\npositive regulation of protein kinase A signaling<br />\npositive regulation of protein kinase B signaling<br />\npositive regulation of protein metabolic process<br />\npositive regulation of protein phosphorylation<br />\npositive regulation of protein tyrosine kinase activity<br />\npositive regulation of receptor binding<br />\npositive regulation of response to endoplasmic reticulum stress<br />\npositive regulation of sequence-specific DNA binding transcription factor activity<br />\npositive regulation of superoxide anion generation<br />\npositive regulation of tau-protein kinase activity<br />\npositive regulation of T cell migration<br />\npositive regulation of transcription from RNA polymerase II promoter<br />\npost-translational protein modification<br />\nprotein homooligomerization<br />\nprotein phosphorylation<br />\nprotein tetramerization<br />\nprotein trimerization<br />\nregulation of acetylcholine-gated cation channel activity<br />\nregulation of amyloid fibril formation<br />\nregulation of dendritic spine maintenance<br />\nregulation of epidermal growth factor-activated receptor activity<br />\nregulation of long-term neuronal synaptic plasticity<br />\nregulation of multicellular organism growth<br />\nregulation of NMDA receptor activity<br />\nregulation of response to calcium ion<br />\nregulation of synapse structure or activity<br />\nregulation of toll-like receptor signaling pathway<br />\nregulation of translation<br />\nresponse to lead ion<br />\nresponse to oxidative stress<br />\nresponse to yeast<br />\nsmooth endoplasmic reticulum calcium ion homeostasis<br />\nsuckling behavior<br />\nsynapse organization<br />\nsynaptic growth at neuromuscular junction<br />\ntumor necrosis factor production<br />\nvisual learning<br />\n', 'PF10515.', 'MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPELQITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSEKSTNLHDYGMLLPCGIDKFRGVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEEEADDDEDDEDGDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPCRAMISRWYFDVTEGKCAPFFYGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEAKHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITALQAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQDEVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTETKTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPVDARPAADRGLTTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITLVMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN'),
('Q38825', '2P1Q', 1, 1.91, 'B/C', 607, 'SIGNALING PROTEIN', 'SIGNALING_PROT', 'TRANSPORT INHIBITOR RESPONSE 1 protein', 'IAA7', '', 'DNA binding transcription factor activity', NULL, 'PF02309.', 'MIGQLMNLKATELCLGLPGGAEAVESPAKSAVGSKRGFSETVDLMLNLQSNKEGSVDLKNVSAVPKEKTTLKDPSKPPAKAQVVGWPPVRNYRKNMMTQQKTSSGAEEASSEKAGNFGGGAAGAGLVKVSMDGAPYLRKVDLKMYKSYQDLSDALAKMFSSFTMGNYGAQGMIDFMNESKLMNLLNSSEYVPSYEDKDGDWMLVGDVPWEMFVESCKRLRIMKGSEAVGLAPRAMEKYCKNRS');

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
